#version: 0.2 - Trained by `huggingface/tokenizers`
Ġ a
i n
Ġ t
r e
t i
o n
h e
e n
Ġ c
Ġ o
t e
Ġ p
Ġ in
Ġ s
Ġ m
Ġa n
Ġt he
Ġo f
Ġ w
a l
i s
o r
a ti
a n
r o
e l
a s
i t
Ġ d
Ġan d
e d
e s
e r
en t
i c
Ġ re
l e
a r
Ġ f
a t
Ġ b
Ġ (
in g
ati on
a te
i d
Ġ e
Ġt o
o s
it h
o m
Ġw ith
l y
u l
Ġ h
el l
e m
Ġt h
r a
v e
ent s
Ġ n
e c
Ġ A
ti c
Ġ T
u s
i m
i a
re s
u r
Ġc ell
Ġp ati
Ġ le
Ġp ro
M L
l o
g en
s i
o t
u n
Ġpati ents
Ġ C
ate d
ti on
u k
i g
u t
el o
e t
Ġa c
Ġle uk
te r
e re
Ġf or
c e
i f
a c
Ġe x
Ġa s
Ġleuk em
h o
y elo
Ġ is
s e
an t
as e
Ġm yelo
Ġre s
Ġ l
Ġs t
Ġw as
u c
Ġcell s
r an
si on
o p
ra p
v er
i b
Ġc on
Ġth at
Ġ I
i l
Ġleukem ia
p res
in e
u m
Ġ 1
Ġ M
ĠT he
o c
Ġc om
Ġb e
o l
Ġd e
i v
Ġ im
te d
m ent
it y
p l
Ġ on
ĠA ML
ro m
Ġc h
Ġa l
Ġmyelo id
u d
Ġ g
t s
gen e
a b
u p
u te
Ġw ere
he r
ic al
Ġd is
Ġt re
o d
y s
he m
ran s
u g
Ġb y
Ġo r
Ġ v
ig n
Ġ H
Ġh a
y t
g n
rap y
Ġ P
ti v
) .
i r
Ġac ute
re d
Ġt rans
i es
Ġex pres
an c
Ġc l
f f
ation s
gn os
s t
Ġ B
Ġ r
d uc
Ġin c
Ġa re
Ġtre at
Ġ 2
q u
a in
a m
g e
y p
Ġcom p
if ic
ti ve
a p
r i
or m
Ġa d
) ,
is t
Ġtreat ment
Ġ D
a y
Ġn e
Ġ un
p ec
u b
ĠI n
Ġst ud
lo g
Ġ F
l as
Ġ S
Ġexpres sion
Ġc yt
Ġs ur
or s
ig h
p or
Ġ W
o us
p h
Ġe ff
ĠC D
t h
o w
d er
Ġas s
en ti
Ġs ign
Ġre l
h ib
Ġa t
Ġ k
v iv
lo w
Ġf rom
p ro
Ġm o
i e
Ġsur viv
Ġ us
Ġa p
A ML
y l
Ġm ut
Ġdis e
Ġha ve
Ġth is
N A
Ġw e
on e
ot he
ul ar
0 0
Ġsurviv al
Ġin hib
if f
v el
in ical
Ġ 3
om e
Ġm ar
o log
es s
Ġc o
Ġs ho
Ġd iff
Ġw h
t her
an ce
Ġan ti
p on
ere n
Ġdise ase
Ġ R
re as
ro w
en ce
i z
ar y
Ġe v
Ġre m
oc i
ac t
Ġ N
e ar
Ġ gene
Ġn ot
v ed
Ġcl inical
Ġ 5
Ġa b
ati ve
os t
r on
ly m
d i
te m
Ġdiff eren
Ġan al
Ġthe rapy
Ġeff ec
Ġc hem
Ġsign ific
al ly
u re
m un
Ġre g
Ġres pon
is k
d ing
ed i
Ġ gen
Ġ en
re n
anc er
othe rapy
S C
Ġp er
Ġh as
g es
Ġsho w
Ġh igh
Ġm on
d e
Ġm et
Ġpro gnos
Ġ O
Ġin v
Ġt um
os e
ĠW e
as es
i on
c l
Ġbe en
f ter
r ug
Ġ hem
Ġs e
Ġrel ap
Ġass oci
le c
Ġin t
Ġim mun
i ed
Ġcon t
Ġ G
al l
ic h
Ġinhib it
Ġp re
orm al
Ġsignific ant
el y
i ti
Ġn o
o un
pl ant
Ġres ul
ia gnos
Ġa g
Ġstud y
Ġac tiv
Ġre c
ra c
y ear
Ġs ub
id e
Ġ E
Ġ 4
Ġthe se
Ġd iagnos
o x
C R
Ġa fter
Ġ =
p ho
Ġwh ich
Ġhem at
por t
Ġt ar
ab le
Ġc ancer
g et
Ġd rug
Ġo ut
Ġchem otherapy
ro up
Ġ it
Ġb et
Ġp o
ron ic
Ġm ay
Ġde v
b in
Ġf act
elo p
re l
Ġ lym
Ġ 0
Ġp res
Ġin f
Ġin duc
Ġdev elop
ĠT h
Ġ L
o re
Ġtrans plant
he n
te in
Ġr isk
Ġ id
Ġassoci ated
is sion
t ing
gene tic
D S
h yl
i p
Ġb ut
Ġmo lec
Ġo ver
on g
at ing
Ġmar row
Ġthe rap
re e
Ġmut ations
an d
c y
Ġle vel
ro s
Ġch ronic
Ġanal ys
y n
s ed
Ġp h
in ib
Ġp at
Ġ he
enti f
e ver
en d
Ġo b
yp e
Ġcomp le
ul ation
Ġre ce
a d
Ġrelap se
m s
a ge
l ud
al u
Ġs tem
Ġtum or
Ġid entif
Ġrem ission
ter m
Ġth an
Ġcon s
Ġc ases
Ġrespon se
Ġout c
op o
Ġtar get
s o
ar i
p t
Ġm od
Ġin d
reas ed
di tion
Ġ 6
en si
c tion
e u
Ġcyt o
or y
Ġpro tein
oun d
Ġm al
Ġinc lud
Ġal so
Ġg roup
ĠC ML
ate s
eu tic
Ġ ro
w e
em ia
Ġun der
Ġb one
er s
L L
ug h
Ġs yn
Ġ year
a ys
Ġha d
Ġb lo
as t
Ġresul ts
we en
Ġpati ent
ec h
Ġp ot
os is
Ġc an
Ġres ist
ic ation
Ġmolec ular
ul d
om a
f orm
Ġex p
Ġanalys is
Ġm ic
ow ever
Ġ low
Ġbet ween
ot h
Ġs up
es ti
Ġs ug
Ġsug ges
iz ed
Ġmal ign
Ġp ar
in ase
Ġcom bin
Ġpro m
ow n
in es
L T
oc y
Ġprognos tic
op t
Ġ 7
Ġs uc
Ġlym pho
st r
Ġd ec
at inib
a red
ĠTh is
tiv ely
Ġo ther
Ġtransplant ation
r ib
Ġmo re
Ġs pec
enti al
ie tic
Ġyear s
Ġw ho
Ġd em
Ġhemat opo
Ġb i
os i
if er
rel ated
Ġne w
Ġsignificant ly
ur ren
Ġd at
Ġn ormal
Ġdifferen ti
Ġal l
c t
ar d
duc ed
Ġcyto genetic
Ġap pro
ĠD NA
l ifer
Ġtherap eutic
g res
us ion
ac ter
ul t
b le
Ġgen es
Ġb las
um an
Ġb oth
Ġstud ies
Ġn on
w o
p le
ent ly
3 4
Ġm a
Ġthe ir
Ġf ol
Ġlevel s
Ġshow ed
s er
Ġp l
esti g
or t
Ġk inase
Ġm ul
Ġst r
R NA
T he
Ġmon th
Ġc or
iv ed
Ġinv estig
il ity
Ġm ost
il d
Ġactiv ity
Ġdat a
ar acter
Ġinc reased
Ġmar k
% )
a us
ti m
Ġdiagnos is
Ġh uman
Ġit s
Ġde te
Ġf ound
v en
p end
he d
Ġp red
en c
Ġim pro
Ġro le
r im
Ġch aracter
un ction
iti es
an is
ri al
ab ine
olog ical
Ġmonth s
es t
Ġcomple te
id ence
a il
on d
Ġfol low
Ġev alu
Ġd ur
Ġ 9
Ġm an
a g
Ġac c
Ġ 8
Ġob ser
Ġblo od
Ġch rom
Ġap opt
i te
o ut
on str
pl as
A B
Ġhematopo ietic
ir st
Ġresist ance
Ġdem onstr
ĠH owever
Ġcomp ared
ech anis
c ri
Ġleukem ic
ro l
Ġin ter
hyl ation
o gen
Ġ el
ur ther
Ġal lo
Ġus ed
Ġs am
il l
Ġm edi
ĠM DS
u al
as ed
Ġh ig
Ġf irst
Ġ K
ĠThe se
u e
Ġover all
Ġm echanis
Ġ <
ĠF LT
Ġw ell
Ġa r
Ġtre ated
p tion
Ġinduc tion
t ain
em ent
op las
b las
urren t
Ġprognos is
c h
Ġleuk a
Ġd es
Ġpres ent
Ġ U
om es
Ġ1 0
Ġt wo
Ġeffec t
m on
Ġpro gres
Ġim port
d rom
re qu
Ġus ing
igh t
Ġinclud ing
< /
r ic
Ġtrans cri
y c
Ġf e
Ġsyn drom
Ġinhibit ors
1 1
Ġus e
ys plas
osi tive
o ur
in ed
in ding
Ġw he
Ġfact ors
Ġhig her
Ġ ra
pec tively
Ġsuc h
ic in
Ġpot ential
Ġmalign anc
Ġapopt osis
Ġdevelop ment
n ormal
ot ype
Ġpo or
R A
Ġrem ain
Ġp rim
Ġchrom os
re g
Ġf requ
Ġg row
Ġf unction
Ġoutc ome
Ġs ec
Ġt im
Ġobser ved
Ġfact or
en s
M T
ic ity
s es
0 1
Ġab normal
ie w
Ġv ari
pend ent
h ie
c c
Ġac hie
Ġon e
Ġeffec ts
Ġinv ol
Ġon ly
Ġdifferenti ation
gene ic
i ve
Ġdrug s
SC T
c ell
Ġpred ic
Ġh yp
Ġpro v
a k
uc le
i le
Ġmut ation
o g
l u
u res
a v
C D
Ġre v
ter n
Ġim atinib
ate g
Ġt rial
Ġdur ing
i ted
Ġanti gen
Ġr ate
d ysplas
ar ly
pres sion
Ġag ents
Ġint o
Ġmul ti
Ġad dition
ac h
Ġind ic
Ġdis c
Ġidentif ied
Ġgrow th
m in
Ġa ge
Ġch ild
Ġmod el
Ġ up
Ġleuka emia
t in
lo c
ĠA l
K I
c ent
id ual
tion s
y ros
Ġeff ic
yros ine
Ġpre v
C ML
ocy te
Ġm i
f ore
f ree
b er
Ġdifferen t
as s
l i
ati c
Ġthe re
yp es
Ġno vel
i tion
Ġimport ant
Ġsec ond
ar abine
pl ic
Ġn um
f er
ra f
AB L
h w
ver s
Ġk n
Ġo cc
Ġres pectively
Ġcombin ation
Ġs c
Ġim p
Ġo ur
Ġco uld
Ġl ines
2 1
Ġm e
Ġpro lifer
ot ox
Ġth ose
si ve
ub icin
es is
Ġph ase
Ġde term
de pendent
C T
ac y
SC s
ĠC R
Ġrev iew
j or
Ġ qu
r ation
Ġinhibit or
on al
Ġre por
i ous
y m
r y
pl es
Ġpat hw
ĠB CR
ys tem
Ġmic ro
Ġmyelo dysplas
Ġallo geneic
Ġtim e
at ure
Ġmet hylation
Ġc ar
Ġt yrosine
Ġl ine
Ġcont rol
Ġs el
Ġreg im
Ġa m
Ġne oplas
L A
% ,
Ġma jor
c ess
Ġde f
Ġspec ific
ver y
at h
ti t
Ġl ong
t en
s up
Ġv it
Ġto x
Ġgene tic
Ġsam ples
Ġe p
ul ated
Ġa ut
Ġmalignanc ies
Ġcom mon
+ )
f ul
Ġl i
I T
Ġoutc omes
t ho
Ġs ensi
Ġprim ary
Ġanti b
Ġs im
Ġrece pt
ab l
Ġin te
c ted
Ġex t
it or
is tic
Ġ J
Ġs ystem
s pec
aus e
iz ation
Ġm ain
Ġd on
duc tion
olog ic
tho ugh
Ġch an
Ġmedi an
Ġprogres sion
Ġstr ateg
Ġd el
ve re
ti l
re ase
Ġanal y
1 5
Ġc ol
n e
1 0
Ġs er
Ġmyelodysplas tic
al ity
f ication
ve al
Ġsugges t
Ġre veal
olog y
Ġvit ro
Ġwith out
Ġcon f
tiv ity
ph a
z ed
t rans
Ġp op
om et
Ġad v
u tion
te ro
Ġ V
Ġprolifer ation
at ory
Ġass ess
Ġc urrent
Ġimmun e
blas tic
Ġre ac
( +)
Ġf inding
Ġ1 2
Ġs h
Ġper form
R D
Ġd i
1 3
Ġd ose
1 2
Ġc ase
1 6
pres s
Ġexpres sed
Ġsign al
ĠM D
Ġblas ts
and ard
P M
Ġe arly
ĠH ere
Ġdemonstr ated
Ġre f
C L
Ġgen er
Ġcyt otox
A T
F S
Ġd ays
Ġin iti
M DS
tic al
p o
qu i
or ubicin
a z
S F
Ġrepor ted
Ġocc ur
Ġantib od
y cl
Ġse qu
ĠO ur
Ġ1 9
Ġeffic acy
Ġsel ec
en cy
Ġd a
Ġlym ph
Ġex am
Ġp os
rac t
Ġsyndrom e
Ġco un
ĠA LL
Ġpat ho
anc ed
r isk
ip her
Ġ y
c rib
ff ec
Ġinhib ition
raf t
Ġdiagnos ed
Ġprom o
Ġw hen
ver se
ĠThe re
os ph
Ġrece ived
Ġst andard
Ġmark ers
Ġm in
H D
g ative
d ine
ipher al
Ġnum ber
ro ugh
Ġmechanis ms
i as
ere d
en e
le uk
Ġ .
Ġf urther
Ġinduc ed
Ġp hen
Ġre port
v ing
Ġh ist
Ġcyt arabine
Ġth ree
Ġabnormal ities
Ġtranscri ption
Ġa im
Ġcons id
e x
re at
Ġb ec
Ġ +
he s
Ġfor m
Ġchild ren
Ġtrial s
Ġtherap ies
Ġdes crib
Ġm g
at ures
A C
Ġs ome
Ġreg ul
Ġk ary
ol id
i al
l ine
Ġdete cted
Ġper ipheral
Ġpro f
k e
Ġen h
Ġprev ious
Ġfinding s
Ġdevelop ed
ra m
Ġlow er
2 2
Ġhe tero
Ġe m
a re
Ġpro gen
Ġse ver
3 3
Ġreveal ed
Ġo p
ho d
Ġo l
Ġchromos ome
Ġeffec tive
Ġshow n
Ġre duced
Ġ ran
o tic
Ġcon dition
Ġcon cl
Ġp ost
m edi
er g
ĠT o
enc ing
ge ted
1 7
Ġf ail
Ġv s
si ble
Ġr ates
vers us
Ġrecept or
Ġinvestig ated
Ġ Ġ
ol d
Ġn ucle
p ar
t al
il ar
ing le
u ce
ocy tic
Ġidentif y
Ġmic e
Ġl ar
iv o
5 3
Ġd id
Ġv ivo
om al
Ġblas t
Ġw ill
A LL
Ġinc idence
im al
Ġinf ec
Ġag ain
tain ed
Ġv alu
st an
in t
ĠP h
Ġpres ence
Ġimp act
in duced
Ġra re
Ġp ositive
Ġsever al
IT D
ĠF urther
1 9
cy tic
Ġpar tic
G F
m a
5 6
Ġde ath
Ġcl as
er r
te red
Ġtum ors
Ġmi R
ensi ve
M P
Ġanaly zed
Ġperform ed
Ġactiv ation
op h
ĠA T
Ġap p
1 4
Ġt es
Ġagain st
Ġs ingle
Ġachie ved
it her
is hed
Ġtox icity
Ġ ML
Ġl ess
Ġm or
se qu
Ġrelap sed
Ġgroup s
Ġsim ilar
ar k
Ġinc rease
Ġmet hod
Ġre pres
i ly
Ġ er
ort ality
Ġpop ulation
ract ory
P L
Ġ2 0
is m
c ute
ic i
Ġfe atures
6 0
spec ific
at us
Ġda un
ven tion
Ġsho uld
Ġcor rel
er m
Ġdon or
b ased
ate ly
Ġne ed
Ġcharacter istic
Ġc ri
Ġm ortality
ĠI I
Ġd ue
ĠT KI
ot yp
Ġth rough
Ġclas si
a x
ati ents
Ġl im
Ġs m
Ġst atus
Ġad ult
s ing
Ġkn own
Ġrel ated
Ġc yc
Ġtarget s
Ġprotein s
Ġen d
re ct
p ositive
Ġ1 5
Ġremain s
oc yt
Ġexp er
Ġab err
y d
Ġrespon ses
Ġa ffec
pro lifer
Ġa v
Ġ [
ate r
Ġre le
Ġpo lym
e p
i qu
O S
E T
Ġcont rib
Ġb ased
j ec
Ġcomp ar
i genetic
00 1
Ġwith in
P A
res ist
ĠA s
Ġwh ile
ran ul
Ġstud ied
en ted
Ġd own
ation al
s et
Ġprov ide
Ġcomple x
Ġd o
Ġpro p
em ic
Ġrec o
Ġlympho blastic
Ġchan ges
ĠH LA
ac k
c in
ab ility
Ġevalu ated
ĠN PM
m ac
Ġm RNA
Ġm y
Ġev idence
Ġcharacter ized
Ġhetero gene
ĠC I
Ġres idual
c k
av or
Ġsignal ing
ical ly
v ir
Ġf usion
Ġinc reas
Ġwhe ther
Ġtrans form
D H
g er
Ġc aus
or der
Ġre qui
Ġon c
) -
Ġco ur
a f
prolifer ative
/ -
Ġam ong
Ġ1 1
ar ran
Ġmechanis m
C SF
at ric
vere x
Ġinvol ved
os ide
ro p
Ġmulti ple
Ġvari ous
Ġneoplas ms
al th
l ed
is ing
Ġimpro ved
ul ts
est abl
ĠI t
d ose
v ement
Ġtar geted
Ġne ut
Ġfollow ing
om ic
t r
Ġpartic ular
Ġsup press
Ġdis order
is s
ly c
Ġmalign ant
Ġcon cent
Ġac id
c es
is e
m ents
Ġ es
ĠAl though
A K
Ġstrateg ies
t ype
Ġdisc us
Ġregim en
Ġw or
Ġep igenetic
et y
edi atric
Ġbet ter
ĠD N
Ġad min
iz e
pho log
Ġpathw ay
Ġlymph oma
' s
Ġdec reased
Ġconf ir
em b
cy te
ĠML L
Ġappro ach
gen esis
Ġe ither
pl ication
ul ating
Ġleukem ias
ro ph
2 0
Ġ establ
avor able
Ġhigh ly
a ce
ogen ic
Ġme as
x im
Ġ -
Ġcol on
T o
Ġprov id
Ġtrans loc
un g
Ġc ult
Ġg ranul
Ġkary otype
Ġimpro ve
Ġcell ular
o ver
3 8
v o
g o
ĠI L
Ġman y
plic ations
Ġdaun orubicin
Ġav ail
V HD
Ġ1 4
gen ous
ab ol
b ility
arran g
ĠR NA
ene f
Ġconfir m
Ġcytotox ic
Ġref ractory
Ġal ter
Ġcor related
iv idual
Ġol der
Ġexp os
I n
Ġto tal
Ġhemat ologic
er ase
ĠP atients
Ġb enef
ogen esis
an e
l es
Ġwhe reas
Ġsyndrom es
E B
9 5
Ġ x
Ġt iss
Ġm ight
ĠA n
Ġd er
Ġpre c
A cute
m ore
Ġin dependent
Ġ1 3
i x
Ġinvestig ate
Ġcl onal
Ġprevious ly
iv en
vel y
oc l
C s
ter s
Ġa ra
Ġo verex
Ġmor pholog
ĠO S
Ġm it
at ur
Ġpathw ays
ĠM RD
Ġmy el
reat ment
Ġno vo
Ġsm all
oci ated
Ġcharacteristic s
p ite
Ġ1 7
Ġcyt omet
Ġmyelo genous
Ġ loc
Ġrec ent
ti dine
as is
on s
Ġpat tern
Ġind ividual
um or
der ived
ari ate
Ġint ensive
yd ro
at in
Ġsensi tivity
Ġev ent
stan ding
reg ulation
rom b
ass ociated
Ġreg ion
ocyte s
v al
Ġtarget ing
ĠFurther more
ĠA B
en ic
Ġqu an
Ġsignific ance
ĠM ore
in al
Ġt ype
c hed
Ġnew ly
c om
Ġconsid ered
Ġfail ure
M D
Ġpro b
Ġ3 0
en ia
Ġdeterm ine
u red
ant s
S T
A L
u es
Ġresist ant
d om
iv ing
Ġf low
til l
Ġt r
ĠR A
Ġp ediatric
olog ous
Ġmark er
yt h
at or
yc in
o od
ies is
Ġr ati
2 5
ech n
Ġs et
Ġmet abol
Ġre t
al id
Ġcancer s
Ġh owever
2 3
li ke
Ġmin imal
o res
Ġhe alth
Ġ2 00
Ġregim ens
Ġre arrang
Ġ5 0
Ġne gative
% ),
Ġt echn
Ġ1 8
Ġs till
Ġag ent
Ġavail able
Ġinf lu
Ġantibod y
W e
Ġp las
Ġdiagnos tic
vention al
ane ous
Ġass ay
ĠB M
o k
Ġth romb
P CR
Ġad verse
Ġf our
Ġinte rac
Ġman ag
re ated
Ġevalu ate
Ġsequ encing
Ġco h
it abine
Ġassoci ation
Ġv ar
Ġantigen s
Ġcombin ed
Ġpredic t
H SCT
Ġsuc cess
Ġhemat ological
Ġdis tin
i or
Ġst ron
g roup
le ar
z ym
Ġ rap
reg ulated
Ġcyc le
Ġpromo ter
c r
term edi
Ġunder standing
Ġs o
Ġf am
Ġrele v
Ġsub set
Ġbe fore
Ġlar ge
Ġsecond ary
Ġt ypes
op hen
Ġpos sible
Ġprogen itor
Ġab out
Ġvalu e
Ġindic ate
Ġexp lo
Ġph osph
Ġmodel s
Ġpro t
lo t
Ġg raft
Ġdete ction
Ġbenef it
al pha
Ġ1 6
Ġtransform ation
Ġfrequ ently
os ine
Ġphen otype
RNA s
Ġad ults
em ents
Ġlympho id
Ġsuppress or
Ġbe ing
termedi ate
Ġra di
othe rap
Ġthe y
Ġdemonstr ate
Ġb inding
yth ro
ul es
Ġd os
ĠI m
in d
Ġpatho genesis
or ding
os s
Ġc r
Ġ versus
Ġcytogenetic s
Ġincreas ing
Ġprof il
ĠN K
t y
ol ution
Ġclassi fication
at ched
resist ant
Ġ9 5
Ġal one
x t
A P
t reated
U N
Ġcon ventional
Ġfollow ed
0 5
) (
Ġbi ological
Ġs us
k in
em at
anc es
A b
v es
Ġappro ac
Ġv ia
Ġmon itor
Ġiniti al
Ġcour se
e v
Ġcont in
ĠC h
ĠW T
ho od
Ġexam ined
Ġbec ause
medi ated
Ġs ite
Ġpro cess
Ġcont r
Ġapproac hes
am e
oc hem
ĠTh us
Ġfrequ ency
Ġdi rect
Ġun c
e uk
Ġob tained
Ġop tim
Ġbi om
Ġc ap
a ges
u le
o id
Ġuse ful
am m
Ġle ad
vir on
Ġch ain
ĠM P
et hyl
ell ular
ar mac
Ġdifferen ces
O R
Ġc are
an s
Ġaut ologous
Ġcontrib ute
Ġdise ases
Ġlim ited
Ġf oc
Ġ very
% ).
u ally
Ġc ycl
Ġpro te
Ġind uce
f ace
ist ration
Ġab s
olid ation
yl ation
ĠJ AK
C I
Ġcytomet ry
Ġcar cin
ens ity
Ġmanag ement
ti al
Ġe ach
Ġbiom ark
Ġof ten
Ġlympho cyte
Ġ2 4
Ġcoun t
ul l
Ġ+ /-
i ally
Ġmyelo proliferative
Ġper cent
Ġinclud ed
om p
Ġin termediate
Ġrap id
w ent
Ġp ur
Ġmet hyl
ar c
ate le
Ġo ption
Ġconcl usion
Ġrec ently
viron ment
reas t
Ġaddition al
rac ycl
Ġchromos omal
( -
is h
Ġ ir
ĠMore over
5 0
Ġstron g
% .
I C
ĠA d
Ġsugges ting
res t
Ġantibod ies
der ly
m ut
Ġs af
Ġ >
Ġpl ay
om y
Ġprom ising
s is
Ġl ack
u ra
O X
Ġy oun
Ġl oss
Ġd om
Ġheterogene ous
R P
Ġdistin ct
ab ly
Ġresul ted
i od
in ation
Ġconfirm ed
Ġer ythro
Ġimmun ophen
e k
ĠH L
Ġrati o
Ġrece iving
Ġfoc us
C C
ĠO n
Ġcontr ast
ĠR ec
tiv ariate
Ġb reast
Ġ6 0
Ġtranscri pt
Ġexpos ure
Ġenh anced
t umor
Ġd ay
un d
Ġstrateg y
Ġdeterm ined
et hylation
Ġcyto k
1 8
th racycl
Ġdisorder s
ĠI DH
ous e
Ġf lu
ox y
Ġfam ily
ain ing
uc t
Ġblo ck
Ġcomp ound
get her
Ġcons olidation
Ġpl atele
er ation
Ġinf orm
r in
Ġcorrel ation
Ġestabl ished
Ġstr ati
ros is
3 7
Ġacc um
Ġs tim
re m
ĠA ra
ati vely
ul ations
Ġanalys es
os up
Ġline age
Ġev ents
Ġresul t
Ġal low
Ġdel e
Ġre p
Ġpar t
a ir
Ġcoh ort
Ġrec om
is ion
ĠDN MT
2 6
Ġcontrol s
Ġm emb
all en
Ġsub group
ĠS t
Ġel derly
Ġcolon y
Ġan y
Ġdef ined
otyp ic
oc ol
us t
r al
pres sed
Ġph armac
Ġs u
Ġen zym
Ġmonitor ing
B M
Ġsur face
Ġk e
if ied
ia ble
Ġcri tical
Ġreac tion
Ġ "
I S
Ġcl on
or ph
ĠThere fore
ti de
k n
Ġch allen
Ġdes ign
ir c
Ġapp ear
ĠL euk
Ġprom yelo
Ġan thracycl
pec ially
Ġsub sequ
Ġg re
Ġsh ort
Ġran dom
yelo id
Ġfunction al
Ġac tive
Ġm ouse
Ġen c
C A
Ġadv anced
R T
Ġprot ocol
Ġinhib ited
UN X
Ġn ec
Ġ ess
s enic
Ġdescrib ed
Ġsup port
op ro
Ġt ri
Ġse en
Ġ2 1
in ce
en ing
ud e
Ġchild hood
Ġex hib
ar ch
Ġ1 00
ĠN o
Ġsam e
Ġes pecially
Ġsub t
Ġalter ations
ti es
Ġres t
otherap eutic
Ġrepres ent
Ġtes ted
ĠB cl
3 0
Ġper s
Ġhealth y
ĠA m
go ing
2 4
am ide
arc oma
Ġis ol
ly ing
Ġtransloc ation
H R
er ated
Ġquan tit
iqu e
Ġli k
as c
ri or
Ġcondition ing
56 2
Ġcurrent ly
urren ce
Ġsensi tive
er ic
ocl onal
Ġreg ulation
leuk emic
I L
Ġab ility
Ġf avorable
ĠP CR
ĠAl l
ib le
Ġdete ct
ot ypes
Ġ4 0
is ed
Ġparticular ly
Ġk ill
n al
t he
Ġdur ation
Ġfrequ ent
Ġacc ording
roph il
Ġ2 5
oc h
' -
ĠA PL
ac tiv
Ġper iod
Ġinfec tion
ĠC N
Ġs um
is tered
lo b
ne gative
e ro
Ġaberr ant
Ġke y
c ence
Ġcytotox icity
in k
it al
Ġret ros
el ph
Ġidentif ication
Ġpres ented
) /
ĠĠ ĠĠ
Ġess ential
Ġor ig
g ed
D R
Ġc ause
g ra
Ġdescrib e
as atinib
Ġdifferen ce
Ġt er
o f
Ġoverex pression
Ġcons ist
Ġgen omic
a ding
r id
ce pt
ut ure
kn own
c al
2 7
ph osph
at ors
Ġwe ek
Ġreco gn
xim ately
Ġen g
Ġal tern
pres sive
if e
T KI
ati s
ran ge
Ġfe w
Ġsubt ypes
Ġpromyelo cytic
Ġsum m
m ic
rac ellular
Ġse vere
l ong
Ġp rior
C N
Ġv alid
it ors
d ed
Ġrequi red
ĠU n
g an
Ġm ed
Ġcontin u
Ġdos es
g ing
i lot
Ġs olid
Ġ u
Ġa z
Ġmajor ity
Ġmolec ules
Ġmet ast
ĠA t
Ġre duction
p lo
e w
Ġth us
Ġmalignanc y
B C
M R
it u
ĠG VHD
Ġv ir
az a
Ġmon oclonal
Ġpolym orph
Ġin s
ĠF or
os ed
h ip
Ġplas ma
ur ine
ĠS T
d rug
d uce
Ġsyn erg
ten ance
Ġexper im
l ing
Ġev en
ĠH SCT
3 5
Ġto l
00 0
Ġc ur
B P
Ġal pha
Ġoccur red
ran e
Ġassess ed
Ġl ed
Ġpot ent
D AC
I I
Ġdec itabine
Ġdon ors
Ġconcent r
Ġthe m
Ġser um
Ġthere fore
f ied
Ġsuccess ful
ti s
Ġpro long
iti dine
Ġplatele t
Ġcons tit
er ior
enc ed
Ġaim ed
g i
Ġcaus ed
Ġg iven
ici ent
opro tein
es pite
M S
ocyt osis
Ġ if
Ġc irc
Ġlik ely
ur s
Ġaberr ations
Ġdom ain
4 5
Ġin de
Ġhist one
Ġg ra
Ġunder lying
Ġinclud e
Ġo x
Ġtox ic
Ġcon c
ac itidine
Ġre se
Ġform ation
Ġtiss ue
c ed
Ġcl ass
Ġl ab
Ġphosph or
b id
Ġun f
Ġn ow
Ġtum our
Ġ2 2
Ġadmin istration
Ġim m
F LT
Ġinter val
ĠMD SCs
Ġtreat ments
y b
in ally
res pon
c on
Ġpot enti
oc k
Ġmain tenance
N K
Ġrel ations
Ġf ive
Ġl ung
Ġsc re
M A
w ard
Ġinform ation
Ġimmun otherapy
Ġneut rophil
Ġgre ater
a ren
Ġtrans f
ar b
Ġhe l
Ġprogen itors
ĠC T
pec tive
Ġmicro en
Ġar senic
Ġrelations hip
Ġsugges ts
l amm
Ġag gres
cl inical
Ġquantit ative
Ġle ast
on ucle
ip i
or ing
Ġclinical ly
B F
Ġexper i
Ġisol ated
Ġevalu ation
Ġf uture
Ġdiscus s
Ġconcentr ations
Ġd asatinib
Ġpredic tive
Ġha emat
li al
om ycin
Ġ2 01
et a
Ġun known
C h
opo ietic
D A
F N
Ġaccum ulation
Ġstrati fication
S P
Ġe t
a i
Ġhematopo iesis
ec t
Ġmul tivariate
u tive
o h
Ġle ading
Ġinflu ence
Ġ X
ĠA fter
Ġc ent
Ġs arcoma
Ġder ived
p ts
g p
Ġwor k
Ġl ip
Ġstr uct
Ġmark ed
ĠB CL
op enia
0 2
ul in
Ġmicroen vironment
fer ase
Ġsugges ted
Ġal though
Ġinvol vement
Ġsup por
Ġc er
Ġcult ure
it s
Ġpolym erase
Ġset ting
om atic
Ġl ig
ap opt
ilot inib
blas t
trans plant
Ġhigh l
om as
Ġg u
Ġmethod s
t rib
esti m
elph ia
Ġindic ated
Ġmut ant
tic ally
il ad
9 0
ilad elphia
or ter
Ġinf usion
ĠR es
ap p
and s
Ġl ife
Ġs il
and id
Ġd ied
Ġbi ology
ĠAm ong
Ġprec urs
Ġconcent ration
EB PA
z e
P D
Ġprop er
Ġchem otherapeutic
Ġh ow
Ġel ev
Ġappro ximately
I M
Ġdec rease
ĠMP N
n er
Ġr at
ĠC om
Ġpro por
h ydro
Ġimmun osup
Ġ estim
Ġpro duc
um ab
Ġresul ting
ĠO ver
Ġs p
Ġdis pl
en tical
Ġrec urrent
Ġaggres sive
enc es
C P
Ġor der
ĠM cl
H O
gen eration
ĠMD R
Ġrese arch
Ġre tin
pl an
Ġsh orter
Ġmut ated
Ġd ys
Ġhel p
as p
ant ly
f old
ĠB MT
ĠU sing
9 8
ow led
asc ular
I P
ĠP D
ores cence
es ion
Ġto gether
Ġ2 8
Ġprof ile
k g
Ġpercent age
Ġoptim al
ura ble
0 4
Ġrec ipi
Ġprovid es
ul ate
ub le
N P
or k
Ġl esion
Ġs ix
b eta
Ġsaf ety
od ing
Ġneed ed
ic e
Ġpar ame
ĠLeuk emia
atur al
Ġachie ve
Ġass ays
% ;
im in
apopt otic
po int
ym pt
ĠPh iladelphia
Ġaltern ative
ĠE x
blas ts
Ġu til
Ġimport ance
d s
ĠR UNX
Ġbiomark ers
res s
Ġan tic
E GF
owled ge
r ing
Ġunder st
Ġhyp er
Ġcri ter
Ġun related
ros s
Ġconsid er
Ġpattern s
it ing
Ġcom plications
ific ation
A F
Ġc andid
Ġyoun ger
ĠO f
Ġrelev ant
yb rid
ib rosis
Ġre al
Ġeffic i
Ġpos si
medi an
ul f
d ay
ph yl
m end
8 0
ti ally
Ġm ac
Ġcon duc
4 0
Ġinfec tions
i el
Ġhe re
or por
Ġran ge
ochem ical
Ġev olution
Ġpro phyl
ĠC on
Ġorig in
Ġcompound s
al lo
it t
Ġall el
Ġinf il
c yt
T h
o ic
ĠW ith
Ġw ild
Ġrecept ors
Ġs ide
Ġh om
Ġreco very
Ġcarcin oma
Ġst age
Ġg ood
Ġneut rop
Ġunder went
2 9
Ġhyp omet
Ġre duc
os omal
Ġc al
Ġl ink
M RD
Ġweek s
h ost
Ġpropor tion
re ak
Ġm uc
I R
Ġn ilotinib
a de
o uld
Ġb asis
b il
Ġimm ature
Ġb as
3 6
oph il
Ġw ould
Ġp an
Ġh ybrid
s tim
ĠAT RA
pec ted
Ġconcl ude
Ġcriter ia
Ġrandom ized
) ;
Ġto ward
cy tidine
Ġactiv ated
lym pho
ra in
Ġp rac
Ġanti tumor
Ġhyp othe
Ġadv ances
Ġem erg
Ġlymphocyte s
os p
am ma
00 01
Ġinvol ving
Ġassess ment
Ġ enti
Ġcondition s
Ġkn owledge
Ġ ver
Ġadmin istered
Ġd am
er n
ĠTKI s
Ġabs ence
Ġlympho cytic
Ġto ol
Ġoption s
Ġp osi
Ġinc orpor
k ing
Ġac tion
Ġli ter
Ġun ique
op oside
od y
Ġm el
ac et
Ġtranscription al
ox ide
Ġsubsequ ent
ĠT reatment
N F
Ġpop ulations
Ġaffec t
Ġcommon ly
Ġneoplas m
Ġm es
iz ing
Ġd u
Ġpromo te
Ġdispl ay
Ġbi op
Ġan emia
Ġad he
Ġunc lear
A M
Ġcyt osine
Ġ i
at al
g ram
Ġleukem ogenesis
Ġrecom mend
ak en
Ġin si
ra y
Ġm urine
Ġinte g
Ġ2 3
l d
och ond
e an
Ġpotenti ally
oxy cytidine
g h
Ġf ree
Ġliter ature
Ġn atural
m it
Ġb est
Ġpl ays
ox orubicin
Ġg l
and em
i um
o red
Ġregul atory
om on
Ġch im
Ġgranul ocyte
Ġhe p
Ġanal og
Ġmemb rane
Ġrearrang ements
Ġexp an
Ġac qui
Ġfunction s
t u
o ve
ra di
ĠH e
Ġelev ated
Ġst atis
ĠC l
Ġcoun ts
ĠO ne
H CT
Ġinterac tion
ine tic
Ġprofil es
u ted
gen ic
Ġheterogene ity
Ġy et
Ġt est
Ġaz acitidine
ĠP ro
Ġthromb ocyt
Ġse em
Ġb reak
G VHD
ĠMD SC
1 00
Ġc ateg
Ġpl us
Ġcl in
trans ferase
Ġhyp erm
ĠP B
Ġconduc ted
Ġs ympt
Ġ ly
ĠC EBPA
Ġint racellular
A s
Ġt andem
Ġc ho
Ġphosphor ylation
Ġdele tion
Ġmeas ured
Ġsite s
en ter
s ub
Ġnucle ar
ull ary
Ġmit ochond
Ġad j
Ġad d
Ġparame ters
Ġinduc es
osp ital
Ġsub type
Ġrepres ents
Ġ2 7
ar ding
Ġint ro
Ġunder going
g kin
tim e
plic ated
Ġtiss ues
Ġbet a
Ġli ver
Ġinsi gh
Ġpro duction
s y
ar ubicin
od gkin
Ġinf lamm
Ġlong er
Ġc he
Ġint ra
Ġdevelop ing
t ar
Ġser ies
ĠT P
ĠD espite
h ile
e g
Ġsu ff
Ġc le
C M
Ġst rom
ĠI M
Ġselec tion
Ġappro ved
spec tive
t o
Ġf rac
ex pression
Ġbec ome
Ġet oposide
A l
tain ing
ur al
Ġcomp on
Ġara bin
Ġ j
Ġwhe re
C G
0 3
is on
ul ative
ti d
Ġ2 6
Ġdec ision
Ġobser v
Ġtri oxide
ĠOver all
Ġexplo re
oph ag
Ġthe n
asp ase
ist ry
d en
ĠF inally
F U
ce p
Ġl en
Ġmolec ule
Ġs itu
ri tic
Ġ2 9
Ġrel atively
Ġab le
o gene
hes is
l ess
p er
j ug
Ġanthracycl ine
Ġprolong ed
Ġma de
Ġmain ly
7 0
Ġkn ock
Ġh ydro
Ġinv as
c ap
M E
um ulative
end ritic
Ġcr is
ub l
ax is
Ġantic ancer
D N
(- )
Ġremain ed
Ġnec ess
Ġcol lec
z umab
ia b
is ts
ak ary
Ġc lear
ĠC LL
Ġpers ist
re am
ed ullary
+ </
t hesis
Ġtes ting
Ġproper ties
ĠL SCs
Ġmel an
4 4
C B
o ugh
Ġselec ted
if ically
ap se
V I
Ġcl one
Ġsub stan
Ġloc al
c ome
H L
M N
acy tidine
5 7
Ġwh ite
A PL
Ġsynerg istic
ĠR T
Ġl ate
Ġexpres sing
Ġinter fer
Ġg lyc
Ġsumm ar
ple te
IS H
omon ocytic
Ġexpan sion
B MT
Ġar tic
Ġrel ative
p ri
Ġapopt otic
ent al
ĠC yt
Ġchem o
Ġprogres s
ĠE R
Ġreg arding
p re
Ġ( <
e f
ĠC M
oh ist
E R
st ream
in f
Ġsubgroup s
t reatment
Ġdam age
in ts
Ġpo ly
hem ia
Ġx en
Ġmyel oma
em al
Z A
Ġsystem ic
Ġpresent ation
Ġlesion s
Ġstrong ly
ram edullary
Ġaffec ted
Ġcris is
Ġw id
Ġtranscri pts
o tide
> +</
Ġ3 5
Ġacqui red
Ġenzym e
Ġcytok ine
Ġprev ent
Ġcar di
or ts
itt le
Ġgener ation
Ġunf avorable
d own
Ġh arb
Ġimpro vement
ar t
ain ed
Ġexpres s
Ġmyel omonocytic
ĠM edi
r one
Ġd oxorubicin
Ġrearrang ement
b ers
Ġcontinu ous
resist ance
Ġcap ac
Ġf ac
ĠH CT
Ġreg ard
Ġselec tive
on tin
al ys
Ġinvestig ation
Ġs ib
Ġlab or
lo phosph
A R
u rop
Ġc ure
lophosph amide
Ġd endritic
Ġm atched
ĠG roup
Ġor al
Ġb ur
ĠT wo
Ġprofil ing
Ġtransloc ations
L I
ĠF AB
Ġdo es
2 8
P B
Ġachie ving
om erase
Ġsib ling
ever al
Ġsympt om
p G
Ġc umulative
am in
Ġp ubl
Ġvari ety
Ġex cl
Ġg ast
der s
Ġ4 5
Ġro les
log ical
R M
Ġl ast
Ġun treated
raft ment
ĠMedi an
Ġrelev ance
p ir
ung al
ĠM CL
Ġarabin oside
Ġme g
Ġme an
Ġse ven
Ġacc el
Ġup on
op y
Ġir radi
Ġprophyl axis
Ġe qu
iti s
Ġ3 3
7 5
rap h
w ork
Ġgener al
rem ission
Ġ3 6
leuk emia
Ġ8 0
ĠT ET
y ing
Ġf emal
Ġinhibit ory
Ġdisc ontin
ĠB oth
Ġs al
Ġnum bers
Ġre verse
ul atory
Ġs te
Ġerythro id
res ting
et work
Ġclon es
Ġof f
ak e
ĠI FN
Ġdiscus sed
hyl ating
id entical
Ġgra de
ot her
A D
Ġpo int
Ġhist ory
Ġcapac ity
Ġde g
Ġ4 8
X L
Ġindic ating
Ġonc ogenic
ph ase
L C
Ġwor se
ĠD C
Ġradi ation
ero x
Ġal tered
Ġrespon sible
Ġ7 0
Ġconf idence
Ġp ast
Ġdiff ic
Ġcons ec
rol led
Ġmetabol ism
Ġabnormal ity
o le
Ġcaus es
press ing
Ġmeas ure
Ġmon ocytic
otyp ing
Ġm ature
Ġmedi ated
Ab l
plan ted
ai red
Ġcl us
Ġv en
Ġb ody
ĠB y
Ġneutrop enia
Ġsup pression
pl ied
Ġpar tial
Ġvalu es
Ġex ist
ĠA S
Ġcombin ations
n ess
in s
Ġcer tain
ut aneous
Ġretin oic
Ġmelan oma
em ber
9 9
Ġsub jec
Ġacc oun
Ġ3 2
Ġmeg akary
pec t
D NA
ĠM S
Ġrepor ts
Ġindividual s
Ġus ually
Ġpro spective
pri ate
Ch ronic
Ġd et
at ho
lob ulin
Ġcent ral
Ġs omatic
l or
Ġprac tic
Ġk in
8 8
ir d
Ġre duce
atur ation
ĠST AT
Ġmulti drug
Ġpur p
T P
Ġt yp
. ,
Ġsubset s
ĠC P
Ġsel f
in ing
Ġp ep
f ibrosis
Ġcompar ison
Ġtransf usion
r up
s te
Ġspec ifically
P h
de oxycytidine
Ġdesign ed
yl ate
Ġvir us
ran si
Ġflu orescence
line age
TKI s
onucle ar
Ġincreas es
Ġartic le
Ġcour ses
Ġeng raftment
tit ution
uc id
MP N
x y
Ġcycl es
ur ing
Ġex pl
Ġdirect ly
Ġhybrid ization
Ġend othe
Ġkin ases
6 7
Ġar rest
Ġtreat ing
y si
Ġprovid ed
6 17
Ġde pendent
Ġs plic
Ġs kin
Ġv ac
Ġext ramedullary
Ġda ily
A z
id ase
Ġc aspase
Ġdiscontin u
Ġoccur s
ĠII I
Ġpan el
Ġep it
alys is
Ġpre clinical
Th is
Ġconsec utive
Ġsyn thesis
ĠM ul
Ġretros pective
Ġestabl ish
am ic
Ġan gi
bid ity
Ġrecipi ents
Ġs ince
og raph
ĠC pG
m i
om in
Ġexhib ited
Ġap plication
Ġchan ge
Ġappear s
ocl ax
Ġan t
ĠP R
Ġgener ally
iqu es
r u
Ġsc ore
Ġap plied
Ġf ar
am icin
Ġprob ability
Ġl ittle
op er
ĠC ancer
Ġst ate
im mun
lud arabine
ec ted
op ath
Ġel ucid
ĠC BF
bin ding
Ġmitochond rial
A ra
Ġfe as
Ġtechn iques
ĠB ec
re hen
ant rone
Ġgen ome
Ġadv ant
Ġinterac tions
Ġimmun ohist
Ġmal e
te en
Ġmyelo fibrosis
3 1
tu zumab
f unction
Ġmorpholog y
u ro
Ġob jec
Ġ3 8
cep ti
re cted
mut ated
Ġde ple
Ġhyperm ethylation
Ġp anc
Ġdes pite
o v
Ġman if
Ġlead s
Ġcyt oplas
Ġvar iable
Ġdis trib
Ġcytok ines
6 5
Ġder iv
ĠW hile
Ġ3 1
Ġtol er
Ġre ver
Ġrece ive
ĠW hen
ron t
Ġsup erior
Ġf ib
Ġim plications
Ġrec urrence
Ġrequi re
stim ulating
re c
Ġm ass
ĠE urop
Ġneoplas tic
Ġdifferenti al
or d
od es
ĠV EGF
Ġh ospital
ab il
Ġbur den
Ġt ransi
ult aneous
S A
Ġ3 4
Ġcur ative
g lyc
iff eren
Ġanti leukemic
Ġspec im
f eren
Ġst aining
Ġdu plication
D C
er v
Ġne xt
o genetic
Ġanaly ze
Ġfrac tion
ĠM E
o lec
Ġde pend
r ia
en se
Ġenh ance
ĠM T
Ġgener ated
gen ase
Ġhighl igh
Ġl ater
ĠD FS
Ġover come
ĠAT O
ĠRec ent
Ġvari ant
Ġsus cepti
ĠE T
Ġaut ophag
Ġint ensity
Ġs ol
m l
n d
ad es
Ġconsist ent
ox antrone
Ġpro duced
Ġpredic ted
ĠB cr
os in
Ġtrans l
Ġprotocol s
Ġxen og
Ġcon sequ
Ġpred omin
Ġ9 0
Ġcon te
Ġkill er
Ġto po
Ġcont aining
ĠCN S
ĠM yeloid
ĠDN R
Ġhypomet hylating
en ib
Ġid arubicin
i an
Ġm aturation
Ġt ra
Ġinhibit s
g ely
Ġg reat
Ġwho le
Ġcar ri
Ġsuppor tive
ensi tive
az acytidine
- -
Ġlar gely
Ġfac il
o ly
ĠS CT
Ġappro priate
Ġe ight
ĠAd dition
Ġdiffic ult
I F
8 6
m al
ur viv
x ed
Ġimmunosup pressive
Ġexperi ence
Ġst ages
o b
ĠG M
ed ing
Ġor gan
b y
Ġinter nal
Ġreview ed
ĠIn te
Ġstrom al
Ġpractic e
Ġbiop sy
Ġqu ality
Ġcyc lophosphamide
Ġsymptom s
Ġirradi ation
Ġman ner
Ġmorpholog ic
Ġlig and
Ġmac ro
yn amic
Ġse par
om en
v ari
op atho
MD SCs
Ġ '
] ,
Ġchromos omes
G M
Ġpro ble
ĠBec ause
Ġfacil it
Ġpoor ly
Ġrest ric
P R
Ġdo uble
Ġn etwork
G S
Ġdef ine
n c
Ġth ough
pha ges
Ġleuk ocyte
ari ly
Ġconte xt
Ġnecess ary
ĠS everal
Ġactiv ities
Ġendothe lial
cap e
abl ative
Ġ Q
Ġallel e
leuk in
Ġretros pectively
i er
is ms
om ide
Ġsil encing
Ġvari ants
Ġam pl
aren t
Ġd oc
o very
Ġinterfer on
roph age
acet yl
Ġrecogn ized
Ġref lec
iel d
ici ency
anc y
Ġreg res
ro g
Ġchrom atin
al f
Ġprop osed
Ġrapid ly
Ġt el
Ġis s
Ġmethyl transferase
rehen sive
si zed
et oclax
RA S
Ġtrans planted
Ġcytogenetic ally
Ġcompar able
3 2
Ġh ost
Ġ4 6
Ġclin ic
Ġ3 7
Ġrep air
id ed
Ġmon onuclear
Ġint ensi
iz es
went y
ĠH DAC
Ġmutation al
ĠL SC
S S
id es
Ġqu es
Ġche ck
ĠA N
i tive
Ġd ysplas
p op
Ġim plicated
Ġmes ylate
Ġne uro
Ġat t
Ġleuka emic
enc ies
Ġcirc ulating
ro und
Ġ4 2
Ġ5 5
Ġter min
Ġsim ultaneous
Ġan imal
Ġag ed
Ġocc urrence
Ġiniti ation
Ġb ro
e tic
ac tive
t ration
Ġar m
Ġmicro M
ĠM Y
z y
fer red
Ġconc ern
Ġ7 5
st ate
ogen ous
ĠH R
Ġscre ening
Ġ Z
Ġcal c
Ġmon ocytes
Ġexperim ents
Ġregres sion
v ious
Ġat ten
Ġgen otype
Ġknock down
glyc oprotein
Ġs or
Ġr ational
ros c
Ġst ress
Ġquan ti
ĠT rans
ĠS ince
Ġsequ ence
ĠP re
Ġst able
H P
Ġprev al
Ġcon jug
Ġaccel erated
Ġf ludarabine
v age
Ġmit oxantrone
omp an
Ġacc ompan
Ġcateg or
in c
e ared
ĠE VI
Ġmi xed
Ġth ird
ĠM ost
e ffec
ĠA cute
Ġpro ced
Ġ4 4
Ġbiomark er
C H
Ġdown stream
Ġlink ed
Ġl at
00 2
Ġwid ely
Ġwh ose
ag ing
ĠC X
Ġchallen ge
r ate
Ġd ri
Ġdisc overy
Ġgranul ocytic
g al
C F
ear ch
Ġfail ed
ud ed
Ġcr uc
Ġpolymorph isms
Ġexplo red
Ġshow s
Ġcor respon
Ġtoxic ities
ĠK IT
Ġpresent ing
Ġmorpholog ical
ĠG O
de f
I V
Ġha ving
os yl
Ġd r
12 3
ĠRec ently
Ġpurp ose
Ġunderst ood
i otic
ra g
Ġrele ase
E L
T OR
Ġdec ades
Ġlabor atory
Ġvalid ated
Ġshow ing
Ġtim es
7 7
Ġ4 1
Ġspecific ity
Ġro ut
Ġremission s
Ġdel i
Ġde p
Ġautophag y
ĠP ML
Ġon set
Ġer ad
Ġcruc ial
3 9
resting ly
Ġde gra
raf ts
ren ew
Ġtrans por
Ġdetect able
Ġprecurs or
Ġm ast
Ġregion s
Ġcult ures
Ġgu id
Ġmacro phages
os ome
Ġal ong
f t
m atched
Ġac t
Ġinte rest
Ġinfil tration
Ġwh om
Ġlim it
Ġmetast asis
4 7
osin ophil
6 6
n ing
activ ation
ĠC C
Ġsub pop
M F
os omes
en ed
Ġmetabol ic
ting u
Ġdis s
Ġcandid ate
A S
Ġtransplant s
Ġstatis tically
ĠCl inical
ere g
am ine
Ġmuc h
Ġfemal e
2 00
Ġpubl ished
Ġsal vage
Ġinter leukin
Ġdoc um
Ġpro gram
P T
inetic s
Ġ6 5
m et
Ġcar ry
Ġter ms
Ġen rolled
ĠEurop ean
Ġinduc ing
Ġanthracycl ines
A G
is p
Ġmarked ly
9 6
ochem istry
lo bin
Ġacc ur
Ġmin or
Ġoverex pressed
Ġel ect
alid omide
em tuzumab
ven ous
Ġcomp are
Ġpredic ting
com it
Ġspecim ens
ĠTh ree
ec tion
Ġmanif est
w ide
Ġs our
rel apse
Ġdel ay
Ġv in
Ġinde pend
Ġdis tingu
B I
Ġde ep
ad y
Ġ Y
ĠS e
Ġ5 6
ig ible
Ġ3 9
Ġmi RNAs
Ġdistrib ution
Ġsystem s
Ġsuccessful ly
Ġha plo
ol ar
r h
Ġsc hed
Ġinsigh ts
AT A
Ġobjec tive
id ine
Ġclassi fied
it able
Ġinf erior
Ġtol erated
Ġh alf
Ġph ys
Ġdet ail
Ġemerg ing
Ġ lo
ĠSt ud
zy g
Ġal k
ĠIm mun
Ġexam ination
ia c
Ġfor ms
Ġblo t
Ġp ul
Ġestim ated
tid es
Ġreg ulated
Ġex on
Ġat tem
Ġdisplay ed
Ġrat her
Ġex pected
5 4
Ġsensi ti
Ġreac tive
Ġprocess es
Ġadhe sion
Ġm at
7 9
Ġrespon d
3 15
E M
ĠM M
ĠI g
Ġser ve
z og
Ġimp aired
Ġcom or
Ġprecurs ors
Ġre as
ĠInte restingly
is omy
ĠE FS
Ġd iv
N PM
Ġperform ance
Ġclus ter
ĠH igh
Ġrecom bin
g th
all el
Ġex er
Ġexperim ental
urviv al
M yeloid
osi tion
Ġyoun g
on es
Ġonc ogene
Ġtr ig
I m
he st
Ġdiff er
m ost
H odgkin
ĠĠĠĠ ĠĠĠĠ
en ess
od e
Ġ4 7
Ġaut h
ĠG ST
a emia
Ġintra venous
Ġv ascular
Ġs pl
Ġadvant age
ĠN ot
Ġpredic tion
C d
ĠA L
a un
Ġcomp r
ĠM N
Ġdifferenti ated
4 3
vari an
6 8
ĠThe y
Ġf rag
us ive
Ġmor bidity
Az a
zog amicin
Ġcon comit
st inal
Ġhaemat ological
yelo dysplas
Ġst ar
Ġincreasing ly
ĠP T
H C
Ġf ront
ĠM y
Ġcollec ted
Ġcomp rehensive
Ġ her
Ġcharacter ization
Ġrep e
ram atic
C LL
ri tis
ĠIm atinib
Ġox id
c tive
h igh
Ġpolymorph ism
t ake
Ġin jec
activ ated
Ġhep at
Ġf ul
is ted
Ġb el
Ġmetast atic
Ġdeple tion
eric an
Ġintro duction
Ġpo lyc
Ġantib iotic
P C
Ġdef in
Ġam oun
g l
Ġd ramatic
erox idase
Ġmi RNA
ĠC omp
Ġad en
Ġg li
Ġ ve
ĠM R
og lobulin
Ġinteg r
Ġcho ice
Ġo varian
ĠG ene
f ractory
ĠC ell
Ġcor d
Ġhig hest
Ġbro ad
ĠB A
Ġan other
Ġimmun ity
Ġdis rup
ib ility
Ġg o
Ġre pro
Ġpossi bility
9 7
Ġse x
Ġmicro ar
Ġup take
Ġbe h
Ġven etoclax
Ġsubstan tial
Ġsup pressed
vers ely
ĠRA S
R R
ar a
ĠP A
ĠA p
Ġdem ethyl
) )
Ġmyelodysplas ia
el ine
Ġli ke
Ġo zogamicin
Ġde hydro
8 5
Ġin st
mit ted
8 7
b ly
m e
Ġem b
Ġ4 3
end ed
Ġsyn the
Ġd ereg
Ġcheck point
az ole
Ġexam ine
E N
Ġcont ro
9 37
rin s
Ġmet h
Ġem plo
yelodysplas tic
ici ans
- ,
> -
Ġh is
Ġn an
Ġactiv ating
Ġeffec tively
ex pressing
Ġext rem
Ġremain ing
A m
GF R
Ġregul ator
Ġspec ies
renew al
tr um
Ġac et
Ġoccur ring
Ġaut o
ĠW HO
Ġinflamm atory
tiv eness
Ġdeg ree
Ġdegra d
+ /-
p s
ver si
Ġvia bility
L R
if y
Ġaccompan ied
Ġc ross
re x
Ġaffec ting
u an
ĠA b
Ġsubsequ ently
ĠT aken
ap h
Ġdown regulation
Ġs ple
Ġn ic
cr ist
f act
ar r
Ġrelap ses
ĠG ATA
Ġenzym es
Ġreac tiv
Ġcult ured
Ġstruct ure
ard iac
s el
Ġsign ature
l ab
Ġ5 1
Ġpharmac ok
Ġdef ec
Ġregul ators
Ġp ap
ur in
Ġde acetyl
Ġinde x
Ġd ate
Ġn ine
crist ine
oplas tic
log ic
tar geted
Ġimmunophen otype
g amma
ff in
Ġsec re
in te
it inib
ome gal
si gn
blast oma
Ġauth ors
Ġg amma
Ġvar iab
Ġr s
f y
Ġup regulation
Ġdegrad ation
Ġutil ity
ren ch
Ġsub c
Ġdysplas ia
4 8
O L
Ġtr isomy
re fractory
ĠH OX
lu x
Ġseem s
ĠS ix
lo geneic
Ġlymph omas
int ensity
mon ary
n is
ic ine
O T
Ġdemonstr ates
Ġeffect or
Ġcorrel ate
ĠCD K
c o
ĠI V
Ġful ly
Ġe osinophil
Ġmo bil
Ġrec ru
Ġinvas ive
oc ar
ĠB ased
ero us
n ot
Ġchim eric
hem at
Ġ5 4
Ġon going
Ġepit he
rex ate
Ġdeacetyl ase
Ġidentify ing
Ġext ensive
Ġrequi res
Ġdehydro genase
pl atin
ĠF our
ric hed
Ġapp arent
ut ations
Ġal ive
Ġapp eared
Ġposi tivity
W T
Ġn or
ĠAB T
Ġcytoplas mic
7 1
Ġo ste
ati ves
ĠS im
ow er
Ġcorrespon ding
ĠC SF
in ated
F I
es tern
ĠP I
Ġ5 3
Ġlack ing
ĠAS XL
Ġmul tic
Ġs ize
Ġprolifer ative
Ġimmunophen otypic
Ġtumor i
Ġblas tic
ific ations
og lobin
Ġup regulated
af enib
Ġh our
ĠT wenty
et al
Ġev ol
r ine
m ethyl
Ġiniti ally
ot rexate
Ġindepend ently
c oding
Ġm ust
Ġb ind
ag on
is omerase
Ġmyelo ablative
Ġthere by
Ġsumm ary
otox icity
6 4
et in
ĠN B
Ġsplic ing
Ġthrombocyt openia
Ġangi ogenesis
ĠAB L
Ġfrequ encies
Ġcompon ent
4 1
Ġre d
Ġ ill
ĠHere in
Ġsubjec ts
Ġf ind
Ġprim arily
Ġother s
Ġdem ethylation
AT RA
Ġkary otypes
Ġcap able
Ġregul ate
Ġir on
Ġhighl ight
Ġ6 7
Ġimpro ving
Ġtoward s
Ġexp and
Ġenh anc
ĠIm port
ĠS c
Ġco re
Ġinhibit ing
op ic
ĠW BC
Al though
t ment
ĠI C
Ġpre gn
lob al
Ġpep tide
D FS
Ġb rain
ĠA cc
ĠF rench
Ġel imin
Ġox y
Ġev id
Ġc is
B CR
Ġsam ple
11 7
Ġpro state
Ġdiscontinu ation
in duction
Ġs pon
ĠHe alth
er ate
s p
ĠT NF
ĠG en
Ġnucle otide
d C
ulf an
opath y
Ġg erm
Ġchan ged
Ġm ig
Ġver a
Ġimmun oglobulin
Ġmemb ers
Ġsuscepti bility
Ġprob ably
Ġre nal
Ġcom plication
Ġdec reas
R ec
ur n
yl ated
Ġvariab les
% -
+ ,
ĠO r
Ġol d
O C
ĠD ec
Ġ5 2
Ġcarri ed
Ġrare ly
an ti
Ġ ul
Ġb en
S D
ĠC urrent
Ġcontribute s
Ġinfil tr
ĠIn tern
Ġmed ical
Ġ4 9
Ġunderst and
Ġprogres sive
Ġreac hed
erv ous
Ġp a
Ġma xim
Ġdi verse
ĠB C
ĠRes ults
Ġant agon
Ġcontro versi
Ġn ervous
Ġsu itable
Ġstim ulation
4 2
8 3
or ld
iv ariate
ite s
Ġneutrophil s
Ġen vironment
ĠJ an
Ġex cess
Ġd ynamic
r ich
Ġc ardiac
Ġm ember
Ġhypothe sis
ol er
Ġad ap
app a
Ġmyelo blastic
Ġsple en
A n
Ġgo al
Ġchallen ges
Ġexpos ed
d el
Ġvin cristine
i i
Ġp e
Ġex ce
Ġal most
Ġ7 2
Ġcharacter ize
Ġmethyl ated
F R
ati ent
Ġtrans duction
Ġe very
Ġeff lux
Ġab ove
Ġpro duce
ot ing
us e
RA R
4 9
Ġtrans port
olec ular
d r
m ark
Ġf ungal
Ġconcomit ant
s ensitive
ĠC FU
Ġis o
Ġcl os
Ġatt rac
Ġdeli very
Ġrem ark
ĠF ISH
yt hemia
Ġb le
ET O
uc h
ĠS NP
Ġspec trum
Ġtermin al
Ġmicro RNA
Ġdaun omycin
v iew
Ġ z
Ġdocum ented
Ġb cr
Ġb ack
Ġcombin ing
el ines
6 2
ĠG S
KI T
: </
Ġpossi bly
Ġat trib
Ġgranul ocytes
Ġm im
Ġfe ature
Ġpredict or
Ġen abl
bid ities
Ġrecommend ed
Ġ5 7
Ġcycl in
po ints
ograph y
ĠAN LL
Ġcompon ents
Ġsub str
ifferen ti
ĠImport antly
A N
Ġb us
Ġac ross
Ġpharmac ological
Ġxenog raft
Ġa min
Ġeffec tiveness
Ġas pir
Ġtrans fer
Ġpre feren
Ġinter vention
Ġpar tially
Ġbi ologic
op e
ap an
m od
or rh
00 3
Ġphen otypes
Ġhaemat opoietic
R F
Ġin n
Ġ6 1
Ġhour s
Ġmod ifications
Ġradi otherapy
at he
I N
v ements
Ġc ost
ĠIntern ational
an y
ĠC ons
Ġproble m
B L
Ġ5 8
Ġregul ating
olog ies
ĠK IR
Ġmin im
Ġchemo resistance
Ġf atal
Ġf ever
Ġv ol
ĠR IC
Ġpreval ence
Ġphen otypic
ĠCyt ogenetic
d T
us ed
Ġprop ose
Ġol ig
Ġmeth otrexate
Ġmedi um
r as
Ġpre par
H LA
Ġsign atures
res is
A ZA
Ġpul monary
Ġtechn ique
Ġemb ry
rins ic
oc omp
Ġb l
Ġt em
ti ous
Ġne g
Ġchim er
Ġampl ification
Ġp ower
ĠEx pression
Ġrout ine
ritis h
7 3
ir ty
Ġem ph
E FS
Ġun til
Ġep id
Ġof fer
Ġprovid ing
Ġt erm
P V
t aneous
Ġoxy gen
Ġhypothe sized
Ġres pect
a di
ĠJ apan
Ġextrem ely
ines e
Ġw ide
Ġl ight
Ġgast ric
ment ation
Ġeff orts
min istration
6 1
Ġg ain
en sion
em i
ĠAT P
Ġsuff icient
Ġare a
str uc
Ġemerg ed
ĠI T
ĠN F
MD R
Ġtopo isomerase
Ġcle arly
Ġtherapeutic s
ĠH D
Cd R
6 9
Ġcontroversi al
Ġinc ub
00 5
Ġindic ates
Ġanalys ed
AL C
ĠP V
ĠD rug
in ant
Ġmod ified
Ġsus tained
Ġrestric ted
ensi tivity
Ġdat ab
Ġimp air
Ġf ield
Ġcandid ates
Ġobserv ations
ĠB H
Ġprim itive
Ġdeath s
Ġdys function
gra ms
Ġcomplete ly
oper ative
Ġ6 4
ML L
Ġreduc ing
k t
u tively
os por
E S
9 2
yp ical
tern al
ere b
Ġrisk s
ove red
H A
u ff
Ġs he
Ġpred isp
ĠCh inese
U P
ĠMul tivariate
Ġ6 6
Ġeffici ent
> ,
P atients
ar row
Ġad op
Ġem er
Ġno ted
opo iesis
F ISH
w ise
id s
tar get
ĠA ZA
Ġrecombin ant
U C
v ant
Ġincorpor ation
Ġcons isted
ure a
Ġexperi enced
Am erican
Ġp ut
Ġconcl uded
Ġg lobal
ic ial
ĠS F
Ġly s
Ġexhib it
Ġleuka em
Ġgl ut
ĠM RP
ĠAML s
u rac
an gi
ST AT
ear ing
az ard
Ġe ar
Ġvac c
s c
Ġselec tively
ĠAddition ally
R UNX
Ġmod ification
Ġme ans
Ġfocus ed
en ding
Ġm ism
5 2
b i
k it
l l
con taining
Ġmicroar ray
z ard
on azole
ĠB one
Ġunder go
ud ing
Ġha zard
ec ond
ĠIn c
Ġend ogenous
Ġdele tions
Ġsystem atic
Ġobserv ation
Ġpanc re
cyte s
Ġ log
Ġm as
Ġchem ical
vir us
ic t
P I
5 5
os pho
ĠC Y
Ġpo ints
Ġ6 2
cyt osine
Ġerad ic
gan ization
Ġpromote s
Ġcytomet ric
er ing
ĠR e
T K
Ġh and
Ġint r
Ġinflamm ation
p os
ĠOn ly
Ġg emtuzumab
Ġsequ ential
Ġsour ce
ĠC H
Ġassoci ations
Ġnucle oside
p eroxidase
ĠS M
Ġmost ly
Ġmain tained
Ġf l
Ġn g
Ġcomple ment
Ġp aren
Ġ6 3
21 0
Ġv ary
ĠF ive
O D
Ġadd res
Ġproduc t
Ġconsider able
in dependent
Ġbi o
5 1
Ġw ay
rial s
Ġun d
Ġext ent
e qu
ap s
AP K
el s
A A
Ġs i
Ġemplo y
port un
MD SC
Ġfib ro
Ġspon taneous
ot al
Ġchallen ging
Ġdemethyl ating
B ritish
at a
us tr
Ġtransform ed
Ġguid elines
Ġsummar ize
I D
Ġor g
Ġdifferenti ally
te s
Ġs w
ver age
inte stinal
Z H
dition al
ĠOr ganization
vers ity
7 2
ren ce
d im
l ic
er tain
Ġ %
po iesis
Ġmig ration
Ġa plas
Ġwe ight
ĠCM ML
c le
Ġhem oglobin
Ġh ome
Ġin activation
Ġha em
Ġsor afenib
Ġaccur ate
Ġcon fer
Ġb al
Ġn ature
Ġsurviv ors
Ġop portun
Ġloc ated
g in
Ġaccoun t
Ġimmunosup pression
Ġproduc ts
Ġclos ely
en ias
Ġen riched
Ġallow ed
y R
Ġcarry ing
Ġcis platin
Ġ5 9
B CL
ex ist
effec tive
Ġproced ure
Ġcl ar
Ġpolyc ythemia
Ġbeh av
ĠD uring
7 6
b earing
Ġf ull
Ġ( >
Ġpre treatment
ore r
Ġnum erous
Ġenc oding
Ġthrombocyt hemia
ĠI d
Ġcontrol led
Ġis l
Ġcon ver
Ġsignal s
Ġconstit utive
L SCs
h azard
or b
Ġmet a
Ġma king
DN R
Ġques tion
t a
Ġl ands
ro intestinal
Ġe ti
ĠRNA s
Ġthough t
Ġb cl
ĠS ub
Ġpro s
Ġtre nd
Ġpo orer
Ġcompar ing
or in
Ġtool s
Ġdistingu ish
et h
Ġconc urrent
4 6
Ġenti ty
Ġrecommend ations
Ġn one
Ġfacilit ate
xim ab
ĠW orld
Ġpredomin antly
Ġel igible
m yelo
ĠCom bin
Ġtransi ent
Ġepithe lial
Ġiso form
Ġlen gth
c ol
o ura
Ġpro ven
Ġmod ulation
Ġgu ide
Ġrecipi ent
c ancer
is es
Ġcont ain
Ġachie vement
ak ing
op enias
Ġevalu ating
ph ysi
Ġtechn ology
Ġrational e
Ġm amm
Ġinclud es
Ġdown regulated
Ġclon ogenic
ĠH odgkin
qu is
Ġconsist ing
Ġharb oring
Ġl nc
th al
Ġattrac tive
+ /
M Y
Ġrecogn ition
Ġover view
Ġpred nis
Ġex cept
Ġcoun ter
Ġgl uc
Ġrespon ders
U T
s ess
Ġm TOR
Ġevalu able
Ġcorrel ates
Ġrati os
lo id
ol es
5 8
ĠD Cs
Ġdiss em
Ġbus ulfan
Ġappro val
li er
zyg ous
Ġs l
Ġth ym
Ġlen alidomide
ĠO ther
M M
om an
Ġt w
Ġmut ants
ĠK G
ĠD own
t ur
Ġcategor ies
00 4
Ġse p
9 3
ĠC o
k appa
ĠH SP
Ġ= .
Ġallow s
ĠR OS
Ġdec ade
iv al
Ġ6 8
Ġoxid ative
Ġspec t
Ġcoh orts
Ġcomor bidities
ĠC ox
C yt
Ġm is
Ġpatho physi
mac rophage
Ġbas eline
Ġdecision s
Ġreg istered
otherap ies
Ġstruct ural
S G
lu orescence
Ġimpro vements
Ġste p
os omy
ĠP gp
cri ption
ĠE n
Ġmic rosc
D espite
ĠW estern
Ġline ages
Ġ NA
Ġimmunophen otyping
on ic
Ġc opy
Ġpro ved
Ġdifferenti ate
Ġmain tain
Ġfeas ible
ĠBA ALC
Ġmyelo blasts
Ġtes ts
ĠAn alysis
8 2
Ġpap er
duc ing
Ġ200 0
Ġkill ing
Ġfeas ibility
D M
ĠR el
ĠCT L
Ġpregn ancy
Ġlands cape
9 1
ĠM C
LA G
9 4
ĠD S
Ġvari ation
Ġext rac
Ġadd ress
Ġtumour s
ic ro
Ġexpl ain
ost atic
otox ic
lo od
ĠH emat
Ġinvas ion
Ġimmun ological
Ġph ases
Ġinsigh t
ĠP C
8 1
Ġ ur
Ġdramatic ally
Ġp ain
Ġvalid ation
Ġc utaneous
ut inib
Ġalk yl
os min
Ġph ysi
Ġconstit utively
Ġul tim
Ġpar allel
ĠN ew
Ġble eding
re ady
oph osmin
ĠAcc ording
Ġc ereb
Ġinfec tious
gnos tic
Ġdelay ed
as ion
Ġpartic ip
Ġpersist ence
ac ute
ĠR eg
Ġpost remission
mon th
Ġinst ability
O H
ĠI D
omegal y
Ġmicro RNAs
ria m
k inase
Ġmyelo peroxidase
pec ts
Ġcyt openias
f ungal
Ġvir al
Ġd urable
Ġdefec ts
RA ME
Ġgrow ing
mac yt
Ġhydro xy
M yelodysplastic
Ġsequ ences
Ġal ready
Ġdisc rim
E G
Ġtumori genesis
ĠD AC
Ġloc us
Ġsubpop ulations
m ed
E P
Ġ7 1
Ġinflu enced
Ġdi rected
Ġins titution
Ġlat ter
us ted
C l
ol one
m an
ĠC ol
form ing
enc h
ĠAd ministration
7 4
the less
Ġsur ve
Ġm id
Ġsaf e
Ġchimer ism
Ġar ray
riam ycin
Ġ7 8
rect al
Ġ8 5
ĠOn c
Ġcle av
ec tin
Ġcon cept
mi R
Ġen tered
ne um
all ing
ĠE ZH
t ase
Ġas pects
ĠS R
Ġdiff use
Ġr ib
Ġgast rointestinal
lo rectal
Ġnec rosis
Ġpersist ent
ugh t
Ġun us
ĠCX CR
Ġhe av
Ġeffici ency
Ġanimal s
E C
am ycin
Ġwe ak
cell ent
ĠCM V
Ġh ar
ĠA P
Ġexam ple
Ġbenefit s
p ut
Ġvalu able
Ġcontrib ut
Ġear lier
E RT
Ġsup pressive
el ing
ĠS I
Ġamin o
D P
u pl
Ġcontinu ed
ar n
Ġconstit ute
v HD
Ġun de
ĠS ome
Ġint oler
Ġ6 9
ic ations
il arly
Ġat ypical
r ant
Ġas sign
transplant ation
Ġim aging
Ġpers onal
Ġpancre atic
Ġcont ent
Ġcan not
8 4
ic k
aun orubicin
tur b
i one
Ġid entical
Ġser ious
or ation
ild ren
RA IL
raf ted
I FN
er ved
Ġcar b
Ġc os
ĠP K
itu ximab
u tions
Ġex cellent
ĠD LI
Ġhem orrh
ĠT LR
Ġmod ul
Ġphen omen
ar ing
rin c
o blastic
ĠN UP
Ġs earch
sequ ently
m ented
Ġw oman
Ġres id
Ġregul ates
Ġlar ger
Ġexpand ed
al ities
Ġt urn
ub iqu
Ġrel ation
ĠD e
Ġtyp ically
it in
ĠH SCs
abil ities
Ġsimultaneous ly
pro tein
V L
Ġsched ule
Ġput ative
Ġbec ame
Ġcompar tment
Ġreactiv ation
ĠTo gether
at form
Ġp le
el ed
Ġplas macyt
Ġmed icine
Ġprom oting
ill ance
CT P
Ġatten u
Ġemer gen
ra z
ĠMP O
Ġbreak point
Ġderiv ative
Ġad ded
all ed
Ġsc ores
ĠT dT
quis ition
es e
Ġdef iciency
Ġenc oura
Ġrel iable
II I
Ġspl en
ffin ity
Ġimmunohist ochemistry
Ġimmunohist ochemical
Ġlig ands
Ġc atal
ĠA r
ib r
Ġsh if
Ġhighligh ts
Ġmultic enter
t wo
g or
um in
Ġext racellular
ĠCom plete
log y
Ġprec ise
Ġch lor
Ġiniti ated
Ġer a
Ġso ught
ges t
6 3
Ġsc oring
gor ith
Ġinvol ves
Ġcateg ory
Ġco lorectal
Ġdatab ase
las si
Ġpre vention
und red
F AB
ac tic
Ġclinic opatho
Ġthromb osis
Ġiss ues
Ġdetail ed
M e
O N
an alysis
Ġavail ability
Ġmet aph
ogen es
Ġaffec ts
at ase
id ne
Ġreac tions
Ġa ug
Ġal gorith
ĠR FS
Ġ200 8
Ġgra d
Ġunus ual
hem otherapy
Ġmyel osup
Ġpatho logical
ĠRA EB
Ġst ability
ĠIn hib
Ġpres ents
Ġpromo ted
I DH
g reg
th rough
Ġy iel
Ġt en
ĠComp ared
Ġd ual
Ġderiv atives
ra w
plant ation
Ġdis mal
ĠW he
com mon
Ġelect ro
Ġpredict ors
P S
Ġex c
tim al
Ġreas on
E s
Ġr h
Ġpl atform
f lu
ab in
qu id
com p
con t
ot ent
kappa B
Ġhydroxy urea
ĠM F
ag ent
l ink
Ġcomplex es
Ġsupport ing
Ġve ct
Ġt aken
Ġp air
Ġanti fungal
ĠN e
ĠTh irty
Ġro b
ix ed
Ġlip osomal
Ġenti ties
Ġgenetic ally
Ġrec ons
ĠE v
Ġnic he
re ction
Ġ7 3
Ġdemonstr ating
Ġstatis tical
Ġb is
ve red
Ġsim ple
si es
Ġac quisition
ĠH SC
ĠP RAME
Ġav oid
Ġblock ed
Ġemploy ed
ĠT ar
Ġmon otherapy
Ġsubstan tially
7 8
Ġp y
ar abin
ur an
Ġmon ocyte
Ġbenef icial
ĠRA R
B V
Ġk idne
e ti
Ġun ivariate
cell s
Ġtranspor ter
Ġdiv ided
Ġrob ust
O P
Ġun s
Ġmon osomy
Ġint rinsic
Ġrecru it
Ġph ospho
a urin
Ġcycl ospor
on atinib
Ġalter ation
ĠN ever
Ġdisc overed
Ġamoun t
ed ed
ĠA C
ia bility
Ġimmun od
Ġh undred
ĠC AL
Ġiss ue
Ġsubc utaneous
ĠMPN s
DN MT
Ġinvestig ations
Ġcolon ies
Ġf as
ĠStud y
ĠE ight
di rect
z ing
Ġlip id
Ġp neum
i etin
ost aurin
p atient
Ġb il
Ġsol uble
ĠOnc ology
Ġin effective
m ission
Ġenti re
u vant
Ġm Ab
8 9
Ġprom ise
I s
) :
ov ascular
Ġsign alling
Ġonc oprotein
Ġpur ified
ĠS ystem
Ġmod if
immun e
al ian
ĠNever theless
5 9
ĠS uch
Ġ7 6
l im
ch an
av o
Ġsi RNA
Ġsl ight
Ġfront line
Ġcleav age
Ġf ibrosis
in iti
y ond
ĠP U
Ġad equ
Ġinter pre
ĠA K
Ġdescrib es
os es
Ġpar ad
Ġle ft
Ġcon struc
Ġintensi fication
Ġleuk ocytes
Ġexpression s
ym al
Ġcounter par
E D
Ġc en
O G
Ġp rinc
Ġr ight
ĠPro gnostic
Ġremark able
Ġmod alities
Ġrest ored
Ġelucid ated
Ġap plic
Im atinib
Ġd ensity
Ġsurviv in
Ġmod erate
w ing
om plete
re arrang
Ġd imin
ven ess
Ġelucid ate
Ġtra ditional
Ġ4 00
HD AC
Ġleukaem ias
Ġs low
all mark
Ġadhe rence
Ġmanifest ations
Ġr ise
ise ase
Ġultim ately
g round
s tit
och rom
Ġtyp ical
D L
Ġimmunod ef
si veness
ad en
Ġpros pectively
ol low
Ġpos sess
Ġcoun tr
Ġtel omerase
Ġneg atively
Ġill ustr
Ġplasmacyt oid
Ġblock ade
Ġbiop sies
ĠG iven
Ġinter n
Ġh allmark
Ġinjec tion
Ġw omen
ri x
Ġne arly
Ġcountr ies
ĠS ign
Ġrespon ded
go v
th ree
Ġ7 4
Ġcontrib ution
Ġret ro
Ġmuc os
Ġoff ers
avo urable
> =
Ġ q
Ġm ild
Ġchem os
ĠPre vious
Ġhaplo identical
M C
Ġc enter
x in
om ib
Ġl ost
Ġ7 7
di rected
lympho id
on c
Ġpower ful
ax el
ex pressed
ĠH CC
Ġmaxim um
Ġa verage
Ġspec ial
Ġstim ulated
Ġm en
Ġrev olution
pec ific
Ġ8 8
Ġflu ores
or te
om od
Ġf etal
ĠM MP
Ġab rog
Ġpl ace
57 1
u ary
00 6
Ġdri ver
ath ione
res h
Ġplatele ts
Ġatten tion
ĠT R
Ġallow ing
ri le
ĠS he
emb rane
mic ro
ar iable
Ġgen otypes
Ġneed s
imin ary
Ġeffici ently
oly tic
Ġpharmacok inetics
ac tivity
Ġmolecular ly
Ġaim s
Ġgerm line
lo f
ĠMY C
Ġalkyl ating
Ġinc omplete
Ġover l
Ġes cape
ĠC AR
ch lor
Ġmac rophage
ati tis
Ġfam il
Ġim medi
Ġt et
ro gen
D Cs
it ored
- (
] .
ĠH MA
ost at
Ġpo ol
Ġattem pt
ĠI P
Ġmon itored
Ġun common
Ġas c
lamm atory
MPN s
if orm
Ġma gn
ĠF if
of uran
Ġtransl ation
Ġparen tal
Ġsw it
Ġ ion
Ġdeterm ination
V EGF
Ġevent ually
Ġscre en
def icient
Ġne ither
Ġsus p
Ġreduc es
ol ute
c ting
iv es
ĠB i
N T
Ġhep atic
te ct
a ve
U S
ocar cin
Ġpre ven
Ġhist or
Ġhypomet hylation
Ġmod ulate
Ġli quid
Ġwor ld
Ġtw ice
p r
gra de
ost asis
l t
Ġb acter
Ġr ituximab
o tides
Ġprote as
ĠJan uary
Ġb o
ho l
Ġdeterm ining
Ġ7 9
ĠU S
Ġtechn ologies
ĠUn ited
Ġur g
Ġim ple
Ġattrib uted
0 6
Ġac cept
Ġne ar
ber rant
Ġvari ations
ar tic
Ġblock ing
z omib
in hib
it ation
Ġpneum on
ti f
Ġpl an
I ST
Ġrat s
Ġk inetics
Ġf ram
vir al
Ġgreat ly
Ġpathophysi ology
oly sis
ĠM ed
Ġcont ained
ĠCh ronic
inf lammatory
p erg
ĠS out
Ġflu id
al an
Ġres c
Ġprom in
13 3
ĠT reg
cl uding
Ġpreferen tially
y r
Ġstim ulating
Ġrever sed
oc ellular
Ġ8 6
Ġle uc
Ġmedi ate
Ġvac cin
ench ymal
i pro
Ġdiscus ses
Ġintro duced
ĠT HP
ĠL FS
Ġ8 1
Ġincorpor ated
Ġtrig g
ĠIn de
phosph ate
ĠIT D
m L
Ġanti apoptotic
b rile
t ox
Ġbe yond
Ġv iew
Ġreflec t
Ġtel om
ost atin
lympho cytic
Ġemergen ce
ĠM K
Ġgener ate
G O
Ġ ed
elo w
ĠM any
Ġkidne y
ĠT BI
omic s
rearrang ed
ra ys
00 8
Ġsign s
ĠN on
Ġdereg ulated
Ġbehav ior
l in
Ġre plication
ĠT RAIL
Ġma ke
ifferenti ated
ĠI GF
ensi vely
Ġregard less
ĠNot ably
Ġmobil ization
Ġeti ology
verex pression
Ġvar ied
Ġbel ong
Ġf resh
ĠAra C
Ġcur ve
Ġmeasure ment
ĠCY P
Ġco ag
Ġlimit ations
ofuran osyl
ĠA SCT
ĠER G
Ġ ubiqu
Ġscre ened
Ġre ach
Ġup d
Ġgli oma
orte zomib
Ġg rafts
oid s
Ġcaus ing
Ġtranscript ase
atis fact
Ġleukem ogenic
Ġunc ertain
Ġbi ochemical
Ġradi o
Ġabs ent
ĠSe ven
C BF
Ġactiv ator
arran ted
Ġenhanc ing
lof arabine
M ML
ific ant
ĠF MS
ĠS er
Ġphosph atase
orm ally
ĠF as
Ġsep sis
Ġphenomen on
perg ill
R FS
Ġques tions
oc c
Ġpersonal ized
ĠI FI
ĠF ood
ran d
ĠF rom
Ġabs olute
Ġrem o
Ġre pl
Ġel ements
Ġext ensively
zym e
Ġcardi otoxicity
Ġemph as
Ġcen ters
am il
term inal
Ġtoler ance
Ġquanti fication
Ġinn ate
ir ing
Ġimmun otherapeutic
it rate
reat ening
Ġstar ted
Ġde x
Ġprogres sed
Ġsil enced
Ġdr iven
Ġw arranted
lo ad
Ġbe aring
Ġonc ogenes
Ġp onatinib
ĠC B
Ġimmun omod
Ġsub cl
ĠAn ti
J AK
ol ic
ĠF ollow
Rec ent
a ut
Ġbel ie
Ġrepro duc
il ms
Ġcyt openia
ĠM utations
Ġext ended
Ġexce ption
Ġun iform
Ġqu ies
Ġmast ocytosis
Ġre pression
Ġst art
ĠS urvival
Ġclassi f
upl ed
n on
ĠA R
ĠA c
Ġc ured
Ġun ex
Ġant ine
Ġconsequ ence
Ġcontribut ing
Ġcyt ostatic
Ġhuman s
re es
ĠP P
ri ef
ĠL T
Ġexist ing
Ġaddres sed
ĠC CR
ort y
Ġdom inant
Ġv is
Ġenh ances
Ġb elow
Ġdep ending
Ġb ound
Ġn am
Ġop en
Ġconcern ing
Ġacet ylation
Ġare as
Ġhe art
ĠAB CG
Ġly sis
Ġin direct
Ġinc id
19 9
p hen
Ġen rich
ĠRes earch
Ġdissem inated
Ġad oles
Ġ ide
Ġen able
lec tively
Ġa x
ap pro
Ġreac tivity
Ġc op
uan ine
Ġincub ation
m yeloid
Ġhyp ox
f our
Ġf it
ĠS econd
Ġsm ok
Ġanalog s
Ġkary otypic
Ġantibiotic s
ĠC a
ĠM V
cl usion
Ġmal es
Ġcarcin ogenesis
w w
os ing
ens us
ĠC A
ĠS p
ĠN HL
atisfact ory
Ġorg ans
Ġre ferred
par ag
o ff
ĠF DA
Ġselec t
Ġnucle ophosmin
Ġin ser
ar di
Ġep is
Ġtrig ger
A d
Ġso le
Ġepid emi
M B
p ted
ĠI ts
th ym
ĠPh ase
Ġvar iability
Ġso ft
Ġac ts
Ġ9 6
initi ating
Ġantine oplastic
Ġcl ose
Ġmeas ures
Ġlocal ization
Ġsummar izes
S R
Ġa ffinity
Ġfocus es
Ġevid ent
Ġeradic ate
ati d
Ġd im
dr iven
Ġth i
Ġintern ational
ran ial
ĠH ox
ari al
ten tion
Ġsuppor ted
Ġrecruit ment
w ays
re active
tiv es
ater al
Ġsepar ate
Ġst rain
ign ant
Ġa w
iv ely
Ġg ive
SC C
Ġstim ul
Ġcardi ovascular
Ġdynamic s
ĠT F
Ġde b
Ġsurviv ed
Ġpot ency
ĠCol lectively
he resis
red uc
Ġinter ven
Ġintegr ated
Ġencoura ging
ren t
s ide
er c
00 7
Ġap plications
ĠAl logeneic
Ġal log
form ation
Ġfunction ally
Ġstandard ized
ok al
Ġben z
SC LC
Ġab er
ĠL C
15 5
def ined
Ġdecreas es
Ġglut athione
re tin
Ġst op
Ġcomplex ity
Ġposi tively
Ġphysi ological
u x
ĠT CR
ĠM MR
ĠCh ildren
Ġestim ate
Ġsubstr ate
Ġmain taining
Ġp ron
Ġr ing
Ġclar ify
l it
Ġsetting s
ĠER K
Ġcon st
ĠE L
Al logeneic
Ġb rief
ĠA z
ĠB u
ĠST I
Ġfe brile
Ġres pir
Ġmim ic
Ġl act
f or
ĠP o
Ġbas ophil
L SC
oun ced
po lym
Ġsuppor ts
Ġparad ig
Ġcomp osed
ist ent
Ġdys regulation
Ġrelap sing
feren ce
Ġelimin ate
A r
E x
Ġ8 4
AT O
Ġenc odes
ĠT RM
ĠS H
ĠO ut
rim ary
19 5
Ġdepend s
Ġpromin ent
ĠM on
qu iring
Ġconsist ently
ĠSt ates
Ġcatal y
th reatening
N HL
Ġal ways
Ġwh at
Ġneutrop enic
Ġtranspor ters
m all
u ed
Ġcorrel ations
Ġeosinophil ia
CM ML
Ġmyelosup pression
Ġc DNA
ent ric
ec tive
tiv ariable
Ġprob es
y ro
hydro xy
ĠCurrent ly
ethyl ated
Ġallel es
athe cal
CN S
Ġconsequ ences
Ġactiv ate
Ġdu plications
Ġstrom a
Ġclear ance
Ġback ground
Ġprinc ip
ĠM echanis
ĠM olecular
app ing
Ġadj uvant
Ġdeg rees
Ġcom plicated
urac y
rest ric
Ġes cal
ĠD A
Ġsub un
Ġequ al
Ġsubpop ulation
ĠStud ies
ur y
op timal
b al
us ively
si vely
Ġreas ons
Ġrepe at
Ġassign ed
an g
ĠH ist
Ġt end
Ġfocus ing
Ġpanc yt
ocarcin oma
F A
ograph ic
Ġrepe ated
b e
ĠB ax
Ġimmun op
press or
m g
m ing
ĠE p
Ġadequ ate
x imal
Ġle thal
las s
Ġar ter
elph alan
Ġd one
ho ut
ĠG r
Ġext ra
Ġtransi tion
Ġloc i
Ġmegakary ocytic
n t
Ġhe ad
Ġhom o
Ġproble ms
I AP
ĠD ata
Ġinf ant
o blastoma
on or
pro gen
ĠHOX A
Ġm ate
ment al
Ġcompar ative
ĠA kt
Ġa round
ĠB lood
Ġrec or
Ġob tain
Ġ8 7
Ġsecre tion
R es
T L
or pholog
Ġto p
ĠD R
Ġ8 3
Ġes ter
L euk
f ive
in ternal
Ġutil ized
ti ple
at ch
Ġorig inal
Ġ9 2
Ġinterval s
Ġconjug ate
Ġmicrosc opy
rom ised
ĠF orty
Ġdete cting
Ġinvol ve
ĠB PD
Ġnew er
Ġprob abilities
ok ine
link ed
Ġth ro
Ġex pect
ĠM o
Ġar ising
Ġfluores cent
Ġenrich ment
C E
or o
Ġmod est
Ġother wise
tect able
T BI
im ination
Ġacc uracy
ĠAB CB
Ġprevent ing
g ue
ĠS ET
Ġcare ful
ival ent
Ġmid ostaurin
ĠPK C
ad der
ort un
Ġphys icians
Ġbind s
ochrom e
t ro
Ġdis app
Ġmicro g
Ġfusion s
Ġun its
od ium
ĠF OX
Ġcontrib uted
Ġisl and
Ġvaccin ation
Ġpron ounced
v as
oc itrate
ĠP er
Ġra d
Ġb ortezomib
ac lit
ger y
Ġdefin ition
Ġauto immune
Ġpe ak
aclit axel
M G
ĠN ine
Ġimpro ves
Ġt ub
ug hout
Ġeng ine
Ġth res
Ġmetabol ites
Z F
s ense
Ġsplic e
Ġstar ting
ĠBPD CN
ar g
ĠA g
Ġel imination
Ġpharmac ologic
Ġprophyl actic
ĠInhib ition
el f
Ġ8 2
Ġsynthe tic
T reatment
Ġe th
Ġne ver
Ġsur g
cell ular
Ġappear ance
Ġco oper
Ġtransfusion s
Ġproced ures
ati bility
Ġe as
si x
ĠC G
ĠF lt
ad ap
Ġnan op
Ġmyelo cytic
Ġpep tides
Ġpair s
Ġw arr
Ġsever ity
Ġfew er
in os
ĠT K
Ġanti proliferative
Ġcytoplas m
et ween
Ġonc ology
Ġclin icians
T ERT
Ġlocal ized
Ġaccept able
e ight
t rials
Ġclass ical
arabin ofuranosyl
C Y
m TOR
Ġinterven tions
ĠAl so
otyp ically
C y
Ġ9 3
Ġprote ctive
Ġintr athecal
Ġheav y
o virus
on ine
et ry
tiv ir
ox id
exist ing
l ip
as one
Ġcontin ue
ĠFollow ing
row th
Ġprote ction
Ġinfusion s
Ġcalc ulated
Ġpreven ted
ĠCon versely
ĠIP SS
Ġtelom ere
Ġn M
Ġbas ic
Ġmulti lineage
Ġdeterm in
l ation
ol ved
olog ists
Ġran ging
ipro cal
ĠP MF
Ġdri ve
Ġor ally
ĠN RAS
Ġproteas ome
Ġthro ughout
ortun ately
0 7
es ted
Ġnucle i
ĠU CB
parag inase
Ġpneumon ia
or a
Ġmeas urable
M y
Ġ ent
Ġprof ound
ĠM arrow
trans fer
rec ip
p ed
Ġre n
oc al
Ġon ce
ĠS ur
ĠNot ch
Ġmut a
Ġhemorrh age
am eth
Ġpredisp osition
in ter
Ġmamm alian
Ġn m
ĠF c
eren ce
ĠE P
par ame
Ġmeasure ments
ĠM G
Ġbiological ly
Ġperiod s
Ġins uff
progen itor
Ġleuk ocytosis
Ġolig onucle
TK D
adap ted
r s
Ġd ig
ell ing
Ġab und
tero id
de h
The re
Ġdiagnostic s
Ġfemal es
angi ogenic
Ġpancyt openia
7 37
ĠD L
Ġcons ensus
Ġsuscepti ble
ĠPA RP
od ed
Ġindic ations
parame ter
et hod
ĠI RF
Ġcounterpar ts
N et
iv otal
Ġfrac tions
Ġimmun ologic
ĠBM I
ĠA D
ĠM ut
S NP
Ġc y
olec ule
ameth asone
m ean
ĠIg G
Ġnanop artic
Ġc ut
Ġf avor
Ġpercent ages
Ġsurve illance
Ġre tained
Ġg ran
ĠN ational
Ġsus pected
Ġexcl usively
Ġdecreas ing
C FU
Ġc re
Ġan omal
Ġar ms
Ġgenetic s
Ġ #
in ate
ter ing
Ġpharmacok inetic
Ġnon relapse
Ġpromo ters
polym erase
S M
Ġmat rix
gl ut
Ġm us
Ġcalc ium
Ġsplen omegaly
Ġrevolution ized
Ġp ivotal
Ġpro grams
Ġexist ence
i versity
Ġre tention
Ġst abil
ĠM SCs
Ġprob e
Ġinteg ration
ĠDec ember
Ġrecons titution
ad j
Ġpart ner
Ġisoform s
ph oma
Ġpre l
ot rans
ĠH ence
ĠCh rom
ch ar
vers al
Ġindividual ized
Ġstruct ures
Ġmanifest ation
+ ),
K L
en es
tic ular
Ġco upled
ĠRes pon
Ġeff usion
Ġidentif ies
Ġindic ator
ĠD ifferen
Ġadop tive
E F
Ġimmun ocomp
Ġvect or
restric ted
0 8
in ducing
Ġp H
op le
Ġmes enchymal
Ġswit ch
ĠA A
Ġinter f
ĠP G
ĠS D
Ġpre p
Ġhere in
ĠSc oring
Ġvacc ine
is ation
es ides
ces sive
ĠId entif
d ec
k ed
ĠK n
Ġparadig m
rap eutic
jec tion
CA M
T NF
] )
ati ble
GF RA
Ġund ifferentiated
t ation
Ġvary ing
Ġrespir atory
Ġcyt os
mut ant
lympho blastic
Ġexer t
Ġmetaph ases
yro id
Ġb ul
ĠLeukemia Net
ĠH yp
ĠG y
Ġdimin ished
Ġcon j
Ġsur gery
U D
Ġdisc over
Ġposi tion
retin oic
Ġa id
ĠG erm
Ġadv ent
Ġamoun ts
Ġintoler ance
Ġinter ference
Ġestim ates
c an
c ho
k el
Ġun it
ĠN one
ĠCAL R
ag ed
com ing
CA R
Ġunde tectable
ĠM CF
ĠH IV
ĠW nt
ĠK MT
Ġimmun otherapies
S E
a u
Ġco expression
Ġinf ants
ĠCon sequently
ur k
Ġel ic
Ġar ise
Ġin her
ĠE arly
P ro
Ġtrans ferase
MR C
Ġmism atched
Ġshif t
M utations
ar com
ing er
Ġbe gin
Ġex ists
ier arch
G R
m olecule
ĠE M
os arcoma
ĠM APK
ĠThe ir
Ġaut og
L FS
ĠI DA
Ġglyc oprotein
Ġdisrup tion
C K
I NK
om ing
ĠF low
Ġenhanc ement
D LI
de ple
Ġpredic ts
Ġharb or
mal ignant
Ġprogram med
Ġvol un
n ed
Ġc lofarabine
Ġtrans m
ĠK a
ten sion
Ġfrag ment
Ġm elphalan
Ġy ield
Ġrepro gram
Ġtrans genic
Ġdifferenti ating
an ger
Ġl as
ĠP TP
ĠO verexpression
Ġsc i
ex t
Ġhighligh ted
og uanine
Ġtransf ected
Ġdereg ulation
ĠSR SF
Ġran ged
erg y
ĠCom par
en z
Ġm ening
ĠH ospital
Ġhem opoietic
Ġdef ining
ĠAK T
- )
Ġattenu ated
r ies
et ing
ri king
Ġanalog ue
H T
um b
Ġrap amycin
Ġrever sible
Ġminor ity
C on
f usion
Ġc alled
Ġag greg
Ġrec iprocal
ĠE le
Ġ9 4
Ġcarcin omas
Ġphosphor ylated
Ġslight ly
H SCs
ap lo
Ġsurviv ing
Ġmetabol ite
Ġdos ing
as et
Ġn odes
ĠN R
Ġevol ving
s ure
Ġb ar
her n
Ġimmun ore
Ġcr yp
Ġcer v
AN LL
) ]
un c
oc rine
ip hen
Ġin j
ap amil
Ġenh ancer
b ody
Ġs AML
os utinib
ol itinib
ĠR as
Ġsub optimal
Ġob st
Ġreview s
Ġaberrant ly
cal e
Ġxenog rafts
Ġbal anced
y de
in cluding
transfer ases
ho ld
Ġv es
Ġcontrol ling
ater nal
>- </
n ucle
Ġre quiring
Ġn od
Ġ201 7
ER K
Ġenvironment al
ĠS okal
Ġdat aset
ĠFif ty
deh yde
ĠN GS
sequ encing
ĠPB SC
Ġdiscontinu ed
Ġpa ediatric
Ġprel iminary
Ġiniti ating
ĠAT G
Ġtoler ability
Ġ ult
Ġne ur
Ġrepres ented
Ġhyperm ethylated
ĠAddition al
Ġaplas tic
Ab s
ĠA F
Ġgen der
Ġmitochond ria
cl usive
Ġprim ing
Ġform ed
ĠSim ilar
Ġvacc ines
her in
Ġ9 8
Ġepis odes
Ġpro ce
ĠC enter
Ġover t
Ġob vious
Ġocc up
Ġerad ication
Ġsurg ical
R IC
er y
Ġn it
Ġobst ac
Ġs qu
Ġis ocitrate
Ġ8 9
of luorescence
respon ders
Ġsynergistic ally
le vel
ist ance
> )
Ġprom pt
mi RNAs
Ġcos ts
ator ies
Ġdys regulated
ethod s
0 9
ac ed
ux olitinib
ĠD ue
ĠL A
Ġits elf
clinical trials
ĠMT X
cont rol
Ġimmunomod ulatory
S t
Ġf inal
Ġ2 001
Ġcyt ochemical
Ġben ign
p osed
Ġe ct
Ġh old
ur ip
RA EB
Ġbreak points
atid yl
Ġc oding
ter ior
Ġma k
Ġeffic ac
ĠAB MT
Ġsensiti z
ĠInde ed
Ġad mission
ĠE BV
Ġalk al
Me ier
e al
y e
ĠT r
um our
Ġdiff ered
arcom as
N C
W HO
Ġre tic
Ġcop ies
el i
The rapy
Ġf il
ĠG vHD
Ġmicro grams
ĠM icro
Ġad riamycin
Ġsmok ing
Ġves ic
C EBPA
Ġf und
ĠW ilms
Ġreg ular
ad herin
Ġassess ing
ĠCC yR
Ġrem od
Ġprognostic ation
Ġclas ses
Ġset s
Ġgluc ose
a emic
Ġlo ad
Ġmit otic
ĠKa plan
ĠM AC
enti ally
ogen icity
Ġvit amin
Ġsusp ension
Ġn ode
reg ulate
Ġser ial
Ġhom olog
Ġanalog ues
ĠMT T
Ġaccur ately
Im mun
Ġprednis one
Ġac tu
tit ative
Ġfibro blasts
Ġin versely
is ons
Ġdis t
n ine
Ġs odium
ĠIn t
Ġprolifer ating
Ġphys ical
v i
Ġprac tical
Ġmegakary ocytes
Ġspect rom
ĠA ut
Ġres olution
Ġanti sense
Ġtr ue
ĠK i
Ġaber ration
w ay
ĠA M
Ġimmun os
Ġcollec tion
Ġincid ences
se ud
Ġpl urip
Ġref erence
ic he
ĠF irst
ĠSim ilarly
vas ive
Ġinc l
til ity
Ġconsid eration
Ġstim ulate
Ġvolun te
H G
te t
Ġs ulf
di tive
Ġvalid ate
ĠĠĠĠĠĠĠĠ ĠĠĠĠ
Ġactu arial
ro us
ĠM PL
Ġsm ear
Ġbul k
c itabine
o yl
Ġp aclitaxel
Ġchrom at
Ġaplas ia
recip itation
Ġrespon ding
crib ed
iab ly
Ġlnc RNA
it ol
ĠT en
ĠGen ome
Ġmate rial
in ely
ĠC E
ig her
ac rine
Ġcon gen
form ed
ort al
Ġdos age
Ġcirc um
v ent
Ġcom mun
Ġstrati fied
Ġsynthe sized
a e
Ġocc asion
Ġm ach
Ġg el
ĠIn ter
cri pt
ĠGST T
(+) /
Ġequ ivalent
eti tive
se ven
Ġunc on
Ġmetast ases
h ion
Ġd erm
am inase
Ġ201 6
ĠUn iversity
bil ical
Ġsubstr ates
e b
p ing
ĠB P
Ġag on
Ġhypox ia
Ġconf ers
Ġhist ological
D X
m t
Ara C
MY H
Ġapplic able
D s
em citabine
Ġass um
cl onal
ĠRel apse
Ġprep ared
R s
c ents
Ġbar ri
Ġrespon siveness
ĠCell s
Ġm il
ĠI K
Ġha ir
Ġper turb
Ġinterfer ing
Ġlnc RNAs
Ġax is
Ġadj usted
Ġintensi fied
I g
Ġh ierarch
ig u
Ġex act
Ġcyt ochrome
get ing
Ġdex amethasone
8 35
00 9
ĠL ow
Ġ9 1
Ġacid s
ĠET V
through put
en in
Ġerythro po
Ġlat ency
Ġinher ited
it one
oplas mic
ĠAccording ly
Ġyiel ded
Ġb ase
Ġcon ce
Ġad mitted
ĠL RP
Ġmak es
ĠC d
am ous
Ġ3 00
Ġcomple ted
Ġdi rection
RAR alpha
ĠJapan ese
w ith
ros p
ĠUn der
Ġhelp ful
Ġpreval ent
Ġchemos ensitivity
v ascular
w ed
Ġm ess
Ġsho ck
Ġdevelop ments
Ġuseful ness
Ġenc oun
PB SCT
N CT
on in
Ġs par
res pective
gen s
ause a
Ġsuff ering
Ġj u
Ġlabor atories
D a
b l
Ġind ication
ĠS K
Ġinte ract
opath ic
Ġlip osomes
Ġsensiti zed
e ff
Ġab dom
Ġmul tivariable
Ġ19 90
ĠEx per
P s
Ġ15 0
Ġconjug ates
Ġelectro pho
er ating
ĠS U
all i
Ġconver sion
Ġv ess
Ġsup er
r d
he rent
Ġst ates
Ġpur ging
Ġprednis olone
Ġple ural
Ġthres hold
id enib
Ġembry onic
Ġbl adder
orb ol
Ġcontain s
x L
ĠA RA
tic os
st age
Ġcol lab
A kt
Ġf at
Ġinvestig ating
Ġincl usion
H SC
l ines
op es
ĠCR EB
Ġdomain s
in one
ĠG C
ord ance
Ġopportun ities
i ers
Ġtr yp
Ġcyto reduc
Ġd ie
ĠT GF
ĠI R
Ġinvestig ational
raf ting
Ġexhib its
PT D
Ġdetermin ants
Ġd est
Ġinj ury
ed uc
ĠM e
Ġcom pl
Ġsur rog
ĠE m
Ġmechanis tic
I t
s urvival
ol ip
Ġlim iting
G T
al k
ch rom
Ġhist opatho
Ġblock s
d iagnos
m ism
Ġmod ulating
Ġnetwork s
ĠSI RT
> <
d raw
Ġh orm
ĠA Z
Ġmedi ators
PM F
Ġhist ocomp
AG E
Ġcyclospor ine
M yc
an ding
RA RA
Ġrepor ter
Ġadap tive
Ġalgorith m
Ġch ance
cy cle
Ġlow est
Ġfund a
x l
Ġc at
ĠM UC
Ġsur v
on y
is c
Ġres our
Ġrec ur
W BC
Ġ9 7
ĠUn f
Ġcompr ising
Ġbenz ene
Ġform ulation
Ġreduc tase
Ġbacter ial
V P
Ġb osutinib
Ġn ormally
th i
Ġbi os
Ġbec oming
c are
Ġdi versity
ev ent
Ġrepresent ing
u ly
Ġproduc es
Ġside ro
er ve
am ination
ĠS h
Ġint rac
adi ly
in form
os ity
pr ising
Ġqu al
Ġdel ine
Ġneut ral
Ġhomo zygous
a ro
Ġv al
ĠL ong
B A
Y K
Ġh r
am ily
Ġman ip
A SCT
Ġ um
Ġimmun ofluorescence
Ġmulti p
Ġimportant ly
Ġinte resting
stim ulated
MN s
target ing
ĠF A
Ġspectrom etry
Ġsurv ive
Ġanti oxid
Ġenzym atic
pro ximately
ult ure
Ġacc ess
Ġext end
Ġlim its
Ġadvant ages
ĠSign ificant
M MR
l ife
ia z
ul ates
ac onazole
Ġprot o
Ġpart ly
Ġexcl uded
Ġsour ces
Ġtransm embrane
F C
ver sion
Ġ9 9
Ġimmunophen otypes
Cl inical
lim iting
mism atched
ici an
Ġhome ostasis
Ġbal ance
ĠSout hern
Ġtim ing
Ġum bilical
R OS
s mall
Ġc ys
si l
ĠIn d
Ġtem por
Ġsubun it
Ġsqu amous
P N
Ġt rac
Ġo c
ĠR em
Ġcol l
A IR
u zumab
Ġneoplas ia
Ġunf it
Ġir respective
Ġincorpor ating
deple ted
P K
p rom
ĠC s
ĠJ un
Ġthromb ocytosis
Ġconsider ably
c adherin
Ġt ract
K it
p in
am b
Ġrout inely
ocar di
Ġh ope
ĠB R
Ġimmun o
m aking
tero ids
Ġadoles cents
Ġlympho proliferative
Ġconstruc ted
Ġconj unction
ĠUnf ortunately
pres ent
Ġel usive
omet ric
MP O
Ġrelationship s
Ġregard ed
Ġprepar ative
Ġn ausea
Ġcontin ues
Ġtri ple
Ġadj ust
Ġcryp tic
ap heresis
ĠO R
Ġneuro blastoma
Ġconcern s
Ġpe ople
Ġhaem opoietic
Ġuns atisfactory
Ġwith draw
Ġdele ted
Ġenabl es
Ġtrigg ered
iche amicin
Ġc od
ant h
RA F
Ġselec tivity
Ġoptim ize
Ġste ady
Ġmism atch
ĠR R
Ġcor rect
tim ulatory
Ġ201 0
Ġlact ate
A MP
ine age
Ġmod ality
Ġreveal s
Ġy r
Ġan aemia
Ġto m
Ġres emb
ĠL ym
Ġinter s
ne xin
Ġdistin ctive
respon sive
Ġn ut
Ġcon n
ĠV P
Ġsched ules
chan ged
Ġpatho logy
Ġ200 5
Ġsaf ely
Ġlik eli
Ġlikeli hood
Ġas pergill
Ġper sis
Ġph ag
Ġmulti parameter
r c
Ġp al
Ġb ac
ĠM a
ill ary
Ġrev ised
Ġengine ered
Ġcy tidine
iphen otypic
Ġh TERT
od ynamic
cept or
Ġquies cent
s a
ĠH igher
Ġad ditive
ĠD isease
sel ected
1 210
Ġp alli
Ġpatho logic
Ġbil ateral
Ġcoag ulation
arabinofuranosyl cytosine
Ġf avourable
ur ora
2 01
ot rop
ĠC CA
Ġhighligh ting
Ġresid ues
Ġclinicopatho logical
Ġworld wide
Ġt ake
Ġs enes
ati gue
Ġres pective
Ġcom b
Ġsh ared
Ġpers ons
ĠMechanis tically
Ġcongen ital
m o
m yc
Ġa GVHD
ĠN CT
Ġnon coding
ĠT umor
lo red
Ġun changed
ĠS oci
Ġco vered
ĠN or
Ġsup ple
Ġra ised
IP SS
Ġelect ron
hemat ologic
Ġefficac ious
Ġ2 50
Ġstudy ing
ensi ti
Ġcardi omy
f amily
Ġtransf ection
Ġex osomes
we ek
ĠmRNA s
ĠCBF B
Ġtransl ational
Ġhis ti
Ġser ine
Ġsynerg y
Ġconsider ing
Ġsummar ized
m C
in a
Ġp ts
Ġar g
inform atic
ĠS A
oci ation
Ġimp ac
trans l
the rapy
CG A
Ġlys ine
Ġbegin ning
ĠC or
ĠIn duction
Ġmod ern
Ġhuman ized
umor al
Ġparame ter
Ġinn ov
Ġd iab
Ġpres um
38 8
Ġver apamil
amin o
ĠInc reased
Ġencoun tered
Ġde oxycytidine
ĠP l
ĠJ MML
er ative
ĠF uture
unction al
Ġman age
Ġcerv ical
M O
P re
w t
ĠH O
Ġtherapeutic ally
Ġ201 3
Ġmim etic
Ġnam ely
v s
Ġp ilot
ĠI f
Ġim plic
ĠS P
ĠPh armac
Ġinflu encing
Ġins tit
Ġg emcitabine
Ġr uxolitinib
Ġnanopartic les
p red
ĠH U
Ġnon lymphocytic
Ġar ch
Ġindic ators
Ġrandom ly
Ġdistingu ished
Ġsurrog ate
Ġac tin
Ġco operative
Ġclus ters
Ġrestric tion
Ġaden ocarcinoma
Ġretro viral
Ġmagn etic
8 16
Ġs em
Ġpro ve
Ġinter cal
Ġsibling s
Ġexer ts
Ġopportun ity
ĠL i
plas ia
Ġrearrang ed
M CL
Ġn ull
av ail
Ġlack ed
Ġmucos itis
tivir al
ĠH u
ir th
ĠD n
ep tide
b o
o gn
Ġcom m
Ġrespon sive
ĠME K
Ġimpair ment
ĠC O
Ġinf requ
cy c
Ġpatho genic
ulf ite
Ġfunda mental
E p
T RM
Ġs arcomas
Ġf inally
ĠF LAG
Ġk ind
Ġblot ting
urac il
3 00
ĠH A
Ġ12 0
ĠMul tiple
ac ent
il tr
ĠM A
Ġ5 00
ĠG VL
Ġbreak s
ĠTrans plantation
Ġemph asis
Ġterm ed
Ġfol lic
Ġcor ticos
ĠV PA
12 5
Ġmit ogen
ai lored
Ġhom ogene
ĠCDK N
A c
por ted
Ġexpos ures
Ġvir t
ĠSix ty
methyl ated
chlor ide
Ġper me
lassi fication
ĠP FS
ĠMS I
M icro
T yrosine
um i
reg ulating
I G
N GS
Ġp aired
Ġmyelo poiesis
ĠI A
ĠF T
ĠMed ical
o L
p a
Ġup stream
Ġtranscript ome
pre ad
ste p
s h
uc ifer
Ġch ap
Ġtrans duced
Ġcomp osition
de oxy
s en
od ies
Ġcomple tion
myelo proliferative
om iting
ol ent
Ġat tained
str ati
Ġhetero zygous
N E
Ġcons erved
Ġnucle us
Ġoff ered
ĠSoci ety
Ġenc oded
ĠSe qu
Ġchromat ography
in us
en tion
pres ses
yn ucle
13 2
Ġtom ography
. )
ĠLeuk emic
ucifer ase
Ġth yroid
Ġ200 7
Ġequ ally
ĠQ uan
M SCs
T R
n es
en h
ĠH OT
Ġadv anc
Ġinjec ted
Ġenabl ed
Ġbios yn
S everal
f ront
Ġt ail
te ine
Ġg lobulin
ĠP ost
Ġcategor ized
a fter
Ġb and
Ġintravenous ly
ĠWhe reas
ĠF ox
Ġbas al
Ġdefec tive
OC S
Ġclinicopatho logic
Ġaspergill osis
ro tic
Ġb rom
ĠM HC
ĠH ep
Ġmo tif
Ġneutrophil ic
Ġconjug ated
Ġhepat ocellular
ĠB a
activ ating
35 1
ĠJan us
Ġcomplement ary
Ġunex pected
H igh
ti tial
li um
Ġspl enic
Ġsecre ted
Ġmus cle
Ġvolunte ers
H OX
v ity
Ġc a
Ġmod e
Ġpar a
s cale
ĠS HP
ph al
Ġout side
Ġid i
fer on
Ġpredomin ant
ĠSNP s
Ġhar ves
ĠHOT AIR
C V
Ġc asc
te ction
um e
ox ynucle
Ġexplo ited
Ġcer amide
inf iltr
ĠTar geting
en ger
Ġv ul
pho ter
Ġisl ands
et ho
Ġsc a
Ġdel ta
Ġprec ision
Ġphosph atidyl
Ġprote ct
Ġen ergy
ag ic
ĠV ari
Ġkary otyping
Ġerythro poiesis
os ides
Ġtrans duc
ĠNo vel
phosph or
cep ted
Ġerythropo ietin
l ig
it ory
le x
Ġpro apoptotic
tim es
Ġform ing
Ġexhib iting
Ġmas sive
Ġw ww
as h
id in
trans cription
Ġso on
Ġprote omic
photer icin
Ġv ast
ĠP L
ĠK RAS
Ġdr iving
zyg osity
ĠGST M
Ġp arent
Ġf ms
ew ork
Ġurg ently
Ġreprogram ming
ĠR Q
ĠCX CL
H SP
p es
Ġse g
Ġquanti fy
Ġabrog ated
Ġc GVHD
el ve
Ġsyn geneic
osi te
Ġsc hem
c omes
Ġcur ves
myelo ablative
if ying
Ġind olent
Ġmic rom
Ġtes ticular
Ġfram ework
Ġimmunop recipitation
or tic
leuk aemic
Ġelectropho resis
R CC
Ġc ess
te rol
ĠT w
et ric
ous ly
Ġproportion al
adj usted
te ced
ĠE r
Ġantagon ist
Ġun able
Ġinfiltr ate
ras tim
Ġimmunodef icient
Ġimmedi ate
M RP
plo id
Ġz inc
flu oro
S H
S e
t umour
as umi
ac in
Ġex ogenous
Ġmorpholog ically
Ġ200 4
Ġimmunocomp romised
Ġs ear
le m
ĠO CI
Ġsec tions
Ġreco vered
Ġreflec ted
ĠB AL
ĠL y
Ġph ot
Ġel ement
PA R
mic rol
omegal ovirus
0 11
in ery
it ary
Ġsc al
prising ly
ĠL DH
%) ;
Ġsc an
az acitidine
stit ute
er ythro
Ġab n
Ġ hen
Ġan teced
Ġst riking
ĠM i
ĠN SCLC
Ġimple mentation
B u
Ġth or
Ġfollow s
88 2
C o
Ġinfec ted
g one
re pt
es pread
om er
Ġunder gone
ĠU RD
Ġwid espread
ĠA berrant
rac tion
Ġmic ros
Ġdi arr
rem ia
Ġsubjec t
col or
Ġ %)
Ġeffect ors
Ġsuppress ing
respon se
acet ate
Ġdeple ted
l nc
w n
Ġt ended
ĠH S
Ġne o
Ġaccoun ts
Ġsidero blasts
oc on
Ġha m
ĠR isk
ĠAs s
em a
si ze
ĠC K
ĠF L
cy cl
Ġlo op
Ġmodif iers
Ġbo y
Ġconst ant
d ds
Ġa ff
Ġre inf
ar m
Ġpre treated
ch aracter
Ġste ps
Ġinsuff icient
Ġp um
Ġac cepted
Ġreg istry
Ġdiagnos es
rel ative
ch ain
MT X
Ġsim ilarly
Ġlar gest
Ġrest ore
Ġcal icheamicin
D I
Ġper ic
Ġpatho genetic
Ġgrad es
Ġin verse
Ġw t
Ġf er
Ġg ave
od ds
erm al
G vHD
T C
ĠT L
01 5
AC S
Ġutil ization
ĠGene tic
b or
in ting
Ġper spective
hemat opoietic
onc ogene
infiltr ating
C S
Ġre induction
Ġre adily
Ġgli oblastoma
Ġcess ation
Ġf atigue
Ġinflu ences
Ġinfiltr ates
ĠWhe ther
H MA
c at
Ġb irth
si an
ĠS pec
Ġclon ed
thym ocyte
( +),
L F
he a
Ġs hed
Ġun met
Ġreport ing
Ġmy ocardi
BM C
Ġlab eling
Ġsuff ered
Ġidi opathic
al s
Ġform er
Ġtransform ing
Ġnec k
ect omy
i ent
ar ity
ir l
year s
Ġdef ect
Ġsystematic ally
Ġeas ily
Ġt aking
ĠP IM
ĠL e
yc osis
leuk ocytosis
Ġsepar ated
Ġfrag mentation
ension al
M yelo
c ons
Ġp or
Ġf inger
ĠM AGE
ros pective
Ġinte stinal
Ġextrac ted
arn ib
Ġproduc ing
Ġallel ic
Ġexpl ained
Ġfamil ial
t ol
ĠH sp
ust ine
Ġapparent ly
ĠCombin ation
Ġhistocomp atibility
Ġhen ce
o te
u tis
in ary
on ance
te ad
Ġcons ists
Ġmedi ates
ĠNK G
Ġpro jec
Ġex cessive
Ġchem okine
Ġ< .
Ġvia ble
Ġexcl usive
G L
h yd
l ined
ĠT AM
lo x
ap sed
Ġaccum ulate
Ġabdom inal
Ġanteced ent
p tive
reas ing
CT L
Ġcri tically
Ġdysplas tic
Ġbelie ved
Ġantioxid ant
C AL
Ġt ailored
Ġg irl
Ġeff ort
Ġampl ified
Ġresc ue
Ġpalli ative
B D
d aunorubicin
i re
Ġs oci
ate st
ĠT PA
Ġpro of
Ġsubcl ones
b it
w hile
Ġb iphenotypic
ate ll
ĠN RM
Ġdevelopment al
ĠPD GFR
Ġharb ored
Ġestablish ing
immun otherapy
Ġmach inery
otrop ic
Ġsenes cence
Ġinnov ative
C ancer
b ut
b ack
d es
gl uc
Ġalgorith ms
Ġplurip otent
Ġinters titial
ĠM ean
Ġv omiting
ĠTh rough
ĠK asumi
ĠAB O
ĠSt at
PB SC
Ġmodul ators
b ial
or ption
em ory
ĠI tal
ĠE ven
Ġdec line
Ġ200 6
Ġins tead
Ġdeli ver
m m
r uct
ĠS up
Ġam photericin
oxy genase
ĠCT LA
Ġimmunodef iciency
ĠGerm an
ar ma
Ġpos aconazole
Ġgre atest
tox icity
Ġo wn
ĠB esides
ear ance
Ġiniti ate
Ġcondition ed
Ġmegakary oblastic
loid y
Ġd raw
ic es
ĠS E
Ġchemo resistant
Ġinser tion
ut able
Ġdis turb
ĠBCR P
Ġknock out
Ġven ous
Ġattem pts
) ),
M ul
T ET
g r
v it
ĠH uman
ad rib
Ġvit al
Ġthromb otic
ĠCons istent
Ġre versal
et te
entif ic
ĠMD M
Ġcompr ised
adrib ine
Ġa ges
Ġactiv ates
ive red
Ġrele ased
Ġfar nes
Ġevol ved
ĠCs A
Ġeng rafted
Ġrad ical
re ceptor
Ġn ude
ĠT FR
ĠB e
ĠO ct
Ġag ing
Ġallo genic
cyt arabine
ĠDec itabine
Ġorg anis
entric ular
Ġin herent
op sy
ĠW h
OT CH
Ġremark ably
ifferenti ation
F L
ĠS N
Ġcomor bidity
lab eled
Ġr ub
Ġint act
Ġinf used
opo ietin
Ġcontinuous ly
Ġuniform ly
Ġinterf ere
Ġretic ul
b one
i ance
in ucle
Ġp en
ro x
ur ation
Ġres onance
Ġev asion
ĠG ra
Ġhe at
Ġg old
Ġtre n
ĠH b
Ġqu ite
trans formed
C X
G l
as paraginase
ĠD OX
Ġsup presses
12 0
ĠX IAP
Ġimmedi ately
i gen
Ġcon ferred
ĠS OCS
Ġdef icient
par tment
ator ial
Ġfrag ments
pos ure
Ġrecor ded
Ġbac te
o tid
Ġst ain
ran k
Ġprop ensity
Ġ200 9
Ġide al
Ġext ract
hes in
Ġpost transplant
oph age
Ġcyc lo
mod ified
K s
ran dom
Ġde aminase
ox in
Ġmeas uring
Ġaspir ate
I Cs
Ġin active
Ġf err
ĠM O
cap t
Ġinterpre tation
r ight
Ġchemotherapeutic s
Ġhistor ical
V s
Ġc athe
Ġchan ging
ord ant
Ġfl av
Ġfas hion
C AT
L M
os ts
ĠB etween
ĠL SD
Ġunder t
Ġmodel ing
ĠWith in
n ers
ute s
ĠU p
Ġmethyl transferases
IS A
to gether
erox ide
Ġvesic les
Ġm dr
Ġdis par
Ġdisc re
Ġferr itin
Ġrecogn ize
Ġirradi ated
fact or
ĠPTP N
ocon jug
R Q
Ġs olution
Ġg ained
Ġchan n
Ġ19 97
les terol
Ġquanti fied
lem tuzumab
Ġp ict
Ġcom mitted
ĠF GFR
Ġcod on
> :
P FS
Ġst ained
ĠD el
ĠPB SCT
EN T
Ġaspir ation
Ġaug mented
U R
ĠP SC
Ġsome times
ST RA
Ġprocess ing
Ġcap t
w h
im us
Ġen l
Ġpatho log
ĠCons id
re tic
ĠM ET
Ġprom pted
Ġsp re
Ġvol ume
Ġfas ter
Ġanomal ies
Ġect opic
g ranul
or gan
Ġdo ub
CM V
Ġdiv ision
Ġbio informatic
Ġvul ner
Ġst ren
ary n
SC ID
Ġreduc tions
Ġincub ated
Ġmedi ating
Ġmultiple x
ĠCTL s
Ġremod eling
itone al
Ġqual it
T G
h yp
Ġc utis
ĠM ay
ad s
Ġlymph atic
Ġrest oration
Ġplace bo
> .
I DA
q PCR
Ġres olved
ĠN OTCH
ĠJ NK
ĠAt las
Ġexperim ent
col ony
Ġcyclospor in
c lass
ĠS CF
Ġanaly zing
ĠCI K
Ġseem ed
Cyt ogenetic
ĠReg istry
Ġtend ency
rosp inal
E K
om b
asc ul
Ġubiqu it
Ġundert aken
i ver
Ġt e
Ġf ixed
Ġon es
ĠF luorescence
Ġepit opes
A berrant
N RM
is ter
Ġac ting
Ġover load
sel ective
Ġpara ffin
cat enin
Ġd il
rol imus
ĠAn other
Ġir re
Ġhep atitis
Ġglyc olysis
event y
n ic
Ġm emory
el igible
Ġtransplant ations
Ġcharacter ised
Ġmedi ator
HO P
Ġremo val
ophage al
Ġh sa
ff ic
ĠB E
Ġmedi ast
ti b
Ġclass ic
ati vity
ĠF C
Ġimmun ogenic
Ġag re
ct ure
Ġdel ivered
/- )
Ġj ust
k s
ĠS OX
ĠL AK
ven ile
Ġcataly tic
% ]
G r
Ġcyt omegalovirus
Ġdevelop s
Ġgener ating
allel ic
ĠIGF BP
ĠF unctional
Ġcons um
Ġloc ation
Ġstron ger
Ġpur ine
Ġnut ri
Ġw ors
Ġmet allo
ari um
Ġend points
Ġprec eded
CC yR
rain ing
ĠTrans plant
P gp
ĠIn iti
15 0
ring t
Ġj us
Ġattrib utable
ĠNe ither
h uman
Ġd ip
ĠP MN
lym phoma
Ġag o
c arb
Ġp seud
Ġchem otherapies
Ġen ter
Ġpre leukemic
Ġmarrow s
10 5
Ġ12 3
Ġrequire ment
Ġdepend ence
met abol
ĠTreg s
Res ults
Ġre jection
Ġsuppress ors
Ġcompr ise
ĠRe al
gin ine
Ġmess enger
O b
P P
t ub
ĠJ uly
Ġform al
mi RNA
Ġim plication
Ġanti leukemia
Ġover coming
Ġtr ich
lot arg
ĠEurop e
Ġdiarr hea
G A
Ġ urine
os ter
ra ble
ir teen
Ġco inc
Ġmon o
int ensive
Ġ200 3
Ġaccoun ting
dim ensional
ed ded
Ġe con
Ġun i
Ġinduc ible
Ġvar ies
Ġaccum ulated
Ġtri phosphate
EL N
Ġcluster ing
ĠmTOR C
Ġsci entific
character ized
ĠT T
ĠL D
BF M
Ġ201 2
Ġspecim en
Ġlog istic
Ġurg ent
tol erated
ĠN S
Ġlymph aden
Ġcompar isons
Ġprepar ation
ĠEle ven
Ġm aternal
gnos is
Ġout patient
MS A
ĠCo operative
ĠDn mt
Ġs pite
ĠA xl
ĠT A
ĠT G
Ġl ay
op urine
ĠP atient
Ġsmall er
ĠUn ivariate
Ġelev ation
Ġj o
Ġoverl apping
Ġplan ned
ringt onine
) ).
5 00
os f
Ġac l
ho g
Ġpre transplant
ĠAd v
Ġshort ened
Ġdefin itive
ĠTar geted
Ġwithdraw al
Ġpersis ted
Ġth alidomide
ce u
Ġmon osomal
Ġpre ferred
ple x
Ġtim ely
Ġup per
Ġsh are
Ar senic
Ġexpect ancy
F D
H I
T reg
Ġc ranial
ĠThe rapy
Ġrec ap
Ġar sen
Ch rom
lympho cyte
Ġsympt omatic
ĠSub sequently
Ġbiosyn thesis
d a
id ing
Ġex plan
ge hog
ĠS LC
Ġobser ve
Ġ19 98
Ġprec eding
ob ox
Ġdocum ent
Ġgrad ually
Ġobstac le
Ġcoll a
Ġh osts
ĠH GF
ub in
ĠIn stitute
Ġab ol
Ġlate st
Ġeosinophil ic
G VL
t rolled
om ain
ĠT ox
Ġex ons
ĠB ET
ĠO CT
ĠL Y
com plete
Ġfacilit ated
. (
B cl
ol l
ĠAm erican
Ġsubjec ted
ĠImmun ohist
Ġbarri er
Ġval pro
Ġarch ite
c er
e ve
plas tic
14 0
Ġconfirm ing
Ġconsequ ently
ĠAp proximately
Ġadjust ment
Ġfollic ular
STRA CT
t or
ĠA Y
ĠM ethylation
oc ortic
Ġg al
ĠR I
li k
ĠCh ina
Ġoptim ization
Ġisol ation
Ġmean ing
Ġparticip ate
Ġleuk apheresis
Ġv ascul
Ġgen otoxic
Ġsub s
Ġ12 5
Ġexcl uding
Ġtren ds
b umin
m ature
Ġf ung
ĠA I
st ances
Ġun selected
Ġco hesin
ĠCR C
Ġrepres sed
Ġsitu ation
Ġtem per
Ġescal ation
C CR
ĠIn f
Ġoverex pressing
Ġcollab or
Ġmultip otent
ĠJun e
M cl
Ġc ros
Ġm yc
it ud
Ġcomp etitive
Ġbec omes
Ġpart ners
Ġaden osine
Ġarter ial
atell ite
g rowth
i ety
Ġl if
Ġmod ulated
Ġunder l
otyp ed
Ġmemb ran
Ġrese arc
Ġreproduc ible
Leuk emia
Ġt rim
Ġc ry
Ġs ial
ph ing
th ase
ence phal
Ġdi et
Ġ19 99
ĠDL BCL
g u
Ġa CML
se q
Ġcom mit
gres sion
ag ement
Ġ20 11
Ġrecru ited
Ġextrac ts
Ġhorm one
arma ceu
h aps
u ter
ar s
ol ate
Ġad ding
art inib
ĠID O
Ġintoler ant
ĠC CN
Ġepigenetic ally
Ġmanag ed
inf ected
Ġester ase
inos itol
Ġrecap it
on om
is hes
Ġf used
CT LA
Ġmamm ary
Ġbis ulfite
Ġspar ing
ĠAZ D
lik ely
f ying
m RNA
s ur
uc cess
ĠM arch
Ġde oxynucle
Ġhetero genous
bil ities
ĠKn ock
ĠTw elve
er capt
Ġg ives
Ġmar g
Ġver ified
Ġmicroar rays
Ġembry os
Ġconce pts
4 12
H V
a ive
Ġf av
ĠPC NA
Ġconstitute s
G E
p at
ĠC ycl
if arnib
ĠP ediatric
ĠN etwork
Ġint ense
Ġmi xt
AK T
Ġelimin ated
Ġubiqu itin
Ġstrain s
H emat
b ound
Ġcl adribine
iz artinib
oph osph
Ġconfir ms
Ġunf avourable
oh ar
Ġutil izing
O ver
R el
ĠD iagnos
ĠL IN
CB T
H uman
y rate
Ġo wing
Ġl ibr
ĠH N
Ġint ron
Ġnucle ated
Ġhyper leukocytosis
acet ylation
ĠRespon se
H N
c umin
or atory
ĠThe n
ĠP F
ĠF act
ĠAl together
blast ine
Ġaug ment
tiv ation
ub ation
str uct
Ġins ulin
Ġdiscover ies
ĠC BL
th ird
Ġimmun ocyt
av ing
ade qu
Ġdeep er
lic ting
ĠVari ous
M ed
Ġo dds
Ġno te
Ġph orbol
est rogen
ĠIm pro
ĠLeuk aemia
Ġweek ly
Ġsear ched
ch ronic
cyc lophosphamide
Ġa lemtuzumab
uc tion
od omain
Ġpot ently
ĠHOX B
ohar ringtonine
C urrent
g rastim
Ġs inus
ĠP BP
Ġper mit
Ġinter phase
Ġprev ents
Ġrep er
ĠRAS SF
Ġminim ally
Ġdistinguish ing
- /
Ġre tain
ing ly
ĠS o
Ġphen otypically
Ġenc aps
Ġprepar ations
R I
Ġa ven
al ing
ĠP rimary
ir ubin
Ġinduc er
opt osis
Ġwork ers
Ġcho lesterol
Ġcarri ers
Ġw ays
ĠR S
Ġnot ably
Ġreveal ing
Ġprote omics
18 1
ympt omatic
Ġoverl ap
B T
ar ge
Ġh yd
ĠA DA
rim idine
ĠNo v
Ġhydro x
Ġtoler able
armaceu tical
c hemotherapy
Ġ ibr
ĠT ME
Ġfol d
01 3
Ġsh RNA
Ġtr unc
Ġsepar ately
Ġcereb rospinal
Ġvis ual
a res
b p
c hem
s AML
Ġp ure
Ġin oc
Ġto o
ĠF CM
Ġ18 0
Ġmobil ized
Ġsurve y
Ġprincip al
Ġoligonucle otide
Q OL
Ġex ternal
erg ing
Ġepit ope
Ep igenetic
b ic
Ġin adequ
om at
ĠC AG
Ġun likely
ĠE xt
Ġcombin atorial
ĠU K
ev elop
Ġprote cted
Ġsor ted
Ġoste osarcoma
Ġvess els
Ġin version
Ġm M
Ġdis cl
ĠS yn
Ġsurvival s
Ġprob able
Ġplas m
Ġmegakary ocyte
ĠPT EN
Ġenabl ing
ĠPer ipheral
m ol
ve illance
Ġcomp ens
Ġprognos es
Ġra b
16 3
Ġvirt ually
R E
h om
op l
ĠP res
iz umab
ĠE GFR
Ġma ximal
ĠSt andard
hydro x
eg akary
rec ogn
kel etal
Ġhomogene ous
I ON
Ġan n
ell ar
ĠW ork
Ġbreak through
Ġtransduc er
Ġc av
Ġc urable
Ġline ar
13 0
Ġfraction ated
Ġwarr ant
Ġreper to
in ion
ĠS pecific
ĠN ext
ip ifarnib
Ġop inion
Ġapp ly
Ġadj acent
Con clusion
O M
Ġs teroid
ot in
ĠB las
01 2
ffec ted
Ġaccoun ted
Ġemplo ying
thi oguanine
Ġtrich ostatin
M APK
m arrow
us ting
av ir
Ġdeterm inant
Ġorig inally
app ed
ĠGS H
tox ic
Ġupd ate
Ġcareful ly
Ġpict ure
T rans
er tib
AB STRACT
Ġsus tain
Ġestablish ment
aun omycin
ĠMa jor
Ġg er
yl transferase
Ġunder sc
Ġsugges tive
B s
n o
ol in
Ġun methylated
ĠL oss
PL C
Ġbio avail
Ġheav ily
Ġfamil ies
aut o
G C
ac ement
ĠP ar
ĠU SP
01 6
ne g
ok ines
Ġoptim ized
Ġattem pted
Ġminim um
G ST
M K
ĠI s
Ġ19 80
Ġhist ologic
jec tive
ii i
ĠQuan titative
le eve
Ġe IF
Ġprognostic ally
Ġar ises
Ġqu in
Ġ13 1
Ġerythro leukemia
Ġstrati fy
Ġexer ted
Ġdeb ate
G G
f il
Ġm ill
ĠA MP
ĠC CL
ment ary
AML s
Ġpl ant
leuk aemia
Ġprec ed
ĠCP T
inhib itory
Ġle th
ĠC L
Ġad ip
UN CAT
Ġlab eled
ĠTR UNCAT
ĠTRUNCAT ED
' ,
T T
Ġcon formation
las es
Ġmethod ology
ĠIFI s
Ġuncon trolled
o blast
ĠT im
Ġ1 10
ĠD r
ĠD DX
Ġ200 2
Ġrandom ised
Ġincorpor ate
Ġreflec ts
Ġantagon ists
D e
Ġac tions
ĠW OR
Ġ19 95
Ġrecombin ation
N OS
ol us
Ġapplic ability
ĠWOR DS
A p
c alled
Ġin eligible
Ġn ative
op hyl
Ġimm ortal
Ġantic ip
Ġcommit ment
en ari
Ġp ass
as idenib
em ias
ĠE ach
Ġhetero zygosity
prolifer ation
Ġes ophageal
Ġpropor tions
ĠCP X
Ġmetaph ase
H AM
] ;
Ġf if
Ġco ver
ĠG l
Ġsyn thase
Ġgenomic s
Ġfat ty
leeve c
Ġc oc
st rand
Ġrel ies
Ġsc enari
Ġlo ok
o z
ly sis
ĠH ER
ear ly
Ġ10 4
17 0
par t
ĠAn g
Ġhome obox
ĠAr g
Ġasc ites
Ġwarr ants
B H
Ġ ,
Ġc G
Ġre ly
om orpholog
AT G
AT P
Ġtoler ate
UT OS
d em
op res
ĠP S
ĠD M
Ġper m
Ġcont act
Ġdes cription
ĠIdentif ication
ĠExper t
M ost
Ġt esti
Ġco exist
Ġwh y
ĠK D
ĠAB C
Ġcirc ulation
ps tein
Ġemphas ize
Ġl iving
Ġg over
Ġen comp
ch ron
Ġpotenti ated
Ġsensiti ze
Ġmediast inal
H CC
er ical
ur on
Ġcomp rom
ĠS L
ĠS rc
ance rous
Ġinter rup
ne oplastic
ĠNPM c
Ġfib rin
Rec ently
e tes
Ġw ater
it ude
Ġmod ify
Ġperform ing
Ġsor ting
sel ectin
ĠAr senic
ĠEp igenetic
Ġren der
osf amide
er ately
ul ph
Ġn as
Ġas ymptomatic
Ġfe ed
omet hylating
ĠPD GFRA
econd ary
Ġillustr ate
ĠD aunorubicin
ĠS eventy
ĠAL DH
Ġbeh ind
ĠAz acitidine
Ġpen et
uccess ful
a der
ĠA ge
Ġst om
ĠP rom
Ġinc ons
22 3
ĠRA D
Ġret urn
Ġpromyelo cytes
Ġevid enced
bi ological
Ġmodul ator
Ġexc re
Ġreason able
ĠHox A
urk itt
a ffected
Ġw estern
ĠT ERT
Ġconf ig
Ġdi hydro
ract orin
20 4
ĠComp rehensive
Ġill ness
Ġtemper ature
ractorin ess
H U
Ġactiv ely
ĠE C
str um
ch ing
37 8
h mC
p ered
Ġf ate
ĠT SA
Ġhyper tension
AD M
Ġobjec tives
Ġrib onucle
B arr
E VI
T CR
U L
r il
en g
ĠC y
ĠM an
ĠP ub
ĠD IC
ĠS ingle
Ġ6 00
ĠUn like
Ġdispl ays
Ġcarri er
Ġmyocardi al
Ġbacte remia
Ġibr utinib
O K
Ġs phing
pl ay
Ġat tain
ast ruct
Ġnon specific
11 0
az ine
Ġnucle ic
Ġend point
Ġpolym er
Ġgluc ocortic
ĠHMA s
Ġbrief ly
B E
or ic
ĠB im
establ ished
75 4
A g
I A
l en
l and
p y
Ġallo SCT
Ġ100 0
Ġsepar ation
els on
Ġcereb ral
tet ra
res olution
ĠS YK
rib ose
itor ing
Ġpur s
Ġnecess it
phen yl
prom oting
c hes
in duc
at um
Ġsub d
dition ally
Ġassay ed
Ġstron gest
Ġsynerg ism
onom ous
ercapt opurine
G N
s on
Ġ iv
en etoclax
Ġb u
ĠA u
ac r
11 6
Ġdiscus sion
co hol
Ġbis pecific
Ġreperto ire
d ays
ĠA urora
ĠF R
Ġper haps
Ġdiagnos e
Ġplay ed
Ġresc ued
Ġsmear s
B B
a emat
ur ally
Ġse ro
ass ette
(- /-)
ĠIK ZF
opl atin
A Es
O CT
v alu
loc al
Ġy e
ĠNK p
ĠImmun ophen
Ġdissem ination
G ene
c ts
Ġin strum
res ted
Ġres ection
ĠM od
ĠG BM
ĠL in
ĠU V
Ġcar ries
Ġcompr ises
ĠMR C
Ġaspir ates
N S
ic s
ĠM in
Ġne ph
Ġflu or
Ġaz acytidine
ĠHemat opoietic
Ġclassif ications
Ġdisapp eared
Ġrecur ring
Ġthor ough
Ġagre ement
F LAG
i DAC
Ġm and
or i
ĠM PA
ath y
Ġlong itud
spec tives
Ġadv ance
13 7
16 754
Ġclassi fy
Ġcarcin ogen
Ġdisplay ing
ĠPA X
diagnos ed
> /
Ġd en
Ġh ot
ĠT yrosine
ĠH HT
Ġper spectives
Ġindic ative
min omycin
Ġsc ar
Ġconf licting
Ġstim ulatory
Ġsevere ly
Ġadj usting
rosc opic
ĠAb l
Ġvect ors
Ġvalpro ic
M o
a ved
ĠA G
ĠM OL
Ġk b
ĠG F
Ġsuc c
Ġ10 5
Ġam el
Ġfoc al
Ġrep op
Ġmed ication
Ġrequire ments
Ġvin blastine
anti gen
load ed
ĠGra de
A DR
H E
p an
Ġl uciferase
Ġallo c
01 4
Ġhyp ers
IS PR
Ġspontaneous ly
n it
Ġ ze
Ġp eroxidase
Ġs CD
ĠB U
Ġdesign ated
ĠEight y
Ġhold s
educ ed
D T
ly tic
ur idine
her s
ĠG P
ALL A
Ġmed ia
Ġmat ter
Ġlymphaden opathy
Ġp olar
ĠM yelo
Ġhist amine
hod amine
Ġinform ative
Ġpoly clonal
Ġdefin i
Ġtrigg ers
m or
ac char
Ġv entricular
Ġless er
ep tid
Ġartic les
Ġangi ogenic
Ġminim ize
MY C
L P
M on
Ġ iod
ĠThe rapeutic
Ġrel iably
ĠAl lo
Ġref ined
Myelo proliferative
recogn ized
ec itabine
Ġen sure
so zyme
Ġapp rec
Ġpharmac odynamic
cyt osis
ĠPR L
G B
Ġgranul es
Ġpanel s
Ġdr ives
ĠSpec ifically
r f
ĠM SC
Ġantigen ic
Ġser ves
12 6
Ġphosph ate
Ġdiscrim inate
Ġbelie ve
ĠSur prisingly
Ġresour ce
i red
id ation
ant le
Ġsub stit
ag ul
reg ulates
22 0
Ġhaemat opoiesis
Ġcos timulatory
Ġdisapp earance
ĠDifferen t
Ġarg inase
fluoro uracil
Ġamel ior
Ġze b
4 50
es ity
ĠT M
Ġex port
ĠM orpholog
Ġen rol
Ġlympho blasts
Ġ19 96
Ġfour th
Ġpharmac ology
Ġpreferen tial
Ġtrigger ing
s w
Ġm iss
as i
Ġerythro cytes
Ġconstit ution
Ġfibro blast
ĠConsid ering
Ġcry opres
Ġtesti s
Ġsucc umb
b ital
he x
Ġp g
Ġre generation
Ġpro drug
Ġpro ximal
ĠC hemotherapy
Ġser ved
Ġcap ability
Ġ201 8
Ġintensi vely
present ing
Ġabol ished
Ġinadequ ate
W ith
in vasive
ĠI G
Ġob struc
Ġdemonstr ation
Ġinter play
asp ases
Ġintra vascular
effec ts
Ġintr at
ĠAz a
P ML
d ens
ĠC irc
ut ational
Ġg iving
ĠP im
ĠD onor
ĠF B
pro te
Ġar rays
Ġcondition al
Ġrepresent ative
appro ved
H yp
M ethods
o bin
o blasts
on ical
hem atic
ĠN OD
ĠL yn
ms acrine
aza C
jug ated
Ġthym idine
l der
Ġf ast
op ho
ver sible
ĠB ut
ĠB urkitt
ĠF lu
ast atic
Ġmain st
14 5
20 3
Ġconc ordance
ĠCyt arabine
Ġdisrup ted
Pre vious
A RA
O ne
R S
f l
h aplo
ve olar
Ġst rand
Ġimmun oconjug
Ġmod erately
ĠK DM
Ġgrow n
Ġref ine
Ġpost ulated
MP D
Ġsimilar ities
Ġsep tic
Ġhistor ically
Ġcolla gen
0 25
P E
Ġun affected
Ġmut ually
ĠE l
Ġep igen
ins uff
urviv in
bal anced
Ġdataset s
Ġanti micro
Ġtransl ated
f ib
Ġin activated
Ġco val
ĠR ho
Ġimmun ogenicity
Ġhydro chloride
ĠVEGF R
Ġcircum vent
Ġqualit ative
Ġp ent
Ġr arity
ult ured
atur ally
ĠRes istance
Ġacqui re
ĠCl onal
Ġpa uc
Ġagon ist
Ġmanip ulation
ut rophil
rom bin
Ġpum p
s yn
ĠS W
ther n
Ġdef ines
Ġpubl ic
Ġcre ate
lig and
P G
Ġan e
pl en
ox ane
Ġfol ate
urin ary
Ġabund ant
Ġscal e
oric onazole
en riched
Ġn aturally
ĠA ug
ĠE pstein
og ram
sup pressor
Ġpolymorph ic
Ġretin oid
Ġhospital ization
Ġreflec ting
Ġgain s
orin ostat
TL V
ĠUnder standing
ĠLi ke
Ġpauc ity
Ġ urinary
Ġne ural
Ġun like
ĠS anger
ĠTh irteen
Ġalter ing
Ġdep th
ĠSET BP
Ġimpac ts
Ġpro spec
Ġout line
ech an
Ġprolifer ate
MDS s
Ġ201 4
ĠME C
Ġneuro logical
Ġconcurrent ly
Ġrecor ds
F DA
in v
Ġsubcutaneous ly
Ġecon omic
Ġt ipifarnib
ar ning
un itinib
ĠI HC
Ġdis char
Ġcomp uted
Ġcomp atible
Ġne on
ĠN T
ĠN ucle
Ġref ractoriness
Ġdescrib ing
NP P
Ġepidemi ology
S I
p eptide
um erous
Ġpres sure
AB MT
Ġneg ativity
Ġconfer ring
cons olidation
ĠMean while
S L
o emb
Ġt ax
os en
em ptive
tion al
iv id
ĠH P
anc ies
ĠS AM
ĠE nd
Ġunc overed
Ġox ide
PD GFRA
ĠZ NF
Ġcoag ul
Ġdeoxynucle otid
G en
Ġt rough
ti le
om ized
ell ed
ific antly
tem por
Ġnum erical
Ġsimilar ity
Ġorigin ate
ĠAb normal
Ġindirect ly
ĠFOX O
Ġirre versible
t ments
Ġle ct
oc clusive
Ġco ord
21 4
omet ry
Ġcompar tments
Ġconsider ations
Ġly sozyme
Ġstop ped
Ġderm at
f a
Ġre gen
pl ies
Ġco op
Ġser a
ĠMD A
Ġact ually
Ġmeaning ful
Ġmembran es
, "
D OX
Ġs por
Ġ( "
ox yl
Ġstem ness
Ġqu ick
Ġcol i
Ġsp erm
Ġdistrib uted
ĠPrevious ly
HOX A
im atinib
Ġch osen
Ġal cohol
Ġxen otrans
Ġnic hes
Ġstimul i
SNP s
Ġdiab etes
Ġexplan ation
Ġantimicro bial
in ations
er al
ĠS tem
ast atin
Ġinst ances
ĠFour teen
Ġmodif ying
ĠKnock down
on omic
an ol
er b
Ġnon myeloablative
Ġaut ocrine
Ġpossi bilities
Ġpredisp osing
ĠCombin ed
Ġupd ated
Ġham pered
ĠItal ian
Ġscar ce
Ġmainst ay
T M
s ho
if t
Ġcon struct
ĠH T
Ġinduc ers
ens able
ĠCI R
Ġonc ogenesis
opro te
Ġhemorrh agic
Ġarchite cture
c or
er atin
ran ded
ĠM ethods
am p
ĠN O
qui red
Ġcur cumin
Ġguid ance
ĠAp ril
chan ge
e ven
m yelodysplastic
Ġa msacrine
il ineage
Ġtrans ferred
ĠB MP
qu in
Ġacc om
Ġprop ag
Ġplas tic
CC N
aren ess
Ġindepend ence
Ġhazard s
4 00
T umor
] ).
b cr
Ġc ation
Ġc ul
Ġin term
Ġdis ap
ĠB IM
ist ing
Ġmo iety
ĠL DAC
Ġexcl usion
Ġred ox
in termediate
un ding
ĠM n
ĠB L
ĠIn v
ĠN PC
Ġab l
Ġaim ing
Ġtri ed
bil ized
Ġact ual
Ġevol ve
ĠHemat ology
raz ol
ĠMOL M
hematic al
T wo
V A
Ġan tiviral
Ġhemat ology
ĠCR ISPR
po inting
Ġintegr ity
Ġback bone
Ġintrac ranial
Ġmill ion
D el
Ġc reated
ĠA reas
Ġal bumin
Ġcont ra
Ġprolong ation
Ġconcomit antly
Ġadap ted
Ġimpair s
ĠMF C
ĠFOX M
O ut
d onor
f low
re onine
ge al
Ġro und
Ġexam ples
Ġsm o
Ġdesign ing
Ġmagn itude
pergill us
ĠSecond ary
Ġent ry
Ġju venile
Ġinstit utions
evelop ment
re ported
si RNA
ĠC OX
Ġex ome
st andard
CD K
Ġselec ting
Ġkill ed
Ġexpan ding
erv ation
Ġorgan ization
ĠMR I
Ġintegr ating
Ġgoal s
Ġresid ue
Ġoligonucle otides
M MP
d isease
in ety
ĠB RD
ĠS wed
Ġsam pl
Ġ10 3
Ġgener ic
14 3
Ġcaus ative
emb edded
Ġinterac ting
Ġmanag ing
BM Cs
Ġhyper plasia
ĠCl in
Ġorgan ic
ĠCB T
Ex pression
Ġinfrequ ent
Ġcasc ade
Ġacl arubicin
G ranul
U n
v ated
Ġ )
or afenib
lo ok
ĠM et
Ġdis p
ĠF IP
Ġen s
Ġstr ict
Ġcycl ing
Ġmed ications
Ġhom ologous
ode oxy
Ġevid ences
Ġcompl iance
Ġjus ti
Ġlibr ary
he re
is ti
ation ally
ce in
ĠK ary
ĠEx posure
Ġcooper ate
enh ancer
Ġpor tion
B las
d le
n ec
Ġp eg
Ġb rid
ĠP N
Ġcyt ological
Ġag ar
Ġtechn ical
ĠAd riamycin
AD P
Ġclar ified
Ġbehav i
Ġoccasion ally
j o
p rim
Ġd og
ar ate
ĠA CA
ĠM al
tiv ities
ĠD H
ĠS ep
Ġspec ified
ag ents
Ġacc es
Ġer yt
Ġinde ed
Ġalkal ine
Ġconsum ption
Ġye ast
F M
on yl
ul ties
Ġde oxy
Ġim pressive
Ġanaly se
Ġwork up
Ġtyp ing
Ġdatab ases
Ġquies cence
Ġdig es
dec itabine
transl ational
phosphor ylation
Ob jective
Ġconstitution al
Ġb ands
Ġal fa
Ġprogres ses
Ġreac ted
Ġara C
Ġcontr ary
Ġhaplo type
Ġphys ician
Ġweak ly
Ġsensitiz ation
ot ential
op enic
ĠD asatinib
Ġexam ining
Ġnucle otides
hemat ological
Ġepid ermal
nucle otide
Ġdisap pointing
ic o
Ġop p
ĠPro tein
Ġillustr ates
Ġspor ad
razol ium
S ince
T A
V D
p ur
v est
Ġt raining
Ġb ron
gen icity
et ent
Ġinf ar
01 7
ocyt openia
Ġve in
ĠCompar ison
Ġcytoreduc tion
Ġcomm erc
Ġchap ter
Ġperic ardi
Ġane up
F as
L D
ter itinib
Ġactiv ators
ĠE S
Ġsup ern
Ġam b
Ġdistin ction
pos ing
Ġplatform s
1 01
Ġ err
Ġc aspases
ĠS tr
ĠN ilotinib
ĠG emtuzumab
Ġpresent ations
AS XL
ĠLym pho
Ġreticul um
ĠcG y
c ulture
Ġf al
Ġfor ward
Ġen ough
Ġint rap
ĠG IST
Ġinterac ts
Ġpurp oses
pred nis
Ġbioinformatic s
aryn geal
Ġdeoxynucleotid yl
F or
G AL
] -
Ġt wenty
Ġus age
SC F
12 4
Ġexam inations
ĠRNA i
Ġprote ase
Ġstruct urally
Ġdri vers
Ġnod ules
induc ible
g R
Ġ estrogen
Ġt ight
er t
ĠL PS
ĠAl tern
sup pressive
Ġet c
Ġven o
Ġallog raft
Ġmening eal
eff icient
Ġtryp tase
Ġmiss ense
h i
Ġc assette
ro unding
Ġn erve
ĠH MG
ĠR et
ĠN a
ĠO b
CL US
ON CLUS
ĠHu M
0 26
i ation
m ethylation
Ġan a
ul ed
ĠC SCs
Ġ1 16
rel iminary
Ġcaus al
Ġhealth care
Ġrandom ization
Ġcontinu ing
ER G
Ġconfig uration
i ter
Ġre fer
Ġre agents
tic s
Ġcomp eting
ĠS ALL
Ġk Da
Ġup front
Ġsequ enced
Ġ19 94
ITD s
Ġdiffic ulties
Ġtra ffic
Ġtra ditionally
ĠMy D
ĠPG P
Ġharves ted
Ġsubs titution
sur face
ĠMPA L
ONCLUS ION
B one
F v
re activity
ar ray
il teritinib
Ġal le
ĠD U
ĠS S
Ġdiff ers
oun ding
Ġar ginine
Ġstandard ization
19 6
In t
Ġfacilit ates
Ġmat hematical
sp ot
EP O
ĠOut come
Ġcav ity
N e
c ardi
p ly
he rence
ys t
Ġk inetic
Ġsc at
Ġem pir
sequ ent
In c
Ġdet ox
function al
ĠME IS
man ip
Ġmuta genesis
Ġchann el
M any
r astruct
os c
Ġsur rounding
atele t
Ġ201 5
ĠGST P
Ġyiel ds
Ġhierarch y
Ġmixt ure
H u
T F
z es
ĠC oun
Ġne urop
las ma
ĠS CI
ĠR ev
Ġmon oblastic
ĠL M
17 2
ĠMP D
ĠEL ISA
Ġpresum ably
vit amin
ĠPub Med
manip ulated
t reat
Ġre act
os ses
Ġass emb
34 35
KI R
Ġrecurrent ly
ĠHSP Cs
Ġexc iting
Ġretro virus
Ġclassif ier
ĠEm erging
ĠNor thern
Ġmimetic s
Ġcorticos teroids
ĠAug ust
c he
t t
as ic
et he
ĠW E
ĠN ormal
RA P
Ġepidemi ological
Ġcapt ure
ĠNov ember
0 38
g ent
n ull
Ġde terior
NA s
Ġse greg
Ġint ention
Ġassess ments
Ġmit osis
v able
ran ce
Ġcyt omorpholog
Ġimmun ost
ĠTh ose
ad C
ĠK ore
(+) )
Ġ14 0
Ġsp an
Ġcommun ication
an ine
Ġn ested
ĠF ms
Ġcons olid
Ġfail s
Ġapp lying
Ġcellular ity
oh yd
Ġhom ology
Ġglyc os
C a
Ġd ye
ist ries
MP L
ĠET S
ĠMut ation
dec an
Ġmil est
Ġdirection s
Ġopp osite
G I
Ġtre ph
od al
am etric
Ġanti angiogenic
Ġhemat ologists
ĠJ ak
Ġclonal ity
Ġproper ty
Ġexpl oration
Ġmanif ested
Ġher pes
Ġadop ted
Ġactin omycin
transcription al
= .
ar ged
Ġ( -
gn etic
ĠS CL
ĠN et
Ġen asidenib
Ġcoun te
Ġhist ones
Ġj unction
Ġsusp ic
Ġdest r
Ġspre ad
6 00
p atients
on ly
Ġthe ore
Ġe ye
Ġr as
Ġhyp ere
d m
w ild
ĠT c
ĠF eb
Ġend omet
Ġoxid ation
ĠAp optosis
ĠSub sequent
Ġrepl aced
Ġnam ed
ethe less
F lu
g ulatory
or adi
ĠA sian
Ġha ms
ri um
term ined
otox in
Ġlung s
Ġinteg rin
len gth
Ġalle vi
X C
te can
ML LT
rel apsed
ild hood
ĠU pon
mon ocytic
Ġra ce
Ġpartic les
Ġhom ing
Ġaddres sing
EG s
Ġpool ed
Ġcytoreduc tive
Micro RNAs
ĠSAM HD
L y
T r
e tion
ic l
Ġf ore
ud den
am ples
Ġunder way
ru ary
ĠEv idence
Ġlongitud inal
N ucle
is ely
Ġn ational
iti g
Ġqu izartinib
ĠV LA
EB P
25 0
Ġdiffer ing
Ġinfiltr ating
Ġmaxim ize
Ġion izing
Ġju xt
T E
y el
Ġm echan
Ġre pressor
Ġcyt ochemistry
Ġprogres sively
Ġ19 92
Ġche st
Ġche lation
MF C
Ġoccup ational
erythro id
Ġtrunc ated
ĠSCI D
L S
c irc
m ia
r iv
ĠC ONCLUSION
Ġres er
Ġpre mature
loc ation
int oler
ax ine
Ġprec isely
itt ent
Ġpubl ications
Ġgli omas
Ġleukaem ogenesis
Ġmas ses
C ons
id ium
ĠT I
ol ated
ĠB T
Ġar ma
01 8
Ġhist ology
ophag y
Ġconver ted
Ġfresh ly
Ġreach ing
Ġaggreg ation
ĠCCN D
Ġdiscl osed
obin ostat
Ġarma ment
X R
Ġm er
Ġpro inflammatory
ĠD OT
ĠR h
ĠR CC
ĠO K
ĠE UTOS
Ch ildren
ĠY et
ĠIC U
Ġmodul ates
Ġprincip le
i atric
Ġ /
ĠC MR
Ġg ilteritinib
ĠL EF
og lyc
Ġconclusion s
Ġess entially
ipi ent
Ġorigin ating
Ġdiscrim in
Ġtempor al
ivid ually
Ġsporad ic
w an
Ġm apped
id ic
ĠC V
Ġv oriconazole
ĠH M
ow el
00 05
Ġco gn
Ġob taining
Ġar th
Ġtox in
Ġhom oharringtonine
Ġcounterpar t
Ġcardiomy opathy
retic ulin
+ .
y al
Ġle arn
ĠC EM
Ġk appa
di ploid
Ġachie vable
Ġop erating
ĠCon ventional
Ġcarb oplatin
Ġresearc hers
T c
o uble
Ġd CK
ia m
01 0
Ġ19 93
000 2
Ġremo ved
ĠMG MT
Ġcytos olic
Ġcoagul opathy
D O
il st
ir ubicin
Ġad duc
Ġun ra
Ġanti metabol
Ġform ulations
Ġhypothe size
ĠQ OL
ĠCH FR
raz oxane
Ġreinf or
m olecular
Ġand rogen
Ġb ox
ĠA ustr
Ġad versely
Ġper man
IT R
Ġfail ures
Ġox idase
Ġhaplo insuff
ĠFif teen
Ġproce ed
Ġhierarch ical
Ġcys teine
Ġkind s
strati fication
N SD
Ġf ace
om ated
Ġl osses
ist rib
Ġun manipulated
ĠS urvivin
ĠR ever
Ġnon leukemic
PA RP
Ġepigenetic s
CG H
lassi fied
ĠLT C
Ġmarg inal
Ġp p
ur ia
Ġg ing
Ġinc re
qu e
ĠR ep
ox if
Ġout growth
Ġdec lined
Ġlig ation
Ġmis sing
Ġabund ance
ĠSD F
/ =
R B
T dT
ent ral
om ab
Ġthromb opoietin
Ġsitu ations
-- >
urk at
Ġproce eded
Ġphosphatidyl inositol
Ġabn ormally
pat hw
f rom
re le
al c
Ġe ver
si bility
od ophyl
Ġha p
ĠB ak
qu inone
orm ycosis
are t
ici ently
Ġshort ly
Ġrecogn izing
Ġbelong ing
ĠUCB T
ĠHOTAIR M
Ġsampl ing
Ġsupern at
Ġfal se
Ġd rop
ist one
tem ber
form ance
Ġref in
Ġver sion
Ġelic ited
Se q
0 21
X Y
s k
Ġan nexin
ĠT IM
ĠM UD
ĠH er
Ġsub lines
Ġob esity
Ġpatho gens
Ġed uc
t hen
ar ies
Ġf o
Ġcomp utational
BP D
Ġed ema
Ġsensitiz es
Rel apse
L a
ĠA Es
Ġwe igh
de g
Ġimmun ob
Ġcyto lytic
Ġnormal ized
ĠU l
trans f
Ġsh ap
Ġtranscript omic
Ġins ensitive
ĠTP O
Ġgeneral ized
Ġleuc ocyte
Ġcommun ity
Ġaccom pl
Ġarmament arium
F T
c enter
id emi
ĠP MA
ĠS omatic
Ġco expressed
Ġwhere by
ĠGS K
ĠSF RP
ĠBR CA
lnc RNAs
ĠCycl in
O ur
c ar
d l
Ġan th
ĠT N
ĠC r
uc il
ĠM B
Ġde acetylation
ĠP reliminary
dition ing
Ġ10 1
Ġ10 2
Ġprogen y
Ġmethod ologies
Ġdisrup t
Ġtransfer rin
A E
D uring
T FR
d am
in in
Ġan sw
Ġsub stances
requ is
Ġthere after
PM N
02 8
allo SCT
Ġdepend ency
ĠCX XC
Ġneur onal
ĠRem ark
amb ucil
o ber
Ġm atur
ĠT CGA
Ġst aging
Ġbe g
ĠF LA
Ġmicro tub
oph orin
ocyt oid
atin um
Ġunc over
Ġclon ing
i ant
o verex
he um
Ġs emi
ac es
ĠD ose
ĠS el
ĠO DN
Ġsup eroxide
Ġprogres sing
Ġ19 86
ĠAT M
Ġsol ely
ĠMy lotarg
Ġexce eding
Ġide a
Ġlect in
ĠFeb ruary
odophyl lot
i rable
ly s
ĠM yc
ĠM ll
Ġbut yrate
rough t
Ġsplen ectomy
ĠCa uc
Ġaw areness
ĠEP O
A t
T CGA
i ated
Ġb owel
id i
Ġgen omes
ĠV CR
12 2
tr al
Ġprolong s
rosc opy
Ġcomb ine
Ġmetallo protein
C as
m Ab
Ġthe ms
le rosis
ĠA E
et axine
Ġex tension
ĠH is
ĠL ip
Ġdem ographic
mac etaxine
Ġsp ind
ĠBA X
micro L
m ercaptopurine
Ġm itig
Ġbe gan
ĠP AR
Ġtrans gene
Ġen tering
Ġtarget able
Ġlympho blast
Ġpl ate
ail ed
ĠAn d
ind ividual
Ġsuff er
Ġthym ic
ĠmAb s
ĠTox icity
Ġbioavail ability
ĠSep tember
P rimary
Ġ1 60
Ġcom plic
Ġcom mentary
ĠH C
st alk
pro ducing
pt osis
Ġ19 88
otyp ical
Ġpredomin ance
lab el
Ġconstruc ts
Ġadoles cent
Mul ti
H e
M olecular
Ġt am
ac itabine
ĠP rospective
Ġass ist
Ġep irubicin
ias is
ĠCh an
Ġenc ode
Ġcle aved
opath ies
inc ubation
ĠInc reasing
Ġeradic ating
Ġresemb ling
ĠPBP C
el ves
es sion
ĠC aspase
ĠC HOP
ĠH PV
ĠF ew
Ġus es
Ġshort ening
Ġexpl oring
Ġtransl ate
ĠMY B
Ġmyelosup pressive
cont rolled
Ġarter y
ĠChrom osomal
Ġleth ality
Ġthems elves
b enz
Ġm antle
or g
Ġb rought
em pl
ĠT CD
Ġas paraginase
Ġdis tal
Ġint ended
Ġaltern ate
erv ised
ĠSix teen
ĠSc i
Ġneur ons
Ġexcre tion
Ġs udden
Ġde plete
ĠP red
Ġr hodamine
oplas ia
19 0
ev alu
apopt osis
alys es
ĠZ F
Cd A
Ġprojec ted
Q O
Ġde partment
ĠH TLV
ĠS et
Ġran ges
Ġwork ing
Ġexc ision
Ġstop ping
Ġsca ff
Ġinfar ction
BPD CN
6 38
p en
ed gehog
ec onomic
Ġas tro
Ġ1 15
ĠH I
las ting
Ġpl atinum
Ġcor on
Ġdiscrim ination
flu or
Ġphospho lip
ĠMicro RNAs
0 24
N O
i ar
Ġf us
ul ose
ĠT otal
ĠC hem
uk ary
ut ing
ac c
Ġres ol
Ġcon tempor
CF C
Ġdim ethyl
ĠAdv ances
+ ).
0 27
c G
n r
p timal
y le
ro se
Ġex empl
Ġ1 11
Ġper itoneal
Ġ10 7
Ġ10 9
Ġchain s
NP s
ĠCombin ing
ensiti z
Ġcoop eration
T SA
ig or
Ġbi as
ĠJ urkat
ind ow
Ġerythro blasts
26 3
Ġche l
Ġbroad ly
ĠCH K
Ġmicrosc opic
ĠHep G
Ġunderl ie
eptid ase
. <
Ġs atisfactory
id ent
ĠC andid
ol ab
Ġappro pri
Ġanaly tical
trans duced
ochem ically
Ġaz a
ĠMT H
Ġstabil ization
Ġdestr uction
Ġd inucle
id ostaurin
ĠC ases
ĠP EG
ĠP lasma
ĠB I
ĠN rf
Ġind ividually
Ġmark s
000 4
Ġsp inal
Ġj ud
Ġobserv ational
hydroxy vitamin
ĠCCA AT
Ġmanage able
ĠFact ors
oprote ctive
A ut
ĠA UC
Ġl ap
Ġl ist
ĠI N
ĠE MR
Ġeosinophil s
Ġcros stalk
U G
i pl
i genic
or age
Ġf ine
Ġe c
lo op
tion ed
Ġst rept
Ġcon form
ĠCD C
ron ectin
all s
Ġbi allelic
Ġnormal ization
Ġprim ers
In f
ĠCom mon
Ġrepl acement
Ġassum ed
Ġstren gth
Chrom osomal
Hemat opoietic
s tem
t inib
on ate
Ġc reat
Ġb odies
Ġb olus
ĠT W
ĠM ac
Ġreg istries
Ġdiagnos ing
Ġra ise
Ġtranscription ally
Ġ15 2
VI D
Ġmaintain s
Ġbelong s
Ġcut off
sil on
Ġmand atory
ĠRemark ably
I d
J MML
a ffinity
b anding
h ans
Ġw indow
Ġn aive
ĠC SC
ĠI NPP
Ġg ang
ĠH h
ĠL ICs
Ġinvestig ators
Ġ8 33
ful ly
erg ic
HO DS
Ġrecons tit
Ġbacter ia
ĠSer um
ĠNine teen
ĠSequ ential
ĠAY As
Ġintrat umoral
istrib ution
f R
Ġc AMP
Ġs unitinib
an ib
pt in
Ġaddition ally
loc king
ass ay
ĠCon clusion
vari ates
Ġlys osomal
Ġchlor o
Ġdig ital
anger hans
Ġmicros atellite
ĠAss ociation
Ġorganis ms
gu ided
Ġunra vel
E X
w are
Ġb ad
ĠS C
Ġpre requis
form in
Ġlip osome
Ġsp e
Ġaccel erate
Ġautophag ic
del ta
Ġthi oguanine
inter feron
Ġhair y
ĠOct ober
ĠAMP K
ĠH EL
ĠS orafenib
ĠU SA
ĠAs pergillus
Ġcho ices
Ġimple mented
be it
ĠChrom osome
D rug
Ġp rone
Ġs ap
Ġan c
id ol
ĠP BMC
igh teen
Ġchem okines
Ġno tion
erm ethylation
Ġcirc RNAs
Ġretin oids
Ġver ify
Ġnan om
Ġmuta genic
ĠSK M
overex pressing
L OH
ĠA f
ho ur
Ġext rinsic
Ġnucle olar
20 6
Ġaltern atives
ĠImmun e
Ġhepat os
Ġsca ven
Ġgal ectin
Ġinterm ittent
C om
K ip
al y
Ġf ulf
ĠT EL
Ġpro c
ri p
Ġno tic
ĠV enetoclax
com bin
Ġly tic
Ġstimul ates
ĠDA U
Ġdog s
8 33
F CM
Ġp ip
Ġin ability
ig aret
ol ism
ĠD EK
ĠG raft
01 9
15 3
Ġalter s
Ġglyc olytic
DP H
DL BCL
Ġphag ocytosis
HMA s
Ġp erox
Ġor bital
ĠH edgehog
Ġid enti
acter ial
Ġnon malignant
Ġmul tim
yc ho
min al
Ġend oplasmic
Ġoptim izing
ĠClinical ly
54 9
etho x
Ġseg ment
ol or
ĠP rior
ĠF e
ĠG FI
Ġpl aced
Ġ8 00
ĠK inase
Ġimp ly
ne x
19 3
Ġsp ace
Ġload ed
Ġdeline ate
Ġmicrom ol
R N
S SC
al so
im ent
ĠM yelodysplastic
ĠB r
ĠR D
de p
Ġcar minomycin
MP s
Ġcycl ic
Ġestim ation
Ġelimin ating
bi ology
dim ethyl
aden osine
ĠSign ificantly
Ġhair pin
ĠIniti al
A cc
i ters
t otal
Ġm u
ĠM ain
Ġsensi tivities
ĠHe La
Az acytidine
opatho logy
met astatic
Ġinjec tions
Ġthym us
occ ur
lox acin
ĠPDGFR B
B etween
f e
f ord
p ose
v astatin
Ġo v
te st
Ġre vers
ar iably
Ġe ukary
ĠD i
ĠW P
Ġpre cl
Ġhyp oplasia
par ametric
cin ate
Ġcho l
Ġadj un
Ġendothe lium
Ġacet ate
An ti
Ġlas ting
ĠRem ission
ĠHN SCC
plen omegaly
B U
M SC
M AC
im etic
ac yt
ĠB D
Ġgen otyping
Ġdifferent ly
Ġimp rin
Ġtopo tecan
Ġcheck points
effec tiveness
Ġoffer ing
ophosph ate
Ġhot spot
Ġspind le
N SCLC
c GVHD
t ri
as ertib
Ġon to
Ġg est
ist in
ĠD I
Ġrel ate
iti de
Ġgroup ed
PD GFR
Ġfib ronectin
Aza C
Ġpy rimidine
Ġnm ol
Ġlas er
Ġdefini tions
Ġimmunoconjug ate
GAL S
N L
T AM
h r
an k
ro phages
os a
Ġpro st
lo vir
ran g
ĠH aplo
ĠD OK
ox a
ĠL ittle
Ġnon lymphoblastic
AB C
Ġsequ entially
ĠCBF A
Ġglut amine
for ced
Ġobstac les
ĠMe is
Ġoc ular
T rials
c il
id entif
ĠR B
Ġsub mitted
Ġem ission
Ġ13 0
04 8
Ġintro duce
Ġtumori genic
Ġchemical s
ĠInde x
ĠHox a
Ġresour ces
Ġca ution
Ġincons istent
Ġsubd iv
Ġsuspic ion
0 45
E xt
Ġt as
Ġm apping
Ġ1 13
ol i
ys teine
ĠH CL
Ġinv ariably
CR i
ĠL ab
Ġkn ow
MS O
Ġdetail s
Ġincomplete ly
Ġbasophil s
Ġsplice osome
g then
m yb
t yrosine
Ġas pect
Ġg ram
ĠE wing
GF P
Ġexper t
vo ir
Ġtr ilineage
cal c
Ġaggres siveness
04 7
Ġcal reticulin
ĠSe vere
Ġelic it
transl ated
0 22
h aus
en zyme
Ġm other
Ġb anding
Ġde ad
RD M
ĠII alpha
Ġprote ome
Ġke ep
Ġslow ly
ĠAM KL
Ġfeed back
prednis olone
Ġhaploinsuff iciency
M et
P o
S econdary
Ġp ig
ĠH BV
ĠP os
ĠF ACS
raf ish
Ġconfirm ation
Ġgre en
Ġsuff iciently
met h
Ġtraffic king
Ġreser voir
intoler ant
C pG
Ġt AML
he ad
ĠH es
ĠIn tr
ĠR adi
ĠN D
Ġhe ight
Ġnon responders
Ġprov ision
10 7
po ly
Ġexam ines
Ġexplo it
Ġpolymorph onuclear
Ġlip ophil
MN C
Ġregard s
Ġvirus es
ĠBC OR
ĠCytogenetic s
Ġpros urvival
ĠEv i
Ġinterpre ted
ĠNon etheless
Ġimplic ate
Ġneon atal
L V
z en
as tern
om ies
ac id
ĠP ET
ir m
ĠN umerous
ĠE ffec
Ġcontrib utions
Ġrep ur
ders on
Ġsubcl one
erc ul
ĠIdentif ying
ĠMET HODS
B AC
s in
he l
Ġs a
an titative
Ġd uc
Ġst ably
Ġr un
ĠR ac
ĠTh y
ip odophyllot
ĠK LF
ĠML D
viron ments
Ġlig ase
allo geneic
lympho cytes
Ġpanc reas
Ġasc ertain
Ġstain s
Ġarth ritis
) ].
J un
T LR
ĠM er
th reonine
Ġdur ations
Ġaut onomous
13 1
Ġexpress ers
Ġdefin ite
ĠEp idemi
V al
m es
p ting
el ect
ĠM b
ĠB CP
ay er
ĠS V
Ġco variates
our se
38 2
Ġabs cess
respon ding
co agul
ĠAcc um
ĠSeven teen
Ġfit ness
Ġallog rafts
ĠPo lym
Ġencomp ass
> ),
d ensity
Ġd ict
Ġre ne
st able
Ġmo tility
ĠE MT
Ġro ute
ĠK B
ĠK PT
ens in
Ġqu ar
CSF R
EB V
ĠAn derson
Ġthromb oemb
ĠAd verse
Ġbasophil ic
Ġjo int
ĠLIN C
Ġimmunost aining
E arly
M an
os idenib
Ġv orinostat
ĠR BC
Ġsub line
Ġhyp o
Ġneoplas ias
(- ),
Ġorigin ated
Ġaw are
Ġimmunore activity
Ġagon ists
Ġhistopatho logical
ĠGP X
D G
Ġp s
le b
Ġb esides
ac cept
Ġal beit
ĠS y
Ġper f
vers y
Ġgl and
Ġacet yl
Ġautog raft
CX CR
ĠWork ing
Ġpreced e
ĠAf ric
I H
s ensitivity
Ġin appro
ĠB l
ĠB RAF
Ġr heum
ĠR a
Ġphen yl
ps in
IN G
Ġphenomen a
Ġchlor ambucil
ĠInd ia
Ġuni versal
0 35
M I
Ġle t
ĠC S
Ġst ay
il ed
Ġob sc
Ġfail ing
Ġflu x
37 5
Ġhypomet hyl
ophag ocytic
Ġdet rim
ara C
Ġaggreg ates
Ġimmunore gulatory
Ġult ras
Ġrab bit
Blas tic
P O
Y N
p air
u ous
he res
or n
ur veillance
ig lec
ac erb
ĠM it
Ġcomp romised
Ġanti tumour
rac ted
Ġsug ar
Ġgener ates
CI R
Ġmat ching
Ġbrom odomain
Ġm ir
it ness
ĠT ho
ĠI F
ĠM I
ĠD evelopment
Ġun balanced
Ġchem ot
Ġnon hematologic
ch in
Ġ10 8
Ġder ive
Ġregion al
OR TC
Ġpers on
Ġtransi ently
ĠGen omic
Ġbl ue
dim er
Ġcereb ellar
Ġswitch ing
ĠBa F
Ġintrap er
/ /
B lood
N B
Ġs ens
er ves
Ġf in
Ġde ac
Ġinc urable
Ġen orm
Ġpre fer
Ġevalu ations
Ġhyp ocellular
Ġpost transplantation
ĠAB CC
Ġprocess ed
Ġabs orption
ĠSt atis
Ġguid ing
Ġantagon istic
Ġregular ly
Ġsulf ate
opho re
: //
B R
T wenty
c ourse
ĠA DR
gen ome
Ġl on
Ġco verage
Ġmic ron
Ġel ong
Ġconf ined
ĠAd ult
ĠAN D
orb ent
Ġphysi ologic
Ġdex razoxane
T ar
T RAIL
a GVHD
h isti
k Da
v is
Ġex acerb
Ġcon ven
Ġch ron
cell ulose
li x
(+) -
ĠCI P
ety lases
Ġu ro
Ġlo ading
ĠMy el
ĠCoun cil
Ġfulf ill
L RP
a CML
m ul
y es
Ġa ir
Ġs ick
ĠA DM
ĠC CG
ce ption
rac h
and mark
Ġind isp
Ġ10 6
Ġra ises
ish ing
Ġu ter
Ġgra di
Ġexperi encing
Ġglyc osyl
pre c
phen otype
Ġzeb rafish
Ġidenti ty
F MS
ud es
ĠD ay
Ġassoci ates
ĠU T
Ġinflu x
mut ation
Ġscre ens
Ph iladelphia
gluc ose
ĠImmunohist ochemical
Ġplasm id
Ġhypers ensitivity
" )
M HC
o ter
Ġn arrow
pro p
Ġen tero
Ġallo reactivity
ill er
10 3
Ġwor th
orph ic
02 9
Ġhyper cellular
ĠME F
Ġstep wise
ĠEv alu
Res istance
Ġperme ability
Ġfer tility
Ġdoub ling
igaret te
ig ibility
Ġmyelo blast
Ġim plies
tiv ating
Ġnot able
Ġph armaceutical
spec trum
ĠV it
Ġreactiv ated
bi ased
Cyt arabine
Ġdiscrim inated
Ġsoci o
acchar ide
oxif en
L DH
W hile
ec re
ĠAT L
ĠUn til
Ġclin ician
rec ipient
Ġpancre atitis
Ġentire ly
Ġepidemi ologic
Ġring ed
Ġrepeat s
Ġprofound ly
chrom osome
Ġanticip ated
Ġcryopres erved
Ġana plastic
Ġdetox ification
Ġhypere osinophil
Ġ ~
Ġ vers
Ġ 000
it he
ĠA CM
um n
oc occ
ir ds
ĠB FM
Ġmo bility
ĠU GT
Ġ19 84
14 6
Ġradi ological
Ġaccum ulating
Ġatt ack
Ġdr as
Ġsubun its
Ġanomal y
ĠAut ologous
Ġdiscre p
Ġscenari o
Ġstom ach
ĠAu er
ĠTho ugh
Ġdeac etylases
V PA
c is
Ġm l
Ġd up
id al
Ġto day
Ġcomp rehen
Ġk g
ĠN eu
Ġstandard s
In ter
Ġmuc ormycosis
Ġhydro gen
Az acitidine
Ġhospital s
Ġble omycin
ĠSM C
Ġmucos a
Ġeas y
bor n
encephal opathy
Ġtheore tical
Ġprerequis ite
0 23
C r
N R
R O
S V
j i
t opo
in ine
ul monary
ĠR un
Ġab lation
Ġhe x
Ġprote cts
Ġlink age
ĠNA DPH
ĠSR C
St ud
Ġsuper family
G emtuzumab
P SC
] ),
ĠM UT
Ġal veolar
qu ine
ome res
ĠR educed
ĠG ranul
ĠL eu
Ġdi ver
Ġ19 91
ma x
Ġplas min
ĠCon c
Ġclus tered
Ġhar vest
Ġmimic king
Ġdiab etic
Ġschem e
Ġreturn ed
Ġassemb ly
Ġjuxt am
ĠChan ges
A I
e ted
re ater
Ġan at
Ġex change
Ġor th
Ġrel ie
rac ting
ĠL GALS
ag ged
Ġerythro cyte
Ġsil ico
Ġaccompan ying
Ġgran ular
Ġinfrequ ently
Ġperme abil
Ġquick ly
Ġdetrim ental
X X
Ġre plic
ec tions
ĠD is
ĠF US
ĠL OH
MT G
IT C
ĠGen es
Ġrib osomal
ĠDe tection
Ġbasophil ia
1 21
I GF
es cal
ĠT et
ĠC ALLA
Ġr ationally
ĠW NT
ĠG ram
Ġsub mic
ad ministration
Ġel igibility
Ġfunction ality
ach ment
Ġdel ays
ex ome
AM KL
Ġinterpre t
ĠEL N
Ġimmunos urveillance
Ġvess el
Ġimpac ted
Ġger iatric
Ġtight ly
R H
b x
ot opic
Ġcon v
CR C
term inate
Ġpl ants
Ġmulti kinase
Ġsequ el
Ġpromo tion
Ġoverex press
ĠCT N
ĠCl us
Ġcarb ohyd
ĠMon itoring
Ġcoexist ence
Ġcomprom ise
Ġamb igu
Ġenorm ous
P U
n l
Ġn orm
ĠT opo
Ġdef ense
Ġloc ally
ĠRec e
SP C
Ġcent r
Ġsuperior ity
ĠSim ultaneous
Ġimmunos orbent
Ġubiquit ination
T O
b s
ĠT UG
ac izumab
ĠS ox
ph asic
Ġpres ently
Ġinf er
ĠL AM
Ġcharacter izing
Ġar rested
Ġdisc ordant
KI P
Ġdos ages
UT R
upl ing
H F
d isc
r ations
re ening
ys tal
ĠN SG
ĠN oxa
ad vant
li oma
23 1
Ġinde terminate
Ġmilest ones
Ġrefin ement
. "
b odies
b right
on ad
Ġs keletal
ur ance
am pt
Ġun accept
Ġev ade
Ġcont amination
Ġnon random
Ġop er
oid al
urs or
Ġconc ordant
cyt otoxic
Ġpan obinostat
Ġnecess arily
ĠMS D
ĠPR R
Ġmen tioned
ĠMo Ab
ĠSA HA
Ġchap er
Ġrub omycin
Ġhams ter
Ġging ival
Ġjuxtam embrane
Ġthe r
ĠA ff
ho le
Ġim bal
od ip
olog ist
iz ations
Ġtim ed
CT s
Ġcol or
Ġquantit atively
Ġsp ot
ĠMul ti
ĠPR MT
Ġfacilit ating
Ġpregn ant
RAR S
Ġcooper ating
Ġobvious ly
raction ated
Ġepigen ome
Ġendomet rial
Ġobsc ure
ampt othe
S K
Ġs teroids
Ġm m
ĠT ie
Ġleuk openia
Ġcom e
Ġun res
Ġun iqu
Ġsyn chron
Ġmicro gram
In d
ĠPre clinical
ĠMN DA
Ġmid dle
Ġillustr ated
Ġfram es
Ġaw a
Treg s
Ġpurs ued
- [
7 20
O UN
it us
Ġb p
pres ented
Ġr ash
Ġmon ocytosis
Ġall oster
LA M
Ġaut opsy
Ġbro ader
rection al
VEGF R
Ġsoft ware
ĠPl k
ĠTW IST
2 21
Ġh al
ec ul
ĠI S
Ġ1 14
ĠP M
Ġanti thymocyte
Ġrece iver
ak es
Ġaut omated
Ġcorrel ating
ethyl ene
Ġquantit y
04 6
Ġvac u
Ġhaem opoiesis
Ġavoid ed
Ġult rastruct
Ġnit ric
ĠHb F
Ġdil ution
identif ied
amptothe cin
L K
k b
at rol
ĠT S
Ġex haus
ver atrol
st randed
ĠCD X
ĠR P
Ġassoci ate
Ġint ent
Ġpatho biology
Ġinteg rate
Ġneuro toxicity
ĠPT K
Ġturn over
ĠRAR S
Ġadequ ately
tro duction
Ġdiscre te
Ġwors ening
Ġglycos ylation
Ġtreph ine
deg ib
Ġscaff old
K D
p i
ĠA PA
ĠC ase
las degib
Ġk it
ten ding
trans cript
Ġhydro lysis
Ġcontro versy
Ġdist ant
" ,
A AG
B i
i ol
s ulf
or al
ro zen
ic tion
Ġb order
Ġto ok
ul a
Ġas ked
op eptidase
ĠN inety
de pend
ail ure
Ġindic es
Ġ19 85
asp in
Ġneuro logic
ĠOut comes
ipl inary
O V
d oxorubicin
h ic
Ġ %,
on set
Ġp olic
Ġal dehyde
pro gnosis
ĠN CCN
Ġep ipodophyllot
Ġpool s
Ġemphas izes
Ġinsuff iciency
ĠKn owledge
ulph an
valu e
Granul ocytic
riv ation
transf ected
ĠT SG
ĠC lassification
Ġfor ced
Ġdis advant
ĠN E
Ġchem oradi
ĠE ighteen
Ġme eting
Ġcol umn
Ġop posed
ĠAn nexin
CB L
Ġelucid ation
ĠME G
ĠPre treatment
OC K
Ġq RT
Ġeth nic
glut arate
ĠDifferen ces
Ġformal dehyde
Ġobstruc tion
Ġmechan ical
ĠCandid a
) =
F c
G al
uc onazole
ĠH iDAC
ri e
Ġun recognized
Ġper mitted
Ġexper ts
ME K
200 9
Ġplan ning
Ġreproduc ibility
Ġbarri ers
ĠBe fore
Ġbrid ge
S B
l ived
Ġ ip
Ġd ia
ell es
ĠH em
ĠP O
Ġexpres ses
ĠE ff
Ġro om
Ġdef ic
int uzumab
Ġ[ (
ĠAs sess
ĠCh k
Ġpotenti ate
Ġconduc t
stim ulatory
Ġequ il
Ġdifficult y
Ġdep rivation
Ġemer ge
ĠEn g
comp atible
OP HO
ĠBAL B
decan oyl
Ġsick le
f loxacin
i ples
v in
on i
Ġp i
Ġp ose
Ġp ack
is sive
ĠP E
Ġad ren
Ġun ve
Ġimmun ology
we ight
Ġcan onical
Ġmonth ly
yc es
Ġaut osomal
Ġser ially
Ġdown regulate
lot ypes
Ġretin al
Ġhyper diploid
03 2
ĠCBF beta
ĠHDAC s
Ġrepe ti
Ġchlor oma
Ġprinc iples
Ġhead ac
Ġfavor ably
CTL s
ĠMn k
b is
Ġc e
te l
et ter
Ġg e
ĠP hen
ĠD T
ĠD AS
ult ures
Ġmethyl prednisolone
ĠSt rept
ock et
Ġhelp er
iel ds
Ġlink ing
pected ly
03 9
Ġconsequ ent
ĠCC gR
ĠEle vated
Ġcorticos teroid
Ġbehavi our
' .
L ong
N UP
m ain
Ġw a
el an
im e
de x
Ġro ds
ass ess
Ġ11 8
Ġclon ally
aren tal
ste ad
Ġlimit ation
Ġoncoprotein s
Ar g
Ġperm its
ĠACA s
Ġrefer ral
Ġrevers ing
" .
A UC
C O
h ift
Ġb uff
Ġth irty
ĠT OP
Ġl um
Ġl amin
op ir
am ate
ĠN G
Ġlen tivir
angi ogenesis
Ġrib osome
ĠInv estig
Ġappropri ately
opir idol
C BP
Ġt ro
es ter
Ġb ring
op ically
ĠCD H
ĠG TP
ĠG leevec
ĠU nex
LA K
15 7
lot ting
Ġexperi ences
ef itinib
Ġdisrup ts
Ġepithe lium
thym idine
rd U
ĠLe vel
Ġinoc ulated
Ġiod ide
Ġbron ch
Ġerr or
tt p
0 36
M in
on ym
Ġf ields
ĠA ct
ĠC LAG
Ġtrans mission
Ġcyt ology
oun t
Ġhe par
Ġfunction ing
Ġreco ver
Ġwor st
Ġclinic o
Ġhepat oma
Ġul c
Ġmeta plasia
Ġmucos al
ĠRespon ses
ĠFox M
Ġdraw n
Ġs ke
ĠC umulative
se vere
ĠI CAM
ĠD EGs
ĠIn stead
ĠR and
ĠL ast
Ġdes irable
Ġprov ir
Ġme et
Ġ19 89
Ġrepres sive
lyc ythemia
Ġdom in
ĠX RCC
Ġcho osing
wh at
organ ic
Ġcreat inine
t on
Ġt ry
he p
Ġh ind
ĠC ellular
ran ular
ĠI TP
ĠF GF
Ġtransplant able
Ġph yt
Ġind ust
LT S
Ġbi ogenesis
ag er
10 9
Ġsome what
Ġcent res
Ġdiscontin ue
Ġcorrespon ded
Ġtet razolium
Ġswit ched
Ġtub ercul
Ġenl arg
Ġte am
Ġaven ues
Ġann ual
Ġenrol l
Ġbeg un
Ġhepatos plenomegaly
dep th
ĠMUT Z
D asatinib
L eu
P EG
re presented
Ġc ancerous
Ġp ecul
Ġh ard
ĠC lass
Ġg p
Ġap heresis
Ġout put
Ġmulti t
Ġconstit u
per formance
Ġve hic
Ġtumori genicity
mo bilized
granul ocyte
Ġnas oph
Ġplastic ity
Ġcomprehen sively
N D
Ġ( +/-
ul lo
et axel
Ġl ive
Ġl andmark
ir radi
Ġcomp osite
Ġwh ilst
ĠL P
ive c
ĠCT A
bil irubin
mod ifying
ĠBH AC
Ġspect roscopy
ĠReg arding
Ġfil grastim
aro xin
ĠCor rel
etho xy
Ġxenotrans plantation
ĠCTN NA
A MSA
b ac
l ies
Ġh yal
Ġn et
ĠD ef
Ġanti leukaemic
Ġcont amin
Ġdev ast
Ġexp ensive
reg ulatory
Ġran k
AL DH
lot inib
Ġmethyl cellulose
Ġlen tiviral
Ġnecess ity
anti body
Ġexce ed
lassi f
Ġhisti ocytic
CAL R
Ġcontempor ary
Ġhypomethyl ated
E Cs
E MA
T ME
W ilms
f avorable
w orld
ti g
Ġp DC
Ġm olar
Ġex tending
ĠM ice
oc las
Ġtre mend
ph ospho
rac tions
Ġpres erved
ad d
ad herence
Ġidentif iable
ĠK BM
ĠK IF
ĠU C
ym et
racycl ine
ĠMul tivariable
Ġdisrup ting
Ġintr igu
ĠBlas t
Ġdevast ating
P BP
a em
n ai
u ing
v ess
Ġs ym
Ġm om
Ġh OCT
ur pose
gen ce
et us
ol ed
ĠH ow
ĠB N
Ġun defined
Ġpres cribed
ĠL ys
ch ie
Ġ19 87
ram e
mut ations
Ġplay ers
Ġter ti
Ġglyc ophorin
ins titution
EN L
Ġsw elling
Ġfram e
Ġinser tions
Ad v
ĠHist ological
olip osomes
HAM M
ĠImmunophen otyping
ori ented
Ġnotic ed
E o
f olate
n icity
on a
er ism
Ġf ig
ĠC U
ist ate
Ġk eratin
ĠN OX
ĠE t
ad ays
Ġinter rog
icin al
13 5
ĠPT C
anti gens
Ġspect ra
Ġduc tal
Ġuniqu ely
ĠUnex pectedly
H ep
d L
s uch
Ġp as
Ġd ich
Ġd ile
Ġre agent
os aroxin
ĠA UL
ĠP HA
Ġmet formin
ĠE po
ĠL angerhans
dition ed
Ġel ast
Ġachie ves
Ġhetero chrom
(- )/
Ġrh G
Ġparad ox
ĠMV D
ĠGr b
inos itide
Ġeffusion s
Ġassum ption
ĠExper im
Ġcasc ades
Ġcollabor ative
Ġiv osidenib
Nucle ophosmin
ithe lial
Ġdup lex
disc iplinary
2 000
P er
V CR
n eu
Ġc igarette
res tim
ot inib
ĠB FU
Ġun modified
ie u
drom e
Ġprolong ing
con jugated
ĠPB L
AR F
Ġcomor bid
Ġultim ate
Ġpossess ed
tif icial
Ġcollab oration
Ġimmunocyt ochemistry
Ġperman ent
Ġterti ary
> ).
E l
m imetic
Ġ &
in ostat
Ġp ort
ra il
pl ate
rom eric
Ġg amm
ĠS al
Ġmet al
ĠO lder
Ġsub cellular
ĠCR M
Ġam en
Ġsim pl
Ġ19 83
Ġ17 0
ĠPD CD
Ġcategor ization
Ġreactiv ate
ĠEn gl
ĠHyp ermethylation
Ġlay ers
Ġinappro priate
Ġindisp ensable
Ġgradi ent
Ġalloster ic
m egakary
t ory
en alidomide
Ġro ot
Ġmark et
Ġallo reactive
Ġmicroenvironment al
-- --
Ġpreven tive
Ġmotif s
Ġfarnes yl
Ġcompens atory
Ġprospec ts
ĠRever se
Ġeukary otic
c ies
Ġb ran
ly ce
Ġh umoral
Ġg ate
ĠG u
ĠE B
Ġcombin es
Ġadhe rent
Ġbur st
Ġtermin ation
ĠIg M
Ġdemethyl ated
Ġsple ens
Ġbus ulphan
ĠLym phoma
Ġnutri tional
ĠSCL C
Ġaccompl ished
Ġprovision al
K GR
e res
re al
Ġd ying
Ġim age
Ġim ages
Ġmon ol
ĠG rowth
Ġacc ordance
Ġprof ession
Ġoptim um
Ġlack s
the tic
isp an
UR K
Ġenl arged
Ġcarcinogen s
Ġresol ve
BAC KGR
OUN D
ymet rix
BACKGR OUND
N atural
Ġc m
Ġb ond
ell a
ac tion
Ġ1 21
anc oni
ĠB as
Ġun responsive
Ġter at
000 3
Ġadop tion
Ġemergen cy
PK C
amb da
PAR C
Ġcoval ent
Ġadduc ts
Ġrheum at
Ġlentivir us
K K
Q oL
t DNA
or f
as ian
Ġf rozen
Ġleuk ostasis
ĠP AP
ĠB is
pro duction
Ġgen otypic
ĠL EN
Ġunder pin
Ġmin ute
Ġeng agement
CN U
Ġarabin osyl
renew ing
Ġsched uled
ĠBi o
Ġescal ating
ĠMut ational
ĠInt ensive
Ġsupple mented
Ġhisti ocytosis
ĠMi R
Ġelong ation
A Z
Ġ lob
Ġt rap
Ġn ur
ĠT oll
Ġ1 17
ĠH o
ĠP DAC
ri an
Ġap art
Ġlympho histi
ser ine
requ ency
tin ent
Ġmin utes
ĠĠ Ġ
Ġradi olab
Ġpur ged
18 0
ew is
Ġorigin s
Ġdiscontinu ing
Ġuns uccessful
Ġhallmark s
ote pa
Ġenlarg ement
H X
d is
Ġ $
te b
Ġe cho
ac rolimus
ĠH DC
ĠP RDM
th romb
ear rang
ystem ic
Ġcol itis
/- </
In vasive
ans w
Ġcur ing
Ġanalog ous
Al l
ĠIg H
Ġdiv iding
Ġunde termined
chlor o
ĠLA IP
Ġmer its
que ous
bac co
lies t
b its
m yel
ro genic
ent re
ec ting
Ġcon dens
Ġch ond
ab s
ab dom
Ġinc on
ĠD AT
ĠS B
Ġhemat o
ĠAT R
omy el
Ġsil ent
Ġhydro pho
Ġwid er
ĠId arubicin
Ġperturb ation
lnc RNA
Ġsoci al
Ġstren gthen
638 45
- .
S er
T S
Ġ1 12
Ġon t
ĠH as
st ud
ist ently
ĠN RP
di hydroxyvitamin
Ġcor ner
Ġimp erative
ĠmiR s
Ġacid ic
ĠST AG
Ġsynerg ize
ĠPD L
Ġassign ment
Ġproteas omal
Ġplasmin ogen
Ġelast ase
H IV
e tions
Ġm ap
Ġd ense
at s
tiv ated
ĠR ap
plant s
ĠTh romb
osi tivity
Ġallo HCT
Ġar gue
Ġra ising
methyl cytosine
lim ited
ĠPo or
Ġult ra
Ġdihydro chloride
ĠRev iew
Ġtam oxifen
Ġlymphohisti ocytosis
ĠHas ford
b ase
an ucle
ut rop
ĠP ers
ph orbol
ren e
Ġhem e
trans planted
Ġamong st
Ġisol ate
ced ented
pre cedented
Ġrever sion
Ġsol utions
ĠAb s
dC yd
ĠEn h
comp etitive
ĠAK R
Ġhistopatho logy
Ġschem es
Ġmicrotub ule
Ġrepeti tive
ĠLevel s
Ġmultit ude
) %
L ym
p e
Ġin patient
Ġan ch
Ġd orm
us ulfan
Ġst ored
Ġun mutated
Ġchem ically
Ġmod ules
Ġprim ed
Ġimp lying
17 75
ung in
Ġchallen ged
of ib
Ġhyper bilirubin
03 1
Ġelucid ating
ria p
ĠHDAC i
ĠTrans cript
Ġz one
cho line
kel et
ention ed
Ġfarnes yltransferase
Out comes
Ġsocio economic
0 33
B cr
Q B
U sing
b oth
Ġc ust
ĠC HR
rom atic
ĠD DR
Ġcyt ologic
de ox
ich ia
ĠE G
11 8
11 9
Ġmulti step
Ġpatho gen
Ġrest oring
Ġchemo immunotherapy
Ġmig r
Ġextrac tion
Ġparallel ed
ĠAc tivation
Conclusion s
local ization
Ġplate au
ĠRa ji
C EM
b rain
c ultured
id az
im umab
ter ations
ere x
Ġde pression
Ġtrans activation
ĠB etter
ĠIn di
NA c
ren ol
ĠAn alyses
ĠSt riking
rid ine
mic rog
MS P
per t
Ġchlor ide
omat ous
Ġeryt hemat
Ġhap lotypes
Ġov ary
onym ous
S YK
U CB
ĠA PC
Ġle arning
ĠC AM
Ġres veratrol
Ġcl ues
Ġun stable
ĠW hole
ĠG R
ĠE ORTC
we et
Ġlympho cytosis
Ġinter cellular
ep tides
Ġnec ro
Ġaltern atively
ĠVEGF C
Ġdoc etaxel
ĠMY D
An thracycl
ĠNA D
Ġshif ts
ĠSer ial
Ġtop ic
adj uvant
ĠFT Y
Ġadvanc ements
Ġimmortal ized
ĠCONCLUSION S
F RP
S ign
b lood
f ludarabine
Ġc ot
ĠA NK
Ġr ich
ĠS il
Ġse e
lec t
Ġorigin ates
ĠPro te
Ġmultic olor
Ġcatal ase
ĠEv ent
Ġbo ost
Ġaber ran
hydroxy glutarate
diagnos is
ĠCO VID
ĠImpro ved
Ġglucocortic oid
Ġglucocortic oids
Ġdischar ge
Ġultrastruct ural
O verexpression
f rame
Ġt acrolimus
it onin
ĠM AT
pl ained
ys is
ĠH aemat
ĠD MSO
ĠE sc
ym ethyl
Ġtox ins
10 6
Ġ19 82
plo red
Ġcriter ion
gal act
Ġhepat ocytes
>- /-</
ĠAb out
Ġslow er
Ġadvanc ing
ĠPres ence
prec ursor
Ġsequel ae
Ġframes hift
Ġintrigu ing
B ET
F B
d aunomycin
f osfamide
Ġun precedented
ĠN QO
ĠG A
ĠG G
rac onazole
ĠE D
Ġcor rection
Ġimp ed
ĠJ Q
Ġer up
roph ic
Ġ13 9
iven ess
Ġcap illary
Ġvalid ity
Ġmelan omas
Ġpoly ploid
Ġaden ovirus
Ġmas ter
Ġeradic ated
Ġradio immunotherapy
Ġconn ected
Ġpresum ed
HSP Cs
Ġvulner able
tetra decanoyl
. -
E r
R C
r it
u v
u fact
ast uzumab
Ġgenes is
tim ulation
Ġcommon est
ex posed
zym es
Ġeng raft
Ġdys p
Ġcardi otoxic
zy go
Ġdiss ociation
Ġaddres ses
ĠCombin ations
Ġimple ment
Ġpneumon itis
ĠHist one
Ġcre ating
Ġautog rafted
Ġencaps ulated
Ġneurop athy
icl ib
Ġmetalloprotein ase
Ġspe ed
Ġheadac he
Ġpecul iar
C hemotherapy
J NK
L in
a ur
i Ds
s Ab
re t
Ġan not
Ġre app
Ġth ous
Ġ2 10
Ġcomp eti
Ġun answ
ĠR are
ĠR ef
ĠN M
Ġper i
ĠG PI
ĠE MD
ĠL ess
Ġret ard
Ġquantit ation
Ġretin oblastoma
cyt ogenetic
Ġcollec tively
osyl transferase
Ġhar m
Ġdip loid
Ġjusti fy
Ġamen able
Ġunansw ered
C ell
] /
a ud
Ġw ent
om orphic
um ber
ĠP BMCs
yl ase
Ġfound ation
Ġpos es
roph y
Ġ> /=
30 9
Ġmed ullary
Ġhelp ed
Ġantic o
Ġdam aging
Ġsol ub
Ġlat ent
Ġaspir in
ĠATP ase
Ġpossess es
Ġspecial ized
Ġretic ulin
Ġmil ieu
factor ial
Ġbu il
Ġaneup loidy
Ġlymphoblast oid
Ġnasoph aryngeal
t AML
w ell
Ġp ocket
Ġ( +
em ble
ĠC an
uc cinate
hem a
ĠP at
ĠS m
Ġen forced
ĠE g
ip oside
Ġhe red
Ġep silon
Ġop ening
Ġplay ing
Ġhelp s
link ing
Ġleuc ocytes
Ġflav on
Ġalloc ated
dam aging
Ġconform ational
ĠStatis tical
Ġdras tically
0 34
D ecitabine
g lobin
le uc
at t
ĠA LC
ĠT CL
et inib
if lu
Ġst res
Ġg ap
Ġg ating
ĠR HAMM
ĠK I
Ġser v
Ġfurther more
33 8
mac rophages
AD D
Ġmanif es
ĠPT CH
Ġembry o
Ġfl an
Ġturn ed
Ġed iting
Ġgran ule
ĠInter feron
Ġimplic ating
wh ich
Gene tic
Ġempir ical
ĠTc R
Ġtas k
1 000
d ifferentiation
t rial
Ġb ax
Ġr ising
ĠS amples
ĠE SCC
Ġbi le
Ġ12 6
Ġonc ologists
ok ed
ĠCh ildhood
Ġmed ullo
Ġmes othe
Ġinteg ral
Ġinternal ization
Ġhepat otoxicity
Ġdemethyl ase
ĠRAR beta
Ġunex plained
sho p
ĠSwed ish
ĠAfric an
M s
N o
S N
k et
o lo
is tering
um a
ĠB TK
Ġr ule
ph thal
gres s
Ġpl ac
tim ately
Ġman us
Ġinter im
ĠU PD
11 5
Ġpotential s
Ġhyp oplastic
ĠAT F
Ġmethod ological
Ġaction able
Ġquestion nai
Ġpy ro
inhib itor
Ġdim er
Ġdeb ated
Ġren ders
Ġscan ning
, +
N ew
R e
m entioned
Ġm ol
Ġb re
Ġh or
Ġch ick
her ichia
Ġun identified
Ġprotein ase
Ġsuc cessive
ch icine
av es
loc k
21 3
Ġsel en
Ġsh ut
amm alian
itu itary
Ġlip oprotein
Ġtel omeres
Ġpolyc omb
Ġescal ated
Leuk emic
Ġbrom ide
otin amide
ĠWE HI
sk y
ĠMTH FR
coagul ant
Ġsubmic roscopic
g able
p ass
t ail
Ġb ab
ot or
ĠC are
ĠI ll
ĠM IR
Ġat taining
ĠG ab
Ġsub f
Ġspec tral
urren ces
Ġocc ult
Ġdeterm ines
ĠV alid
ĠV OD
Ġref ers
ack ground
In ternal
ĠRec urrent
000 7
con ditioned
Ġchim a
Ġharb our
Ġadap t
Ġhaem orrh
Cl onal
Ġdeline ated
Ġjud ged
Ġthromboemb olism
G leevec
t rol
al in
is tein
Ġf oci
ut ation
ol ine
ĠCD A
Ġco efficient
ĠN an
ĠG PR
Ġpre existing
Ġpo ison
Ġallo HSCT
Ġhyp ot
ne a
ĠBM SCs
Ab elson
29 9
Ġexcl ude
Ġsecre te
Ġabrog ate
ww w
Ġnod ular
Ġcover ing
ĠMin imal
ĠSy k
Ġhydropho bic
Ġcorner st
' )
2 53
C ore
Ġa queous
in ite
ot ency
Ġ1 19
Ġ2 15
ag land
ill in
ĠK it
sup ervised
14 7
NK T
Ġauth or
Ġher al
Ġexce eded
Ġattrac ted
Ġparticip ation
ĠCA RT
erc etin
unc tiv
Ġcathe ter
Ġregen erating
Ġlap atinib
V H
g ia
it ting
im eric
Ġmyelo proliferation
ĠH om
ĠP atho
Ġun biased
ĠS PARC
Ġint ake
ĠL CH
ĠL AA
rib onucle
az adC
ores cent
Ġcontr as
Ġstrati fying
Ġsensiti zing
Ġsubc lassification
Ġund erex
Ġrepl ace
ĠMo Abs
Ġtail or
Ġlay er
Ġgover n
nec ess
ĠTN BC
Ġrepur posing
Ġorth otopic
elan oma
N G
P H
R b
in come
Ġt akes
Ġw itness
it um
it oclax
ĠA HR
ĠI FD
Ġv ag
ĠP artic
ĠB raz
Ġun equ
Ġout look
ĠTh r
10 4
18 7
Ġlab el
Ġhaemat ologic
Ġcent re
Th irty
Ġj a
200 8
Ġintegr ative
Ġinst ance
tes tis
Ġimmunocomp etent
Ġcat abol
ĠPharmac ological
Ġunexpected ly
Ġdispar ity
ĠDiagnos is
Ġscat ter
Ġchemoradi otherapy
hep atic
Ġmom ent
H b
M Cs
k a
v ate
ar in
ML H
Ġ1 38
ĠM ark
Ġim planted
Ġg et
ĠH ES
Ġun necess
Ġgen otyped
ĠG lobal
Ġlow ered
ag s
10 8
Ġcr ystal
Ġhel d
Ġlip ids
ĠPR C
Ġbl ack
umin a
ĠTR EM
Ġeth nicity
Ġmening itis
Immun e
ĠInd ividual
Ġvulner abilities
isting u
ĠBraz il
L O
a q
i tic
t oph
ti fication
Ġm aspin
Ġ( '
ur ate
ĠM ass
ĠM FI
am er
Ġimmun otoxin
Ġ12 9
12 7
ici encies
20 5
Ġmit omycin
Ġsynerg ized
Ġevolution ary
Ġposi tions
ĠPro gram
rec ting
AN CE
CNS L
ĠHyp er
Ġflav opiridol
ensitiz ation
Ġlipophil ic
Ġsa fer
Ġcondens ation
Ġhyperbilirubin emia
L N
a qu
Ġre press
Ġf all
Ġf rail
ĠA AML
am id
ĠS CN
ĠDNA M
Ġ19 73
Ġevent ual
Ġresult ant
29 4
Ġconsec utively
ĠSc reening
CY P
Ġdiet ary
Ap proximately
Ġpericardi al
Ġcarbohyd rate
Ġtubercul osis
A X
O nc
X W
Ġc amptothecin
Ġh ip
Ġth rombin
ib rium
ol uble
Ġg ro
Ġat he
Ġco existing
ple tion
enc aps
Ġer lotinib
IC U
dC K
Ġear liest
ĠHemat ologic
Ġallog rafting
Ġnit rogen
Mul tiple
ĠAI DS
Ġribonucle otide
ĠKary otype
Ġdiges tion
Ġanc est
ĠLast ly
Ġenroll ment
lassif iable
Ġhered itary
Ġmanus cript
C HOP
L BL
Ġle ptin
Ġbe v
ĠL I
Ġman ufact
21 9
ry ostatin
Ġ12 7
Ġ12 36
Ġret rie
Ġisol ates
AR S
AS E
Ġaden ine
Ġparticip ates
Ġten iposide
Ġalkal oid
Ġoccasion al
cycl ing
Ġorganis m
Ġfif ty
oz ol
Ġadjun ct
ĠIntr igu
Ġambigu ous
ĠIndi an
ĠEsc herichia
P l
V IM
te cted
Ġs FRP
es sive
Ġre nd
Ġh ENT
ĠM AL
Ġr IL
ay ers
ĠIn termediate
ĠS te
ĠW il
Ġrel ating
Ġit raconazole
and ed
LT C
mon ocyte
po or
Ġ13 2
ward s
Ġrever t
ĠZ R
Ġoste oclas
Ġtub e
Ġlas ted
olip id
ĠLike wise
Ġcoron ary
Ġgang li
ĠEvalu ation
Stud ies
ĠEng raftment
ozol omide
F low
G P
P SCs
c ysteine
l av
Ġin activ
an es
lo pec
ĠB inding
Ġcomp uter
Ġrespon ds
Ġhem ophagocytic
Ġrec essive
ĠL nc
Ġtumor al
Ġsc lerosis
Ġimp ending
Ġ12 8
Ġmor pho
com plex
Ġcarcin ogenic
Ġke pt
Ġgre w
Ġaltern ating
Ġox al
ĠCom plex
Ġtermin ally
aun o
Ġlys ates
ĠSout hw
Ġreproduc tive
Clinical Trials
present ation
CAL GB
Ġdeterior ation
ĠRun x
Ġbev acizumab
S omatic
c utaneous
k ine
Ġp el
Ġd C
ic a
Ġre ad
ol ide
Ġg efitinib
ĠP cG
ĠD et
ĠD AP
ĠO ral
ĠL ewis
Ġdec ipher
Ġel even
Ġmulti functional
Ġmulti parametric
Ġpost operative
Ġmed icinal
Ġtransf ect
Ġdam aged
Ġpul se
Ġimmunological ly
Ġgrad ual
Ġengine ering
Ġenhancer s
Ġadvanc ement
Ġneph ro
Ġsuccumb ed
Ġrend ered
P urpose
T PA
U RD
n an
o in
Ġw all
at osis
im etric
Ġl intuzumab
ĠP seud
act ing
ĠN atural
ĠL DL
Ġind ole
ĠV AF
Ġadmin ist
25 5
ĠCon ditioning
ĠComp ound
Ġextrem e
appro ximately
ĠTF PI
umb ar
ĠMicro array
Ġeduc ation
Ġmicron ucle
M yb
R NP
S O
d c
Ġw ound
Ġn om
ĠT ra
il ities
ĠM c
Ġde em
anc ial
ĠF H
Ġblood stream
11 2
Ġsh ares
ĠPh ys
Ġrepres ses
Ġend ocrine
Ġyiel ding
ĠPU MA
ĠGerm any
pur ged
pathw ay
occur ring
escal ation
ĠAssess ment
C SA
P ediatric
R as
o vir
s q
y g
Ġm um
Ġ( +)
Ġh ttp
ec ause
ter one
ĠD APK
ad ir
AB T
Ġmulti disciplinary
Ġmulti factorial
Ġmicro vess
Ġmy r
05 5
Ġnec rotic
ĠCon tin
Ġpersist ently
ĠBec lin
IF IC
ĠTrans cription
Ġinfiltr ated
Ġtet ra
Ġsmok ers
ĠTK D
ĠDL X
ĠBR E
ĠWh at
ĠBE AM
Ġsupernat ants
ĠIntrigu ingly
lopec ia
E ZH
M UD
N ase
R II
f ocal
Ġto bacco
ter al
Ġst ro
op tive
ĠI DR
Ġg yn
ys regulation
ĠF N
ĠN ow
ĠE ct
Ġprolifer ations
ke ep
par tic
OR R
Ġcontinu ation
04 9
Ġrever ted
ĠPC a
ĠSI GN
Ġthres hol
Ġnit ro
ĠSU MO
Ġrecapit ulate
ĠEg yp
IFIC ANCE
ĠSIGN IFICANCE
D E
L ys
O I
U CBT
ti tion
en sed
Ġc ere
Ġan ion
Ġf ounding
om eric
ĠC As
Ġ1 34
ĠM idostaurin
ĠF CH
ĠS CC
Ġab ilities
Ġmon ocytoid
Ġsec tion
Ġhyp og
ex on
RT K
Ġmicroen vironments
ai wan
Ġsal iv
Ġexpect ations
ĠLY N
Ġlif es
ĠEpidemi ology
ĠAff ymetrix
Ġtremend ous
kelet on
ĠValid ation
Ġin organic
Ġs izes
Ġan terior
ic ted
om bin
om yces
ĠT aiwan
Ġex pon
Ġde fer
The rapeutic
Ġinvestig ates
Ġar tificial
Ġend ocytosis
osup pression
Ġpharmac ogenetic
Ġrecogn izes
Ġver teb
Ġund es
Ġpathophysi ological
Ġq PCR
ĠSh ort
ĠSequ encing
Ġaven ue
Ġcommerc ially
che str
Ġshap e
Ġdinucle otide
renol anib
Ġthreshol ds
i ary
p rin
or ylation
ĠM ol
Ġg all
Ġv ision
ĠP ol
ĠN Y
Ġhem olytic
Ġpo inting
ĠL im
Ġpar am
ag glut
MT D
ĠV D
Ġ12 4
jec ted
the rapeutic
activ ator
Ġcris es
ĠPA I
BCR P
Ġpharmacological ly
Ġfl uconazole
arabin oside
Ġunex plored
Ġhistopatho logic
asi rox
combin ed
Ġincon clusive
ĠStriking ly
C MR
F ox
d ouble
m ixed
v ation
Ġb right
us ing
ter ious
yelo cytic
Ġl ic
st ine
ĠS mall
Ġus ual
ĠR est
act in
ĠE GF
ĠL SPC
ros arcoma
Ġpat h
ad a
Ġcan ine
Ġpar ts
reg s
Ġmor ph
Ġdaunorubicin ol
Cs A
Ġ18 1
Ġgl omer
Ġinvas iveness
Ġoste oblasts
Ġparticip ants
Ġuncertain ty
occ urrence
Ġhypox ic
Ġfavor ing
Ġhomolog ue
Ġperturb ed
ĠEr ythro
Ġlearn ed
Multi drug
Id entif
R alpha
s ecre
u ation
Ġp r
Ġp ortal
Ġp ituitary
Ġin termedi
Ġd ro
Ġn adir
ot omy
ĠC al
ĠI U
Ġ1 33
Ġor tho
ĠH PLC
anc re
ĠB ay
Ġcomp elling
Ġimmun ization
ĠE stim
est aur
tit utive
Ġconf ocal
13 8
Ġphen otyping
ex press
Ġadmin istering
Ġapproach ing
CA G
Ġcirc ular
36 2
Ġpregn ancies
ĠSub group
ĠSystem ic
Ġinterf eres
Ġextend s
Ġtrac king
Ġstriking ly
ĠRet rospective
El derly
Ġrheumat oid
riap ism
Ġdeem ed
ĠFCH SD
C bl
i o
n umber
v elop
Ġd F
Ġe yes
ĠT H
ĠC AF
Ġg lob
Ġg round
Ġv osaroxin
Ġtrans cribed
ĠD X
ĠS DS
Ġse ek
ĠE astern
Ġro se
ech st
Ġcor rected
Ġrev ision
14 4
rect omy
In troduction
Ġutil ize
allo HSCT
Ġpoly peptide
ĠDC K
67 6
ob ese
ĠZ AP
sign al
Ġpredisp ose
ĠNew er
ĠAP Cs
ĠRAR alpha
Ġdimin ish
Immun ophen
ĠCE A
hion ine
ĠIniti ally
Ġcation ic
Ġunres olved
K MT
O s
d gehog
g reater
s ingle
Ġin ev
Ġf u
if ies
ĠM ixed
Ġbe ads
ĠB ad
Ġinc omp
ĠS MA
viv o
Ġover production
Ġhe dgehog
14 1
rophil ic
Ġcirc RNA
Ġmel ting
As p
sy ch
Ġxenog rafted
gl igible
Ġnanopartic le
Ġoccup ancy
Ġrab bits
Ġexceeding ly
ĠLab oratory
Ġecho cardi
Ġmedullo blastoma
itum omab
ĠEct opic
H GF
H HT
] :
d t
g uanine
w or
Ġa rose
Ġs aturation
Ġf ood
om ers
Ġh MLH
ĠT rials
ĠT fR
if ug
oc cal
ĠH K
ĠP CD
ĠS w
th rombin
Ġmon os
ĠG LI
ĠL N
ros por
so red
Ġinter view
Ġprim er
Ġmulti agent
ĠV er
Ġblock age
26 77
04 1
gram med
emal e
Ġaccel eration
Ġrh IL
Ġcytos ol
phosphor ylated
cer amide
Ġimmunocyt ochemical
Ġcontra ind
idi rectional
Ġreconstit uted
Ext ramedullary
Ġchemot axis
Ġheterochrom atin
abdom y
4 01
B ackground
G ATA
b ox
i ke
p erm
Ġt able
Ġp un
ĠT AD
Ġis ot
Ġ1 53
ĠN H
Ġab st
ĠE ML
ĠE MA
Ġhe lix
Ġ14 3
18 5
ĠAm eric
Ġpractic es
onc ogenes
Ġupd ates
Ġincid ent
Ġintercal ation
Del ta
Ġantimetabol ite
Ġproc aspase
Ġultras ound
Ġfin ancial
Ġconv inc
G AP
R af
S c
j un
p rimary
r p
en og
as ing
ĠT el
ĠM IC
Ġv i
ĠS OD
th ora
ip arental
Ġsup posed
tal k
oh ort
Ġconjug ation
ĠY oun
ĠTNF R
Ġadap tation
Ġepis ode
ĠTL S
Ġcathe psin
Ġvascul itis
Ġfif th
Ġpolar ization
Ġacces sibility
Ġunnecess ary
ombin ant
D F
P ET
s m
ic ase
ic ines
ic lovir
Ġg lasdegib
Ġor chestr
ĠP an
ĠS GI
Ġco upling
ĠN MR
Ġspec ulate
Ġpl aus
anis h
ĠU se
ĠCh IP
Ġsu it
Ġsubt le
Ġ201 9
ĠX PD
ĠPro gnosis
Ġpolyc hemotherapy
Ġattenu ate
Ġalloc ation
d oc
Ġp it
it ron
at ases
os itis
Ġn ation
ĠA URK
ĠC entral
Ġprognostic ators
ĠK e
Ġpredic tions
Ġhyp odip
Ġup regulate
otox ins
of sky
Ġsp ati
Ġ28 0
Ġbur dens
Ġpubl ication
arn ofsky
ĠInhib itors
enh anced
Ġpenet ration
acr yl
Ġchol angi
g el
p ers
Ġt it
he xim
ĠT E
Ġg ut
ĠP e
ĠF K
ĠN IH
ĠO ptimal
Ġpre malignant
ĠL FA
Ġbi phasic
Ġext ran
Ġmin i
Ġunc lassifiable
Ġdele terious
Ġfac ial
Ġaccel er
ru vate
immun ity
Ġtem plate
Ġapproval s
Ġple i
ĠMon oclonal
Ġradical s
ĠTim e
Ġscenari os
mor bidities
fib rotic
ĠMain tenance
Ġuter ine
Ġvehic le
ĠSouthw est
C OX
d ifferentiated
m pl
o ted
t ocol
it ated
ĠM us
ĠM Cs
ĠD isc
ph an
enti s
00 00
Ġco expressing
Ġ4 50
Ġnew born
Ġthrough put
Ġonc olytic
Ġ14 5
Ġprec ip
Ġimm o
ĠPB X
ov ine
Ġdysfunction al
Ġopportun istic
Ġple thora
Ġrh GM
aut ologous
Ġthi otepa
My lotarg
Ġphag ocytic
ĠExt ramedullary
ĠAustr al
Ġincre ment
ĠSci ence
Ġconven ient
ĠHo echst
Ġaberran cies
D ata
W P
or ted
Ġex osome
Ġres erved
ĠO wing
ĠO PN
Ġpres ervation
ĠL og
ĠL arge
oth rip
Ġ12 2
Ġsu ited
Ġexer c
Ġproblem atic
Ġimpair ing
sc Fv
Ġavoid ing
ĠTAM s
Ġdispar ities
Ġcommerc ial
Ġansw er
istin ct
Ġps ycho
hexim ide
othrip sis
f ms
ul ator
ĠH IF
ĠH ispan
qu antitative
Ġne gligible
othe lial
ĠN OPHO
Ġnon invasive
Ġcol chicine
ĠV IM
12 8
Ġop ened
Ġ14 8
Ġinform ed
Ġcent ury
02 01
Ġreal ized
IF D
sp ring
ĠHemat ological
Ġpeak s
Ġautog rafting
Ġcoinc ided
Ġvascul ature
ĠKore an
ĠOK T
ĠStrept omyces
ĠIll umina
Ġwitness ed
estaur tinib
) ],
N OG
T I
d in
at her
ĠC SA
Ġres ting
Ġl ose
ĠH PC
anc omycin
Ġr igor
ĠG I
ĠE Vs
21 6
Ġpos terior
Ġins urance
PB X
Ġoff spring
ĠVEGF A
ob iotic
ĠQ u
Ġdep osition
Ġmas sively
Ġunde restim
ĠAD CC
Ġtail oring
Ġneo adjuvant
ĠItal y
Ġchann els
Ġpatholog ies
Ġcoc ulture
- /-
H iDAC
S OD
b rom
f inger
Ġa urora
Ġo macetaxine
Ġf lex
ec tious
un it
Ġis chem
Ġl ambda
ĠM H
ĠM IT
ol s
ĠP t
am ustine
th irds
ost ine
ad riamycin
Ġmore over
ĠU L
CD A
Ġinte stine
14 98
BM I
Ġaccording ly
Ġmed ically
Ġins ide
ĠPro gression
ĠCons istently
ĠHSP C
ĠDe partment
Ġemphas izing
ĠSur veillance
Ġphosphatidyl serine
Ġmyc ophen
Ġinoc ulation
Ġundersc ore
haplo identical
ĠTI MP
Ġhypereosinophil ic
Ġpolic y
Ġstro ke
Ġischem ic
+ -
B AL
O lder
P LL
le u
Ġf em
Ġf ix
Ġh ub
if ostine
Ġcomp ares
Ġad ds
Ġrel ates
ĠN U
ĠE OC
Ġout lined
end amustine
ĠV RE
yd aunorubicin
Ġexplo res
Ġoptim ally
Ġhyper calc
omon as
Ġharb ors
Ġsal ine
ĠHR QOL
Ġpul sed
ES U
Ġexplain s
Ġweak ness
ĠHyp omethylating
iaz ol
Ġsem iqu
microl iters
Ġencaps ulation
fil grastim
Ġthorough ly
Ġcoval ently
Ġcoord inated
ĠDet ailed
N RAS
c AMP
d R
f ixed
m ammalian
u it
u ity
Ġd nr
ic ular
un related
Ġst orage
ib ly
ĠH B
ĠF LI
Ġag lyc
CR L
CR p
ĠL o
Ġidentif ier
gres sive
Ġel ab
ĠK arnofsky
ĠCR i
ĠV al
Ġer yth
ĠCh aracter
Ġpur ification
Ġpotenti ation
ĠCT C
Ġrecommend ation
Ġcollec tions
Rec urrent
Ġul cer
Ġmis diagnosed
Ġweak er
Ġnever theless
Immun otherapy
Ġdist ress
ĠSh p
ĠSA MD
Ġarsen ite
ĠImmunohist ochemistry
ĠMan agement
ĠPN H
Aut ologous
Tar geted
Ġdiver gent
entis ts
Ġa lopecia
Ġs IL
ĠC lofarabine
ut lin
et oposide
ĠP oly
Ġsur prisingly
por ts
ĠO RR
ĠG AB
Ġexp ense
Ġstr ing
vers ally
Ġmicro biological
Ġcolon ization
Ġ16 1
DR B
Ġcal f
Ġlink s
Ġlink er
Ġhospital ized
effec t
sign ificant
Ġlys osomes
Ġbio active
ĠNe utrophil
Ġphospho inositide
Ġsubcl onal
Ġperturb ations
Ġdisturb ances
Ġuni versally
ĠFact or
Ġscaven ger
Ġunderpin ning
ĠEgyp ti
ancre atic
B ecause
S ix
en al
Ġp eroxide
or bidity
Ġd ot
id el
ri end
Ġne igh
Ġk et
Ġhem opoiesis
ĠG ata
rac ts
Ġob ese
ers en
loc ations
Ġme pes
po ietic
17 8
int rinsic
Ġ15 5
Ġ13 7
AL SG
ĠBM S
Ġunc o
und ice
of lu
MS D
Ġpersist ing
Ġpreferen ce
Ġhaem oglobin
ĠAnti body
Pro tein
Ġnecessit ating
Ġstrict ly
ĠDi rect
Ġradiolab eled
earrang ements
Ġcornerst one
Ġunequ iv
Ġgro ove
Ġpit f
Ġmepes uccinate
5 21
b reak
e a
h istone
Ġad opt
ĠR PM
Ġen jo
ox ins
Ġhyp erg
Ġsim ulation
Ġ15 1
Ġ15 4
Ġflu ids
Ġwork flow
04 3
ĠEx amination
ĠRT K
Ġxen obiotic
Ġhepat ocyte
Ġvol asertib
Ġbil irubin
Ġemphas ized
ĠMechanis tic
ĠCG L
Ġcorrect ly
Ġsem is
hyp er
Ġfung i
ĠNucle ar
Ġpeg ylated
ĠAltern ative
ĠAltern atively
Ġjunction s
Ġexempl ified
Ġplac ental
Ġmum ol
D ifferen
Ġa eti
Ġt un
ĠC yc
Ġg lobin
ap ses
li ter
17 7
Ġgranul opoiesis
over all
Ġ13 5
Ġtr astuzumab
Ġpur ity
ĠSt age
Ġthrombocyt openic
Ġcorrespon d
co ated
Ġmultic entre
Ġparticip ating
Ġkidne ys
Ġhundred s
ĠMed icine
Ġneutral izing
Ġtempor ary
strati fied
Ġprojec t
ĠGF P
ĠIG HV
ĠUl timately
Ġdia me
Ġdysp nea
ĠZR SR
B K
H ere
b f
q RT
lo ts
ĠC BP
ac ts
Ġst atin
pl atelet
ute ro
anc iclovir
ĠF ailure
ĠF anconi
ĠCD DO
pro gression
Ġmo un
Ġap t
Ġrec onstr
Ġpar acrine
Ġcharacter izes
Ġop tic
UN EL
05 9
Ġsus taining
Ġblock ers
osup pressive
Ġcent ros
ĠPD X
Ġwild type
66 2
ĠĠĠĠĠĠĠĠ ĠĠĠĠĠĠĠĠ
Ġantagon ism
ĠCCR F
St at
GL IS
Ġdisturb ance
HN MD
ĠBlas ts
Ġattain ment
Ġrepop ulating
Ġamelior ate
ĠMorpholog ical
toph an
D iagnos
E MT
h alf
h aemat
Ġc ures
Ġm old
Ġre expression
Ġb ig
Ġres ected
Ġst and
il imumab
Ġde al
ĠH AA
ĠD ros
ĠK m
Ġqu ercetin
Ġreported ly
Ġ19 70
ĠALL s
Ġnucle osides
Ġcompar atively
Ġdown regulating
Ġexplo iting
24 8
Ġrecogn ised
ophil ia
ĠPB SCs
ransi ent
200 3
ĠMN C
mod ulation
Ġshif ted
Ġtelom eric
ĠSET D
ĠCompar ative
Ġresemb led
Ġcardiomy ocytes
Ġaff or
ĠAY A
Ġpropag ation
lyce rol
ESU LTS
F ACS
L ittle
e IF
f irst
i platin
z er
Ġ ie
Ġ utero
Ġs atis
Ġm tDNA
Ġthe ory
ĠT RA
Ġres ide
ĠP AT
ĠCD w
der ing
ĠE uro
yn chron
Ġaut otrans
33 0
Ġpartic le
Ġ17 6
yth aemia
Ġimmunophen otypical
ĠAt g
04 4
ob acter
allel e
ĠCSF s
Ġplurip otency
Ġuncon jugated
des ign
ĠDel ta
Ġpseud o
Ġinterrup tion
Ġstom atitis
HE J
ĠSwed en
Ġcytomorpholog y
org anis
Ġperox idation
Ġgest ation
Ġchaper one
ĠPDL IM
Ġpyro sequencing
idel ity
A Y
G BM
H K
Ġc N
or ies
as urable
Ġd ed
Ġb ench
Ġn av
ter in
oc id
Ġdev oid
ĠU PA
omet abol
Ġ16 3
ĠNK T
ochem otherapy
Ġprote cting
tumor igenic
Ġrest ores
ĠHe tero
Ġorgan ized
ĠInte gr
ĠMY H
Ġacet ylated
Ġfibro tic
Ġcataly zes
Ġrecur red
Ġhope fully
Ġharves ts
ash i
Ġcyclo heximide
Ġfav ored
Ġinstrum ental
Ġsmo ke
Ġcogn itive
Ġprost agland
ĠPos sible
Ġimbal ance
ĠEff orts
C SCs
H S
K O
M al
T SG
n ose
en em
ic ated
ar ib
om ark
ec yl
ĠR IT
lym ph
di hydro
Ġmod ule
ĠK S
Ġdef iciencies
Ġ19 81
Ġprop oses
ane oplastic
ĠCT CF
Ch IP
Ġbreak age
Ġnan o
Ġcontribut or
Ġrepop ulation
ĠDU SP
ĠCauc asian
8 00
B ased
P BMC
S urvival
m ma
n aph
r ig
r ide
Ġs ense
Ġf uc
Ġb ovine
os te
ĠC SP
ut ral
ine ered
Ġdis omy
Ġun less
ome ter
Ġchem op
ĠG al
Ġpre transplantation
Ġlympho kine
Ġantib acterial
ĠV y
13 9
Ġcoun sel
roph yl
25 9
IC AM
NK G
Ġgu anine
IR F
Ġminim izing
ĠHD MP
ĠSH IP
au rospor
Ġderm al
Gl n
Ġprospec t
Ġsubdiv ided
Ġdefic its
Ġfig ures
Ġja undice
Ġancest ral
Ġgyn ec
0 53
B N
B oth
R BC
n aive
re ating
ti tis
on st
Ġc renolanib
Ġo il
al og
or ically
ĠC MA
Ġres emble
ver ted
Ġ2 30
ĠD em
ĠD KK
ĠF AK
Ġper tinent
Ġro d
Ġdem onst
ven tive
Ġevalu ates
MP S
ĠDN X
Ġ17 7
ST I
Ġabs orb
Ġpotenti ates
CP T
Ġmuc in
Ġrepeated ly
tro viral
ĠEP HX
Ġmening i
Ġcircum stances
olip ids
Ac tivating
CV AD
da ily
Ġsubstit utions
Fas L
ĠHMG B
ĠKore a
Ġnation wide
Ġplei otropic
Ġmycophen olate
1 34
E MR
O n
d an
p ic
Ġ ile
Ġp aternal
Ġs ister
Ġd ock
um ented
ĠM ic
ĠB rdU
am ed
ĠD HA
ĠE NL
opo lym
Ġgroup ing
Ġdec ided
av age
Ġmicro bi
omet hyl
22 4
Ġpost induction
ĠPh armaceutical
oph istic
Ġ20 6
Ġtr uly
Ġ16 5
CC A
Ġcandid iasis
mit otic
Ġsplic ed
gl ia
Ġsynthe tase
Ġoste oblast
Ġcarb onyl
ĠChrom atin
Ġconn ection
Ġpersis ts
Ġlif est
Ġrecapit ulated
ĠCirc ulating
Ġdiscrimin ating
Ġnanom olar
TO F
Adv ances
ĠSil encing
Ġlifes pan
G IST
L DAC
S ome
U SP
f requency
k L
Ġc ock
Ġp sych
er ly
os amine
Ġpro coagulant
Ġde phosphorylation
Ġv as
Ġv ancomycin
ie ties
Ġrem ove
ĠN CI
ĠE V
Ġdev ised
ĠK O
Ġvit re
ĠV ir
ram etinib
14 2
Ġloc ations
Ġtr is
Ġinde f
Ġgu ided
Ġspl it
lab oratory
sign aling
ĠTNF alpha
Ġmis sed
Ġpain ful
ick ed
Ġpossess ing
Ġfluores cein
Micro RNA
ĠDel etion
Ġtrim ethylation
ĠFB XW
Ġsmo oth
Ġathe rosc
L e
M UT
M ixed
U PD
r ated
Ġp DCs
ic idal
ut on
Ġun iparental
th yl
Ġmon ophosphate
oun der
Ġmod es
enc oding
Ġmechanis tically
33 5
Ġop eration
PA P
Ġ17 2
MD M
Ġmetabol izing
Ġcount ry
Ġstatis tics
rins ically
lim ersen
Ġmate rials
Ġmus c
Ġimmunos timulatory
Ġoc clusive
Ġcomb at
microl iter
Ġencomp as
Ġcontra d
Min imal
Ġdemonst rable
ophistic ated
Ġlifest yle
0 37
D MR
F P
G roup
S ystemic
k B
k ip
m Abs
Ġ rac
Ġ %),
ro bor
as ome
le y
ĠC FC
ĠM uc
ĠH V
ĠP CA
ri tion
Ġmar ine
ary otype
ĠE st
ĠL ate
34 2
Ġdete cts
ĠK CL
Ġprim e
fer rin
Ġ18 6
CI P
Ġflu oro
ĠX PC
Ġfac ed
TP O
ĠSur face
sil enced
vit ro
ĠSW OG
odeoxy uridine
ĠEffec tive
Ġdile mma
Ġoxal iplatin
Ġacceler ates
E po
T N
f it
g ration
h it
Ġc ipro
Ġp ren
as ia
Ġf um
Ġf air
Ġf its
Ġb ryostatin
Ġh it
ra d
ĠA XL
ĠT C
ĠT CF
ĠT aq
Ġfor ty
ĠF U
ĠS iglec
ĠN P
Ġen um
ĠE GR
hen oyl
Ġinterac ted
Ġclon ogenicity
Ġtransf used
Ġlife time
Ġsal t
Ġhepat omegaly
ĠAb elson
Ġchimer a
Ġrh abdomy
Ġhistological ly
Ġseg ments
acin omycin
Ġdeliver ing
ĠMO LT
Ġdispar ate
Ġgover ning
ĠMEC OM
Ġdischar ged
osa ic
Ġdisadvant ages
% <
- <
E n
K RAS
l ia
Ġs ophisticated
Ġb ed
ĠC ri
ĠM uch
ĠP ur
ĠP otential
Ġcl osed
ĠD ifferentiation
ĠF AS
de ath
ogen omics
ateg ies
Ġqu ad
Ġext r
ex p
ĠML F
Ġ15 8
lyc omb
com mitted
Ġmetabol ized
ok inetic
ĠRec ogn
ĠST R
Ġimmunosup pressed
04 2
IR C
Ġadhe sive
Ġtra jec
ĠCC AT
olar ization
ospor in
Ġbo ys
Ġclassif ying
ĠNor th
ĠEr k
Ġpass age
nit ros
Gen omic
Ġmitig ate
Ġdomin ance
Ġsolub ility
Ġmesothe lioma
Ġfix ation
L Cs
N eu
Z L
s us
Ġb idirectional
ĠT IG
us arium
Ġle g
op ulation
od ay
Ġor phan
ĠS uccessful
ĠCD I
Ġco factor
ĠR E
iz able
Ġimmun oma
CR EB
ĠL MO
opo lys
Ġspec ulated
Ġma fosfamide
ither to
ĠML LT
20 9
Ġprot otype
EGF R
ophil a
Ġrecru iting
exist ence
Ġeti ologies
Ġabrog ation
lip id
Ġautog rafts
St andard
Ġabdom en
Ġwithdraw n
Ġsinus oidal
Ġperm issive
Ġrender ing
Ġacces sible
Ġdead ly
Ġconstitu ents
Ġquestionnai re
ĠPartic ular
encaps ulated
ĠEgypti an
Ġcock tail
C ycl
G TP
N ilotinib
R h
S ET
X A
f i
re presentation
Ġin put
al dehyde
Ġb r
os ulfan
om ycosis
ĠA part
Ġl umbar
ĠM r
ap osi
Ġne u
Ġun reported
pro duc
Ġpre emptive
ari osis
Ġinter individual
LA IP
Ġext rap
Ġcorrel ative
Ġ14 1
Ġbenef ited
Ġ18 8
Ġsuccess es
Ġphosph atases
Ġprofil ed
(- /
ura min
ust rian
orph isms
Ġeng ager
orpor ation
Ġhybrid s
ĠAS H
Ġorgan elles
Ġauto immunity
Ġvariab ly
Ġparen ch
Ġmimic s
Ġtub ulin
Ġstabil ized
Ġsci entists
Ġimmunore active
cyc lo
ĠFox p
ĠMO Z
ĠTox ic
ĠDiagnos tic
Ġaneup loid
tri phosphate
ĠBl ack
assess ment
Ġhypercalc emia
aurospor ine
A SP
C hem
F s
K G
R isk
T GF
v L
in ted
Ġc odes
Ġm osaic
Ġf irm
Ġb ases
os um
ĠA Q
ĠA DP
gen es
ĠC och
Ġfor ce
Ġl up
Ġbe ar
ĠP a
ĠB AD
ĠS till
ĠS weet
ĠR OC
ĠR ESULTS
Ġse ed
ĠL AP
Ġchrom othripsis
Ġprote olytic
PB SCs
Ġconcern ed
Ġfrag ile
PC NA
ĠAp pro
Ġoxy genase
quis ite
Ġallog rafted
Ġfibrin ogen
asi ans
amp ath
Ġdeoxy ribonucle
Ġanth rac
Ġsap acitabine
acyt arabine
ĠRece pt
Ġequil ibrium
ĠEngl ish
Ġcust om
Ġshut t
Ġdefer asirox
Ġextran odal
Ġcipro floxacin
A CT
H CL
a im
c ross
p ine
v ocid
Ġt rametinib
te ch
Ġp mol
Ġs ter
Ġto t
ur g
ĠC x
ac hed
ĠM ZF
Ġun translated
Ġrel iability
Ġgen istein
ad m
form e
Ġallo BMT
ch i
Ġantigen emia
Ġestabl ishes
MR I
tis one
Ġlab elled
Ġly sed
ĠIM iDs
Am ong
inte racting
Ġtem ozolomide
Ġundergo es
ĠAnti gen
TL D
ĠTr x
Ġdest ro
avail able
Ġtax ol
Ġabl ative
ĠStr uct
vocid ib
D own
D onor
H M
i op
k ill
s econdary
he sion
Ġf etus
im inib
op recipitation
Ġde amination
ĠB locking
ĠD MR
ast rointestinal
Ġ17 9
Ġamin opeptidase
Ġpathophysi ologic
ĠDe pletion
micro RNA
Ġcop per
ĠBu Cy
ĠFc gamma
ffic acy
Ġresearc hes
ĠAccum ulating
Ġthous ands
4 21
I HC
y rin
Ġo ct
ĠA chie
ĠC OL
Ġl ac
ĠM BD
st rom
ĠD D
ĠIn formation
por ter
ular ine
ron ate
di oxygenase
ges terone
Ġdev iation
Ġinte restingly
12 36
az id
Ġnucle oli
)- -
Ġ14 9
Ġcap abilities
Ġdistinct ly
Ġkill s
Ġproper ly
Th r
MN Cs
ru it
Ġclos er
RF LP
Ġeti ologic
OP P
Ġchemos ensitive
Ġradio immun
Ġprincip ally
hyd rop
Ġformal in
Ġarsen ical
ĠClus ter
tetradecanoyl phorbol
Ġflan king
istingu ish
doc umented
F GFR
ti um
Ġf ide
at able
Ġb ona
ul itis
ĠA RT
si te
ĠC ro
ĠC ross
Ġac quiring
Ġch ances
ĠH ck
ĠD P
por tive
ĠR C
Ġchem istry
Ġ4 21
Ġdrug gable
ip er
ocy an
Ġcor robor
ag ulation
ens ely
Ġmulti focal
tr ig
ening eal
Ġaz anucle
Ġsil ence
Ġequ ip
Ġinternal ized
Ġmaxim ally
ĠPV T
Ġparticip ated
HDAC i
Co V
Ġexperiment ally
Ġdisp ensable
ĠHI DAC
fe til
ĠGu id
Ġhor iz
D isease
F GF
g raft
v ents
w here
y lases
Ġm ult
er ving
Ġf ell
Ġf ores
ĠC IT
Ġde ubiqu
Ġv enti
ĠH IC
Ġun pred
las ses
ĠS EM
ĠS cale
pro grammed
Ġmo fetil
Ġind istinguish
Ġmulti forme
min imal
plic on
spec ially
Ġop tical
Ġend onucle
ĠRA RA
ĠHL H
MS I
Ġunf old
Ġpep tid
Ġmat ch
NPM c
ĠDown regulation
Ġion s
ĠLT B
Ġmodest ly
Ġgran ted
Ġthor ac
Ġgal act
ĠNeu ro
Ġindef inite
K P
M AP
Ġc ode
an il
ĠC F
Ġl in
ĠM AP
Ġg anciclovir
yp ing
th y
ĠR o
Ġint rinsically
ĠL enalidomide
end azole
Ġpl acent
Ġmulti targeted
KI Rs
Ġmicro organis
ex cluding
Ġ20 4
Ġadult hood
tumor al
24 3
27 80
000 6
CP X
ĠCon trol
29 3
Ġclinic s
ereg ulation
Ġlog s
Ġaug mentation
ĠEM I
Ġspar se
ĠCor responding
Ac quired
dem ethoxy
osc opy
mes enchymal
zygo tes
ĠFH IT
Ġlup us
R eg
S IR
m u
o hem
Ġo uter
Ġp es
Ġw arning
as al
Ġe jection
ĠT ax
gen erated
ig ration
Ġac kn
ho xy
Ġl estaurtinib
ĠI b
od erm
ĠR ET
ĠE BMT
ĠE specially
Ġhemat oc
ill us
Ġup regulating
ĠV AEs
22 6
ĠAs p
EB MT
AL K
CI K
Ġconstit uted
(-) )
ĠAN C
ĠAL K
Ġsynthe size
Ġpa ve
ĠInc idence
Ġencoura ged
can onical
bl ue
aro ten
cycl ic
Current ly
Mo Ab
ĠBD CA
transcript ase
ĠRand omized
ĠEt oposide
ĠCoch rane
G s
P RAME
g uan
Ġ encephalopathy
Ġin activating
al ine
ar ts
gen ases
Ġex isted
ĠI RA
Ġby pass
ĠS ide
pro por
ox ic
ensi fication
Ġdec ay
Ġadv oc
Ġmin d
Ġneed le
ST M
dom ain
ĠOn ce
ĠDNMT s
Ġsp p
allo HCT
ĠMR K
ĠDec reased
orb ic
ĠLA As
Ġimplic ates
ĠPL K
Ġdisturb ed
Ġpermit ting
ĠProm oter
ĠBis ulfite
Ġelab or
Ġstring ent
Ġindistinguish able
D IC
F lt
I ENT
R IT
a P
h al
o ub
t ypes
or ub
ro le
os u
im en
Ġpro xim
Ġfor k
um ors
pl enic
ab ase
ug e
ub ated
ĠR PL
ĠN OS
Ġmet ach
Ġpre metastatic
ĠL R
Ġexp ands
Ġinter genic
ak ed
Ġmodel ed
16 9
Ġcoun ting
kn ock
Ġconcentr ated
Ġly se
Ġcapac ities
ĠCpG s
ria d
Ġadvantage ous
ĠGS E
Ġadop tively
reduc ed
Ġcerv ix
omat osis
hydrox ymethyl
syn onymous
Inc reasing
Ġip ilimumab
Ġdro ple
ĠPAT IENT
I AL
V ari
V AD
W G
a rom
r ates
s ue
z z
Ġc CD
Ġin os
Ġre direct
Ġf ish
Ġn oc
ĠM SP
ĠP H
ĠP eg
Ġk i
00 001
ĠR b
ĠO X
ox o
ad min
Ġma x
11 4
Ġlower ing
Ġdown regulates
Ġcult uring
oh n
Ġsubstan ti
Ġdepend ed
ĠET O
Ġtransl ating
Ġsubc lasses
Ġparen ts
Ġsimple x
Ġtet rap
Ġalkal oids
ĠInt racellular
Ġnut lin
Ġpreced es
Ġsphing osine
BE AM
Hyp omethylating
Ġantimetabol ites
Ġpermeabil ization
Ġhepar in
Ġpsycho logical
ĠRPM I
ĠPATIENT S
C HR
H istone
p atho
Ġf ron
ra ms
um ines
Ġrel atives
Ġunder to
ard less
Ġnon hematopoietic
ĠK ing
ach ing
Ġpost ulate
Ġend ostatin
Ġadmin ister
Ġ13 6
IC AL
Ġconc ert
ĠPD GF
Ġcho ose
Ġmegakary opoiesis
inhib iting
ĠFT Is
ote can
ĠUp regulation
Ġmarg inally
Ġann ually
Ġeryt hema
Ġallevi ate
At ypical
Ġcomplic ating
Ġpip eline
Ġheight ened
thromb otic
Ġhypot ension
Ġparam ount
ĠYoun ger
Ġunderto ok
. ).
P IM
z h
Ġo phthal
es pecially
ĠH MC
ĠH HV
ĠD ex
ĠD oxorubicin
Ġcyt oprotective
ĠR educ
ĠO SCC
CR F
ĠL ower
Ġcons erv
Ġsim ply
PM A
Ġ19 6
17 3
Ġapp eal
owled ged
ĠPD E
Ġcalc itonin
Ġguid eline
Ġoste ogenic
month s
Ġhar ness
Ġoccasion s
Ġpal sy
carb on
Ġfung us
avir in
prim ed
ĠWE E
Ġfulfill ed
Ġhemato lymphoid
Ġerythemat ous
Ġcot reatment
ĠDros ophila
Ġhoriz on
- ),
f en
m edullary
p al
te e
as tic
at ured
id arubicin
ĠA v
ĠT n
Ġac uity
ĠI BD
Ġch arge
Ġrec tal
end ocrine
Ġsup ply
Ġdem and
Ġup coming
ALL s
CC G
ĠCyt otoxicity
ins ensitive
Ġsi RNAs
ĠNA NOG
aut onomous
Ġaw ay
Ġstimul us
Ġcooper ates
ĠCG P
Ġdetermin ations
ĠAPA F
Ġharm ful
acryl amide
A fter
E le
I MA
P ost
b ine
k i
m yr
u venile
Ġt on
er ge
om ical
ot a
Ġim plantation
ĠB reak
ĠB ID
ĠS f
ĠS MN
Ġdiff usion
Ġrespon der
ĠG L
ĠK aposi
ne utrophil
Ġop ens
MP Ds
Ġradi os
Th ree
Ġinteg rins
ored oxin
ĠHDAC Is
Ġoxid ized
ĠAp plication
Ġimmunoglobulin s
ĠPK M
Ġattenu ation
Ġencoura ge
Ġbelong ed
bl ind
Ġresemb les
Ġintercal ating
Ġaff ord
Ġbu ild
acchar ides
Ġcogn ate
Ġsuit ability
0 30
F OX
I K
N on
O DN
P F
T HP
a ment
c ohort
i j
Ġp ay
ic ate
le t
Ġpro ptosis
Ġst aurosporine
oc ys
oc occal
Ġdis ulf
ĠH pa
ĠP PI
ĠD ep
ĠD CC
ĠD aunomycin
ion ine
Ġimmun oliposomes
ĠE gr
form ations
Ġdes erves
Ġapp ra
ĠAn thracycl
atur ing
18 8
26 5
Ġhel icase
Ġincorpor ates
inc a
Ġdiss ect
Ġnic otinamide
Ġadap tor
ES O
itone ally
anth racycline
Ġreinf usion
eng ineered
Ġprodrug s
ĠUl tr
iment in
Ġunaccept ably
Ġkeratin ocytes
294 002
ĠBay es
- ).
7 01
B Cs
b enef
g ar
r ically
ut ch
Ġac ad
uc l
uc cal
Ġg rafted
ĠP LC
yl ating
ĠR G
ĠR BP
Ġper fusion
ĠL QB
form erly
Ġsh ar
22 5
Ġhetero dimer
In hib
ydro xy
inf usion
LI Cs
ĠCP NE
ĠY B
ĠIC OS
olone y
ĠDifferen tial
Ġsuspension s
Ig H
ĠSup pression
nit ro
Inc reased
ĠCauc asians
Ġkeep ing
ĠBN IP
aud i
Ġhaemorrh age
Ġenjo y
V T
W AF
X ome
is en
it on
at ches
ĠT aking
ot ri
ĠI AP
ĠH i
ĠB V
ĠS ensitivity
Ġmo ve
cl ones
ĠG E
Ġdes ired
og rams
10 2
omet h
vention ally
Ġcap s
Ġimmunophen otypically
Ġinsi gn
Ġintro ducing
ubl ic
ĠRT Ks
Ġexpl aining
adi an
ĠDrug s
Ġuns u
Ġvolunte er
BA ALC
anth ine
ĠPl atelet
ĠWh ite
Ġwors ened
Ġhydrox yl
EBP alpha
Ġmatur ing
Ġcentr ifug
Ġborder line
Ġhyal uron
Ġchond ro
utrop enia
ĠdF dC
Ġdock ing
C OG
C ALLA
F rom
F LA
M ET
b B
d ate
u arial
Ġd in
Ġd ura
Ġh in
ur ative
et u
op rop
oc in
ĠH SA
th iazol
ĠR us
ĠR ad
ĠR IST
ĠN SC
ĠU A
Ġdisc ern
ĠAl most
HD T
Ġrare r
ep ithelial
Ġprop idium
Ġpoly s
ĠInte gration
Ġdiv ide
co upled
anti bodies
ochrom osome
aden ine
Ġabrog ates
ĠSout h
ĠFas L
Ġcytostatic s
Ġconst ants
ĠPo lycomb
Ġconj unctiv
Ġdivision s
Ġbioavail able
Ġdisp osition
pathw ays
Ġsupernat ant
Ġimmunob lotting
Ġimprin ted
Ġencompass ing
Ġintraper itoneal
Ġdorm ant
ĠANK RD
uv ants
auno Xome
opolys accharide
Ġpes tic
0 20
D endritic
E LL
Q R
c ase
m ir
y lo
Ġ ros
Ġm L
Ġre evalu
om ically
gen erative
ĠN C
cl one
Ġint ric
Ġimmun otoxins
ĠG n
Ġpo isons
Ġpar aneoplastic
Ġdec ide
Ġnon s
Ġnon toxic
21 5
15 2
ĠV in
ĠV III
ĠV ery
33 9
ĠPh osph
18 4
37 0
Ġprior ity
90 7
ĠCyt otoxic
Ġpoly p
Ġdistingu ishes
ĠImmun ological
Ġchimer as
EC OG
Ġphospho protein
Ġvis ible
Ġsplice osomal
Ġtrac k
ĠRho A
Int ensive
Ġsegreg ated
Tr p
rele ase
Ġadren al
Ġbuff er
ĠCorrel ation
Ġtransfect ants
Ġackn owledged
myr istate
F our
G EM
K i
S MM
V ascular
h n
h TERT
l act
Ġc ef
Ġc opolym
Ġd ic
Ġb in
Ġh ur
Ġn aph
ĠA PBSCT
ran ulation
il ateral
Ġg aining
ĠP rim
am pl
ĠF usarium
Ġsur f
ĠN CR
tem pts
Ġse iz
Ġrec urrences
Ġout per
Ġout lines
ĠL IF
yn am
Ġcons ult
Ġmal formations
Ġar bit
Ġvari ance
Ġsc ant
ĠCR s
Ġ20 5
af ety
In k
In duction
Ġ16 2
Ab normal
Ġhypothe ses
ER C
Ġparen teral
Ġmodif ier
Ġmess age
Ġsupple ment
Gl c
Ġte a
Ġfav our
Ġimprin ting
Ġrene wed
Ġintraper itoneally
ĠMyel osuppression
ococc i
Anthracycl ines
aqu es
Ġretrie ved
Ġmicrovess el
Ġarbit r
m ast
p m
w hel
Ġt a
re troviral
is ib
el ong
id ity
ĠA SP
im er
Ġpro hib
ac iclib
Ġcon ve
ĠI ran
ĠI CI
ĠM yb
ĠM oloney
Ġim plied
ĠH RM
ĠH CV
anc ing
Ġ2 25
Ġmo ving
Ġper ipher
ĠG AL
ĠL LC
Ġover look
yc arb
Ġconf ounding
60 9
Ġonc ometabol
Ġ14 7
In te
Ġ17 4
IM EMA
Ġhyper ther
Ġpoly phen
AR OS
Ġpolyc ythaemia
NT R
ocarcin omas
Ġconst antly
Ġrespir ation
Ġbulk y
Ġsupple mentation
sh ap
Ġgirl s
ĠWork shop
Ġadip ocytes
Ġsphing omyel
cor tisone
Ġcul min
Ġphospholip id
Immunophen otyping
ĠMus ashi
Ġtot ally
Ġunpred ict
admin istered
ĠBayes ian
& #
D ysregulation
M IC
l uciferase
s plic
Ġb uccal
ĠT er
ĠT rial
ĠM si
Ġg ross
ff e
ĠB ritish
di phenyl
Ġchem ore
Ġhe aling
term ination
CD C
Ġmicro d
Ġser ving
16 0
Ġgener ations
Ġ19 79
Ġmethyl ome
Ġplay er
DA U
Ġintra hepatic
Ġste re
rup tion
Ġdistrib utions
Ġpap ers
Ġquestion ed
Ġthym ocytes
Ġalkyl ator
rinc ip
Ex pert
GR L
Ġpal p
Ġphot o
Chrom osome
oblast omas
ĠCy A
Ġsubstit uted
Ġobstruc tive
Ġprefer able
Ġannot ated
Ġsaliv ary
Ġcholangi ocarcinoma
Ġchemop re
) [
A HNMD
D i
R OC
re plete
on ucl
an us
ĠC NA
ut h
od ermal
ĠP ositive
ap t
ore x
Ġhyp oth
Ġtransloc ated
ĠAn imal
ĠCT X
ĠEx cept
AF F
Ġhybrid isation
GS H
methyl transferase
Ġemploy ment
ĠHist orically
ĠAut opsy
Ġpatholog ically
Ġjus tif
Ġtrim ester
Ġimmortal ization
Ġanticip ate
Ġinstrum ents
Ġdiges tive
Ġfo ot
ĠSet bp
Ġastro cyt
Per ipheral
agglut inin
propor tion
D ox
L s
M el
n atal
ati le
Ġd ere
ĠA KI
ĠT iss
ĠT yr
si um
Ġcon ges
Ġcom pression
Ġdis mut
ĠP bx
ies ter
st ance
ĠF ludarabine
ĠN ord
ĠE ph
ĠE HR
34 7
Ġacc r
Ġfirst ly
Ġsc Fv
22 8
Ġcolon ic
Ġ17 5
Ġ16 8
ero bic
Ġvalid ating
Ġsynerg izes
ĠPro lifer
Ġadj uvants
ĠER BB
AD C
Ġsomatic ally
Ġangi opoietin
Ġdepend encies
IF I
Ġquanti ties
Ġdegra ded
rh yth
Ġemb edded
Ġasc er
Ġthi oredoxin
ĠSH B
Ġdist ance
ĠAut ophagy
ĠPL ZF
ĠHS V
Ġham per
ĠMyelo proliferative
Mon itoring
Ġpublic ly
Ġconsolid ated
ĠKI AA
A u
T s
c ing
Ġ il
Ġ edi
Ġa ph
Ġt ric
ti p
Ġp et
Ġre pressing
Ġre sequencing
Ġf ed
at abase
Ġh op
ĠC ar
Ġun available
port ing
ĠL E
Ġph leb
Ġ6 77
ser um
RNA i
rol ong
ĠK iller
ch ip
Ġsc ope
ĠV DR
14 9
tr yp
ĠRA GE
Ġdom inated
Ġdesign s
Ġif osfamide
Ch ildhood
Ġtranspor ted
An gi
Ġinser ted
Ġlact o
Ġcre ates
ĠPG E
ĠCompar ing
ĠCd c
Ġhorm onal
Ġformer ly
atum omab
Ġpharmacodynamic s
Ġcryopres ervation
Ġfus ariosis
Ġunve il
Ġindust ry
Ġchima erism
Ġneigh b
omark ers
B r
B ax
C NAs
O ptimal
f s
s ided
x e
Ġt MDS
Ġf a
Ġe chin
os idase
ĠA DC
ĠA PR
um ing
ĠD DI
Ġne uramin
ĠF unction
ren d
ĠO cc
ĠG ol
ĠTh at
end s
ad ecitabine
min ant
Ġonc ological
rop athy
Ġradi onucl
Ġprote ases
Ġerythro cytosis
BC P
Ġlab elling
con cept
Ġgl ands
ubl ished
44 9
99 9
ĠY M
Ġful minant
del eted
mark er
ĠCH IP
Ġpy ruvate
stit uted
Ġparadig ms
My D
NC aP
Ġhistocomp atible
Ġger minal
tetra hydro
Ġcounte ract
oglyc an
Ġglycosyl ated
Ġwa iting
Ġprovir al
Ġindole amine
Ġincomp atibility
Ġdiame ter
Ġproxim ity
Ġchemore fractory
E m
F e
g ered
l ich
Ġp Rb
as sium
ul os
ul ators
ĠI CC
Ġ1 56
ĠCD DP
Ġsub family
and on
Ġman nose
rol ase
Ġtwo fold
01 25
Ġsel dom
Ġsh aring
PM s
AC C
ram er
Ġend s
Ġprovid ers
Ġradi ographic
cyt ometric
Ġ29 3
Ġdeple ting
ĠQ T
Ġher itable
Ġmism atches
Ġconver t
ĠAg ents
Ġeth yl
ĠCd A
Ġdraw back
Ġlif elong
chem ical
Ġsperm at
ĠVit amin
Ġcompeti tion
Ġnom ogram
keep er
ĠGuid elines
ĠCIT ED
Ġoncometabol ite
V enetoclax
c ause
c hol
h aemia
Ġt rop
al veolar
ar tis
Ġf ounder
Ġb endamustine
os us
un translated
ĠC ertain
Ġas ynchron
ĠM CP
ol ation
ĠF requ
ĠS MD
ĠR OR
ĠN f
Ġsub clinical
Ġhemat oma
Ġro ugh
Ġpar as
Ġsc arc
21 2
Ġmicro vascular
Ġdi alysis
14 8
Ġend ow
Ġ15 7
jec t
Ġprot on
27 5
Ġmac rom
cyt ometry
Th y
Ġi NKT
Ġidarubicin ol
Ġatt achment
Ġpap illary
Ġbl ind
Ġmas ked
ĠRel ev
gluc uron
Ġqualit atively
encephal itis
ĠImpro vements
ĠClin icians
ĠSm ad
aroten e
xe os
' t
( +/-
5 15
D MP
H sp
i ence
ĠA V
ĠT es
ac ing
Ġres ides
Ġdis proportion
ĠP onatinib
ĠB reg
ĠS PI
pro cess
enc oded
MT S
ile p
AT E
Ġsequ est
par ative
ĠDN M
val ent
und ant
18 6
phosph atidyl
ĠX PO
inc ubated
Ġprogram me
Ġelect ronic
ereb ral
Ġconstruc tion
MG MT
Ġglycoprotein s
tet razolium
Ġoc clusion
ĠJun B
ĠPharmac okinetic
Ġubiquit ous
Ġundersc oring
Ġbehavi ors
ethox ydaunorubicin
heres es
Ġanat omic
IGF BP
Ġmorph ometric
Ġaeti ology
Ġunfold ed
Ġmicroorganis ms
oub ted
D PB
f uc
h l
p aired
r yp
Ġc IAP
Ġp riapism
an n
Ġb ud
ly te
Ġth ick
ec al
im ine
im etry
ĠM ortality
ol ding
ĠF usion
ĠF rance
Ġap ical
ĠR AC
ĠN RF
Ġcont ents
Ġappro xim
ne y
Ġref used
Ġ14 4
Ġtechn ological
ĠMP T
Ġcytok eratin
ĠLeuk emias
Ġunf ortunately
arb oxyl
ĠX Y
Ġsol vent
Ġneuro endocrine
Ġcalc ulation
Ġsubc ateg
Ġelimin ates
mod ulating
Ġmis diagnosis
ĠReg ardless
Ġleuc ine
Ġproce eding
201 7
ensiti zed
Ġmixt ures
Ġpenet rance
ĠHP RT
Ġcul tivation
Ġpas sive
Ġspati al
ĠKing dom
Ġappeal ing
3 18
T el
b locking
e able
Ġc ame
ic ide
Ġre ading
ly l
im ilar
Ġg iant
anc tu
ĠB IRC
ĠS ection
pro b
row ing
Ġab andon
Ġse vent
Ġcont rac
Ġout standing
Ġpo inted
Ġnon sense
ag rel
Ġremain der
Ġprolifer ated
16 5
Ġ- -
Ġ14 2
ĠAd optive
uct ase
Ġins ensitivity
Ġreal istic
Ġthrombocyt haemia
Ġfib ers
Ġalong side
ĠImmun otherapy
ĠIg A
Ġolig oclonal
ict ory
Ġconcept ual
Ġsearch ing
Me is
Ġadmission s
Ġpum ps
Ġpatholog ists
Ġunderl ies
Ġretain s
Ap optosis
ĠLympho id
irradi ation
Ġharbour ing
Ġcounsel ing
adm ium
SMM HC
. </
H ER
S BP
k D
m n
s qu
w al
Ġa GvHD
Ġc as
Ġc ir
ar ia
ar ginine
ac illus
ĠM X
ĠM at
Ġcl aim
ĠD ual
ĠD OCK
ĠS RP
ĠR RM
ĠN utlin
CR P
ĠL MP
Ġnon obese
12 9
HD C
CSF s
ok ing
Ġunc lassified
26 6
Ġconduc ting
Ġcollec t
Ġimmunohist ochemically
abil izing
Ġsol itary
mal e
ĠQ ing
Ġmobil izing
ĠCAL M
Ġview ed
Ġstabil ize
with out
ĠADA M
Ġdefini tively
ĠTM Z
Out come
Un der
ĠRep e
Ġdiscrep ancy
Ġhard ly
idaz one
Ġinactiv ate
Ġnephro toxicity
Ġimmo bilized
Ġimmunoma gnetic
Ġventi lation
Ġunpredict able
Ġdismut ase
agrel ide
> </
B S
L GL
d G
d ia
m ouse
re en
ar th
Ġb ones
id amide
ĠC EP
ĠC EC
Ġex ec
oc and
Ġcom es
Ġdis per
ys mal
ĠH AT
ĠIn s
pon taneous
ĠN VP
Ġover c
Ġtherapeutic al
Ġdes erve
Ġqu inone
LA C
Ġli vers
Ġinte rested
par ticular
OS E
val idation
ĠRA F
IC E
Ġ25 1
Ġaz u
BF U
ĠX X
Ġsix ty
EGF P
mit oxantrone
ĠPR O
Ġatt ached
Ġcalc ulate
EL ISA
ĠAL OX
aph ase
Ġmim icked
Ġmicrosc ope
Ġtend s
ĠEP Z
Ġcytos keleton
Ġmach ine
Ġaccess ory
FL IP
Ġjo ining
ĠCL EC
local ized
Ġinstrum ent
Ġhypers ensitive
Ġseptic emia
Ġens uring
Ġbron cho
ĠAustr alian
Ġpp m
PMN s
TAM s
Ġdict ate
Ġepipodophyllot oxin
ĠExperim ental
Ġpr ur
ĠSw it
Ġnav itoclax
Ġplacent a
Ġaccr ual
particular ly
G DS
I le
M oL
N ep
S h
Z Nep
d o
d asatinib
f os
Ġin ges
Ġm mol
Ġw an
or ig
Ġb orn
ĠT p
ur ic
ur onic
Ġac ted
ĠP r
Ġcomp e
Ġne ovascular
ĠF I
Ġco ugh
ĠR ituximab
Ġrem in
ron g
Ġint ram
ĠE hr
ĠE lect
ĠCML SCs
ry onic
Ġam ifostine
press ant
14 13
ax ia
Ġaz oles
Ġderiv ation
86 9
Ġdelay ing
ĠBA Y
Ġhand ling
ĠNew ly
man n
III a
ĠTar get
ĠTr isomy
ĠInt ra
ĠCd x
ĠMe as
Ġinstit ute
CX CL
aryn x
atum umab
Ġzeb ularine
rele vant
ĠLip osomal
Ġprecl udes
Ġlon gest
Ġexhaus tion
Ġlamin in
PBP C
ĠPseud omonas
wor thy
Ġexerc ise
Ġpitf alls
ĠFunction ally
M ac
S U
S W
s al
Ġc ues
Ġm ental
ĠA HSCT
ĠT AK
ĠT UNEL
ĠI MP
ĠI MA
Ġch ip
Ġg as
ĠF M
ĠS ch
ĠCD D
Ġrem it
Ġag glut
hen yl
Ġprom pting
ĠJ M
Ġmit ogenic
Ġpredict able
CI MP
45 1
Ġsix th
ĠEx amples
cap es
Ġoff set
ĠMy Ag
inte g
Ġund oubted
eth ylases
Ġrib avirin
ĠBi ological
occ us
ang u
Ġaggreg ate
Ġtryp tophan
ĠPharmac ologic
Ġacl acinomycin
avir us
Ġapprec iated
CDK N
ĠStr ategies
ĠGTP ase
ĠLnc RNA
Ġplaus ible
dan amycin
3 17
F if
M i
l ate
m embrane
s ection
v ariate
w a
Ġd ental
ic are
Ġre taining
ĠT oday
ia e
Ġle aves
ut athione
Ġleuk o
rom a
Ġtrans amin
Ġun supervised
ĠN IL
ĠL NCaP
Ġpl aques
CT D
LA P
Ġpop ular
ex cept
Ġ20 8
ĠAs ia
Ġprop os
Ġtransform ations
Ġ17 3
Ab nl
ĠPD K
allo BMT
ocar ri
Cyt Abnl
Ġunde tected
Ġcarb on
inter pre
enz a
Ig G
ĠFox O
Ġsear ches
Ġmyocardi um
ĠIs olated
Ġpolymer ization
odeoxy adenosine
Ġec otropic
Ġchloro quine
ĠLim ited
Ġhyperther mia
ĠEhr lich
4 86
C irc
E v
G H
P ancreatic
m ustine
p osition
s s
t ure
t rim
Ġa romatic
on t
on ide
Ġm ere
is ertib
an in
le thal
ar il
Ġh ouse
ec tr
ĠC NAs
ac cin
Ġcon ventionally
ĠH F
Ġr ules
ĠR KIP
Ġreg ained
Ġpres erve
Ġinf idelity
end othelial
Ġmark ing
ĠU PR
loc ated
Ġsc ored
ĠCR P
Ġcar mustine
ĠJ ohn
15 6
Ġform ula
ĠDN ase
AP B
50 6
opro tection
Ġ22 8
Ġevolution arily
Th romb
Ġste adily
ĠQ oL
Ġevol ves
orrh agic
Ġelectro por
flu idic
DNMT s
Ġexception s
Ġtop ical
Ġsurg ically
Ġabund antly
Ġsulf oxide
Ġshed ding
Ġdoub t
Ġsial ic
Ġfav ors
ĠADA R
ĠSyn drome
Ġcomprom ising
Ġregen erative
ĠBio informatic
Ġanch orage
Ġbuil t
Ġflavon oids
ĠKe y
ĠTaq Man
Ġdestro y
Ġacad emic
ĠNord ic
C CL
F rench
H is
M it
S p
a R
c ancerous
i k
Ġa rach
Ġh id
Ġh itherto
ĠT echn
ĠT DT
ĠI X
Ġcom ing
ĠP ax
Ġr up
ĠD CL
ĠD AF
ĠD istinct
Ġab or
ĠL ack
ser ved
oplas m
reg ion
21 8
Ġthree fold
AC AM
19 4
Ġmultiple xed
abol ic
Ġprot umor
PD X
Ġadd iction
ĠIM F
Ġhydro cortisone
ĠMT D
Ġtra ce
Ġdereg ulate
Ġpap ill
Ġz eta
ĠCons olidation
ĠRe ported
ĠCAL GB
inhib itors
for ward
Ġrad ically
Ġconce ption
Ġcompl ained
ĠQuan tification
Ġabn l
ient ation
Ġnas al
Ġsynchron ous
ĠTSG s
ĠUL BP
Ġhematoc rit
shap ed
Ġedi tion
Ġneuramin idase
ĠGol gi
Ġoverc ame
3 20
D LT
M ore
T n
Z D
a ff
g lobulin
l a
m eg
o viral
Ġ zyg
Ġt ur
en a
Ġp ed
el al
el erated
el even
Ġn os
us c
Ġst ra
ĠI le
ĠM ax
ol ization
Ġtre osulfan
ĠB sAb
ĠR uxolitinib
iz ers
ĠE LAM
Ġdev ice
Ġover comes
term ining
ari ant
Ġall ergic
ard ia
Ġsim ulations
MP AL
23 5
ĠAt tempts
Ġcent romeric
Ġhyper t
ĠCon comit
Ġi PSC
ĠPro tocol
per ipheral
DN M
Ġpurp ura
Ġpurp osed
vari ant
EM I
Ġpap ules
Ġolig ode
tur nal
ĠNA LM
Ġur idine
ĠDe ath
Ġexception ally
ĠAc quired
ĠHist opatho
ĠMut ant
ĠIK AROS
Ġelectropho retic
thi o
ĠLong er
hyp omethylating
hom ologous
Ġweigh ts
Ġchron ically
ĠGranul ocyte
Ġantico agul
Ġechocardi ography
Ġmonos omies
ĠAustral ia
ĠVy xeos
Ġnoc turnal
Ġsurf aces
orex ia
rolong ed
B GRL
P BMCs
R Y
b red
d U
e ither
h u
m elanoma
en op
ed ical
id onin
ter p
Ġis ob
Ġmyelo cytes
ĠM ex
ĠP AS
ĠP PV
ĠB AP
Ġcomp atibility
ĠD LT
ĠF YN
ĠS ARS
Ġwe alth
Ġ3 50
iz er
Ġreg rowth
Ġcan al
ass emia
Ġmicro glia
Ġep i
Ġ19 2
Ġpos itron
Ġpost natal
19 2
Ġpattern ing
Ġgra ding
Ġgu an
mit oyl
Al lo
Ġher b
Ġcontroversi es
Ġembry onal
ID s
raz one
Ġvesic ular
Ġerythropo ietic
Ġcat s
Ġhomogene ously
Co A
Gl ivec
Ġubiquit ously
ĠAza C
Granul ocyte
Ġdrop ped
Ġnanom ed
ĠConc ern
ĠITP R
Ġintermedi ates
trig gered
Ġoverlook ed
Ġoligode oxynucle
C entral
E valu
H h
L ow
M BC
S ub
T IM
d ys
d ai
n a
x or
Ġc admium
Ġan x
is al
Ġd CTP
es te
ĠA im
im ycin
Ġde ox
Ġde pressed
Ġim plants
Ġch am
yt oplasmic
ĠB AK
Ġ2 35
ĠS em
iz yg
ĠN CAM
ĠL ineage
Ġbi och
Ġbi otin
Ġ< /
Ġanaly tic
Ġ19 60
Ġconsid ers
Ġdiscus sing
OR T
Ġi NOS
ER IAL
Ġtermin us
Im pro
AN C
Ġradio activity
SE PT
Ġfil tration
ĠDn r
Ġspre ading
ĠGl ivec
ĠMorpholog ically
Ġmonol ayers
Ġprofession al
ĠMAT ERIAL
Ġerup tion
Ġserv ice
Ġgangli osides
ĠNU MB
Ġprostagland in
ĠPharmaceutical s
Ġhop ed
b usulfan
o u
p id
Ġan g
al tered
ati o
ic an
ar yl
om ial
ell itus
gen cy
ce ti
Ġcom et
Ġor idonin
Ġr RNA
ĠD ys
ĠD atabase
one gative
Ġgen ital
Ġmon ke
ox ib
ĠL ig
we igh
Ġpot assium
ch im
ĠU D
RA C
Ġup regulates
Ġmi x
ath iop
ĠV M
Ġ19 4
leuk ocytic
Ġonc o
Ġ16 7
ĠAd j
CN L
IF Is
200 5
Ġaden ocarcinomas
Ġolig os
ĠHD T
col itis
Ġpy r
pr int
parag ine
inos a
ĠAD E
ext racellular
nucle otid
Ġneutral ization
ĠEr bB
Ġcapt ured
Ġvulner ability
Ġamelior ated
ĠNucle ophosmin
ĠHP Cs
ĠClin ic
Ġcytomorpholog ical
iam ond
Ġastro cytes
Ġdinucle otides
Po lycythemia
Ġentero colitis
Ġepipodophyllot oxins
ĠAct uarial
ĠCU DC
Ġgate keeper
Ġselen ium
secre ting
ĠLog istic
ĠEst abl
Ġdin aciclib
Ġsequest ration
athiop rine
4 60
A reas
H aplo
T ie
V OD
X IAP
g f
p DC
Ġa ver
Ġin efficient
Ġs anctu
Ġd s
Ġd ynam
ar an
at onin
os sible
Ġle ak
ĠC ur
ĠI a
ine al
oc ular
iv ol
Ġal ign
Ġtre e
Ġr uled
ĠD F
ĠS Y
ĠS n
th at
ĠG H
ĠG W
ĠG ADD
ich lor
Ġag gra
Ġro utes
Ġprom ises
Ġbi od
Ġpl ans
our nal
Ġreview ing
Ġmicro bial
abl es
Ġanaly zes
Ġ19 78
Ġpost consolidation
Ġ15 9
ĠCI N
Ġ17 1
Ġsu icide
Ġcontinu um
Ġclass ically
Ġlip opolysaccharide
Ġelev ations
Ġestim ating
ored uctase
Ġknock ed
HL H
ĠCyt osine
ĠCM C
rec ts
Ġattem pting
Ġepid ural
Ġgran zyme
Pro gnostic
Ġhisti ocytes
Ġarchite ct
Acc um
Ġunaccept able
institution al
ĠCare ful
Ġmeningi oma
Ġconserv ative
4 24
C er
D DP
G D
M od
T CD
U p
d CTP
f ractionated
l ands
p ositivity
s olid
y loid
ti zing
Ġm ellitus
el in
ĠT op
ĠT ransient
ur red
ĠC ardiac
ĠC bf
oc ally
ud ine
ĠH H
Ġ2 14
ĠF ab
ĠS kin
ĠR II
row n
Ġreg istration
ĠO mn
ad herent
oth i
reg ular
Ġpatho gn
ET V
group s
Ġso il
Ġappear ing
Ġperiod ic
98 059
Ġrever ses
ĠME L
ob enz
vious ly
ĠAp p
quid ar
Ġhomo zygosity
Ġloop s
Ġnecessit ate
ĠFlu orescent
ĠEl derly
ĠGIST s
ĠBr uton
Ġperf orin
Ġexceed s
ĠTra ditional
ĠEstim ated
Ġxenobiotic s
Ġencompas ses
ĠCro hn
ĠDep ending
Ġechin ocand
D CL
H PLC
L Ps
T EL
Z n
g s
k l
y ric
te x
Ġs L
an tic
ic tive
Ġre ader
Ġb er
os amide
ĠA CT
ĠC OG
ĠM dm
oc t
rom ycin
Ġg onad
od er
ĠH AM
ĠD ays
Ġk D
oci al
ĠO x
ĠWe e
ĠL IM
ĠL GL
ĠL SK
term inus
Ġcyto lysis
11 1
ĠV TE
Ġ19 76
Ġmin eral
Ġgranul ocytopenia
go od
atur ated
Ġir regular
Ġimmunophen otyped
ĠX L
Ġglyc ogen
Ġoste op
ĠInc ubation
ĠRe ports
ĠRel apsed
Ġaug ments
Ġintern ucle
Ġsci ence
Ġefficac ies
Ġtryp an
ĠAdv anced
ĠIN CB
Ġrene wal
Ġquar ter
vin cristine
Lym phoma
Ġpoison ing
Ġinev itable
Ġcentros ome
AY As
Ġatherosc lerosis
Ġcontrad ictory
ĠRecept or
osu quidar
ĠHpa II
benef it
whel ming
Ġascer tained
% /
+ ]
/ (
= </
N OD
V C
f et
f ield
o ke
w ere
Ġan orexia
an i
ul sed
ĠT MD
si al
Ġl inc
Ġl osing
Ġch arged
gene ity
ĠB SC
Ġ2 38
ĠE SR
Ġpres erving
ĠL CL
ĠL AT
Ġcharacter isation
Ġel ectr
ĠK u
ĠK ras
Ġsc ans
Ġregim es
til es
RP F
HR s
gra d
27 0
Ġphosphor yl
inf ection
Ġdeg ranulation
ĠPR K
olec ules
Ġgli oblastomas
Ġpa id
Ġbl un
onc ology
Ġimmunomod ulation
Ġdim ension
ĠĠĠĠĠĠĠĠĠĠĠĠ ĠĠĠ
201 0
Ġadip ose
Ġlook ed
Mo Abs
Ġimmunoconjug ates
Ġjusti fied
acyt osine
Ġunve iled
Ġge ographic
RC MD
Ġstres ses
hydroxymethyl cytosine
ivol umab
A PA
F ew
J D
T CE
f ection
m as
p ost
in otecan
Ġp eu
or ot
id ans
ul sion
Ġth in
Ġl ies
ĠI NT
ĠM ST
Ġal vocidib
Ġg rafting
ĠH E
ĠB mi
ain t
ph armac
Ġap pend
Ġdise ased
Ġco ated
ĠN Ps
ear son
Ġhem izyg
Ġpres cription
ensi fied
ĠV II
af ungin
38 7
Ġexpos ing
23 0
ĠRec ombinant
Ġprior iti
sub stituted
Ġglyc ol
Ġsubjec tive
ereg ulated
Ġeti ological
Ġcontribut ors
inhib ition
Ġpromin ently
CE A
Ġprompt ly
ĠInter leukin
Ġderm is
Ġfer ro
but yrate
Cytogenetic ally
ĠExt ensive
Ġquin olone
ATP ase
Ġspan ning
Ġweigh ted
Ġgest ational
Ġvers a
Ġmanifes ts
Ġhypodip loid
Ġunderestim ated
Ġmoun ting
ĠRus sian
ceti us
Ġpeu cetius
" ).
( +).
C omp
L FA
P TP
X N
d A
h ist
o urea
Ġt iter
Ġc ast
Ġp loidy
or ax
Ġex quisite
Ġ2 13
Ġun stimulated
ĠF X
ĠF CR
ĠF ITC
Ġpre incubation
Ġunder line
oplas ms
til in
12 98
18 2
Ġblock er
Ġhelp ing
04 0
Ġcal ib
Ġantitumor al
Ġequ ation
Ġcertain ly
Ġpractic ing
Ġdiss ection
Ġphys ically
ĠImport ant
ĠCH G
Ġhome odomain
Ġsl ides
Ġtw in
Ġtw ins
EG G
Ġattenu ates
SR SF
ĠSU V
Ġcys t
Ġcollabor ate
ophosph orylation
Ġhydrox amic
ĠProm ising
yst olic
Ġcounte racted
Ġmother s
ĠPolym erase
Ġsens or
Ġdiscrep ancies
Ġcentr ally
irradi ated
oled ronic
stud ied
Mal ignant
Ġparench ym
Ġcentrifug ation
Ġbiod istribution
othi ocyan
. ),
0 67
A UL
H As
M IT
N a
N ot
T MDS
W A
o D
v ia
Ġf lor
id azole
Ġe ase
ra ined
ĠT f
im od
Ġpro angiogenic
ter ia
Ġl ie
ĠM Ab
ĠM AD
Ġg lial
ĠB er
log ically
ĠS us
ĠS mo
pon ectin
ĠWe b
ĠE fficacy
ĠL IC
pt om
ast ric
oma virus
Ġnon lymphoid
li oid
ĠCR p
Ġregim e
Ġsystem ically
Ġ19 5
Ġhetero dim
par tial
ĠOn going
Ġeng aged
ochond rial
radi ation
ME IS
Ġsol vents
315 1
Ġher bal
An g
del etion
ĠKIR s
Ġembry ogenesis
Ġshe ep
Ġrobust ly
Ġoverl apped
amil ial
ĠAg s
lip oxygenase
Ġvesic le
Ġcat ast
Ġpeg filgrastim
Ġsegreg ation
Ġfore ign
Ġstrept ococci
ĠMit oxantrone
Ġvacu oles
prin ting
Identif ication
ĠCSP G
Ġabsorb ed
Ġrhabdomy osarcoma
ĠRelev ant
process ing
, -
T OP
V M
a uc
d PCR
f luorescence
m ate
t led
Ġt al
en vironment
Ġre plicated
ra emia
ĠT umour
if osine
ĠM u
ĠM CR
Ġbe ars
ĠH DA
ĠP in
Ġcl ue
ĠD E
ĠD es
ĠD ouble
Ġat omic
ĠR ather
ĠE zh
ĠL RH
ast inib
ĠDNA s
Ġnon adherence
ak i
Ġam plicon
Ġiniti ates
Ġconcl usive
Ġ16 4
Ġtranscript omes
RT Ks
ĠCN L
DR G
Ġfib rosarcoma
CH N
Ġepithe lioid
Ġz ero
Ġglut amate
ĠBi opsy
Ġexception al
Ġcataly zed
Ġent ail
ĠMicro RNA
iver tinib
ĠNov artis
Ġquin acrine
Ġneph rotic
Ġxenotrans plant
elect ro
% :
) +
B l
B y
L PS
f ungin
Ġt RNA
he red
Ġc c
Ġs aving
om s
ot t
Ġl avage
Ġg ot
ĠB al
Ġad s
Ġdem ethylases
CT N
Ġmicro fluidic
ĠJ H
Ġassess able
AT L
Ġ19 8
Ġpost transcriptional
Ġend ocytic
ĠAn aly
OR s
RP OSE
CA s
Ġmed icines
Ġoste oblastic
Ġlys osome
AA V
ĠNA DH
miR s
Ġresid ent
Ġshif ting
Ġextra vas
Ġrad otinib
yroid ism
Ġchromat ographic
Ġgel atin
aro se
Ġadjust ments
Ġsem inal
Ġbiosyn thetic
Ġpass ages
Ġanth ra
Ġphospholip ase
Ġchloro acetate
Ġprecl ude
PDGFR B
ĠPolym orphisms
ĠGranul ocytic
PU RPOSE
ĠExperim ents
Ġnur ses
ĠPCD H
Ġpun cture
Ġstatin s
Ġdrople t
Ġpalp able
Ġlacto ferrin
fet oprotein
3 26
E ight
M AL
W F
t un
v entricular
Ġt iters
en edi
Ġc ALL
Ġp ric
is her
es ide
at oclax
ĠH IP
Ġr Hu
ĠF PD
ĠS OS
ĠS afety
Ġanti retroviral
Ġev oked
Ġcor tical
AB CB
ĠK AT
inding s
lyc emia
zym atic
Ġ16 9
AP C
ĠCh ar
Ġnow adays
NP C
ĠWith out
raph y
Ġneuro de
ĠSe par
ĠPA OD
Ġsecre tory
ibr ary
teroid al
Ġelic iting
Ġreprogram med
Ġnod al
ĠEm base
Ġintrac ytoplasmic
ĠSequ ence
rox acitabine
Ġcyclo oxygenase
egakary ocytes
ĠImmunophen otypic
Ġapprec iation
Ġepigen omic
Ġreinfor ce
Ġindust rial
ĠEG CG
Ġconvinc ing
Ġaffor ded
naph thyl
Ġthorac ic
ĠSf pi
Ġunsu itable
B G
B w
D aunorubicin
H em
N H
T f
V ON
b astinib
m k
p enia
p rincip
Ġa ided
an aly
el ic
ar ting
Ġb ic
Ġ( -)
ul ind
Ġh ab
Ġn ame
ec ts
ĠC HO
ib ular
ĠI CH
ĠM el
ĠP NA
ĠP EL
ĠD audi
Ġsur prising
ĠR F
ĠR PS
ĠG li
ĠG AP
Ġpre leukemia
ĠL ung
ĠL Ps
Ġmod elling
Ġdec iding
tim ing
ĠAl ong
ĠCR T
Ġaut omatic
Ġstandard ize
ex posure
Ġder ang
Ġbiom edical
Ġ25 4
Ġsp ine
Ġhom ogenous
Ġ33 342
Ġpredomin ately
ĠZ EB
mod ulated
Ġinterpre ting
ĠAnti bodies
ocal cin
Ġstabil izing
tet rap
ensiti zing
sh RNA
strati fy
Ġperic ent
nic ulitis
Ġnutri ent
Ġlibr aries
Ġmetalloprotein ases
Ġprofession als
Ġmigr atory
Ġnecro tizing
Ġcontras ting
Ġexpon ential
Ġlic ensed
Ġglob ally
Ġinos itol
Ġconges tive
Ġcompe te
Ġparenchym a
' d
4 19
B e
E V
M u
T opo
V ECs
d iester
r P
r utinib
in dex
on ing
on ia
Ġan emias
it ating
Ġd od
Ġd rain
le g
Ġf re
Ġe g
os arcomas
ĠT rich
us ias
Ġle af
ĠC MPD
Ġleuk otri
Ġres um
Ġl ived
Ġl ives
ĠI CRF
pl ace
ud an
Ġor bit
ĠB K
ĠB in
Ġcomp an
ĠD ynamic
Ġun w
ĠCD R
Ġmet ron
Ġhem olysis
Ġar rhyth
Ġfe atured
ĠJ SB
ck point
CI s
Ġ24 0
Ġpromyelo cyte
Ġunf ractionated
Ġsp ent
ĠCon ditional
Ġbreak down
Al terations
Ġ26 77
ME C
67 7
Ġquanti fying
met hoxy
Ġcost ly
ĠNA C
Ġinstitution al
Ġradio active
thym ic
Ġtub ular
ĠInf ection
ĠDr r
iam ine
ĠSel ective
Ġvers atile
Ġske wed
Ġcatabol ism
ĠAmeric a
ĠRE H
ĠAQ P
(+/- )
E nd
E UTOS
F orty
m er
o R
y loc
Ġ %.
Ġa CGH
Ġp CytAbnl
el ta
id er
Ġe cc
ĠA LT
im b
Ġle aving
ut uzumab
Ġis ochromosome
od in
st ained
ĠF isher
ĠR an
ĠO T
ĠE ast
ĠE TP
ĠE MB
hes ia
ĠML C
Ġpolym eric
af il
Ġtr iaz
25 8
30 2
Ġcirc uit
Ġj e
Ġinterfer ons
ĠZ n
CH IP
osyl ceramide
Ġcre ation
Ġcytos keletal
SE ER
Ġect opically
ĠCd k
Ġdest abil
Ġcat ar
Ġdocument ation
ĠBET i
ĠCL IP
ĠSS X
ĠAccum ulation
Ġbronch ial
ĠNOX A
ĠLAIP s
sq m
ĠHispan ics
ĠParticular ly
Ġintric ate
Ġcopolym er
Ġsanctu ary
ĠGAP DH
5 99
8 39
C i
C OL
G ly
M CF
c ateg
f emale
l ining
m ar
p oc
y rid
en o
Ġp STAT
Ġin g
Ġm CR
an tit
it ine
Ġd PCR
ic ol
ar senic
ing ol
Ġn erves
ĠA RF
ĠT ype
ĠI CT
ĠM IF
Ġg ent
Ġ2 98
Ġap plies
Ġ3 44
ĠR O
ĠE ither
ĠL ibrary
Ġover representation
Ġro ad
Ġsugges tions
ail able
Ġacc ident
Ġinter face
yc lovir
MT P
ass ociation
ĠV E
ĠML FS
over l
Ġinflu enza
Ġcr ude
Ġapproac hed
Ġprote olysis
Ġir inotecan
24 2
Ġquantit ate
Ġaz athioprine
aza deoxycytidine
con tin
NK L
Ġpredomin ated
Ġcorrespon ds
ĠĠĠĠĠĠĠĠ ĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠ
Ġz oster
ĠCH I
ĠId a
Ġplasmacyt oma
Ġmen in
nucle ar
bl adder
Ġdeline ation
Ġmanip ulating
Ġconn ective
ĠSE PT
granul ocytic
idic olin
ococc us
Ġsym met
Ġparadox ical
ĠEnh anced
ka ros
Ġosteoclas t
Ġunequiv ocally
Ġfair ly
Ġcir rh
poc amp
3 24
D evelopment
I QR
N CI
T et
U A
a h
b cl
f o
w in
ti se
Ġc um
Ġs ig
ic kn
le rogenic
ar ith
Ġb inary
ĠT Y
ĠT SP
ĠT umors
im ide
ĠC AT
ĠC ampath
Ġv on
Ġne vi
Ġimmun ized
ox ia
ound s
Ġsugges tion
Ġchrom atid
raf enib
21 7
atur ity
Ġmyel otoxicity
Ġexplo itation
omy ositis
Ġdesign ation
Ġconsist ency
Ġpan niculitis
Ġseem ingly
ĠCyt oplasmic
Ġsol ved
aph yloc
ifferenti ating
Ġpredisp osed
Ġphospho prote
Is olated
ĠBi omarkers
Ġhistor ies
restric tion
glut am
ĠSK OV
ĠTw ist
Ġrub idazone
Ġnutri ents
Ġnote worthy
ĠADA MTS
Ġwarrant ing
Ġundersc ores
Ġcoc ultured
dem ethoxydaunorubicin
mor tem
ĠChem o
ĠBas eline
myel oma
ĠPhys icians
Ġabst racts
zer land
Ġgynec ologic
anil ide
Ġdisulf ide
Ġta urine
ryp sin
ĠQing dai
Ġprur itus
Ġundoubted ly
Ġbioch ip
ickn ess
C lo
c ore
k aryotype
p ent
ic les
os timulatory
Ġpro gesterone
et ine
Ġst ream
Ġch ose
qu ality
Ġcomp etent
eren ces
ĠR etin
ĠG fi
ĠG IMEMA
Ġhemat ologist
ĠTh ird
Ġmic rol
Ġbi ased
ill ing
Ġar t
ĠV CAM
AT H
po fungin
Ġ19 0
19 8
ep i
af or
face ted
rin king
HR F
27 6
Ġmel atonin
omon ic
Ġsal v
ĠMS H
Ġfib er
Ġdep olarization
PT EN
ĠMM C
Ġolig omer
Ġhemoglobin uria
Ġquestion able
HDAC s
eff ici
Ġimmuno assay
ĠPar tial
Ġsubd ural
Ġcolor imetric
Ġprovir us
Ġdimer ization
Ġnitro blue
ĠRest oration
053 1
ĠHV EM
ĠRecogn ition
Ġinsign ificant
ĠProlifer ation
ĠElect ron
Ġstra ight
Ġhemizyg ous
ĠEMB ASE
Ġcirrh osis
0 99
B reast
G li
L SD
a ine
k p
p ot
ti ff
he ro
Ġs ac
em etic
Ġth al
ĠT AL
us h
Ġpro thrombin
ot ensin
ĠI kappaB
ĠM Abs
ĠP RT
anc h
Ġk its
Ġco variate
ĠN early
ad verse
ĠU MRD
Ġam ph
Ġep o
Ġaut ophosphorylation
15 8
ne utral
Ġpost translational
ĠML N
60 2
In s
dom inant
Ġ18 5
tis ense
Ġphosphor ib
Ġcent rom
ĠCon tr
ole t
Ġfraction ation
ĠMY O
osyl ated
ĠPT Cy
Ġdehydro genases
ĠNF AT
Ġgluc uron
alan ine
yr s
Ġvis cer
otrans ferase
ĠMe CP
Ġtransduc ers
Ġreinf used
pat tern
ĠLIN E
Ġmultim odal
Ġexacerb ation
mul ti
Ġgamm opathy
Ġmicronucle i
TSG s
guan osine
Ġleuko encephalopathy
Ġpathogn omonic
ptom eningeal
usias m
Ġing red
4 35
D r
K C
N CCN
in ess
Ġc ave
Ġs HLA
is o
Ġd uct
Ġd iac
ve rolimus
Ġn ivolumab
ĠT SC
ĠT dt
ut rition
ter y
se par
oc op
ĠAML CG
Ġch idamide
Ġg aps
ĠD MP
ĠF l
ĠS ES
ph ther
Ġrel ax
ĠO A
Ġse rous
Ġag arose
Ġdifferenti ative
ĠK EGG
ĠU IC
Ġage ing
Ġref ining
Ġnucle olus
Ġlim b
Ġ30 9
rin k
ĠSt able
35 9
ĠCT D
ĠIC E
del etions
Ġz este
69 3
Ġfl uct
ĠRel apses
Ġmen og
Ġtransition al
ĠMG CT
Ġsem in
ĠSpec ial
Ġapprec iable
PG P
ĠAbnormal ities
Ġperman ently
Ġdich ot
Ġlob e
deox yc
Sign al
ĠCan ada
amid ronate
ĠSMA D
ĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠ ĠĠĠ
Ġmusc ulos
ĠIRA K
Ġremin is
Ġnanomed icine
effici ents
phther ia
Ġmusculos keletal
I DAC
L DL
N QO
a HR
e po
i em
o geneic
q ter
Ġa fore
Ġa ffin
Ġc lo
es enchymal
Ġb are
Ġto lerogenic
Ġth a
ĠC ardi
Ġas cribed
ver t
ĠM IP
ĠB ortezomib
Ġr ig
ĠD au
log ists
ĠF ull
ĠS MNs
Ġmo ieties
ensi ties
Ġsuc ces
Ġ9 00
ag o
Ġdes orption
Ġprov ing
CD P
Ġam yloid
Ġspecific ities
Ġem o
Ġnucle osome
specific ity
Ġcharacteristic ally
Ġmy ogenic
Ġprec on
Ġmyel omon
Ġ18 2
phosph atase
35 5
40 9
Ġcal cein
Ġwhere in
Ġhydro ly
ĠER M
PB L
immun oglobulin
65 5
Ġintensi ties
yelodysplas ia
Ġrepro duced
Ġhome ostatic
chlor odeoxyadenosine
Ġasc orbic
eb pa
Ġassum e
Ġsenes cent
Ġneo antigens
Ġinherent ly
igen in
Ġpure ly
ĠMan n
214 662
Ġherpes virus
circ RNAs
car cin
Ġspot s
Ġhind ered
No vel
Ġhip pocamp
ĠAURK A
ĠAchie ving
ĠSwit zerland
Ġwan ted
accin ation
Ġcc RCC
F usion
I B
S ingle
b re
t rend
Ġ 00
Ġt ran
ti ated
Ġc alls
Ġs in
Ġs ystolic
Ġm aps
el ec
Ġd m
ate ver
ĠA DCs
ĠT D
res pectively
lo ur
ac quired
Ġl aun
op tim
op terin
ĠM ethyl
ĠH an
ĠH alf
Ġr DNA
Ġ2 16
am s
ri zz
ĠF gr
ĠS SC
ĠW est
Ġat axia
Ġinv ariant
Ġhem in
oun ting
Ġinf ancy
ogen in
ens es
og rastim
Ġimp ossible
12 99
Ġop erative
lyc er
roph ot
ish ment
orph ism
Ġtri pt
24 54
Ġ25 9
000 9
ĠCon f
ĠRT PCR
Ġdet achment
immun oprecipitation
pop ulation
Ġphys ic
Ġlog arith
58 9
Cyt osine
ĠMC S
Ġphysi ology
Ġcarb oxyl
ĠTLR s
Ġtet ramer
ĠAc tivating
Ġide ally
Ġdeb rid
Ġeth anol
inter leukin
Ġcy an
ĠIdentif ier
ĠTGF beta
TR EM
Ġpatholog ist
ĠBE AC
Ġconsum ing
Ġrecapit ulates
BT B
Ġdiscl ose
GST T
Ġempir ic
osc opic
Ġadduc t
meth otrexate
Ġcontamin ated
stud y
Ġmanifes ting
ĠdC yd
Ġdecipher ing
Ġadminist rations
Ġrigor ous
Ġflex ible
ydroxy urea
ĠJM JD
Ġzyg omycosis
Ġanx iety
Ġdynam ically
Ġafore mentioned
A RT
C MP
D D
D EGs
H ES
M UC
P y
k er
p S
p ulsed
r Hu
Ġt ill
Ġp od
or tium
it ably
Ġd ry
ec rosis
res ts
ur ations
ig hed
ĠI karos
st abilizing
ĠD endritic
Ġun altered
ĠF ound
Ġrel iance
Ġ3 000
Ġco efficients
Ġmet ric
Ġhemat opatho
ogen y
ĠK U
Ġhyp okal
ĠAl terations
Ġam mon
LA T
ĠJ ude
Ġconf usion
line ar
17 4
MP R
ĠML H
Ġexper tise
20 7
ores cein
Ġrep osition
Ġsp hero
Ġhybrid oma
Ġver ification
radi otherapy
Ġ26 4
Ġmean while
75 9
def ining
Ġoxid oreductase
85 8
Ġpa rox
ĠFOX P
Ġren in
Ġcod ons
HSP C
ĠWh ilst
Ġfung emia
HN SCC
BH AC
cor rected
Ġerr ors
Ġont ogeny
Ġbre ath
ĠTrx R
Ġendonucle ase
patho logical
Ġrough ly
Ġarach id
princip le
rizz led
ĠFound ation
E A
P LA
S up
T AD
f ac
t ors
t age
an alyses
os ocial
ĠC ity
ib us
ĠM eth
iv ascular
Ġon line
Ġch r
Ġg ins
up s
ĠP AF
ĠB lock
ay ed
ĠF MR
othe ned
ĠR CTs
ĠO GG
iti mate
Ġpar tition
ill i
Ġdes m
our idine
ep id
Ġoptim ism
MS H
Ġdys megakary
HL F
Ġglyc osides
ĠGroup s
AD CC
Ġtra its
PR S
met hionine
Ġnan ocarri
Ġacet yltransferase
Ġadap ter
Ġepid erm
sc ore
Ġmamm als
Ġmis interpre
Ġcarb oxy
ĠNe oplasms
Ġbil iary
ĠEL F
ĠDR B
mTOR C
au tious
Ġdoub led
Ġvisual ized
Ġcompens ate
Hyp er
mul tiple
Ġreplic ative
Ġstrengthen ed
Ġpolyploid y
iflu oro
Ġmyr istate
Ġfem oral
Ġsemis olid
ĠToxic ities
Ġindefinite ly
oprop yl
Ġasynchron ous
Ġelectropor ation
Ġelectr ical
Ġparox ysmal
D ef
S el
S LC
V II
c lassification
f DNA
in omycin
Ġt i
on ok
Ġm otor
ar ger
ĠC z
et ence
Ġfor tilin
Ġim min
Ġor d
ĠP PAR
Ġ2 20
ĠD LC
ĠD ZNep
Ġun ilateral
ĠR af
ĠR XR
ĠR ING
Ġen de
Ġhem angi
Ġint ronic
ĠG EP
Ġno gal
Ġsub stitute
ĠTh ai
ĠL act
ĠL ater
Ġph age
Ġcomple ting
Ġmic rosp
Ġpar ac
Ġlympho poiesis
cri ptive
drom es
Ġmalignanc es
ass ays
ass isted
Ġaut ore
13 6
Ġform at
erg istic
ĠAn n
ĠBM A
xt ran
Ġshort en
Ġsp ans
Ġcle ared
Ġampl ifications
Ġphospho diester
Ġphysiological ly
Ġtop ics
Ġmultip otential
GST M
fil ing
Ġexcre ted
Ġdiscussion s
Ġpericardi tis
Inter leukin
Ġvi ro
Ġrac ial
tech n
phosphatidyl inositol
meg a
ĠOmn ibus
2454 206
onok iol
F ITC
G raft
G EP
M b
N TP
O VA
c ut
c aus
h ap
i ans
i PSCs
p as
p urin
s CD
u rafenib
Ġ :
Ġ ut
Ġc autious
Ġs lo
Ġf eline
om ere
em urafenib
si bly
ce ived
Ġl a
Ġst ri
ĠI CB
ĠH CMV
ĠP rolonged
ĠB AG
Ġinc ome
Ġun purged
NA E
Ġco vers
ear s
ĠO p
lec tion
ip t
Ġmal t
ious ly
ĠJ agged
Ġwhen ever
ĠThere after
MP ATH
rop er
Ġ17 8
CA RT
24 7
cept ors
Ġmetast as
ĠRes idual
IP S
pre treated
oper atively
Ġtra uma
Ġdep os
lab elled
Ġmobil isation
ench ing
ĠAP P
ĠSI RP
ĠDe ep
Ġchlor omas
Ġdimin ishes
Ġslow ed
MB TL
Ġstabil izes
ĠAF P
Ġfil ament
vi olet
Ġvirt ue
ĠFT I
Ġfarnes ylation
Mon oclonal
Ġcoord in
ĠDH AP
Ġreact ing
ĠRep ublic
Ġimmunob i
Ġadjun ctive
Ġpig ment
Ġsens ing
ĠCorrel ations
Ġaglyc one
Diagnos is
Ġpren atal
Vari ous
Ġhyaluron an
Ġneighb oring
overl apping
Ġaffin ities
Ġphysic ochemical
Ġut most
9 29
J uvenile
R educed
a que
h ang
Ġ lot
in atumomab
en n
Ġp ol
Ġp ir
Ġs arc
Ġd ensities
Ġf os
Ġf ight
Ġb sAb
Ġh its
ĠA MML
ĠA MG
ĠT AA
ĠC lo
ac arb
Ġas paragine
Ġres idence
ine urin
Ġv inca
ĠF orm
ĠF PA
Ġcyt ometer
Ġab ivertinib
ure ment
ĠL CA
Ġid elal
opt otic
osi tions
Ġnon significant
Ġpl ating
Ġel acytarabine
Ġar resting
11 57
Ġes ters
Ġmit oses
MD C
ok inase
Ġcycl ins
ĠLeuk aemic
Ġimm aturity
Ġwork s
cyt okine
sub type
BMT R
Ġchemo att
pre viously
Ġaccel erating
Ġmegakary oblasts
Ġtransi tions
Ġsepar ating
anti le
Ġbl inatumomab
Ġresid ing
Ġelic its
ĠAut o
PK B
Ġcardiomy ocyte
Ġharves ting
Ġphot odynamic
Ġaugment ing
oemb ryonic
Ġpropag ate
Ġmilest one
Ġallevi ated
He at
Ġgang ren
Ġprost atic
ĠConc urrent
ĠRece iver
Ġlum inal
Hep at
ĠRap id
Ġvag inal
RNP K
Ġhyperg lycemia
Ġpsych osocial
Ġfork head
ĠReduc tion
Ġpestic ides
Ġphleb otomy
Under standing
Ġidelal isib
+ ;
0 70
9 13
A ustrian
C SC
C hip
D is
E CM
L oss
f icial
m A
p ired
r atio
s ystem
t ra
w as
Ġa er
Ġs tiff
Ġd n
ar f
Ġf rank
ĠA EL
ĠT AR
ol lic
ĠP rophyl
ĠB CNU
ĠD SS
ĠF DG
NA C
ĠR ed
Ġpre m
CR T
Ġmay be
Ġanalys ing
Ġpar ap
Ġcor tex
11 3
Ġsc le
22 2
Ġpart hen
ero yl
ipi ents
40 6
erox y
Ġfar m
ĠQ D
ĠClinical Trials
54 16
Ġstar vation
Ġantagon ized
Ġglut aminase
Ġconver ting
ibr ative
initi ated
Ġleuc ocytosis
ĠCB A
MB A
Ġent h
SE A
PN H
ĠSP HK
SH AP
ĠTG IF
Ġsial yl
Ġpurs ue
ĠBT Z
Ġkappa B
ĠMTH FD
Inf ections
Ġquar tile
Ġinfer red
ĠPhen otypic
ĠInvestig ation
Ġulc ers
ĠEB NA
Ġreapp earance
Ġserv ices
PH OS
haemat ological
orub icine
Ġendow ed
integ rin
Ġrup ture
oder ma
Ġinternucle osomal
4 90
E urop
H ox
P oly
S Q
f ur
f mk
g ated
h ot
h ybrid
m atic
v ision
Ġc ac
Ġp ow
Ġp lots
id is
Ġh P
Ġth reonine
ĠA MD
ĠT reating
Ġex it
uc tive
rap ies
Ġcon versely
ĠM ouse
Ġde als
ab out
ĠP ort
ĠP CNSL
Ġr TM
am ers
Ġun limited
pro ven
ĠN ET
ĠN HEJ
Ġ5 11
Ġper in
ĠG as
rac il
ĠE SHAP
ĠL V
ĠL arger
Ġmic afungin
34 4
ag ocytosis
MT T
trans location
16 7
33 7
int ro
60 3
ater n
Ġmy osin
05 1
ethyl ating
Ġmethyl cytosine
BM SCs
27 7
IM ATE
Ġhyper leukocytic
ophag us
Ġknock ing
Ġequ ival
Ġ34 35
PR C
Ġbro ther
ĠZ BTB
Ġgo ing
Ġextrem ities
Ġmust ard
Ġantagon ize
Ġlys ate
ID O
ĠRel ative
ĠHemat opathology
raz ine
ED D
Ġrevolution ary
Ġreproduc ibly
enz ene
Ġcryp t
Ġnod ule
ĠSE ER
class ical
Trans location
rastruct ure
ĠOK B
elect ron
Ġhepar an
ĠRand om
Ġmonol ayer
Ġtrap ping
Ġimplement ing
Ġunderex pressed
Ġglomer ul
Ġfluoro uracil
Angi ogenesis
orig in
Ġviscer al
ĠCz ech
6 18
H H
L G
M VD
s econd
in ic
Ġo s
Ġm ercaptopurine
an o
it ri
it ance
Ġf ruit
Ġ( [
Ġth reat
ĠA MM
un t
Ġas th
ĠH G
Ġha pt
ĠP AK
ĠB CG
Ġ2 27
ĠD a
ĠD uration
ĠF ever
ĠG T
ĠG e
ĠL S
Ġob limersen
Ġsup ra
Ġlympho penia
out h
ĠMDS s
ĠK H
Ġadv ised
Ġreac ts
Ġdi versi
Ġdi phtheria
ex as
Ġform ally
AC E
Ġop erate
17 1
Ġrele asing
ep ine
Ġ14 6
Ġtr ia
PCR s
Ġprot racted
UN CX
Ġcap it
CA N
24 6
Ġeng rafting
ect able
ĠCom orbidity
Ġretin opathy
36 5
Ġmes enter
Ġcardi oprotective
immun ization
Ġrestric ting
ĠTrans fection
Ġdegra de
47 3
Ġ56 2
Ġz oledronic
Ġolig od
Ġtw elve
OP N
ĠAc tivity
KL F
Ġremod el
des cribed
Ġbacte raemia
Ġmono allelic
hex ia
ĠFB W
fib rom
ĠRev ised
Ġreinfor ced
Ġstrept ococcal
Acc ording
ĠRadi o
Ġhypereosinophil ia
Ġanat omical
ĠTopo isomerase
ĠTranscript ome
galact osidase
Ġretard ed
ĠTranscription al
Ġisot ope
Sc a
Ġstand point
Ġneovascular ization
usc ular
orot ate
Ġecc rine
Ġmalt ophilia
Ġpir arubicin
0 75
4 80
8 055
> >
I PA
L E
R adi
S mall
T en
c ases
d ri
s oluble
x ts
Ġ %).
re pair
al one
ent in
Ġb TCE
Ġh MSH
ĠA lox
us p
ĠP rac
ĠP RPF
ir y
Ġtrans pos
Ġr IFN
am ole
ĠF riend
ĠR earrangements
ĠN ITR
Ġen velop
Ġmet am
ĠO dds
Ġhem ostatic
ĠE NE
bin utuzumab
Ġ0 1
ĠL DA
Ġblo ts
ber rations
ep igenetic
af arnib
oid es
ans h
Ġ24 6
ĠCN T
27 4
respon siveness
con f
Ġi i
Ġacqui res
Ġ27 2
ĠCyt okine
Ġ35 8
Ġconte xts
Ġatt end
Ġcalc ineurin
ĠMM M
ĠPT D
Am B
Ġreactiv ating
Ġepithe lia
Ġpredisp oses
oura ging
Ġspect rophot
Ad ult
Ġstimul ator
ĠPer formance
Ġmuta gens
TNF R
ĠCompar isons
ĠCE ACAM
ĠSh an
Ġmismatch ing
ĠMa gnetic
IG H
ĠPL X
Ġmicrom olar
ĠSLC O
ĠSyn dromes
Ġfibrin olysis
Ġnecessit ates
sho ck
Ġconsolid ative
Ġhams ters
Ġmicrotub ules
Ġcomplic ates
Ġfus es
Ġjoint ly
Ġimbal ances
Ġarabinosyl cytosine
Ġerup tions
ĠNow adays
Ġcere us
ĠMol t
Ġsemiqu antitative
Ġunderpinning s
rig el
Ġrod ent
Ġfirm ly
Ġelabor ate
Ġnaph tho
ĠENE ST
H a
O E
T dR
d ig
h ospital
Ġt ap
on ecrosis
ed om
ĠC ore
Ġis othiocyan
Ġst en
ĠP HF
ap enem
ĠD on
ĠD iff
Ġun iversity
ĠS DAC
ĠS udan
ĠG alpha
ĠG LC
ari an
Ġunder lines
ugh ter
Ġinter patient
MT H
CD DP
Ġep ilep
are a
Ġconfirm atory
AL Y
Ġmetabol omics
Ġtechn ically
Ġ18 7
Ġsus pend
ĠDNMT i
BM NC
Ġsubt yping
Ġ22 9
arb urg
Ġgu aran
app rec
ĠPro b
Ġj ob
ophag ocytosis
Ġmacro cytic
Ġaccompan y
EL DI
ĠY AP
ĠPT X
Ġmeth ionine
ĠSc a
ĠSF K
Ġhar mon
Ġbehavior al
ĠMon osomy
be ing
ĠCG H
CY T
Con ventional
oconjug ates
Ġarsen al
ĠInf ections
no vo
Ġincons ist
acr itinib
Ġiod ine
Ġneon ates
Ġdermat osis
Ġtreph ines
alc one
dam age
Ġmatur ational
Ġdemographic s
Com bin
main ly
Ġont ology
Ġbuil ding
Ġchick en
ĠBrazil ian
Fox p
obacter ium
Ġlac Z
erge tic
ĠVin cristine
Fif ty
Ġreminis cent
epo etin
apprec iated
3 100
8 12
A DA
M c
N s
a round
b and
c ine
f ect
g ical
r ived
t omy
t andem
Ġ ure
Ġa ud
on ous
te ll
Ġin ner
Ġm b
Ġan emic
or ial
an z
an ks
er ix
Ġ( (
em erg
ĠT exas
Ġle ptomeningeal
Ġl isted
Ġcon den
ĠM urine
Ġor ientation
ĠD BA
ĠS IN
ĠR Nase
Ġgen otoxicity
Ġen vironments
de termined
Ġprognostic ator
ass emb
Ġimp eded
Ġmin us
Ġkary otypically
Ġ18 3
OR C
IL s
drug s
Ġsp aces
PR L
Ġcalc ulations
ĠY ork
Ġmat ured
Ġaden oviral
Ġmultic entric
ĠNB T
ĠHD M
Ġbil ayer
tect omy
Ġprep are
ĠAM oL
Ġdest ined
Ġmicros omal
metabol izing
Ġcoinc ident
Ġlook ing
Ġsphing olipid
ĠMod ern
ĠIG SF
ĠNa B
Ġscat tered
leb rand
prop yl
ĠVit D
depend ently
Ġske wing
Ġantico agulation
iflu or
ĠPol ish
ĠCharacter ization
Ġulcer ations
design ed
Ġtrajec tory
ĠFcgamma RII
Ġcorrobor ated
umines cence
Ġperipher y
Ġaph idicolin
ĠAPR IL
Ġdisproportion ately
prob able
Ġoligodeoxynucle otides
Ġalign ment
Accum ulating
Ġcalib ration
Ġextravas ation
ĠBin et
Ġdm CEBPA
Ġimmin ent
purin ol
E DC
b acter
k iller
l oss
n el
t able
v ic
z ation
Ġt ag
re a
en i
Ġc oded
Ġp ix
Ġin gu
Ġm H
ar lier
Ġh n
ĠT TP
ig il
Ġg m
ĠH MT
ĠP le
ĠP CM
ĠB CHN
Ġ2 11
Ġ2 60
Ġ2 37
ĠD ox
Ġun characterized
ĠIn fusion
ĠF v
ĠS SEA
Ġmut ual
ĠR am
ĠR ates
oci ations
ĠN ST
ĠG D
Ġsub stance
ĠE Cs
Ġ4 15
Ġinf antile
ĠL L
ĠL atin
Ġover whelming
ast asis
ten se
az ol
az acytosine
Ġselec tin
Ġkary otyped
Ġpost treatment
60 7
jec ts
ĠAn gi
ind es
ĠFor ced
Ġgu adecitabine
36 3
rain ts
osp erm
AM s
ME L
Ġlocal ize
Ġderiv es
77 6
ĠAL CL
Ġaden omas
Ġintegr ates
SD F
ĠCons titutive
Ġlength s
ollow ing
Ġradio resistance
ĠMG US
ĠTr p
ĠAZ T
inucle ar
Ġmembran ous
ĠUK ALL
ĠPres ent
De tection
part ate
ĠAllo SCT
Ġincre mental
Ġcoron avirus
Ġuro the
depend ence
Ġpack age
Ġsimpl ified
Ġbran ching
ĠCAM AL
Sign ificant
Ġgall bladder
Differen t
Ġapt amer
Ġtris omies
strom al
ĠIran ian
ĠTiss ue
tetrahydro folate
SW OG
ĠConcern ing
Ġstraight forward
Ġdebrid ement
Ġnogal amycin
Ġstiff ness
ollic ular
Ġperin atal
Ġingu inal
2 60
9 00
C EC
D MA
D nr
M ethylation
S eventy
V O
V AF
c hemia
j it
l son
Ġ uc
Ġt ach
Ġt roxacitabine
is omer
it ro
Ġh rs
em in
ĠA gency
ĠC u
ĠC ulture
ĠC ASE
Ġleukem ogen
Ġis chemia
Ġg lycerol
ĠP NP
ies cent
ĠB ar
Ġ2 53
ĠS timulation
Ġrel iant
ĠR EP
Ġsub m
pho lin
Ġover weight
Ġover ride
Ġpot encies
Ġdec omp
11 52
Ġmulti faceted
Ġadv is
AC A
19 90
ocyt opoiesis
25 80
ves icles
Ġcycl ase
IC C
Ġerythro blast
phosph ates
Ġprac tically
As s
Ġcollec tive
Ġintensi fy
ĠMY CN
Ġexer ting
ĠAp af
Ġsize able
Ġmaxim izing
69 1
Ġlands capes
ĠEn asidenib
Ġcereb ell
Ġsplen ocytes
Ġion ophore
ĠCB R
Ġsidero blastic
Ġantioxid ants
Ġcomm enced
ĠSup portive
Ġirre versi
Ġinversion s
Ġplasm ids
pan sion
Ġsubstit u
ĠIG H
inv olved
ĠNa Cl
Cons titutive
Ġaccompl ish
ĠSet d
Ġrelie ved
Ġhyperdiploid y
ĠRare ly
Ġretard ation
Ġbab ies
Ġenum eration
knock out
Ġmicrod iss
section al
terp ene
419 259
Ġdrain age
Ġsalv aged
iem sa
Ġenth usiasm
ĠREP ORT
C utaneous
M a
T ERC
c s
c en
on ography
Ġo mic
Ġs acr
ro tid
er yth
Ġto s
os ylation
Ġh opes
Ġth reatening
Ġth irteen
ĠA lu
ĠA MSA
ĠC ADM
il in
ĠM CC
oc arb
Ġch i
Ġch or
ĠP ep
st at
st ract
ĠB est
ĠD utch
ĠD aunoXome
ie f
ĠR U
ĠN BM
Ġper ception
Ġper ceived
ĠE SA
Ġthan ks
est in
Ġdes per
Ġdes criptive
og ones
15 4
CL IP
Ġsequ es
Ġ19 1
38 4
ĠAn t
MD A
Ġradi ologic
Ġprote oglycan
respon der
Ġsp ared
04 77
Ġeffici encies
gh ai
Ġstatis tic
75 1
Ġiss ued
Ġaccompan ies
Ġvascular ization
ĠIC SBP
Ġspon ge
Ġemer ges
UC Y
Ġfl t
ĠReg ulatory
VL B
Ġmild ly
occ i
Ġeth idium
Ġent rap
Bu Cy
ĠSup er
%] ),
Ġdip lo
ĠEC OG
ĠEl igible
dimethyl thiazol
Ġhotspot s
Ġperf ect
121 0477
Ġdisadvant age
Ġtro pho
Ġortho log
ĠPan el
Ġadvoc ate
GEM M
squ are
Ġbroncho alveolar
Ġphosphorib osyltransferase
eroyl anilide
Ġconden sed
% (
) "
3 22
6 98
P cG
W hit
a verage
c enti
h ave
n k
p aclitaxel
t MDS
u ated
v ol
z eta
Ġ encephalitis
Ġa ux
Ġs atellite
Ġd ark
ic amycin
os om
om o
ĠT ri
ĠT RF
Ġex osomal
Ġl ag
il iated
ine xor
ĠM U
ĠM g
oc an
Ġbe henoyl
Ġch ori
Ġch ief
Ġal anine
Ġv igor
ĠP ulmonary
ĠP earson
ĠB v
Ġ2 26
qu ar
ĠD oses
ĠD anish
ĠF MC
th ione
Ġ3 22
Ġco x
ĠN J
ĠN ME
Ġab rup
ron ous
Ġinv alu
cl us
ĠG B
ĠG astrointestinal
Ġover represented
Ġpat hom
Ġcomple mented
Ġsuc ce
34 0
AB CG
ĠK DR
ens is
cent re
Ġsel inexor
10 99
12 08
Ġ19 3
17 76
Ġpolym ers
Ġmethyl ase
ish man
ĠAd en
Ġneutrophil ia
Ġdys granul
Ġ28 5
Ġhyper active
cyt oplasmic
100 2
ins ic
Ġexpl oratory
ĠMT SS
mal arial
ĠAN G
HP Cs
ĠPT L
me asurable
EN G
Ġauto antibodies
Ġadop ting
Ġfibro us
Ġrib o
ĠInhib itor
inter cal
Ġexact ly
Ġhorm ones
Ġcys tic
Ġpalli ation
ensiti ze
ĠConsid er
Ġagre ed
ĠMod el
quin ones
Hu M
Ġdeterior ated
Tr isomy
Ġmitig ated
benz yl
Ġlipophil icity
Ġchemot actic
Ġther mal
Ġawa ited
Ġscaffold s
ĠUPD s
anes ulf
Ġbed side
hydrop eroxy
ICAL M
ocys tis
Ġpolyp eptides
Ġmenog aril
Ġhypokal emia
1157 77
ĠShan ghai
Whit ney
Ġinvalu able
7 00
= -
A HSCT
K B
P RT
S IN
T RA
c m
c ultures
m ortality
v ar
Ġ *
Ġ 001
Ġin exp
Ġs n
Ġe verolimus
ĠT CM
ot o
ĠC utaneous
se where
Ġst och
Ġg r
her lands
Ġor i
ĠP AD
ĠP neum
ĠP opulation
ĠP ICALM
ĠB o
ĠD XR
ĠF DC
Ġat rophy
Ġ3 17
Ġ3 20
pon in
ĠR ich
ĠN L
ĠN DRG
ĠG old
ĠG MP
ĠG VH
aus al
Ġachie vements
Ġqu enching
10 62
Ġ19 75
Ġform ulated
AC s
Ġran king
PA N
ranul ocytosis
20 40
orph yrin
rid in
Ġthem e
blast omas
Ġhyper acetylation
cyt in
ophil ic
Ġprac tition
PB A
ĠMY BL
Ġdiss ected
rh G
Ġve get
Ġbeh ave
Ġsecre ting
Ġmobil ize
ĠCons ensus
ospor ine
Ġbehav es
Ġvaccin ations
ĠSp anish
DLI NE
Ġfil es
Cytogenetic s
carb ox
uter ine
PLC beta
ĠNet herlands
lys ine
Ġunravel ing
ĠInvestig ations
ĠUC HL
Onc ology
ĠWil lebrand
ĠIntegr ated
nitros ourea
Ġophthal m
ffe ine
Ev idence
yrid amole
Ġoligomer ization
Ġcac hexia
Ġinexp ensive
< </
B SC
C ip
D ifferentiation
G lu
H TLV
M ut
P DAC
S tem
e oxycytidine
l ives
m ass
s aving
t ases
he tero
Ġp and
Ġs orter
Ġm HA
Ġre ality
os amin
ĠT RAF
Ġac yclovir
Ġex chan
Ġres erve
ĠM sp
ug inosa
ĠH tr
ĠH ope
ĠH ierarch
ĠB CT
am ides
ĠIn clusion
ĠIn vasive
igh ts
Ġanti emetic
ĠR W
Ġper cutaneous
Ġper ivascular
Ġmet als
ĠO l
cl ature
ĠG em
ĠL ITR
Ġhe aring
Ġtumor icidal
Ġunder represented
Ġexp ired
Ġhematopo etic
ĠK Y
Ġmulti organ
Ġconf ound
Ġ19 50
Ġphen otypical
reat ments
Ġregul ations
sequ ential
ĠAs c
Ġonc ologic
Ġindividual ize
ophen yl
Ġerythro leukemic
ĠRec ipients
24 4
ĠAt ypical
Th d
radi ol
70 6
LC H
Ġrever sibility
omen clature
Ġlo vastatin
Ġpa rotid
003 24
ĠNF kappaB
Ġunus ually
Ġimmunop eroxidase
ĠMut ated
ĠHO VON
Ġmicrom egakaryocytes
cons uming
Ġwors en
ĠHGF s
Ġhap p
ĠRP RM
Ġdefic it
Ġphyt ohem
Ġultra violet
Ġnecro ptosis
ret azine
ĠHom o
ĠErythro id
Ġreconstr uction
ĠHetero geneity
Ġvitre ous
ĠTes ting
Ġazu rophilic
Ġped ig
ĠXL OC
Ġchemoatt ract
1099 48
Ġpand emic
5 50
B a
C yc
H BV
H MG
R earrangements
b et
b ile
c ious
d n
r ating
on di
Ġd an
es ylate
le ag
le ep
id ental
ec d
ĠT CA
si ll
ĠC ot
et ron
um es
ĠM IM
ĠM eg
iv a
her ited
ĠB AT
ĠB reast
yp ically
ĠD iv
ub er
ĠF ed
Ġrel ied
Ġwe ighed
00 15
00 20
ĠR AL
ĠN HD
tem is
Ġper it
ĠG vL
Ġsub con
ĠL BL
ore tin
Ġrece ipt
Ġmic elles
ven etoclax
ill s
ĠU M
ĠU til
ĠJ CS
ĠV AE
Ġy rs
Ġless ons
prolifer ating
Ġdown loaded
Ġcomplex ed
Ġ18 9
Ġtri tiated
Ġvir idans
Ġtol l
arb epoetin
Ch i
Ġsp in
Ġsp are
ĠEx p
lor o
Az adC
Ġdep si
ĠMN s
ĠMy oD
Ġve ter
Ġemb olism
fact ors
sel f
Ġrecru its
ĠPI K
Ġred istribution
Ġz osuquidar
Ġminim ized
ĠSub jects
ĠMed icare
Ġconst raints
Ġcataly ze
alk yl
Ġintercal ated
ĠPBP Cs
ĠGl uc
Ġcoc ultures
fl ight
Ġcomplic ate
test ing
Ġuro kinase
omyel itis
Ġdorm ancy
ĠPat hw
ĠContin uous
Ġseiz ures
Ġchemopre ventive
Ġjustif ies
Ġremit ters
nucleotid ase
Ġblun ted
Ġepo etin
Europ ean
erix afor
Ġirreversi bly
Ġabrup t
leag ues
* )
/ +
E ffec
I DR
J ALSG
L ip
L EF
L enalidomide
N umerous
O x
S m
b c
u i
Ġa thymic
in um
en zymes
Ġc itrate
Ġs ch
Ġan agrelide
Ġre jected
ec ycl
ĠC e
Ġfor sk
ho u
ho ea
yelo cytes
ĠI ron
ĠI SR
oc used
Ġtre tin
ĠP CT
ĠB le
ĠB TG
ĠF P
ĠS taining
ĠW ild
Ġap igenin
Ġ3 18
Ġimmun oflu
ĠG EM
ĠE CM
ĠL IL
ad ditive
ad ecyl
Ġdec ont
Ġcytogenetic al
ple en
Ġ8 36
Ġel ution
Ġel sewhere
Ġallo purinol
omes tic
Ġmicro be
spec ified
Ġcol istin
ĠV I
Ġdi phosphate
stan tial
PA G
iss em
emb ers
Ġthromb opoiesis
Ġu PAR
Ġcirc adian
atal y
ĠPro gress
Ġintra genic
CG L
ĠIg E
ĠAp optotic
Ġauto HSCT
ĠIntern al
MY B
ĠNA s
Ġrib oside
ĠSI K
Is ocitrate
aden osyl
Ġasc iminib
Ġion ic
Ġremo ving
amil ies
ĠCA SP
Ġect o
Ġsuper ficial
Ġtempor arily
Ġintercal ator
Ġbrom odeoxyuridine
ĠBe yond
Ġsial ylated
ĠPar ty
prote ctive
ĠMal ign
yst all
Ġversion s
pen et
acc elerated
Inter feron
topo isomerase
mimetic s
ĠSal vage
Lym pho
Anthracycl ine
Ġflavon oid
Ġunderex pression
perm issive
Six ty
ĠStruct ural
azid ime
Ġdeubiqu itin
ĠGL UT
Ġcham ber
leg itimate
Ġgangren osum
Ġdysgranul opoiesis
ecycl ine
Ġforsk olin
Ġtretin oin
) /-
2 002
6 20
6 50
A nal
C re
C yd
D DR
E ML
H B
M utation
N J
S AM
g emtuzumab
l arge
o y
in compatible
in tense
he lix
Ġp in
Ġp ace
Ġin verted
Ġre a
Ġre ads
Ġb randed
Ġth irds
Ġn inety
ĠA MN
Ġpro l
ac yl
op ress
ĠI l
ĠI PA
ĠI MR
il ate
ĠM or
oc ysteine
Ġde generation
Ġch art
ĠP uma
ĠB Z
ĠB SA
ĠB SI
ĠB AFF
Ġcomp act
ĠD eregulation
ĠS ympt
Ġ3 60
Ġanti mitotic
Ġnot or
ure tic
ĠE arlier
Ġid ic
Ġmark eting
est radiol
10 60
az one
Ġ19 77
Ġcoun ted
Ġ20 7
ĠAs xl
Ġdo ing
rop he
95 2
ST R
Ġ24 8
Ġaccum ulates
HR QOL
of urin
ect asia
blast oid
Ġdys cr
ĠEx ogenous
Ġinsi pid
Ġhospital izations
ĠET C
co lour
athe red
IN T
Ġput atively
ĠInc orporation
Ġthym ocyte
oman nan
ĠCol ony
Ġelectro lyte
ĠNe gative
onc ogenic
oxid ant
lip osomes
Ġmanip ulate
prom oter
ĠNor way
Ġphot os
Ġgover ned
Ġpolymer ases
Ġamb ulatory
SSC P
ĠWP SS
Ġcomputer ized
ĠSUMO ylation
Ġexpon entially
ĠCyc lophosphamide
TN BC
ĠBreak point
ometh acin
Ġastrocyt oma
Ġleak age
enedi one
Ġmetron omic
ĠBlock ade
acarb azine
Ġaer uginosa
indes ine
Ġcerebell um
Ġtos itumomab
Ġinsipid us
A chie
B rdU
F ms
F ollowing
M antle
R XR
V LA
a CGH
b ur
in o
re p
en zymatic
Ġw k
al as
an yl
Ġf acet
os tim
ul ing
Ġh ij
un der
Ġis ogenic
ĠI r
ĠM k
oc or
Ġv an
st atic
ĠB id
Ġr AAV
Ġ2 56
ĠD EX
Ġun regulated
ĠF il
der iv
ĠR FC
Ġmon ensin
de velop
ĠO macetaxine
lec tro
CR IP
Ġdev ices
Ġdec lines
Ġar yl
ens ing
Ġmulti dimensional
LA A
16 6
ĠMD C
Ġlymph osarcoma
Ġ15 00
Ġmy riad
20 2
Ġcytotoxic ities
Ġ18 4
30 3
och alas
con jug
Ġsp i
Ġhyper activation
Ġi tem
Ġ23 2
Ġlocal izes
Ġpoly ethylene
ins on
Ġtransfusion al
rec ise
Ġrestric tive
Ġregres sed
Ġneuro genesis
ĠTrans locations
HP C
Ġelect ric
methyl guanine
An n
ĠCytogenetic ally
angi ectasia
aut ophagy
appro val
ĠCd h
with standing
Ġpal ate
Ġvirt ual
SH V
Myelo fibrosis
ruct ose
rank fur
Ġnutri tion
Ġcolla genase
ĠIs sue
Ġdihydro orotate
syn drome
Ġtax ane
Inf ant
Ġprefer ably
ĠPO U
ĠAbs ence
Ġcompeti tively
Ġtetra hydro
ĠTaiwan ese
Ġinterview s
ĠVer apamil
ĠDisc overy
Neu ro
Ġazanucle osides
Ġconsult ation
Ġarbitr ary
Ġcontrac tility
dU rd
Ġfre edom
Ġhij ack
rankfur t
6 31
G iven
P CNSL
R L
R ef
V E
c urative
f ort
f alin
i et
i very
i lection
n g
t um
Ġo binutuzumab
Ġp riv
Ġs ulph
or rect
or iasis
as omy
ing ap
Ġh um
im olar
si ed
ĠC CI
ĠM em
Ġde ter
Ġv ice
ĠH ip
ĠH EK
Ġtrans it
Ġtrans aminase
ap arib
ĠD evelop
ĠF IC
ĠS PR
ĠS CH
ĠR M
Ġgen otypically
Ġse pt
Ġpre therapeutic
Ġrec lassified
ĠL eb
Ġ7 00
Ġlympho hematopoietic
Ġnon hematological
li ance
ĠV orinostat
Ġdi recting
AT M
leuk emias
17 9
ma jor
oph thal
Ġrele ases
roph agocytosis
Ġder iving
com ple
ĠAd ding
ĠOn t
ĠAm B
ĠUn supervised
gi an
Ġcirc ulatory
ĠCT P
ĠEx pl
bil ization
den se
inf ectious
LI F
PB T
99 6
Ġtransl ates
Ġreflec tion
pop ulations
inc reased
66 9
Ġdiss ecting
ĠGen otyping
Ġhypothesis ed
del ivery
Ġeradic ates
Ġbio techn
link s
Ġhistor ic
ĠPo oled
ĠMechanis ms
Ġremod elling
Ġintrac erebral
Ġphag ocytes
ĠLi ver
Ġaff lic
bor ne
hyd ration
Ġvalpro ate
Ġdescription s
Ġfluor ochrome
Ġlongitud inally
Ġpropag ated
Un til
prednis one
Ġsudden ly
Anti body
Ġps oriasis
Ġawa its
Ġcontamin ating
ĠProte omic
Ġimped es
pic uous
Ġmult inucle
arom ustine
Inhib ition
Ġcas pofungin
Ġinges tion
Ġcatast rophe
Ġcompan ies
ĠContr ary
Ġmicrosp heres
ansh inone
ĠHierarch ical
ingap ore
C ardi
D au
E SCs
H SV
M t
P red
h arb
o assay
r ho
t azidime
in ating
Ġo val
Ġs rc
Ġw r
el le
Ġd rinking
Ġb ip
os ic
Ġh sp
ĠA PM
ĠA IC
ot uzumab
uk S
iv ariable
Ġ2 21
am mon
ĠD en
ĠF ortunately
ĠS pect
ĠW M
ĠW IF
Ġ3 25
ĠR L
ĠR MS
rac tive
Ġsub pathways
ĠE LL
ĠE CG
Ġpo re
Ġpres sing
hen ium
yn thetic
ad ren
Ġmod ulatory
LT R
Ġdem ands
Ġnormal s
Ġmark eted
Ġ< /=
Ġar isen
yc ardia
Ġprov oked
ach man
ry ing
sup porting
abl ation
ĠJ ALSG
ĠV ar
ĠV AD
Ġ12 00
Ġhist ochemical
19 99
Ġsm CEBPA
Ġcompar ability
vir ally
20 11
ĠAB SCT
Ġdiagnostic ally
(- ).
ĠLeuk apheresis
Ġshort coming
Ġ25 8
'- (
27 9
Ġconcentr ate
con ditioning
98 9
Ġhom od
host in
Ġ27 0
Ġintra epithelial
Ġarabin ofuranosyl
Ġpoly amine
ord ered
MF I
Ġdeep ly
ps ins
ĠSM O
Ġavoid ance
ĠAC E
Ġslow ing
CBF A
ĠLT R
TL S
ĠPTP IP
eff lux
prom yelocytic
Ġca ud
arm acy
Ġintron s
GC NA
Ġinterrup ted
Ġinterrup tions
Ġfeed er
py rimidine
ĠMorpholog ic
opho res
Ġphenyl butyrate
Ġexacerb ated
ĠLAM E
Ġconstitu ent
Ġsym p
Ġinterrog ation
ĠTranscript omic
ĠRef ractory
att le
Onc ogenic
ĠPhys ical
Ġcontraind ication
sm ok
ĠAv ailable
Ġhur dle
ĠEph A
Ġblind ed
arboxyl ic
Ġtransamin ases
ĠSn ail
Ġsaving s
Ġleukotri ene
ĠNITR Cs
Ġenvelop e
Ġsten osis
ĠDon ors
thione in
Ġphytohem agglutinin
3 98
> (
B MP
C EL
C ertain
D ose
I E
R etin
T MA
W orld
a ult
p el
Ġa ortic
Ġt ent
Ġt yros
Ġp u
Ġs fR
Ġm Ci
er in
Ġf ab
Ġf ear
ith i
om ed
Ġth ink
ĠC le
Ġfor th
Ġr GM
Ġinc ap
Ġtreat able
Ġ2 33
Ġ2 17
ap hereses
Ġad mixed
ist ant
ĠS um
Ġap par
di pine
SC NP
Ġmon onucle
ĠO C
ĠO V
ĠG reater
Ġob vi
ad ine
Ġpred ilection
Ġacc ru
ĠU BA
reg imen
hw achman
Ġcombination al
acy tic
onal ized
Ġcol leagues
trans fusion
Ġsh RNAs
Ġphen ocop
Ġop posing
Ġimpact ing
MP T
ET A
Ġcontin ually
35 8
As pergillus
Ġcho line
Ġ26 1
Ġfac ing
omin ant
ĠME DLINE
ĠQ ual
ĠImmun osuppressive
Ġhis tidine
Ġsubc lass
ĠHD I
Ġconver ts
ĠEn zyme
lassi fy
cont ent
ĠSout he
Ġthi ol
Ġdeb ul
ĠMon onuclear
recip itated
Ġmuta gen
ĠIK BK
alk aline
sil encing
ĠCs s
Ac tivation
Se vere
Ġdiarr hoea
GST s
Ġbeg ins
ĠHC Q
Ġdeplete s
Ġchel ating
main tenance
ĠHistological ly
Ġbab y
Ġsubf ractions
Ġmanufact ure
Ġconvinc ingly
ĠTRA LI
Cycl in
ĠPa ediatric
Ġster ile
Ġarsenical s
tryp tase
Em erging
Ġscarc ely
ĠRepe ated
Ġanthra quinone
ĠChar lson
Ġcentrom ere
elec oxib
Ġimmunobi ology
Ġappar atus
0 65
3 28
C HO
D iamond
F ludarabine
I da
M CR
M BP
N HEJ
O r
P ulmonary
R a
R ap
a I
i D
r IL
Ġc red
Ġs ingly
Ġm ycosis
Ġw ave
is platin
ar ted
Ġe yel
om olar
ec tivity
ĠT un
ĠT NK
ĠT TR
Ġle vo
si gh
ot ub
Ġex plic
Ġl actic
Ġst ent
Ġbe x
ol ig
pl ification
gene ous
Ġv entric
pro B
yl c
NA P
Ġco express
ĠR N
ĠR out
Ġhem ophagocytosis
Ġout patients
Ġdev oted
Ġfol ic
RA Y
CT M
sup ported
Ġstrateg ic
ne al
Ġsh orte
Ġ19 7
ram ycin
Ġinterac tive
ĠNK L
AP E
Ġyoun gest
18 00
Ġrep aired
Ġimmunosup pressant
Ġproduc tive
IP K
Ġ27 5
Ġ27 7
Ġ26 2
Ġhydro lytic
AR RAY
Ġcytokines is
Ġhospital isation
Ġtra b
ĠCC K
Ġoste ocalcin
Ġiso enzyme
Ġpreferen ces
Ġdysfunction s
flu fen
Ġremo ves
ĠAR C
ĠSecond ly
Ġextra ord
Ġcooper atively
ocal y
Ġinher itance
Pro gnosis
Ġtempor ally
Ġinstit uted
sh ift
Se e
CAL CRL
but yl
Ġinsertion al
ĠImpro vement
ĠHER V
Ġdermat ologic
Ġcoop erated
Ġabl ate
ĠRet ro
Ġtheore tically
ĠSel ection
Ġunravel ed
Tar geting
Ġworth while
Ġequil ibrative
Ġrecover ing
utrop enic
Hb F
Ġread out
Ġundes cribed
Ġglomer ular
Ġautotrans plantation
ĠRC MD
Ġgalact omannan
Ele vated
ĠUltr as
Ġdura bility
Ġcef tazidime
Ġlinc RNA
Ġflor a
Ġdod ecyl
anch nic
Ġurothe lial
Ġdesper ately
Ġstoch astic
ĠDiv ision
Ġshorte st
4 95
B CNU
G erm
I NPP
J H
R CA
S can
T CM
g lycerol
p olar
s itu
t oler
Ġc otrans
an a
Ġd ib
id ences
Ġh uge
Ġh onokiol
ĠA SC
ĠA VA
im ex
ut in
elo c
ac ch
uc ena
oc he
Ġch ills
Ġal isertib
her ing
ĠH ybrid
ĠH azard
ĠP ak
ir med
ĠB SO
ap sing
ĠS i
ĠS CE
ĠS GN
Ġsur round
ĠW arburg
Ġco activator
ĠR ub
ĠR OCK
ĠN CA
ĠN MA
Ġper taining
ĠO D
ĠO LF
ion al
ĠE NT
Ġdes c
ne o
Ġ12 98
Ġem odin
17 5
Ġtes tes
Ġ20 2
Ġtransform ants
ĠMP Ds
ĠSt rong
ĠSt aphyloc
Ġsu PAR
Ġrecogn izable
ĠUn treated
Ġu racil
Ġdys erythro
ĠPD T
Ġcal ibr
Al a
Ġ29 9
cap s
ĠME LK
GM CSF
Ġampl ify
CH T
ĠMN Cs
ĠAr ray
Ġelectro cardi
Ġrh yth
ĠCA MPATH
etho prim
idin yl
Gl utathione
Ġmediast inum
Ġexplan ations
Ġsinus itis
hydrox yp
Ġleth ally
ĠProm yelocytic
Ġpent asomy
Blas t
Ġretrovirus es
deg ree
FT Is
Ġansw ered
ĠPos aconazole
Ġdict ates
Ġquar tiles
Ġair way
prop idium
ĠSimultaneous ly
Ġlum p
Ġterat ogenic
ĠPat tern
Ġstres sed
ĠIndividual s
ĠMc Ab
Ġcere vis
Ġundes irable
ĠPe ople
Ġeryth rophagocytosis
Ġmicrobi ome
Ġcocktail s
Ġpeptid ase
Ġmax illary
Glc NAc
Ġsphingomyel in
angu age
Circ ulating
Ġhid den
ĠConcomit ant
Ġentail s
Gli oblastoma
emerg ent
Ġomic s
ĠLeb an
ĠOLF M
A EL
D DX
G el
P ar
T TP
c ally
e o
m elphalan
n utrition
o tes
s orted
t ailored
Ġ ign
re xed
Ġc up
Ġs kill
ic itis
ic ella
ith orax
om i
Ġh ERG
ĠA CR
ĠT PL
ĠT CTP
ĠT MTP
ig ecycline
Ġas k
Ġmyelo poietic
ĠM MF
Ġde bil
Ġg am
ĠP CL
Ġcl ient
Ġ2 19
am ines
ĠD u
ĠD ic
Ġun labeled
ĠF emale
Ġdiff us
ĠN ur
ĠN SA
Ġimmun ochemotherapy
ĠG TI
Ġsub acute
ĠL PN
Ġro t
osi tes
cent ration
Ġimp art
ym met
ym idine
crib ing
56 76
ise ases
ace tic
enic illin
23 7
18 3
18 9
CN Q
000 8
Ġgra ded
Ġwork shop
Ġsp ac
Ġutil izes
Ġmes ilate
Ġi PSCs
Ġ27 8
rec ision
ĠTrans formation
CH K
Ġprogram ming
ĠImmun oglobulin
ĠMM SCs
Ġtrig lycer
Ġlike wise
Ġoste onecrosis
Ġattrib utes
ĠSF Ks
ĠCH T
myelo peroxidase
Ġrecons id
Ġchemos ensitization
Ġaccept or
Ġradio resistant
Ġbenz o
Leuk emias
Ġoccup ations
mo bility
ĠHep at
ash ing
ĠAss ociations
Ġcathe psins
ĠTA As
ĠRS K
ĠcG MP
Ġribonucle oprotein
ĠOb jective
Ġassemb led
Ġfore front
Ġimmunob lot
Multi parameter
Ġulc erative
microg lobulin
Ġerythemat osus
Ġmanufact uring
ĠMc Abs
Ġground s
WP SS
Ġappra isal
Ġdere pression
Ġil legitimate
Ġphosphoryl ates
ĠSmo othened
Ġbare ly
Ġarachid onic
Ġoligod end
Ġdecont amination
Ġshortcoming s
5 40
D ue
F AS
F rankfurt
G ET
H IF
N M
Q u
S DS
S equ
U M
d ull
f ies
l osamide
o rel
p iper
t ailed
w i
Ġt ext
Ġp amidronate
Ġs ed
Ġs om
ar ach
id ylate
ul der
Ġn omenclature
ĠT B
ĠT EM
us al
ĠC EL
if osfamide
ho x
um ping
Ġg add
ĠH TR
). (
Ġr ho
Ġun event
ĠS arcoma
ĠS BF
ĠS AR
ĠS ELDI
Ġat RA
Ġk er
Ġmo ved
00 16
Ġco b
ĠN I
Ġ5 000
Ġ5 71
Ġper p
Ġper centi
Ġag ranulocytosis
ide oxy
ĠE W
Ġob atoclax
Ġcyto fluor
Ġprognostic ate
Ġbi oph
ĠK P
ĠU LK
ĠAl liance
Ġsim ulated
po lycythemia
Ġda ughter
Ġnucle ase
60 8
ace ous
05 0
Ab stract
Ġ24 1
Ġ24 3
Ġmethyl ene
Ġshort ness
24 1
IL P
lamm ation
ĠCom mit
stim ulation
Ġemerg ent
Ġhydro carbon
Ġpoly ke
Ġequ imolar
Ġlater al
ian al
ĠZ eb
ĠPre vention
inc reasing
200 6
PT Cy
ĠHigh ly
Ġmultic ellular
Ġinfiltr ative
Ġamin otransferase
ĠCons ortium
Ġimpair ments
ES As
Ġleukaem ogenic
ĠSM G
Ġund iagnos
Ġsurvivors hip
MM C
ĠEn tero
Ġhemorrh ages
Ġple x
Ġcatal ys
Ġfamil iar
Ġleuc osis
ĠFirst ly
Ġca ffeine
Ġpict ures
Ġcros sing
Ġtrunc ating
Trans locations
Ġlook s
Ġconsolid ate
wan ted
Ġpip er
ĠDis ruption
transcript ome
Ġassumption s
Ġheral d
ĠMark ed
Ġosteoclas ts
ĠHispan ic
design ated
Ġded icated
Ġmicrobi ota
ĠPur ified
Ġhypoth yroidism
Ġdrawback s
Ġsubcateg ory
Ġpapill omavirus
Ġviro therapy
Ġparthen olide
Ġasth ma
Ġisothiocyan ate
Ġori ented
issem inated
Ġbex arotene
Ġcerevis iae
% +/-
0 68
4 98
B TK
D MSO
E SCC
G vL
H g
O B
S tr
b etween
b endazole
h R
h ing
h ab
m dr
r ituximab
en te
Ġin bred
el arabine
Ġd op
ic idin
Ġf use
os an
ra C
ra um
im plantation
si rolimus
Ġex tern
ho w
ho ol
ĠI so
ĠM eta
od ial
Ġv imentin
ĠP MNs
ĠB X
am ethox
ap er
ĠD ar
ĠD MA
Ġun ilineage
Ġun wanted
Ġat rial
ally l
Ġpre leukaemic
ĠE PC
pho x
ĠL SA
ad elta
Ġcons cious
oth io
Ġsup ervised
ser ies
Ġinter rel
Ġrev is
Ġimp er
Ġimp osed
Ġsim vastatin
Ġdi oxygenase
16 8
Ġ19 9
22 9
MP P
60 32
Ġ24 5
26 2
Ġ25 2
ĠCN DAC
Ġvir ul
ĠST C
Ġsummar izing
Ġdiffic ile
Ġsol ute
oly l
ob yl
Ġorgan omegaly
ĠQ Tc
def iciency
ĠY AC
ĠY KL
ĠAL FA
Ġdiscrim inant
ĠDe termination
Ġattenu ating
Ġcen tered
rearrang ements
ĠBi ochemical
ĠPP P
reduc ing
Ġposition ing
ĠLA MP
Ġcompl aining
iaz ofurin
Ġcoll ateral
ĠHu R
tor ies
Trans cription
HE MA
ĠHMG A
Ġchel ators
Ġchron ological
cis platin
Ġexhaus ted
Ġtry ing
ĠEngl and
Ġinev itably
Ġnewborn s
Ġfum arate
Ġmetach ronous
ĠAnthracycl ine
Ġshar p
splic ing
Ġradionucl ide
enop ausal
Ġpyr ro
ĠBer lin
ĠAnaly zing
Ġneurode generative
Ġresum ed
ĠOT X
ĠMeth otrexate
ĠAnn ual
ĠMem orial
harb oring
Ġundiagnos ed
E OP
E Vs
J anus
M ST
P CD
U TP
c ently
c CD
l amed
o ylation
p g
p athy
r yl
ti go
Ġm ug
ro blasts
Ġd elo
er gence
om ustine
Ġth ickness
ĠA po
ĠT ac
res ident
Ġpro lymphocytic
ĠC hib
ĠC CT
ine a
Ġch arts
ĠP ark
ĠP OG
am ple
ub endazole
ĠIn sigh
ĠF indings
ĠS J
ĠS l
Ġk d
Ġ3 28
ĠN SD
de tected
cl a
Ġhem opathies
Ġpre operative
Ġrec ycl
ĠL BH
pt ake
Ġsuc cin
av idin
Ġam ine
15 9
ĠV beta
po R
ĠHLA DR
Ġmy ocytes
les tero
ĠRA P
25 7
IC OS
ĠAd ults
mut ational
Ġinform ing
Ġanthracycl in
Ġrest rain
phosph on
Ġeng age
Ġins ults
Ġhyper proliferation
Ġhere by
29 61
mit ogen
bers ome
Ġgast ro
opy ran
Ġrestric t
47 143
ĠImmun ob
Ġbroad ened
Rec ombinant
Ġvol tage
PS L
ĠAc ad
Ġvis it
Ġincid ental
ĠGerm line
ĠGC S
ĠMA LAT
ĠVari ant
Ġschem a
Ġmicros omes
mm as
Ġcoinc idence
RI NF
ĠSL E
prote asome
Ġcytological ly
ĠLympho blastic
Ġrefin ements
ĠPred nis
Ġanc illary
Ġrelie f
ĠMulti drug
Ġinterrog ated
Ġdile mmas
Ġnur sing
ĠPers istent
ĠSte p
Ġpel vis
Ġhypog onad
ĠMH H
Ġquad rant
Ġshutt ling
Ġton sill
ĠFrequ ent
ĠIntra venous
Ġhypert rophy
ĠCbf b
067 47143
Not ch
Ġcum bersome
Ġemo tional
Ġ836 858
ĠsfR ON
Ġdelo cal
3 99
7 39
7 49
8 19
D eregulation
H om
L im
L angerhans
N MA
N OPHO
P os
P CA
S al
W hen
c a
f ailure
h am
m p
o active
s he
Ġ logical
in jected
he sive
is opropyl
an ning
Ġd acarbazine
er ally
Ġre qu
Ġre bound
Ġf el
Ġf ructose
ra xin
Ġn aked
si b
ĠC en
Ġl aryngeal
Ġst o
sion ate
ĠI LT
ĠM t
ol dering
Ġim plant
Ġg a
Ġg raph
Ġv indesine
ĠH EM
ĠH FD
Ġad di
ĠS ensitive
ĠS elf
Ġk r
Ġsurviv or
ĠR BM
ĠR MA
ĠN CS
di rectional
ĠE ts
ĠL a
ĠL ife
ĠL uciferase
ĠL ukS
ore g
ip per
Ġcons tell
Ġind omethacin
Ġnon neoplastic
ser a
Ġcharacter ise
out hern
plas m
ĠK M
ĠU DP
Ġmulti gene
ĠBCR ABL
ĠV H
Ġcondition ally
Ġsm oldering
ET S
Ġmy ofib
Ġhematological ly
ĠCh allen
Ġpharmac otherapy
Ġquantit ated
Ġ29 1
pir atory
Ġrever ting
ĠCNS L
Ġneuro fibrom
Ġ44 6
Ġdiss imilar
Ġnan os
Ġnic losamide
Ġred und
Ġill um
Ġcore pressor
cle rosis
ĠAP ML
Ġcos timulation
ĠNe utropenia
Ġcen sored
HDAC Is
ĠTR IM
Ġexpect ation
SM O
deple tion
ĠLA MA
Ġderm atitis
AMP K
ĠHU VECs
Ġarch ived
Ġpor cine
Ġmono blasts
ĠCycl osporin
Hemat ologic
Previous ly
Ġdermat oses
standard ized
ĠKary otypic
010 759
Ġchel ator
Acc urate
ĠEffec ts
Ġpolyploid ization
Ġreapp eared
oste al
Ġvitre oretin
Ġtrajec tories
ĠAnthracycl ines
ĠICOS L
Ġnons teroidal
Ġapproxim ate
Ġsevent y
GDS PV
MAL DI
separ ated
Ġsucces sively
Ġslo pe
Ġdepos its
Ġpathom echanis
Ġrea ders
Ġwr iting
Ġpercenti le
4 18
A V
A dr
B SA
L IC
N ext
P onatinib
b r
c ad
n s
n amed
r AML
s im
s IL
t onin
Ġc GvHD
Ġp ull
is ome
it ric
ĠT re
ĠT reatments
Ġpro line
ĠC LA
ĠC CDC
et yl
if ier
ac ces
uc ted
op us
op ap
Ġbe am
Ġch ar
up le
ĠP art
ations hip
Ġ2 34
ĠD ig
Ġun ifying
ĠS a
ĠS APK
Ġco administration
ĠR al
ĠR EF
ĠN HA
Ġpre fibrotic
ĠE LA
ĠE nc
ĠL ight
Ġpat ch
Ġbi ocomp
Ġfol ding
tim ate
RA D
01 26
ĠAl tered
+) -
ĠJ WA
ex isted
Ġmor bidities
Ġdaun osamine
Ġcaus ally
af ide
tr insic
ĠAn emia
Ġvar icella
ĠCh imeric
CI C
30 4
Ġconc ise
ĠCT R
Ġdys myelo
ĠHR QoL
200 7
uan g
49 1
Ġvol umes
ĠPV R
target s
bi otin
ĠCo expression
ĠCol on
Ġcarb apenem
Res pon
ĠAg ain
with in
Ġfunda ment
Ġqual ified
ĠFA O
Ġtrac ked
Ġneo angiogenesis
cycl ine
ĠLD E
Ġhydrox ycarb
Ġconfig urations
fib rin
ĠMal ignant
Ġansw ers
ĠRadi ation
rach ial
main tained
dex amethasone
Ġport end
Ġprecip itation
brom o
ĠCri teria
oderm ic
Ġconjunctiv al
ĠGn etin
ĠIns titution
Ġmere ly
Ġabor tion
Ġpericent romeric
ĠBEAC OPP
Ġmetric s
Ġdysmegakary opoiesis
cen tered
Ġdepsi peptide
ĠISR CTN
4 37
4 75
5 57
8 01
9 706
K S
M ast
P r
Q PA
T AIR
Z V
c lassified
l able
n atural
r t
Ġa erobic
in jection
Ġt s
on it
on ogenic
en gth
Ġo le
Ġp lot
Ġp aving
Ġm DCs
an gl
Ġre localization
Ġf are
ate chin
id o
id ative
id able
Ġh TERC
ĠT ST
ĠT ypically
et tes
Ġtrans genes
anc ement
ri on
ĠD ist
ĠF CI
ĠR ab
ĠR PB
ure us
oun ders
ox imine
Ġout break
and ibular
ad ed
Ġsyn decan
Ġcor neal
%) :
Ġobser ving
Ġchrom ophore
Ġar rests
Ġdes cent
yc o
ens ation
lu ent
Ġme bendazole
CT X
ĠJ S
Ġreac hes
Ġdi rects
po ietin
Ġmin ing
Ġform idable
ocyt oma
Ġes ophagus
Ġtr un
Ġtr ivalent
ĠBM F
05 2
Ġcap ecitabine
Ġrepresent ation
ĠUn i
Ġlab ile
Ġgu inea
ĠRes istant
HO TAIR
Ġintracellular ly
Ġcle an
Ġ45 4
Ġangi otensin
ĠPR S
ord oma
ob i
ĠCC NA
ĠSe attle
ĠComp uted
87 1
Ġantagon izes
tes ted
oura bly
Ġthym oma
Cyt otoxic
arn es
Ġrobust ness
DNMT i
Ġion ization
Ġion ising
Ġresc ues
ĠITD s
ĠLC S
ĠcDNA s
deh yd
ĠTr k
Ġsurrog ates
version s
ĠMi Seq
Ġreticul ocyte
ĠBE X
Ġmetallo thionein
bic ans
Bs Ag
Ġadip ogenic
Ġfluor ometric
Ġenrol ment
Del etion
jo ene
jo ining
ĠStr ati
Ġstrength s
Ġabscess es
Ġuter us
ĠRun t
Ġreplic ate
Ġunres ectable
Ġhyal uronic
Ġfig ure
Ġparadox ically
Ġimped e
olo l
ĠAmeric ans
ĠQu izartinib
Ġmicrobiological ly
Ġunequiv ocal
Ġreconstr ucted
ĠTIG IT
Ġfores t
Ġfron ti
Ġpay load
Ġfa ith
Ġsphero ids
ĠProphyl actic
atern ally
itri ol
ĠENEST nd
ĠMsp I
Ġmicrobe ads
Ġexplic it
Ġunevent ful
sib ling
8 602
A O
F l
K A
K FB
L EN
O ste
P rom
S HP
S rc
T im
V RE
c aspase
c idin
i ph
p H
w af
re ceptors
on amide
en di
Ġs iglec
Ġm ist
al ent
is ot
as ter
Ġd end
Ġd yes
Ġre ady
at hesis
id aza
ith ine
ĠA GO
ur ies
ĠC hest
ran i
op ag
ĠI on
ĠM ar
od ine
ĠH AL
am phen
am ellar
), +
ĠD BT
ĠS hwachman
Ġmo bile
Ġanti serum
Ġper ifosine
Ġper inuclear
ion ic
iti des
Ġag ree
Ġ6 17
Ġbi otrans
Ġcor p
Ġchrom ium
ens oring
Ġocc urrences
Ġvit rectomy
Ġdi ethyl
osph ing
hod omycin
int ensification
ep silon
ger ing
emb ran
Ġgranul o
romb opag
ched ule
25 1
ĠMP S
Ġcarcin oembryonic
ĠHL X
CC gR
Ġrecom m
orph y
Ġins pired
DA S
Ġxen ogeneic
Ġfac ility
Ġ36 5
ĠMul tic
Ġangi ogenin
acetyl cysteine
ĠTrans location
HP V
Ġdiss ociated
Ġpul ses
Ġstar ts
Ġhepat o
ps ia
platin um
Ġmig rate
Ġincub ations
bi ologic
hazard s
ĠSub set
ĠDS B
OH dG
macyt oid
flu orescein
ĠNon hematologic
Ġimmunomod ulating
Ġax illary
ĠEL K
progen itors
Ġent inostat
Ġagon istic
Ġdeline ating
ĠGra des
Ġillness es
>/ <
Ġden aturing
Ġintrat umor
Ġpent ostatin
Ġround s
Ġscat tering
TF E
ĠHM X
Ġincre ments
ĠRB Cs
Ġmir r
Ġentero c
Ġtro ponin
ket o
GIST s
ĠVir us
demethoxy gel
Ġtric arboxylic
Ġarchitect ures
Ġthal assemia
Ġlogarith mic
MTH FR
quar tile
hydroperoxy cyclophosphamide
ophthal m
Ġaccru ed
Ġlevo floxacin
eloc ity
amphen icol
( +
0 56
3 34
9 25
D x
D AT
G astrointestinal
M H
O macetaxine
S pecific
T g
f its
f action
j unctiv
l ating
n ov
w ater
x if
y ed
Ġt ack
Ġs leep
es in
Ġre di
Ġre bastinib
Ġ( ~
om ir
ra red
ĠA U
ĠA ctive
Ġpro thrombotic
ML PA
gen itor
gen omic
gen ital
ot roph
ĠC alu
ĠC HD
ac o
ran ib
op ard
ĠI AT
ĠI ST
ĠI PRS
Ġg els
ĠP y
Ġtrans well
ĠD ysplas
Ġun appreciated
Ġun maintained
ĠIn troduction
ĠS lo
ĠS AA
low n
ess ential
ĠN N
edi ranib
de ep
ion ization
Ġcont acts
ĠG ood
ĠG ITR
ĠE U
ĠE BF
Ġinf rastructure
hen tic
Ġover growth
Ġmal nutrition
form s
Ġsuc cinate
ser v
Ġcor recting
est one
og l
Ġprev ail
Ġcar ing
Ġinte l
ĠV av
Ġdi athesis
AC M
tr ifluoro
Ġmetabol ically
Ġmetabol izers
23 187
ĠBM MCs
AP Cs
50 8
37 3
ĠLeuk ocyte
opro tect
ĠST ING
Ġhyper fractionated
Th rough
Ġdam pen
Ġmel flufen
Ġ26 6
88 9
ĠMT S
rog rap
ĠImmun ocyt
Ġminim ise
Ġsi rolimus
Ġclar ifying
Ġthym idylate
Ġantifungal s
omod ulin
Ġdeb ut
ĠPo lo
ĠRespon ding
Ġsqu are
ĠTr yp
itone um
Ġcompl ain
Ġqual ify
ĠHep atic
transcription ally
Ġdocument ing
Ġtrim ethoprim
ĠSyn ergistic
Ġsustain s
plen ectomy
Ġbrid ging
ĠMal ay
ĠES As
oglyc ans
Ġchol est
Ġreservoir s
ĠMyel oma
Ġhypercellular ity
Ġsubf amilies
Ġmicronucle us
ĠContin ued
Ġverteb ral
Ġvi remia
ĠDem ethylation
Ġextr usion
Ġmosaic ism
pal mitoyl
IK ZF
ĠUltr astruct
Ġguan osine
Ġappend icitis
Ġhab its
tetrap loid
Ġrelax ation
Ġreposition ing
Ġphosphodiester ase
pas sed
Ba F
ĠUtil izing
ochalas in
Ġextraord inary
Ġdyserythro poiesis
Ġplex us
odial ysis
amethox azole
ĠChib by
Ġfel t
2 11
8 22
8 14
A HD
A urora
C ellular
C lofarabine
F raum
I CT
M V
M n
P opulation
Q L
S OCS
T CL
T yr
b anded
l ac
v omiting
Ġp gp
al bumin
Ġd oxy
ic ago
le man
at o
at eness
id ines
Ġe ther
ĠT ipifarnib
ot yrosine
un favorable
ĠC t
et s
ter pen
ho use
ĠI WG
oc omial
ol vement
Ġg athered
ys ical
Ġv ide
ĠH CK
ĠH aving
Ġ2 95
ĠD O
ĠF etal
ĠS ap
ĠS DH
ĠS HC
ĠW RN
ph ost
pro gnostic
Ġus ers
yl ine
00 25
Ġ3 15
Ġ3 36
Ġ3 75
pon ent
ĠR os
CR s
Ġhemat otoxicity
DS B
Ġcomple mentation
Ġprotein uria
Ġpar alysis
Ġnon mutated
Ġnon intensive
Ġpl ates
ail and
ĠK RN
tin ction
tin ostat
ĠCR LF
Ġ19 74
AC As
Ġop ac
Ġnucle ocyt
Ġpartic ulate
GF I
Ġdaun orubicine
ET LAM
Ġmyel omas
ĠAB I
ores t
Ġfour fold
Ġcarcin ogenicity
Ġ24 4
RP N
tis sue
ĠCT As
Ġlip ase
Ġsp urred
Ġsix teen
ĠEx cluding
cyt otoxicity
lympho blastoid
Al tered
ME G
ER S
LI N
opy rimidine
Ġmegakary ocytopoiesis
Ġsol ve
Ġdocum ents
Ġpul p
ĠSc ore
use i
Ġfever s
Ġolig o
ĠEn tinostat
Ġpain less
ubiqu itin
Ġillustr ating
Ġtet ras
Ġtet racycline
hol ide
Ġed ge
ĠAD EP
ĠAM O
Ġsulf ide
Ġenzymatic ally
Ġcys titis
Ġconn ectivity
Ġcathe ters
HI DAC
Ġinterrup t
Ġdiscrimin ative
wan n
ĠFLA MSA
ĠODN s
Ġphospholip ids
ensitiz er
Ġappropri ateness
Id arubicin
hel per
Ġrun t
Ġthromboemb olic
Ġhal t
ĠEnh ancer
Ġfrail ty
partic les
Ġsemis ynthetic
Ġsatis faction
Ġile um
Ġtetrap loidy
Ġparas ite
ĠMeas urement
Ġechinocand in
Ġautomatic ally
ĠTrich ostatin
Ġje opard
Ġmisinterpre ted
intro duction
Ġepilep sy
Ġguaran tee
Ġexchan ges
Ġincap able
acch arom
ĠStaphyloc occus
Ġdebil itating
orel bine
Ġconscious ness
Ġfundament ally
demethoxygel danamycin
rograp holide
Fraum eni
) <
, </
2 80
8 776
; =
B RAF
E OC
K inase
M ic
N BT
O f
O ME
P OG
T ri
b ar
c ue
f lo
f osf
i PSC
k d
o ured
p ublished
on ed
he ther
Ġc ope
Ġs we
Ġm cl
Ġof atumumab
is is
or p
as ts
Ġd ck
Ġd iaz
Ġd arbepoetin
Ġre w
Ġto lu
ML D
ot rich
ĠC OS
Ġfor ces
Ġas ymmet
Ġl end
uc cin
ĠI DAC
ĠM BL
ĠM ethod
oc yst
iv udine
ĠH a
ĠH MP
ĠP FI
ĠB BP
Ġr pS
Ġ2 90
Ġne omycin
Ġun targeted
ĠF PN
ĠF ZD
ĠW D
Ġ3 10
ĠN at
Ġclinical trials
Ġhem ostasis
Ġint ensely
Ġrec ord
ĠE s
ĠTh ailand
Ġbut yric
end ar
Ġsyn cytin
Ġnon p
Ġnon canonical
Ġpred ef
Ġinter con
av ach
Ġsim ulate
Ġdel icate
Ġconf ounders
ĠV ENT
press ors
33 97
Ġpost chemotherapy
int ensified
ĠOS U
com pl
till ation
Ġret roper
ĠBM MNC
05 7
Ġcontin ual
ĠCh icago
CI N
Ġrapid ity
Ġmethyl ator
30 6
MS G
Ġhaemat ology
Ġmac ul
Ġadd icted
Ġharb oured
ĠAS Nase
SA HA
ob acterial
PT K
Ġspl anchnic
HC V
Ġaden oma
Ġsex ual
Ġnic k
co il
Ġoste olytic
ĠHealth y
55 8
Ġnone x
Ġcleav able
Ġreason ably
Ġfas cin
HDAC I
Ġchemos ensitizing
ĠSer ious
ĠAR HI
Ġvis ited
Ġbound ary
Ġfit ted
Ġpancyt openic
transfer rin
ĠCE Cs
bl estone
Ġval ine
Ġseg mental
ĠFL IP
cycl in
Ġfer til
Ġdip yridamole
ĠPres ently
Ġfif teen
Ġribonucle ic
Ġpolar ized
Ġantimicrobial s
prim ing
Ġmer it
Ġeduc ated
ĠFew er
Ġcontempor aneous
Aut ophagy
Ġrelie ve
Ġther mod
Ind ividual
Ġbran ch
ĠMark ers
Ġhypodip loidy
Ġtit ration
ĠPe ak
ĠAppro priate
Ġton sil
ĠHi wi
Ġabandon ment
ĠFI AC
Ġisob avach
Ġpric e
ulind ac
Ġsig ma
ĠHtr A
smok ers
ĠIKBK E
Rap id
ĠCommit tee
Hom oharringtonine
Ġkr usei
Ġdoxy cycline
Ġnucleocyt oplasmic
;= &#
fosf ate
Ġpredef ined
ĠVENT X
Ġisobavach alcone
% ],
- ;
/ *
5 20
D ex
I WG
L ET
M idostaurin
N U
S urvivin
T D
V it
V TE
W E
b lot
i ponectin
m at
m us
p EFS
Ġ ;
Ġa UPD
in ii
Ġo ocytes
Ġp ione
Ġs ound
Ġs keleton
Ġm pl
Ġm ock
is ive
or ative
ro red
Ġd omestic
Ġf ur
Ġf oster
at inase
Ġb im
em et
ĠA LA
ĠA ustrian
ĠT RP
Ġac ridine
Ġleuk aphereses
ter ature
ac tions
Ġmyelo ablation
Ġor chi
ĠH ydroxyurea
yt openia
st atus
ĠB MD
Ġad iponectin
ĠS PAG
ĠW BCs
ph ag
yl enin
ĠR hodamine
reas es
Ġen gen
ĠO ATP
ĠG SCs
Ġpre therapy
Ġpre incubated
Ġsub eroylanilide
ĠE lectro
Ġhemat ogones
ĠL PA
Ġob lig
ag lobulin
ag greg
ĠU s
Ġdevelopment ally
og uan
CD R
Ġthere of
CT A
Ġcar inii
Ġline arly
15 1
Ġ19 72
Ġform ulating
Ġpost mortem
Ġapp eti
ET P
Ġtransform s
Ġgranul omatous
23 9
ĠIm medi
50 3
Ġlab els
arb y
Ġhom ogen
Ġadhe re
Ġintra uterine
Ġglyc ine
inf ective
ograph ical
Ġ38 4
Ġstaining s
Ġdoc tors
Ġneuro ect
Ġdeli vers
ĠMM B
Ġcross linking
Ġreactiv ates
ĠHSP s
Ġpy oderma
Ġuncertain ties
Ġide as
Ex per
Ġmicrog ranular
arg y
ĠPG K
CAR s
Ġphag ocyt
ĠLi terature
Ġexogenous ly
atell ites
Ġvascul ogenesis
Ġvisual ization
ĠPS AP
Ġsero positive
Ġpolar ity
With in
Ġcytomorpholog ic
Ġfore c
Com plex
Ġtas ks
Ġmir rored
Ġglycosyl phosphatidylinositol
Ġworth y
ĠTS LC
tel omeric
Ġbuff y
ĠThromb ocytopenia
zygo te
Ġchick ens
Ġheral ded
ĠMass ARRAY
Ġpel vic
Ġadminist rated
prin ts
Ġtable ts
Ġrigor ously
ĠHAA RT
Ġbench mark
lymph omas
Ġshar ply
ĠGE O
etu ximab
Ġros ette
Ġanticoagul ant
Ġang le
bre vi
caus ing
enn ium
Ġdebul king
otub es
Ġdiffus ely
Ġorchi ectomy
Ġappeti te
. :
A DH
E U
E t
G y
N BM
P CM
P RDM
R et
S OX
T ra
T AC
V ST
b b
c ataly
g ly
l ayer
m ias
n M
p ol
r C
x pression
Ġo mega
Ġs at
Ġan hyd
Ġthe ophyl
or ac
it a
ed s
es are
es ium
ing ers
ul us
ul um
ĠA ID
im um
ĠC at
ĠC OR
ĠC aco
Ġis otype
uc ine
Ġv ib
Ġv emurafenib
ĠP aclitaxel
st ar
Ġ2 12
qu izartinib
am idine
ĠW ASP
low er
pro f
Ġanti sera
ĠR he
Ġrem ethylation
ĠO s
cl es
ĠG lu
Ġdev i
ĠL F
Ġhe pt
Ġbi ochemistry
Ġnon etheless
Ġnon cancerous
est hesia
mon osomy
mon ophosphate
plic ate
ry o
Ġlymph omatous
leuk ocyte
53 669
ĠPh ospho
GF s
Ġlim bs
PA S
95 5
24 0
Ġter tile
Ġreal gar
Ġcal endar
MN DA
28 53669
Ġcertain ty
Ara bin
Ġtermin ated
ĠHR X
osinophil ic
Ġbroad en
rex ia
lab eling
ĠSc hol
ĠOr g
Ġserious ly
comp ound
ĠSign aling
Ġtet r
ĠLT BMC
Ġinser t
Ad optive
atch ing
ĠCG G
Pro gress
ĠCd kn
Ġtryp sin
Ġmanip ulations
Ġproto oncogene
Ġtrac ed
Ġoc fosfate
Pre clinical
HOX D
Ġvast ly
ĠSN U
wh ite
Ġpseud ouridine
Rel apsed
oz o
oz antrone
ĠProm pt
ARA C
ĠEl ucid
Ġlect ins
Ġsperm ine
Del etions
ĠMet abolic
ĠBD NF
ĠUT X
Ġambigu ity
Ġoper ations
Ġther m
Ġpas sed
Ġbond s
Ġinactiv ates
actin omycin
ĠCharacter istic
Ġextrap olation
ohem orrhagic
Ġmetach romatic
Ġscant y
Au NPs
APB SCT
Ġmonke y
weigh ted
ĠLIM K
rink age
Ġamyloid osis
dri ver
Ġmetam yelocytes
assemb ly
Ma jor
ĠANG PT
ĠMalay sian
esare an
0 66
2 001
3 27
F F
P PV
P PI
R eal
S weet
U GT
c opy
d NK
i arity
m yelodysplasia
n m
p ter
t agged
Ġa ureus
Ġc urren
Ġc ensoring
Ġo zog
Ġp AML
Ġp yl
Ġs ized
Ġs Tie
ic on
le ge
Ġf lo
Ġb or
Ġe ager
ĠA w
ĠA di
im ens
ĠC ultures
Ġex tinction
Ġl ady
Ġst aff
op orin
oc kin
Ġch in
Ġal bicans
Ġv ign
Ġv icin
ĠP ten
ĠB AC
ĠB osutinib
Ġinc orrect
am ely
Ġun specific
ĠF resh
ĠS kp
00 31
ĠR ER
ĠN GF
ost rid
Ġchem il
ĠG ain
Ġrec all
ĠE ST
ĠE KLF
Ġpres s
ĠL ocal
Ġover hang
Ġpat ent
Ġidentif iers
Ġsyn ov
Ġresist ances
Ġall ergy
34 8
Ġcharacter s
ond ensation
ĠU HRF
ĠU ptake
ber g
ĠJ C
Ġcol d
10 75
ĠV en
ĠV IP
16 2
ĠAT PR
Ġ20 20
Ġav idity
Ġdo or
ĠBM MC
ev acizumab
Ġerythro blastic
HR M
rophil in
Ġperiod on
Ġphosphor ylase
Ġ23 1
ĠTP MT
CM C
ĠER p
AR C
Ġseven teen
lor ide
67 3
Ġimmunohist ological
ov itine
Ġ34 2
Ġsched uling
Ġrepro duction
Ġpa ved
rich ment
Ġtransport ation
ĠRe gression
ĠEn forced
ĠCol lege
arn et
Ġrh in
ĠSign al
Ġradio isot
Ġdim ethylation
ĠPo int
bal ance
Ġpeak ed
Ġanomal ous
iphen yl
ĠSU Z
ĠAZ C
Ġsupple mental
week ly
ĠCO II
lem ia
ĠSE MA
Ġspre ads
%] ;
carb azine
Ġfav ourably
Ġexternal ization
Ġsero tonin
Ġtax anes
Ġcoord ination
ĠKary otyping
ĠDH FR
pur ified
Ne utrophil
osc arnet
Ġging iva
ĠFLA D
Ġtam pon
ĠPred ictive
Ġscaff olding
Ġcreat ine
Ġprecl uded
ĠClus ters
Ġnonrandom ized
Ġmm Hg
Ġpack ed
ĠCU X
Ġannot ation
ĠNan o
Ġisot opes
ĠGAB A
Ġmult in
Ġreevalu ated
ĠAnimal s
ĠCar cin
Ġpropos al
ĠBioinformatic s
ĠCur cumin
Ġheterodim eric
Ġderang ement
Ġfluct u
Ġdichot omized
Ġpedig rees
ondi aldehyde
Ġitem s
Ref ractory
ĠFIC Z
ente sis
Ġchar ges
onit rile
Ġvicin ity
( +/
5 87
6 19
D eregulated
F uc
H ist
H IPK
K DM
L Y
L arge
N ov
P ositive
Q ALY
S pontaneous
T ax
T AA
T ILs
] (
c R
k ylating
l on
s r
s pon
Ġ urea
Ġin patients
Ġm atric
is ters
Ġd educed
Ġd ensely
ar cin
ul izumab
ĠT rem
ĠT riad
ĠC ost
et an
Ġex ud
ant ho
Ġl agged
Ġst ret
ĠI ACS
oc onazole
Ġde hydration
ab err
Ġv ault
ĠP DA
Ġacute ly
st ability
ĠF avorable
ĠS mac
Ġcyt openic
ors es
ear man
ron ch
Ġprognos tification
ĠO lig
Ġse as
ĠG ly
ĠE c
yn e
Ġob liter
Ġpl acement
Ġpl erixafor
ĠK v
ĠK CNQ
reg ulator
Ġmicro culture
Ġspecific ation
ĠJ NJ
ĠV MP
33 3
ĠCI C
ĠMLL r
ĠBM M
37 1
BM MNC
Ġshort age
Ġhyper leuc
Ġhybrid ized
Ġliter atures
ĠIM C
pre ventive
ĠCM MoL
ĠAS O
Ġobjec tively
DC K
ĠHDAC I
Ġ75 1
ĠIg f
Ġevery day
Ġclar ification
Ġmodif ies
Ġillustr ative
Ex posure
ĠDA UN
Ġtub ules
Ġeas ier
dec reased
ĠAM kL
Ġsupple mentary
Ġshed s
FD G
Ġcros sed
Ġleth argy
Ġnas cent
Ġsero logic
ĠOb limersen
Ġhypere xpression
Ġuncover ing
Ġfus ing
Ġmultim eric
Ġcarbohyd rates
ĠPhen otypically
Ġbring s
Ġcust omized
Ġsubf raction
ĠPatho logical
Ġcatabol ic
Ġapt amers
Ġmold s
Ġaffor ds
Ġradioimmun oassay
Ġophthal mic
Ġsphingomyel inase
ĠTer minal
ĠSRP K
Ġferro ptosis
ĠBal b
Ġunw inding
ĠSIRP alpha
Ġfilament ous
Ġchemoattract ant
ĠRAL B
Ġveter inary
Ġimmunoflu orescent
ĠRout ine
othio ate
ĠEnc ouraging
ĠStrati fication
otrich um
Ġneuroect odermal
ĠAw areness
Ġtampon ade
) </
. .
5 19
5 96
6 44
C MA
D CA
G PR
L ung
L PD
M X
P eg
V o
b ed
d les
f ovir
h oming
i ro
l f
m is
t w
Ġp t
Ġin hab
Ġm D
Ġan ecd
al loc
or ting
or bidities
Ġre defined
le ts
le gia
Ġf urn
ing s
ate rial
Ġe ro
Ġe NOS
Ġh IL
ĠA k
ĠT LC
im id
ur ines
lo d
ĠC er
ig alloc
ac tically
ac illin
Ġl adder
ĠI H
ĠI VI
Ġde xtran
up ational
up regulated
Ġdis location
ĠP anc
ĠB B
ĠB IN
ĠB asic
am n
ĠD ot
Ġun le
ĠIn activation
Ġcyt oc
ph ys
00 19
Ġco at
Ġanti platelet
ĠR ai
ĠR NF
Ġen for
SC N
Ġint ract
Ġcont raction
Ġsub lethal
ĠE Cy
Ġ4 20
Ġinf lamed
ĠL OX
ore gulatory
ad hesion
Ġcyto genic
Ġunder lined
Ġprom on
Ġsuc rose
Ġbi ases
plas ma
Ġar rang
Ġam bi
ath yroid
spec ifically
Ġadv ice
Ġhetero log
Ġconcl usively
60 6
Ġcomplex ities
tr at
ĠAn tit
AL FA
OR IS
Ġinform s
26 9
IS ION
ĠAm plification
of ovir
ĠUn ion
Ġu PA
Ġconstit uting
gi um
Ġgra ve
ĠX AF
98 33
ade fovir
Ġi ii
ĠPro f
Ġintro duc
Ġintra ocular
Ġglyc olipids
SA A
Ġatt rition
def ective
zyg otic
ĠImmun ofluorescence
79 01
ĠMN KI
Ġamoun ted
Ġnic kel
Ġoste omyelitis
ĠAcc urate
raz ole
Ġelectro chemical
ĠNe oplastic
Ġconstruc ting
Ġfluores cently
Ġubiqu ity
Ad riamycin
Ġdim ers
Ġstimul ators
Ġbenz amide
ux etan
Ġdig ested
ticos teroids
iaz ole
Ġcomm ens
ĠMultiple x
deoxy uridine
Ġca reg
ote ch
Ġcyclo cytidine
tub ulin
Ġhyd rate
Ġhyd razone
Ġcomprom ises
ĠInv olvement
Ġens uing
Ġsuspic ious
Ġmechan ics
Ġhepatos plenic
Ġmu M
occur red
ĠPET HEMA
Ġdefinite ly
Ġce RNA
ĠGTP ases
megakary ocytic
Ġthous and
Ġunco upling
SET BP
Ġdeoxyribonucle ic
Ġsubstanti ate
Ġhin ders
ĠPhosph orylation
Ġhur dles
Ġradionucl ides
ĠMat rigel
Ġclaim s
Ġprotumor igenic
Evalu ation
Eight y
Ġcatar acts
Ġti uxetan
Hepat ocellular
SQ STM
Ġdecomp osition
Ġsacr ific
ĠConsider able
0020 9833
Ġsulph ate
ĠOnt ology
Ġmultinucle ated
ocaly xin
ĠPak ist
ĠPattern s
lestero lemia
Ġbiotrans formation
Ġeager ly
igalloc atechin
9 39
B O
B rain
C ol
D ec
F anconi
H IC
T er
T ype
b est
c ost
Ġ rom
in tention
Ġt in
he al
Ġc n
Ġc ram
Ġc rani
Ġo roph
Ġs no
Ġw il
Ġw ish
ro d
as sionate
ed le
le rotic
Ġb ivalent
om mend
Ġn c
ĠT em
ĠT MDS
lo xin
gen erating
un s
ĠC oc
ĠC yR
et ate
Ġac yl
Ġleuk ocytopenia
ac ular
ac hes
Ġl iv
Ġl omustine
op ine
ver apamil
il s
ol ving
Ġde amin
Ġg ated
Ġg rap
Ġv elocity
ĠP LT
Ġtrans duce
ĠB ub
ĠB eside
ist oyl
ay a
Ġun ivariable
ĠF UT
ĠS olid
ĠS GC
ĠS YN
ĠS ingapore
Ġsur ge
igh ting
Ġass ists
Ġass isted
pro be
Ġwe b
ĠR enal
ĠN up
SC Cs
de tectable
Ġhem ip
ĠE OL
ĠL B
ore loxin
pt y
Ġmal formation
Ġmal ondialdehyde
Ġdec isive
ult uring
Ġnon targeted
ĠK SHV
mon afide
Ġra f
01 347
Ġrev ise
ABL p
Ġsc ro
CT C
Ġmicro hom
Ġaut hentic
Ġser onegative
HD M
erg ies
Ġinfec tivity
19 96
oph or
Ġ20 9
Ġmit ophagy
Ġ30 7
Ġfour teen
Ġvar ie
Ġprot umoral
Ġcr ystall
iod o
18 52
Ġtri phosphates
27 3
MR s
estim ated
IM iDs
Ġpoly uria
Ġ35 4
Ġobjec t
PR O
Ġtermin ology
Ġdegra ders
Ġfrag ility
Ġsubc lassify
Ġspon sored
ĠGen erally
Ġantagon izing
Ġz ipper
mod el
Ġcomplement ing
Ġcomplement arity
Ġbio en
Ġlength y
ĠReg ion
Ġple omorphic
Ġreason ed
comp etent
Ġpy rid
Ġretro virally
133 1852
Ġinterf ered
cho ice
DLI s
Ġvolun t
Ġfil ter
ĠInt ensification
Ġmess ages
VP X
ĠSh h
ĠCor p
Ġinnov ations
Ġpresum ptive
Ġintercal ators
enh ancing
ĠPost remission
ĠSN RPN
ĠDel etions
GE O
Ġcompens ated
Ġpenet rant
Ġsero logy
Ġenrol ling
Ġcoord inate
eral dehyde
quin oline
nec rosis
Tc R
ĠPEG ylated
Ġrepur posed
BR CA
Ġoper ator
ĠAPA AP
Ġphyt ochemical
Ġvehic les
ĠBN ML
Ġport ends
AZ C
Ser um
ĠNan og
ĠCompound s
ĠCal if
ĠTel omerase
ĠAURK B
Ġbig gest
Ġded ifferentiation
ĠCorresponding ly
Reg ulatory
ĠTax ol
Ġhypoth al
ĠMex ico
ĠEstabl ishing
ĠIkappaB alpha
Ġpow der
Ġnaphtho l
Ġadvis able
Ġconfound ed
Ġfacet s
Ġdeter gent
Ġrecycl ing
dehyd es
01347 996
B enzene
D OK
P OT
S KI
T B
T AL
V BL
a resis
d osing
m bilical
p hed
t us
z he
z otinib
Ġ ),
in ol
Ġt actic
on asal
Ġc tDNA
Ġp enicillin
it inase
ar minomycin
at ri
os al
Ġh im
ĠA ur
ĠA CC
ML C
ot ax
ĠC ebpa
ho red
Ġis omers
ran ucle
op rol
ĠI k
gn itive
ĠP aired
anc hored
Ġcl ast
ĠB W
ĠD ip
Ġun restricted
der ma
pro tection
pro fil
Ġco uple
Ġanti estrogen
pon atinib
ĠG NF
ĠG add
oun ter
Ġag ric
rac yt
Ġ4 98
Ġpo ised
ĠL ck
and utinib
Ġmod al
Ġnon cytotoxic
Ġ8 226
Ġinter group
Ġallo immunization
Ġprov es
av idity
Ġsecond arily
Ġnum b
Ġimp eding
ĠV max
12 45
Ġop erated
Ġran ked
ma de
ĠML PA
ĠAs III
ĠCI s
Ġthromb ohemorrhagic
ĠRec ommend
BM A
BM FS
eric ardi
ĠCT GF
90 3
Ġelev ate
IP I
Ġhyper coagul
ĠCon nec
Ġcal or
Ġ23 9
ĠPB A
ĠPB OX
28 9
Ġ36 1
rup ting
Ġexpl os
Ġangi o
Ġrever sibly
Ġtopo isomer
Ġtra it
Ġcheck ed
Ġstress ors
79 7
ĠNot withstanding
ĠPT R
ĠPT LD
Ġrepro duce
Ġnine teen
oles cents
94 19
Ġturn around
ĠInhib iting
Ġpy rim
Ġabrog ating
ĠAc id
Ġbackground s
Ġequal ed
Ġhomo zygotes
ĠAg N
ĠSD Z
deple ting
Ġtransm igration
Ġneur on
Ġfat her
aro tomy
201 3
Ġcomb s
Co R
hyd rolase
ĠTG N
Ġdeoxynucle oside
ĠPF KFB
ĠBlas tic
ĠPar allel
De termination
Ġdihydro folate
145 12
odeoxy glucose
che ckpoint
Ġproceed s
Ġresol ving
Ġjud g
iment ation
ĠLab or
ĠEvalu ating
Ġhaemorrh agic
Ġflex ibility
Ġket oconazole
rophyl axis
ruit ment
Ġradios ensitivity
Ġchondro cytes
Ġpolyphen ol
Ġculmin ating
Tel omerase
Ġdisper sed
roma gnetic
Ġbiotin ylated
Zn PP
Ġads orption
Ġarrhyth mias
599 1
multi drug
Ġhippocamp us
ĠGe otrichum
ĠRich ter
Ann V
polar ized
Ġtrun k
1245 9419
4 16
5 34
5 18
5 92
7 05
E ll
H HV
L CL
M elanoma
M esenchymal
O SCC
P AC
S ox
T BK
a gen
a GvHD
b es
g rafting
h and
h air
v an
Ġt alk
Ġc rest
Ġo range
Ġs ent
Ġs ession
an der
it ter
Ġd Thd
er cept
ic acy
ic oll
Ġf oscarnet
Ġb at
Ġh y
em itting
Ġn i
Ġn t
ĠA IF
ĠT ur
ĠT est
ĠT AF
ĠT HU
ĠC ST
ĠC GM
ac ial
Ġex ocytosis
Ġl ens
ran os
ver ting
ĠM CD
ĠM AS
Ġbe ad
ud d
ĠH ct
ĠH NE
ĠH aem
ĠP RD
ĠP erm
ĠP ublished
ĠB z
ap eptide
Ġun specified
log ram
ĠF AN
ĠS KI
ĠW y
one ph
Ġanti malarial
ĠR EC
ĠN um
ĠN ER
Ġ5 25
ost aining
di hydroxy
ĠO RF
Ġhem odialysis
Ġlym phed
ult ural
ĠK ITD
mon ocytes
Ġaddition s
Ġimp recise
LA As
ĠJ I
omet hylation
ĠV L
Ġiniti ator
Ġiniti atives
33 6
Ġol fact
ĠPh arma
ĠII A
ĠII b
Ġgranul omonocytic
com parative
Ġprob ed
Ġret reatment
Ab out
ans ine
ura bility
ek ing
Ġ25 7
Ġu veal
NK p
Ch an
ĠAmong st
IM F
Ġ28 91
Ġreduc tases
Ġpan myeloid
ĠPro ject
Ġwhite s
Ġfacil ities
Ġampl ifying
alf a
Ġregression s
ĠTrans fusion
200 4
Cd k
68 2
ĠDec tin
Ġinfiltr ations
49 3
49 24
AN DA
ereb rospinal
Ġconver gent
Ġdistinguish able
ĠRel atively
Ġcereb ro
ĠReg ular
ĠReg ister
Ġcarb ox
Ġresid ential
MC yR
008 99
Ġhypox anthine
ĠMon ocytic
be henoyl
Ġarter itis
ĠRespon ders
Ġoccup ied
Ġhomolog s
ĠAM V
Ġmil k
Ġconce ived
eff icacy
ĠLong itud
Ġcoll apse
Se ven
011 989
ĠMi HA
ĠLe uc
ĠDel ayed
ĠTG I
ĠInf ectious
Ġpass enger
Ġcoexist ent
Ġcounte racting
Ġfo etal
Ġsubdiv ision
Ġknow ing
Ġchron ologic
AI DS
Ġgamm adelta
Identif ying
perm e
Ġtable t
Ġsemiqu inone
Ġket one
SET D
Ġfores e
knock down
Ele ven
Ġtrop ical
Ġsevent h
ĠMex ican
auc her
ĠBK M
Ġsemin oma
Ġlaun ched
Ġende avor
Ġheparan ase
Ġmesenter ic
Ġattend ant
iet ins
Ġafflic ted
Lim ited
Ġillum inated
emet rexed
Ġpress ures
zhe imer
Ġexplos ion
Ġlymphed ema
ĠLongitud inal
) %,
5 000
A ge
C al
D U
E ORTC
H AT
L ineage
M uc
N SC
S ALL
T es
Z E
a um
a ise
d g
d uration
m im
n ithine
t le
u PAR
Ġ %;
Ġt MN
Ġs ulindac
Ġd NTP
es ophageal
Ġb if
Ġto uch
os ted
ul ous
Ġh ands
ĠT or
ĠC as
ig o
Ġis omerase
ĠM ast
ĠM elphalan
ĠM OPP
ol k
rom olar
Ġal ike
od on
ĠH ydro
ĠH NK
ĠP OT
ĠB el
ĠB PA
ĠB usulfan
am a
ge rous
Ġcomp etence
Ġcomp assionate
Ġun infected
ĠS ir
Ġmar gin
Ġco bal
Ġper ianal
Ġmet ab
Ġ4 80
Ġ0 13
ĠL U
ĠL CN
Ġmal aise
Ġlympho plasm
str atin
Ġbi ochemically
osi um
34 5
Ġinter laboratory
ĠU SF
Ġfe aturing
11 248
min i
Ġour s
Ġcar n
Ġcar go
Ġcar nit
spec t
Ġconf ron
ĠV NTR
AT F
AT R
ĠThere by
Ġ20 3
Ġav id
PA GE
ĠAn y
ters titial
ons titution
Ġmetabol omic
ĠIm paired
Ġprote omes
ull ar
ĠRec overy
Ġpharmac o
Ġisol ating
lob ase
cal icheamicin
plo ying
Ġphosphor ylate
ai re
ulin ic
PD L
Ġdispl acement
Ġhyper plastic
AF P
Ġ33 1
raph ic
ĠPR IMA
ov aqu
Ġfib r
feren tially
Ġtel angiectasia
effec tor
66 3
ĠAL P
Ġmeth anol
Ġindex es
Ġcorresponding ly
ĠOr bital
Ġglut amic
Ġbio activity
Ġspect roscopic
Ġur ic
Ġpain ting
Ġcleav es
ĠDe termining
ĠRAR B
ĠCAL CRL
ĠMed line
Ġclassif iers
ĠAR G
Ġfit ting
Ġinterven ing
ĠMon ocytes
Leuk aemia
ped ia
Ġcytos ines
Ġassum ing
Ġarg uing
Ġfollic les
ĠFox o
Ġscal p
ĠAss ociated
Ġdil uted
egakary ocytic
Ġbu falin
Ġneph ropathy
Ġpent raxin
Ġcul tivated
ĠMn SOD
Ġras hes
intoler ance
Ġshap ing
FT I
Ġov aries
ophosphate mia
orn ia
Ġdras tic
Ġce phal
ĠEG IL
ĠCan adian
Ġhor se
Ġretrie val
Ġrevert ants
ĠLnc RNAs
Ġmicrovess els
Ġhypog ranular
ĠPt d
Ġfem ur
cyclo pedia
Ġoct ogen
Ġharness ing
Ġoutper formed
Ġfoot printing
Ġpropos als
Tn T
Ġanticoagul ants
Ġoligos accharides
Ġcast ration
Bl ack
Ġdestabil ization
Ġcapit atum
ĠPle ural
eryth rin
ĠSuper Gen
Ġvigor ous
Ġdan gerous
ĠSympt oms
ashing ton
Ġcob blestone
Ġconstell ation
Ġredund ancy
acces sible
accharom yces
Ġthermod ynamic
Ġsat urable
Ġheterolog ous
Ġtopoisomer ases
ovaqu one
0 62
5 178
8 24
B as
H SA
K ras
S okal
U K
c RA
f ant
f ications
i omy
i NOS
n iche
p eptidase
s ential
Ġa racyt
Ġt rib
Ġt iazofurin
re gression
Ġc upl
Ġs ing
Ġm EFS
er idis
ar rays
Ġf ingers
Ġb ank
Ġh ous
Ġn ight
ĠA ST
im ustine
ib inin
Ġcon tig
ĠM NK
ĠM AF
Ġch a
Ġch ordoma
ĠH ost
ĠH SF
ĠP ME
ĠP EP
ĠB lo
Ġr AML
am es
ge vity
yp t
yp tic
ĠD B
ĠD ysregulation
ĠF ib
ĠF gf
ĠS ex
ĠS unitinib
Ġsur m
ĠW t
ĠW ashington
Ġass isting
ĠN PT
Ġsignific ances
ĠO P
ĠO FA
Ġimmun ode
ĠG o
ĠG ES
ĠG emcitabine
ĠE ud
ĠE me
ros ing
end it
ast ases
Ġexp endit
Ġsug ars
Ġ7 50
Ġdec alc
Ġnon receptor
enc ement
ĠU TR
Ġfe eding
Ġra w
Ġhyp h
ĠAl a
CT R
ĠCR PC
ten one
IT P
Ġcol loid
Ġref erences
Ġda iry
53 1
Ġend osomes
ocyt osine
Ġav ian
vo ked
Ġder an
Ġcytomet rically
Ġindividual ization
AL P
AL CL
23 6
ind uce
AP ML
05 98
amm aglobulin
Ġheterogeneous ly
Ġtranscript omics
ĠCN E
Ġconcentr ates
Ġcirc ulate
Ġcirc HIPK
Ġimm igration
Ġaggres sively
Ġsil ica
Ġdam p
ĠPB S
iab les
ĠCyt openia
Ġcardi ologists
Ġ45 2
rup lex
65 2
urviv ors
Ġatt ract
Ġcalc ulating
CF Cs
ara ffin
me as
Ġoste o
ĠSim ple
ĠPI G
117 619
ĠGen eral
Ġtem sirolimus
ĠHD D
MY ADM
ĠEn cyclopedia
ĠMYC BP
Ġrepl en
Ġcop ing
Ġtop ological
ĠPer cent
educ ational
Ġinstit utes
deoxy glucose
Ġscal able
Ġwt CEBPA
random ized
Ġcoinc iding
ĠHN RNPK
ĠImpro ving
Ġsinus es
ĠGl n
ĠAu SCT
mor pholin
450 9706
fl av
ĠPN s
ĠSS ST
Ġjuxt ap
Ġlap arotomy
Ġdict ated
MI BI
Ġfulfill ing
Ġborder s
Ġpi ec
Ġinterrog ate
Ġtrap ped
Ġanch or
Ġmigr ated
Ġboost ing
Ġrepress ors
ĠSte ady
sus cepti
role um
Ġki logram
ĠHSA NPs
Ġseiz ure
Inte ractions
Ġpet roleum
Ġmacrom olecular
Sh ort
Thromb ocytopenia
Ġnos ocomial
Ġds RNA
ingol imod
contin uation
VII a
ĠTAR GET
Ġsuspend ed
Ġnotor iously
Ġfab ric
Ġreconsid ered
phost in
Ġinhab it
Ter minal
Ġnc RNAs
ĠSYN CRIP
ĠRecommend ations
ANDA RD
Ġlymphoplasm acytic
Ġcupl ike
eridis tim
0598 72
117619 22
) (+)
2 95
3 139
4 20
4 38
4 65
4 68
A f
C CI
F os
G ITR
M CP
P las
R G
R ev
R CTs
S or
S AR
a rol
d b
h ENT
i ents
m CR
m idostaurin
n oid
Ġ ix
Ġa joene
Ġt ip
Ġt ong
Ġt igecycline
on fer
Ġc lot
Ġc icl
Ġc dc
Ġs MDS
Ġan k
or osis
as er
it ations
Ġd ors
Ġre ally
Ġre initi
ar ub
Ġf rizzled
id a
id ene
os ystem
ra CT
ĠA PMF
ĠT DM
Ġpro carbazine
ML R
ML V
si zing
ot ally
ĠC AD
ĠC alc
ĠC isplatin
et ting
ĠM ith
ĠM ill
ĠM ach
ĠM embrane
ĠM ZL
Ġde form
Ġde aling
Ġde part
od aunorubicin
od iaz
ĠH MBA
st aining
ĠD EC
ĠIn dependent
ĠF li
ĠF OS
ĠS oluble
ĠW right
pro ic
Ġ3 27
ome obox
Ġanti de
Ġanti mon
ĠR ob
ĠR LS
ron i
ren al
ĠO ste
ĠO Rs
Ġhem oblast
Ġsub telomeric
ĠE AC
ĠE GT
ox al
CR M
Ġafter wards
ĠL NA
Ġcons tip
Ġro tenone
Ġpl aces
Ġman ual
ĠU BE
CD Ks
ĠAl zheimer
jor ative
ym ot
Ġmicro vesicles
Ġaut och
(+) ).
Ġblast oid
Ġ[ <
Ġmyel otoxic
ĠMP B
activ ators
27 36
tis ol
oprotein s
Ġphosphor othioate
Ġfive fold
Ġhaemat ologists
Ch k
ĠRes piratory
app earing
Ġ28 9
Ġprophyl actically
ĠCon jug
29 6
Ġdu od
ĠPro filing
ĠIM iD
Ġsummar ises
Ġpoly valent
Ġven a
Ġsol ani
Ġpredomin ate
ob acillus
77 7
Ġeosinophil ias
Ġold est
Ġpe jorative
Ġtransfer ring
struc tive
ĠRe as
Ġspect acular
Ġrib ose
Ġelectro static
Ġbil ineage
Ġrevolution ize
NT s
Ġvis its
Ġcataly tically
ĠHist ology
Ġcooper ativity
Ġmuta genicity
ople x
ĠKn own
Ġfil m
Ġassum es
BA X
Ġbac illi
Ġarch ival
ĠCO AP
HN s
Ġencaps ulating
Ġhyd rophilic
Ġnecessit ated
Ġsero logical
oxyl in
Ġsegreg ate
Ġimmunost ained
ĠCandid ate
Ġreconstit ute
Ġlon gevity
Ġhex am
Ġchaper ones
ĠDT X
assess ed
Ġchima eric
Ġauthor ities
Ġheral ds
Ġcontras ted
Ġsaliv a
ĠSw iss
Ġfum ig
ĠFU BP
ĠRecogn izing
Chem o
Ġanthrac enedione
Ġshutt le
ĠDD IT
ĠYB X
ĠPrim ing
Ġthick ening
Ġtur ning
Ġmonke ys
Ġmix ing
grad able
ĠPRK CH
Mu LV
ĠChemo resistance
Ġglucuron idation
Ġdiac etate
Ġsin onasal
ĠOp tim
ĠPort ug
Ġtach ycardia
Ġseques tered
Ġinterrel ationship
ĠInsigh ts
Ġhypogonad ism
Ġfronti er
hodomycin one
ophthalm itis
ĠOrg anis
ĠCalif ornia
Ġderan ged
Ġtong ue
onfer roni
Ġcicl osporin
Ġconstip ation
2736 100
. ;
/ +</
4 25
4 055
9 11
< .
C MPD
D aunoXome
E AT
G em
I BD
J M
M ZF
N ormal
c re
c ure
d ichlor
i LRP
m B
p tively
w ich
in activating
ti a
on os
Ġc Kit
Ġc lock
Ġo u
Ġo titis
Ġs pro
al m
ent a
le th
os ely
Ġh orses
Ġn elarabine
ĠT AN
ĠC entre
ig gering
op ulmonary
op eptides
ĠM ature
ol ia
pl ates
rom eg
ist ar
ist ronic
ĠD iseases
Ġne opterin
Ġun transformed
Ġun mas
ĠF in
ĠS NA
ĠS EC
Ġcyt ochemically
der mal
Ġat om
Ġmo tivated
Ġsurviv es
yl ic
Ġ3 19
ĠR X
Ġassoci ating
Ġsyn ap
Ġpar athyroid
Ġprom isc
Ġbi ol
Ġnon in
Ġnon complex
ple mented
Ġmedi ation
ens or
Ġhyp ophosphatemia
Ġdisc ordance
Ġsc r
Ġam ide
ĠV AP
Ġperform s
press ants
Ġy olk
ex pected
PL D
Ġgranul ocyt
com partment
Ġthromb o
atele ts
IC H
IS GDSPV
ĠLeuk em
gra des
CN T
ĠST S
Ch imeric
Ġinfusion al
PD GF
29 71
Ġdam ages
Ġmel ars
acet amide
FU S
Ġmelan ocytes
57 148
ĠER CC
Ġlabor ious
erox amine
ĠAS M
Ph armac
Ġ37 9
ĠHR s
ĠPre incubation
Ġprogram mes
Ġelect romagnetic
most ly
PC a
Ġextrem ity
Ġauto HCT
Ġdaunomycin one
TK s
Ġfl ight
ĠMC yR
ĠDS Bs
ĠReg imen
Ġpy rexia
ĠAC SL
Ġbil ineal
Ġfluid ity
tox in
ĠMK N
Ġring s
polym er
ĠMolecular ly
Ġload s
Ig M
ĠLym ph
201 2
Ġvul var
Ġpathogenetic ally
Ġreticul ocytes
ĠUp regulated
Ġte eth
%] ).
ĠDiagnos es
Ġsurvey ed
ĠStandard ized
Ġundersc ored
Ġquin ine
ĠSL IT
ĠNT SR
Ġana erobic
Ġshap ed
ĠMyc obacterium
Ġec ulizumab
Ġscaven ging
Ġlon afarnib
Ġdiver gence
Ġnorm ocellular
Ġinfer tility
Ġawa it
-[ (
sulf amethoxazole
PBP Cs
earrang ement
chloro quine
ĠGA DS
Ġcontraind icated
Ġpun ct
enog raft
ĠAustral asian
ĠIntegr ative
Ġazanucle oside
Ġequip ped
Ġbin der
Ġastrocyt omas
Ġscarc ity
imb urs
Ġingred ients
Ġmetastas ize
Ġinconsist encies
ĠPneum ocystis
Ġforth coming
Ġspac er
Ġpolyke tide
oreg ional
Ġdysmyelo poiesis
terpen oid
ĠUs ually
Ġintract able
Ġintroduc es
Ġcram ps
ĠBub R
ĠLabor atories
ĠWy eth
ymot rypsin
romeg aly
3 11
8 31
C ox
F VIIa
M ap
P LT
P HA
R and
S econd
V CAM
c umulative
d F
e tel
f orin
g all
k y
p rone
p DCs
r at
r itin
t k
v ariable
z o
z one
Ġc lots
Ġc fDNA
Ġc elecoxib
Ġp acritinib
Ġs and
Ġm ating
Ġan cho
el a
as te
Ġd min
Ġd UTP
ic ul
ate rials
ec utive
ĠA CL
ĠA IM
ĠA berrations
si g
ĠC orporation
ac ogen
Ġwas te
op a
op eptide
oc ine
rom osomal
ĠH ID
ĠP ir
ĠP LA
ĠP SA
Ġtrans ducing
ĠB acillus
Ġ2 22
ap hyl
ĠD MN
ĠIn jection
ĠS BP
ĠS HA
Ġcyt ochalasin
por ters
ĠW istar
yl in
00 13
Ġ3 30
Ġanti thrombin
Ġev oke
Ġ5 40
di opathic
ĠG lyc
ĠG CA
ĠE MS
Ġ4 30
rel ation
ĠL ine
ĠL AL
Ġ6 70
Ġsyn apse
Ġdec om
Ġnon remission
Ġcor tisol
ven ted
Ġel uted
ill a
ch ond
ch ymal
ĠU PS
ĠU PN
tern ational
fer ritin
Ġsc ram
Ġimp etus
Ġdef enses
ath min
ĠV EN
Ġsh rinkage
Ġiniti ative
hes us
19 1
Ġav ascular
38 9
In termediate
Ġthromb omodulin
Ġradi ograph
ĠCh ain
ĠMP FC
(- /-
ĠSt arting
HR QoL
activ ate
Ġeng aging
BP s
aren chymal
DA F
Ġgu ides
ĠRes cue
Ġelev ating
Ġanalog y
ĠCl ostrid
Ġ27 9
Ġlen ograstim
Ġlocal isation
Ġsummar ise
Ġgast rectomy
ĠIFN gamma
ĠAS S
ĠSTAT s
86 6
Ġrestric tions
nc RNA
rosc ovitine
Ġ44 7
Ġdep rived
AS H
ĠMM oR
ĠIT GA
Ġsl ide
ĠReg ulation
Ġsurve ys
Ġassign ing
Ġchlor amphenicol
Es sential
ĠNe utral
ĠSystem atic
ĠCAR s
inhib ited
yr yl
ĠMK W
Ġrepl ating
Ġvis c
Ad o
SM X
Pro te
Ġcircum vented
Ġcomm encing
HSP s
Ġseg mented
Co lorectal
ĠInf ants
ĠExt ra
eng aging
ĠPub med
valu es
Ġye asts
hex yl
Ġseptic aemia
ĠRho H
Ġaccom mod
ĠMal e
Ġrefer ring
Ġmatur ity
ĠSel ecting
tral ine
evalu ated
ĠMit ochondrial
Ġhypocellular ity
ĠStatis tically
Ġpermeabil ized
lyce ro
chloro ethyl
ĠNeutrophil s
Ġdot s
ĠGal ectin
FOX P
Ġchip s
chim erism
Ġgonad al
ĠLact obacillus
ĠRadio immunotherapy
Ġhapp ens
Chi ari
ĠRetro viral
Ġredi recting
compl iance
Ġvib s
Ġraf ts
Ġautoch th
Ġfumig atus
Rand omized
Ġancho red
' ).
5 88
: :
A CR
D OT
D QB
D PMNs
G u
G LI
G MPs
H PR
H MMR
K a
L PC
N CAM
P GE
R ho
T CA
V DR
a ver
d istance
f atigue
f ocused
h il
m ix
m enopausal
s ystemic
Ġ ).
in ning
Ġt ension
re view
on an
on ding
Ġin timate
Ġs s
Ġs on
Ġs atisfact
Ġs TNF
Ġw ard
or ily
el uting
as an
it rop
ed ema
Ġb FGF
ĠT g
ĠT eff
ot rophic
Ġex ant
Ġst ated
op sies
ĠM ild
Ġim pression
ĠAML profil
ab elson
ĠH BsAg
ĠP OL
am ivudine
Ġcomp ositions
ĠD PP
ĠD VPX
Ġne arby
Ġun responsiveness
ĠF G
ĠF und
ĠS LL
ĠS uv
ĠW al
ow ing
Ġass urance
AML CG
00 005
Ġco iled
Ġco factors
ĠN umb
Ġper tain
cl av
Ġhem ogram
Ġint ui
ĠG iemsa
Ġsub mission
ĠE PI
ox azole
Ġhemat odermic
Ġout weigh
rel apsing
ĠTh anks
cy ano
ad ult
we ed
ast hen
Ġpar ty
Ġdem anding
ct b
Ġnon response
ogen omic
Ġar temis
oplas ty
01 74
tern berg
Ġsc in
21 64
Ġmicro transplantation
ne edle
12 96
crib e
ex trinsic
22 7
Ġpost operatively
17 21
jec tives
PA D
Ġmit ozantrone
ĠMRD Cons
Ġthromb oses
Ġprote ogenomics
ĠOn col
ĠAra CTP
Ġ40 8
27 1
Ġcirc PAN
ĠX I
Ġsil ences
CP s
Ġreduc tive
Ġpoly glutam
LI NC
oper ating
ov orin
Ġtoler ant
Ġtra ined
ob arb
rosc opically
ĠPre p
Ġcategor ize
Ġ56 37
Ġhaplo id
rh IL
ĠImmun ostaining
ĠAL X
ĠMR S
ĠBC S
Ġolig oblastic
adi p
ĠCH M
Ġfl ubendazole
OD E
Cyt omegalovirus
Ġmicrosc opically
DM APE
ĠRAR G
Ġmodif iable
ĠBi ol
ĠHox B
ĠTF F
ĠAz acytidine
ĠPo lycythemia
Ġeth ical
Ġent hal
ĠEP Cs
Ġgran ulation
Ġgel onin
ĠIK K
ĠNCT U
Ġarg um
nes ota
ĠRisk s
mm aya
oster one
Ġquin idine
dem ethylating
ĠMin nesota
Mon osomy
asi tic
Hyp ermethylation
ĠCommon ly
ĠSV T
escal ated
Ġulc eration
neu ropathy
idaz o
Ġquestionnai res
Ġmorpho genesis
Ġverteb rate
ĠLo Vo
Ġworkflow s
Differen tial
lipid emia
Ġfetus es
umines cent
Ġchemopre vention
Ġexec ution
oplasm osis
DLT s
ĠLig and
Ġtript onide
Ġammon ia
Ġgins eng
Ġequival ents
ĠRam an
Ġsubm andibular
Ġmicrodiss ection
ĠPep E
Effec tive
ocor tical
ĠFil grastim
ĠQual ity
Ġreadout s
Ġbioph ysical
she ll
ĠCen ters
ĠDig ital
Ġfaith fully
trifluoro acetyl
ĠImmunocyt ochemical
Ġretroper itoneal
Ġarrang ement
Ġtactic s
Chan ges
Ġcarn osic
Ġinhabit ants
ĠOrganis ation
etel stat
Ġsatisfact orily
ĠAMLprofil er
Ġintui tively
" -
3 60
A SC
B W
E SC
E ven
G rowth
H MT
H ispan
M OL
P t
S LL
S ch
S ES
S iglec
W H
W hether
Y L
f uran
g ers
h igher
i vers
l ance
o P
p p
r hodomycinone
y er
Ġ ell
Ġa leukemic
Ġt andutinib
en yl
Ġp B
Ġw ant
al t
an king
it ant
ic entric
le ading
ar ter
id ases
em ergence
Ġn C
ĠA H
ĠA si
ĠA rea
us sus
ot anshinone
un fit
se p
Ġl ib
ĠI RM
ĠI PI
ĠM aternal
Ġg ar
Ġdis ordered
Ġor nithine
Ġv igil
ĠH BC
ĠP ap
ĠP RA
ĠB ro
ĠB ac
Ġ2 18
ain s
Ġcomp action
ist ence
ĠIn duced
ĠIn nov
ĠF rag
Ġass istance
Ġat ovaquone
pro tocol
00 11
Ġ3 24
ĠN m
Ġmon omeric
ormal dehyde
rac ranial
ĠE very
ĠL m
ĠL Cs
ĠL NK
hen e
Ġpat ents
Ġcons ent
Ġcons ervation
LL C
Ġdec lining
Ġnormal ised
ĠK YN
Ġprov oke
ber ine
Ġsecond ly
Ġme rop
Ġmicro particles
ath rin
+) ](
Ġser traline
HD MP
Ġinfec tive
PL GA
PA I
DH A
EB L
Ġ30 8
Ġbenefit ting
Ġerythro leukaemia
of lav
CN V
Ġins tig
cyt ochemical
Ġi PS
mit ting
Ġcle ave
70 7
Ġglyc olipid
pri ately
Ġpoly neuropathy
Ġcardi oprotect
28 8
99 4
Ġdiscontinu ations
Ġeight y
opatho logical
Ġrestric ts
ĠQ RT
Ġampl itude
Ġ37 2
Ġneuro t
Ġmat ches
Ġvascular ity
ĠPT H
ĠBA VC
sel ection
Ġclos ure
AN T
ĠSub optimal
MM M
EG R
Ġpersonal ised
Ġrh EPO
ĠCAL CA
Ġasc itic
hol ate
Ġaccept ance
ĠAc tivated
ĠSp ain
ĠHist amine
Ġdig oxin
ĠDL D
Ġdist orted
ĠInter fant
ĠBR CC
Ġresemb lance
201 4
Ep ithelial
Ġphosphatidyl choline
ĠSN Vs
Ġtrunc ation
ĠExt racellular
ĠPres ented
Ġrepop ulate
ĠEl acytarabine
SI RT
ĠNO AC
Ġempir ically
ohyd rate
600 125
Ġdiscrimin atory
ĠLip osomes
evalu able
ĠSy rian
Ġacetyl transferases
ĠAfric a
Ġsynchron ization
ĠHem e
ĠTOP K
tig raphy
ĠWil m
Ġnephro toxic
keep ing
Ġpath s
Ġcontraind ications
exp anded
Ġbypass ing
ĠRBP s
hl itis
Ġintram uscular
ournal s
ker atosis
ĠProb ability
Ġsubstitu ents
ĠPathw ay
ĠBle eding
Anal ysis
ithi ocarb
Ġeyel id
Ġcurren ts
Ġhyperleuc ocytosis
onos etron
Ġautochth onous
ĠAsi ans
ussus ception
Ġmerop enem
0 74
C onc
E MD
F CR
F LI
K n
M MF
M dm
N ational
N IL
O A
O ral
O varian
P he
P CL
P PA
R gamma
S Y
S IG
b led
b reast
c n
d iab
h ttp
k ary
n u
n at
p ig
p yr
r ub
r atic
v ul
z olid
Ġa qu
re verse
ti gu
Ġc all
Ġm DC
Ġthe ta
Ġand rographolide
Ġf aint
Ġb ott
os clerosis
ith ium
em ulsion
ĠT aspase
us sion
im idazole
Ġle ver
ML P
ot s
elo id
ac ted
ho lic
Ġmyelo blastoma
ĠI NF
um p
ol ateral
od eling
Ġv iol
ĠH s
ĠP LL
ĠP MP
ĠP CI
Ġr icin
qu il
ĠD op
ĠD PB
ĠF LC
ĠS an
Ġcyt od
ph rine
Ġmo vement
Ġmo uth
Ġap ex
iff use
Ġco existed
Ġwh atever
ĠN EP
ĠO N
Ġhem odynamic
Ġse rop
lec ted
ĠG rowing
Ġsub verted
ĠE DS
Ġpo orest
Ġcons picuous
ĠCML s
Ġpar alog
Ġpl aque
AB CC
ĠU NC
ric tion
Ġgrow s
tern ative
min o
min ute
KI I
atic s
Ġkn ockin
til b
ĠV ZV
az op
az omib
Ġ. </
Ġem etine
Ġwill ing
Ġinfec t
Ġend osteal
Ġend ophthalmitis
Ġcolon ized
Ġprovid er
In ternational
ĠBM SC
ĠIm C
ĠIm aging
Ġ24 2
Ġ24 9
Ġpur ge
Ġsaf role
Ġpharmac ogenomics
BM F
30 8
respon ses
con ventional
MA A
Ġreal ize
ĠCon ference
IR ES
ĠPro genitor
CG CG
Ġ26 9
per sed
ĠCyt os
rec urrence
Ġ34 9
ob ut
Ġcruc ially
Ġact ors
Ġdiv ides
Ġemb olization
Ġnan ocomp
Ġill umin
Ġpa rest
mod ulin
Ġtem pered
Ġoxygen ation
Cyt okine
Ġmis localization
ĠCTL p
Me asurable
ĠRAEB t
Ġleuc openia
ĠSp i
Ad ditional
ĠGr MDSC
IAP s
ĠPer haps
Ġtub es
ĠCG I
ĠCG RP
ĠSD FA
Ġgel danamycin
Ġconce iv
ĠIR IS
alk ylating
chrom atic
aro x
anth rac
week s
ĠPharmac odynamic
ĠMi HAs
hyd razine
ĠFC MRD
Hemat opoiesis
ĠArg inase
py rid
ĠMod ulation
Ġden oted
Ġjusti fication
ĠDH X
Ġpericardi um
Aut o
Ġstrept avidin
ĠMac rophages
Ġrheum atic
Ġreplic ating
sulf oxide
Ġchond rosarcoma
Ġsolub il
Ġgangli oside
Ġmorpho genetic
ĠBrdU rd
Ġinput s
diphenyl tetrazolium
ĠLE AP
Ġmacrom olecules
Ġsubcateg ories
Ġagglut ination
ss ential
Ġhouse keeping
Ġaggra vated
Ġechinocand ins
ĠLAT S
ĠRan GAP
antit rypsin
ĠRetin oic
pot enti
Ġnanocarri er
Ġepiderm is
Ġcoordin ately
intercal ating
Ġpractition ers
ĠFed eral
Retin oic
Sequ ential
opap ular
Ġtetras omy
ĠMAS Q
Ġhyph ae
Ġix azomib
5 01
A v
C SP
C lass
D n
E ST
F PD
G lyc
G fi
I CD
K m
L o
M Ab
O RD
P CT
P NP
P lasma
R ed
R ib
S yn
S AK
T umour
T oll
a a
d ideoxy
g a
h a
i res
l ambda
m elo
r ical
t os
t yp
t ric
y oto
Ġa head
in active
Ġt ags
Ġc M
Ġc ance
Ġm OS
Ġan ergy
Ġan aphyl
al ed
ro genesis
el ev
it ative
Ġd GTP
ed iting
ic ting
ic ating
Ġre viv
ar geting
Ġb omb
Ġb eside
Ġwith st
ra x
Ġn arr
ĠA GS
Ġle iomy
lo dipine
ce tes
Ġleukem ogenicity
Ġres ur
Ġst ation
Ġst ory
Ġwas hed
op urines
ĠM ID
oc entric
ab ain
ĠH isti
gn ancy
red undant
ĠB rom
ĠB rief
ĠB ORIS
Ġ2 23
qu ad
Ġun published
ĠF ree
ĠF ADD
ĠS plic
ĠS odium
ph asis
yl lium
Ġwe aken
Ġco enzyme
Ġanti folate
ĠR V
ĠR at
Ġrem ed
ĠN LR
Ġen vision
ĠG AGE
ĠTh om
Ġbut hionine
opo ietins
Ġspec trat
Ġbi ode
Ġnon immun
34 6
ag ers
Ġel astic
oplas tin
Ġdes min
Ġsec ure
og le
Ġme flo
Ġmicro circ
Ġdef eroxamine
trans located
ĠV is
ĠV UD
Ġref usal
ex c
Ġhetero zygotes
ĠmiR N
oph ospho
rop y
Ġloc oregional
ĠAB VD
Ġprob and
Ġ50 5
RP PA
Ġ25 5
Ġaz ide
ĠCT CL
DA s
Ġstruct ured
Ġretin a
Ġutil ised
Ġhyper cho
Ġhyper phosphorylation
80 3
Ġmuc oc
bil iary
Ġrecommend s
Ġsuff ers
CG I
Ġlen gthen
Ġ29 7
ĠCyt ochrome
ĠER alpha
Ġpoly acrylamide
28 1
28 91
Ġsal ient
ĠDC F
lor oma
Ġtyp ed
Ġelucid ates
glyc osylation
ĠME N
Ġsuscepti bilities
ĠInte ractions
ĠQ ues
ĠZ f
ĠTrans lation
ĠTrans well
ĠPre parative
54 2
ĠPA NC
inte gr
sign ificantly
Ġsubc lassified
Ġcore pressors
ĠGen omes
RAR a
Ġhemoglobin opathies
Ġten der
Ġvaccin ated
ofuranosyl cytosine
Ġradio iod
Ad ministration
Ġtub ule
Ġdiscover ing
Ġimmunore ceptor
ĠLA IR
Ġsensitiz er
Ġmach ines
ĠSh b
Ġmanip ulated
Ġarg ues
Ġfinger print
Ġprojec ts
ĠWh atever
ĠAI EOP
ĠCycl osporine
Ġann ounced
neg ativity
oplatin um
pan obinostat
ĠMyelo fibrosis
ĠBL U
MMP s
143 6032
Ġ(- )-
Nucle ar
Ġandrogen s
ĠRever sible
ĠHC Cs
acc ording
Ġreconstit uting
Drug s
ĠFe brile
Po or
ĠEpidemi ologic
MI BG
Ġce ased
Ġhind lim
ĠLP Cs
Ġheterochrom atic
istingu ishing
Ġmanufact ured
Ġpharmacogenetic s
Ġseek ing
Ġaglyc ones
Ġautotrans plant
Ġprostagland ins
Ġneu rosp
Ġelabor ated
glucuron idase
ĠEstabl ished
PTP N
Ġheterodim ers
Ġcircuit ry
Ġamph iph
Ġstri ve
Ġchori ocarcinoma
ishman ia
penet rating
Ġventric le
Ġextern ally
Ġneurofibrom atosis
Ġhydroxycarb amide
yco erythrin
Ġcholest atic
Ġmacul opapular
ĠRhe b
Ġtetr asp
Ġphytochemical s
ĠEud raCT
Ġmelars oprol
melo xif
Ġnarr ative
Ġmeflo quine
' )-
3 50
5 90
A KI
B SO
D ys
H QPA
N MR
T MD
T dt
c ement
d endritic
e ter
e ach
i tions
k ull
m y
y tes
he ckpoint
Ġc DC
Ġs kull
Ġm CD
it ocine
Ġre approval
Ġre imburs
ar ic
at A
Ġb rachial
Ġto oth
em ographic
Ġth r
ĠA CF
ĠT MP
us ual
ĠC yp
ĠC rem
ĠC ETLAM
et ocin
ac ral
Ġex otoxin
Ġl ute
il ic
il ing
um atic
ĠM est
ĠM CT
Ġbe ating
Ġon wards
rom ine
Ġal dehydes
od ality
ĠH AML
gn ogenic
ĠP c
ĠP eking
Ġtrans versions
qu er
am ping
ĠD o
ĠS CP
ĠS IR
ĠW ill
Ġus hered
AML AA
yl glycerol
00 17
00 662
Ġ3 40
Ġen vis
Ġper ior
Ġmon omorphic
ĠE co
ox etine
Ġpres cribing
Ġid arub
ad v
ast olic
Ġlow ly
Ġdec l
ĠDNA m
Ġnon synonymous
est he
11 15
RA G
Ġmulti system
cent ric
ĠCR Cs
Ġdef ensin
Ġlong standing
Ġsensi tively
ĠV K
ĠV ascular
(+) ),
16 1
ĠMD F
Ġstandard ised
ĠAT X
Ġend ors
Ġprop osing
tr ate
Ġes cap
Ġthromb ophilia
oss yp
ĠAd ap
derly ing
ĠSt ate
Ġfunctional ized
ĠUn derlying
Ġsynerg ic
yb ean
MA RA
MA GE
Ġsil ver
fold ed
Ġ28 4
Ġ28 6
Ġconduc ive
CM MoL
Ġarabin ose
cap illary
Ġcollec ting
Ġclear ing
ĠCyt ochemical
ĠCyt okines
28 7
amin ophen
Ġequ iv
ĠIII A
GS K
ĠQ ue
rog lobulin
ĠHDAC is
Ġneuro blastomas
ĠMY ST
ĠY NK
rh GM
ĠStud ying
Ġrecombin ase
ĠGene Chip
ĠPA H
methyl ene
Ġevid ently
ĠBC AT
49 2
Ġamin oglyc
Ġepid id
ĠHD L
ospor on
Ġmas tectomy
pos itron
UT X
EP Cs
74 39
Ġcontribut ory
MC S
Ġspecial ist
micro RNAs
ofuran oside
Ġabsolute ly
ĠAc tiv
four th
Ġ96 21
Ġthi opurines
ĠMechanis m
ĠDR C
Ġdisapp ear
ĠHyp oxia
Ġsulf oximine
ĠEm phasis
Ġphag ocyte
Ġintercal ates
Ġfollic le
CS K
ĠSN ORD
Ġrub id
ĠGl c
ĠPS B
Ġfibrin olytic
Ġribonucle oside
ĠDIC ER
Ġsphing olipids
eptid yl
Ġapprec iably
Ġamelior ation
ĠMorpholog y
Ġcounte racts
Flu oro
Ġallevi ation
ĠOK M
Ġhaploinsuff icient
ĠPred ict
Ġspe ak
ĠHaplo identical
Met astatic
elect ric
ĠIF IT
Ġperson nel
prop ag
Ġcolumn s
ĠEff lux
ĠBas el
ĠPat A
0007 0174
Ġfu eled
GAP DH
Ġpitf all
AY A
On ly
Ġatherosc lerotic
ĠscFv CD
dia mm
Ġber yllium
Ġexquisite ly
ĠTumour s
ĠTAL E
Ġingred ient
Ġclo retazine
Hyper leukocytosis
Ġord inary
ĠCot reatment
develop ed
Ġskill s
ĠNSA IDs
allyl amino
embran ous
Exper im
prof icient
Ġpyl ori
Ġsynov ial
ĠLOX L
Ġagric ultural
Ġcarnit ine
odiaz epine
Ġsand wich
Ġhypercho lesterolemia
ĠHAML ET
" ),
4 64
5 17
6 80
7 61
9 38
A H
I MP
N CR
P CI
S MR
T H
T ime
W nt
Y D
Z NF
b ia
b lown
c K
c ox
d iac
d ifluor
f rag
k inetic
l ung
m RUNX
n ested
o verexpression
p rior
s ues
Ġ roscovitine
Ġt k
Ġc d
Ġo ve
Ġp ic
Ġm IDH
Ġf ract
Ġf asc
at ologic
at ology
at ley
Ġb ru
Ġh ESCs
Ġn ig
ĠA HCT
ĠC ord
Ġleuk osis
Ġleuk ocytic
Ġas partic
se ro
ant um
Ġres orption
ĠThe rapies
rom al
Ġal ert
ĠP las
st atis
ĠB rain
ĠB ody
Ġ2 24
qu iescent
Ġad ef
ĠD MPS
ĠF V
ĠF ine
vel ength
olog ram
Ġsho ulder
ĠR EN
ĠR OI
Ġrem edi
ĠN u
Ġreg ain
ĠO phthal
ĠG a
ĠG RFS
ĠG RAF
ĠE PS
ĠE ssential
ĠL H
ip arib
Ġstem line
oth ia
Ġsup ers
ct omy
Ġnon transplant
Ġinvestig ator
Ġacc ent
Ġallo transplant
Ġallo antigen
ined ichlor
ucle us
li gence
Ġlong term
Ġaut oradi
ĠV inca
ĠV imentin
12 00
CL IN
Ġop i
Ġblast ocyst
19 97
Ġmy ocyte
tr is
iss on
ĠAn tisense
atin s
25 2
ĠBM X
Ġphosph otyrosine
Ġprot otypical
CI I
BM MCs
ĠUn ique
Ġpotenti ating
ĠCT ORC
CP NE
Ġbas ement
36 9
As sess
Ġintra ventricular
Ġj un
Ġlate x
ĠCyt ometry
ER CC
art an
ĠAN L
ĠZ eal
ĠCX C
rag ue
Ġdep icted
Ġdiss oci
54 1
ĠAL IP
ĠPT CL
sp an
Ġadap hostin
dr iving
ĠInc reases
Ġfl ag
Ġund ue
Ġfibro blastic
ĠHSP Gs
EG IL
ĠAP cK
ubiqu it
Ġcompartment al
comp ared
Ġbil ayers
ĠTR L
ĠNon relapse
Ġrepl acing
Ġsmok ed
Ġthi o
Ġdeb atable
Ġbenz yl
FA O
Ġimmunop ositive
ĠSur gery
glut amate
Ġinj uries
nucle oside
nucle ophosmin
Ġoccup ation
DX R
Ġmil der
Ġinteract ome
ĠExper ience
Ġinclusion s
chrom osomal
Ġcomm encement
Ġhomogene ity
ĠHS PA
ĠSN CG
Ġcyclo ph
Ob esity
Ġtemper atures
Ġmyc obacterial
Ġsial ylation
Ġinoc ulum
Ġbreakthrough s
ĠGl utathione
ulph ite
Ġattain able
ĠUV B
insuff iciency
erb B
Ġcul pr
Ne gative
Ġreinfor cing
rele asing
evalu ation
Ġexempl ify
Ġscaven gers
Ġpig s
ĠBCOR L
Man agement
Ġinappro priately
ecre ted
ĠAff iliated
ĠDAS ISION
Ġbran ched
Ġterat oma
dis plastic
ĠMark ov
Pl k
ĠMol m
Ġgall ium
ĠCAF C
Ġrevision s
Ġunco vers
Diagnos tic
Ġdeal t
Ġfuc osylated
Ġmeningi omas
Ġgrouping s
Ġfluoro quin
Ġpren ylation
produc ts
LAIP s
ĠStruct ure
ĠIRA IN
Ġtetrap loid
Ġfron tal
erge tics
blind ed
Ġdiscern ible
ĠmL ST
Ġperipher ally
Ġabandon ed
Ġcontrac tile
ĠRepe at
ĠHistopatho logical
Ġcanal icular
Ġosteop orosis
Ins ulin
Ġmyelomon oblastic
Ġnanocarri ers
Ġspectrophot ometric
Ġsubcon junctiv
ĠFP GS
opress in
Ġign ored
Ġvirul ence
Pos aconazole
Ġmyofib roblasts
ĠTrk A
Ġrecomm ending
Ġprevail ing
Ġintel ligence
Ġcomplain ts
ĠCt IP
ĠSap acitabine
Ġdevi ations
ĠSchol ar
Ġmultin ational
(+/ +)
Ġmatric es
Ġero sion
ĠIVI g
hair pin
oneph ritis
Ġcerebro vascular
ammaglobulin emia
oplex es
asan utlin
ĠnC ounter
Dn mt
Ġperior bital
Ġendors ed
cox on
Ġadef ovir
ĠZeal and
0 72
2 56
5 33
8 15
9 01
A LT
B el
B usulfan
C EP
E pstein
G MP
G PI
G rowing
M arrow
M ACS
N SA
N inety
P HF
S i
S DAC
S MNs
S ternberg
T UNEL
V EC
a genic
b R
c ALL
d os
d up
d ural
d istribution
f atin
h as
h romosomal
m aturation
m ectin
n ary
r us
s kin
s chedule
ti dom
ti amine
he ld
Ġo d
Ġin acc
Ġs outhern
Ġm ort
is atellite
an hydro
an alog
an odine
el iparib
ar re
Ġf alling
Ġf alls
Ġb s
Ġb onding
Ġe up
om ally
om otor
em ptively
ĠT urk
ĠT aked
res sing
ML F
ML FS
ĠC ys
ĠC EB
ut arate
ce ae
Ġas partate
Ġis op
Ġst atic
ĠI CD
Ġde plo
Ġg ag
hem oglobin
Ġv iz
gn e
ĠP SP
ĠP LAG
ĠP eptide
Ġtrans c
Ġtrans activator
ĠB II
Ġr hesus
am y
am oxifen
ĠD VT
Ġun ified
ĠF D
ĠF at
ĠS accharomyces
ph y
Ġat rium
Ġap hereses
ĠR ib
ĠR ow
ĠN MP
ĠO zogamicin
ĠO mmaya
Ġse eded
Ġint ox
ĠG GT
ĠG LS
ĠG PCRs
Ġactiv ations
Ġrec h
Ġ4 10
Ġ4 05
yn ure
Ġexp ose
Ġnormal isation
Ġapopt ogenic
Ġallo transplantation
Ġprov ince
ĠJ L
15 00
ĠV HL
Ġref eren
Ġmin isatellite
ke weed
Ġnucle osomal
PL SG
Ġend osomal
001 8
PA M
Ġmy oblasts
Ġtransform ative
Ġonc ologist
Ġmyel osarcoma
25 27
Ġvar ieties
Ġdos imetry
ĠCh r
ull in
rem odeling
air s
BM SC
the l
Ġter nary
27 97
ĠCT V
onucle otide
ĠX pert
Ġwork ed
Ġ28 1
Ġ28 2
36 18
Ġgl ia
ĠER RF
Ġtyp ified
ysi ological
Az C
Ġangi oregulatory
ĠPR Os
86 8
Ġmacro globulin
RAS SF
Ġcalc itriol
PT X
Ġintegr ations
ĠAp c
EN D
Ġauto BMT
co holic
Ġbrain s
ĠGen istein
Ġiso enzymes
mod erate
003 19
Ġprepar ing
ĠHD CT
Ġendogenous ly
Ġhaem olytic
Ġ59 1
thal assemia
ĠOther s
ĠID OL
Ġhydroxy chloroquine
Ġpersonal ize
ĠWhe atley
cont act
Ġuns olved
onc ological
Ġoverl aps
ĠCB X
Ġimmunomod ulator
non HSCT
Ġbound aries
appro priate
Ġdim eric
ĠChildren s
Ex osomes
inter fer
glut athione
Ġposition ed
Pro lifer
Ġcongen ita
ĠMe eting
inform ative
Micro array
sh ort
ĠMi CK
ĠCK MT
CS s
Ġfinger printing
Ġpen ile
Ġpseud odip
Ġarsen ate
Ġsubs id
Ġ1980 8
Ġcoc aine
ĠAng el
omorpholog ical
eng rafted
ĠMyelo genous
SL N
TM Z
ĠPN ET
vest rol
Inc idence
Ġdrop s
ĠCr I
ĠZF P
fe eding
ĠRadi otherapy
Ġphenyl alanine
Ġpharmaceutical s
Stud y
RH EBL
ĠClus tering
Ġpolic ies
Ġadren ocortical
Ġge ographical
ĠDef in
pe ak
Ġmigr ating
ĠEvent ually
cytogenetic s
ĠMAL DI
Ġrevert ant
ĠTra ditionally
ĠEstim ates
break ing
Ġhyperg ranular
Ġencompas sed
produc t
ĠAchie vement
Ġsubstanti ated
ĠReduc ing
ĠGn RH
Ġarbitr arily
ycarb onyl
Ġpolyphen ols
ĠTiss ues
arboxyl ase
Ġdisper sion
Ġagglut inin
Circ ular
ĠDys regulated
Ġosteop ontin
ĠDrr B
Ġsymmet ric
fo tiamine
Ġhematopatho logists
Ġammon ium
Ġpartition ing
Ġfruit ful
Ġpix el
ridin yl
Neuro blastoma
ĠSouthe astern
Or gan
Ġrhyth m
Ġdelocal ization
Respon se
Ġtolu idine
ĠCarcin oma
phys ician
ĠConnec tivity
Ġjudg ment
Ġbat tery
mim ic
Ġdecalc ified
Ġou abain
leth ally
Ġove restim
Ġmort alities
ĠTaked a
4 30
4 96
5 25
7 85
> );
A Q
B UCY
C omplete
E st
F LC
G enes
L OX
O CI
P c
R ES
S EM
T IG
U V
W R
W NT
X PO
b iotic
c p
f amilial
g onal
k en
l ight
m eric
m urine
n ol
s ia
s ample
v a
z able
he ck
Ġc ate
Ġc ations
Ġc ard
Ġo mitted
Ġin hal
Ġin accessible
Ġthe ories
is olated
as ting
Ġre assessment
Ġe osin
ra den
Ġn u
ĠA HD
ĠA AA
tic e
ĠT m
ĠT on
ĠT able
ĠT DP
im mature
ur ring
ur posing
ĠC AC
Ġl it
Ġl aromustine
Ġcon tigu
ĠI B
ĠI v
il tration
ĠM id
ĠM pl
ĠM ap
ĠM esylate
oc ho
pl icity
Ġal together
Ġal do
ĠH ung
ĠH utch
ĠP MRD
ĠD Q
ĠD AL
ĠD HL
log ist
ĠF SC
ĠF ungal
ĠS Q
ĠS Cs
ĠS CA
ĠS MS
ĠS pontaneous
th a
ow ard
ĠR GS
iz z
di ox
Ġper itoneum
de pr
ĠO ff
Ġinv ade
Ġimmun opro
ĠG re
Ġrec ording
Ġrec tum
ĠE CP
Ġdev ise
ĠL OS
DS Bs
Ġover rid
Ġph i
ad al
ad vert
Ġsyn onymous
opt ysis
Ġ8 16
Ġcar til
Ġam id
sup pressing
ĠJ UN
Ġconf erence
trans formation
ĠV A
Ġsh all
Ġselec ts
HD AraC
19 87
56 5
Ġmor gan
Ġmor bid
Ġdaun ting
ax x
Ġend oscopic
Ġmeas les
abol ism
Ġbenef ici
dom inal
ĠBM Cs
Ġthromb oplastin
Ġprot op
kin ases
ĠCh i
allen ge
Ġvalid ates
ĠUn related
gan ese
aza uridine
ect omized
Ġexpansion s
Ġtyp hlitis
Ph osph
Ġ38 6
ob served
vari ants
rog ation
Ġintensi fying
47 1
Ġvin orelbine
ĠMR CC
inte s
SD IE
ĠCons ecutive
ĠCY R
SG I
ĠRel ated
Ġcereb lon
IDH s
ĠEv olution
Ġview s
Ġupd ating
Ġthi opurine
TKD s
Ġaggreg ated
eli very
Ġfil tering
Ġspectrom etric
Ġuncon trol
Ġneutral ized
ocardi al
ocardi tis
Ġsupple ments
Ġmicros atellites
random ised
Ġdil ated
ĠBE CN
Ġhyd ration
ĠIs ra
len ograstim
ĠAG P
Ġamelior ates
ĠMet aphase
Ġdisappointing ly
Ġreinfor cement
ĠSci entific
ensitiz ers
Com par
ĠMI B
ĠMulti parameter
Ġchemoradi ation
Ġtremend ously
ĠCU EDC
Ġlob ular
ĠEnh ancement
ofib rous
lect omy
ĠHaemat ological
ĠHaemat ology
ĠPatho logy
Ġmoment um
ĠMIC A
Ġorchestr ates
Ġsatis fied
Ġparench ymal
Ġdeubiqu itinase
iton avir
Ġpestic ide
ĠIMP DH
Mit oxantrone
Ġhid raden
ĠConcomit antly
Impro ved
ĠAdj usted
ĠApp lying
Ġderang ements
Ġgins en
Ġdesm oplastic
Ġord ered
Ġfarm ers
ĠHomo zygous
Ġpin point
Ġobvi ate
Ġtonsill ar
Ġexplicit ly
ogl utarate
ĠNat l
phag ia
bb ing
Ġcareg ivers
Ġsacrific ed
Ġcobal t
gall ate
diab etic
Ġserop ositivity
SAK K
adv anced
inedichlor oplatinum
Ġsubconjunctiv al
tidom imetic
Ġmorgan a
+ +
0 77
5 56
7 67
A IP
B v
B SI
C ure
I CI
L BP
M utational
M embers
Q uan
R Ls
b aum
f us
i oma
i itis
m OR
o encephalitis
r Gel
t rac
x S
Ġa ids
re activation
en imex
Ġp EFS
Ġp ending
Ġp orphyrin
Ġs ort
Ġs ave
or r
or aph
ro blastic
Ġre quisite
id amine
Ġe gress
os pecific
ell ow
ĠA hR
ĠT U
ĠT FS
ĠT ATA
ĠT Es
ĠT poR
im utations
ĠC p
ĠC ho
ĠC PA
ĠC arb
ĠC EBPalpha
et tering
ac ridinyl
ant agon
Ġmyelo cyte
Ġmyelo dys
Ġl ists
Ġl arynx
ran ged
ĠI NK
ĠI rf
il le
Ġal iqu
Ġg eared
ĠH AGE
ĠP f
ĠP ON
ir idinyl
ĠB evacizumab
Ġ2 36
yp romine
Ġcomp iled
Ġun separated
ĠF AT
ĠF ED
ĠF icoll
ĠS KIP
ĠW ell
ĠW omen
th an
Ġat yp
yl line
ĠN i
ĠN AMLAA
Ġgen us
Ġper vasive
ĠG AS
ĠG efitinib
Ġsub pathway
ĠE SC
ĠE UR
ĠE OI
Ġhemat opathology
Ġout ward
Ġpo lo
ĠL K
ĠL ucena
cy tid
ros ette
Ġhe arts
ari ans
Ġind o
Ġ6 31
Ġcombin atory
Ġdec arboxylase
Ġspec ially
Ġnon responding
Ġnon linear
Ġpl ated
AB P
ogen s
ill ation
ĠU PC
ens ter
01 84
og el
Ġmulti plicity
Ġme ant
Ġqu er
Ġmicro chimerism
sup plemented
ne w
12 09
Ġem pty
Ġconcl udes
Ġpost relapse
19 95
ma ximal
ĠAT CC
PL ys
38 0
Ġ30 2
Ġtr b
Ġtr ithorax
Ġret reated
Ġinflu ential
Ġthromb opoietic
Ġprot ons
CI S
50 4
OX PHOS
Ġstrati fications
Ġpharmac ophore
ĠUn it
Ġins ured
000 99
45 2
con centration
ĠX p
Ġsil ibinin
ĠPD C
ĠEx c
ĠEx isting
29 269
36 7
ĠCl adribine
Ġmitochond rion
ĠTP T
Ġj unctional
ER IM
Ġpoly phosphate
Ġharb inger
AR ID
Ġ33 9
ĠIFN s
other mal
ĠDC MP
ĠCP G
glyc ophorin
oly s
urviv ing
GS EA
Ġneuro toxic
77 29269
39 6
PT CL
ĠGST s
ĠMN T
Ġnan oc
ĠIC O
Ġpe tech
mod ulatory
sc id
ĠCH IT
ĠCH EK
ĠCo lo
SG L
ĠDS RT
Ġalkyl ators
Ġparallel s
ĠDe po
ĠMPO g
Ġrh amn
comp romised
Ġavoid s
Ġuns us
ED GF
Ġbacter i
ĠAR ID
Cy A
Ġcy CD
ĠPBSC H
vent ing
Ġencoun ter
ĠSU A
ĠARA C
diagnos tic
Ġantioxid ative
Ġaccess ed
anth racycl
Ġconn ections
ĠMA ZE
ĠQuan tit
ĠBAL M
Ġscal es
character ised
ĠBe ing
tub e
Ġecon omically
Ġsial osyl
no ea
PE I
tempor ary
cor relation
benz o
ĠZF X
Ġaza C
Ġmultim odality
ĠFe LV
Ġnarrow ed
Ġattack s
Ġoper ational
CO VID
Hep atitis
myel osis
Ġflan ked
Ġbab o
azadC yd
Ġblack s
Ġanion ic
ĠDX SCNP
Immunophen otypic
Ġprecip itated
ĠPt ch
oflu or
Ġhorizon tal
Ġreevalu ation
lact am
ampl ified
Ġspermat ogenesis
ĠAV N
Ġclaim ed
Ġherb imycin
Ġaver aged
APA AP
ĠMu LV
ĠHDA RAC
ĠDes ign
Ġads orb
Ġcatar act
Ġphosphoprote omic
glutam yl
Ġtran ylc
Ġprem ise
Ġglomerul onephritis
Ġsupra clav
Combin ation
Ġhn RNP
anesulf onate
Ġveget ables
ĠGluc ocortic
ĠDen mark
Ġvitreoretin opathy
Ġmirr or
ĠSlo an
lac tide
OME N
spon sored
aberr ant
imid yl
ĠAntit umor
ĠCoc ulture
tos itumomab
ossyp ol
ĠROI IC
Bel gian
ĠBII B
ĠHutch inson
adal afil
Ġhidraden itis
oraph ane
0184 24
00099 10
Ġrhamn osus
Ġtranylc ypromine
Ġsupraclav icular
% ])
0 61
B is
D EK
E fficacy
G VH
H ID
J ak
K TS
N ine
N ET
R beta
S ARS
T ac
a id
b irth
d on
f atal
g reen
h CB
h OCT
i ram
l ict
m H
m aternal
r is
r ifug
z el
Ġ zygotes
in ins
Ġt au
re porter
on at
he pt
Ġc aro
Ġc ediranib
Ġo edema
Ġp us
Ġp uber
Ġan is
Ġw alk
an uary
an ford
ro ism
el derly
as m
Ġd anger
ent an
ar aldehyde
Ġf ru
Ġe igh
ĠA NAE
ĠT ALL
im a
im p
im erism
gen otoxic
ut ri
ter ase
Ġex tingu
Ġmyelo displastic
ver ty
ĠI AL
ĠM x
ĠM ab
iv ity
ud ied
Ġg lu
od emographic
ĠH ar
ĠP X
ĠP d
ĠP am
ĠP IP
Ġtrans mitted
Ġr ating
Ġr ural
am idase
Ġcomp any
Ġun amb
ĠF requency
Ġ3 34
Ġanti angiogenesis
Ġanti thrombotic
ĠN MD
ĠN OR
ĠN EDD
Ġ5 50
Ġanal ges
Ġint ral
ĠG Cs
ĠG HA
Ġrec lassification
Ġsub lethally
Ġ4 45
Ġpo keweed
Ġpo verty
Ġtransplant ing
term ed
Ġexp edi
Ġmic ellar
Ġpar ametric
Ġcor rects
enc er
ag lyc
Ġ8 35
plas min
Ġel t
Ġel der
ch imeric
Ġmicro angi
ath ies
SF RP
Ġ19 69
Ġol aparib
53 2
Ġblast ocys
19 26
yd oxorubicin
Ġcompar ably
ĠCI MF
Ġonc ogenicity
Ġgranul opoietic
ĠAn tic
ĠAn agrelide
Ġara CTP
Ġso ybean
Ġexplo itable
Ġradi al
Ġcap ital
OR F
ĠRec ruitment
ĠRec onstitution
rin ary
37 2
Ġrep olarization
ĠSt anford
Ġprior i
Ġaz ole
tis ation
Ġimm ense
Ġtransf ecting
ect or
ĠX enop
PD K
Ġpan myelosis
ĠPro v
Ġhydro quinone
Ġglyc eraldehyde
ĠCyt openias
pre leukemic
Ġpoly ps
Ġequ ations
Ġsal ts
ĠIFN alpha
ĠPR CA
abil ization
Ġtra de
Ġsepar ates
acetyl ated
Ġlat rophilin
39 7
ĠImmun ologic
ode oxycytidine
Ġnan ost
69 4
Ġincub ating
Ġhazard ous
ĠRe active
ĠRe action
Ġbal ancing
Ġ(> /=
orb ate
col la
ĠOther wise
Ġmis expression
ĠRel A
EG CG
ĠAr m
chan ging
rearrang ement
ĠMMP s
Ġleuc ovorin
Ġremo te
Ġimmunotherapeutic s
Ġbelie f
ĠLT CIC
ĠCCR T
ĠSp rague
ĠTF s
reduc tion
ĠPo isson
MG DF
ĠAg gressive
ocal c
ĠDifferen tially
ĠEM H
Ġdist amycin
Ġpal in
ĠCor relative
sen ite
Ġschem as
erythro blasts
Ġham pers
hyd razone
Ġwors ens
Ġmono zygotic
Ġunderl ining
onom ously
sur gical
Hemat ological
olin ium
Ġadip ogenesis
Ġperm is
DT A
Ġpent amidine
anol amine
ĠLympho cyte
Ġreinfor ces
benz oyl
ĠIN DO
combin ation
ĠMer kel
Ġsubmic romolar
Ġoper ates
Er k
aud in
Ġlipoprotein s
Ġvag ina
ĠSMA RCA
pers onalized
Ġcentros omes
ĠHetero zygous
ĠMuc in
Ġappra ise
Ġcaps ules
ĠPrim itive
Ġbud s
ĠHistopatho logic
Ġber berine
ĠSepar ating
carcin oma
ams acrine
Ġsucce eded
ĠLIL RB
Ġbiotechn ology
ĠCle arly
ĠOV CAR
Ġdesc ending
Ġcarbapenem s
oguan idine
ĠElucid ation
ronch ial
ĠmD ia
Ġanecd otal
Ġambi ent
Ġbif unctional
Ġsing ular
Ġcolloid al
Ġhexam ethylene
quil ibrium
Ġnanocomp osites
Ġconceiv able
Ġwithst and
ĠVis ual
Ġtetrasp anin
Ġbru ising
acridinyl amino
ĠEUR O
Ġunamb igu
Ġblastocys ts
ĠXenop us
= <
B im
B iphenotypic
B onferroni
C urative
E AM
O wing
P atient
Q D
R X
T SP
Y S
d ated
j e
l ated
m ary
m oid
m ortal
n em
v ital
w ley
Ġa gen
in ases
in activation
ti fied
Ġin ert
Ġs ctb
Ġm S
Ġm V
Ġan aphase
Ġw ort
Ġw ood
is ulind
or ganization
ro blast
as mon
it ate
it osan
Ġd ox
es tion
Ġre ticular
Ġf inely
Ġ( =
os pon
os umab
im aging
lo tho
si RNAs
un treated
Ġex plants
ib b
ĠI O
ĠM esenchymal
rom etry
Ġal b
ab nl
ĠP HD
Ġcl itocine
Ġr if
Ġare na
ĠD CA
ĠF os
ĠF OL
ĠS earch
ĠCD S
NA T
di i
Ġchem ores
Ġchem oprotective
Ġgen omically
ĠG MPs
Ġpre targeted
ide psin
ĠE F
ĠE GFP
Ġ4 34
ox amine
ĠL RR
ore al
Ġcomple ments
Ġsyn t
osi alin
Ġnon myeloid
Ġinter ior
ĠK inetic
ĠU RE
requ iring
11 20
RA PL
RA CE
CT CL
Ġaut onomously
IT A
Ġdel ib
10 89
trans genic
ĠMD Cs
SF Ks
19 86
56 14
ĠML V
ĠML AA
Ġend oscopy
ater ally
ET C
DH FR
roph in
roph osph
ĠBM N
Ġ16 6
ĠIm mature
oid an
Ġmethyl ating
ĠAd herence
26 1
ĠLeuk ocytosis
CA D
ening ioma
Ġrest art
Ġaltern ation
ife rol
Ġu ve
Ġvir ion
Ġtoxic ological
ĠCT SB
Ġcer amides
app earance
ĠCom plications
Ġdys phagia
98 5
Ġreal ization
40 3
cyt o
Ġhom otypic
Ġenti tled
Ġobserv able
Ġglyc oside
Ġ35 1
Ġcardi oprotection
AR s
Ġgast ritis
Ġmeg al
opy on
ĠPR ED
opatho logic
PT LD
ĠPT T
48 9
co gnitive
Ġred undant
ĠGen eration
Ġmaxim ise
An emia
AN XA
ĠCY A
ĠSM Is
Ġsw abs
Ġgluc osylceramide
58 4
ĠNA P
IFN alpha
protein s
Ġexc ised
ĠTR IB
Ġmagn esium
Ġswit ches
ĠAc ross
atid ic
Ġimmunop recipitated
CE PBA
Ġrad on
MG US
Ġren ov
ĠSur gical
Ġremod eled
Ġuncon ditional
mt DNA
Ġval ve
Ġpal onosetron
deoxy adenosine
CTL p
oconjug ate
ĠMay o
Ġdil utions
ĠLD LT
ĠTA p
ĠSyn ergy
Trans formation
ĠGF s
ĠMyelo ablative
Ġcircumvent ing
yst ander
Ġdeterior ating
LS K
ĠRh iz
Ġdiscrimin ates
car rying
ĠCr kl
He alth
ĠChem ical
Ġchel ate
combin ations
PDGFR alpha
calc itonin
Ġlon idamine
Ġconven ed
Cr kl
Ġvacu olization
ĠAssess ing
Ġwa velength
Ġhind rance
Ġtrap s
BET i
leuc ine
Ġcontras ts
Ġfu el
Ġeryth rom
Ġabsorb ance
Ġneu ros
Ġequip otent
Ġcaps ule
Ġbin ders
fuc osyltransferase
Tel omere
mann in
Mod ern
ĠCbf beta
APA F
electro lyte
categ or
win ia
deoxyc itidine
ĠCardi ovascular
ĠPPAR gamma
Ġtranspos able
conf idence
bacter ia
Ġchor oidal
Ġribo zyme
ĠGold man
ĠHope fully
ĠAsc iminib
ĠSpect ra
ĠVar iables
Ġphenocop ies
ĠTun is
Ġpyrro lo
Ġbiocomp atibility
Ġhomogen ates
Ġunle ash
Ġpromon ocytic
Ġgrap hene
Ġcha etocin
Ġexpendit ures
Ġdors al
Ġscram bled
Ġcardioprotect ant
Ġlever aged
Ġneurosp here
Ġepidid ym
propag ating
ynure nine
Ġeigh th
0 71
8 25
A HR
A IF
B BL
C x
C LAG
C ampath
D isc
E MS
E DM
G PCRs
J anuary
L X
L MP
N RP
N rf
P a
P rec
R V
T fR
W i
Y R
b rid
c g
c reat
d min
d ifferen
h CD
h aem
k ines
l er
m id
m FISH
n ilotinib
p ower
p eptides
r um
r atinib
t m
t wenty
v isc
re v
re w
re th
ti te
on ins
Ġc f
Ġc HL
Ġc esarean
Ġc urability
Ġo sm
Ġin advert
Ġs ICAM
or pho
or vastatin
ro ute
as ias
Ġd ies
es ters
ic tions
ar rested
Ġf r
Ġb ystander
id ated
os yn
ĠA lemtuzumab
ĠT andem
ĠT XN
ĠT IPS
Ġle ader
Ġpro stratin
lo ading
ot ine
ĠC re
ĠC ent
ĠC CC
ĠC hern
ĠC aki
ĠC erebrospinal
ut y
ter ative
ce phal
Ġres ensitized
Ġres hap
Ġl anguage
op en
op eration
op iper
ver mectin
ĠI E
ĠI Cs
ĠM PM
ĠP MS
ĠP ublic
ĠP BMNC
ir al
anc ements
Ġcl athrin
ĠB S
ĠB x
Ġr itonavir
ĠD HO
ĠD IMATE
ĠD acogen
Ġun il
ĠIn cluding
ĠF er
ĠF atal
ĠF HL
ĠS ema
ĠW GCNA
Ġat tit
pro duced
00 14
Ġ3 29
pon der
ĠR H
ĠR BL
ĠO DE
ĠG SC
ĠG DC
ĠG CTs
Ġpre processing
Ġpre ponder
ĠE CD
Ġ4 12
Ġ4 33
ox an
Ġinf rared
hen oid
Ġprotein osis
Ġmal ate
Ġunder weight
ast in
Ġsup plant
osi ted
est r
est ra
ag ger
our nem
cell aneous
ak in
ĠAl pha
sup portive
itor ies
ĠJ ournal
Ġconf used
trans porters
ĠV ice
ĠV GS
ĠHere by
Ġ19 71
ipher ing
Ġnucle oporin
Ġcri zotinib
Ġend oc
Ġcomplex ation
ace ae
MD AP
Ġ30 6
ĠBM s
ind ol
ind bis
Ġprote osome
Ġmethyl ations
Ġsaf ingol
CC NA
oxy genases
ĠDNMT I
Ġrest rained
Ġrepresent atives
ĠAm ifostine
Ġins tillation
ĠST ANDARD
Ġthem es
clinical ly
Ġ28 8
ĠEx isulind
Ġunderst udied
gram ostim
ĠHe at
ĠPro c
Ġ27 4
Ġ26 5
Ġ29 2
ĠCM s
Ġcardi opulmonary
28 68
ĠCP E
Ġangi opoietins
immun op
ĠCBF alpha
Ġneuro cognitive
ĠTrans port
CH M
77 4
77 21
met hox
79 77
Ġdisrup tions
ĠAb dominal
nis hes
Ġ54 9
ĠNB s
Ġspon d
Ġben fotiamine
IN S
HLA DR
MLL r
RUNX T
Ġconver gence
ĠSub stantial
Ġcounter balance
Ġmis cellaneous
arn estra
Ġpy ridine
Ġdimin ishing
Ġspecial ists
ĠMed icines
ĠAR HG
My el
ocal in
ĠKn owing
ĠEM HP
ĠInter val
ĠInter phase
educ ation
ĠInd ications
Ġtract able
Ġpal e
ĠCO I
Ġperme ation
tib odies
Ġpseud ogene
Ġexplan atory
ĠDiagnos ed
ĠTME M
chem okine
Ġcav a
Ġopinion s
Ġden aturation
Ġden ote
ired oxin
Ġpent ose
ĠEnd othelial
Ne utropenia
Ġendomet rium
Ġmitig ation
Ġpip elines
Ġeukary otes
TLR s
ĠCCG G
Ġteam s
ĠDef ects
phospho hydrolase
Ġdich roism
rit ten
New ly
Ġhypot onic
Ġincident ally
ĠCyc le
ĠTRA MP
Ġmusc ular
ĠNP BC
ĠAppro val
ĠRecept ors
Ġpolys accharide
Four teen
Ġdic entric
ĠGAL IG
Ġazu rophil
ĠSch iff
Ġarchitect ural
Comp ared
Ġarrhyth mia
Ġrig ors
Ġhippocamp al
Ġhapt oglobin
Ġtria d
Ġentrap ped
Ġtropho blastic
Mut ated
Achie ving
deriv ative
ĠDevelop ing
comple ment
Ġtriglycer ides
Ġsed imentation
Ġpiper acillin
Ġaddi tively
Ġfur nishes
Ġozog amycin
Ġvign ettes
Ġrom idepsin
Ġliv in
suscepti ble
ĠReas ons
Ġbiol uminescence
tilb ene
diamm inedichloroplatinum
Ġatyp ia
Ġelt rombopag
Ġrenov ation
ĠDHO DH
ournem outh
0 81
5 44
7 56
9 33
9 36
B ad
C hol
E to
E PI
F K
F ive
H m
I l
M IR
N ow
O p
O CH
P ub
S MN
S ER
S uccessful
T W
T EM
U MRD
W M
W o
W GS
b les
b acterial
f itness
m M
n ous
p b
p ia
s rc
t an
he im
he alth
Ġc adherin
Ġc lotting
Ġo st
Ġs ati
Ġs CR
Ġm ith
Ġm ech
as partic
ic ts
Ġf ill
Ġb iz
id one
id omide
ul tivation
Ġh CD
ĠT ERC
ĠC SE
se x
ĠI BMFS
ĠM Z
ĠM BP
ol ones
Ġim etelstat
Ġdis abl
Ġdis ability
od ia
rans plant
ĠH Q
ĠH m
ĠH y
ĠP recision
Ġcl audin
ĠB LA
ĠB udd
Ġcomp ose
ĠD ie
ĠD LL
ĠD aun
ĠD eregulated
ĠF d
ĠF oc
ĠS LAP
ĠS indbis
ous es
ph ot
Ġmo uld
00 35
ĠR on
ĠR IP
ĠN pm
ost omy
Ġreg ister
Ġgen u
de tection
ĠO VA
Ġinv aded
Ġhem isp
Ġint ramedullary
ĠG CT
ĠG HR
ĠE dn
CR ISPR
port in
ĠTh alidomide
ad ox
Ġsyn ergetic
Ġexp osition
esti b
Ġdec e
Ġdec ondensation
ult y
Ġnon tumor
Ġnon clonal
Ġnon compliance
ser tion
Ġstr ides
Ġinvestig ative
ite ment
Ġinter change
Ġel eg
Ġar tif
mon ocytoid
drom ic
yc holate
Ġchromos omally
loc us
Ġqu alities
Ġregim ent
IT IM
10 80
trans duction
ĠV f
Ġdi astolic
Ġgener ics
FS E
Ġhetero zygote
omal idomide
oph y
Ġav oc
ep ime
iqu one
DH X
Ġneut ron
38 3
Ġprec a
Ġmetabol ize
Ġ16 40
Ġradi ochemotherapy
CI BMTR
Ġpur ify
ĠAra bin
ĠSt op
BM S
Ġrest arted
35 44
ĠX LA
ĠX III
Ġcer tif
Ġcer amidase
Ġsp ouses
plan ocin
Ġdys m
ĠPD Cs
04 01
ĠCon trolled
ored uction
ME F
Ġsal ic
other s
ĠPR F
ĠPR V
Ġ38 9
Ġautophag osomes
HP CT
Ġdr r
Ġ47 3
87 2
Ġacet aminophen
lab ile
Ġz f
Ġz ones
Ġtem pting
ll ate
Ġmas quer
ĠRe ed
ĠRe bastinib
ĠEn rol
Ġextrac ranial
ĠHemat o
ĠAr tificial
ĠInhib itory
ĠAK AP
OG G
Ġslow s
Ġresc uing
Ġimmunomod ulators
ĠLT LS
ĠSH I
ĠMon o
ĠEp R
Ġextra vascular
Ġ89 12
Ġcompl aint
ĠEm b
ĠEm ploying
Ġneutral ize
ĠHu h
ĠMA GS
Ġtail s
Ġtransduc es
Ġperic entric
capt ure
Med icare
hom oharringtonine
py rene
vest rant
ert inib
Ġdestr uctive
0004 277
ĠIN NO
Ġec osystem
Ġgalectin s
Ġperf used
Ġstay ed
Ġsynchron ized
depend ency
Ġske w
ĠDef ining
Ġsimpl icity
ĠHaemat opoietic
Er ythro
olo ur
ĠWil coxon
Ġmyr istoyl
ĠRest riction
Ġinterview ed
Ġorchestr ating
Ġplaus ibly
ĠCyc lo
lymph atic
Cycl er
Ġequip ment
FOX O
Ġhin der
ĠTechn ical
ĠMax imum
ĠFX III
ĠSus tained
Mu enster
Ġeg g
Ġgent amicin
Ġosteoclast ogenesis
ĠNFAT c
Ġtha wed
optim ization
rHu MGDF
Ġdn mt
Mc Ab
ĠNL GP
ĠExp anded
SAM HD
Ġdyscr asias
adren ergic
Ġcaud a
Ġtrab ec
ĠDic er
Ġperp etu
Ġdop amine
ĠDar win
ĠPrednis olone
Ġdend rim
Ġhepato biliary
Ġvarie g
ĠREC K
Muc ormycosis
Ġantimon y
Kn owledge
Ġremedi al
ĠRow ley
Ġmacroglobulin emia
1209 18
( *)
0 89
6 60
9 274
? )
A den
A URK
B IM
C U
C HD
D ouble
E CT
E HR
F AC
H EL
K aryotype
L CN
L DA
L IM
M U
M k
M at
M edi
M MS
M ounting
N early
O Cs
P bx
T DM
V NTR
W ES
b iphenotypic
d iv
d ifferentiating
g rafted
h undred
l s
p imycin
r g
s orting
v ae
y a
z ero
Ġ ic
Ġt ied
te xt
Ġs en
Ġs atur
an not
as partate
Ġd ps
ic ious
ar gramostim
Ġf ist
Ġf idelity
Ġ( %
id ac
ul ting
ĠA round
tic le
ĠC lear
ut henium
Ġex agger
Ġleukem oid
oc et
oc itabine
iv ial
Ġg lass
Ġdis odium
od ar
ĠH IST
ĠP it
ĠP rop
ĠP IR
ĠP otent
ĠP araffin
ĠB rd
Ġr ice
qu amous
am ents
ri te
ĠIn herited
ĠF ung
ĠF rizzled
ĠS O
00 36
Ġ3 01
Ġ3 53
Ġco ffe
ĠR OPN
Ġev iction
ĠN TR
Ġen v
Ġen anti
Ġmon om
de hydro
de termining
Ġimmun ogenetic
ĠG p
ĠG lasdegib
Ġinf erence
ĠL CP
ĠL intuzumab
DS A
ros atellite
ifer a
Ġacc ord
ill aries
oplas ma
ch ym
ĠU MP
11 30
MT V
MT Z
Ġhyp onat
Ġchild bearing
li omas
ABL O
Ġimp ose
tit utively
ĠJ CML
Ġprogression s
omet rial
ĠV DAC
Ġdi terpene
16 4
Ġpos ed
Ġpatho biological
Ġhist ogram
Ġem esis
Ġem py
erg ed
Ġlar vae
14 11
60 2868
ater minal
Ġonc of
Ġacid osis
Ġwor d
vo virus
ĠIL S
95 8
Ġsmall est
Ġindividual ised
com ponent
AL S
Ġflow cytometry
ĠRA G
Ġexplo its
Ġbenefit ted
ev olution
ĠMP P
Ġcarcin omatosis
omy osin
ision al
ĠSt romal
ral azine
BM B
BM MC
RT S
Ġsum oylation
drug gable
Ġsynerg ies
Ġtoxic ology
Ch aracter
SP T
Ġdispl acing
Ġhyper ammon
Ġlink ers
Ġdu plicate
AM ML
Ġnatural is
Ġlocal ised
Ġsal inomycin
Ġste wards
immun ohist
Ġ38 5
rec urrent
Ġdifferential s
Ġfraction al
Ġmacro autophagy
Ġ37 1
ĠAN T
inc tive
Ġdep osited
osinophil ia
Ġoxid ant
Ġbeh aved
ĠOr gan
Ġattrac ting
ĠGS I
uff icient
ĠCo Cl
Ġmis leading
Ġexc itement
Ġfas ting
DL EU
Ġplan ar
ĠAR L
Ġax es
ĠEL IS
Ex o
lip ids
enz yl
Con f
Ġbar asertib
Ġperturb s
ĠIR X
Ġmultip ly
ĠCO ALL
Ġperme able
Ġneo antigen
ĠAss ay
ĠAss ays
ĠAss uming
DI ABLO
ĠSup ervised
Ġtren ded
organ ized
aryn g
Ġjo ined
Ġfung oides
ĠGl ut
Ġsero logically
Mon osomal
Ġregen erated
Ġpropag ating
Ġsampl ed
Un like
Ġdeoxy adenosine
124 17
Ġendomet ri
ĠHM W
Ġdimethyl sulfoxide
Ġlap a
Ġec chym
Inf ectious
Ġnotic eable
ĠEpidemi ological
Ġultras ensitive
Ġultras onography
ĠIF Ds
Ġgradi ents
Ġawa iting
Ġexhaus tive
ĠStrept ococcus
Ġwa it
Ġimped iment
Ġperi operative
Cell s
ĠHom olog
Pl atelet
Ġpr ud
HGF s
perm eable
Ġneigh bor
Ġextr aterminal
Ġleg s
ĠDMR s
ĠFcgamma RI
ki lobase
Inhib itors
Ġpolys accharides
Abnormal ities
Ġil iac
trim oxazole
Ġdoubt ful
ĠTechn ology
ĠOx idative
pharmac odynamic
Ġcyst atin
elic obacter
Ġpod ocalyxin
ĠmH ags
Ġentrap ment
Ġchief ly
Cyc lophosphamide
Ġdyscr asia
bur icase
Ġker at
ĠEntero c
Ġrevis it
739 358
Sal vage
ĠDist inctive
Prom oter
Ġfascin ating
mus cle
Ġoblig atory
Ġchemil uminescence
Ġbioen ergetics
Ġforese eable
meas ured
ĠMill ennium
ĠMach ine
sig ma
Ġbiode gradable
ĠCrem ophor
Ġidarub icine
Ġrech allenge
ĠIv osidenib
Ġbenefici aries
Ġfru its
Ġsynt hes
Ġuve itis
orpho us
ĠChern obyl
Ġbiz arre
Ġvarieg ation
annot ated
Ġcoffe e
Ġempy ema
Ġstewards hip
0 78
2 98
4 13
7 33
7 90
8 21
8 237
> ;
A MD
B IR
C ur
C OR
C ord
D aunomycin
G n
G AG
H aemat
M ol
N ER
N LR
N SG
P hen
S w
T ransient
a iss
b ax
c ip
e ph
f GN
m orpholog
n ight
o zogamicin
u ros
x a
z mB
Ġ 004
Ġa ort
Ġt ib
Ġt MNs
re pressor
he rapeutic
en vision
Ġc in
Ġc ity
Ġc CAR
Ġin timately
Ġm P
Ġthe ranos
Ġw ing
al ton
an tisense
it oxic
Ġd izz
er a
Ġre established
Ġre organization
le vant
at ous
Ġb ra
Ġb rown
Ġ( +),
om fort
Ġh ob
Ġh MYADM
em on
ĠA cla
ĠT beta
lo us
ot onic
et astatic
ter ation
ac l
Ġas t
ho c
ant inib
Ġmyelo geneous
Ġl ign
Ġwas hing
ĠI c
il ding
il iation
um er
ĠM CA
ĠM MRD
pl us
Ġg ad
Ġg rand
ab normal
ĠB am
ĠB NP
ĠB UCY
yp henyl
ri ed
ĠIn form
ĠS erv
ph K
Ġk ynurenine
00 66
00 152
Ġco activators
Ġanti leukaemia
ĠR oman
iz ome
iz oline
ĠN MHC
di ethyl
tem ia
Ġen ig
Ġmon omethyl
ĠO DC
Ġimmun ochemistry
iti bine
Ġrec on
Ġsub arach
Ġinduc ibility
hen g
hen ol
Ġhe ading
ms a
Ġind el
Ġind els
Ġ6 32
Ġro tation
Ġsup erv
Ġprom otor
Ġprognostic ating
Ġspec ulative
Ġnon melanoma
Ġfol ds
ven tions
rim o
Ġman ners
Ġ8 82
ual in
Ġar gin
mon oblastic
Ġwhe at
MT A
Ġdisc omfort
cent rations
Ġme val
Ġqu ery
LA Q
Ġcommon place
Ġsim ulating
omet rically
ĠV DAs
SF K
Ġstandard izing
Ġ+ ,
AC h
Ġran ks
19 7
cute ll
Ġstatus es
Ġend ed
DH AP
establ ishment
Ġlymphoma genesis
20 36
Ġgranul ocytosis
Ġmyel in
Ġprob abil
Ġdos ed
ĠSt atus
Ġpharmac ogenomic
ĠNo onan
Ġsubt herapeutic
ĠAm photericin
Ġ40 9
aza D
Ġins ult
arb onate
ĠCT Cs
Ġlip o
PD T
Ġproduc er
Ġsp her
asp inal
98 02
ĠPD TC
Ġmac roscopic
orpor ating
cyt ochrome
Ġbiop sied
ochond ria
mit ochondrial
Ġbest atin
Ġhep cidin
Ġtest osterone
Ġcho lec
ĠER EG
amin opeptidase
Ġexcl us
Ġexcl udes
Ġmean time
rup po
ĠPR OT
Ġimmunohist ologic
odes ine
ĠME SF
Ġ46 8
Ġrepair ing
pop ulating
Ġlat ently
ĠY in
ĠY EAT
ĠImmun oprecipitation
ĠPT N
ĠPT GS
ĠPT Ks
Ġaden ylate
me is
Ġnan otubes
co valent
Ġble bbing
ĠGS L
AN D
Ġtem plates
ĠHD ara
005 2
ospor ium
sc at
Ġextrac utaneous
Ġphysi opathology
Ġbis ulphite
lim ination
micro chip
CBF B
occ an
ĠPP X
ĠLT A
ĠLC K
Ar m
Ar ray
Ġcataly zing
ĠHist ory
Ġthro at
CE Cs
Ġren aiss
Ġinsuff iciently
SM s
Ġmus cles
ĠCompar able
Ġmening es
ĠAM U
Ġcircum vents
ĠInter ventions
Ġhierarch ies
ĠIR EM
Ġcat enin
PK cs
Ġtriple t
ĠOR G
Ġcomb ating
ĠPl uronic
ĠMA X
ĠFT T
Ġwt FLT
ĠSup port
Ġirre levant
ĠRI Z
Ġmyc ological
TT F
ĠAu NPs
ĠImmunophen otypically
ĠMin i
>/ </
mor bidity
ĠTherapeutic ally
Ġveno occlusive
TF s
car minomycin
ĠCr kL
He tero
ĠIntr athecal
poly acrylamide
Ġhypo albumin
Ġflux es
Ġmyeloblast omas
Ġreplic ates
Ġsequel a
Gal NAc
vin blastine
ĠLP HN
PBP CT
Ġstrengthen ing
ĠED D
ket one
Ġadapt ations
Ġja w
Ġmyr istic
ĠVer a
ĠTel omere
riend ly
Ġdiame ters
Ġmoun t
Ġnano form
Ġfuc oidan
Ġgynec ological
ĠVir al
Ġenum erate
CREB BP
ĠIb rutinib
Ġdrople ts
Ġhamper ing
ĠOcc asion
Sp earman
ik acin
Ġisob ologram
ĠLig ation
ĠSY TO
tun ing
Ġtriaz ole
tery gium
Ġdichot om
Ġende av
Ġcautious ly
Ġfos tered
Ġtranspos on
ĠFcgammaRII a
Ġselectin s
ĠKY O
ĠMor occan
ĠIr respective
proB NP
ĠLeban on
ĠEW S
Ġimper fect
phosphon ates
Ġrequ ested
Ġsto ol
Ġpatch y
Ġmist aken
Ġforec ast
Arabin ofuranosylcytosine
ĠAdi ponectin
Ġmicrohom ology
ĠNum erical
ĠdNTP s
ĠSir t
ĠGo ogle
Ġfabric ated
Ġscr utin
Ġaccommod ate
Conc urrent
Ġcance rogenesis
quad ruplex
Ġmucoc utaneous
Ġrubid omycin
Fluoro uracil
Experim ental
anthracycl ines
Ġepididym is
ĠEdn ra
Ġdizz iness
Ġprobabil istic
ĠYEAT S
Ġrenaiss ance
) )-
4 14
4 87
A ff
A ST
A mut
B le
D on
E CP
F Y
F NA
F arnes
J I
L CA
M ass
M ouse
M IF
P im
R CT
S NF
S PMs
X pert
c ardiac
d ox
f inding
f ile
g on
g ulation
j ournals
l ational
n amely
p ain
s CR
s FasL
t op
u z
u PA
y oun
in ity
Ġt agged
re port
re ement
on omy
Ġc ebpa
Ġp oll
Ġp omalidomide
Ġs arcom
Ġm ortal
al ized
an one
Ġd ar
ent h
Ġb ivariate
Ġwith held
ĠT al
ĠT ypical
ĠT TC
us ine
us ually
im ethyl
ur ning
Ġpro xy
lo reth
gen er
ce RNA
Ġmyelo pathy
op sis
op sied
um arin
ĠM s
ĠM atched
ĠM ounting
ol ase
ol ating
Ġde generative
Ġim ag
pl er
ys perg
Ġv oreloxin
ĠH ind
ĠH RAS
ĠP ilot
ir on
st yle
st agland
ĠB Q
ĠB rown
am ol
ĠD DP
Ġun re
Ġun rem
ub enimex
ĠF lav
ĠS G
ĠS k
ĠW GA
th re
Ġmo ab
Ġco ating
ĠR IF
ĠR earrangement
ĠN ic
ĠN estin
di uretic
di psia
de amino
Ġcont ention
ĠG AG
Ġsub vert
ĠE NC
Ġ4 35
Ġ4 57
pho retic
Ġhemat ogenous
ĠL G
ĠL O
ĠL ap
Ġtumor ous
form yl
ines in
ct n
Ġnon tumorigenic
ser ver
aus es
Ġpred e
Ġ9 205
Ġel apsed
ĠK CTD
Ġar r
ĠU CN
mon ella
CD D
ĠAl isertib
Ġqu antum
Ġmicro deletion
Ġam ikacin
til ineage
RD s
ĠMD CK
Ġcoun s
ram ine
Ġpost therapy
Ġnucle ases
19 85
56 0
ĠAs PC
Ġmy b
Ġonc omir
val erate
ĠAB STRACT
Ġ30 5
Ġret urning
Ġcap illaries
Ġ24 7
Ġpur in
omy cetes
ĠRec ipient
air y
BM N
Ġtri phosphohydrolase
Ġquantit ating
lob ulated
phosph onate
MR Cs
itu x
onucle ase
oh aem
PD CD
04 31
imin arily
ĠEx cess
Ġhybrid omas
Ġprac inostat
osp inal
Ġver tigo
Ġfree zing
tu in
radi oactive
ĠPro por
sub types
cep ting
57 2
Ġglyc an
Ġpoly dipsia
Ġdoxorubicin ol
Ġfac ts
Ġsymptom atology
Ġ45 8
Ġ36 2
AD E
ole ucine
immun oblastic
ĠME P
ĠME S
Ġautophag osome
Ġbro ken
ĠZ MY
ĠTrans lational
Ġmast oid
47 4
Ġve ins
ps ycho
ĠCDK s
Ġnor th
sp odar
ĠGen otype
ĠDec ision
ĠDec iphering
Ġadap ting
Ġattrib ute
Ġtransfer ases
Ġminim izes
Ġbl ank
UC HL
Ġlog rank
Ġhand led
Ġbio assay
col on
MM UD
Ġmis folded
ĠNA T
Ġpair wise
Ġrevolution ised
Ġfamil iarity
Ġbo ot
ĠMed ica
lin atumomab
Ad ults
retin oin
Ġlact one
Ġarter ies
Ġmicrog lial
vas ively
ĠTK s
SM ase
Ġprel iminarily
nucle otides
Ġsensitiz ers
Ġvitamin s
ĠInter pre
Ġperturb ing
Ġcys tein
sh RNAs
cycl es
ĠTL E
Ġpor tions
Ġte aching
ĠReal gar
ĠTT F
ĠOCT N
Ġcollabor ations
Over all
Ġhyd rolase
Ġibr itumomab
Ġvisual ize
ĠMin or
ĠItalian o
enhancer s
ĠProtein s
ĠLympho cytic
ĠFLA M
idi ob
Inf ection
Ġperox isome
Po lym
Ġrun ning
Ġnarrow ing
AI HA
Ġnorm o
Ġroot s
Ġaberran cy
FB XW
Ġdysp noea
Ġplac ing
Ġcrystal log
Ġincomp atible
ĠYoun g
Ġnav ig
BN ML
En h
Ġextrap olated
hydrop y
ĠDP Cs
Ġafford able
MIC A
ĠEph B
Ġthick ened
Ġinges ted
Ġtransamin itis
ĠPRK AC
Ġprovirus es
ĠConf idence
ĠDa ily
ĠDiff use
osom otropic
Ġribo zymes
Achie vement
ĠHip po
ĠSPR ED
Ġsymp athe
Ġsymp osium
Ġoligodend rog
endi x
Ġcorp us
ĠDysplas ia
ĠUltrastruct ural
ĠTRP V
ĠImmedi ate
Ġrhin osin
mis sing
Ġhypercoagul able
Ġduod enal
Ġdecom pression
Ġexant hema
ithiocarb amate
dos age
Ġunsus pected
Aff ymetrix
loreth amine
ysperg ualin
4 99
9 30
A xl
B ST
E astern
F V
G astric
H isti
H ICAL
I diopathic
K asumi
L ike
O HP
P res
S n
T IN
U be
V idaza
Z AP
a C
a acr
b ortezomib
b FGF
e e
e as
e pt
g old
g els
i olar
i PS
j pg
k head
l ck
m DC
m Tc
n one
o epid
p age
s TRAIL
u its
w hen
y lox
z ia
z hou
Ġa rom
Ġt RA
en oic
Ġc anc
Ġo HA
te remia
Ġp all
Ġp DCL
Ġp ounds
Ġin oper
Ġs FLT
Ġs lic
Ġm t
Ġm dm
Ġm rp
is ory
or able
Ġf las
Ġb arc
Ġb ony
Ġb esylate
Ġ( #
ing e
id ide
os ertib
ul am
Ġn ail
ĠT OM
ĠT rip
ĠT adalafil
si p
si ella
ĠC ultured
Ġac ral
ac itibine
il ag
ĠM as
ĠM ad
ĠM arg
ĠM embers
hem opoietic
Ġv estib
ĠH itherto
ĠH elicobacter
Ġr FVIIa
am us
ĠD iamond
ĠD axx
Ġun intention
ĠF It
ĠW A
enti a
Ġap o
Ġmut KIT
00 33
00 23
Ġ3 38
Ġ3 90
Ġanti myeloid
pon ential
ĠR ICs
Ġmon ocyt
ĠO L
ĠO M
ĠO v
Ġinv est
Ġimmun ogen
ĠG RAP
Ġpre formed
Ġsub analysis
ĠE APB
ĠL eridistim
ip ital
so le
Ġ6 39
Ġall ostimulatory
Ġnon overlapping
Ġcharacter izations
anis idide
Ġapopt in
ĠK OR
ĠK leb
Ġwell s
cell ence
og lin
CD w
plic able
fer ior
Ġqu eu
sup pression
Ġext ram
ĠJ PLSG
trans retinoic
ĠV SV
ĠV accination
Ġassess es
FS F
az in
az an
Ġy ou
leuk em
leuk ins
Ġem ulsion
53 9
Ġapp endix
Ġend emic
Ġend ocan
Ġ[ -
ep am
PA OD
ĠCI BP
)- (
af olin
ĠDN P
20 8
Ġx ero
Ġindividual izing
ind ole
AP P
05 03
Ġcontr al
ĠAd hesion
26 7
CA F
Ġsubt oxic
24 02
lob ases
aza CdR
ĠFor khead
Ġconc urrence
Ġphosphor us
ĠX meis
Ġsil vestrol
ĠCom orbidities
Ġestim ator
Ġdys keratosis
Ġmuc ilag
36 8
ĠCl onogenic
ĠPro tection
Ġadj unc
eg inning
Ġj asmon
den strom
Ġhydro gels
Ġ35 2
Ġequ itoxic
Ġ33 258
immun o
ĠMT A
Ġsol GM
ĠGM B
ĠTrans duction
Ġdegra ding
Ġelect rosp
ĠMy Ms
+/- </
ĠAb rogation
Ġpap ul
hemat ology
hemat opoiesis
ĠPI GN
oler ance
athe cally
PV T
Ġglut araldehyde
Ġintr athecally
ĠSM MC
Ġfl ank
ĠCombin atorial
cancer res
ĠAP N
ĠSI ADH
Ġpair ing
ĠAK N
Ġvaccin ia
ĠAnti fungal
Ġax onal
Ġax itinib
ĠSp red
ĠNHL s
Ad herence
SR s
ĠTF AP
erc ury
yro sequencing
ortun ate
ĠPer iod
can res
Ġneur ite
ĠTr iton
Ġinters persed
Ġaspergill us
Ġkind lin
idin o
Ġsoon er
Ġneo in
Ġdraw ing
metabol ic
Ġcoinc ides
Ġecon omical
Ġsubs ided
ĠPar adox
ĠIs sues
eng raftment
ĠMod ifications
ĠUV RAG
Ġapprec i
ĠPRL s
Gen ome
Ġdermat ologists
ĠMet abol
Ġbrid ged
ĠPN U
ĠDH H
Ġdetox ifying
ĠRep urposing
ĠHer pes
ĠTCD D
Ġexempl ifies
Ġsap onins
MAC E
045 7
ĠSV M
ĠBl ue
Ġexacerb ate
Ġhal ted
iol itis
Ġrecover ies
Ġlandmark s
vess el
Ġgamm are
ĠGu adecitabine
AZ D
abdom inal
Ġanch oring
ĠProte omics
Ġpeculiar ities
SN HG
Ġselen ite
Ġtransfect ant
partic le
Ġverteb ra
Ġglob e
401 01
0000 370
ĠGAB ARA
liter ature
Ġendonucle ases
Ġadvoc ated
Ġki lobases
ĠDex razoxane
Ġhin dering
Ġconve ys
splic e
Ġ156 31
SU MO
Ġtur meric
ĠDLT s
oct adecyl
ĠFX IIIa
ĠDrr A
Ġgent leman
Ġprecon ditioning
Ġtript olide
Ġparac entesis
Ġtap ering
Ġdiplo pia
Cardi ovascular
Ġsurround ed
ĠUni CAR
orp oreal
Ġbim odal
Ġanhyd ride
Ġperiodon tal
Ġcytoc idal
ĠPakist an
Ġoroph aryngeal
Ġhy gi
Ġoctogen arian
Rev iew
dF dC
Ġvigil ant
rub omycin
Ġparest hesia
Auto immune
Ġstation ary
ĠmiRN ome
Ġamphiph ilic
meloxif en
ĠPredict ors
Ġsubsid ies
Ġimmunopro file
Ġmicroangi opathy
ocalc emia
1120 212
Now adays
Ġexagger ated
scat ter
Ġhypoalbumin emia
ĠMedica id
aacr journals
Ġinoper able
ĠGRAP HICAL
ĠKleb siella
Ġadjunc ts
( (
7 27
8 226
C AP
C ostimulatory
D isseminated
G CG
H igher
H IGH
I b
L BCL
M MA
N ur
O cc
R U
R o
T MM
U SA
W D
W GCNA
a el
b as
b ul
d ock
e rom
f an
f ol
f lox
h an
n og
n etwork
s uPAR
t x
t reating
re act
re plication
re actions
ti az
Ġc ec
Ġc itric
Ġp Y
Ġin otuzumab
Ġs es
Ġs emic
al imumab
or ines
ro t
el ian
as y
er ted
ent rifug
ar ber
at ten
Ġh ys
ra q
Ġn if
ec k
si zes
ĠC bl
ig r
ac ridine
Ġis oleucine
se ous
Ġst ents
Ġst ake
Ġcon nexin
ĠI CR
il one
ab an
ical c
od i
ĠP AC
ir tuin
Ġtrans itory
Ġcl om
st ress
ĠB angl
Ġr isen
ĠD V
ĠD SF
Ġne omorphic
ĠF S
ĠF amily
ĠS plenic
ĠS cutell
ĠW W
pro long
00 45
ess enger
Ġanti tubulin
Ġev ac
Ġ5 31
di al
Ġen ters
de xtran
ĠO c
ĠO MA
Ġinv ading
Ġpre cluding
Ġrec alc
ĠE A
ĠE limination
CR PC
Ġtar trate
Ġinduc tive
ĠL ac
Ġid asanutlin
ip tic
end elian
Ġrece ives
so ft
ĠCML BC
Ġdec idual
Ġbi ore
Ġnon acute
Ġnon reactive
34 1
tim ulated
Ġapopt osome
Ġel a
Ġar son
Ġar rived
Ġdes fer
drom al
ak a
og aster
dysplas tic
ĠAl kylating
Ġcontrol lable
Ġam eb
ath ic
IT L
ĠJ e
ĠV X
ĠV p
Ġcase in
az arabine
az epine
ĠALL G
hes ter
ke y
are r
19 61
sequ ence
ark able
ep s
ep ilep
set ron
ack ing
af e
CSF r
rop yl
Ġes capes
Ġcytotoxic s
In iti
ĠAn alog
Ġ30 4
AL M
ok inetics
Ġprot otypic
Ġoptim isation
Ġprote oglycans
Ġcytok inetic
Ġtri um
Ġ40 6
ĠST EMI
35 48
Ġtoxic ants
Ġunf ortunate
con served
con verting
Ġhel ic
Ġorder s
NP Y
Ġhyper forin
Ġreal m
ulf ate
IR I
IR IT
Ġbas olateral
ĠPro jected
Ġbreak ing
sub unit
Ġche aper
per cent
Ġmelan in
Ġmelan ogaster
VI N
Ġseven fold
Ġ36 4
Ġste llate
Ġ38 1
ades h
Ġorgan izing
PR OT
ĠAN XA
ĠZ D
ĠTrans duc
Ġdetail ing
ĠNot able
ĠPT G
ĠPT CY
Ġaden oid
ĠBA SP
Ġoste osclerosis
Ġspon ges
del ivered
Ġtransport ing
005 8
ustr ies
Ġconver ge
Ġthym ine
ĠCo hesin
ĠHemat ol
idne y
comp uted
Ġfas test
VEGF A
ĠBi opsies
ipro cally
aut omated
ĠAR V
ĠAc quisition
Ġinterven e
retin al
inter quartile
Ġdig it
Con temporary
Ġnit ros
Ġgel atinase
cript aid
ĠBP H
Da wley
Ġtrac ts
Ġpal mitoyl
ĠCCA s
ĠSP IRIT
avail ability
Ep idemi
sh aring
Ġseg mentation
ĠEr winia
Ġscan ned
Ġpum ping
UR OC
granul ocytes
Ġdil tiaz
ĠAI HA
ĠAI RAP
Ġreperto ires
fil zomib
Ġsero status
local izes
Ġfluor ine
Ġmand ibular
Ġhot air
HE X
ĠMyelo peroxidase
Ġdeoxy guanosine
ĠLympho cytes
Ġconsolid ations
ĠMB Z
Ġexempl arily
ĠConclusion s
Ġchloro form
Ġsap onin
Ġsubdiv ide
Ġelong ated
ethylene tetrahydrofolate
ĠBio envision
abs orption
ĠRap tor
ĠThromb osis
Ġcot ylenin
ĠHaemat opathology
ĠPartic ip
ĠPseud o
Fox o
ĠMIT F
Ġsatis fying
Ġrod ents
Ġtris omic
ĠCri tical
ĠSTR ING
ĠPH B
ĠPeg interferon
ĠDex a
Ġinsign ificantly
Ġconve y
ĠOcc urrence
chol ines
Ġparas ites
arth ritis
Impro ving
Haplo identical
ĠTrich osporon
MEC OM
Ġphosphoprote omics
Ġsac ral
Ġtha wing
Ġhydroly zed
carcin ogenic
fac il
Ġinconsist ency
igil ance
Ġsubstitu ent
clus ter
Ġantiemetic s
Cyc lo
Ġperit ransplant
Ġsch wann
Ġpu zz
Ġmononucle ated
ĠUltras ound
ĠLeban ese
omi Rs
Ġgam et
Ġoligodend ro
Ġcatalys es
NU MB
Tra ditional
Ġhous ing
ĠDop pler
Ġmicrocirc ulatory
Ġhindlim b
ĠREN CA
Ġoverrid ing
Ġcartil age
MDAP atA
Ġpreca utions
Ġsen ile
Gn RH
Ġaort a
Ġgad olinium
stagland in
ĠInterpre tation
ĠTrip terygium
Ġunintention al
ĠBangl adesh
epilep tic
Ġdiltiaz em
3 01
3 10
4 28
6 40
8 30
9 19
> +/-</
C at
C arb
C bf
D oxorubicin
D DI
D istinct
E MSA
G RP
G iemsa
H ydroxyurea
K iller
P ers
P EL
R enal
T as
T IF
T EF
T TR
T oday
U MP
a gnetic
c ur
c ord
d ynamic
d iaz
h d
l at
n ia
u ate
v r
v um
z ole
re populating
Ġc etuximab
Ġo mission
Ġp orphy
Ġin qu
Ġin ception
Ġs okal
Ġs aturated
Ġm aternally
al low
is ulam
or ylated
ati zed
el otinib
Ġre si
Ġb ryo
id em
id ia
Ġe ighteen
em erging
Ġth igh
ve c
ĠA HNMD
Ġpro erythroblasts
ĠC auses
ut yryl
et o
Ġac romegaly
op ical
Ġcon tem
ĠI SD
ĠI raq
ĠM ich
ĠM VI
ĠM aspin
ol R
ol istic
iv us
Ġv eliparib
ign a
ĠH ong
ĠH IM
ĠH MF
gn ant
ĠP ER
ĠP SM
st rap
qu ate
am pin
ap ro
Ġun set
ĠS phing
Ġdise quilibrium
00 10
Ġ3 21
Ġ3 56
ĠR EL
ĠR NR
ĠN EM
Ġen ocitabine
Ġmon omer
de quate
ĠG NA
ĠG NB
ĠG aucher
Ġno x
Ġfact o
ĠL AD
ĠL AG
Ġid en
ip ulation
ad ec
ad ow
Ġlow ers
Ġpar asitic
Ġprognostic ated
ple mentation
Ġma yt
enc a
Ġblood y
plas macytoid
ĠK ong
ĠK yoto
Ġar ranged
ĠU CA
ric t
Ġfe el
reg ulations
ile ged
og onin
CD H
li quid
ĠCR IP
ym oma
Ġdef ence
Ġsim ian
15 85
15 73
Ġconf lic
ĠV ia
Ġsh iel
12 75
Ġphen olic
Ġhetero cyclic
Ġem an
Ġnucle osomes
int ent
Ġer as
yd aunomycin
ater cept
Ġcompar ator
ĠCI D
In v
ĠAn tim
ix a
Ġprob ing
Ġ50 9
Ġthromb openia
cr isis
Ġ16 00
AP R
Ġsus pect
vironment al
ĠRec urrence
37 7
lob enz
DR s
Ġrecogn ise
mic e
Ġmed ullar
ĠST A
ling s
Ġgra y
Ġwork place
Ġdispl ace
CP S
Ġhyper pig
Th ym
Ġneutrop a
Ġhypothe tical
ern at
Ġi ALL
Ġgl auc
per iod
Ġlocal izations
Ġsummar ised
ĠCyt ological
inf lammation
Ġpoly aden
amin opyrimidine
Ġequ ina
Ġ36 6
Ġkin ome
Ġangi oplasty
mi RTS
cepti bility
ov in
ov igilance
Ġfib res
glyc erate
EL IS
66 336
AS Nase
PT L
isp osing
Ġelect roph
Ġsensiti se
EM H
ĠGST A
ĠAL V
Ġfrag mented
ĠComp utational
Ġdemethyl ate
Ġemplo ys
Ġnor thern
Ġoste ogenesis
Ġ49 2
Ġ57 4
ĠInc idences
equ ivalent
ta u
Ġmis car
comp atibility
onc ologists
ĠIP F
Ġbo osted
Ġleuc apheresis
ĠAnti gens
Ġax ial
ĠHist ologic
atch ard
ĠPer ifosine
Ġpneumonia e
glut aryl
CAM AL
ĠInt ensified
Ġsulf onyl
Ġspar ked
Ġsuper im
ĠGC V
Ġcat tle
Ġtrac er
Ġoc ul
anth ra
ĠCor ixa
ĠHU MARA
MCL s
IG HV
arm ustine
Myelo peroxidase
inucle otide
metabol ite
Ġmyc otic
omat oid
hydrox yb
hydrox ylase
ĠMajor ity
De oxy
ĠHER C
ĠArg ent
Ġinterrup ts
ĠAllo genic
prote ome
inv asion
SI LAC
Ġens ures
TA X
Ġsupern umer
ĠCoun ting
ĠCoun ty
wild type
Ġweigh ing
ĠSel ected
acc um
Ġprerequis ites
fe brile
Ġnonrandom ly
Ġhal o
Ġmeeting s
Fc gamma
Ġdomin ating
tig m
Ġnur se
anucle otide
Ġvag ue
Ġdro ve
Ġechocardi ographic
CCA AT
Ġgalact ose
neutrophil s
Ġdisulf iram
Ġdiscern ed
Ġconjunctiv itis
Ġprohib itive
Ġculmin ated
Ġgross ly
tip otent
Ġgonad otrop
Ġphosphoryl ations
Ġdimension s
Ġbic arbonate
ĠLV EF
entin an
Ġhn RNPK
osperm um
Ġleukemogen s
ĠRU X
ĠTri ple
SIN E
Ġprol actin
ammon ium
Ġtyros in
Transcription al
Ġnanos ized
Ġpathomechanis m
ĠRal A
brevi ated
orac ic
Ġhept ad
Ġstret ch
Ġhemip aresis
Ġclast ogenic
Ġcalor imetry
Ġolfact ory
Ġantide pressant
Sch iff
Ġgar lic
ĠCytos cape
Ġreimburs ement
Ġcd k
Ġpic omolar
Ġisop ren
thel min
Ġpalin dromic
mortal ized
ĠLRR C
Ġosm otic
ĠTXN IP
Ġspond yl
Ġprud ent
Ġmeval onate
ohaem agglutinin
Ġsympathe tic
ĠParadox ically
Ġtrium ph
Cbf b
TEF b
Ġunset tled
lobenz odiazepine
Ġsupernumer ary
3 13
5 97
6 90
7 24
7 02
> )-
A ctive
A yer
B inding
C w
C ys
D Q
D p
D iab
E zh
G IMEMA
L Q
R ep
R ON
T op
Z IP
a emias
d dPCR
f ly
g ic
i osis
l onal
m ay
p arent
p amine
s ycho
x s
Ġ zym
Ġ 00899
Ġa ur
Ġt yr
Ġt ensin
Ġt ables
he k
Ġc alling
Ġp im
Ġp rene
Ġs kip
Ġs argramostim
Ġan thelmin
el ected
it ates
Ġd ub
Ġd raining
Ġd actinomycin
ic ators
ar ched
Ġb ags
Ġb anks
id en
Ġe uch
ul dering
ĠA HA
ĠT O
ĠT AT
ĠT CP
ĠT CE
ot sub
ĠC level
et her
if anib
Ġres ume
Ġl ithium
Ġst ore
ib e
ĠI PS
ĠI EMR
il iary
ĠM en
ĠM apping
ĠM endelian
ĠThe ore
Ġde activation
Ġde phosphor
Ġde arth
Ġg rim
Ġor bits
ĠH Cs
ĠP he
ĠP SGL
ĠB rug
ĠB BB
ĠB enzene
Ġr H
ap si
Ġad hering
ĠD er
ĠD HE
ĠD istinguishing
ĠIn duc
ĠS plenectomy
Ġsur fact
Ġat orvastatin
pro ximal
pro pan
00 27
ĠR oche
Ġnot ing
Ġinv ag
ĠG V
ĠG v
ĠG er
ĠG RB
ĠG reen
ich i
Ġpre implantation
ĠE th
ĠE DTA
Ġ4 16
Ġ4 22
Ġhemat uria
Ġbet amethasone
ĠL AF
DS S
ip hered
ros ome
Ġmod elled
Ġsyn apses
ast inal
form ycin
Ġsup ram
Ġpar ti
Ġdec iphered
Ġspec ulation
Ġbi ologists
Ġnew est
Ġpl ak
Ġcor tic
%) ]
tim ibe
Ġman ganese
Ġ8 61
Ġel ective
ĠK T
Ġar c
Ġar s
Ġhyp opyon
ak otsub
loc i
plic ons
fer asirox
Ġprolifer ator
ry opres
ten otroph
Ġep ig
Ġep ox
15 95
Ġadv ise
press ure
az oline
SF s
Ġpatho genicity
Ġstandard isation
Ġprof icient
Ġpost allogeneic
par an
par ty
Ġdid n
19 94
AK R
Ġgranul osa
95 7
val idated
Ġpediatric s
Ġthromb ocytes
kin je
(- )-
mut agenic
Ġdom inate
Ġaccum ulations
26 48
Ġpharmac ists
CA E
30 39
ĠAPL s
ĠCN V
of usp
Ġeng ulf
Ġeng agers
aza CR
Ġrese arched
ced osporium
Ġhaemat o
Ġlig ases
ze timibe
HO O
98 4
Ġ28 3
itt ently
29 1
IR IS
36 1
lympho proliferative
Ġdu plicated
Ġi at
ĠHe ad
Ġsitu ated
Ġglyc emic
Ġpoly ph
28 3
ole v
ĠMul tid
Ġangi ography
Ġstate ment
ĠQ B
Ġampl ifier
ĠTrans duced
Ġ44 9
39 2
Ġtranspor ts
ened iamine
AS I
PT C
Ġdeep en
ĠY Y
Ġalk ylation
ĠGST pi
Aza CR
Ġher bs
Ġful vestrant
97 3
Ġsex es
Ġdereg ulates
Ġacet onitrile
+/- ,
48 1
ĠFour ier
64 6
ĠSc atchard
Ġiso zyme
Ġaspir ated
RF C
Ġolig omers
pos sible
col l
ĠReg istries
ĠAP O
ĠWhe re
ĠAC K
ĠAC V
Ġed itor
Ġnam es
tives icular
for dii
Res earch
ĠPKC alpha
Ġengine er
Ġent ropy
Ġcut ting
Ġaid ing
Pro grammed
Con genital
control s
Ġhomolog ues
Ġsulf onamide
Ġinteract ors
Ġtrac ing
Ġimmuno affinity
Ġimmuno assays
Ġimmuno electron
Ġbac ul
Ġframework s
MRP s
Ġaff airs
Ġflav one
Ġmetallo id
Ġpseud okinase
ĠLY L
Ġmyc oses
Ġrecapit ulating
ĠPBP CT
Ġcompens ates
hom o
egakary oblastic
Ġsustain able
auto HSCT
ĠCCL SG
Ġadip ocyte
dem ethyl
HU VECs
ĠMan tel
Ġpurs uing
ĠMin istry
Ġden ied
syn the
Ġinterm ittently
Ġdistinction s
oxif ylline
ĠTN M
Ġwindow s
ĠBD F
Ext ensive
Ġsa id
Ġorth ostatic
ĠTopo tecan
onad al
ĠDef ined
Hep G
ĠSal monella
Ġcornerst ones
ĠHom oharringtonine
ĠDAP I
ĠCal icheamicin
ĠdF dCTP
ĠPan obinostat
ĠKe ap
PLL A
Ġtun ing
ĠPur kinje
ĠLAP s
ĠAppro aches
Ġdeoxyribonucle oside
kill ing
ĠDD Is
pal mit
Ġconjunctiv a
Ġfavour s
Di et
tryp tophan
Ġdestroy ed
grad ation
Ġprioriti zation
Be fore
Ġleaf let
Ġje jun
Ġcave ats
Ġautore active
ĠAuto immune
entin el
Ġharmon ization
Ġmicrodiss ected
Ġdiplo type
Ġpractition er
adenosyl methionine
Ġsept al
Ġhomod imer
Ġphenocop ied
ĠRub icon
Ġcalibr ator
hydroxyp henyl
Ġmethylene tetrahydrofolate
opyran oside
ĠImmunob lot
Ġga uge
Mast ocytosis
ĠMultic olor
Ġtack le
Ġvide o
Tri ple
Ġnonex pressing
ĠEST IMATE
Ġfluctu ations
tw ice
otech n
Ġscro tal
Ġvolunt ary
Ġtropical is
Ġfibr illation
ĠPtd Ins
ames hek
morpholin o
Ġpromisc uous
Gu o
obarb ital
Ġenthal py
SIG N
azop arib
Ġreviv ed
rax ofusp
ĠSplic e
Ġspectrat yping
ĠWill iam
Ġdecl ared
7439 21
interfer ing
Ġcontigu ous
depr ived
Compar isons
Ġwort mannin
rev ised
Ġendoc rin
ĠDie go
Mat rix
Ġpoll ut
Ġunrem arkable
ĠENC ODE
Ġprede termined
psycho tic
Ġboot strap
Ġarom atase
Ġmucilag inosa
Ġcec um
3548 25
Ġhelic ases
Tas igna
Ġmiscar ria
Ayer st
ĠClevel and
Ġplak oglobin
akotsub o
tenotroph omonas
1595 48
2648 1585
* '
* /
3 05
4 31
5 85
6 30
9 23
B RA
B ak
D CC
E LTS
F amilial
F IRI
G AA
G CS
H aem
L PM
L ex
L OR
M ax
M CC
P rim
P RD
P ick
R MS
S OS
S orafenib
T rial
T MP
T DT
V inc
X RCC
b ian
c DNA
c armustine
d raining
g P
g erm
i ospermum
k al
k es
l ay
l anguage
p ulmonary
r un
r ctn
s til
s ince
s ensitization
x il
z ens
Ġt ed
re acting
Ġc ited
Ġp heresis
Ġs E
Ġm erged
is rctn
ati de
ro fluor
el ast
es ign
Ġre induce
ar alysis
at f
at ol
Ġb an
Ġb ag
id ering
ul si
em ission
ĠA NP
ĠT X
us ers
res sed
un ting
un mutated
ĠC Q
ĠC MT
ĠC BC
ĠC max
ĠC cR
ut yrate
Ġleuk osialin
Ġmyelo gram
Ġst ran
Ġst aged
rap ped
ib rate
ĠM il
ĠM ix
ĠM AG
ĠAML L
Ġg pt
Ġdis opro
Ġdis sip
ys in
ĠH SM
ĠH dc
ĠP FN
ĠP urpose
ĠP yrosequencing
Ġcl amping
ĠB ex
ĠB fl
ĠB ank
ĠB ournemouth
duc ts
qu at
ap illary
ri oxamine
ĠD os
ĠD MDR
ĠD KC
ĠD isseminated
ĠD ido
Ġun committed
Ġun irradiated
ĠF u
ĠF FI
ĠS ite
ĠS ER
ĠS uccess
ĠS audi
ĠS phK
Ġcyt oprotection
ĠW DR
pro gram
Ġus er
Ġap iospermum
00 75
00 449
Ġ3 11
Ġco herent
ĠR CL
ĠR othia
ĠR enca
act y
act ors
Ġ5 22
Ġ5 32
di p
Ġeffec ted
ĠO B
ĠO H
ĠO ld
cl uded
Ġse a
ĠG PCR
ĠG VT
Ġ4 44
port al
Ġ0 199
Ġ0 295
Ġinf irm
ĠL aromustine
ĠL EDGF
Ġph thal
Ġob ste
term inally
Ġind irubin
Ġunder c
LL O
str ate
Ġnormal ize
Ġall icin
Ġall ergies
ĠDNA zymes
Ġnon infectious
Ġpl k
Ġpl ug
Ġstr atum
The se
Ġcor yl
Ġdur al
ag gressive
Ġinter strand
Ġinduction s
mon o
11 68
Ġsec ured
av itoclax
Ġmicro bes
Ġline arity
Ġspecific ations
ĠV ero
ĠV STM
Ġdi oxin
Ġdi oxygenases
12 84
Ġ19 64
Ġy ellow
Ġhist ograms
ex ons
17 6
MP FC
erm ethylated
Ġav idin
ĠCI ITA
rop ic
ĠIL K
Ġmit ocan
ydro x
25 22
ĠNK RLs
ame ters
Ġ24 00
ish u
IC US
Ġcompound ed
IS R
Ġappear ances
Ġrandom isation
RT PCR
Ġtri phasic
of ect
mic roscopic
BC GF
ĠST IM
ĠST OP
II b
arb ox
Ch inese
andid a
Ġimmunosup pressants
plan ned
IP RS
imin odaunorubicin
ĠEx cessive
Ġhyper uric
Ġhyper polarized
Ġhere after
ophil s
Ġantitumor igenic
tu ximab
As O
Ġintra individual
Ġj anus
70 9
Ġclear ances
57 3
ĠCyt ok
Ġprevent able
Ġlabor atorial
AR E
AR DS
amin obenz
Ġpurp uric
67 2
abil ized
Ġ90 9
ĠGM CSF
Ġmacro cyclic
ĠZ IP
Ġdri ed
ĠPML RARalpha
Ġmast ocytoma
ft pb
47 92
Ġdeep ened
ĠY I
ĠMN NG
HC ST
eline xor
sign alling
Ġevol utive
Ġevol utions
ĠNB R
ĠSc hool
ĠIC US
sp e
ĠGen omically
ĠJan et
orrh age
Ġneg lected
ĠIT T
ĠIT IM
urac ies
angi ocarcinoma
ĠRe activity
Ġhand ful
Ġfl a
Ġ59 4
Ġcounter balanced
ĠPK A
ĠDLI s
ĠDe oxycytidine
Ġsplen ectomized
Ġcatal og
Ġrh Epo
arabin o
arabin ofuranoside
Ġdimin ution
ĠTR E
lof en
Ġbacter ium
ĠTHP O
Ġdim ensional
ĠMon otherapy
Ġimmunop aralysis
ĠGr B
My ocet
inter val
ĠHyp omethylation
Ġoccup y
Ġalkal i
Ġplurip otential
ĠCE PC
Ġfat ality
ĠGC LAC
FC S
anth in
lig ands
ĠMi RNAs
ĠMi SL
Ġloop ing
ĠSpec tral
ĠBe at
ĠMO K
Ġmetallo prote
carb oxy
Ġabol ishes
ĠAI RAPL
ĠInf ant
Ġdiet s
ĠCCN E
Ġhyd rop
Ġger anyl
ĠPS L
Ġdermat ological
Ġinfar ct
ĠES AM
ĠHMG N
treat ments
Ġallevi ates
Nucle oside
RB Cs
ĠIncreasing ly
ĠChem okine
olab eling
ĠBI BW
ĠBr C
Ġascertain ment
ĠPolym orphism
Cr kL
ĠDis rupting
SK Y
ĠNE ACT
Gal Cer
Ġpack aging
Ġlum en
Ġbronch oscopy
ĠEt v
Ġsimpl er
riap ine
FB S
leuc yl
Ġgovern ment
104 2522
Ġget ting
ĠHyper leukocytosis
ĠLI alpha
Ġparam agnetic
Ġmorph ine
Ġorchestr ated
Ġunderestim ate
Ġbig ger
ĠVir t
ĠFU ra
ĠNP Y
Ġneu rom
Ġster ic
ODN s
Ġdura bly
etu in
Ġpolys omy
ĠGAL V
Ġphoto affinity
Ġfa ecal
Ġtrop ism
ĠIns ulin
Fif teen
wa it
Ġprioriti zing
ĠHDA raC
Ġresum ption
Ġcave at
693 955
Ġlaun ch
ĠConf irm
Ġautore activity
Ġpol lu
ĠForm ation
Ġparap legia
Ġcrypt otanshinone
Ġdiversi fied
Ġmesenter y
Ġaccomplish ments
Ġsucce ed
osamin idase
Lympho id
Cardi otoxicity
Ġtent atively
ĠHybrid ization
Ġsom nol
ĠTEM s
ĠIso lex
ĠImmunob lotting
ĠTryp an
Ġjeopard izing
Ġdiaz iquone
Ret rospective
cataly tic
Ġtheophyl line
ĠFresh ly
Ġtin y
Ġwil fordii
Ġnumb ness
ĠMNK PL
Chemo resistance
Prote asome
Ġradioiod ine
difluor odeoxycytidine
ĠLH ME
Ġculpr it
gne tically
Ġintox ication
ĠPON TIN
Wi SE
visc osity
Ġmith ramycin
Ġhyponat remia
Ġenig matic
GalNAc OH
Ġdar atumumab
Ġnavig ate
Ib rutinib
igr atory
Ġstake hol
icalc itol
Ġrecalc it
ĠBrug ada
Ġsupram olecular
Ġiat rogenic
Ġstran ds
Ġdisopro xil
1168 36
Ġgeranyl ger
Ġsomnol ence
0 87
2 90
6 000
8 29
A HCT
A berrations
A cla
B urkitt
C lassification
C andida
D MDR
F DC
F FL
H EK
L i
L CR
N HD
P al
P rospective
R oche
S MC
T UG
U PR
V UD
W af
X S
a ec
a genesis
a rest
a plastic
b ies
b loc
b uff
c HL
c GvHD
c fDNA
d AzaC
e voked
g ability
h abil
i genesis
s ulph
s teroidal
x yl
y rene
z f
Ġa k
Ġa monafide
Ġa gnogenic
in ium
in sertion
Ġt ors
Ġt all
on atal
en ec
Ġc KIT
Ġp si
Ġp ush
Ġm ll
Ġan abolism
or ientation
an ercept
ed ding
es cape
Ġre ass
Ġre habil
ar um
Ġf ared
at ation
Ġb a
Ġ( ,
ul ter
Ġh GH
ĠA ISA
ĠA IDA
im ensional
gen otyping
ĠC w
ĠC AN
ut um
Ġleuk ocyt
ter ile
ere osinophilic
Ġis omer
Ġst rug
Ġst ock
Ġst athmin
ran ulated
rap id
rap amycin
ĠM MS
ĠM CM
ĠM echan
oc o
Ġg ab
Ġg angl
od iamine
hem ic
ĠH SD
ĠH IN
ĠH idac
ĠP Y
ĠP ul
Ġr K
ĠD ameshek
ay ing
ĠF FS
las t
ĠS b
ĠS FI
ĠS OC
Ġsur pr
igh ter
ph ab
th ane
Ġsign ifies
Ġk eloid
Ġmo tion
00 12
00 28
00 47
Ġ3 23
ĠR ational
ĠR NP
ĠR IG
iz olid
iz ole
Ġrem n
ĠN CD
ĠN PV
ĠN SE
Ġ5 60
tem izole
Ġen ucle
SC H
Ġhem optysis
Ġint ussusception
ĠL Z
ĠL PC
ĠL OC
ad hesive
Ġstem ming
Ġ6 30
Ġsyn genic
Ġcan y
Ġdem entia
Ġdifferenti ates
tim ulator
ag it
AB SCT
cri teria
ĠK C
ĠU rinary
requ ent
11 04
RA K
Ġprim ates
reg ister
CD I
Ġmulti protein
Ġup ward
Ġkn ee
CT G
CT Cs
CT As
Ġmicro emulsion
Ġmain stream
Ġanaly tes
Ġconf luent
trans cribed
trans porter
ĠV T
ĠV alu
PM R
az iridinyl
Ġ19 40
Ġlymph otropic
Ġlymph omatoid
Ġhist ologies
Ġregul atable
Ġem power
Ġpost pon
ĠPh arm
ma xim
Ġless en
erm an
ĠII B
ep oxide
tr ue
tr unc
ĠRNA seq
Ġx rs
Ġx anthine
AL OX
ĠRA NKL
Ġset tled
ĠBM B
Ġthromb ophilic
zym a
Ġradi ography
ves pimycin
CC K
Ġweek end
Ġins id
ĠST SS
II A
Ġcirc uits
Ch loroma
Ġet anercept
ĠX R
ĠCom mission
ĠTP R
Ġ26 3
ME D
Ġmelan ocytic
Ġlocal izing
57 7
Ġglyc osphing
Ġpoly omavirus
28 97
Ġ45 1
Ġoff ice
Ġpep M
titution al
Ġpreclinical ly
ĠPR alpha
immun otherapeutic
ĠVEGF Rs
DC leu
mal ign
Ġcontext ual
Ġneuro trans
Ġatt ach
Ġarm ed
ĠTrans genic
Ġdeep ening
ĠStud ent
Ġinjec table
Ġhepat ocarcinoma
97 4
Ġsynthe ses
Ġmeth anesulfonate
Ġnan od
Ġcross links
Ġmobil izers
methyl adenine
ĠSc opus
SD KP
Ġpa rous
An tibodies
ĠCons titutively
Ġminim ising
ĠIT I
ĠIT RT
Ġput s
Ġhaem ostatic
EP S
Ġconcept ually
ĠSI AMs
ĠSome times
ĠDe tectable
ĠAr rays
Ġmen str
micro M
chlor ambucil
ĠBi Q
ĠBi kD
ocarcin ogenesis
Ġmake up
non TLD
Ġvis ually
ĠHox b
ĠTCR D
hydroxy ethyl
Ġtop ology
arabinofuranosyl uracil
ĠAD I
Ġinj ured
Ġremod els
alli ative
ĠCREB BP
Ġdeline ates
201 5
Ac tivated
CV Es
erythro poietin
Ġaff iliation
gluc osamine
ĠSup pressor
FL U
Ġcapt ures
oll en
Ġcollabor ates
ĠRS V
Ġcompens ation
Ġpenet rate
son ized
ĠMod els
sw it
SL E
Ġxenotrans planted
ĠMal ays
che lating
Ġunra v
alc iferol
odophyllot oxin
benz ox
ĠChem otherapeutic
Ġdimethyl ars
yle th
ĠIN SR
Anti gen
Ġduc ts
ĠMI AT
Ġsens ory
Ġrelie ves
Ġheadac hes
Ġge ometry
Ġlamin a
Ġbronch iolitis
Ġkeratin ocyte
Ġduplex es
ĠSal via
Ġterat ogen
Ġincon ven
ĠHom ology
Ġundes ired
agglut ination
ĠNH AC
Ġorchestr ate
Ġspati ally
break point
ynchron ous
dan setron
Ġquad rup
Chem otherapeutic
ĠPLC beta
Ġunsu ited
ampl ification
fuc osyl
MIT O
ĠSus ceptibility
Ġcatast rophic
TOP K
ĠDE AD
Ġsin ensis
multiple x
Sel ective
Ġla id
ĠDeep er
Hox D
IPA M
Radi otherapy
ĠSIN E
260 3618
anesulf on
ĠmHA g
Ġsubcon tinent
Ġdeubiquitin ating
rep itant
ĠUltras onography
Ġrot ating
Ġperp et
ĠChallen ges
HOTAIR M
obi ological
Ġopac ities
Ġswe ats
Ġrew iring
Ġradioisot ope
Ġobliter ans
Ġcommens al
ranucle ar
ericardi al
Ġangio immunoblastic
ĠAgN OR
ĠPRD X
Ġspro uting
Ġvibs anol
ĠWal denstrom
asthen ia
Ġpolyglutam ates
ga uge
Ġremed y
Ġlengthen ing
ĠIFIT M
Ġcompartmental ization
Ġuncontrol lable
767 491
Quan titative
Ġpus hed
Prec ursor
Ġpreponder ance
Ġhemisp here
eph one
Ġtheranos tic
Ġhob bies
Ġspher ical
Ġvestib ular
ael is
iptic ine
ĠParticip ants
Inv estig
Ġhyperpig mentation
Ġparti tioned
Ġted izolid
ofect amine
Ġhyperuric emia
Ġstrug g
/ +)
0 83
4 53
5 05
8 45
8 36
8 43
9 53
A CD
A msa
B rom
B RE
B OM
B IRC
C or
D em
D NP
D iffuse
F AK
G a
H azard
I O
I ron
I KK
J CML
L ac
M pl
M urine
M orpholog
M VP
N Y
P e
P SA
P reliminary
R IST
T al
T FS
X V
Y A
] );
b ol
b iqu
e y
f at
f ound
h ymotrypsin
i os
l atform
l actic
m b
m el
p etic
r ase
u itive
Ġa kin
Ġa febrile
in oc
re plic
on omics
he rol
he aling
Ġc TnT
Ġs po
Ġs entinel
Ġm AMSA
Ġw inter
Ġw aves
or pholin
or dial
el ements
it our
es c
er ically
ic it
Ġre jec
Ġf ilms
Ġf ecal
at p
Ġb c
Ġb id
Ġb urs
id ov
Ġn omin
Ġn atri
ec es
ĠA cl
ĠA dequate
ĠT SS
im idaz
un ivariate
ĠC MPDs
uk a
ter rane
Ġex porter
Ġas ide
Ġmyelo lip
Ġst ays
op ram
ib arotene
il i
ĠM MA
Ġon dansetron
Ġg on
Ġg ossypol
od il
rans plantation
ĠH al
ĠH GS
ĠH EX
st ood
ĠB c
ĠB os
ĠB eta
ĠB linatumomab
Ġr uthenium
am an
ĠD x
ĠD MSA
ĠD auno
Ġun planned
ub a
ĠF AD
ĠF amilial
ĠS CD
ĠS ial
Ġk cal
AML L
00 004
Ġ3 16
Ġ3 14
Ġ3 26
Ġco hesion
Ġco regulator
Ġanti hist
ĠR ats
ĠR KO
ĠN CAL
ĠN alm
Ġab breviated
di oxo
Ġper iton
ĠO atp
ĠWe ek
Ġimmun oc
Ġimmun izing
Ġimmun oblastic
ĠE to
ox icity
ĠTh i
ĠL IS
ĠL PD
genetic s
Ġover night
ensi tivities
ocy anine
rib o
Ġnon selective
Ġnon adherent
wo od
Ġcor ds
est atin
Ġinter disciplinary
ĠK L
ĠK d
ĠU TP
Ġra ds
RA M
RA s
RA GE
Ġsec tor
cc RCC
av oid
Ġmulti target
Ġmulti stage
li ence
Ġnum erically
fer ring
vers ing
Ġme tic
CT OR
Ġmicro fil
Ġaut om
Ġext ents
istic s
spec ies
Ġanaly zable
Ġconf lu
ĠV S
ĠV irc
ĠV ector
13 01
16 63
Ġiniti ators
Ġsequ ester
Ġpos ter
Ġphen otyped
ex change
par ate
19 92
19 81
19 84
14 95
Ġend ocarditis
PA H
PA X
establ ish
Ġgranul oma
95 1
enic ill
Ġtr inucleotide
ĠRA I
ator in
ok emon
Ġbenefit ing
IC B
ĠAd d
rin ogen
BM M
24 9
activ ates
ĠCN Vs
ital opram
of in
35 80
Ġconcentr ating
MS K
Ġtoxic ant
02 84
Ġchemotherapeutic al
Ġdys t
ĠEx pansion
Ġhom ocysteine
Ġproportion ally
tid inol
Ġpoly cyclic
AD Cs
AD CP
AD PR
rup pel
ransi tion
Ġstate ments
Ġinternal ize
Ġsepar ase
opatho genesis
PR F
ĠPre gnancy
MF s
Ġvascular ized
Ġbroad ening
ĠAp oll
EN EST
ĠSim ulation
Ġill icit
Ġspon ging
Rec ept
Ġ49 3
mod ality
PV R
ES R
ĠRe activation
Ġfl ags
Ġclar ity
myelo blastic
physi ological
58 2
Ġthym oglobulin
ĠEn richment
ĠCol lab
ĠOnc ogenic
neum onia
Ġresid ents
ĠAr c
Ġbis acetamide
Ġpy omyositis
uran ofin
DL CL
ĠMV A
Ġselect able
SR C
Ġ84 98
ĠSH G
ang le
ĠDR EAM
ĠPer coll
anger in
ĠAF F
Immun osuppressive
Ġdist ances
Ġ97 88
thi otepa
Ġintrac ardiac
PK M
prom oted
Ġconn ect
ĠVari ants
Ġprojec tions
Ġrub ra
carb ons
carb oxyl
ĠTG ase
ĠInstitute s
hydrox ys
auto SCT
ĠPar ameters
Ġquin ones
De oxycytidine
Ġpurs uit
phenyl alanine
local ize
ĠMod erate
Ġsuccumb ing
hex a
ĠFlu or
tempor al
ĠMet formin
Ġacces sion
ĠSS c
Ne utropenic
tt ps
Ġsegreg ating
Tr x
Ġpremature ly
yal uron
ĠAustr ia
Ġeduc ating
Ġastro cyte
fluor omethyl
Ext racellular
Ġglycosyl ase
Ġpermeabil isation
Ġinterpret able
ĠHem ophagocytic
ĠAct inomycin
neu ro
deox ydoxorubicin
ĠLim itations
Ġortho gonal
wor ds
Ġtit le
Ġexerc ised
ĠMH CII
Ġdnr I
Ġtun icamycin
Ġautotrans plants
Ġrac es
ĠPa Ca
azid o
Ġreevalu ate
Ġcopolym ers
apt omycin
glucuron osyltransferase
Ġ-- >
Mac rophages
Ġabor tions
region al
ĠApp arent
ĠINT ERIM
Ġprescription s
ĠBal anced
categ ories
optim ized
Def ects
Ġsarc oid
Ġdiversi fication
Ġtap ered
Ġperception s
Ġaux otrophic
ĠAden osine
ĠPathw ays
under stood
ĠSPR Y
Ġcaud al
Ġpu romycin
ĠSi Ha
Str ing
isopropyl acrylamide
ĠAgain st
Ġdiethyl stil
Ġasymmet ric
ĠBMD Cs
Ġcrani ospinal
Ġsno RNA
Ġpyrim idines
ĠJI MT
Tes ticular
Ġconfron ting
ĠPME PA
Ġreiniti ate
ĠRob o
Ġhemoblast oses
ĠRX Rs
Ġsynap tic
(-/- ))
Ġbott om
Ġweaken ed
ĠQues tions
Ġthr ust
Ġenvis aged
Ġfasc iitis
ĠGa As
Assess ment
Bis pecific
Ġmech lorethamine
Ġdisabl ing
ĠEnteroc occus
Ġsubarach noid
Ġexclus ivity
ĠOccasion ally
gener ational
Ġpurin ergic
Histi ocytic
ĠMarg aret
Ġcontral ateral
Ġses qui
ĠWW OX
Ġela idic
Ġresi lience
ĠMVI H
Ġiden tically
Ġspondyl itis
Ġprene oplastic
ĠrH EPO
ĠGer iatric
Ġpolyph armacy
olev ulinic
homo zygous
phab eta
agit tal
maxim um
itour inary
idov udine
terrane an
ĠNCAL D
Ġperiton itis
ĠVirc how
ĠApoll on
, (
3 000
A im
A ct
C Z
C ho
C alc
C MPDs
D AP
E CG
F irst
F etal
G RFS
J ARID
K T
L Z
L SPC
L ewis
L ucena
M si
M BL
M eth
M Abs
N an
O ts
O ct
P riapism
Q AS
S z
T SC
T aq
T reating
U se
V AEs
W S
X I
b lock
c um
c Kit
c ount
d ronate
f etal
f ollow
f raction
h P
h ro
h sr
i ra
k ada
l uc
l am
m j
m uc
m HA
n odal
p AML
p ron
p ox
p seud
s ack
t ured
w k
y et
Ġ estradiol
Ġa C
Ġa HR
in avir
Ġt err
Ġt ang
Ġt rophic
Ġc ities
Ġc ensus
Ġo esophageal
te sp
Ġin structive
Ġs ALL
Ġs tigm
Ġan ted
Ġan esthe
ati zation
ro ughout
el esin
ent anyl
ic us
le ural
Ġf ates
Ġf avo
Ġb rand
id ents
id ermal
Ġe uth
os id
om ast
om yc
ĠA ch
ĠA CNU
ĠT e
ĠT EC
ĠT ORC
ur ium
ur itic
ĠC ast
ĠC MP
ĠC cr
ĠC opy
ĠC RAC
if est
ac u
ac ental
Ġas then
se e
Ġres ensitize
Ġl ivid
uc ose
op ietic
ib ed
Ġcon str
Ġcon duction
um s
ĠM ML
ĠM IS
ĠM RT
Ġde af
Ġim idazole
ĠAML Fusion
ab rutinib
Ġdis pos
Ġdis tention
od s
od azole
Ġby passed
Ġv ent
ĠH p
ĠH ap
ĠH LT
ĠH PA
ĠH MCLs
ĠP PM
ĠP ex
ir in
Ġtrans position
st ages
ĠB G
ĠB O
ĠB m
ĠB BI
ĠB elow
Ġinc ipient
ĠD OR
Ġun im
ĠF LL
ĠS of
Ġcyt arabin
Ġsur passed
Ġk inesin
Ġap olip
ular y
00 95
00 0001
00 64
Ġ3 98
ĠR EDD
ĠN am
Ġnot hing
di ol
Ġeffec tivity
Ġen ergetic
Ġmon ograph
Ġmon otherapies
Ġmon ohydrate
Ġmet hoxy
ĠO PG
ose greg
Ġhem im
Ġse ptin
lec alciferol
Ġint ranuclear
Ġimmun ot
Ġpre B
Ġpre adip
Ġrec iprocally
ĠE EG
ĠE CV
ĠE NG
Ġ4 19
ox oguanine
Ġout lining
Ġpo intes
rel and
ĠL on
ari etal
Ġyear ly
ines ted
Ġdec on
Ġspec ify
Ġbi lob
Ġnon ablative
Ġnon mast
Ġnon permissive
Ġnon curative
ort he
Ġmul tivesicular
Ġstr ata
%) )
ond ensed
Ġacc idental
Ġ8 50
Ġprim ordial
01 27
ak ers
Ġmulti plication
Ġdisc ipl
Ġme ter
Ġam lodipine
Ġam plicons
ath ion
ĠJ uvenile
ĠV ST
ĠV BL
ĠV PS
Ġsh unt
16 1961
az ob
ex ate
ex clusive
ex pansion
Ġform ul
Ġpost menopausal
17 161961
19 91
19 89
Ġdaun o
Ġend otoxin
ep sin
iqu id
ĠAs pa
Ġdo zens
tr isomy
lyc ythaemia
38 5
ĠIL EX
ane tesp
Cs s
ĠBM Fs
ok es
Ġthromb ocyte
ĠIm pressive
Ġir respectively
50 9
ĠAd o
CC C
24 534
Ġkey words
Ġaz id
35 7
urs in
Ġox az
MA U
SP NS
ĠBCL XL
Ġsp utum
Ġhyper activity
40 8
Ġneutrop enias
36 6
Ġpan hand
Ġi vermectin
ĠCl ose
Ġhyperm ethyl
ĠCEBPA dm
eg L
Ġcle arer
cep tive
Ġlen ding
ĠER V
amin ergic
AD s
ins oluble
ĠMul tilineage
omin antly
Ġant ag
ord inate
Ġtra vel
PR Os
ĠQ C
ĠZ OL
Ġrational ized
ĠMost ly
CH FR
77 87
Ġdep ot
Ġdep ict
met astasis
Ġemb edding
Ġauto SCT
sign ature
sp erm
49 4
Ġbiologic s
bi ocin
ĠInc rease
ĠInc orporating
ĠRe produc
MM SCs
raz ide
ĠNe utropenic
Ġpy rophosph
ochrom es
Ġchemos ensitizers
micro gram
Ġleuc ostasis
ĠSer ine
ĠCB S
phen otypic
ĠCa ution
ĠMo DC
CE ACAM
Ġnanop latform
inos uccinate
ĠAD s
Ġinterf ollicular
iphen e
ĠCd R
ĠFA H
sil osis
Ġinters ection
Ġcardiomy ogenic
Ġhisti ocytoid
deoxy guanosine
CV D
Ġmicrom et
ĠURD s
ĠLe iden
BD CA
ĠPDGFR s
Ġrub oxyl
>. <
carb am
Ġcoinc idental
ĠInf lammatory
pat ent
Ġsinus oids
Ġhyd ralazine
ĠStandard ization
recogn ition
ĠEpigenetic s
ĠMSC V
fl ur
fl anking
PG DH
quin imex
Ġens ued
ĠProtein ase
ĠOb esity
ĠTI RAP
Ġdrop out
idi opathic
ĠChan ging
olab eled
ĠHaplo type
ĠHaplo insufficiency
Ġsubdiv iding
ercul osis
Ġrun s
ĠSV Z
Ġacetyl choline
Ġhypomethyl ator
Ġvers ican
Ġdiscrep ant
Ġanat omy
Bi TE
Ġmeet s
phospho choline
phospho lipid
AZ T
abs ence
ĠReview ed
Re ports
Ġcatheter ization
lav inone
Ġverteb rates
Ġfu tility
Delta Ex
enog aril
enog elin
Ġpseudo time
omark er
Ġmucin ous
ĠMuc ositis
Ġrhabdomy olysis
Ġimmunoma gnetically
Ġbr us
Ġshutt les
Ġradioimmun oconjugates
ĠNeuro blastoma
ĠIAP s
Ġcaps id
Ġnons emin
ĠPhosph atase
Ġoutper form
Ġpolyphen olic
ĠTer min
Ġtric eps
ĠFrequ ently
Ġcytokeratin s
Ġexec uted
integ rins
ĠDeath s
terp enes
Ġoligodeoxynucle otide
ĠAdj uvant
nucleotid ases
antic ancer
antic hymotrypsin
Ġpric es
Hem ophagocytic
analy zed
ĠZn PP
categ ory
ĠTY RO
ĠTSP O
Ġparap silosis
Ġscle ro
Ġpow ered
ĠPrac tice
Ass ociation
carbox amide
ĠOl aparib
Ġtetrahydro uridine
Ġoval bumin
ĠSouthe ast
Ġmanufacture r
ĠTun icamycin
Ġcalibr ated
ĠPrednis one
ĠAU Cs
Individual s
Vit amin
TAC G
uns aturated
ĠPortug al
Ġartemis inin
ASC O
Ġescap ed
ĠOphthal m
tris phosphate
Organ ic
mimic king
Ġlit term
ĠMid dle
Ġquer ied
ĠQuantit ation
Ġagen cies
creat ine
Hm dUrd
Conf licting
ĠZMY ND
Ġinqu iry
Ġeman ating
Ġglauc oma
Ġgab exate
ĠMalays ia
yleth anolamine
ĠHEX IM
kada ic
sack ie
Ġstigm ata
Ġfavo ured
Ġasthen ia
ĠAMLFusion Chip
anetesp ib
Ġpanhand le
0 97
4 32
6 56
6 2527
7 34
7 11
8 23
B z
B AK
C CT
C yR
C arn
D CT
D DM
E E
E c
E ff
E AC
F H
F FS
F luorescence
F unctional
F riend
K E
K SR
L YN
M ix
M MRD
M eg
M KL
M ethylenetetrahydrofolate
N p
N umb
R EF
S kp
T w
T em
T otal
U mbilical
V ir
Y AC
a ued
c em
c urrent
c hers
c dc
e ably
e itic
f oli
g lasdegib
g raphy
g lycero
h is
h ors
k k
k dc
l amp
m emory
o a
o val
r int
s ome
s MR
s odium
s ensitized
s pleen
t ran
t aps
u ples
v accination
Ġ ubenimex
in stability
ti e
on oids
en afil
Ġc osegreg
Ġp m
Ġp emetrexed
Ġp CSs
Ġin ex
Ġs onic
Ġw ritten
is etron
ro ad
el c
as tigo
it ters
Ġd ATP
Ġd Guo
ed otin
es ts
es cin
Ġre location
ar idin
Ġf ire
Ġh ESC
ra re
ĠA RP
ĠA ES
ĠT s
si Mcl
ĠC min
ĠC hou
ĠC uba
et abol
ac am
ran in
op heresis
ĠI CP
il es
il ine
ine tically
ĠM is
ol asertib
Ġde xt
pl idin
pl acement
ĠAML MRC
Ġg em
Ġg zmB
od oxorubicin
Ġv WF
ĠH IS
ĠP OS
ĠP CP
ĠP AM
ĠP IF
ĠP riapism
ĠB OB
ĠB eginning
ĠB atf
Ġr he
ri ve
Ġun rel
Ġun adjusted
Ġun even
Ġun blinded
ĠIn k
ĠF RA
ĠF BP
ĠF els
ĠS cedosporium
Ġcyt otypes
Ġcyt osp
ĠW ides
ph or
Ġeff lu
Ġap repitant
00 38
00 65
Ġ3 99
Ġco uples
Ġanti blastic
ĠR HO
ĠR omide
iz oph
Ġrem ind
ĠN V
ĠN SCs
ĠN ras
ĠN NAT
ear chers
Ġ5 14
Ġchem oprotection
ren tuximab
ĠO OS
ĠO Cs
Ġse eding
Ġimmun ochemical
Ġcont ractions
ĠG X
ĠG CN
ĠG IG
rac heal
Ġsub G
Ġ4 24
CR G
Ġhemat oxylin
Ġ0 34
Ġ0 72
ĠL BP
ip ol
ip page
Ġover active
ad ate
Ġmod ulations
Ġ6 97
ers us
oth iaz
Ġ7 86
Ġlympho depletion
Ġlympho kines
Ġdem ise
Ġbi CEBPA
Ġnon cycling
ser vation
Ġmul tiv
The rapies
Ġhuman ization
Ġ9 90
ĠK RT
ĠK PC
ĠK inases
ption s
ch ase
ĠU r
mon oclonal
our ce
Ġfunction ed
cell omycin
Ġhyp of
CD DO
Ġup t
Ġocc ipital
Ġme is
ĠCR F
ym e
Ġep ist
Ġep imutations
IT PR
ĠJ A
Ġconf erences
ĠV RP
RD B
Ġdi re
Ġcytotox ins
az ide
az ane
Ġcoun ty
HD I
HD Is
Ġform ulate
Ġpost graft
ĠTo ol
prolifer ations
ep igallocatechin
OS T
ĠAs tel
Ġmy of
ĠCI MP
Ġcaus ation
Ġcaus ality
roph agic
Ġmorpholog ies
com mit
MD ACC
Ġret argeting
Ġthromb us
cr yptic
ĠCh lor
ĠCh TCR
Ġsu icidal
IS M
IL E
MS DT
Ġconc erted
Ġimm ortality
Ġhel ical
BF C
Ġhaemat ologist
ĠX q
Ġsp ring
Ġsp here
Ġdys poiesis
98 831
Ġevolution al
Th irteen
36 333
Ġhybrid ize
Ġmes op
AM I
AM kL
ĠCl aire
Ġche ek
Ġintra oral
Ġintra dermal
Ġ26 7
Ġ29 4
Ġhydro carbons
Ġglyc ogenic
ĠCyt ochemistry
Ġpoly chromatic
amin ated
AD L
Ġendothe lia
immun ized
ĠCBF b
65 83
65 508
ord antly
ĠME CP
ĠME RTK
olec tomy
ĠMT G
ob rom
Ġorgan oids
Ġorgan izations
GS E
Ġneuro protective
Ġdr ift
Ġdiss olved
ĠMM s
68 4
87 13
Ġnan oliposomes
Ġextrem es
Ġacet one
Ġdegrad es
WT H
Ġoste osarcomas
FI AC
ĠDec rease
del exon
mod ifier
Ġcost al
ĠNF E
ĠHD MTX
Ġshe ar
Ġlys osomotropic
pos ures
Ġfl at
Ġsw ift
eth nic
Ġsl ippage
MM oR
Cyt okines
Ġur tic
ĠPK H
ĠAr f
ibr utinib
Ġelectro de
Ġexc it
Ġexc itation
ĠEv idences
Ġphospho glycerate
ĠAC LA
Ġimmunod ominant
Ġintern ationally
Ġtet ram
ĠBi k
ĠBi ologic
yr ase
amil ast
ĠAc SDKP
Ġadoles cence
Ġhypox emia
ĠMV s
Ġdim ethylated
Ġdim orphism
ĠTF E
ĠMon ocyte
Ġimmunop ositivity
Ġeth n
oxid ation
ĠMG C
ĠMG I
Ġmus hro
ĠAF M
RAEB t
ĠTr iggering
educ ated
Ġcompl iant
Ġintrac hromosomal
Ġneutral izes
Ġimmuno editing
ĠSP AC
Ġca ver
infiltr ated
Ġmicros por
ote re
ĠTAM Cs
ĠSup ernat
120 36333
Ġjo ints
ĠRI A
Ġcollabor ating
encephal y
ĠCL PB
oz elesin
BE Z
py rim
Ġabl ated
Ġmillion s
prim arily
Ġsporad ically
Ġintrap arenchymal
Ġneurop sycho
treat able
Ly BC
icl amilast
ĠBT N
oxif ene
ĠCyclin A
ĠTN BCs
Ġplate aued
Ġcutoff s
Ġanc ient
Ġnarrow er
Ġhex okinase
Ġultrastruct ure
Ġtro ub
ona ute
ĠPers onalized
ĠPers istence
trial register
Ġgovern s
amid o
ĠSCN P
Ġoxal ate
Ġread mission
nan omolar
Ġnom inal
Ġground breaking
ĠNH AL
Ġabst racted
enog rastim
Ġtit rated
din itrop
ĠPt rend
ĠLo oking
Ġenjo ying
Ġpsych iatric
Ġpeptid yl
Ġlin age
Reg ulation
ĠBreak through
Ġnaph thyl
Ġprohib it
Ġconve yed
Ġspermat og
Ġdisproportion ate
Ġproceeding s
Ġrealistic ally
Ġoligoclonal ity
male imide
Ġinstrument ation
Ġhypert rophic
Ġepi allele
Ġcham bers
ĠSem enogelin
ĠDF X
Ġflor id
Ġtal db
environment al
tun e
analy tical
Topo isomerase
ider able
iso quinoline
ĠFl k
Ġlogarith m
Ġcyan ide
fac itinib
ĠPAF c
ĠPPAR delta
Ġhemangi oma
Ġsarc oplasmic
Ġcapit ata
Ġjob s
Ġsubm uc
Ġtropho blast
1002 90
Ġophthalm ople
Chi CTR
Sm ad
Ġsch izoph
ĠExpl oratory
toler ance
Ġelectrocardi ographic
Ġtriglycer ide
229 1075
Ġpyrro lobenzodiazepine
ĠPark inson
ĠTre o
Pr kdc
ĠRos well
Ġintercon n
Ġpione ering
Ġtheophyl lin
1075 8713
Ġradioisot opes
Neutrophil ic
Ġseas on
ĠLeuc ocyte
Ġaracyt ine
ĠBlo om
Ġreplen ish
ĠLeukem ogenesis
ĠPir ibed
ĠSHA NK
review ed
alt ons
Ġwilling ness
Ġenvision ed
Ġnonimmun ogenic
Ġaminoglyc oside
Ġeup afolin
Ġpetech iae
Ġcaro tid
Ġpuber ty
Ġmegal oblastic
ĠRhiz opus
ĠTunis ian
Pub Med
ĠDarwin ian
ĠServ ice
Ble eding
Ġslic es
Ġdesfer rioxamine
Ġepox ides
acty ly
Ġrehabil itation
2897 047
biqu itin
Recept or
Ots uka
62527 607
taps im
ĠWides pread
ĠRomide psin
azane planocin
ĠAstel las
98831 01
65508 26
Ġschizoph ren
ĠPiribed il
( <
. '
0 60
0 88
3 16
5 16
6 16
8 70
8 75
A ug
B al
B MD
B AP
C g
C u
C LA
C OP
D EC
D ZNep
F es
F IP
F dUrd
G as
H ost
H omeobox
K ettering
L U
L PA
L GALS
L ncRNA
P BMNC
R BPs
S HG
T AP
T NC
T umors
V NP
V GS
a BOM
c op
c ured
c lassif
d ib
d ered
d iss
e z
e ros
f r
f ate
f riendly
g rowing
i oides
m ode
n ow
n itol
s afety
y ment
re f
re pression
re ferred
re ference
re action
Ġc ab
Ġc yn
te es
Ġp ri
Ġp rin
Ġs lot
Ġs omat
Ġs irtuin
er us
Ġre lying
Ġre plete
Ġre ject
ar rest
Ġb arb
Ġ( %)
Ġto sed
Ġto facitinib
os terol
Ġh ints
Ġh CNT
Ġth yrosine
Ġn yst
Ġn estin
ĠA CD
ĠA verage
ĠA GR
ĠT i
ĠT at
ĠT AC
Ġle aching
Ġpro calcitonin
Ġpro dromal
ot actic
ĠC ohort
et t
Ġfor tun
Ġis oflav
Ġst a
ĠI SM
ĠI reland
il itis
ĠM BC
ĠM aturation
ĠM elanoma
Ġde phosphorylated
pl ating
Ġg arn
Ġg avage
ab ases
Ġdis tension
ĠH PS
ĠP u
ĠP ot
ĠP ts
ĠP AB
ĠP urine
ĠP ositivity
ĠP rincip
ĠP acritinib
Ġtrans differentiation
Ġinc ision
yp ro
Ġcomp eted
ri pt
ĠD ST
Ġun treatable
ĠF a
ĠF ast
ĠF ingolimod
ĠS ole
ĠS PN
Ġcyt ot
Ġwe ap
00 77
00 83
00 49
Ġ3 12
Ġanti apoptosis
Ġanti diabetic
ĠR RT
ĠR IN
act am
ĠN CL
ĠN GR
ĠN ausea
ĠN icl
Ġchem erin
isk ott
Ġmon ochemotherapy
ĠO pen
ose p
ion ate
cl usively
rug s
Ġhem o
ĠG RP
ĠG ANT
Ġpre phase
Ġsub enti
Ġ4 70
Ġ4 65
Ġpres erves
ĠL DC
Ġunder reported
Ġsup plied
Ġprom pts
LT BMC
Ġdec re
Ġdec ursin
Ġdifferenti ations
ct or
Ġnon favorable
ser onegative
Ġpl ag
Ġfollow up
Ġacc idents
Ġ8 14
Ġ8 47
Ġinter leukins
Ġallo antigens
ĠK ruppel
oplas t
ĠU mbilical
Ġprim ate
av alent
CD X
Ġthere in
Ġsc hool
ĠCR L
Ġam l
Ġext rag
ĠJ AG
trans pos
ĠV oriconazole
12 55
CL C
Ġ19 51
osph amide
Ġnucle os
MP A
ĠAT N
Ġlim ma
Ġmy al
Ġmy op
tr iaz
Ġcult ural
In activation
Ġloc ate
com plicated
Ġ50 3
AP N
ĠCh orn
OR E
RP S
CC SG
26 4
Ġanthracycl ins
ening itis
gra ding
Ġter tiles
ĠUn balanced
ĠUn usual
35 2
ĠX enograft
ĠAfter wards
Ġlip ogenesis
Ġlip ocalin
90 8
ĠOver coming
Ġretin itis
ĠEx cellence
Ġcandid emia
ĠCon version
ĠCon clusively
Th i
Ġcal modulin
Ġmuc ous
Ġmes o
AM N
Ġi KIR
Ġfree ze
ĠCl osely
Ġ27 1
Ġcle ft
Ġ29 61
70 82
(-) ),
ĠCyt ology
pre B
inf ant
ĠMedi ator
ĠFAB P
Ġdiscontinu ous
Ġmale ate
Ġ38 7
Ġ34 1
ĠME D
Ġdepend ently
ĠMT Z
ĠMT AP
Ġpredomin ating
Ġorgan elle
acetyl ase
Ġtermin ating
Ġquanti f
ĠTrans ferrin
Ġlat encies
MF L
met al
54 3
Ġ47 1
Ġhepat oblastoma
Ġhepat ocarcinogenesis
Ġaden omatous
aph tho
ĠIV F
Ġmobil ised
sp ace
Ġ49 4
Ġiso zymes
AN CA
Ġshe ll
ĠSM ase
Ġsw ollen
lic ensed
ĠEn vironmental
ĠHemat opoiesis
Ġcleav ing
ĠSI B
DP P
Ġpersonal izing
ĠPK D
Ġelectro chem
ĠRAR s
HDAC is
Ġmucos ae
Ġspecial ty
Ġmen tion
chlor ophenyl
ĠAc etyl
Ġthi ols
ĠBu ilding
ĠDA MP
Ġtop ography
Ġdisapp ears
lip ase
ĠDL K
ĠChrom osomes
TNF alpha
oming ton
Con tro
Ġmak ers
ĠTr ithorax
CEBPA dm
ĠTen ofovir
ĠCE PBA
ĠInter group
Ig A
ĠSK Y
eff iciency
draw al
Ġbios ensor
Ġval spodar
ĠCs f
anth rin
Pre ferentially
pred ictive
pred ominantly
ĠHU WE
Ġintercal ate
ĠPost induction
ĠPL B
ĠMAGE A
ĠWh ich
ĠConsid eration
Ġconsum ed
Ġdip eptidyl
CCR F
Ġtrim ethyl
ĠCCN U
ĠSyn decan
GST P
ĠIs ocitrate
ĠCL DN
Ġpass aged
part um
Ġincons picuous
UL BP
Ag gressive
len alidomide
Ġsubd istribution
acr ylate
Ġfluor ide
Ġexport in
ĠEnd ometrial
Ġcoagul opathies
Ġsmo uldering
ĠMet astasis
ĠKary otypes
ĠOb jectives
Int racranial
Ġneurop athies
circ ulating
transf ect
transf used
ĠMB q
Com mon
igaret tes
Ġmultim er
RN PA
ĠRemission s
meth anesulfon
Ġphenyl acetate
Ġconven ience
ĠDis continuation
Ind igo
Ġvacu olar
Ġbuff ered
ĠClass ical
Ġcontamin ant
Ġinterrog ating
abs orb
Er yt
Ġperi portal
ĠHyper diploid
Ġwound s
DE VD
rp S
Ġunco upled
haemat ologic
naph tho
ĠDem ographic
Ġdeoxyribonucle otide
Ġanthrac yline
ĠNeuro logical
ĠOX PHOS
Ġmax il
Ġconserv atively
ylo xy
Ġoutper forming
Ġculmin ates
Ġfed ratinib
ĠOcc upational
Ġasynchron y
ĠFrequ encies
ĠPr k
ĠSch wann
ĠrHu G
ĠSepar ation
Ġbic istronic
Ġdod ec
Ġleukotri enes
Ġsig moid
Ġthal ass
Ġdiac ylglycerol
Ġclo dronate
caus ed
Dis ruption
ĠRandom ization
ĠRandom ised
usp atercept
Mc Abs
Ġseques tering
Ġlag ging
ĠMalign ancies
Ġhijack ed
Ġarabinofuranosyl cytosine
ĠSum mary
Ġimper atorin
opyran osyl
ĠChallen ging
ĠDysplas tic
ĠUltrastruct urally
cataly zed
Ġhypothal amic
Ġhypothal amus
otax us
ĠConjug ates
Ġargum ents
Ġell ipticine
Ġneurot rophic
Ġviol aceous
exc itation
Ġopi oid
Ġpseudodip loid
AQ P
Est abl
Ġcate chol
ĠTon B
ĠFOL FIRI
Ġreshap e
ĠBx PC
Ġdece ased
AURK A
Ġfist ula
Ġlapa roscopic
Ġcholec ys
ĠNEM O
Ġconflic ts
Ġshiel ding
Ġsulfonyl hydrazine
Ġskip ping
ryopres erved
ĠQB END
germ line
enec id
Ġgangl ion
omast ocytic
ĠSof t
azob actam
cem id
phor ase
Ġmushro om
ĠSupernat ants
Ġophthalmople gia
Ġtosed ostat
Ġgarn ered
ĠNicl osamide
ĠChorn obyl
' (
3 29
5 11
7 53
8 18
9 75
A ld
A dC
A NAE
B RD
B eta
C max
D cl
F ig
F red
G i
G DC
I CIs
L u
N ST
N OX
P rd
P otential
P earson
Q C
R GG
R GD
T u
T AT
T AR
T CF
T RF
T RAP
T MTP
V ec
V accination
X RT
Z R
a ults
a ided
a GC
b en
b randed
g amm
i tively
k o
l un
l pr
m ight
m ercapt
n or
n umerous
p P
p eg
s ol
t anthrin
w arning
y rone
Ġ urs
in ner
Ġc ro
Ġc HSP
Ġc occi
Ġo t
Ġp I
Ġp M
Ġs HD
Ġs VEGFR
Ġan omer
Ġw ogonin
al ay
al ternative
is in
an nexin
Ġd ust
Ġd iphenyl
er atinib
Ġre transplantation
Ġre introduction
ar get
ar inone
Ġf illing
at oid
at adine
Ġh u
Ġh ype
Ġn r
ĠA MF
ĠA PI
ĠT reated
ĠT EX
ĠT riapine
Ġle ave
si tes
ĠC ER
ĠC FSE
ter t
if olia
Ġres pects
Ġl or
Ġl umi
op ulations
Ġcon verse
Ġ1 210
ĠM ir
ĠM yd
oc ecal
oc ratic
Ġch itosan
hem orrhagic
ug ar
ĠH g
ĠH en
ĠH cy
ĠH MD
ĠP arental
ĠP ancreatic
ĠP amidronate
anc ytopenia
Ġcl ivus
ff i
st rong
ĠB oc
ĠB rc
Ġcomp ut
Ġcomp etes
ĠD W
ĠD iss
ĠD OL
Ġun MGMT
ĠIn ducing
ĠF O
ĠF yn
ĠS BC
ĠS AG
ĠS UP
ĠS orted
ĠS pleen
ph rosis
Ġeff luent
th s
th ic
enti x
Ġmo le
Ġmut ator
NA MPT
Ġ3 13
Ġ3 80
Ġmar itoclax
Ġco al
Ġco inhibitory
Ġanti inflammatory
Ġanti diuretic
act one
ĠN EC
ĠN PAS
Ġ5 19
Ġ5 99
Ġreg isters
Ġmon ot
de ad
ĠO verex
lec ting
ĠG CK
Ġag ranular
ĠE CL
Ġ4 60
Ġ4 25
Ġ4 27
ox ome
bin ol
ĠTh roughout
ĠL en
ĠL ately
ĠL IR
ĠL ef
ĠL amin
ip razole
ros arcomas
Ġph armacy
ad th
Ġoutc omp
Ġmod ular
Ġind ustries
Ġexp enses
ocy tidine
Ġlympho cyt
Ġdem yel
ct GMCSF
ard ed
Ġnon fatal
Ġnon covalent
Ġhuman ised
Ġacc uracies
plas mic
echanis ms
Ġinter related
Ġinter ventional
Ġinter sp
blas tin
ĠU E
ĠU bx
ĠU GCG
Ġ10 60
Ġpotential ity
og ranin
ĠCR S
ĠCR BN
ĠCR VO
Ġqu enc
Ġmicro v
Ġcar filzomib
Ġam ended
Ġvit ality
Ġep ip
Ġep oxide
Ġaut onomic
Ġinte rests
ĠJ AR
ne utropenia
Ġconf lict
ĠV ariable
ĠV idaza
Ġdi aste
13 11
CL CA
Ġsequ encer
line al
Ġhetero genic
33 1
Ġnucle olin
par g
Ġvalu ed
19 88
Ġsm el
ep it
Ġmy oglobin
ĠCI HDAC
Ġacid ity
Ġacid ification
Ġcolon ize
Ġder ailed
Ġprec ious
ĠAB CA
ST K
25 4
ores pon
Ġthromb ospon
AP T
Ġoptim istic
Ġcarcin oid
RP IN
Ġsubt raction
asc orbic
Ġdetect or
of ix
Ġrecogn ising
MA F
SP HK
ĠX PG
Ġsp ur
Ġsp ares
Ġretin ol
98 0
98 3
Ġhyper proliferative
AF M
Ġreal izing
80 8
40 7
ĠPro t
ĠPro state
ĠPro MACE
Ġche ilitis
ĠIM I
57 8
Ġglyc oconjugates
Ġglyc opeptides
Ġartic ular
Ġwid th
Ġwid ening
Ġ45 9
Ġste ep
88 5
88 6
ograph ies
ected in
ĠWhen ever
ord inated
Ġpredomin ates
PR R
ĠQ Ch
Ġtermin i
Ġsor cin
Ġrational es
ĠPre transplant
ĠPre fect
inc rease
Ġminor ities
ĠY e
ĠSe pha
Ġlo ose
ĠIg V
ĠGST O
ĠGene tically
ara CTP
ĠAb undant
aph osph
Ġsecre t
Ġmultic olour
methyl ating
ĠWBC ratio
Rec iprocal
83 13
Ġenvironment ally
orrh iz
HA ART
Ġshe ath
ĠSF s
bi opsy
ict or
portun istic
Ġfibro cytes
eth nicity
+/ +
ĠHSP G
Ġmis localized
Ġmicrosc opical
ĠDS X
Cl in
Ġ85 9
CTP P
link er
Ġrecons ider
ĠHSC C
Ġpy ran
ochrom atosis
ĠSign s
Ġpowerful ly
pr t
Ġbacter icidal
Ġtelom estatin
ĠAR IH
Ġvis fatin
Ad j
be fore
ĠCG Is
adap tive
07 02
ĠpH TN
Ġneur itis
09 41
nine teen
Ġsulf oraphane
ĠGSTT I
Ġspar gan
Ps im
ĠIR S
ĠMe asurable
olip in
present ative
Ġarg ued
ĠSA DA
ĠCor on
ĠSP O
ĠBa P
erythro blast
Ġperic ytes
Ġfer mentation
Ġintestinal is
Ġsoci odemographic
back s
ĠBe h
rox ylin
ĠGra ffi
Ġgold en
class ic
ister ia
nic otinamide
ĠFC SS
Gr b
Ġdip yrone
Ġpseud ot
Ġcoinc ide
Ġcros ses
Ġmyc el
Ġhydrox ylase
hydrox yl
Trans fusion
auto HCT
Ap pro
ophyl line
Ġincons istently
ĠCy CD
Ġfluor odeoxyglucose
Ġden omin
Ġden gue
ĠGP x
ĠAza D
ĠFOXO s
sho ps
Int ra
Ġallevi ating
ĠTI E
ĠCV C
ĠRep rimo
car binol
ĠLip id
ĠSci ences
Ġsap acitibine
rip iprazole
Ġpip obrom
Ġrevers ine
tri ple
ĠRB SP
ĠCS NK
Ġmicron s
histi ocytic
Ġhex anucleotide
Ġvacu olation
ĠNE LL
Ġroom s
bis pecific
Ġtro lox
megakary ocyte
Ġunsuccessful ly
ofib rosarcoma
ket oglutarate
Pl GF
Ġmorpho cytochemical
Lys ine
Fox M
ĠErythro poiesis
Ġmonos pecific
Sc ore
gel atinase
Ġimmo bilization
ĠLo e
Differen ces
ĠPDX K
ĠDem onstr
Ġile ocecal
Ġaneuploid ies
Ġseed s
ĠControl s
ĠPLC H
ĠPr x
ĠFI BA
sal t
CCL SG
Tn I
Ġdeox yspergualin
ĠDys function
ĠAdj usting
ĠSn MP
ĠLGL s
mas ked
pharmac ological
Ġprioriti zed
ĠDE VD
afil omycin
neutral izing
Ġfluct uation
Ġpod ia
MPR IN
Ġmisinterpre tation
ĠNET s
Ġglomerul i
conf irmed
Ġaud it
Ġaud itory
Ġpix els
vol ume
Lip osomal
ĠCe acam
Ġphotos ensitizer
Ġhum erus
1800 871
1800 872
toler ant
ĠMt g
Ġpathomechanis ms
Ġoutbreak s
Fl k
osphing osine
Ġenteroc occal
ĠElectro phoretic
ĠEc otropic
tus sis
spect rometry
Ġjuxtap osition
ĠDMN Q
Ġvisc osity
Ka plan
ĠSLL P
Ġscin tigraphy
Hispan ic
ĠInnov ations
cn LOH
ĠBrief ly
Ġequiv ocal
statis tically
Ġinacc urate
Ġbs scFv
ĠTurk ish
Ġindo or
NET s
Ġanalges ic
Ġnanost ruct
Ġunambigu ously
Ġchemores idual
Ġunil amellar
Ġcouns elling
Ġextram ed
Ġneoin tim
facil itated
Ġstakehol ders
bloc ked
Ġpostpon ed
Ġspo res
Ġburs ts
Ġantihist amines
ĠCast leman
Ġmicromet astases
Ġquantif iable
ĠPrk ch
Ġintersp aced
Ġdiaste re
Ġthrombospon din
Ġpipobrom an
- ]
0 92
7 50
7 388
8 50
C min
D IP
F G
F u
F ib
G ra
G ain
H SF
H AP
H MBA
L p
L OS
L CM
L ON
L MC
M ain
M IP
N GF
O PC
P IF
R RM
S im
T ST
U BMT
V EN
W j
X T
Z ip
a UPD
c tively
d p
d oses
d NTP
e NOS
f ed
g li
g iven
g Rs
h if
k x
r unt
s n
s atisfactory
s ensitize
s uccin
t d
t re
t azobactam
w s
y las
z af
Ġa uranofin
re pressed
re pe
on as
he zia
Ġc igarettes
Ġo kadaic
Ġp oli
Ġp ayers
Ġp odophyllotoxin
Ġs CAR
Ġs kelet
Ġs FasL
Ġm PSL
Ġw et
al a
al cohol
ro pho
el ective
as ive
it ous
Ġd iester
Ġre directed
Ġre assess
Ġf en
Ġf ile
Ġb m
ul oxetine
Ġh olistic
ra min
Ġn ong
Ġn ationally
ĠA x
ĠT LT
ĠT rib
ĠT AP
ĠT NTs
im ally
ia d
ur m
ot ria
ĠC AS
ĠC renolanib
et ocho
if ene
ac he
Ġl amivudine
Ġst ark
ran ging
op eroxidase
il encing
um on
ĠM af
ĠM others
oc iclib
ity l
Ġg an
Ġg rip
ts s
ab alin
ĠH Y
ĠH NF
ĠH AD
ĠP el
ĠP EC
ĠP NAs
ĠP okemon
st ra
ĠB F
ĠB lot
Ġcomp osing
ap o
ĠD AB
ĠD ick
ĠD TT
ĠD IA
ĠD urations
Ġun induced
Ġun rest
pec ified
ĠIn patient
ĠF ix
ĠF EC
ĠS or
Ġcyt osin
Ġcyt opathology
ĠW ST
ĠW itness
ĠW SU
Ġat las
pro tect
Ġmo tiv
Ġco res
Ġanti myc
ĠN ec
ĠN DN
ĠN LCs
Ġ5 15
tem in
ure ments
ure tics
Ġrespon sibility
SC A
Ġper mutation
Ġper tussis
ĠO AP
Ġhem ic
Ġse ros
ĠG amma
Ġrec urs
rac tical
Ġsub variant
Ġ0 5
Ġinf arc
ĠL td
Ġover treatment
and a
Ġph ylo
end o
Ġstem s
Ġ6 57
Ġcyto gen
Ġro l
Ġunder methylated
Ġpar af
Ġbi ob
ble ms
Ġnon transformed
Ġnon relapsed
Ġma iled
pend ymoma
Ġimpro per
Ġar ti
ch r
ĠU P
ĠU BMT
ĠU rine
our ney
Ġprim es
Ġinvol vements
og raft
Ġmulti resistant
Ġdisc o
plic ing
Ġimp ractical
Ġme at
Ġmyelodysplas ias
LA L
ĠJ ud
ĠJ mj
Ġdon ov
15 71
Ġsh ot
Ġdi terpenoid
Ġdi uretics
Ġpos ts
ex amination
Ġbec lin
ici ally
erm oid
Ġend om
Ġdown modulation
Ġmy opathy
rop sy
Ġwor ds
les ter
Ġoverex presses
com orbidity
ST IM
ĠBM R
Ġdistin ctively
AP O
ĠMP R
ethyl enediamine
ĠRec iprocal
orph ometric
CA SP
Ġtri terpene
30 25
Ġaz ac
45 8
Ġox ys
Ġlab our
MA N
Ġhaemat opo
ĠX G
ĠX PA
98 01
ĠPD MP
Ġ28 7
Ġhyper phosphorylated
Ġhyper viscosity
ĠCon centrations
allo reactive
AM oL
ored uctive
ĠPro blems
As c
As n
CM SCs
ĠIM Cs
Ġj ourney
70 8
ĠCM K
ins urance
99 90
lor a
ĠCP EC
oper ate
Ġgenome wide
Ġimmunohist ology
ov a
rec iprocal
ĠME Ps
PR s
PR MT
Ġtel ephone
Ġ37 3
Ġ37 6
Ġ37 8
ĠMY XV
ĠZ inc
Ġcategor ised
ĠCC gRs
PT CH
PT Ds
ĠImmun ization
Hodgkin s
ode ox
Ġspl itting
ĠPA LA
Ġnic otine
Ġdeacetyl ating
Ġsubc utis
ĠNB S
anti thrombin
Ġiso electric
Ġ57 8
mod ulate
Ġbl isters
adi um
ereb ellar
Ġshe ets
Ġlys ines
Ġhand le
Ġhaem ostasis
ĠSub cutaneous
ĠCo omb
ĠCo administration
ĠCo agulation
Cyt aBOM
Ġmis diagnos
DM H
Ġur ate
ĠPK S
ĠDe ferasirox
raz osin
initi al
ochrom ic
Ġimmunodef iciencies
Ġretro transpos
Ġtet rach
Ġtranslation ally
ĠBi ology
008 01
ĠSer bian
Ġinser ts
Ad V
MB D
Ġantineoplastic s
lit azone
Ġconst rained
ĠHist opathology
Ġimmunop eptid
ĠEp i
ĠEp CAM
Ġextra hepatic
ĠAD Es
enes ulf
ĠHyp ermethylated
CK D
enz o
Ġimmunore gulation
)] ;
level s
RAEB T
Immun ological
Immun ohist
Ġincl usive
Ġcongen ers
ĠEm atologic
ĠSh orter
Ġpal mit
ĠNor we
Pre treatment
ĠPharmac ogenomics
ĠPost treatment
Ġpara quat
ĠEr lotinib
ploid y
Ġscal ed
ĠLe ishmania
Ġfinger prints
Ġcapt uring
Ġte en
ĠImmunohist ochemically
ĠAI MP
Ġtrim esters
ĠCycl es
struct ured
auto BMT
Ġribonucle ase
eng ers
ĠMan ifest
ĠLin omide
Ġmand ates
ĠTM Q
Ġpent oxifylline
syn thetic
inv olving
Ġdeoxynucleotid yltransferase
odeoxy ribonucle
Ġdeoxy cytid
124 62
Ġglycos amin
circ RNA
Cons iderable
ĠFLA I
Ġtam ibarotene
Ġastro cytic
acc el
ĠSC Es
hel ical
Ġdict ating
Ġperf oration
ococc osis
Ġgranular ity
Ġinterpret ations
ĠNE H
ĠPE CAM
ĠInvestig ating
Min imally
Ġoutput s
Ġdich loride
ĠEpo R
ĠBis pecific
dis parate
myel omonocytic
ĠPers onal
ĠGR K
galact ose
Ġgangli one
URD s
Ġgyn aec
secre tase
Ġabst ract
TI MP
BAL B
hyper diploid
Ġtun e
haemat opoietic
obacter ia
rad ication
Ġdestro ying
Ġhematoc hezia
infusion al
Ġpolyp osis
Ġcef epime
splic ed
Ġfoot print
ĠMX D
ĠMat rix
dia phorase
ik onin
ĠMax imal
ĠSY BR
Accum ulation
Ġappend ectomy
Na B
Ġhab it
Ġdestabil ized
Ġrig id
Ġreposition ed
Ġsphero id
Ġcarboxy fluorescein
Ġmetastas ized
arf arin
ĠFcgammaRII B
ĠAngi ogenesis
osperm ic
ĠPresent ation
Ġvigor ously
ĠFed eration
Ġperit umoral
Ox idative
ĠBle omycin
Ġecto enzyme
ĠMalign ancy
develop ment
conjug ate
Ġpriv ate
Ġdib utyryl
Ġsuccin imidyl
Ġbiocomp atible
Ġfertil ization
Ġengen dered
Ġenfor ce
uns ter
perme abilization
ĠPercent age
Pharmac ological
ĠClostrid ium
sep ithelial
ĠGlc NAc
frag ment
ubiquit ination
Ġinhal ation
ĠHung ary
Ġbabo ons
ĠGlucocortic oid
aglyc one
Ġattit ude
Ġgenu ine
Ġdendrim ers
Ġoncof etal
Ġhyperammon emic
ĠBam HI
Ġargin inosuccinate
Ġendeav ors
Ġqueu ine
Ġjasmon ates
Ġgammare troviral
ĠJe ho
ĠMich aelis
Ġnox ious
anthra quinone
Ġeditor ial
otechn ology
program ming
ISR CTN
Ġrecalcit rant
Ġsurpr ise
Ġperpet uation
Ġnatri uretic
Ġdeaf ness
ĠLon afarnib
Ġbilob ed
Ġbrus atol
Tw elve
Ġcaver nous
Ġtroub les
Ġextrag onadal
Ġcomput ationally
Wj l
zaf ibrate
Ġinfarc ts
Ġdonov ani
% </
2 34
4 26
5 22
6 26
7 44
8 11
8 96
A AD
B SP
B osutinib
C assette
C arcin
C heckpoint
F lav
G PL
H ydroxy
I r
J T
K M
K d
K g
L MR
M as
M ethyl
M IS
M ll
M Ks
M ammalian
P d
Q A
R ad
R ituximab
S kin
S IA
T RAF
V S
V osaroxin
W B
Z inc
a G
c N
c ys
d ish
d Thd
e es
h ar
j u
k az
m essenger
p ow
p erox
p otent
p arental
r heum
s ely
v oriconazole
w ave
y rimidine
Ġa SCT
in er
in ition
in dependence
re cr
ti ter
on vul
Ġc p
Ġc lof
Ġo sc
te c
Ġp OS
Ġp ERK
Ġp aves
Ġp icked
Ġs ore
Ġs emia
Ġs PLA
Ġm ys
al though
is y
is otopic
or ated
an ed
Ġd if
ar se
ar senite
Ġf eces
Ġb ot
Ġb inucle
Ġb rad
os h
om uc
om icin
Ġh int
Ġth iaz
Ġn itrate
ec ho
ec lam
ĠA Is
ĠA ffected
ĠA HCC
ĠT rac
ĠT po
ĠT IL
im mortalized
ur onal
Ġle v
Ġpro drome
si ves
un known
ĠC ong
ĠC MD
ĠC ables
ĠC itro
et rexate
if erous
Ġas pecific
Ġis othermal
Ġis ocratic
se al
Ġl ck
Ġst ores
Ġst alk
Ġst acking
op tic
op ular
op enta
Ġcon gres
um ed
ĠM olecules
oc ardia
iv arox
pl i
Ġch yl
Ġal vespimycin
ab d
Ġdis ag
Ġdis assembly
od icentric
Ġor meloxifen
ĠH ST
ĠH CS
ĠP PMs
ĠB en
ĠB DH
ĠB iphenotypic
ĠB GB
ĠB ilateral
ĠB tk
Ġr in
Ġr ises
Ġinc ur
Ġinc oming
yp ed
Ġcomp osites
ap arin
ĠD ri
ĠD PMNs
ĠD elivery
Ġun antic
Ġun involved
ĠF F
ĠF DP
ĠF CS
ĠS q
ĠS AS
ĠS PT
ĠW inner
der mia
00 67
Ġco herence
Ġdiff raction
ĠR AB
ĠR obin
ĠN omo
Ġ5 13
Ġ5 45
Ġ5 28
Ġreg aining
Ġen ergies
ĠO BF
cl onogenic
ĠG ran
ĠG US
Ġsub sp
Ġsub variants
ĠE d
ĠE duc
ĠE qu
ox aline
Ġout dated
ĠL at
ĠL STRA
ore ceptor
DS T
ip ated
cy an
end ron
ad one
lud in
Ġ6 60
Ġmal aria
Ġcan ertinib
Ġpar icalcitol
Ġprognostic s
Ġ7 69
Ġdec oy
ond ro
Ġobser vers
rol ine
Ġallo responses
ĠK NT
ĠK arach
ĠU CHT
11 99
reg ulators
Ġsec urin
01 29
Ġhyp op
ile y
Ġdisc ouraging
ĠAl vocidib
cent romeric
ass oci
Ġnum eric
21 71
ĠCR E
Ġtox ophore
IT T
ĠJ SH
Ġdon ation
Ġser ver
ĠV i
ĠMD X
po inted
Ġlymph angiogenesis
ram es
Ġpost partum
Ġnucle otid
Ġinfec ting
19 83
56 9
ĠAT C
ĠML R
ĠML Cs
Ġend ure
Ġend opeptidase
ep tidomimetic
iqu imod
PA K
ranul ate
Ġmy o
establ ishing
20 3580
Ġgranul omatosis
ĠIL D
In formation
ĠAn not
Ġmyel osarcomas
Ġnovo biocin
val ence
ST S
Ġrati ometric
25 82
Ġ50 4
ĠBM E
Ġphosph ates
ĠIm plementation
Ġcr ist
Ab M
Ġunc heck
Ġprote oliposomes
ĠAd P
iod obenz
18 26
37 86
26 71
Ġany where
Ġpharmac ist
Ġclon otypes
CA FC
Ġtri terpenoid
Ġsubt yped
24 5
HR S
the se
och lor
Ġaz adC
plo re
Ġtumour igenesis
con version
con ferring
ai ro
ĠRes earchers
ze ylas
IM C
Ġsp henoid
Ġresearch ing
ĠEx osomes
ĠCon focal
29 2
Ġposi tivities
ĠCl pP
Ġhyperm utation
Ġ27 6
Ġdecision al
ophag ic
(-) ).
down regulation
Ġ33 2
Ġdeg ranulate
ĠDC E
ins pired
ĠMS Ds
TP R
rup ted
Ġexpl orative
oper azine
Ġmale imide
Ġ38 2
oly sin
Ġorgan ize
ĠInte rest
ĠInte raction
nc RNAs
ĠQ CC
Ġampl ifies
ĠZ arnestra
Ġquanti fies
inc idence
77 62
AS M
ĠImmun otherapies
54 6
Cd elta
Ġgo es
ĠPA QR
Ġsynthe sizing
ĠAb lation
Ġ67 2
ĠOr ig
Ġ49 1
An nexin
Ġpe aking
BL STM
Ġepid emic
sc reening
Ġmas king
ĠCY BA
ĠSM ZL
OD Y
aps hot
Ġsw ab
cle aved
orb ital
MM s
ĠNA DP
ĠCol umb
Ġple ura
lassi fying
Ġuns aturated
Ġphospho peptides
Ġpneum ococcal
Ġchemos ensitized
Ġion ophores
ĠBi om
NT X
lt rombopag
rand rine
ĠAnti leukemic
atid ylethanolamine
ĠAz adC
ĠSH M
ang ial
be yond
ĠMo ving
ĠTK i
My Ag
inter ference
ĠEP OR
ĠEP HB
Ġabund ances
Ġimmunocomp etence
Pro gressive
ĠIDA ol
ĠPTP ase
HT R
ĠNR BC
Ġsulf ur
Ġsulf hyd
Ġdirection al
Ġsuper sed
olip oplexes
GT G
chrom atin
ĠBR G
Ġimmuno ads
anth one
Ġtom ographic
Ġconn ects
MO LT
ĠSP SS
ĠCO BE
ĠFT IR
Ġthyroid itis
ĠHS L
Ġfer tile
Ġdisturb ing
ĠDel aying
ĠBE VA
ĠTransplant s
carb onyl
Ġabol ish
ĠaCML s
ĠPF OS
Ġinadequ acy
Ġinadequ ately
Trans plantation
Bs Ab
Ġpreced ent
ĠTim ely
omorpholog y
ĠMan ipulation
OK B
ĠFR OUN
Ġden atured
Ġpolar ize
ĠCirc ular
ĠFB S
prote omics
203 2582
haplo type
PG K
ĠHT S
Ġdeoxy uridine
cardi ography
Ġintention al
Ġras buricase
0005 587
Ġanth rop
ĠCr ypt
ĠSel en
Ġidenti ties
ethox yphenyl
Ġdead liest
Ġprovision ally
ĠEffec tor
pair s
ĠIF OS
Ġuro logical
ception s
Ġnarrow ly
Ġradiological ly
Ġnorm oxia
oral es
ĠTSG A
Ġphyt osphingosine
abs olute
ĠATR X
ĠRef ractoriness
iflu operazine
Ġselen ocysteine
ĠNan ocarri
ĠSCN T
Ġmorpho lin
ĠDisc rep
ĠQu iescent
Ġelab oration
Six teen
Protein s
134 6
ĠSiglec s
cyclo hexyl
TGF beta
Ġfores kin
guan idine
ĠPeg ylated
benef icial
Ġenjoy ed
isen ox
Ġhyaluron ectin
lact osamine
Ġstere otyped
Ġneighb our
Ġapproxim ated
BS Is
sal vage
Mi RNA
trim ethyl
elal gia
ĠHistopatho logically
ĠConcern s
Evalu ating
Ġdeox ycholate
ĠrHu Epo
ĠChar les
Hem e
Ġhomogenous ly
599 49
fo ot
ĠTY P
Ġmicrol iter
ĠTD ZD
ĠHan over
Ġdesm opressin
epid oxorubicin
Ġhemangi omas
Ġscle rosing
Ġhapt ophore
cs bp
Ġsacr um
698 6
hetero zygosity
0015 1255
ĠUM IN
ĠExp anding
bur den
conjug ates
ĠHip pel
Pred iction
Ġhomod imeric
ĠNI SCH
068 127
ĠBX H
Ġtonsill itis
Ġvitreoretin al
ĠLight Cycler
serv ations
ĠImmedi ately
gly oxal
star ved
Peg C
ĠPanc ytopenia
Ġdeamin ated
ericardi tis
ĠAgN ORs
ĠTor rent
ĠPOT E
ĠBel inostat
Ġaracyt in
Ġdamp ened
ĠPercent ages
Ġdepart ments
ĠLine ar
Ġillumin ating
Ġtender ness
590 22
464 3786
Ġdeplo yed
ĠIsra eli
Ġginsen osides
Ġnanoc aps
Ġadsorb ed
ĠProv ince
Ġtrade off
ĠARHG EF
health y
Ġsati ety
Ġavoc ad
ĠEmb ry
ĠNTR K
Ġmonom yelocytic
dehydro genase
ĠARL VD
ĠYin ishu
Ġoncomir s
ĠPRKAC B
Ġappreci ate
erom in
cholines terase
Cat enin
Ġepig astric
esign ed
ĠSER CA
Ġpollu tion
Ġunrav elled
953 97
elc ade
astigo tes
Ġdext rose
Ald rich
ĠCoomb s
kaz aki
onvul s
eclam psia
ĠCitro bacter
openta ose
Ġcongres ses
ivarox aban
Ġunantic ipated
ĠKarach i
ĠAnnot ation
Ġuncheck ed
zeylas teral
Ġsulfhyd ryl
ĠFROUN T
0005587 4
ĠNanocarri ers
' :
- </
4 17
4 05
4 85
7 88
8 20
9 15
9 18
9 77
A nd
A HN
C aspase
D B
D c
D ep
D aun
D EX
D OCK
D ifferentiating
D icentric
E I
E SA
F O
F MK
G W
H DS
L PN
M ZL
N OTCH
P NA
P FI
P EP
P rolonged
R x
R HAMM
S MA
T Y
T erm
T eff
U DP
Z eb
b t
c odon
d h
d orf
e osin
i lo
m ening
o C
o ylated
p urine
p otential
s d
u til
v ular
v olution
v orinostat
y cep
y lyl
y anodine
Ġ est
Ġ ZA
Ġ encephal
Ġa CEC
Ġa eros
in ous
re combin
re aching
ti orrhiz
en one
Ġc it
Ġp T
Ġp ra
Ġp RB
Ġp ineal
Ġin struct
Ġs Ig
Ġs uramin
Ġs agittal
Ġm U
Ġm FISH
Ġm cg
Ġm ercury
Ġw ar
Ġw atch
Ġw arfarin
or us
or ations
an im
an olic
an oyl
er ner
ic lo
ic ator
Ġre expressed
ar one
Ġf entanyl
at ypical
id ulin
Ġto d
os oma
os itol
os uccin
om il
ly sozyme
Ġh iPSCs
Ġh OGG
Ġh prt
em ph
Ġth w
Ġn ests
ĠT au
ĠT NC
ĠT oward
ur ity
Ġpro active
un ning
ĠC od
ĠC ap
ĠC ep
ĠC VP
et rosis
Ġac al
Ġis os
Ġres ts
Ġl umb
Ġwas hout
ran olol
op ause
ver teb
ĠI od
ĠI ow
ĠM GFs
ol f
pl atelets
rom e
Ġg BCR
Ġg ather
ab n
ab ove
Ġdis k
Ġv inc
ĠH op
ĠH HEX
ĠH AdV
ĠP al
ĠP ent
ĠP Cs
ĠP GM
ĠP FA
ĠP emetrexed
ĠB GC
Ġr CEC
Ġr yanodine
ap ant
ap art
Ġad nex
ist atin
ĠD BC
ĠD AG
ĠD eline
ĠD CPS
Ġun licensed
pec ting
ĠF anc
ĠF inding
ĠF TBI
ĠF atigue
las tic
ĠS ho
ĠS qu
ĠS itu
ĠS PC
ĠS ON
ĠS anz
ĠW ES
ĠW iskott
NA D
Ġ3 35
Ġco arse
Ġanti psychotic
ĠR ight
ĠN ag
Ġab road
Ġchem otherap
edi ted
edi pine
Ġgen itourinary
SC L
de grading
Ġmet ac
ĠO kazaki
Ġhem ochromatosis
ĠG CM
ĠG PT
ĠG ruppo
ĠE osinophilia
ĠE zetimibe
Ġ4 56
Ġ4 40
bin o
Ġ0 4
Ġ0 14
ĠL ir
ĠL OR
ĠL BC
ĠL UC
ore activity
Ġtransplant ability
DS F
Ġcons ortium
ensi bly
ast ro
Ġmic elle
Ġprom etastatic
ct DNA
Ġnon treated
Ġnon parametric
est rol
Ġ8 75
Ġel utri
ĠK re
ĠK GF
ĠK Cl
ĠK LK
Ġfe ared
Ġra z
Ġhyp ocalcemia
ak ii
Ġmulti omics
ĠAl teration
li ver
Ġocc ured
ĠCR ABP
sup pressed
Ġtox oplasmosis
Ġsensi tisation
Ġdon ated
ĠV OC
Ġdi hydroxyvitamin
12 47
ĠMD V
Ġref lex
AT CG
po oled
Ġda u
Ġpos tim
Ġphen yle
Ġform ats
Ġem t
par allel
MP B
PL ZF
Ġmy otubes
af ur
Ġtransloc ate
Ġgranul omas
38 1
Ġ14 94
In tr
95 471
Ġloc ked
Ġ30 3
ST IC
ST OP
Ġtr ifluoperazine
ĠIm m
Ġoptim ise
Ġprote oly
18 39
Ġ25 00
Ġter fen
ĠAt tention
MR M
Ġconcentr ative
MS Ds
Ġtumour igenic
Ch E
DA UN
oh yp
ĠX V
ĠMDR O
owled ging
ĠEx ome
Ġantic onvuls
Ġhyper lipidemia
AF T
ĠOf ten
ĠCon tro
Ġlink ages
osp amide
AM M
Ġtest able
Ġinflamm asome
CM s
CB A
ĠRT S
ĠCyt omegalovirus
ĠCM F
Ġprevent ative
rone phrosis
Ġgeneral ization
Ġsal es
Ġ48 6
ole amine
Ġdet ach
Ġpractic able
Ġtyp h
uro chol
65 98
Ġ34 3
Ġxenog rafting
Ġtra umatic
Ġfacilit ation
Ġatten ding
HP RT
Ġproced ural
Ġdep icts
AS O
met hod
isp idulin
ĠY L
Ġ39 2
Ġ39 7
ĠImmun osuppression
Ġmat rigel
79 3
Ġdiv alent
ĠPT Ms
HC Q
HC l
Ġpolyc istronic
Ġaden o
ĠGene Xpert
EN U
uan a
aph orin
48 2
48 90
ĠFour th
ĠNB MPR
ĠCFU c
Ġz orubicin
RF s
IN C
Ġolig odeoxyribonucle
pos es
UT M
SG N
Ġextrac orporeal
ĠOnc ogene
Ġintoler able
Ġencoura ges
Ġten fold
ĠAC OT
DNMT Is
Ġbil aterally
ĠBi TE
ĠNon hematological
Ġclassif ies
Ad hesion
Ġdeb ates
ĠDA H
be am
Ġextra hematologic
07 01
ĠEP G
ĠAA V
ĠPG Cs
Ġbul let
Ġbul lous
Pro state
ĠIDA ra
Ġlas ts
ext ra
ĠNR I
Ġsidero blast
anth aridin
201 6
mo bil
mo bilization
ĠPl atelets
Ġintercal ative
bo estrol
Ġemphasis es
ĠFox P
ĠFL U
but hionine
FL D
CX C
Ġcros so
Ġsial oglyc
Over weight
Ġhyd razine
Ġhyd ronephrosis
Ġplasm ocytoid
hom ogene
part ments
TCR s
py ridine
py ridin
116 95471
ĠMod ification
ĠMyelo blasts
Ġsubstit uting
Ġintrap atient
Ġneurop ilin
itig ation
Ġarth ral
AE W
He ad
ĠPred iction
Ġchel ated
Inf ants
Ġscaven ge
Ġproc aspases
ĠLab eling
Met astasis
ĠRadi ological
Val proic
Ġhypo acetylation
udes onide
ĠMEF V
ĠDT ctGMCSF
Ġbring ing
ĠLP XN
Ġunderpin ned
Ġadapt able
Ġauthor ized
Ġauthor ization
lav ine
ĠdC MP
nan ofibrous
Ġnom ograms
Ġlifes aving
ĠCAF s
Ġfood s
finger print
Ġdnr N
oste um
ĠMic roscopic
ĠMuc ormycosis
nitros oguanidine
ocyan in
oxo form
Ġradios ensitive
Ġbuild s
ometh ing
FLA D
Ġprohib iting
Ġjustif iable
Ġdere pressed
Ġaph idis
Fe brile
0125 4890
Ġbud ding
Ġrup tured
More over
Sub stantial
Ġbiotin ylation
Impro vements
Ġaver aging
Ġmineral ization
Ġdimension ality
Ġgelatin ous
Ġanthra quinones
tetrap loidy
ĠBK V
ĠRO BO
ĠTY MS
Ġcentrom eres
Ġrig osertib
Ġsucces sion
Ġhematopatho logic
Ġepiderm oid
hap loid
Ġpigment osum
ĠProphyl axis
intro duced
Ġremodel ers
DMA G
Ġ253 6
Ġortholog ous
Ġaux iliary
Ġhapp ened
Ġdan azol
loro acetate
Ġspi ked
ĠExpl oring
Ġbip otential
Ġtent h
Ġtyros inase
ĠRN ases
Ġelectrocardi ogram
Ġgraph s
ĠColon ies
fibrin olysis
Ġenteroc occi
ĠGITR L
Ġintercon nec
Ġfertil ized
brevi ations
Ġcn LOH
Ġvolunt arily
ĠTur ner
ĠTur key
GITR L
Ġank le
Ġinterrelationship s
ĠSNA I
ĠClostrid ioides
ĠNeutral ization
227 6598
Ġinstig ation
Dys regulated
Ġnig er
Ġautoradi ography
Ġfluoroquin olones
ĠFat ty
ĠSQ STM
ĠExc iting
Ġglu fosfamide
ĠAntic ancer
colla gen
Ġpermis siveness
ĠmS v
Ġost ensibly
Ġfill ed
Ġtib ia
Ġbra akii
Ġheading s
ACh E
Ġarr ival
itux an
ĠPropor tional
Ġmayt ansine
Ġsuperim posed
accum ulation
ĠInduc ible
Ġsurfact ant
Ġbacul oviral
palmit in
Diet z
Ġdissip ation
lofen ac
Ġneurotrans mit
Ġdimethylars inic
Ġbc CML
Ġconflu ence
Ġeuth an
ĠPex a
irin apant
DCT ER
foli o
Ġfire fly
Ġnucleos temin
ĠLoe ys
Ġantimyc otic
Ġseros al
Ġarti fact
Ġcrist ae
Ġnanocaps ules
ĠIow a
ĠDeline ation
Ġproteoly tically
Ġterfen adine
0 86
0 76
3 19
4 45
6 01
7 26
7 40
9 42
9 0009
A min
A NK
A ID
B ase
B reak
C ase
C ON
E AP
E EDC
F ree
G ab
G reat
G MR
G US
I NF
I CRF
I RAK
L ind
M er
M ature
M ark
M uch
M unster
N V
N MD
P seud
Q ual
R BL
S PARC
S pleen
S outhern
U SF
U BA
V RP
V elcade
W h
W BCs
] [
a mental
b an
c ode
e osinophilic
f el
f lux
g un
g ru
g emcitabine
i ens
l ment
l ighting
m OS
n odes
o int
p A
p ediatric
p Rb
r ally
r IFN
s TNFR
s ensing
t amm
t ransition
u ations
v ah
x n
in ar
in eligible
Ġt ion
Ġt ears
re presenting
en ergy
en richment
Ġc PARP
Ġp O
Ġin di
Ġs omething
Ġm em
Ġan onymous
Ġw el
Ġw alls
is omers
ati b
ati l
ro ads
el baum
Ġd ent
Ġd enti
es ophagus
Ġre elin
ar ging
Ġf lud
os ure
ul dipine
Ġh A
em inal
Ġth ric
Ġn s
ĠA ber
ĠA GM
ĠA OE
ĠA ITL
ĠT ween
ĠT RD
ĠT CC
us ariosis
ot opically
ĠC el
ĠC ov
ĠC UR
ĠC gR
ĠC rad
ĠC airo
ut ated
et ylation
Ġleuk openic
ac on
ac ies
Ġex planted
Ġmyelo d
Ġmyelo fibrotic
Ġres isted
Ġl entinan
Ġst one
Ġst alled
Ġst randed
uc k
Ġcon gru
ĠI MS
il atin
pres sively
ine ering
um ine
um ycin
ĠM ER
Ġde pressive
pl atic
ys m
ug g
Ġor derly
ĠH Cl
ĠH ann
yt osine
ĠP ower
ĠB et
ĠB ag
ĠB ach
ĠB AGE
ĠB irth
ĠB ryostatin
Ġr al
Ġtreat s
Ġcomp endi
orm ant
Ġad ozelesin
ĠD RD
ĠD erm
ĠD ensity
ĠD UT
ĠD ana
ĠD MDAPatA
Ġun parallel
ĠIn complete
ĠF AM
ĠF EV
ĠS ol
ĠS AL
ĠS MR
ĠS emi
Ġcyt oxic
ph ar
Ġeff aced
th iaz
th ickness
low ering
pro to
yl thio
00 74
00 006
Ġ3 45
Ġ3 70
Ġ3 57
Ġ3 88
Ġco er
Ġco administered
Ġco hesive
ĠR K
ĠR p
ĠR ag
ĠR atio
Ġrem ittent
ĠN CF
ĠN umber
ĠN utrition
ĠN kx
Ġ5 21
Ġ5 26
Ġ5 30
Ġ5 57
Ġsignific ation
Ġgen o
Ġen ric
Ġmon ocytopenia
ĠO AZ
Ġinv oked
Ġint end
ĠG an
ĠG PC
ĠG lioma
ĠG uang
Ġpre f
Ġno ise
ĠE ti
ĠE DC
ĠE IF
ĠE PR
ĠE LR
ĠE ED
ĠE chin
ĠE ltrombopag
Ġ4 18
Ġdev olution
Ġ0 9
ĠL aser
Ġrisk y
ip enem
ros omal
Ġph arynx
pt otic
we ak
Ġresist in
Ġpar vovirus
Ġpar aspinal
Ġbi weekly
Ġall ied
Ġnon re
Ġnon erythroid
Ġnon redundant
Ġnon preleukemic
ple t
ple ting
Ġfol k
Ġ9 60
Ġ8 13
Ġ8 80
Ġ8 42
Ġblood s
AB I
rol ide
Ġallo transplanted
Ġallo reactions
ill es
Ġmedi al
ch iz
ch ildren
ĠU bc
mon osomal
RA I
RA NKL
01 03
Ġhyp ofib
Ġhyp omorphic
Ġmulti institution
Ġimp arting
ĠCR BP
Ġqu o
Ġmicro deletions
Ġline zolid
ten y
til led
15 24
ĠV ER
ĠV LC
ĠV emurafenib
Ġsh adow
Ġperform ances
Ġdi hydroxy
16 66
Ġselec tions
Ġpos ing
Ġstandard ly
HD CT
33 29
par in
Ġtes ticle
Ġneed ing
ĠAs n
tr ifluor
Ġ14 00
In version
ĠOS I
ĠOS M
Ġprob ands
ues e
Ġtr ivial
ĠRA W
ĠRA JI
Ġmetabol ome
ĠBM NC
ĠBM MSCs
Ġradi i
Ġdos imetric
ind amycin
Ġbiom olecular
Ġmethyl glyoxal
ĠAd r
oxy gen
Ġinform atics
ĠSt ra
CA S
CA Fs
24 24
ĠCN I
of ten
cept in
cal es
Ġaltern ately
SP ES
02 87
Ġdispl aced
HO C
HO VON
Ġdys arth
ĠBMT s
Ġhyper activated
Ġmac ules
29 93
acet amol
Ġadhe red
AM B
Ġgl imp
ĠCl oning
ĠPro of
Ġintra ves
Al kylating
CG TACG
03 01
Ġ26 8
Ġhydro gel
ME SF
ĠCyt ometric
inf rared
ĠHCT s
LI NE
Ġ45 5
Ġmeg abases
Ġ36 3
Ġ36 7
Ġ36 9
Ġ80 6
DNA m
ĠMS K
Ġdistrib ute
erv ical
ĠMT N
Ġorgan izer
Ġreflec tive
Ġneuro imaging
zy lox
ĠZ M
ĠZ heng
ĠPre venting
Ġcategor izes
Ġ44 1
77 9
Ġdep olar
Ġact or
AS NS
PT T
Ġlo osely
Ġexon ic
54 8
ĠMM UD
Ġtrig eminal
Ġher n
Ġher petic
Ġdefin able
97 34
RR s
Ġnan ob
ĠAb ove
ĠSc ot
ĠSc anning
ĠBC SG
Ġz idovudine
Ġvol tamm
Ġbl urred
Ġepid oxorubicin
005 187
Ġ64 6
Ġpredisp ositions
ĠSF M
Ġglut athion
ll a
ĠCH X
Ġsi Mcl
dim ethoxy
ĠCMML s
ĠEn zymatic
Ġcarb amate
ĠDe pleting
Me as
ĠNe oplasm
arabin osyl
onc ologic
Ġpool ing
ĠAR H
ĠAR DS
thym oglobulin
Ġbenz idine
for cing
Ġextra ocular
Leuk aemic
Ġgran isetron
ĠEM MPRIN
fusion s
St age
Ġfil ters
rd heim
ĠUnf avorable
Ġproto zo
sil ent
Ġtrac hea
prom azine
Ġconn ecting
ĠIf i
ĠPharmac okinetics
ĠHU VEC
Ġfollic ul
Ġcorticos ensitivity
sh if
Ġca ught
Ġcess ations
Ġelement al
but yric
Ġrub ber
rox ypro
Ġcyclo pamine
Ġflav us
Ġenl arging
Ġlymphaden opathies
ĠInf rastructure
ars onic
ĠSyn thase
OM s
Ġsteroid al
ĠIs ochromosome
De termining
Ġimmortal ize
ĠCy TOF
phenyl aminopyrimidine
ĠImmunophen otypes
LP Cs
ĠFB MD
ĠKDM s
ĠHP CT
Ġdermat omyositis
Un related
Ġens ured
pur ging
Ġdetox ify
Tr iggering
Cons olidation
ĠTI As
Ġbox es
Ġhap pen
Ġfo amy
ĠCr yptic
evalu ate
fluor ouridine
Ġconform ations
Ġperox ides
Ġperox iredoxin
iment ary
ĠDI SC
Po lo
Ġsa w
mes artan
ĠADM ET
NR W
Ġhex ose
pi rox
sulf ophenyl
ĠHem ostatic
Ġpi lo
Ġadren ergic
Ġdomin ates
ĠBas ophils
ĠRap amycin
ofib ers
ĠProte ome
ĠGA VE
Ġengraft ments
ret astatin
ĠRef erence
Ġpocket s
ĠSm oking
115 54
amer a
ĠHyper CVAD
oin osine
ĠShort ly
Ġseek s
enog rafts
Ġsupposed ly
ĠTNFR SF
Ġaeti ological
Ġtun ed
Ġcorrespond ence
ĠVy as
ĠMic roscopically
Ġvas opress
Ġvas odil
Ġoperation ally
ĠMuc orales
ĠTaq man
ĠCri tically
Ġextrap olating
iop sis
SIR s
ĠRus sia
apt ured
Ġspermat ocytes
Sh p
Ġintram olecular
ĠJohn son
Ġelectropor ated
Ġds DNA
Ġaggra v
Mod el
ĠApp elbaum
ĠrHu GM
ĠSOS T
Ġsymmet ry
ĠRetin oids
Ġcave olin
ĠCardi otoxicity
Ġtran sepithelial
Ġcarboxyl ic
Py omyositis
207 2671
Ġarachid onate
ĠLact ate
hot spot
Ġequival ently
Radi ation
ĠAngi opoietin
ĠPresent ing
ĠRU VBL
ishman iasis
Ġgr ise
ĠSympt om
Pred icting
Par tial
omi R
Ġvirul ent
ICOS L
Ġsto ichi
antho lysis
Ġubiquity lation
ĠDip loid
Cal reticulin
Ġmetab onomics
flav one
Plas macytoid
ĠPortug uese
ky o
icul opathy
oP lex
Ġillumin ate
arox ysmal
anthrac ene
elev ation
ĠZf x
ĠActiv ator
Ġfract ure
Ġcycloph ospamide
NSA IDs
Prolifer ation
Ġoverestim ated
TIG IT
Phosph atase
mH ags
ĠNMD AR
osyn cr
immunop recipitated
Ġdysm orphic
div iding
Ġsatur ating
ĠInform atics
youn ger
ĠNic otinamide
Ġcrystallog raphy
oepid ermoid
ĠPseudo zyma
Fcgamma RI
Ġdephosphor yl
Ġpollut ants
lay ered
Ġban ked
ĠVirt ually
Ġtors ades
ĠHal oPlex
ĠWeek ly
Ġmetic ulous
1663 26
ĠAdd ressing
ĠAch illes
sperm ine
Ec otropic
Tem ozolomide
Ġsubmuc osal
aphtho quinones
Ġskelet rophin
Ġshot gun
ĠJeho vah
opular iopsis
mening oencephalitis
EEDC K
Lind au
ĠcPARP s
Ġthric e
ĠCrad dock
Ġcompendi um
ĠDUT T
Ġunparallel ed
Ġenric hes
Ġdysarth ria
Ġglimp se
ĠZheng zhou
roxypro gesterone
* ,
0 80
0 85
1 001
3 21
3 90
5 53
5 14
6 12
6 23
6 28
7 70
8 37
A di
A oa
B etter
E CD
E LA
E nl
G p
G lobal
G ES
H ydrox
J P
J ECT
L NA
L ight
L og
L DC
L PI
L Vs
M MTV
P DA
R EL
R FI
R emission
T i
T able
T po
b endamustine
b urg
b rown
c III
c TnT
c ultivation
d P
d f
d ual
d ue
f es
f ew
f irmed
g ran
k yl
m CD
m RNAs
n am
n ish
n iotic
p her
p neumonia
r ative
r ast
r henium
s HLA
s orafenib
t ax
x ar
z ol
Ġ lying
Ġt ex
re porting
en et
en otrans
Ġc am
Ġc FLIP
Ġo min
Ġp he
Ġp arietal
Ġs ul
Ġm os
Ġw ished
is ocitrate
ati ds
an al
an at
as ense
it as
it ure
Ġd d
Ġd UCB
Ġd TTP
Ġd ithiocarbamate
ent rapped
Ġf allen
Ġb und
Ġb atch
Ġb ols
Ġb afilomycin
id ofovir
os ensitive
os olic
os plenic
ul are
Ġh MRP
Ġh olding
Ġh iPSC
Ġh sr
Ġh ttps
Ġh ispidulin
Ġth y
ve y
ĠA O
ĠA AC
ĠA CH
ĠA HF
tic les
ĠT ro
ĠT yro
ĠT UR
ia bilities
res id
res hold
ur ge
Ġpro jection
gen in
ot rophy
un ate
un adjusted
ĠC ulturing
ig ation
ut yl
ut omated
Ġac quis
Ġac ryl
Ġfor odesine
ac cepted
Ġex plant
Ġex omes
Ġex onuclease
se g
ant ar
Ġl umin
Ġl ags
Ġst aphyloc
op f
op erated
op ontin
op sonized
il ent
um ar
ĠM ong
ĠM FS
ĠM eningeal
ĠM tss
Ġde ferred
Ġim balanced
Ġch ym
Ġg ibb
Ġv edotin
ign an
ĠH ut
ĠH ill
ĠH undred
ĠP opulations
ir ming
Ġtrans pl
Ġtrans activating
ĠB ra
ĠB Cs
ĠB ackground
Ġr ation
Ġr PRL
qu estion
am eric
ge oning
ist ency
ĠD G
ĠD ramatic
ĠD YR
Ġun t
Ġun identif
ĠIn stit
log raft
ĠF ront
ĠF MLP
ĠS X
ĠS lit
ĠS BB
ĠS ecre
ĠS urviving
ĠS criptaid
ĠS elinexor
ĠW a
ĠW GS
ĠW iley
Ġrel uct
Ġat oms
pro state
pro gressive
pro voked
Ġmo vements
ie x
00 96
00 43
Ġmar ij
Ġmar cellomycin
ess or
Ġco injected
ĠR PN
Ġev oking
Ġev odiamine
ĠN ip
ear ning
di palmitin
ren s
SC D
ĠO F
ĠO TS
Ġinv ited
ĠG rafts
ĠG AMs
iti ous
Ġag ammaglobulinemia
Ġ4 95
Ġ4 000
Ġ4 75
CR BN
port ant
Ġit ching
Ġ0 6
ĠL CT
ĠL andmark
ĠL ARC
ĠL isteria
yn thesis
Ġph ycoerythrin
Ġhe al
Ġmal function
Ġunder diagnosed
Ġsyn cy
Ġmic row
Ġpar an
ocy cl
Ġspec ifying
Ġwho l
Ġnon mutational
Ġnon smokers
%) ).
%) ],
Ġman nitol
ag lycero
Ġ8 41
AB CA
ĠU AE
11 12
11 77
ens it
ucle otides
CD N
dysplas ia
Ġmyelodysplas ic
Ġep oth
ful l
Ġanaly zer
Ġcol cemid
10 65
ĠV C
ĠV IV
Ġexam s
Ġphen obarbital
ex presses
ex ponential
Ġkary o
MP C
Ġmor row
Ġend osome
Ġmy x
ĠCI BMTR
tr astuzumab
ĠAn c
Ġmit oc
ĠAB BV
Ġprob enecid
Ġflow er
Ġflow cytometric
Ġthromb oxane
cr ystal
oss a
05 4
kin s
kin in
kin son
Ġoptim izes
Ġbiom aterial
CI MF
(- );
Ġir rig
CC As
ĠAra U
ĠAra b
ĠSt ar
Ġpharmac ovigilance
Ġshort ens
Ġ100 58
ĠAm p
HR U
Ġ40 2
of acial
rid il
ĠUn its
ĠUn purged
BC S
Ġvir gin
Ġphosphor ylating
MA s
SP E
ĠX i
ds RNA
ĠCon genital
Ġmuc oepidermoid
Ġi As
Ġhep ate
Ġly n
sub population
Ġintra vit
Ġj ournal
jug ular
pre p
Ġpoly unsaturated
Ġwid en
Ġwid ened
Ġfac es
Ġbur geoning
Ġste alth
Ġ48 1
Ġ48 5
Ġdet orubicin
ĠCP P
Ġfib ril
Ġsol es
Ġfacilit ators
ĠQ ALY
ĠHR G
EL F
39 015
PT H
PT N
PT Ks
met ach
isp osition
96 9
ĠIg VH
68 1
ĠComp uter
Ġdisrup tor
ĠAp plied
Ġinst all
Ġemb oli
Ġsynthe tically
Ġsynthe sizes
Ġreactiv ities
Ġdeacetyl ates
ĠPI AS
methyl glutaryl
mark ed
Ġattrib uting
AN L
mod ium
HA A
55 9
pos tive
ĠSM CD
tes unate
Ġhaem olysis
ĠSub stit
eth al
MY D
Ġtw ist
ĠKG la
ĠPC BP
Ġpain ts
ĠID s
turb ed
Ġcarb am
Ġcos timulator
III B
Ġpy ogenic
chan nel
omod ulatory
lof acial
chlor oma
Ġuncommon ly
Ġion omycin
Ġed ges
ĠAnti proliferative
ĠAnti biotic
Ġreproduc es
Ġunex posed
Ġenrich ments
Ġpron ucleus
Ex pansion
Ġtend encies
Leuk ocyte
Ġexpect ancies
Ġmicrog lobulin
lip osomal
lip osome
rs f
Ġgran ulated
Ġimmunocomp rom
Ġparadigm atic
nucle ated
Ġoccup ationally
ĠMPL W
Ġcommun icate
Ġsuper ven
Ġtryp tanthrin
ĠTGF B
ĠTGF BR
ĠMe V
chrom osomes
ĠInd ones
Ġtrac es
anth rene
ĠSoci al
Ġarg u
ĠCor rect
ĠCO OH
ĠMA LT
Ġidi osyncr
ĠEr PC
SH IP
Ġpum ped
ĠTL D
ĠLe ptin
Mul tic
ĠSN S
Ġpen is
ĠFC DSA
Ġpseud op
Ob jectives
Ġlogistic s
Ġjo in
Ġvascul itides
ĠHN RNPA
ĠExt ended
hydrox yc
ĠDr p
Ġanticip ating
ĠArg onaute
dem ethylation
eng ineering
hex adecyl
ĠNucle otide
ĠNO MO
Ġens emble
Ġbrid ges
Ca T
Ġreser ves
ĠBT s
ĠMB NL
ĠFLA N
ĠFLA NG
acc ine
ipl ostim
ĠHh aI
Ġnotic eably
BU B
Met abolic
Ġpig mentation
ĠNeu NAc
SV M
SV T
Ġhex amer
Ġorth otopically
ĠDis contin
Ġsynchron ously
Ġvacu olated
depend ant
ĠNE UT
ĠEng agement
ime ter
CO BRA
Ġbronch us
megakary oblastic
Ġradiolab el
ĠAbs olute
Ġengraft ability
Ġstres sing
ĠNan op
toph ysin
Ġpel let
Ġhypog ranulated
Ġnadir s
Ġ143 6032
Sc reening
Ġburdens ome
ĠDisc ussion
Ġdnr O
ĠTRA DD
134 5
Ġile ostomy
ĠNP Cs
sus tained
Ġseed lings
Ġventi l
Ġpeptid ases
ĠRo quinimex
Ġinos itide
Ġnoc odazole
patho logic
ĠNSC LCs
ĠGn T
Ġbin ning
ĠNCR I
ĠTes ts
Ġhouse hold
Ġpapill oma
sial ylated
pharmac ologic
ĠSepar ate
Ġtriaz oles
Ġphosphoprote ome
Ġhydroly zing
ĠClo retazine
Effec ts
ĠBZ LF
deriv atives
Ġpriv ately
ĠVar iability
Ġeyel ids
Germ line
Ġrhyth ms
ĠNSA ID
ĠBX P
Ġsiglec s
Ġcorp uscular
Ġedge R
Et oposide
Ġseas onal
.. .
Ġfurn iture
Ġcytoc entrifug
ĠPakist ani
Col ony
Ġhemip legia
Ġscro tum
dg A
Ġmetab onomic
Bas eline
Ġtrib bles
ĠAST A
ĠOP CML
Ġreiniti ation
Ġdeform ability
ĠRob ust
Ġhemoblast osis
ĠOptim ization
Ġnonin ferior
opa enia
ĠSHA RP
ĠGlyc ophorin
Ġargum ent
Hispan ics
Ġcytod ifferentiation
anthrac enedione
tric itabine
Ġresur gence
ĠAngel ica
ĠTm x
diox opiper
Ġaliqu ots
ĠVisual ization
Ġrif ampin
Ġerythrom elalgia
Chol angiocarcinoma
LIM K
quadruplex es
Farnes yltransferase
Ġsarcom atous
BMN Cs
ĠOv id
Ġevac uation
Initi al
PROT AC
Ġgamet ogenesis
Ġcontem plate
Ġpolyaden ylation
PRD X
Ġglycosphing olipids
malign ancy
swit ch
rinogen emia
Ġdiethylstil boestrol
Taq Man
Ġapolip oprotein
Ġdecon volution
Ġdiscipl ines
ĠOphthalm ological
Ġlitterm ates
Vir idans
Ġunrel iable
ĠPrincip al
aphosph orines
ĠDemonstr ation
Ġneointim a
Ġgan glia
Ġrol ling
Ġsemia utomated
Ġbrad ycardia
tiorrhiz a
Ġacal abrutinib
Ġanticonvuls ant
Ġinterconnec tions
Ġomin ous
Ġacquis itions
ĠHundred s
ĠDYR K
Ġunidentif iable
Ġmarij uana
aglycero por
39015 33
, )
2 33
2 38
6 11
6 86
7 60
7 98
7 43
8 10
8 05
8 77
8 41
9 02
> :</
A leukemic
C BC
D APK
E ph
E FI
F CI
F eb
G aucher
H MP
H IST
I MS
J apan
M CD
M RT
M echanisms
P ol
P rior
P PAR
P ICC
Q T
Q Ds
R est
R IN
S us
S NA
S ystem
S PM
S NAs
S imilar
S ecreted
T Es
T HU
V av
V AC
V AL
X O
Y n
a ware
b ronchial
c up
d itary
d iam
h orm
h NP
h anded
i C
k S
k ind
l amellar
m row
m FI
n ig
n mol
p lying
p ocket
r antly
s ise
s ympt
s unitinib
s ensitizing
s TREM
s emin
t ag
t ry
t MN
u ating
x ds
in ones
Ġt ul
Ġt rain
on ium
Ġc NPM
Ġc ADPR
Ġo ocyte
Ġo HSV
Ġp aus
Ġp rion
Ġp AbM
Ġin effectiveness
Ġs RNA
Ġs UCBT
Ġs izable
Ġm ine
Ġm HAs
al wa
al phabeta
or se
or ough
ro plet
el ection
as temizole
as parg
it rogen
Ġd dPCR
ic ates
Ġre def
Ġre introduced
Ġb irinapant
id us
id emia
id ae
Ġe pendymoma
ul ted
Ġh oc
ra isal
Ġn ations
ec urin
ĠA NA
ĠA ura
ĠA IL
ĠA IDs
ĠA UROC
ĠT ER
ĠT raining
ĠT RAP
ĠT nl
ĠT gf
ĠT otally
im etinib
ML N
gen otype
ot omies
ĠC CM
ĠC EF
ĠC heckpoint
ig a
Ġac ylation
ce eding
Ġmyelo ic
Ġl ing
Ġst ands
Ġst rip
Ġst ories
uc in
op eptid
ĠI SG
ine ural
um inal
ĠM OR
ĠM IG
ĠM aryl
ĠM yelodysplasia
Ġcom ment
Ġcom fort
iv inostat
pl ed
pl akin
ĠAML SG
Ġch ylo
Ġmyeloid s
Ġg arg
Ġg anetespib
Ġtre es
od ular
od ione
od aunomycin
ĠH un
ĠH RA
ĠH hex
ĠH CPs
Ġha ven
ĠP ros
ĠP ast
ĠP As
ĠP OD
ĠP MC
ĠP LAC
ĠP BFC
Ġtrans glut
Ġcl umping
ĠB CA
Ġr im
Ġr IP
Ġr TNF
am v
ri o
Ġad mix
Ġad alimumab
ist at
ĠD oc
ĠD IV
ĠD CTD
ĠD ifferentiating
ĠD MDC
Ġun per
ĠIn otuzumab
ĠF ran
ĠF AP
ĠF IS
ĠS AT
ĠS EF
ĠS plenomegaly
ĠS urvivors
por al
ĠW olf
th alidomide
pro v
pro filing
00 61
olog ia
Ġanti fol
ĠR g
act uarial
ĠN IS
ĠN amely
Ġ5 65
edi on
Ġen TNF
ĠO IP
ĠO NC
Ġinv ariable
cl adribine
Ġhem or
Ġimmun onegative
ĠG ree
ĠG OS
ĠG EN
ich DMH
Ġpre leukaemia
Ġsub com
ĠE oL
ĠE ilatin
ox omil
CR A
Ġtar sal
Ġpo res
Ġdev ising
Ġfact ory
ĠTh orough
ĠL ink
ĠL NF
ĠL OI
ĠL KP
ip ifera
Ġover whel
Ġph os
Ġcons pic
so ur
dition s
Ġ6 22
Ġ6 80
Ġ6 29
Ġunder served
Ġunder appreciated
Ġpar acetamol
ocy temia
Ġ7 61
Ġlympho proliferation
Ġdec orated
Ġbi ogenic
Ġnew s
Ġappro x
Ġnon apoptotic
Ġnon inflammatory
Ġnon responsive
Ġnon methylated
Ġpl ain
Ġpl icamycin
aus sian
Ġ8 18
cri pts
ĠK F
ĠK R
ĠK up
ĠK ATO
ĠK lotho
ĠU DLI
ĠU CMSCs
Ġra y
Ġra ft
MT OR
MT OE
01 37
og a
av able
av uconazole
ĠAl b
KI s
ber ger
li ximab
CT CF
CT ILE
Ġregim ents
sup er
tho l
Ġsensi bility
Ġinte ro
ĠJ ust
ĠJ ew
spec ifying
15 02
ĠV iability
ĠV IST
ĠV izome
Ġsh HIST
13 65
ĠHere ditary
Ġpost infusion
Ġpost grafting
19 00
MP Ps
oph ysis
ax ation
ocyt omas
ep ithe
PA F
Ġdo zen
Ġmy le
tr b
AK A
Ġwor rying
emb ered
xim e
To bacco
In appropriate
95 4
Ġx antho
Ġdetection s
Ġradi otherapeutic
ĠIm mu
ind olyl
ĠNK M
ĠWT s
OR ETA
Ġmethyl ate
Ġoption al
50 11
ĠAd V
ĠAd olescents
ura zolid
iod endron
rem ic
IS BH
ĠLeuk aemias
Ġrest raining
ĠAm icus
Ġ40 3
DR I
27 157
Ġmed oxomil
plo iting
BC OR
Ġvir ally
ĠST ABC
Ġunf ixed
Ġimm ensely
Ġtransf ers
arb onyl
Ch imerism
ĠX P
ĠX RT
ĠRes ult
ĠRes veratrol
PD s
Ġsp ending
Ġdys regulations
ĠBMT B
98 6
esion s
Ġhyper inflammatory
ĠCon centration
allo p
cyt olysis
Ġcal pain
Ġhypothe sise
osp here
Ġmel ena
acet amido
Ġthrombocyt openias
Ġcho lester
Ġche ap
Al ternative
per ipol
44 1
44 4
ĠCM M
Ġpoly electrolyte
Ġxen o
ĠMedi terranean
28 57
Ġoff icinal
ĠDC OE
ĠAS E
Ġpractic ed
TP MT
Ġangi osarcoma
oper ational
Ġdistrib utes
Ġtoler ating
SA Es
DC F
ĠMT C
ĠET I
nd G
Ġtransl atable
ĠDNR ol
Ġinternal izing
ĠQ LCs
ĠQ LQ
Ġ37 4
Ġrepair s
Ġneuro hyp
Ġscreening s
ĠZ BC
ĠZ yg
Ġconjug ating
def inite
66 4
66 21
AG GG
96 8
ĠY T
Ġ56 3
ĠImmun oreactivity
EM MT
allel ically
ĠComp etitive
ĠGene MAN
Ġdisrup tive
ĠAp g
Ġmeth adone
>- <
48 958
co lored
co enzyme
methyl nog
ĠGen eric
dC SA
anti pol
Ġpa resis
ĠCFU s
Ġbus iness
Ġvol atile
MDR O
005 9
ES HAP
sc oring
ĠCY T
ĠRe h
ĠRe porter
ĠSM s
Ġemploy ees
cle avable
Ġcisplatin um
col lectively
Ġcounter flow
Ġsl a
ĠCo upled
ĠEn caps
ĠEn forcing
ĠNA SH
onic idin
ĠPC OP
EG TA
Ġmid line
ĠSI LAC
ick man
III NP
ibr itumomab
Ġrh SCF
Ġrh abd
ĠMF CI
Ġpneum atosis
Ġchemos ensitize
Ġchemos ensitizer
Ġasc ending
Ġasc orbate
pr iv
ĠInde pend
ĠSer a
ĠCB DCA
Ġclassif iable
non specific
ĠLT MC
Ġax ons
ĠLC FU
ĠMon osomal
Ġimmunop rophylaxis
Ġarter i
ĠMo A
tro ducing
ĠAg ilent
lip o
Ġnanopartic ulate
ĠPG L
cho lesterol
nucle olar
Ġnit rox
ĠLA MPs
ĠEBV aGC
Ġalkal osis
ĠMPL V
ĠInter ruption
ĠSK NO
rd G
isc overed
ĠFA I
Ġcys ts
PN ET
ĠRem oval
amb o
MPO g
Ġtriple x
Ġinters ti
otrop y
mo Ab
Ġinnov ation
ĠPl us
ĠPl GF
ĠPharmac ogenetic
Ġinstit uting
pred ominant
Ġsem a
ĠOCI M
erythro cyte
Ġmicros pect
character istic
ĠTAM C
Ġsoci ety
Ġreticul o
TG IF
ascul ature
Ġmetallo peptidase
ĠLD D
ĠAdv ancements
ĠLY s
eve rolimus
ĠRI NF
ophosph atidic
ĠHN RNP
hom ocysteine
Ap plication
ĠCy CR
Ġrepop ulated
Ġenrol ed
Hyp aque
ĠFlu Mel
RS K
insuff icient
Ġpent avalent
ĠEnd ogenous
ĠHT SC
oprote ase
Ġinterm olecular
ĠMn ks
Ġsmo othened
Ġorganization al
ĠClin seq
ĠClin ics
Ġens ues
Blas ts
ĠSep sis
TA As
Ġglycos idases
ĠSCL N
ĠCV Es
Ġanth rapy
ĠCr KL
ĠLip o
fluor odeoxyglucose
fluor ocytosine
Ġresol ves
ĠSC ORE
dimethyl amino
Ġeukary ote
LV EF
ĠMit ogen
Ġexacerb ates
Ġuter i
Ġentero bacteria
Ġ000 48958
ĠNeu rop
AI EOP
PU MA
Ġnorm ative
Ġnorm oblasts
Ġoper able
Ġmm RD
Ġalloster ically
ĠPO EM
vin yl
ĠNG DN
Min or
Ġphyt ohaemagglutinin
ullo blastoma
ĠDef iciency
Adv anced
Hep atic
Ġgamm opathies
Ġbran ches
Ġterat ocarcinoma
Ġreapp raisal
Ġshut off
Ġget s
ĠContin uing
ĠDLX s
ĠFN III
Fox O
Ġlic hen
ĠErythro poietin
Ġintermedi ately
ĠSOD s
ĠMIT O
Ġweakness es
dihydro daunomycin
Ġfuc osyl
ĠMic rosatellite
Ġenum erated
ĠPur ging
Ġster ically
Ġlac I
Ġcorrobor ates
ĠMSP Cs
Ġharness ed
Ġcentrifug al
Ġchondro itin
FLA I
Ġdic arbonyl
ampl ing
Ġoutper forms
Inte raction
Ġmicrod osing
Ġstere ochemistry
tip ifarnib
ĠLE UTX
Ġmacrom olecule
glucuron osyl
fuc opentaose
ĠRAC ER
ĠJohn s
Ġoligos accharide
Ġaggra vation
ĠsL ORETA
ĠTMD s
ĠKras G
ĠMu DC
Ġmetron idazole
antit op
ocop herol
Ġprecon ception
ĠMethyl transferase
MPR SS
Sup pressor
hap ten
Ġcoordin ates
Dis continuation
Ġattend ance
Ġharmon ize
Ġure mic
ĠmH ag
ĠBar asertib
ĠBest atin
Ġsn apshot
HMG B
ĠCot ylenin
ĠRL IP
omed in
ĠSum mar
ĠQual itative
Ġrot ational
ĠHepat ocellular
Ġdop aminergic
Ġextern a
ĠHEM rel
Ġole ic
Ġplot ted
Ġcope ptin
ĠMethod ological
Ġphagocyt ose
ĠCat enin
Ġbor ne
ĠEST s
Tax ol
Dec ember
Ġoroph arynx
Ġni osomes
Ġolfact omedin
Seven teen
ĠPtd Glc
ĠPEP P
ĠBlo omington
Ġdamp ening
Ġpiec es
ĠFin land
ĠFin nish
MOL M
ĠInnov ative
Ġconsent ing
Lo op
Ġleiomy omas
ophospho lipids
ĠDo HH
Ġsupers et
CLIN ICAL
Ġfluoroquin olone
ĠCEB PE
Ġglia din
ĠPMRD T
tha wing
orr hea
ĠXp bx
Ġdelib erate
categor ization
brid ge
Ġdies ters
estr uctive
complement ing
Ġartif acts
Ġperpetu ated
ĠProp osed
Ġecchym osis
ĠHomolog ue
Polym orphisms
Ġrhinosin usal
Ġhys te
Ġclom iphene
ĠTransduc er
lat ency
Ġneutropa enia
Ġgonadotrop in
ĠMix l
aminobenz amide
ĠYI IS
Ġnomin ated
ĠHGS OC
Ġimmunoc aptured
Ġmicrofil ament
ĠHLT BMCs
ĠNam alwa
Ġhemim ethylated
ĠARP P
commit ment
Ġinterconn ected
Aug ust
diss ected
Ġisoflav one
Ġplag ued
Ġmaxil lofacial
Gi edion
ĠHen an
ĠDW JM
Adj uvant
Ġspargan osis
umon ji
9990 999
Ġdeoxycytid ylate
pow ered
ĠDri ver
ĠazadC yd
ĠEmbry os
Ġisos chiz
ĠHop kins
ĠFanc a
ĠLir iodendron
Ġphenyle phrine
Ġemt ansine
Intr athecal
ĠYL ISGDSPV
ĠAber rantly
Ġcoer ule
Ġhypofib rinogenemia
zylox ycarbonyl
770 6621
Ġparan asal
Ġwhol ly
Ġmitoc ans
Ġirrig ation
Feb ruary
nig uldipine
Ġtul ipifera
asparg ase
ĠMaryl and
Ġtransglut aminase
Ġsubcom partments
ĠVIST A
urazolid one
peripol esis
Ġneurohyp ophysis
ĠGeneMAN IA
+ :
0 63
6 53
6 67
7 15
7 80
7 66
8 17
8 94
9 35
A MR
C isplatin
D en
D auno
D USP
F orm
G ro
G AB
G RAF
G CTs
H AD
H AG
H Ms
J urkat
K CL
L H
L ate
M AML
N N
N DRG
P si
R IF
R III
T LT
T iss
T IL
T LC
U s
V en
V IP
V TC
] =
a ortic
b g
b ecause
c d
d u
d ide
e val
f olding
f ormaldehyde
g lioma
h sp
h uang
l apse
n ate
n imustine
o economic
r ication
s um
t RNA
t raining
u ent
u ously
v if
v ill
v imentin
x azide
y ositis
Ġt il
re ad
re ader
re tt
re ports
on to
Ġc rop
Ġo ught
Ġp ink
Ġp aternally
Ġin struc
Ġs ure
Ġs ight
Ġm omet
Ġan eu
al ive
is othiocyan
an omer
Ġd g
Ġd w
Ġd ates
ent gen
ic ip
Ġf ighting
Ġf ossa
at en
at ography
at ka
Ġb ent
id azine
Ġto uc
Ġwith hold
ly tes
Ġh CG
Ġh inge
ell s
Ġth iamine
ec tic
ĠA min
ĠA Cs
ĠA GVHD
ĠA LI
ĠT ail
ĠT PM
ĠT BP
ĠT EP
ĠT amoxifen
im ents
im ers
im urium
Ġle ishmaniasis
Ġpro granulocytic
lo ugh
un icip
ĠC Z
ĠC os
ĠC am
ĠC eb
ĠC VD
ĠC etuximab
Ġis otopic
Ġres ensitization
uc c
op urin
ĠI CF
ĠI csbp
il ution
ine oplastic
ĠM ia
ĠM IA
Ġcom a
rom atin
Ġal d
Ġal bino
Ġg lo
Ġg DNA
up take
Ġor ient
ĠH ear
ĠH AG
ĠP BC
ĠP recise
Ġtrans parent
ff er
st atin
st rain
ĠB enef
ĠB BR
Ġinc urs
qu o
ain amide
yp hil
ap rox
ap ars
ri er
ri ally
ri tes
Ġun bound
Ġun idirectional
Ġun aware
ĠIn direct
ĠF ocal
ĠS hen
ĠS PM
ĠS onic
ĠS ki
ĠS PMs
ĠS ecreted
Ġass ure
NA DH
NA SE
NA DPH
00 34
ome ters
Ġco immunoprecipitation
Ġanti metastatic
ĠR yR
ĠR III
act ol
ĠN PI
ĠN LS
Ġ5 34
Ġ5 70
edi one
Ġper ip
de azauridine
Ġmet hox
ĠG ir
ĠG CL
Ġpre emptively
iti zed
Ġno isy
iagnos is
rac in
ĠE BM
ĠE mt
ĠE CS
ĠE LTS
ĠE uros
Ġ4 39
CR D
CR LF
Ġ0 8
Ġpres cribe
Ġpres pecified
ĠTh ymidine
ĠL MC
ĠL estaurtinib
ĠL earning
genetic ally
ip athic
ree x
end ous
pt olide
Ġind uration
Ġ6 71
oth iol
oth ymidine
LT s
ard enafil
ble omycin
Ġnon proliferating
Ġnon elderly
Ġnon reciprocal
ser tional
ond on
Ġ9 83
ag in
ĠK SP
ĠU lt
requ ently
ysplas tic
Ġra ys
01 91
av ian
Ġantigen ically
Ġmulti ples
ach y
KI F
21 90
CT GF
ration al
ym eth
ry anodine
Ġmicro L
Ġmicro chip
Ġam ines
cess es
Ġaut ofluorescence
Ġaut opsied
ĠJ ones
Ġdel eting
ne xt
Ġconf id
Ġconf ront
tero car
ĠV osaroxin
ĠV RL
13 77
Ġref inery
az epam
Ġoccur ing
Ġ19 53
Ġcoun term
Ġcoun ties
Ġhist omorphological
Ġpost transcriptionally
53 5
53 6
19 93
60 698
yd ase
ET E
001 80
Ġdown modulated
Ġdown modulate
DH L
ise q
20 2190
over age
In herited
Ġx yl
ST C
AL IP
25 78
Ġmetabol izer
ĠBM AL
HSCT s
ior idazine
ĠIm idazo
ĠCh imerism
IC SBP
ĠAd op
mut KIT
Ġfocus sing
37 4
37 90
rem e
ĠAra bid
ĠSt ress
ĠSt rict
Ġ40 70
gra di
phosph atases
ĠAt t
ĠAt ten
MR K
Ġins ectic
Ġeven ly
ĠHSCT s
Ġcur ation
Ġalpha IFN
Ġgra vin
Ġconc re
DA G
DA VID
FN s
SP RY
Ġwork er
Ġwork shops
omas tia
ĠRes ource
Ġestim ations
Ġdispl aces
ĠEx cellent
Ġutil ising
Ġhyper variable
Ġhyper fibrinolysis
80 6
Ġmac rolide
Ġconduc tivity
29 7
Ġpan ning
rain vill
osp heres
Ġmel t
Ġmes oderm
radi o
ĠPro ducts
Ġly sing
sub strate
CG E
CG ATCG
BMT s
inf ants
Ġpoly chond
Ġfac ile
AR G
Ġmegakary o
Ġcentral ized
ste ps
ograph s
ĠPR ES
uro xazide
Ġtra ils
ĠSCT s
Ġampl if
Ġcalc ification
ĠTrans fer
HP G
Ġdri p
gal us
rag matic
39 3
Ġact omyosin
PT E
PT R
96 86
Ġ56 9
Ġsensiti sed
79 4
Cd r
ĠAL s
Ġrepe ating
ĠGene Scan
me ans
48 4
ĠHOX C
Ġoste openia
FI A
Ġ67 27
ĠSc hering
ĠGen otypic
Ġcontroversi ally
FR ET
mark eting
Ġinn oc
athe ter
ĠCons istency
BL P
005 109
Ġsystematic al
ĠRe pressive
ĠRe expression
ID OX
Ġeti opathogenesis
Ġgluc ocor
ĠCo existence
ĠCo ulter
ĠHemat oxylin
riam ine
med ical
ĠSR Y
put ation
IFN s
Ġcarb onate
Ġcatal ysis
Ġchlor promazine
ĠRAEB T
cont aminated
ĠBi phasic
occ up
ardi an
Ad verse
hydroxy urea
ĠBax ter
Ġimmunop recip
TL p
inos itides
Cy tidine
Ġdig est
enes cence
ĠPG D
ĠIdentif ied
ĠHyp othe
ĠCompar atively
Ġult raf
St ate
ĠTr isenox
ĠAM H
ĠAM egL
Ġsulf onate
ĠInter im
ĠInter fer
Ġmil tiorrhiza
Ġencoun tering
thi oinosine
Ġhope ful
ĠSP F
ĠSP INT
sen ical
ĠPL GA
fluoro adenine
Ġphot otherapy
cycl osporin
Ġaff irm
GL P
BD NF
ĠSE RPIN
ĠWh y
random ly
Ġubiquit inated
Ġlogistic al
Ġfung aemia
encephal ic
sur ance
ĠPBP K
Ġencaps ulate
Epigenetic s
Ġanticip ation
Ġpass aging
Ġcover t
oz antinib
dem ethox
eng rafting
OK T
116 57
ĠFR ET
mor bid
Ġamelior ating
hex idine
ĠIG K
ĠCirc RNAs
ĠFB XL
Ġane ur
quin oxaline
Ġpeg interferon
FM CA
Ġinfar cted
ĠOb viously
Ne oplastic
cardi otoxic
Ġreser pine
Cons idering
ĠMUD s
Ġeduc ational
Ġfo am
Ġfo rel
Inf lammation
Ġproc ainamide
Ġmultim ers
Ġgram icidin
Ġrepur pose
Ġrene wing
Ġexacerb ating
ĠMyel omonocytic
mul tipotent
Ġindisp utable
Inter cellular
ĠGranul ocytes
Ġconv ulsion
Ġuniqu eness
Ġhal ving
Ġge ometric
aem p
ĠLys ine
Ġlob ules
ĠHo ok
Ser ial
Ġauthor ised
Ġunderex plored
arin apars
encaps ulation
Ġosteoclas tic
nan opro
ĠContin uation
Ġglomer ulos
ĠLN Cs
ĠVer sion
Ġspati o
Ġmini atur
Ġexerc ises
brom odomain
Ġfuc ose
ĠVy atka
Ġile al
ĠMuc or
Ġbed s
ĠTIG AR
strom a
azid opine
ĠRo yal
Ġmicroorganis m
ĠPeg filgrastim
FLA MSA
Ġdic lofenac
ampl ifications
Di rect
Ġjustif ying
Au SCT
Br PA
ĠOcc ult
ĠMeas uring
ĠMeas urements
Mi RNAs
globulin s
ĠSY NE
TOP O
Bl adder
elic ited
Ġpericent rin
place bo
Ġunw illing
icol a
Ġamph otropic
Ġamph ipathic
Ġsemin omas
Sup portive
epid ermal
tra umatic
hybrid ization
ĠAMM oL
dri ed
Ġnaphtho quinone
Ġepilep tic
Combin ed
ĠRam os
ĠBar rett
ĠAnt agon
Ġchori o
TRA MP
Ġpedig ree
ĠGluc uron
ĠMalign e
penet rance
Ġnotor ious
conjug ating
rho tic
omed ullin
Ġtrab ectedin
Ġsurround s
hydroxyp ropyl
ĠSl ight
Ġga it
AV N
fibrin ogen
557 46
serv ative
Ġrew ire
ĠMethod ology
mat rix
ĠCharacteristic s
ĠNano String
Ġsession s
ĠPerm e
Tes ts
Ġjuxtap osed
ĠEGT A
ĠConjug ation
Ġgranulocyt openic
ĠNeutral izing
arter ial
ĠBrom odomain
sero positive
NSA ID
Ġreferen t
ĠDefin itive
antagon ist
Ġaliqu ot
ĠPf izer
Ġbacteri ophage
Ġinadvert ently
cephal us
ĠBLA ST
ĠEnrol lment
rg tm
ĠClear ance
Ġpathobiological ly
ĠELIS POT
ĠGlut amine
Ġneighbor hood
Ġlign ans
Ġsuperv isory
Ġpall or
Ġelectrosp ray
Ġvertebra e
ĠScutell aria
percent age
Cyclo oxygenase
ĠMultid imensional
Ġmiscarria ge
Ġgeranylger an
Ġcany on
benzox ad
Pe ak
ili ximab
mHA gs
Ġlivid ans
Ġformul ae
Ġoxaz aphosphorines
Ġnonsemin omatous
etabol ites
Ġefflu xed
Ġepist axis
Prkdc scid
Ġschizophren ia
Ġelectrochem il
ĠCoron ary
Ġdenomin ator
Main tenance
repe at
ĠAx itinib
otria zole
stra galus
Ġunrest rained
Ġhemic olectomy
Ġglycosamin oglycans
Ġtroubles ome
perox ydase
ĠCong ress
bt b
Ġtod dl
Ġelutri ation
ĠKre bs
Ġtyph imurium
Ġeuthan ized
ĠCel gene
ĠHann over
enet riamine
Ġhepate ctomy
Ġantifol ates
ĠGree k
ĠKup ffer
Ġofficinal is
Tiss ue
Ġmomet asone
terocar pan
60698 5
00180 115
ĠArabid opsis
rainvill amide
Ġpolychond ritis
005109 26
arinapars in
' '
' ),
- ],
/ '
0 84
4 33
4 70
5 10
5 45
7 81
8 38
8 48
8 42
A CL
A ging
A lemtuzumab
C Q
C OS
C ER
C hester
D EG
D BA
D ormant
E vi
F SC
F PA
F LAM
F usarium
F ollicular
G ran
G CSF
G AM
G lioma
G ADD
G VT
H CMV
H oxa
K DR
L B
M r
M PM
N SE
N LS
P RP
P ancytopenia
Q RT
R are
R VI
S o
S olid
S AP
T IC
T AN
b A
b rachial
b server
c et
d ic
d aun
d ifferenti
f used
f rail
g rin
h QPA
i ren
l terin
m h
m atching
n ell
n owledging
p arenchymal
r itation
s Ig
s mo
t yping
t ocopherol
u f
u ard
u lectomy
v ille
x A
} ,
Ġa sial
in compatibility
re activated
re versing
Ġc MET
Ġc TCL
Ġo estrogen
Ġo mitting
Ġo esophagus
Ġp lec
Ġin activity
Ġs yphil
Ġan aemic
Ġan esthesia
Ġw ax
al e
al amin
is sible
or ous
or ds
an ia
an oic
an other
el ement
as paragine
it an
Ġd ithi
ed er
ed ge
Ġre ward
le ft
ar ming
at ran
at tie
id ze
os acral
ul is
ul tivated
Ġh MDS
Ġh osp
em y
Ġth yro
Ġth ings
Ġth ioridazine
ĠA ck
ĠA beta
ĠA xin
ĠT MA
ĠT GM
ĠT opic
ĠT MC
ĠT anshinone
ur gery
Ġcell ulitis
Ġpro tr
ĠC i
ĠC ure
uk er
ig m
ig us
Ġac r
se eds
ant rene
Ġl ining
Ġl amp
Ġwas h
Ġcon forming
ĠI NA
ĠI de
ĠI terative
ĠM ev
ĠM ental
ĠM ars
ĠM egakaryocytic
Ġcom utation
iv ir
Ġim iquimod
pl ated
Ġch ymotrypsin
Ġal coholic
Ġdis orientation
od ec
od ocalyxin
Ġv ial
ĠH CD
ĠH PP
ĠH airy
ĠH iseq
ĠP SF
ĠP RP
Ġtrans verse
Ġcl indamycin
ĠB ig
ĠB GP
am l
Ġcomp ly
Ġcomp ute
ap orin
ap Seq
ri ers
ĠD un
ĠD yn
ĠD ok
ĠD urable
ĠD ifferentiated
Ġne arest
Ġun cl
Ġun question
log ies
ĠF re
ĠF it
ĠF ig
ĠF ac
ĠF red
ĠF ram
ĠF ET
ĠS uc
ĠS CM
ĠS chin
ĠS ftpb
ĠS rsf
th oracic
Ġat m
low CD
pro lyl
Ġus her
00 44
00 42
00 78
00 224
Ġ3 96
Ġco regulated
Ġco localization
Ġco umarin
Ġanti zyme
Ġanti myeloma
ĠR FI
ĠR FB
ĠN ectin
Ġ5 88
di en
Ġeffec ting
Ġreg ios
Ġen ding
Ġmon oxide
ĠO GT
ĠO pin
Ġint uitive
Ġcont our
ĠG ap
ĠG BMT
ĠG AD
ĠG SS
Ġactiv in
Ġrec re
Ġsub ventricular
Ġsub nuclear
Ġsub optim
ĠE H
Ġ4 36
pho resis
Ġinf ers
Ġinf liximab
ĠL os
ĠL MB
ĠL IG
ĠL enograstim
ĠL xn
ĠL esions
ĠL ondon
yn il
Ġtumor ogenesis
term inating
ari o
Ġ6 64
Ġ6 93
Ġcyto genomic
Ġro entgen
Ġunder treated
Ġ7 97
Ġlympho granul
Ġspec iation
ult ry
Ġnon viral
Ġnon histone
Ġnon adverse
Ġnon healing
ple mentary
34 54
ort in
Ġ9 27
Ġ9 69
Ġman eu
ag i
Ġ8 000
Ġ8 94
Ġchrom ogranin
Ġel ude
ill ar
mon onuclear
mon itoring
ric k
Ġfe eling
ysplas ia
reg istration
ens zel
MT O
01 40
01 06
Ġhyp oglyc
av ior
Ġmulti lineal
fore ign
Ġsc hol
Ġimp rint
ĠCR D
Ġqu est
Ġmicro f
Ġam orphous
ful ven
ĠJ B
ĠJ ord
ĠJ nk
10 50
trans lation
trans locations
ĠV CM
ĠV eno
ĠV olasertib
Ġ12 92
ĠMD ACC
az e
az z
Ġhist oplasmosis
ex am
AC P
33 2
erg ot
ĠTo kyo
17 35
par tite
ĠPh orbol
56 42
PL S
ax o
ocyt hemia
OS IS
PA SE
)- ,
atric ide
omic ron
20 449
ĠIL s
EB NA
Ġprec ancerous
Ġmit ral
MD F
ST AG
AL I
ĠRA E
ĠRA N
Ġ50 8
Ġplas mon
Ġthromb ocytemia
Ġprot uber
ĠIm plications
euk emic
ĠMP Ps
ĠJAK i
Ġcarcin oids
Ġcount less
Ġir ritation
Ġsaf eg
RP s
Ġerythro derma
Ġblock ades
Ġrep utation
CA I
CA MPATH
the sized
Ġprior ities
CN I
Ġcontinu ity
Ġins oluble
Ġalpha GalCer
Ġgra vis
Ġunf eas
ĠCT SG
DA H
Ġcent uries
90 9
ner able
ĠOver weight
98 1
IP R
ĠPD MS
Ġmac ular
40 70
cyt okines
cyt ometer
ĠWith drawal
IR E
Ġpan or
lympho poietic
acet one
NF H
Ġi terative
ĠPro B
Ġthrombocyt opaenia
Ġhyperm et
ĠPB K
Ġdeletion al
Ġintra vital
Al pha
Al lyl
Ġj umping
Ġwhere ver
Ġ29 6
Ġmelan ocyte
44 6
VI A
MN NG
ĠER Y
Ġcardi ogenic
art on
Ġsib s
28 2
PB Ls
Ġoff icial
AD I
ins ulin
Ġpep tic
ĠPR SS
ĠBec k
Ġ34 7
ades ine
vari ance
Ġnetwork ing
ĠQ Ds
ĠAN NL
ĠMY ADM
Ġrational ise
Ġrational ize
ĠPre ventive
Ġcategor ical
inc RNAs
Ġ44 3
ĠPML RARA
ĠGST mu
PC yR
87 6
Ġemb rac
Ġdereg ulating
co iled
Ġmultic lonal
Ġred ness
ĠAcc elerated
RAR s
Ġclos est
Ġble ed
Ġz o
mod erately
Ġfatal ities
Ġprepar atory
Ġchimer ical
ĠHD Is
005 144
Ġput ting
ĠCY B
pos itories
ĠSM YD
dim CD
eth amine
Ġmamm al
ĠNA E
ĠRel atives
ĠMC J
Ġextrac ting
icro bial
Ġbleeding s
Ġcereb ri
ĠReg imens
ĠID US
Ġcleav ages
Ġhar ringtonine
IFN a
ĠPK Cdelta
ĠNe o
Ġpy ram
DL X
Ġretro grade
Ġtet rac
Ġmagn et
ĠMK s
JAK i
ĠSp earman
Ad olescents
MB T
Ar ginine
ĠMon te
ĠDA UR
Ġrepeat ability
mg r
Ġoligonucle osomal
ĠMut ants
Ġstabil isation
Ġcytos ar
Ġposition al
HT S
ĠLA U
ĠLA NA
Ġfund us
ĠInt rap
Ġspectrom eter
ĠAut omated
tet ram
Ġcircum vention
Ġcircum stance
009 00224
Ġmess engers
Ġspar sely
ĠSU RVI
ĠIR E
Ġdest abilizing
Ġpal ms
Ġhisti ocyte
bo ard
strati fying
NE QAS
ĠPost mortem
Co operative
ĠHS ulf
Ġaff licting
Ġfer ric
ĠSpec imens
cons isting
des cent
Ġmultiplex ing
Ġdil ute
tub ule
Ġtrim ethylated
Ġhyd razide
163 11
De po
ĠGl axo
ĠSL FN
Ġinterrup ting
Ġfeed ers
induc er
ĠImmunophen otype
Ġmand ate
Mo DC
antigen emia
ĠGP AT
Mon onuclear
ĠTherapeutic s
ĠTM I
sw ap
Ġintrat racheal
prote cted
Ġmainst ays
ĠRho x
ĠClonal ity
syn thase
ĠSW I
inv igor
Ġdermat ofibrosarcoma
Ġregen erate
Ġquick er
anol s
oprote omic
ĠMal attie
Ġerr one
026 2
Ne o
functional ized
Ġspan ned
Ġglycos idic
Ġcogn ition
yal gia
Ġfo etus
Ġmatur ating
ĠPred icted
ĠBI OSIS
silon RI
Com orbidity
Com orbidities
Ġfulf il
ethox yb
ĠFe atures
Ġpig ments
ipodophyllot oxins
ĠSV C
Ġobsc ured
Ġfin ished
ĠNeu ramin
Cr ypt
ĠTet ramer
Ġnorm ocytic
Ind ications
Ind oleamine
ĠRP PA
sulf oximine
ĠHem oglobin
Ġpack ing
Ġce ase
ĠAct ually
Ġintrigu ingly
Ġmom elotinib
dL N
ĠEB ER
dis rupting
ĠPers on
ĠGR II
ĠProte asome
ĠGG CC
Ġpyro ptosis
Ġchick s
104 5642
amid um
Ġpel lets
MUD s
wor th
DF F
pers istent
pers ister
Ġunderestim ation
Ġaglyc on
Ġtun n
ĠHetero geneous
ĠFU rd
GTP ase
urg ical
ĠDP YD
Ġcorrobor ate
Ġfron to
Ġafford ability
Ġheterodimer ization
ĠHi Seq
ometh ane
MET HODS
ĠPhosph atidyl
Ġspermat ozo
phosphatidyl choline
Ġbud get
ĠQing huang
Ġintram ural
Ġgas oline
Ġremit ted
ĠHF CL
Ġpyr rol
Ġaver ages
Ġaggra vate
ĠHH IP
Ġirregular ly
Ġblun t
ĠFPD MM
ĠRF X
Ġfre ely
imb rin
Ġgent uzumab
Ġchr ys
Ġslo pes
Ġpigment osa
Ġos mol
Ġos seous
Ġspectrophot ometry
Ha enszel
ĠDiff ic
ĠProb abilities
Ġure thane
Ġtag ging
Ġaux otrophy
ĠConsider ations
Ġsn ail
ĠPneum onia
ĠRich ard
Sm ith
HB c
ĠBZ M
Ġcompact ness
ĠFil tering
Ġbiotechn ological
Ġgam ut
ĠDu plication
ĠStep wise
Ġrequ est
Ġdissimilar ity
Ġhydroxycarb amidum
fibrin olytic
ĠSubset s
Ġtack led
Ġgels olin
ĠPy omyositis
yline Dx
Ġopac ification
ĠCOS MIC
ĠHa CaT
Ġengen der
gly cin
Ġozog omycin
Ġvign ette
Nov artis
Tax R
tw ined
Ġmicrohom ologies
Ġcrystall ine
ĠAur A
ĠFAN CF
ĠTor onto
Ġpiec e
Ġgranulocyt opoietic
DOT A
Ġss HHT
ĠFund amental
0011 1345
ĠHs ps
integr ity
ĠAdap hostin
ubiquit inated
ĠAngel es
Ġprotop orphyrin
ĠCarb oplatin
Ġmyelodys platic
Ġextingu ished
Ġcapital izing
categor ized
Ġfr atricide
ĠPublic ly
ĠFoc us
ĠFoc using
phot on
Ġinterchange able
ĠArabin oside
Ġmasquer ade
Ġtrabec ular
Ġtrabec ulectomy
Character ization
Sw iss
ĠSk ylineDx
ĠLap atinib
hydropy ran
Sn MP
Ġinvest ments
Ġxero derma
atten uated
ĠAnalog ous
Ġschwann oma
Ġpuzz ling
cur ve
Ġporphy rins
Ġelectroph ysiological
Ġtyr phostin
Ġeuch romatin
ĠMAG ED
Ġobste tric
spe aking
Ġfla wed
Ġak lavinone
Ġba ical
ĠPul se
Ġinsid ious
ĠAcl acinomycin
ĠBeta ig
ĠApparent ly
Ġsarcoid osis
pron ged
Ġtang ible
Ġunim pressive
ĠReproduc tive
his tidinol
Ġneuropsycho logical
Ġcab ozantinib
Ġweap on
osep tic
Ġsubenti ties
mercapt opurin
entix afor
ĠLef t
ĠLamin in
Ġdemyel inating
Ġepip od
ĠCAS PASE
ĠNorwe gian
accel erating
ĠSq CC
iclo pirox
urochol ate
atil ity
Ġvoltamm etry
resid ue
Ġnoninferior ity
cup ine
Ġintero bserver
2857 58
ĠGir ona
Ġconcre te
Ġinnoc uous
Ġglomerulos clerosis
Ġsyphil is
ĠAck nowledging
ĠTopic s
ĠSchin zel
ĠOpin ion
Ġsuboptim ally
Ġschol ars
ĠJord an
Ġprotuber ans
Ġsafeg uard
Ġunfeas ible
005144 88
ĠSURVI VIN
ĠNeuramin idase
Ġspermatozo a
) '
) >
. /
4 77
4 69
5 13
5 70
6 21
7 69
8 95
8 65
A XL
A sian
A tt
A rea
B er
B ank
B AFF
B acillus
E wing
F o
F in
F As
F ungal
F Ps
F indings
G o
G Cs
G add
H Cs
H EM
I U
I f
I on
I EM
K H
K LAK
K SHV
L IL
M IM
N f
N i
N OR
N LC
N ES
O DH
O dds
O rig
P Q
P aroxysmal
R un
R NS
R LS
S y
S odium
S udden
S ingapore
T ru
U E
V in
V er
W estern
a is
b ach
b elow
b aceous
b udesonide
c ov
c assette
d ry
d UCB
f u
f osine
f avourable
g ate
g ot
h CT
i us
i NKT
j ust
k str
k opf
m en
m ds
m DCs
o rene
o formycin
p ension
p ridil
r ubicin
r GO
r hodamine
s ched
s ame
s hel
s FRP
s pontaneous
y rol
z in
Ġ ug
Ġa lo
Ġt ell
Ġt ank
re ading
re ticular
Ġc T
Ġc yp
Ġc ow
Ġc AML
Ġc Ig
Ġc idofovir
te ra
te cting
te worthy
Ġp ter
Ġp ho
Ġp emph
Ġin osine
Ġs it
Ġs un
Ġs oc
Ġs ash
Ġs MIC
Ġs tilbene
Ġm ined
al tern
or is
an ing
an emia
Ġd iam
Ġd rink
ed d
Ġre occurring
Ġre implantation
Ġre joining
le aned
Ġf ission
Ġf azarabine
Ġb illing
Ġb lown
ing ding
id ul
id igm
Ġe rection
os il
om ol
om ori
om ogram
Ġh CTM
Ġh KSR
Ġn a
ec e
ec rolimus
ĠA X
ĠA ALL
ĠA LAK
ĠT NT
res eni
Ġpro B
Ġpro MMP
ĠC ut
ĠC ateg
ĠC MS
ĠC PD
ĠC CB
ĠC HA
ĠC EBP
ĠC ryopreserved
et ary
et antrone
Ġac ro
ac a
ac tively
Ġas part
Ġis let
se ros
ant oic
Ġl ights
Ġst asis
op ping
Ġcon d
ĠM J
ĠM iss
ĠM NP
Ġcom utations
Ġbe pridil
ol der
ol ane
Ġim pressively
Ġal umin
Ġg ame
Ġg ivinostat
Ġg leaned
ab lastic
up loidy
Ġdis hes
ĠH ans
ĠH SR
ĠH dm
ĠH uang
ĠH AND
ĠH ickman
ĠP ow
ĠP atched
ĠP HL
ĠP aternal
ĠP ingding
Ġcl ival
st roph
ĠB ul
ĠB LM
Ġr hod
Ġinc urred
orm oblasts
ĠD l
ĠD imin
ĠD omb
ĠD MPs
ĠD KO
Ġun proven
Ġun anim
ĠF olate
ĠF arber
ĠS ant
ĠS par
ĠS eg
ĠS ample
ĠS timulated
ĠS tenotrophomonas
igh ted
ĠW ang
ĠW erner
ph rotic
Ġsign ed
pro phyl
pro staglandin
yl ines
one y
othe lin
Ġco insurance
Ġanti CD
Ġanti par
Ġanti epileptic
ĠR ing
ĠR PA
ĠR ON
ĠR NS
ĠR FT
Ġrem itting
ĠN ig
ĠN omogram
Ġ5 01
Ġ5 20
Ġ5 24
Ġ5 36
Ġ5 66
Ġgen ic
Ġgen ders
ren ds
SC R
ges tin
ĠO PA
ĠO per
ion yl
Ġse baceous
ĠG SPT
all antoic
ormal in
rac inostat
rac iclib
Ġsub additive
Ġsub ordinate
ĠE OCs
Ġ4 28
Ġ4 138
ox il
Ġout do
Ġbet ulinic
bin ders
Ġinf using
ĠL ic
ĠL HX
ĠL nk
ip ar
ip ped
Ġover activated
Ġover produced
Ġpat ented
ad ic
ad raciclib
term ine
Ġ6 34
Ġ6 25
Ġ6 37
form at
Ġexp ir
Ġmic onazole
oth re
oth orax
Ġlympho depleting
rib ofuranosyl
Ġnormal izing
Ġnon functional
Ġnon competitive
Ġnon homologous
Ġnon irradiated
34 9
Ġma gic
ag ar
Ġ8 45
Ġallo immune
Ġallo PBSCT
ill iant
ĠK MS
ĠK AI
Ġar d
ch ic
ĠU sp
ĠU CK
11 28
Ġpredic ated
Ġhyp usine
Ġprov okes
og els
av y
Ġdisc s
Ġgrowth s
min thic
loc ks
ĠAl dehyde
Ġsc RNA
acy cl
ym p
Ġcommon alities
Ġli ters
ĠJ EG
10 38
Ġser glycin
ĠV ite
ĠV KA
Ġ12 05
12 34
PM P
Ġref ractive
Ġmin ire
Ġhist ochemistry
Ġform azan
ke wed
Ġem ulsi
hod gkin
Ġnucle oplasm
53 808
19 80
ma gnetic
56 8
ĠAT T
Ġpolym yalgia
ep tic
cin osis
cin onide
Ġmy loid
Ġonc otherapy
af etinib
Ġes c
Ġexpos es
ĠAn alys
ĠAn ecd
ons tit
com ine
Ġtr ies
yth ymidine
Ġset backs
ĠBM C
Ġunderstanding s
lot oxins
ind le
ĠCh AT
ĠMP seq
Ġerythro leukemias
ĠHL F
Ġfocus ses
ĠOn co
ĠOn comine
37 6
ĠSt aging
ĠSt athmin
CA RD
Ġnec ropsy
ĠNo teworthy
30 7
IL S
Ġretros pect
)/ (
of ection
Ġsumm ing
CN C
CN DAC
ĠAt ra
ĠST OI
Ġcur tailed
Ġcirc MY
urs ors
45 53808
Ġconc urs
oh orts
02 38
90 4
app arent
Ġsil ic
IM iD
ĠCom m
Ġestim ators
Ġproduc tivity
Ġdys lipidemia
asp ir
ĠPD PN
NP V
Ġhyper trig
AF Y
ulf ide
allo on
Ġhom ologies
ade oxycytidine
Ġmes odermal
Ġmes angial
Ġadhe siveness
Ġly so
As paraginase
Ġ27 80
CG R
cep silonRI
DN X
CB R
ĠCyt o
ĠCyt oreduction
ĠCM MRD
Ġpoly amines
PB HSCT
opy ruvate
Ġdeg lyc
Ġ48 3
Ġ48 8
ole ic
ins ured
Ġpep R
Ġpep tidomimetic
ĠPR I
oper fusion
immun osuppressive
Ġcytoplas ts
Ġhospital ised
SA MD
ob alamin
Ġmacro cytosis
Ġ37 7
Ġtermin ator
ĠZ oledronic
ĠZ hang
ĠZ INC
Ġrational izing
ĠTrans formed
HP S
Ġcategor izing
CH G
77 1
77 8
77 57
BI D
ĠImmun ology
54 61
Ġmat hematic
ĠMR E
Ġgo at
97 6
ĠAp elin
Ġinst ant
me ter
Ġacet al
versi al
Ġoste olysis
ĠOr ally
Ġpe er
mark ers
Ġback ward
Ġamin othiol
Ġolig opeptides
Ġshe et
sc a
sc an
ĠRe pression
Ġbio assays
Ġfibro genesis
dim HLA
gin ia
Ġclar ifies
ĠWorld wide
ĠDown stream
ĠHSP B
Ġspect rofluor
Ġur ban
Ġcereb rum
ĠSI Bs
Ġamino acid
Ġcos mid
Ġturn s
Ġplasmacyt osis
Ġreason ing
Ġpneum ocystis
Ġbil iver
OG T
DL K
aden opathy
ĠSign atures
Ġchemos ensitivities
Ġmen opause
orte x
micro environment
ĠBi ochemistry
Ġbo ard
Ġbo ok
Ġdex niguldipine
aut ograft
Ġbelie fs
Ġepis omal
atid iform
ĠTF P
ĠDA E
ĠDA VID
ĠHist oC
FA CT
Ġarter io
Ġester ases
Ġrad iculopathy
ĠTK is
Cy te
Ġren amed
ĠFc R
ĠMG DF
CFU s
char ge
Pro gression
Ġtransm issible
Ġmening oencephalitis
Ġmening oseptic
Ġect odermal
Ġfil tered
Ġmitotic ally
Immun oglobulin
Ġdist or
ĠAut hors
ĠSU LT
alk er
ĠInd icators
Ġtrac he
ĠRem aining
PK A
prom o
anth idin
ĠSA Es
ĠCor ticosteroids
ĠPharmac ists
ĠMEK K
Micro transplantation
sh an
Ġbrom o
ĠHep a
Ġprotect in
ĠPL WH
Ġphot opho
011 2
Ġaff iliated
Ġbirth s
ĠBe Wo
Ġpen al
ĠGra vin
Gl ucose
ĠMO F
hyp ocellular
Ġdil ation
Ġdil atation
ĠTA Q
ĠTox oplasma
Ġcollabor ated
Ġsial yltransferase
ars ine
Rel apses
struct ural
armaceutical s
chem otherapeutic
Ġcav ities
Trans cript
ĠCL B
ĠCL IC
oz ide
Ġfeed forward
ĠALDH s
Gene tically
Ġfluor izoline
pan el
DT PA
LP XN
ĠRho B
syn thesis
inv estig
ĠEnd o
Ġsperm idine
ĠHT B
ĠMet AP
Ġens ue
here after
jo int
ĠDH AC
Ġfal cip
ĠGIST IC
ĠRet rie
ĠOb atoclax
ohyd rolase
Ca uc
Ġfore most
ĠBT LA
ĠCV E
ĠRever sal
Ġweigh ting
Ġshap es
FT IR
ĠRemark able
overex pressed
Ġ160 9
Ġexcision al
pen alized
Ġjud icious
ĠMac ro
Po lycomb
ĠPos sibly
ĠIntr at
ĠRadi ologic
mes ylate
Ġgland ular
Ġacetyl ase
ĠAfric ans
Ġfin ite
ĠDis appearance
ĠMulti parametric
Ġhal cinonide
ĠHem in
ĠPO LR
ĠEff icient
Ġadren omedullin
tel angiectasia
ĠPhen formin
Ġdich lor
Ġsimpl ify
ĠBas al
dis play
Ġecho text
Ġhyperbilirubin aemia
ĠSm ith
Ġmedullo blastomas
Ġmesothe lial
253 6
Ġwitness ing
Ġvag us
ka wa
Ġunnecess arily
encaps ulating
ĠWil son
GP X
ĠdC k
Ġmicronucle ated
ĠEgyp t
ĠPol and
Ġlic ensing
ĠRest oring
secre tory
Ġintermedi ary
ĠSDS E
ĠTel omeres
Ġsuit ably
ĠTE A
Ġextran asal
Ġacceler ator
0000 3790
Ġprecip itating
ĠQu ercetin
Ġstring ency
Diagnos ing
ĠDros ha
Ġgynec omastia
Ġvas opressin
ĠVir ginia
FP GS
En g
ĠBlack fan
Ġanthrac ylines
ĠCF Cs
Ġtetrap eptide
gar gin
Ġacad emia
Ġros etting
Ġconsult ant
Ġconve ying
apt an
Ġconges tion
ĠProlifer ating
Ġascer taining
Ġpet ro
ann in
Tel omeres
squ ared
Ġprur itic
orig inated
Mi R
section ally
Ev asion
156 9686
Thromb osis
ĠTechn iques
Allo SCT
Ġang iod
ĠOmn i
sial yltransferase
analy tic
Ġtriaz ene
separ ation
ĠFl ubendazole
deoxyc oformycin
Ġmyelomon ocyte
lycer idemia
Ġhematopatho logist
Ġdepos it
ĠForm erly
hospital ization
ĠDiff ering
ĠSudan ese
ĠAngi ography
osperm ia
Ġadvis ory
Ass ociated
Ġchor oid
osom opathies
omo ucine
ĠTri oxide
ĠAden ocarcinoma
TRA LI
ĠmHA gs
ĠRW PE
ĠOl mesartan
Sm oking
ĠCe phal
Ġprol ific
BrdU rd
ĠMDC KII
Ġpriv ileged
Mt x
adren o
Ġmononucle otide
ĠRetro virus
ĠASC AT
Ġdesc end
ĠEW SR
Ġpolyke tides
ĠZeb ularine
ĠSl ug
Respon ders
ĠLCS s
ĠMultic enter
junctiv itis
Ġintel lect
CIN V
Ret ro
Ġanhyd rase
ĠElucid ating
Ġexud ative
ĠAk ti
lod alton
Ġladder ing
Ġcrani ofacial
ĠBel gium
Ġpharmaco ec
Ġoctogen arians
Ġsynap tophysin
Ġradiograph s
asthen ozo
Ġartemis inins
trifluoroacetyl adriamycin
ĠBac teremia
Class ical
Glyc oprotein
Rib osomal
typ ic
IMP DH
diac etyl
Ġtransc obalamin
ĠIsra el
Ġginsen oside
trac king
lactam ase
Ġextingu ishes
ĠMab Campath
ĠPX D
Ġinadvert ent
Ġcertif icates
Ġsalic yl
immunohist ochemistry
Ġscrutin y
Don nell
Ġcystein es
idiob olus
Ġflas ks
Ġmonocyt ogenes
splice osome
Ġoligodendro cytes
hydroxyb utyrate
ĠArgent ina
Ġanthelmin tic
ĠTheore tically
apsi gargin
propan ol
Ġjejun um
Ġbootstrap ping
ĠTX U
Ġmetalloprote ases
ĠPharm ion
trunc ated
Ġnanod rugs
Brom odomain
Tal azoparib
replic ating
Ġgon ads
ĠHap Map
Ġazid opine
Ġinex orable
Ġmesop orous
Ġmicrospor us
Ġmyop ericarditis
Ġlor azepam
Ġmonot onous
ĠLen tiviral
Ġpseudot umor
dp f
ĠMaf osfamide
ĠWitness es
protect or
Ġparaf ormaldehyde
Asc iminib
ĠEmatologic he
Ġgynaec ological
iner ies
ĠEduc ation
ĠCep rate
Ġmetac entric
Ġpilo ted
Ġthy roglobulin
Ġstaphyloc occi
Ġunt oward
Ġintravit real
sympt oms
opeptid ases
Ġhyste rectomy
Ġglucocor ticosteroids
Ġchorio allantoic
ĠGlucuron idation
mh TRAIL
Ġlymphogranul omatosis
0140 7757
Allyl amino
Ġerrone ous
KLAK LAK
Run x
kstr in
shel f
Ġpemph igus
reseni us
ĠPow der
ĠPingding shan
stroph anthidin
ĠDimin ished
ĠDomb ret
Ġminire view
ĠcircMY BL
Ġhypertrig lyceridemia
Ġbiliver din
ĠHistoC heck
Ġmeningoseptic um
Ġphotopho bia
ĠRetrie val
Ġechotext ure
0 98059
3 53
4 40
5 54
6 15
7 31
7 96
7 87
7 83
7 309
8 26
8 98
8 175
9 56
9 205
9 339
> +
> .,
A plastic
B Z
B o
C ases
C ardiac
C UR
C ancerous
C ONCLUSION
C igarette
D et
D IM
D TC
E PA
E PC
F E
F ADD
H ar
H ck
J X
K line
L ine
L iss
L BC
M ercaptopurine
M eningioma
N I
N pm
P DH
P ER
P EC
P otent
P leural
R p
R ag
R RT
R OCK
S en
S ir
S ession
S urvivors
V ZV
X b
X LA
a ith
a urine
a Cdr
b us
b ran
b ands
b ociclib
c as
c lo
c ium
c DC
d dC
d nr
d iseases
d iffuse
f inal
f imbrin
g am
g ains
h sa
j uvenile
k icidin
l one
l aden
m and
m eta
m olecules
n ode
o zyme
p aced
p kb
r or
r RNA
r ants
s l
s ug
s ema
s mol
s imilar
t g
t ures
u is
x anthine
x Ki
x enograft
y ring
Ġ 0001
Ġa il
Ġa NK
in st
in terstitial
Ġt or
re pressive
ti r
he at
he reas
Ġc res
Ġc row
Ġc ement
Ġc TnI
Ġc iclopirox
Ġo pt
te rom
te enth
Ġp iclamilast
Ġp ragmatic
Ġs ine
Ġs out
Ġs ided
Ġs aved
Ġm HDM
Ġan tion
Ġan ova
Ġw ine
al ias
al lograft
is ible
or ods
ati aceous
an um
an ones
el e
ent y
Ġre vel
Ġre uter
ar ms
ar ag
ar rhyth
Ġf ated
at wo
Ġb ene
Ġb rach
Ġb iphenyl
Ġb afetinib
Ġ( +/
Ġe at
Ġe if
Ġe ts
os ensitivity
ith romycin
Ġh CI
Ġh BM
Ġh ollow
em peripolesis
Ġth apsigargin
Ġn ab
ĠA FS
ĠA EG
ĠA msacrine
ĠA lopecia
ĠA mino
ĠA ChE
ĠT rap
ĠT SH
ĠT ABC
ĠT igecycline
ĠT rends
im otecan
res idual
Ġle gal
si as
si vity
un til
ĠC up
ĠC ess
ĠC omet
ĠC ef
ĠC ES
ĠC ranial
ĠC MNs
ĠC irm
ĠC urative
ĠC elecoxib
ut a
Ġac h
Ġfor ks
Ġex cepting
Ġl oses
Ġst ub
Ġwas ting
op inavir
ib enzo
Ġcon idiob
ĠI dCSA
um ps
ĠM W
ĠM CNU
ĠM abs
ĠM CTD
ĠM egakaryocytes
oc clusion
oc idal
ol on
ol omycosis
Ġde aden
iv astatin
pl it
rom y
ud a
Ġg ondi
Ġdis omic
Ġdis omies
hem otherapeutic
ug es
ĠH z
ĠH SG
ĠH TLp
yt hemic
ĠP DH
ĠP ERK
red i
Ġtrans activate
Ġtrans thoracic
st one
ĠB ack
ĠB rian
Ġr d
Ġr alpha
Ġr ights
Ġinc ontin
am is
am ar
ĠD pl
ĠD PD
ĠD ll
ĠD rs
ĠD uloxetine
ĠD actol
Ġun matched
Ġun methylation
ĠIn As
ĠIn terstitial
ĠIn cluded
ĠF ul
ĠF AC
ĠF FP
ĠS PL
ĠS IL
ĠS teroid
ĠS BD
ĠS NAP
ĠS ymp
Ġcyt CD
Ġcyt ostasis
Ġcyt ochromes
ĠW i
ĠW an
ĠW at
ĠW AS
ph yrin
ĠCD P
Ġk arminomycin
Ġk lotho
Ġk aemp
Ġap icidin
othe cium
00 000
00 39
00 48
00 46
vel s
Ġco localize
Ġanti plasmin
Ġanti fibrinolytic
pon ents
ĠR x
ĠR ath
ĠR MN
ĠR ictor
ary ing
ĠN CC
ĠN MDA
ĠN itric
Ġ5 17
Ġen olase
Ġmon op
Ġmon ocentric
ĠO UN
ĠO pa
Ġint ends
Ġimmun otypes
ĠG b
ĠG CSF
ĠG raph
ĠG TT
ĠG astric
ĠG YS
all ic
ich ostatin
Ġinhibit able
Ġpre treating
Ġrec lassifying
ĠE X
ĠE b
Ġ4 90
ox olone
ĠL Q
ĠL k
ĠL EC
ĠL opinavir
DS PE
ip e
ip ping
Ġbut yl
Ġover sh
Ġhe el
so il
Ġ6 56
ensi tisation
Ġro str
Ġro adm
Ġunder m
Ġpar aly
Ġ7 60
Ġ7 37
Ġ7 81
rib osyl
Ġnon radioactive
Ġtheir s
Ġcor tisone
Ġfound ations
Ġpred ate
rim al
Ġman umycin
Ġ8 11
onstr uction
Ġinter dig
ĠK at
ĠK PS
ĠK TS
oplas ts
Ġdes ensitization
ĠU sed
Ġ10 43
Ġra kicidin
RA LS
Ġmutation ally
CD T
CD Rs
ber t
fer til
Ġsc ission
Ġimp arts
ĠCR Ds
Ġcar ne
ĠJ er
ĠJ ia
ĠJ asp
ĠJ CV
spec tion
spec ial
Ġmedian s
10 24
10 66
ĠV im
ĠV CP
ĠV LP
ĠV WF
ĠV AV
ĠV oreloxin
ĠV eter
ĠV ersus
12 24
Ġref ines
Ġgener a
AT IP
po lyc
Ġlymph angiogenic
Ġpatho biologic
Ġkary ot
Ġprof ib
Ġnucle o
53 518
int ra
int ron
14 97
PL CB
ism uth
Ġ[ >
Ġprop ria
Ġprop ranolol
DH E
DH ODH
Ġcaus atively
order s
)- [
Ġvarious ly
tr iazole
tr ichostatin
ĠDN IG
emb ryonic
ace a
vo id
ĠAn xa
Ġ13 69
Ġ17 70
MD P
ĠRA PA
25 44
23 2
cr ystall
Ġphosph atidic
lot annin
ind el
UN E
ev i
ule tin
ĠMP G
ĠJAK s
CI HDAC
IC O
Ġerythro dys
18 70
18 97
rem othecium
ĠSt roma
Ġclon otypic
Ġtri epoxide
Ġsubt otal
ĠAm az
Ġ40 4
DR lo
rid ge
Ġsumm er
ĠUn known
ĠUn common
Ġmed roxyprogesterone
Ġu rogen
Ġaz o
MR S
osed ostat
35 156
45 88
con vs
ĠCT G
ĠCT MP
Ġet a
transplant able
ĠPD N
esion al
imin o
imin ating
ĠEx o
ĠEx posures
Ġmac rophagic
Ġi EMR
ored u
Ġexpan sive
ĠPro ven
ĠPro cess
As xl
sub cutaneous
sub eroylanilide
Ġ27 3
cap to
ME A
44 2
44 8
Ġglyc od
pre emptive
Ġpoly glutamate
Ġpoly arthritis
ĠMedi astinal
ĠHCT CI
pir ubicin
Ġmeg ad
opy rim
work ers
LC S
ole yl
67 4
Ġangi ocentric
ograph ically
ĠPR UNE
oper idol
immun ologic
immun ogenic
uro blastoma
Ġobjec ts
glyc olic
ĠMT ase
Ġsol CD
IF EM
86 1
ĠInte stinal
acetyl transferase
SS s
Ġbro th
ĠZ btb
ĠTrans forming
ĠTrans mission
ĠPre B
ĠPre transplantation
ĠGO CYT
47 9
ĠClinical trials
PT M
Ġ65 5
96 3
Ġvin yl
ĠY H
ĠY J
ĠSe z
Ġhaplo HCT
olar ic
Ġphys ico
ĠMy S
Ġinjec ting
ĠComp elling
97 2
Ġdemethyl ates
Ġnan orods
lab elling
ĠIV LBCL
not ably
64 9
ĠNB E
Ġ67 2544
BCR ABLp
anti thymocyte
Ġpe ers
RAR beta
Ġattrac tion
Ġattrac ts
Ġremark ed
Ġble b
Ġneg atives
ĠIT RA
ĠPV C
ospor amide
ospor ins
sc RNA
ĠCH MFL
ĠSM AC
Ġsi GL
tes ts
Ġsw allow
lic idin
76 47
ĠId entical
ĠSub cellular
oles ter
93 17
ĠCo lorectal
Ġmis folding
ĠRel axation
ĠReg istration
Ġhydroxy glutarate
Ġ78 4
EC MP
Ġcarb onic
ĠPK B
ĠDe ox
Me CP
PS M
Ġuns atis
Ġphospho inositides
ĠTR I
ĠTR IP
ĠShe lterin
Ġaccept ors
yr istoyl
ĠCYP s
CBF beta
aut ocrine
ĠPP Cs
ĠMV P
ĠCA ST
ĠCA MS
thym ine
SR Y
Ġmimic ry
Ġlact osylceramide
ĠDA MPs
ĠDA ZAP
ĠEp c
Ġtransition ed
Ġhead s
TL OL
ĠAg reement
ĠCG E
oxid ative
lip tin
ĠMG A
ĠIRF s
ĠPG s
ĠEM Vs
enz amide
Ġ94 21
Ġnod osum
ĠAF AP
Ġovert ly
ĠTr f
NC S
ĠMAC S
Immun otherapies
Ġsuper coiled
ĠMe Wo
mism atch
isc her
Ġqual ifying
aro yl
Ġproto oncogenes
Ġcys tectomy
ĠInd irubin
ĠInd isulam
Ġcoll ision
Ġimmuno enzymatic
Ġpal m
ĠMa h
ĠMa gn
MO MP
pred isposing
ĠHu Arg
ĠHep atitis
Ġanteced ents
ĠFL ICE
LF s
CAL M
ĠSE IFEM
ĠBe ad
Ġheat m
Ġdiscre tion
hyp ert
hyp ermethylation
Ġmetallo enzyme
Ġdip eptide
Ġecon omy
ĠTT T
Ġlymphaden ectomy
ĠCCN T
ĠDiagnos tics
ĠSo on
RI A
MK K
ĠDr uker
Ġtesti mon
Ġpenet rating
ĠPub chem
phenyl indole
ĠFR B
ĠFR O
Ġfluor olysis
Ġden otes
LP HNs
Ġiod o
hex amide
RS V
ĠRho D
Ġtax odione
ĠHT ATIP
cor responding
VA X
Ġdisp ensing
101 348
Ġestrogen s
ĠHMG CR
Ne omorphic
ĠLM I
ĠLM Vs
istrib uted
ĠCyclin D
lys ophospholipids
Ġmitig ating
ĠPAR K
He J
He N
He paran
Ġinfarction s
Ġcoron atus
ukary otic
Ġaza Cyd
ĠBI RD
ĠMac rophage
ĠMain taining
fe ed
fe rol
MSC V
meth acrylamide
meth ynil
ĠAccum ulated
ĠRa RF
ĠMI RAGE
vis fatin
Ġuro plakin
Ġair borne
Stud ying
ĠConc ordance
Ġconv ul
SK M
Bi omarkers
ĠEng ineered
CO AP
ĠTOP O
Ġlum ines
Ġlamin ar
Adv ancements
ĠPBL s
ĠEB Cs
ĠThromb opoietin
ĠMYD GF
galact osylceramide
ĠNM ZL
Ġbre adth
ĠIll ino
ĠFH CRC
ĠCal ichDMH
Ġechocardi ogram
Ġplaus ibility
doc tor
pers on
ĠDisc ordant
Ġprecip itate
ĠVal proic
Ġsatis fy
ometabol ic
Mal e
Ġvas omotor
Le vels
DMR s
rad ical
Standard ized
ĠControl ling
ĠALK BH
orub idus
ĠAv p
FLA N
Ġprohib itively
ĠCar minomycin
Ġphleb itis
Angi otensin
chol anthrene
glucuron ide
ĠTes ticular
HER V
Ġarach noid
Ġabor tive
Ġnos ological
ĠSem iqu
Ġsoil s
Ġosteop etrosis
ĠLCL s
orot rast
ĠMST N
MIT OX
ĠMu LVs
electro phoresis
ĠrHu EPO
Ġneurode generation
Be yond
ĠZn O
Ġsemin iferous
Py MT
ĠClo Bu
tra de
Ġprem enopausal
Ġscle rotic
Ġparthen ogenetic
ĠhP c
Ġasth matic
ĠHG U
ĠPrac inostat
TNFR SF
Ġguaran tees
Ġharmon ized
ADA M
ĠAnt p
clus ters
ĠHtr x
ĠAsc orbic
ĠRAL S
ĠECM O
ĠVI MD
Ġdeubiquitin ylase
Ġvan adate
comple mentary
ĠOnt ario
ĠCss BU
Ġcred ential
Ġcred ited
Ġcred ible
ĠPCL P
ĠNur sing
Ġreconsid eration
piper idinyl
Ġfamiliar ize
498 67
ĠBX D
Ġrevis ited
Pos terior
Ġneurofibrom in
Ġnanos cale
ĠTre osulfan
opap ain
Mn ks
lac Z
Ġtolu ene
Ġasymmet ry
ĠEs cal
Dex razoxane
aggreg ation
Ġoverhang s
Ġperiodon titis
Ġfluctu ating
KDM s
Ġfurn ish
ĠDot Scan
Ġenfor ces
Ġsno RNAs
Ġvarie gated
Ġhypercoagul ability
LCL s
ĠCas itas
Ġreplen ishment
Ġantide pressants
Ġunmas ked
Ġwaste water
ĠsTNF Rs
ĠsTNF RI
Ġlib eral
Ġsolubil ization
Ġanaphyl actic
Ġaminoglyc osides
680 626
ĠNu MA
Ġaccent uated
Ġallotransplant s
Ġdissoci ates
Ġdeplo yment
ĠFD CP
ĠDefin ition
ĠHung arian
asm uch
Ġrating s
Ġalb um
ĠEF E
Ġvirion s
SER EX
Ġartif icially
Ġzf Mcl
Ġzf BLP
Ġmasquer ading
ĠEnrol ment
0036 9317
Ġwing less
ĠTbeta RII
ĠPROT EI
ĠMini MACS
ĠHind III
Ġcanc eled
Ġbarc oding
ĠGABARA PL
Occ upational
prolong ing
0045 9339
Ġameb ic
Ġnitros ourea
Epidemi ological
ĠBex xar
Ġcoryl i
buff ered
ĠBikD D
Cor ticosteroids
Dem ethoxydaunorubicin
Ġrejec ting
Ġmyelolip omas
Ġflags hip
Ġsesqui terpene
Meth otrexate
Ġanesthe tic
omyc ine
Ġdispos al
Ġpreadip ocytes
Carn itine
Ġhypof ractionated
Ġurtic aria
Ġspermatog onia
Ġsomat ostatin
Ġmyal gia
naphtho quinone
ĠSoft ware
ĠDiss ection
ĠSepha dex
Appro priate
hif a
ropho blast
ĠDick kopf
Ġimmunopeptid ome
Ġhabit ats
Ġchyl omicron
associ ating
Ġanthrop ometric
unning ham
Ġarthral gia
Ġneurotransmit ters
GMR alpha
trifluor omethyl
2424 908
Ġdephosphoryl ates
Ġargu ably
Ġcytocentrifug e
diam idino
Ġconspic uously
Ġcoerule orubidus
Ġminiatur ized
Ġgeranylgeran ylation
Ġtoddl er
idze in
ĠMars den
Ġtunn eling
Ġosmol ality
hydropyran yl
othre itol
Ġard uous
sca ven
Ġintellect ual
diacetyl spermine
7309 123
8175 347
aith ful
smol dering
Ġail ments
Ġantion c
Ġreuter i
atwo hl
Ġbene ath
ĠhCI NAP
ĠCirm tuzumab
Ġstub born
Ġconidiob olomycosis
Ġgondi i
Ġincontin ence
ĠDactol isib
ĠSymp osium
Ġkaemp ferol
ĠGraph ical
Ġroadm ap
ĠJasp amide
Ġurogen ital
Ġ672544 02
ĠHuArg I
ĠIllino is
ĠPROTEI NASE
+ (
- (-)
- /-)
3 25
4 10
4 36
4 66
4 61
5 28
6 10
7 16
7 22
8 40
8 32
> +/
A ur
A hR
A CDR
B id
B GS
B TG
B locking
C IT
C MS
C ontin
C ETLAM
D AB
D EN
E ighteen
F UN
F PN
G ate
G EF
H ome
H CR
H PA
H AL
H SR
H airy
I X
I BMTR
J ohn
K b
L PL
L BH
M IDA
M GFs
N EC
O AP
P ossible
P lough
R at
R ing
R BP
R ER
R ob
S SP
S AF
S ensitive
S EC
S terile
T CTP
T IPS
U F
V ar
V GH
V WF
V acu
W t
Y AP
b icity
b ras
b omb
c ules
c overage
d op
e ye
f al
f lex
f itting
f indings
g os
g ias
g afur
h CG
h MSCs
i h
j al
j ian
k re
k at
l r
m igration
n L
n our
n avitoclax
p ay
p CytAbnl
p EEDCK
s MDS
s titution
s teroid
s TNF
s urviving
t TA
u a
u ximab
v ak
x ine
z opic
z oster
Ġa usp
in formed
in herited
Ġt af
ti rp
on avir
Ġc il
Ġc LPM
Ġo roxylin
te gafur
Ġp ean
Ġp ival
Ġp razosin
Ġp terocarpan
Ġs cl
Ġs anger
Ġm d
Ġan tin
Ġw bc
al tering
is obut
or um
or tia
ati os
an onic
el ia
it uric
Ġd dC
Ġd oll
Ġd altons
Ġd ensit
er an
er ations
Ġre express
ar temis
ar tite
Ġf ag
Ġf etuin
Ġb w
Ġb reas
Ġb rac
Ġb rentuximab
Ġb iex
Ġ( .
ate tra
id ox
os ider
em tricitabine
Ġn emat
Ġn aring
ĠA SCs
ĠA ET
ĠA plastic
ĠA MED
ĠA ripiprazole
ĠT MS
ĠT HE
im pro
im idazo
Ġle fl
si lyl
un omide
ĠC PM
ĠC amb
ĠC UL
ĠC SL
ĠC unningham
tion nai
uk e
Ġac cepting
Ġfor get
ce iv
ac ia
ac hie
Ġex tirp
se greg
Ġmyelo iod
Ġres timulation
Ġres ectable
Ġl ieu
Ġl angu
Ġl angerin
Ġst orm
op erm
ĠI SH
ĠI SI
il m
pres sives
ĠM AML
ĠM ethylated
ĠM egakaryoblastic
pl atform
Ġch ir
Ġch alcone
Ġch iral
Ġal ph
Ġg rant
od en
ĠH CR
ĠH ex
ĠH CP
gn es
ĠP ut
ĠP aste
ĠP reex
st rept
st yrene
ĠB or
ĠB ow
ĠB iod
ĠB arr
ĠB lotting
Ġr utin
duc t
Ġinc o
Ġcomp utation
ific ance
ap ent
ĠD if
ĠD av
ĠD istribution
Ġun complicated
ĠIn verse
ĠIn sertional
ĠF dCyd
ĠF arnes
Ġexpression al
th yroid
th orax
enti ation
Ġk inetically
Ġmo Ab
Ġap pli
00 37
00 72
ĠR ous
ĠR AT
Ġev ap
ĠN ox
ved ilo
Ġ5 80
Ġ5 44
ron ucle
di oxin
Ġreg orafenib
edi at
SC E
SC M
Ġper for
Ġhas n
Ġhas ten
Ġmon ogenic
ĠO varian
ĠO ptions
Ġcont racting
ĠG Z
ĠG el
ĠG reat
ĠG FR
ĠG aussian
Ġpre loaded
Ġno tified
Ġsub seros
ĠE cho
ĠE AE
ĠL OD
ĠL sh
ĠL umbar
Ġid er
and rogen
Ġph armaceu
Ġpat ches
Ġhe terom
end oglin
lud e
term ittent
Ġcons ulting
Ġcons ulted
Ġcons ortia
opo esis
Ġtarget ting
Ġind isc
Ġ6 15
Ġ6 24
Ġ6 86
Ġ6 49
Ġunder take
Ġcan n
Ġresist ence
oma gnes
form amide
Ġpar vif
Ġ7 39
Ġ7 68
Ġ7 93
osi ve
Ġnormal ity
Ġnon treatment
Ġnon engraftment
Ġnon dividing
Ġnon americ
ag liptin
Ġ8 23
Ġ8 37
Ġ8 28
Ġ8 31
out come
AB GG
AB VD
rol ina
Ġinter lineage
Ġinter changing
Ġel ected
Ġallo type
ĠK IS
ĠK IP
ĠK AS
ĠK han
Ġar te
Ġdes ulf
ĠU O
Ġsec urity
ak er
og ic
av beta
av alin
Ġdisc oura
min or
min ogen
loc ating
ĠAl log
Ġimp recision
ĠCR TC
Ġmicro b
Ġam etantrone
LA CS
Ġgenetic ists
ĠJ X
ĠJ ian
ĠJ umonji
Ġconf ounder
pha rose
tero ides
ĠV B
(+) ;
PM S
SF I
Ġ19 66
Ġ19 68
Ġpos ses
Ġy outh
Ġhetero cl
Ġhetero cycles
Ġol omoucine
medi um
ĠTo y
Ġblast osis
int ensively
19 72
oph aryngeal
ĠAT AC
sequ ences
Ġmethod ologic
Ġer ase
PL K
Ġend anger
ĠAs pir
ĠAs ynchronous
Ġdo i
Ġmy e
tr ideoxy
Ġmalignant ly
Ġtransloc ates
Ġ14 26
In trinsic
Ġmyel omastocytic
ĠAB V
AL s
25 49
Ġmetabol isms
Ġret ri
Ġstill birth
ok u
Ġthromb i
05 8
Ab breviations
ev oned
Ġcap ping
Ġcap sa
Ġpur ifying
Ġmethyl ates
arc o
ĠAd min
mut A
CC CP
ĠRec ords
18 83
Ġstrati fies
Ġrep os
ĠSt ata
kn onc
Ġpromyelo id
Ġess ence
Ġ40 7
activ atable
cal modulin
CN KI
CN Vs
CN Ts
ĠUn ivariable
Ġu vr
Ġins pir
Ġcur b
BP H
oprotein emia
MS Ns
Ġox ides
Ġconc ur
MA D
MA X
Ġhel ices
ĠX TT
Ġlip olysis
Ġlip oplexes
ulin um
Ġcer tified
PD Cs
ork head
ĠEx tension
ress a
Ġantic arcin
Ġhyper acute
AF C
ĠCon ceiv
Th alidomide
Ġcal phostin
lympho blasts
NF kappaB
atal izumab
ĠCl ones
100 0027
eg s
03 10
FU O
Ġhydro chlor
ME R
ME Ps
MN KI
Ġglyc ans
pre treatment
Ġpoly d
Ġpoly ubiquitin
emal es
AR M
PB S
Ġmeg ac
Ġ36 8
Ġ80 9
AD EP
Ġ48 4
Ġ70 8
Ġpast oris
ole oyl
ĠCP SF
Ph ospho
Ġexpl osive
ĠIII a
Ġant racycline
ru x
immun ology
Ġfeas ibly
65 4
Ġfib rates
DC OG
IF Y
Ġsepar able
Ġcheck ing
Ġ55 8
ĠZ este
rosc ope
ĠTrans membrane
CH IT
47 8
Ġdeep est
ĠY K
Ġlo x
ĠImmun oliposomes
Ġsensiti sing
Ġrecombin ations
allel es
Im C
Im portant
ĠPT M
HC K
Ġbel inostat
PC K
Ġrepro grams
ĠPA INS
87 8
Ġnan ofibers
crist in
sel en
ĠSim vastatin
ĠPI GA
ĠSc opulariopsis
ĠAcc ess
ĠGen otypes
49 45
uch i
Ġ57 2
Ġsubstr uct
AN S
AN OVA
mod ification
Ġ58 9
Ġolig omet
ES I
Ġlys ophospho
ĠRe ad
pos sibly
Ġfl ares
ĠSub t
Ġoverview ed
ĠDown regulated
Cyt ostatic
Ġstep ping
ĠMC V
Ġplasmacyt omas
ĠAr bor
FAB P
Ġelectro genic
Ġelectro lytes
Ġrh IGFBP
flu ence
ĠNe ph
ĠNe bras
Ġlipid omic
ED TA
Ġintern ally
Ġtet hered
ĠBi otech
ĠBi omarker
Ġed ible
Ġed elf
ĠFMS like
Ġrepl ated
ĠCB SCT
ĠCa rolina
retin ide
polym orphisms
ĠMon tan
hydroxy glut
IAP H
ĠBlood wise
Cy TOF
ped ic
ĠPARP i
dec reasing
cho lecalciferol
ĠMAPK s
Ġtransm ig
ĠEle vation
Ġneur ones
ĠMicro transplantation
ĠInt ensity
Ġcoll aterally
amb ogic
Ġpal sies
Ġcomb o
Ġelectron s
Ġhisti ocytoma
ĠPl an
bo ok
inus oidal
CV C
idin ium
ĠPL P
011 5
ĠMi RNA
cycl osporine
chain s
ĠLe ave
Myelo ablative
Ġsoci etal
Ġorganis ation
ĠDOX ol
Ġdoub ly
Ġlymphatic s
Ġexperiment ation
Ġpseud otyped
tub erculosis
Ġlymphaden osis
ĠInf iltr
ĠNetwork s
struct ure
Med ulloblastoma
chem o
hom ogenous
hydrox ycho
Trans forming
ĠIs olation
Ġmill ig
Ġ110 6
ĠProm pted
HU VEC
ĠCy tidine
BB B
Ġmand ible
126 1000027
ĠFlu orescein
fl uconazole
haplo insufficient
Ġdischar ges
SL D
ĠMet astatic
prim itive
Ġdiges ts
ĠOb servation
EPO CH
osc ow
Ġneurop atho
Ġglycos idase
icl onal
ĠHM s
rele ased
FT D
requis ite
At tempts
ĠLip ofectamine
yle p
Ġec z
Ġbolus es
Ġsap iens
Ġimprin ts
osa hexa
045 4
calc ium
ĠRac ial
ĠMit ox
ĠMit otic
ĠMit omycin
Ġsens ors
ĠMyel otoxicity
mul tivariate
Ġair ways
prop ionate
Ġentero toxin
Ġcomprehen sion
ĠIS EL
Ġethnic ities
ĠPE ITC
ĠDT IC
Ġbehaviour s
Ġdomin antly
hep atitis
ĠClass ic
oclas ts
ĠLys is
Ġdich loroacetate
Ġrheumat ological
thromb osis
thromb ocytopenia
Ġstrengthen s
Ġont ogenesis
ĠThromb ocytosis
ĠPers isting
Er bB
ĠNM U
Ġperi osteum
SN Vs
Ġcrystal s
Ġgro o
Ġancest ry
ĠLI LACS
ĠSte ering
Ġread mitted
ĠMc Don
Ġhypog ranulation
Ġgall ate
Identif y
sych iatric
brom odeoxyuridine
ĠLo DAC
ĠLo uis
Ġeryth romycin
ĠSETD B
ĠIntegr ity
naph thal
ĠDem ethylating
Le ishmania
TN FSF
En forced
Neu rop
Rh abdomy
Ġbr illiant
ACT RN
ĠCro ati
guan yl
Ġcaps ular
ĠPhosph orylated
Ġstere o
Ġstere ospecific
Ġdere presses
Ġunveil s
ĠAV E
fuc ose
Ġcas ual
ĠSwit ching
do tes
sal ic
Ġpopular ity
Mit ochondria
Ġnanomed icines
ĠVM AT
Ġmineral ized
ĠHDA RA
Ġneurode velop
Ġcompan ion
contin uous
Ġsymmet rical
ĠPRT N
Ġhydroly zes
Sel ection
pas ses
Ġla w
ĠOp tical
Ġfos ters
Ġfos tering
ĠConcurrent ly
Hepat osplenic
Radi o
ĠLDA RA
anz c
Ġoverwhelming ly
emin ent
Ġcox sackie
ĠBo ulder
osamin yl
ĠGem C
comple xed
Ġbip artite
Ġhomod imers
Ġtent ative
olig o
Germ an
ĠASC L
caps ular
Par aneoplastic
UM IN
Ġcytofluor ometry
Str ategies
how ever
ĠELA NE
ĠMar ine
(+ +)
Ġcholest asis
Mn SOD
Mic rosomal
Ġswe at
Ġhomogen ate
Ġforec asting
Ġbenchmark s
ĠPhospho inositide
Hist orically
Nov ember
Ġcommens urate
best os
Ġrom iplostim
ĠTem ozolomide
ĠTem poral
Ġdeamin ases
ĠRegion s
Ġpyrim ethamine
Ġcarbox ylate
Ġtouch ing
ĠCas pofungin
Ġavid ly
Ġcephal osporins
ĠFib rin
Ġsurm ised
Ġsurm ount
Ġimmunode pletion
ĠOptim izing
ĠDMN T
ferritin emia
obarb ituric
pyrid yl
ĠQues tionnai
integr ated
Ġlute olin
ĠEco RII
Ġescap ing
Ġfract ures
Ġpseudodip loidy
ĠTU BB
new ly
benzo quinone
Ġbabo on
ĠGlucocortic oids
Nine teen
Ġanis omycin
estr uction
morpholog ic
Hetero geneity
ĠTal alay
thre o
Ġpapul osis
ĠMetabol omic
Ġhygi ene
Occ urrence
bul bar
Ġnif uroxazide
prolong ed
ĠPTG IS
ĠSphing osine
ĠGv H
Ġendocrin opathies
Ġtall imustine
Ġinconven ience
Ġquadrup ole
Ġstrugg le
Ġcytosp ins
ĠUr gent
Ġmyof ibr
Ġexcit atory
Ġfortun ately
Ġdecre ment
triaz oles
Prd m
Ġlymphocyt openia
Ġsmel ter
Ġspur ious
ĠJmj d
3025 03
enesulf onamide
ju ven
ĠOrig inally
ĠColumb ia
Ġimmunoads orption
ĠCrypt ococcus
ĠDiscrep ancies
Ġneighbour ing
And rogen
GW AS
ycep in
Ġaeros ol
recombin ant
Ġpostim plantation
Ġoligodeoxyribonucle otides
Ġcrosso ver
Ġdenti st
Ġhern iation
Ġprotozo an
Ġvasopress or
pher d
Ġxantho granul
Ġrhabd oid
Ġarteri oles
Ġintersti tium
eval in
Ġforel imb
Ġplec kstrin
ĠDun n
ĠGSS G
Ġmammal ians
Ġacro centric
Ġoutdo or
aspir ate
Ġbook ended
Ġpenal ty
Ġfalcip arum
ĠCephal otaxus
redi rected
amis ole
Ġmegad ose
>+/ +</
FUN D
Gate ways
MIDA M
zopic lone
Ġpean ut
Ġpterocarpan quinone
Ġbreas ts
osider in
Ġlefl unomide
Ġalph avbeta
Ġappli ances
ĠRAT IFY
vedilo l
Ġindisc rim
evoned istat
Ġcapsa icin
ĠConceiv ably
ĠNebras ka
Ġedelf osine
ĠMontan ide
1261000027 1000
osahexa enoic
ĠMcDon ough
% ].
0 980
6 35
6 70
6 32
6 244
7 19
7 23
7 123
7 42
A part
B LT
C DS
C MPN
C orrect
D IMATE
E very
E vent
E OV
F AM
F TBI
F arber
F actors
F orkhead
G CT
G SCs
G CB
G emcitabine
G DI
H i
H BsAg
I LT
I kappaB
I CLC
L MO
M Z
M ent
M ortality
M CA
M sp
M embrane
M aternal
M VA
N u
N or
N pG
N OC
N aive
P el
P ure
P PMs
P alliative
R v
R uxolitinib
R ICs
R WR
S et
S ex
S ep
S cle
S uccess
S BB
S KIP
S ELDI
S ilencing
T m
T yros
T echn
V p
V AP
V RC
W I
X change
Y oun
[ <
b ec
c atal
c DCs
c amptothecin
c Tf
d HPLC
f uture
f ected
f use
g ain
g ativity
h y
h ome
i KIR
i ocalcin
l ights
m olar
m IDH
m embranous
p ase
p aren
p STAT
r n
r x
r GM
r ather
s ec
s tic
s par
s phing
t ypical
t rium
v us
y ocardial
Ġa ro
Ġa fl
in yl
in ogen
Ġt g
Ġt PA
re acted
ti ble
ti zed
on ig
he rapy
he pat
en om
en um
Ġc DCs
Ġc atch
Ġc Bi
Ġp ust
Ġp AKT
Ġp GP
Ġp Ka
Ġp Crkl
Ġp onicidin
Ġin equ
Ġin quiring
Ġin efficacy
Ġs tic
Ġs ternal
Ġs LDH
Ġs ensed
Ġs TGF
Ġm ts
Ġm ute
Ġm ish
Ġan trum
Ġthe ses
Ġthe sis
Ġw ake
Ġw atching
al o
al coholic
is able
is ternal
or tical
el ight
as us
Ġd l
Ġd ith
Ġd ell
Ġd ol
Ġd ull
ic iclib
Ġre induced
Ġre juven
ar te
ar itin
Ġf rig
at n
Ġb iclonal
Ġ( $
Ġe ph
ith in
Ġh MSCs
Ġh olo
Ġh CPT
em ary
ra ce
Ġn DNA
Ġn eratinib
ĠA omori
ĠT ag
ĠT AS
ĠT ACE
ĠT MPRSS
ĠT lr
us es
us sian
ur bed
ML I
ot ong
ot rim
un ophen
un its
un iform
un restricted
ĠC um
ĠC LTR
ĠC PLD
ig i
Ġac adesine
Ġleuk otoxin
if osphamide
Ġex ces
Ġas ton
Ġas bestos
ho ok
Ġis lets
ant hem
Ġmyelo peroxydase
op otent
ĠI GFR
ĠI EC
il is
ĠM ak
ĠM ock
ĠM AR
ĠM atch
ĠM HRF
ĠM aterials
ĠM MTV
ĠM AKA
oc opy
oc adherin
oc entesis
Ġbe zafibrate
iv icin
iv antinib
pl os
Ġon ward
ĠAML HD
Ġal gin
ud i
her ins
Ġdis lod
od ibenzo
ys es
Ġby product
Ġv oid
Ġv entral
ĠH TT
ĠH dA
ĠH lf
ĠH omeobox
ĠP i
ĠP reg
ĠP IC
ĠP CC
ĠP apan
ĠP SR
ĠP NC
ĠP IIINP
ir ic
Ġtrans mit
Ġtrans activated
Ġtrans endothelial
Ġtrans generational
Ġtrans carbam
Ġtrans jugular
st ro
ĠB CH
ĠB cor
Ġr t
Ġr ic
Ġr CD
Ġr mhTRAIL
duc tal
duc tor
am o
ri ter
ist ol
ĠD h
ĠD m
ĠD DS
ĠD AK
ĠD BP
ĠD omain
ĠD do
ĠD arbepoetin
ay n
Ġun tim
Ġun avoid
Ġun beneficial
ub stituted
ĠIn ability
ĠIn effective
ĠIn tention
ĠF PR
ĠF ES
ĠF bx
ĠF MAU
ĠF cepsilonRI
ĠS AD
ĠS ERS
ĠS plit
por phyrin
ĠW C
ĠW R
ĠCD CP
Ġass es
Ġsign ifying
Ġmo tivation
Ġus ur
one gativity
00 53
00 73
00 89
Ġco ined
Ġco localized
Ġco lour
Ġsho ot
Ġdiff used
Ġanti pro
Ġanti proliferation
Ġanti dotes
ĠR oc
ĠR CT
ĠR ps
ĠR enin
ĠR PP
ĠR OM
ĠR DRs
ĠN UTM
Ġ5 95
ron ucleus
lym arin
di hydrop
ure lla
Ġper il
Ġper nic
ges tive
de activation
de gradation
ĠO AS
ĠO PC
ĠWe ak
Ġhem ophilia
Ġint ubation
Ġimmun ities
Ġimmun ocytes
ĠG LT
ĠG ross
ĠG ray
ĠG TG
Ġsub chronic
Ġsub capsular
ĠE RP
ĠE radication
ĠE pirubicin
Ġ4 23
Ġ4 67
ox e
ox ymethyl
CR Es
pho id
pho bil
Ġout paced
Ġpo le
Ġ0 3
Ġpres acral
ĠTh ym
ĠL as
ĠL PL
ĠL ev
ĠL MR
ĠL VL
ĠL NL
ip ron
Ġchronic ity
Ġph arm
ad mitted
Ġcons ume
ari ous
pt an
ensi ble
ensi fying
Ġunder treatment
Ġunder report
Ġcan ines
Ġmic ell
Ġbetween ness
Ġpar ity
Ġpar vum
Ġprom igratory
Ġ7 95
Ġlympho proliferations
Ġdem arc
Ġdem atiaceous
Ġbi allelically
Ġnormal izes
ct p
Ġnon small
Ġnon cons
Ġnon lethal
Ġnon comparative
Ġfol inic
Ġpl enty
%) /
Ġpred nimustine
est ock
Ġ9 000
Ġ9 48
ag uanine
Ġ8 97
Ġ8 93
Ġchrom atids
out comes
AB s
Ġinter specific
Ġinter twined
ĠK o
ĠK AN
ĠK idney
tain able
ch ins
ĠU tx
Ġ10 34
</ =
yc n
11 16
ens ins
MT C
01 77
01 707
Ġhyp omagnes
ucle otide
og ranul
og astric
CD KI
ateg ic
ĠAl gorith
ABL I
Ġsc id
Ġimp oses
ĠCR B
ĠCR R
ĠCR FS
ĠCR Es
Ġqu atern
Ġmicro transplant
Ġmicro biology
Ġmicro titer
Ġam ylase
Ġam pal
LA D
LA MP
Ġvit real
Ġep ic
Ġep iphen
Ġsensi ble
ĠJ PN
ĠJ UR
ĠJ IH
ĠJ azz
Ġdel imotecan
trans port
ĠV on
ĠV ib
ĠV pr
ĠV APA
ĠV OCs
Ġsh am
ĠMD ASI
Ġref ocused
az aguanine
Ġstandard izes
Ġphen ocopy
ex ists
Ġform ations
22 89
Ġhetero genicity
Ġem itters
Ġconcl uding
Ġpost diagnosis
medi ans
erg ism
17 36
old ed
Ġnucle atum
Ġnucle ophilic
int o
int ended
19 82
19 78
Ġsingle t
Ġless on
ĠII V
ĠII a
Ġlim elight
ep he
PA Fc
ĠAs ide
emic arb
Ġonc ogenetic
ĠDN T
emb les
ĠMLL bcr
38 21
Ġ14 25
Ġ17 37
Ġ17 76
com mentary
MD s
AL MA
ĠBM MSC
Ġphosph atidylethanolamine
Ġradi ations
ĠNK X
ĠCh idamide
ĠCh loroma
Ġunc or
Ġabs orp
Ġpur ines
sis ted
iod ocytosine
CC US
und rug
Ġstim ulations
ĠAra bia
BM E
Ġclon ogeneic
Ġdesign er
opro lifer
ĠAm plicon
24 1736
ĠPCR s
Ġkill ers
Ġperiod ically
Ġter t
of requency
of ilin
27 2
Ġmonoclonal ity
ĠST G
ĠST K
ĠST AR
Ġsynerg izing
MS S
45 4
Ġrese aled
onucle osides
Ch loro
FN D
FN QT
SP N
SP P
SP AC
ai ke
estim ate
90 56
ĠRes ulting
PD C
PD N
Ġimmunosup pressor
Ġsp ray
98 05
NP BC
ice al
ĠEx pressed
ĠEx ploiting
Ġcandid a
ĠCon ditions
Th yroid
Ġhom otrim
IR R
Ġbas ically
Ġemerg ently
0001 5
Ġposi tives
atal anib
HCT CI
ĠPro us
ĠPro to
ĠPro coagulant
CG C
ogene ity
ME N
ĠCLL s
44 3
57 418
Ġglyc oprotease
pre ferentially
pre gnancy
ĠCM B
Ġcardi o
Ġcardi ology
PB GD
Ġgast r
Ġ45 00
Ġequ ine
Ġste rol
ole an
Ġmegakary oblast
Ġpractic ality
TP TE
Ġexpl orations
ĠPR s
ĠPR IT
ĠPR EF
Ġderiv ates
rec onstit
Ġburden ed
Ġ34 8
glyc ans
glyc osylated
feren ces
Ġdepend ant
osin ic
ob server
Ġorgan ogenesis
acetyl lactosamine
Ġregres sing
SS O
SS VM
Ġneuro epithelial
ĠMY EOV
ĠHR S
Ġstress ful
ĠTrans lating
ĠPre emptive
ĠPre conditioning
inc orporation
ĠCX orf
66 6
ĠCC US
Ġelect rophilic
ĠY ang
Ġlo ts
Ġsensiti ses
ĠMM olR
ĠHigh lighting
Ġyoung ers
ĠAL FY
ĠMR CK
97 88
RR Y
ĠPA CRG
ĠAp heresis
Ġinst alled
Ġdereg ulations
Ġnan otechnology
Ġauto inflammatory
+/- +/-
arr hea
Ġnine ties
Ġsecre tions
inte raction
ĠIV S
Ġmobil ising
methyl transferases
ĠSc ores
Ġprostate ctomy
ĠTNF AIP
ĠGen omics
ĠBC BM
Ġback ed
Ġamin opterin
Ġolig opotent
adi one
ĠIT CZ
Ġlys ophosphatidic
bi phosphonates
Ġmas k
ĠRe induction
ĠSM RT
ID FY
Ġsw ine
Ġmeta plastic
col i
UT O
Cyt operm
DM Cs
Ġextrac hromosomal
Ġpain t
ĠDAC i
ĠSR I
Ġassign ments
Ġpersonal ization
Ġcos m
protein ase
Ġalgorith mic
Es ophageal
comp eti
Ġbis ulfate
Ġpneum othorax
ED DS
Ġretro elements
ĠCAR L
Ġtet racycl
Ġtet anus
Ġtet randrine
Ġmagn a
ĠBi allelic
alan yl
yr us
ĠNon myeloablative
aut ophagic
ĠAR EB
Ġantine utrophil
Ġax on
ĠCa jal
ĠCA MP
Ad P
Ġdim orphic
Ġthi olester
polym eric
Ar f
Ex pl
be i
ĠBlood stream
Ġ92 21
ĠPer it
ĠPer turb
ĠAg a
ĠAg NPs
cellular ity
Cy CD
oxid ants
ĠSur vey
ĠMut agen
CFU c
SM AC
Ġpartner ing
Ġprel amin
ĠAA I
SE Am
GR IK
Ġsci ences
ext ramedullary
ĠHospital s
Ġcryp ts
ĠATG CC
Ġnit rite
Ġmak er
Ġadriamycin ol
ĠAM I
Ġcommun icating
ae I
Ġuncon ventional
Ġconce ive
Da C
ĠSK P
Ġfat hers
ĠEm ergence
olip osome
FC MRD
Clinical ly
ĠInd ividually
ĠRR EB
Ġpal bociclib
Ġbac illus
ĠMa Tu
ĠSA gs
ĠPl erixafor
Pre p
Ġsem en
Ġcorticos terone
Ġmitogen s
sen ile
TR IM
ĠVari ations
Ġphot oreceptor
Ġelement ary
Ġham art
Ġaff ording
ĠGenetic s
Ġpor cupine
tol aryng
GL UT
gluc onate
ĠHuman Methylation
ĠBe adC
Ġorganis ed
Ġflav in
LM IC
human ized
Ġcoinc ubation
ĠNS UN
Ġlymphaden oma
ĠTA CTILE
ĠImmunohist ologic
Ġgal lotannin
Ġsubs cales
ĠInf lammation
412 6
Over whelming
Ġimmunocyt ological
Ġimmunocyt okine
Ġdiscl osing
ĠSyn thetic
Ġplasm apheresis
RE ST
MAPK s
Ġger min
De ath
Ap c
omorpholog ic
py ran
phenyl butyric
ĠFR YL
Ġsero conversion
Ġneph ritis
ĠMOL rel
ĠMyelo blastic
450 3
Ġmiss plicing
hex osaminidase
Ġpent a
syn onym
cor related
amp icin
Ġdisp ers
Ġens embles
Ġpeg aspargase
Ġdog ma
ĠSS VM
Int ensifying
ĠRev Man
tt rium
Ġdeterior ates
Ġimmunost ains
Flu or
Ġmer ge
Ġoutgrowth s
ĠHer ceptin
ĠTN FSF
ĠCr uc
ĠCauc asus
Ġspind les
ĠBI K
Ġproc ured
Ġperox idases
ĠRD F
ĠDi verse
ĠDi OC
Anti apoptotic
Anti angiogenic
ĠBD V
ĠDI RAC
NL G
poly glutamate
ĠEffec t
ĠBl k
ĠBl ank
ĠMI SC
Ġantagonistic ally
Ġmyeloblast osis
Ġattack ing
Inter phase
Ġnorm oxic
ĠTopo II
bs Abs
ĠLAM s
HF TBI
221 5
Ġhal operidol
Ġwa as
Ġreferral s
ĠInvestig ators
Ġhind brain
Ġnasoph arynx
add icted
Ġsym bol
Ġsimpl ifies
megakary ocytes
Ġterat ogenesis
orf man
ĠSB DS
Ġhydropho bicity
ĠThromb otic
anucle ar
Lym ph
deox ydaunorubicin
ĠHaemat o
ĠEsc italopram
rit onavir
ĠRef in
Ġunequ ally
ĠSouthw estern
yg d
Ġtetra ethyl
Ġstro kes
Ġcere ana
Ġanion s
Ġhypog ammaglobulinemia
Ġdefer ves
Ġortho pedic
ĠEstim ation
Ġfu els
Ġfu eling
Ġmonos accharide
Delta Psim
Raf pS
Ġorchestr ation
0000 2549
din arily
brom ide
Ġhub s
Ġeryth ron
ĠDem ethyl
Ġile us
ĠEst rogen
Ġrhabdomy osarcomas
ĠCri zotinib
sus taining
Cycl osporine
Ġbr ighter
Ġradioimmun o
Ġendonucle olytic
ĠNeuro fibrom
Ġlin ifanib
293 111
Ġinos itides
Ġki lobase
ĠDex ter
IK AROS
Non coding
Ġappra ised
ĠRG D
nitro quinoline
ĠHi DaC
Ġhyaluron idase
Ġchondro id
ĠRad otinib
ĠVin blastine
mast ocytosis
Di hydroxyvitamin
Ġunveil ing
ann iocalcin
dia mino
Mi HAs
ss I
ik is
ĠPAS D
Ġguan idine
ĠFab sc
ĠsL ex
ĠOx PHOS
Comp rehensive
Ġsensor ineural
ĠGli oblastoma
ĠRan ge
antit atively
Ġsymmet rically
ĠTY RP
ush ing
ĠNFAT C
Ġemo tions
Ġprecon ditioned
Sup pression
Sup erior
Ġparac ancerous
ĠICB s
ĠSIRP s
Ġbrother s
Adult o
Ġure teral
Ġtag raxofusp
omo uc
benzyl thioinosine
ĠBo iss
ĠGold en
Ġveget able
Mut ant
ĠRW R
ĠOl omouc
ĠKY SE
HMG A
bet am
Ġabrupt ly
Ox R
Cre ERT
Ġprol idase
Ann ually
ĠDevelop ments
Ġfab rication
Ra ji
ĠSi rolimus
caps ule
ĠNur ses
Ġspac ers
piper azin
Ġcatalys ing
Str uct
ĠInsigh t
Ġrestrain s
Ġhypogonad otropic
sim vastatin
2007 45
Oste osarcoma
ĠHLX B
Ġmirr ors
ĠRos ai
ĠWD TC
Vit D
Ġpione er
aggreg ometry
ĠOs x
Neutrophil s
ĠTrem endous
Ġexud ate
ĠOlig o
ĠmD OR
Ġanecd otally
ĠAk aike
Ġliv estock
ĠDip yridamole
Ġni hil
ĠNum bers
Ġconfron ted
Ġpharmaco economic
Black fan
ĠCalc ium
Ġdepart ure
Gem C
Ġunmas king
Ġpromisc uity
ĠACL Y
Ġcytod ifferentiating
ĠHisti ocytic
Ġelastic ity
ĠPc SLN
Ġenvis age
ĠVK H
Ġerosion s
dup lex
Ġtransc end
ĠRib osomal
ĠApc Min
Ġcard inal
Ġprotop orphy
trac k
ĠDepo Cyt
Ġanis otropy
RX Rs
Disc ussion
differen ce
Op tim
ĠHy C
Aden osine
Ġic aritin
immunohist ochemical
Ġecchym oses
790 9
acl arubicin
Ġsuperv ision
Ġlipo ATRA
Ġnanoform ulations
Ġdichotom ous
414 9056
ĠMs bA
ĠDecision s
azan avir
ĠPeriod ic
RU X
Ġsemic on
ĠOc ular
Ġbiore positories
Epidemi ologic
Ġoligodendro cyte
Pers istence
ĠHIM eg
ELIS POT
Diab lo
Diab etes
ĠDer ived
ĠGv T
ĠConfirm ation
ĠConfirm atory
ĠMechan ical
Ġremn ants
Ġenucle ation
Ġupward ly
ĠValu e
inoc ulation
orpholin o
00004 128
Cho osing
ĠBm f
orthe ast
Ġhypermethyl ations
Ġantag omir
734 693
Ġsonic ated
dinitrop henyl
Bal anced
BMD Cs
chlorophenyl hydrazone
absorb able
Ġcholecys tectomy
TAR GET
ĠBrc a
ĠPrefect ural
ĠBeh cet
Ġmycel ium
tre osulfan
ĠPEC oma
Ġoxys terol
Ġcp CML
Ġbot ulinum
Dep ending
osuccin ic
Break point
Ġflud arabin
ĠAsn ase
Ġintraves ical
ĠProteome Xchange
Ġgrise us
ĠWa als
Ġreluct ance
ĠQALY s
Ġsuperven ed
aglyceropor in
Sus tained
Ġsla ughter
ĠEncaps ulation
ĠNeurop atho
Ġdw arf
unicip al
ĠHear t
Ġperip ancreatic
ĠSERPIN B
nanopro bes
icola ou
Ġdithi othreitol
Ġprotr usion
avior al
exam ined
Ġembrac ing
Ġpyram idal
ĠGlaxo Smith
Ber lin
sched ules
Ġug ly
Ġantipar asitic
chic tr
1128 503
Ġcarne us
ĠJia otong
ĠSez ary
ĠSemiqu antitative
Ġstubborn ly
Rob o
Ġausp ices
artemis inin
Ġnaring enin
ĠPaste urella
Ġsubseros a
ĠAllog rafting
Ġheterocl itic
rux olitinib
FUND ING
Ġfrig ida
ĠCPLD IDFY
Ġexces sively
anthem i
ĠPreg abalin
ĠPapan icolaou
ĠDAK O
Ġuntim ely
Ġunavoid able
Ġpernic ious
phobil inogen
ĠKAN SL
01707 004
ĠJUR L
2289 195
Ġhomotrim eric
ĠBeadC hip
ĠGlaxoSmith Kline
ĠCPLDIDFY C
0 69
3 95
4 22
4 23
6 25
6 27
6 43
7 04
7 62
8 47
9 22
A cl
A AT
A lox
A monafide
B ut
B ron
B AT
B MDSCs
B AG
B ortezomib
B right
C ad
D J
D es
D ay
D OR
D imethyl
E H
E UD
E gr
E lectro
F d
F Cs
F olate
F usariosis
G CA
G GT
H p
H CH
H edgehog
I CR
I PD
J s
J nk
J umping
K R
M ar
M yelodysplasia
M aterials
N CA
N EP
P at
P ep
P Cs
P aclitaxel
P GL
P recision
P araffin
P gP
P racinostat
R ab
R PA
R earrangement
S LP
S PAG
T YK
V SS
V PS
V SV
W hole
Z Q
Z T
Z U
Z arnestra
a j
b ond
c ens
c uma
c erebral
d rop
d osed
d atabase
d rew
e te
f ast
f ractions
f arious
g ement
h t
i tem
i As
l ably
l incRNAs
m ath
m ycin
m rp
m igratory
n omial
o ikis
r ystal
r ategies
r FVIIa
s RNAs
s olution
s cribed
s atellite
s uccessful
s plenomegaly
s Tie
s aturated
x R
x pressing
y S
y an
Ġ {
Ġa te
Ġa KIR
in complete
Ġt elop
Ġt aut
re versal
ti ae
ti ometry
on oid
he retic
en imine
en atide
Ġin ap
Ġs eren
Ġs IgM
Ġs yring
Ġan hydro
Ġan oikis
Ġw ishing
ro tein
el em
el ess
it ted
Ġd ated
Ġd iphen
Ġd aptomycin
es es
er ad
Ġre administration
Ġre assembly
Ġre establish
Ġf un
Ġf unding
Ġf ingolimod
at ine
Ġb row
Ġb ismuth
ing ival
ing ham
os emicarb
om itting
om orphism
om andibular
Ġwith drew
ly ase
ul osis
Ġh o
Ġh omes
Ġh umor
Ġh TR
Ġth umb
ve ctor
Ġn ose
Ġn itidine
Ġn idul
ec tives
ĠA ir
ĠA AL
ĠA DL
ĠA CHN
ĠT oc
ĠT ub
ĠT DS
ĠT IA
ĠT ILs
us ts
us itis
ur ately
Ġle an
Ġpro kary
Ġpro collagen
ML T
un determined
ĠC LFS
ĠC WP
ĠC erebral
ĠC KII
ig hest
ut ory
Ġac H
Ġac rosome
Ġac antholysis
if en
ac il
ac rid
ac avir
Ġleukem ogenetic
Ġres p
Ġl enti
Ġl umina
Ġl iabilities
ib und
Ġcon us
ĠI OL
ĠI diopathic
il ation
ine phrine
ĠM f
ĠM l
ĠM ur
ĠM ist
ĠM olecule
ĠM elan
ĠM oscow
Ġim ine
Ġal er
od ic
ĠH art
ĠH MB
ĠH CE
ĠH yaluron
ĠP rin
ĠP ediat
red uce
Ġtrans mitting
st ren
ĠB ron
ĠB UN
ĠB MDSCs
ĠB PT
Ġr ivaroxaban
Ġad o
ist y
ĠD an
ĠD SC
ĠD TC
ĠD omestic
Ġun sub
Ġun inter
Ġun transplanted
ĠF uc
ĠF lux
ĠF TL
ĠS ab
ĠS MT
ĠS ero
ĠS ites
ĠS CS
ĠS BT
ĠS chedule
ĠS ecurin
Ġcyt ometers
por adic
ĠW ar
ĠW AF
ph age
enti ty
pro us
Ġmo od
00 26
00 76
00 673
Ġinhib itions
Ġmar iz
Ġanti human
Ġanti py
Ġanti hypert
pon ins
ĠR HOX
ĠR FL
ĠR ober
ĠR osu
ĠR ounds
iz ability
ĠN ations
ĠN elarabine
ĠN atalizumab
ĠN ortheast
Ġ5 53
Ġ5 23
Ġ5 75
Ġab use
ost rept
di one
di phosphate
Ġchem osis
Ġreg ist
edi yne
Ġen ediyne
ren ic
de azaneplanocin
de acetylase
ĠO CM
ĠO AD
Ġinv ad
ĠWe i
cl osure
Ġse vo
ĠG RI
Ġpre leukemias
iagnos tic
Ġsub til
ĠE FI
ĠE US
ĠE GC
Ġ4 17
Ġ4 53
Ġ4 77
CR S
Ġout we
Ġout flow
Ġbet anin
Ġ0 16
Ġpres c
Ġpres timulation
ĠL MS
ĠL NP
Ġover regulated
ong ru
Ġph il
Ġph asing
entif ically
end othe
ad olescents
Ġind istinct
Ġ6 23
Ġ6 000
Ġcyto reduce
Ġunder representation
Ġsup planted
Ġsup plying
Ġlympho poietic
Ġdec ellular
Ġhematopo eitic
ble matic
Ġnon blastic
Ġnon con
Ġnon high
Ġnon complete
Ġnon allogeneic
Ġnon autonomous
Ġfound ed
ag atran
Ġ8 02
Ġ8 04
Ġ8 68
Ġchrom omycin
Ġhematopoietic ally
rol izumab
ĠK K
ĠK yn
ĠK mt
ĠK ettering
Ġar row
Ġar che
Ġar tesunate
ĠU BL
Ġ10 88
Ġ10 603
yc lo
RA CT
01 28
01 32
01 79
og rafting
CD CP
Ġantigen icity
Ġmulti state
Ġprev ailed
fer ases
21 01
Ġme iotic
ĠCR KL
Ġreview ers
ym ethylation
ym ethoxyphenyl
Ġtime points
Ġam end
Ġam astigotes
Ġam niotic
Ġam ygd
ath ionine
Ġep inephrine
IT RT
15 01
ne phrotic
Ġser onegativity
ĠV iro
Ġsh ikonin
12 54
12 61
PM RD
Ġref ract
az ines
ycl ic
Ġ19 57
Ġlymph nodes
HD L
Ġaim ins
Ġform ic
Ġform yl
AC F
AC ARE
Ġhetero trim
Ġem blematic
Ġop poses
Ġnucle ob
Ġblast ula
ITD neg
19 98
19 79
ĠML s
Ġmor ibund
PL CH
Ġ20 30
ax ial
Ġend oredu
ocyt otic
Ġav ium
Ġav rainvillamide
ep irubicin
Ġdown ward
Ġmy ogenesis
Ġmy opathies
Ġmy asthenia
ĠCI S
tr in
tr ivial
emb rolizumab
In duced
Ġx anth
ĠMRD pos
ĠMRD neg
ĠAB CM
ched uled
Ġpediatric ians
Ġ18 00
Ġassay ing
lear ning
Ġradi ofrequency
ĠNK H
Ġuseful l
ethyl enimine
Ġfoc ally
Ġcycl ization
Ġprote otoxic
Ġir AEs
IC P
Ġerythro cytic
18 01
ĠDNMT Is
26 46
ĠSt x
ĠSt atins
ral ethal
Ġgre y
opro st
opro be
opro genitor
arch ing
Ġ100 3
Ġ100 00
Ġsubt ractive
Ġrest arting
ĠAm es
24 72
Ġconditioning s
Ġdetect ably
the rapies
DR C
DR E
of ilm
Ġaltern ations
35 4
II a
Ġlab yrin
respon d
NK s
Ġhaemat opathologic
Ġhaemat opietic
Ch l
Ch lor
SP I
oh isti
ĠX ist
ĠX enotrans
Ġlip osarcoma
IM Cs
Ġproduc ers
Ġsp ice
ĠPD Z
04 38
Ġsix fold
ĠEx posing
ĠEx ception
ds DNA
Ġhyper hydration
Ġhyper ferritinemia
AF X
cyt oma
MRD pos
36 4
Ġprac ti
osp ot
Ġver tic
Ġdam s
Ġmes ench
AM C
AM O
AM MoL
ĠPB B
Ġj iro
per fect
ough ly
Ġglyc o
Ġglyc ocaly
ĠCyt oreductive
pre vious
ER R
inf ectives
Ġpoly amides
Ġpoly nomial
Ġ35 9
Ġcardi ologist
28 558
amin obut
amin olevulinic
Ġgeneral izability
Ġ48 2
Ġpractic ability
Ġkin etocho
67 437
Ġobjec tivity
Ġderiv ate
SA Y
glyc olide
ĠME CL
Ġconsequ ential
mal ate
ob s
Ġsepar ators
Ġ' '
PR K
PR CA
ĠQ HP
Ġdoc tor
Ġ46 3
Ġ55 1
Ġtermin ate
ĠZ O
Ġstress or
EL s
77 2
47 86
ĠY ttrium
Ġ39 3
ĠImmun operoxidase
Ġsensiti ser
EM ACARE
Ġ47 4
Ġ47 6
Ġconcomit ance
Ġher bic
ĠMR SA
Ġintegr ator
Ġcord ycepin
ĠRAS GRP
ĠPA N
85 2
Ġmeth ane
Ġnan ogels
Am plification
Ġauto antibody
ĠAb ivertinib
Ġmobil izes
ĠNB D
Ġcore ceptor
ĠGen der
ĠGen zyme
ĠDec reasing
SD IEM
ĠIntern et
An tisense
Ġz VAD
Ġback cross
mod ulates
Ġbl ister
ĠHD LM
005 163
ĠSF mutation
sc ores
bi osis
ĠCY CLIN
ĠSM Cs
Ġfl uc
Ġfl ax
Ġsi lymarin
ĠId h
Ġcounter ing
MM olR
ĠCo Q
ĠCo gnitive
Ġalkyl transferase
EP HX
74 02
Ġmid brain
Ġrib osomopathies
Ġamino ac
ick le
Ġple uritic
ĠAr senite
ĠAr ticle
ON E
Ġpy kn
Ġuns cheduled
initi ation
omod ulation
VEGF C
artic ular
Ġpromin ence
ĠAR NT
Ġincid ents
ĠSp inal
Ġdim ly
Ġthi ostrept
007 156
ĠTCR G
Ġpron ormoblasts
ĠBu falin
Ex plore
ĠOut standing
ĠOut patient
ĠOut side
ĠMon itor
ĠEp idermal
Ġhomo e
Ġobtain able
Ġtop ographies
ĠMo bilization
tro virus
ĠFOX D
ĠFOX N
Ġtub erc
arg ine
My ers
Ġstabil izer
adj acent
ĠHyp erg
CAR E
GR I
GR OV
Ġsci entifically
ext ensive
Ġaggreg ometry
ĠNR G
)] -
ĠSimilar ity
ĠLA RP
urip otent
ĠTr ue
Ġfil aments
Ġfund ed
vi ro
ĠAut otrans
HG s
Ġsulf ated
Ġcircum scribed
Ġmach ineries
Ġgel ation
Da udi
ĠMe ier
chrom atid
Ġintrac ereb
Ġintrac isternal
Ġqual ifies
BA g
ĠFA CT
ĠFA SAY
sil ateral
Ġtempor omandibular
Ġtrac ers
otrop ism
Pre transplant
Pre venting
816 5
ĠHA EMACARE
sh PIM
ĠPost transplant
ĠPost operatively
Ġvul gar
Ġphosphatidyl inositide
ĠVari ation
HSP Gs
Ġphot olabeling
ĠCK D
ĠCK K
Ġmyocardi tis
Ġpor ous
Ġpor phobilinogen
gluc an
gluc oside
gluc ans
ĠSup T
ĠSup erior
ĠSE NP
Ġdisturb s
ĠSN HG
Ġcyclo pent
Ġcathe licidin
omb oid
PP O
Ġmono blast
Ġmono amine
ĠAdv isory
ĠRI SCT
ĠRI CTOR
ĠInf iltration
Ġcollabor atively
Ġmyc obacterium
Ġpartners hip
Ġcry ogel
sur veillance
Ġdeoxynucle otides
Med ical
Ġhyd atidiform
Ġhydrox ylation
hom olog
ĠPres ident
Ġquin tile
fil tered
oblast osis
De ep
Ġfibrin opeptide
BE AC
BB R
ĠMod ified
Ġfluor ogenic
>/ =
ĠMOL P
DT Cs
hex anol
Hyp ocellular
ĠFlu oro
PE CAM
PG D
plen ism
Ġdepth s
ABMT RR
ĠHP IP
sho wed
quin azoline
Ġround table
prim e
hi PSCs
ĠNa F
ĠNa AsO
ĠOb servations
Int ensification
Ne ural
Ġneurop sychiatric
Ġ(- /-)
TE X
ĠRep air
021 7
transf ection
ĠCr ystal
He La
ĠPred isposing
gthen ing
calc emia
Ġkeep er
Po lycythaemia
ĠIntr insic
LV ET
hel minthic
ĠBCP s
ĠMit ochondria
Ġsens ation
Ġconven i
Ġvers atility
Inter quartile
023 7
ĠDis closure
escal ating
Ind isulam
ĠPM BL
Ġvacu ole
KD EL
Ġce RNAs
039 53
Ġlentivir ally
Ġtro ponins
ĠAct ual
Ġtubercul oma
phospho lipase
Ġport folio
chloro acetate
Ġchond rosarcomas
ĠThromb ocythemia
Ġpathogen eses
ĠCAM K
ĠProte ase
galact osyl
Ġadenovirus es
ĠRef ined
Ġmesothe liomas
ket ch
Re activation
Ġadapt ors
ĠHyper calcemia
LN Cs
Ġmorpho line
prin ted
ĠEGF L
secre ted
Ġcircular ity
Ġpun ch
DF X
Ġnation ality
ĠDisc ordance
uit ment
ĠEgypti ans
oflu orene
ĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠ ĠĠĠĠĠĠĠĠ
alog s
pic ious
Ġvas oactive
Ġmusc ulus
Ġquad ruplex
Ġleg itimate
opolys accharides
Ġcustom arily
HM W
Ġradioimmun otherapeutic
Ġradioimmun oconjugate
Ġpeptid oglycan
Ġthorac otomy
ĠNeuro logic
Vari ation
Vari ant
Vari ants
Inhib itory
Ġchondro blastic
Ġros ettes
ynam ically
Ġsupplement ing
Ġstere otactic
ĠTyr phostin
Ġpet s
tryp tic
Ġproton ated
ann ual
arth ropathy
Ġexec utive
Ġwan ing
ĠNIL G
ĠDCL SG
ĠReported ly
Ġconception s
aff iliated
Ġnos ologic
Ġguan ylate
ĠLig ands
Ġonco hematological
ĠClinic odemographic
gs u
hist ochemical
Ġcalib er
Ġcyst athionine
Ġindustrial ized
Hem opoietic
End ogenous
ĠmCR PC
Ġaccident ally
ĠThird ly
Ġsac ro
Ġphosphorib osyl
Ġglucuron ide
iso quin
ĠFl ight
Ġmenog arol
Sel ected
Ġparap rotein
Ġhapt en
ĠDa oy
ĠLDA raC
Ġtach yp
Ġerythroblast osis
Ġperfect ly
TRA Q
Ġgr asp
carbox ymethoxyphenyl
leep ing
ĠUtil ization
Ġdeubiquitin ases
Ġtetrahydro folate
Ġobvi ating
olig os
Ġventric les
Ġgam mac
Ġtext ure
OB JECT
aper one
ĠRAP TOR
Ġrebound ed
Ġaddi tivity
Ġdysmyelo poietic
obi ologic
Ġpayload s
embran es
ĠSlo vak
Ġcontemporaneous ly
ĠALA S
Ġoblig ate
Ġphagocyt osed
ĠSchol ars
Ġbor on
Ġimmunohistological ly
Ġstret ches
Col lab
otax in
Ġhy rolase
ĠPerm utation
ĠVL B
ĠMast ocytosis
ĠHydro x
Ġduod enum
Ġspro uty
Ġunmas k
ĠSNA IL
Ġscin tillation
oP ortal
Ġlib eration
oflav in
Ġneurot rophin
ĠPTH rP
NIL G
nat ally
pyr rol
vul nerable
azop anib
Ġrheumatic a
Av ailable
typ ed
Ġanaphyl axis
ĠRV SP
Ġremed ies
Ġlute in
diac ylglycerol
kinetic in
prior ity
Ġjun B
Ġthio apt
Ġdispersion s
ĠCho osing
Ġexpedi tious
Ġnanost rategies
colla genous
Ġpermis sible
Ġunambigu ous
Ġneuros urge
osyn thesis
Myel osuppression
Op portunistic
Ġeleg ant
Ġeleg ans
ĠArabin osyl
ĠFung i
Ġenanti omers
aryng itis
Ġendometri osis
Ġsynthes ome
Haemat ological
Ġ004 00673
Ġ004 28558
Ġrecon ditioning
Ġdichotom ize
Ġimag ined
Ġcystein yl
Enh anced
Ġrhinosin usitis
none xpressing
ylox yp
ĠMas sive
immuno assays
Ġbiore actors
Ġschwann omas
ĠIraq i
Ġmedullar is
ĠArgent ine
Ġzym ography
Ġdub bed
Ġengulf ing
ĠMechan ically
Ġremn ant
Ġenucle ated
ĠValu es
enicill amine
MSK CC
carboxyl ic
DAP I
flur ane
Ġoutcomp ete
epit opes
00801 489
Ġpalmit oylation
rheum atic
Ġosc ill
aparin ux
rames hift
Ġnucleotid ase
Ġlumb osacral
Ġvinc ulin
Ġniger icin
phar anthine
Ġpref ers
Ġaggrav ates
Ġacryl amide
ĠInstit utions
Ġepoth ilone
Ġfibril s
Ġcarbam azepine
Ġventil ator
semin oma
ĠTgf br
ĠSAT B
Ġphos ho
allop ian
methylnog arol
Ġnitrox yl
ĠSummar izing
Ġglo ves
Ġconfid ential
Ġcounterm eas
gradi ent
Ġinsectic ides
Ġamplif iable
Ġaneur ysm
Ġelectrochemil uminescent
ĠFram ingham
ĠSuc cessive
Ġhypoglyc emia
ergot amine
invigor ated
ĠPhosphatidyl inositol
Ġchrys anthemi
ĠNig er
Ġarterio venous
Transcript ome
Retro viral
ĠWat son
Ġinterdig itating
Home ostasis
Ġlangu ished
ĠPut ative
Ġevap oration
Ġretri eve
Ġanticarcin ogenic
Ġtransmig rate
ĠInfiltr ating
Ġneurodevelop mental
Radio immunotherapy
Ment en
Techn ological
spar ing
ĠcBi oPortal
Ġmish aps
Ġeph rin
Ġtranscarbam ylase
ĠAlgorith m
Ġepiphen omen
Ġabsorp tiometry
ĠCruc ially
Ġnihil ism
EUD RACT
VSS S
Ġtelop eptide
Ġinap plicable
Ġseren dip
Ġnidul ans
ĠPediat r
stren gthening
ĠBPT ES
Ġuninter rupted
Ġmariz omib
ĠRosu vastatin
Ġsevo flurane
Ġsubtil is
Ġoutwe ighed
Ġdecellular ized
Ġheterotrim eric
Ġlabyrin th
Ġjiro vec
Ġglycocaly x
Ġthiostrept on
007156 37
Ġvulgar is
Ġneurosurge ons
) '.
. ].
/ )
4 67
6 22
6 65
6 368
7 10
7 999
8 28
8 49
9 21
9 309
A k
A FS
A WT
A HA
A pa
C ar
C up
C MT
C PM
C AC
C ST
C opy
D m
D er
D art
D DE
E EC
E OI
E hl
F X
F ever
F AL
F CA
F ront
F rance
F ZD
G e
G old
G PB
G AS
H ow
H MD
H Be
I p
I VI
I HDAraC
J B
K e
K AP
M ith
M ath
M WT
M orbidity
M OPP
M nk
N onad
N itric
O GS
P atched
P CP
P PK
R ac
R KIP
R unt
S pec
S AML
S DH
S DA
S OC
S pr
S tenotrophomonas
T ox
T RP
U PA
U biquitin
V PM
V orinostat
W f
X B
X D
Z M
Z OL
a OR
a ffin
b u
b ent
b ow
c E
c T
c ation
c her
c am
c mm
c ediranib
d x
d AR
f oc
f resh
f aced
f rozen
g ents
g us
g lu
g amy
h IL
i jo
k ot
k aline
l os
l up
l ost
l ite
l eness
m dC
n arinone
n odular
o ho
o lymphoid
p d
p ies
p act
p ALL
p terin
p ump
r istone
r AAV
r rAML
r Siglec
s L
s omy
t ress
t ransient
t amoxifen
t apsi
v iable
w ares
y rophilic
z a
z il
z ers
Ġa u
in i
in activated
in structive
Ġt ec
re programmed
re presentative
on n
he t
he bei
Ġc enti
Ġc yl
Ġc aroten
Ġc ullin
Ġo tolaryng
Ġp DLI
Ġp BR
Ġin versus
Ġs C
Ġs MR
Ġs ides
Ġs ending
Ġs TREM
Ġm RCC
Ġm oll
al vocidib
is ations
is ox
or os
an imal
ro tide
ro thrombotic
el zer
as aki
it r
it z
Ġd NK
Ġd CF
Ġd TAL
Ġd rew
es tive
er als
Ġre assessed
le to
ar p
ar ified
Ġf ra
Ġf uran
Ġf ears
Ġf allopian
at ability
at uximab
Ġb ib
Ġb ore
id oc
id arabine
os er
os omies
om ple
om ata
om embranous
om elotinib
om ogeneity
ly x
ul s
Ġh os
Ġh PD
Ġh ES
Ġh sc
Ġh inting
Ġh yg
Ġh BMSC
em pt
em odin
Ġth iazole
ec ity
ec otropic
ĠA vo
ĠA WT
ĠA plidin
tic a
ĠT b
ĠT as
ĠT it
ĠT cl
ĠT SCs
ĠT HC
ĠT ctp
im el
im at
ia ceae
res cence
lo dine
ot arget
ot yrol
un ich
un olol
ĠC RA
ĠC XL
ĠC BV
ĠC ensus
ĠC JX
ig l
ig mentation
ut hw
Ġac ous
Ġac etic
Ġac ivicin
ac ide
Ġex ported
Ġas ks
Ġas ODN
yelo cyte
se o
se ver
Ġres ampling
Ġl eridistim
Ġwas tes
op recip
rap ine
ib rotide
ĠI HD
ĠI RP
ĠI PT
ĠI UR
ĠI OV
ĠI HDAraC
il izumab
Ġ1 150
ĠM ec
ĠM ember
ĠM dr
ĠM rs
ĠM enin
ĠM idol
ĠM orbidity
ĠM MSD
ĠM aster
ĠM orphometric
Ġcom ethylated
Ġbe ig
Ġbe et
ol ineage
ol ignan
Ġde polymer
ĠAML Tim
Ġal phoid
Ġg yrus
up front
Ġdis put
Ġdis association
od ef
ys ema
ug li
Ġv p
Ġv IL
Ġv icious
Ġv idarabine
ĠH mg
ĠH HSC
ĠH PMA
yt trium
yt herapy
ĠP PA
ĠP MR
ĠP YK
ĠP MI
ĠP ICU
ĠP ulsed
ĠP aper
ĠP odocalyxin
Ġtrans cellular
st ent
ĠB acter
ĠB ER
ĠB gl
ĠB SM
ĠB acterial
ĠB endamustine
ĠB SMs
Ġr MLL
Ġr rAML
Ġr lipo
Ġinc rim
Ġ2 157
qu am
qu encing
am age
ĠD og
ĠD MF
ĠD imethyl
ĠD aptomycin
Ġun activated
Ġun expressed
Ġun rearranged
Ġun tested
Ġun informative
Ġun randomised
Ġun transfused
ub ble
ĠIn ev
ĠIn side
ĠF ar
ĠF eline
ĠF IA
ĠF urazolidone
ĠF ischer
ĠS FN
ĠS CAR
ĠS CV
ĠS ISBH
ĠW G
ĠW isc
ph as
ĠCD KI
th usiasm
Ġsign le
Ġrel iab
Ġk alli
pro line
Ġmo MDSCs
Ġmo uthw
Ġap DCL
AML SG
yl osing
yl guanidine
one ogenesis
one tics
00 30
00 62
00 266
Ġinhib in
Ġinhib iti
ome w
ess el
Ġco elic
Ġco localizes
Ġsho res
ĠR Z
ĠR en
ĠR FA
ĠR inger
ĠR VD
ĠR ituxan
ĠR atios
ĠR ayn
ary otic
Ġrem ember
Ġrem ethylated
ĠN b
ĠN ative
ĠN ature
ĠN DR
ĠN CB
ĠN nat
ĠN aphthoquinones
ĠN aeI
Ġ5 12
Ġ5 77
Ġ5 876
Ġab ound
Ġchem otype
ren ess
Ġmon itors
ĠO rid
ĠO GP
Ġinv ent
ĠWe ighted
cl am
cl inic
lec tin
Ġcont racted
ĠG RM
ĠG DP
ĠG Ps
ĠG ICs
ĠG FD
ĠG iga
ĠG ingival
plant ar
Ġsub nanomolar
ĠE i
ĠE mi
ĠE jection
Ġ4 11
Ġ4 26
ox yp
CR Cs
CR EM
Ġafter ward
Ġout set
Ġout number
Ġpo ultry
Ġpres erv
Ġpres epsin
ĠTh orotrast
ĠL is
ĠL an
ĠL gr
ĠL ength
ip rone
ros omes
yn thesized
Ġhe s
end odermal
Ġob sole
ad herins
opo ly
ari ates
Ġ6 10
Ġ6 50
Ġ6 27
Ġunder reporting
ers ensitive
ers ican
LL SG
Ġsyn d
Ġsup pose
Ġpar sim
Ġ7 22
Ġ7 40
Ġ7 73
Ġ7 82
Ġ7 2527
Ġlympho reticular
Ġdec oded
Ġdec aten
rib las
ifer min
ĠDNA MT
Ġnon human
Ġnon cross
Ġnon reducing
Ġpl umb
Ġcor n
enc ers
ological ly
Ġ9 24
ag mus
Ġ8 12
Ġ8 26
Ġ8 71
Ġ8 76
Ġ8 81
Ġ8 74
Ġchrom ogenic
AB O
ogen ol
Ġallo antibody
Ġallo immunized
ĠMDS S
ĠK W
ĠK en
ĠK OPN
ĠK lf
ch osine
Ġdes quam
ĠU F
ĠU ser
ĠU BC
ĠU biquitin
Ġ10 98
Ġ10 79
Ġ10 58
11 195
RA L
ens ors
01 72
og al
og litazone
ures is
Ġmulti lamellar
loc arb
fer ral
Ġme pol
Ġprolifer a
ĠCR I
Ġqu asi
Ġrepor ters
Ġmicro Ci
Ġcar gos
Ġdef e
Ġdef ibrotide
ath ing
Ġcommon ality
ĠJ P
ĠJ MD
ĠJ SI
ĠJ CCG
Ġmain land
Ġdel ves
Ġdel tan
10 40
10 79
veal ed
trans forming
trans membrane
Ġpop ulate
Ġpop lite
omet a
omet ostat
Ġsh ield
Ġdi aryl
Ġdi uretic
13 20
13 04
Ġsignal ed
CL IC
az imine
Ġ19 67
Ġ19 65
Ġ19 62
Ġda idzein
osph ate
Ġmin ise
Ġtranscription s
Ġform ulary
Ġprof iciency
22 06
Ġprogen ies
33 27
Ġpost paclitaxel
Ġpost natally
medi ate
Ġnucle oplasmic
53 25
ĠPh ot
ĠPh yt
ĠPh armacy
ĠPh omogeneity
MP red
14 70
Ġmor ning
Ġsimilar s
ark er
Ġer aser
ism atched
Ġend oderm
Ġaffec tion
ater s
Ġdo ors
ĠHLA Dr
cin tigraphy
Ġmy A
Ġmy ositis
avor ably
atric opeptide
iss ure
Ġes orubicin
20 55
Ġ14 12
Ġconfirm ations
In di
EB C
95 76
Ġ13 70
Ġmit ox
Ġmyel osu
Ġflow ering
25 88
23 06
Ġ200 00
ĠBM SFs
Ġpredict ability
Ġ16 99
ind ividually
ind icators
ĠCh M
ĠMP C
ĠMP XI
Ġpur ported
ĠRec urring
Ġbreast feeding
Ġ60 6
und us
Ġallow ance
Ġdele te
allen ged
Ġpharmac oproteomic
RT A
RT Q
Ġtri phosph
Ġ100 5
30 65
rophil es
Ġsum s
lob ated
lob ular
of l
27 8
27 40
Ġu L
Ġaz acytosine
Ġins urm
ĠST AP
Ġsynerg ises
MS s
MS LN
Ġconc an
Ġconc ordantly
Ġphosphor amid
Ġunf avorably
onucle oside
ĠX MD
ĠX IST
Ġlip opolysaccharides
Ġcer ivastatin
Ġgu arded
90 348
PD E
ĠCom C
ĠOver represented
Ġsp ic
CP P
CP SS
Ġdys hematopoiesis
04 99
04 69
ĠEx change
Ġantic ancerous
Ġunderst ated
Ġmac aques
Ġmac roscopically
40 95
ĠCon sequences
Ġmuc ins
Ġpan CD
stim ulus
lympho blast
Ġdu plicon
ĠPro duction
Ġseem ing
ĠPB ASCT
Ġ27 29
03 24
Ġ26 292
less ness
per i
Ġhydro lases
cap ing
ME S
Ġclear cut
ĠER S
ER M
inf inity
Ġpoly agglutination
Ġcardi olipin
amin ofluorene
Ġpubl ically
ĠTET s
AD ME
Ġ48 9
Ġ70 6
ĠAS Os
ĠMS s
lor odibenzo
88 4
88 174
ĠCP Cs
ĠCP SS
Ġendothe lin
67 18
617 64
Az ad
Ġepit ome
Ġangi ostatic
ĠPR RT
immun ophen
function ing
Ġpanc reat
glyc ol
feren tial
DC E
ĠME NK
ĠME LC
ĠME LP
ĠMT LC
Ġsol ving
Ġsol GMRalpha
ian et
Ġtra verse
Ġorgan ellar
Ġinternal isation
ĠInte racting
Ġsepar ations
PR V
PR RT
PR ES
ĠQ RS
ĠQ SAR
Ġ46 1
Ġclinic obiological
ĠAN Ts
Ġdysplas ias
Ġtermin ates
Ġ75 4
Ġ75 8
ĠZ hebei
ĠTrans gene
IV E
IV S
39 4
39 53
47 2
47 903
47 90348
ĠCC l
Ġ65 1
96 33
Ġelect rophiles
rh EPO
ĠGST alpha
Cd c
ĠAL WP
ĠPT S
Ġoxid izing
Ġhepat omas
97 48
ĠPA O
ĠPA UF
ĠAp rt
Ġdemethyl ator
Ġdemethyl zeylasteral
EN C
Am eric
Ġacet o
Ġauto inhibitory
Ġcross linked
Ġcross react
gamma SN
Ġsecre tes
inte gration
Ġrs TRAIL
hemat ous
Ġoste olineage
ĠPI BF
Ġhour ly
Ġred dish
ĠIC ER
Ġbrain stem
Ġspon gi
sp inal
ĠGen erate
Rec ruitment
anti plasmin
Ġadap tively
An aplastic
del ayed
Ġefflux ing
RAR E
ĠGS Ls
Ġemph ysema
PV A
ĠHD J
ĠHD s
Ġincub ator
ĠPV HA
ES PCR
Ġshe l
ĠInc isional
PI A
ĠRe placement
ĠCH S
Ġbio activation
equ il
Ġfibro collagenous
76 3
DNR B
eth idium
myelo genous
col chicine
MY CN
Ġgluc os
Ġdissem inate
Ġsl ugg
ival ence
Ġmis regulation
Ġmis classification
ĠNA LP
Ġur gency
ĠDAC A
med icine
EP G
EP s
man agement
ĠCol chicine
ĠOnc ologists
ĠOnc otyrol
Ġrib osomes
arn osic
ĠDe tecting
Ġemergen cies
Ġrh TNF
ĠEv ents
78 338
78 797
Ġpy rin
Ġpy raz
ĠRAR E
Ġphospho kinase
MC V
Ġ77 62
Ġmen adione
micro dissected
Ġoverl ay
ĠIP H
pr uritic
Ġaccept ability
tif ocal
Ġplan aria
ĠMK B
ĠFas R
pergill osis
Ġemphas ise
Ġimmunotherapeutic al
Ġsubcl oned
aut opsied
Ġuniform ity
non myeloablative
ĠAc H
ĠLT F
ĠSp ry
Ġsoft wares
Ġthi oct
Ġthi obarbituric
Ġdeb ris
ĠLC SC
Ġlact ation
ĠSH H
Ġescal ate
ĠHist ochemical
be h
ĠEp imutations
ĠGr MDSCs
ĠPer i
ĠPer tinent
Ġsplice osomes
ĠCG C
Ġcytoplasm atic
07 03
inter cellular
rs olic
ĠAD D
KL HL
UD I
ĠPTP gamma
ĠEle ments
ĠAF T
Ġoccup ies
Ġnit rop
ĠLA SSO
St anniocalcin
Immun omodulatory
Ġcongen er
Ġmil gamy
009 267
ĠUnder going
Ġencoun ters
ĠSK W
Ġsuper b
ĠMe SH
ĠEm berger
Ġhistopatho logically
isc iplinary
ĠSh RNA
Ġtiming s
prom yelocytes
ĠBR LF
otrop ium
Ġarg yrophilic
ĠCor ticos
ĠHO M
ĠHu H
Ġcomm ences
ĠCO MP
Ep idermal
ĠSequ enom
CV Cs
ĠPL D
SH M
ĠLy on
011 1
011 88174
ĠMi ki
Bu Flu
ĠFL G
ĠFL V
Ġaff lict
Ġpor omas
Ġpor omatosis
hyd ramine
back ground
ĠSup eroxide
opsy chosine
Ġreticul ohisti
CX XC
Ġflav ones
Ġundert aking
ĠUp front
Ġdoub ts
hyp usine
Ġdip loidy
ĠPMN L
carb ohydrate
Ġenter itis
GA An
plex es
Chrom atin
Ġabol ishing
Ġabol ishment
Ġvascul ogenic
itud es
gu ardian
sur gery
ĠKnock ing
Ġhydrox ylated
Ġhydrox ymethyl
ĠPres epsin
hydrox ylated
ĠWork ers
ĠSpecific ity
no ise
fil tration
Ġmill ennium
dem ethylases
ĠDM ET
Ġdihydro ergotamine
HU GE
ĠMan ufact
GN B
ĠMod ulating
ĠGBM s
ĠMin imum
Ġneph rectomy
Ġfluor inated
Ġden osumab
ĠGF AP
Ġrepop ulates
ĠAza CR
obin s
ĠAug mented
ĠHP F
ĠEnd ostatin
Gen otypic
Ġmeaningful ly
erb A
CCN U
Ġcul tiv
ĠClin i
Un successful
ĠKary ogene
Ġdeoxy hypusine
ĠHMG I
ĠRet ransplantation
ĠOb ese
026 78338
Hu EPO
TF II
TF PI
TE PA
ĠBT SA
ĠCMR F
ĠHM OX
Ġging iv
ĠTIM E
ĠGSK J
iant o
idi osis
ĠAE Us
Ġmitig ates
benz ene
ĠSet s
NO B
NO AC
stem ness
Ġperox yn
itide psin
oli ovirus
haus er
ĠFACS can
ercul ous
ĠSV V
ĠEMT s
ĠCS K
Ġstay ing
Tar get
Ġexacerb ations
rach lorodibenzo
Ġindisp ensible
Ġmyeloblast oid
ĠCTN NB
Ġinfer tile
disc overy
Ġchaper oning
Ġther mo
720 9748
Ġhal ting
Ġhal ogen
ĠAnnexin V
Ġip silateral
Ġdia min
ĠPO MP
bis ome
ĠPhen otyping
ime tidine
Ġlamin ectomy
ĠInvestig ational
ount able
Ġpecul iarity
Ġ(+/- )
bilirubin emia
ĠDef inite
Ġcontamin ants
phospho gluconate
Per ianal
neu T
Ġrheumat ologic
Ġlob es
ĠHo elzer
Ġultra deep
ĠGR alpha
cytogenetic ally
Ġbre ed
Ġbre eding
Clonal ity
Ġheral ding
ĠPatho genic
Ġcatabol ites
Ġathe rothrombotic
ICU s
ĠVAF s
Ġadminist rative
Ġnitro cellulose
Ġdefer iprone
ĠNY HA
Ġlic henoid
ĠVer ification
Ġisot onic
ĠNH W
Delta N
Ġorchestr ators
gel onin
pers onal
ĠTE PA
Ġmini ature
0000 27
Protein ase
Ġreconstr uct
ĠEuro cord
ĠDelta Peak
Ġnano vesicles
Ġchemop rophylaxis
ĠGal NAc
Ġtris accharide
Ġextr uded
nitros o
Neu Ac
Neu NAc
produc er
ĠASH AP
Ġdeoxyribonucle osides
Ġanthrac ene
ĠCx cr
ĠCx Ca
Down regulation
ĠCOL O
Ġlac rimal
Ġunpred icted
Ġlin oleic
ĠOX i
ĠDex amethasone
THP C
Ġdin itrop
Ġros emary
ĠPrim ed
ĠASP S
Ġprohib its
Ġstere os
Di hydro
uth rie
ĠEHR s
347 03
Ġpet rol
Br uton
Br Tet
tetrahydro uridine
ĠAV NB
prob ability
ĠMat hematical
Ġbroncho pulmonary
ĠPr mt
Ġcompe tit
ĠBiological ly
ĠHF TBI
region s
Evalu ations
Sub cutaneous
Ġbioch anin
Ġdynam ical
ĠCur cuma
ĠCIN V
ĠApp earance
DCL SG
kl anonic
ĠACT H
pharmac ology
hist ological
ĠSus pension
Ġtal d
electro por
By ar
Ġgelatin olytic
enedi ones
NH W
Ġstream line
anch or
deoxyc yt
Ġcyan obacterial
Ġmicrosp here
ECM O
Ġdn NUMB
Ġequival ence
Ġthreat s
Ġtria ge
dig it
Ġisothiocyan ates
MTH FD
ĠAMoL s
ĠFcgammaRII A
VO Cs
clus tered
Ġpathom orpholog
ĠRW E
Lip o
ĠGEM IN
Anal yses
Ġpin ometostat
Ġvan C
Ġhijack ing
ĠDevelop mental
Ġbip olar
Ġbip otent
Ġ233 1
ĠOC UM
358 000
ĠRout inely
Qu est
ĠCEL SR
Ġcob imetinib
Ġcytofluor imetric
ĠDMA A
olyl polyglutamate
PCD H
ĠSJ L
ĠHFD DDE
ĠPart ly
557 6
yco formycin
Ġforest ry
Ġfaith ful
iph atic
Ġdend rites
ĠMar itoclax
Ġenteroc occus
MH CII
Specific ity
Tri partite
Ġnonp apillary
phag ocytic
Tra ditionally
ĠOs seo
FF PE
PPI s
ĠBAC H
Hist amine
Nov antrone
Peg ylated
Ġpromon ocytes
Ġambi tions
ĠHaem onetics
ĠLU MA
ĠMAF B
Ġank yrin
Ġank ylosing
Ġdeform ity
ĠFOS B
dichlor o
ĠLeukem ianet
Ġpunct ate
Ġvibs anin
arter iolar
ĠBro ad
ĠFrag ile
Ġinstig ated
Ġaqu atic
CGCG CG
Tumour s
ĠHisti ocyte
ĠSplic ing
Ġspeak s
ĠNu SAP
Ġdissoci ating
phy seal
Ġhaemolytic a
Est rogen
Ġcate chins
Ġinhal ed
ĠGre aves
556 78797
cytid ylic
Ġindo locarb
HID Cs
ĠAntic o
Ġchemores pon
Ġpyrrolo pyrimidine
Disc overy
cephal y
ĠBS Is
Ġattit udes
Ġost hol
Ġavoc atin
Ġcertif icate
Ġenanti omer
ĠUMP K
Ġendometri otic
Cur cumin
morpholog y
Ġast rog
Ġlign an
ĠInform ative
ĠPROT AC
Hetero zygous
Ġnanoform ulation
ĠFlav opiridol
Ġpall adium
Ġflas k
Ġapo E
Ġinvest ment
leukem ogenic
Ġelectrosp inning
ĠGABARA P
ĠScutell arin
Ġameb iasis
cur cumin
ĠHMF G
apro ximately
Ġpim ozide
ĠTO PS
ĠTheore tical
Ġinvag inations
Ġcortic otherapy
ASI x
ĠDos imetry
0075 001
Ġphthal ocyanine
sulph atase
Ġpsi TPTE
Ġmicroemulsion s
Ġinconven ient
esc ens
ĠBc I
aman itin
ĠSial yl
fluoromethyl ketone
ĠSPRY CEL
0095 2588
flur idol
Eff icient
LU MA
classif ications
Ġnyst agmus
Ġcytot olytic
Contro versial
Ġthalass aemia
ĠOverex pressed
ĠYe ast
Ġextramed ullar
Fib roblast
succin imidyl
apo ietic
Ġbiob ank
Immunohist ochemistry
Ġteen agers
Flav opiridol
recr uitment
ĠEd itor
iodobenz ylguanidine
ĠSelen oprotein
orus ide
Ġadnex al
mobil izing
Ġsialoglyc oprotein
Mer kel
Qual itative
tax ol
anat omical
ĠAHF RT
Ġchym opapain
ĠSecre tion
rens ic
Ġsyncy tial
Ġmicrow ave
ĠTGFBR II
ĠIndones ian
Japan ese
System atic
VAL OR
Ġchylo thorax
ĠFran cis
Ġoverwhel med
thol omew
Ġanthrapy raz
ĠUlt ra
demethox ydaunomycin
smo oth
Ġuncl arified
Ġ894 999
Ġfeeling s
Ġmicrof lora
Fin der
Sy k
Vin cristine
omol gus
ĠMiss ense
ĠSpar c
Ġsilic one
Cauc asians
adreno ceptor
bran ched
Ġbrach ytherapy
ĠTrap ianto
ĠCess ation
ĠRMN D
Ġerythrodys esthesia
Ġglycod elin
feed back
Ġnemat odes
Ġextirp ation
ĠBiod istribution
Ġposses sion
ĠToy ama
ĠSubt raction
Set d
Tyros in
ĠIGFR II
Ġalgin ate
Ġpharm oc
ycn ogenol
Ġtetracycl ic
Expl oratory
Ġtetraethyl ammonium
Ġradioimmuno assays
betam ipron
FUNDING This
Ġdiphen hydramine
ĠToc ilizumab
ĠHart ford
Ġinvad osome
Ġphil os
1801 018
ĠAutotrans plants
Ġconveni ently
Ġphosho protein
6368 32
7999 17
Ehl rich
GPB B
Nonad herence
rSiglec s
leto e
ĠAvo iding
ĠMidol lo
Ġdisput able
ugli el
ĠInev itably
ĠSCAR B
Ġreliab leness
Ġkalli kre
00266 136
Ġcoelic olor
ĠRayn aud
ĠOrid onin
Ġobsole te
Ġmepol izumab
Ġpoplite al
Ġminise quencing
5325 45
2306 283
2740 348
Ġinsurm ountable
0469 1502
61764 370
47903 53
Ġslugg ish
Ġthioct acide
009267 31
" ;
- :
/ :
0 223
4 27
4 694
5 95
5 23
5 83
5 228
6 88
7 35
7 86
7 82
7 4588
8 60
9 333
? ),
A IC
A SS
A Is
A UROC
B acterial
B udd
C ateg
C PA
C PD
D SC
D DL
D TR
D BT
D MPS
D RAM
D IDOX
E en
E os
F ab
F DR
F DP
F vs
F requent
F MAU
G RF
G ruppo
H Q
H IS
H PMA
I so
J E
J F
K PS
K aposi
K yoto
L ocal
L ITR
M im
M ethod
N MP
N ras
N HA
O mi
P OD
P GR
P eptide
P RPF
R ub
R PM
R IL
R ai
R IP
R ank
S b
S j
S ec
S ur
S oci
S IL
S MS
S DC
T or
T PL
T CP
T beta
T rich
T FA
T DO
T NTs
U CN
V is
V HR
V ancomycin
V RL
V igi
W ASP
W arburg
Y B
Y NK
Z osuquidar
] ):
a w
a iton
b w
b ism
b evacizumab
c MPN
c Ig
c DDP
c osporamide
d low
d uring
e pendent
e RY
f if
f ounder
f requent
g k
g ro
g em
g row
g lob
g ranular
h its
i y
i ud
j unction
l q
m P
m os
m EFS
m outh
m eningioma
n as
n os
p L
p T
p Y
p et
r A
r athe
r TM
s u
s or
s pread
s kewed
t yros
t osyl
u oden
v iac
w hether
y ramine
Ġa HCT
Ġa klanonic
in aciclib
Ġt an
Ġt ant
Ġt aps
Ġt iling
Ġt ivantinib
re vert
on ant
he ll
he sias
en ol
en na
Ġc ass
Ġo z
Ġp om
Ġp ear
Ġp DFS
Ġp LSC
Ġp evonedistat
Ġin gest
Ġs end
Ġs ociated
Ġs WT
Ġs VEGF
Ġs ellar
Ġs itting
Ġs onography
Ġs VCAM
Ġan ym
Ġan abolic
al eukemic
or ient
or ylase
or arrays
an ium
ro ot
el ly
el imination
as ar
Ġd f
ed ospor
er as
ent ation
ic ke
Ġre induc
Ġre transplanted
ar asar
at RA
Ġb all
Ġb ark
Ġb ull
Ġb ish
Ġb arium
Ġb ZIP
Ġb Zip
Ġb ambo
ate amine
id oxoform
Ġe ug
Ġe LPI
Ġto co
om ine
Ġh osted
ell osis
em ulsi
Ġth irst
ĠA DH
ĠA def
ĠA joene
ĠA CIN
ĠA UTO
tic es
ĠT BC
ĠT ID
ĠT VTC
im ate
im age
ur istic
Ġle verage
Ġpro coagul
Ġpro lyl
lo xy
lo ids
gen uity
si lic
si bilities
ot ope
ĠC ant
ĠC AP
ĠC BM
ĠC atal
ĠC LC
ĠC dC
ĠC LTC
ĠC ofilin
uk emia
ig an
ut aster
Ġleuk opheresis
ce a
if ep
ac cess
ac quisition
ac yclovir
Ġas ympt
Ġas eptic
Ġleukem ogeneic
ase pase
Ġmyelo iud
Ġres orting
Ġl ays
Ġl ifer
Ġl ucid
Ġl uspatercept
Ġst ating
Ġst ature
Ġst anding
Ġst yrene
ver ts
ĠI MD
ĠI BR
il lo
il iter
il lous
pres cribed
ine ar
ĠM AA
ĠM NPs
ĠM ount
ĠM oxe
oc ortin
Ġcom utated
Ġbe acon
Ġde pri
iv ation
Ġim aged
pl aces
rom as
Ġch air
Ġal iphatic
up stream
Ġdis h
Ġdis abilities
Ġdis organized
Ġby products
Ġv ap
Ġv angu
ĠH MR
ĠH EC
ĠH PN
ĠH Gs
ĠH onokiol
ĠH BAg
yt oin
gn ation
gn ase
ĠP Q
ĠP ra
ĠP ant
ĠP age
ĠP erox
ĠP rec
ĠP ras
ĠP yr
ĠP ortal
ĠP ERS
ĠP iPS
ĠP gP
tiv ariant
Ġtrans version
Ġtrans dermal
Ġtrans bronchial
st in
st ant
ĠB LC
ĠB GS
ĠB US
ĠB ronchial
Ġr ick
Ġr ye
Ġinc iting
am ib
yp h
Ġcomp acted
Ġcomp ilation
orm one
ĠD us
ĠD RP
ĠD DL
ĠD oub
ay as
Ġne oc
Ġne ov
Ġun insured
ĠIn oc
ĠIn troducing
ĠIn nate
log raphic
ĠF ow
ĠF NA
ĠF BL
ĠF dUrd
ĠS ear
ĠS ag
ĠS CML
ĠS af
ĠS RF
ĠS BA
ĠS PAN
ĠS leeping
Ġcyt apheresis
ĠW ing
ĠW alker
ous ai
ph ases
th yroidism
der ness
Ġass er
Ġat opy
Ġat tested
Ġmo xif
Ġap pointed
Ġap heretic
yl idene
00 88
00 79
00 85
00 41
00 69
Ġ3 37
Ġ3 013
Ġ3 903
Ġmar ital
Ġmar ried
Ġco lectomy
ther s
ĠR CBT
ĠN if
ĠN ap
ĠN FS
ĠN LF
ĠN ago
Ġ5 608
Ġper vasively
ĠO TR
ose i
Ġhem inested
Ġhem ocyanin
Ġimmun ize
Ġimmun otyping
Ġimmun izations
ĠG ate
ĠG PA
ĠG round
ĠG DM
ĠG pr
ĠG rand
Ġpre relapse
Ġpre Ts
ely x
rac on
rac oxib
Ġsub normal
Ġsub band
Ġsub verting
ĠE J
ĠE up
ĠE SCs
ĠE verolimus
ĠE QA
ĠE AFT
Ġ4 29
ox ycarbonyl
ox oglutarate
CR AC
Ġdrug gability
rel la
Ġlym oho
Ġpres elected
ĠTh in
ĠTh rombin
ĠL SF
ĠL EL
ĠL omb
ĠL ille
Ġhe aled
ad in
Ġ6 01
Ġ6 05
Ġ6 40
Ġ6 43
Ġ6 69
Ġcyto gene
Ġmal onyl
Ġro uted
Ġsyn teny
Ġresist ent
Ġsup ralethal
esti s
own ia
Ġ7 33
Ġ7 76
Ġlympho bal
Ġhematopo esis
ct r
ult ative
Ġnon AML
Ġnon resistant
Ġnon activated
Ġnon responder
Ġnon white
Ġpl t
Ġpred ated
Ġcharacter ising
ail ability
ond aparinux
Ġ9 85
Ġ8 67
Ġ8 91
AB W
Ġinter dimer
Ġel uting
Ġallo depletion
ĠK le
ĠK inetics
ĠK osei
Ġar rive
Ġdes erving
ĠU FT
Ġ10 25
mon ization
mon otherapeutic
11 29
Ġra m
Ġpotential ities
Ġprim aries
MT ase
01 45
Ġinvol ution
Ġhyp oc
Ġhyp ochlor
Ġhyp oproteinemia
ak o
Ġmulti genic
Ġmulti linear
Ġmulti probe
Ġmulti farious
ach lor
Ġup modulation
CML SCs
ass a
Ġnovel ty
fer il
Ġsc edospor
CT AG
Ġqu inte
Ġmicro bic
Ġmicro domain
Ġcar tr
Ġam ple
Ġam idine
+) ;
ful ness
Ġext ral
spec tral
Ġdon ations
Ġanaly zers
ne utropenic
ne uronal
ne uploidy
10 88
Ġser pin
Ġconf ounds
trans activator
omet rical
Ġadv enti
ĠV iable
ĠV isc
ĠV ITR
ĠV ardenafil
13 26
13 181
AT C
az olin
SF T
Ġlymph angi
ffec tive
leuk aem
Ġfurther ing
Ġphen ytoin
ex ternal
ex clusion
olid es
Ġprof lavine
Ġhetero plasmic
33 59
par ation
Ġinfec ts
stan tiated
int act
ĠPh il
19 68
ma ges
Ġmor in
60 4
Ġdaun orub
ĠII beta
Ġend odermal
ocyt oses
Ġpolym yositis
ĠAs sisted
af A
tr ical
tr ast
Ġparticular ities
20 31
Ġtotal ing
EB I
Ġprec ultured
Ġloc k
ons in
val anol
ĠAB W
MD V
ST L
ST ANDARD
Ġtr ifluoro
ĠRA M
ĠRA MP
Ġset ups
Ġset tle
Ġtechn ologic
ĠBM ECs
ĠBM MNCs
ok aryotype
ophen one
ind olent
ind olo
ty ryl
05 794
)( *
ev is
ĠCh l
Ġbiom ass
oid in
amm ary
Ġcycl er
CI L
ĠAd alimumab
omy osis
RP E
CC Bs
ĠRec lassification
tumor ous
18 05794
rin otecan
37 34703
Ġrep olar
26 121
Ġsu ite
BM MSCs
IS MA
orph osis
irc orarrays
ĠLeuk openia
Ġfunctional ities
Ġtri os
Ġ100 9
gra vity
of en
mic roscopy
ĠUn sur
Ġu MRD
ĠAt azanavir
ĠFor odesine
ĠST Ps
Ġcirc le
Ġunf olding
con text
MA R
MA LT
Ġhaemat oc
Ġhaemat oma
ĠX II
Ġwork places
Ġcer cosporamide
Ġretin amide
Ġdys regulate
Ġlesion al
ĠEx tending
Ġutil ities
Ġantic yt
Ġcriter ias
cyt os
cyt openic
Ġbas ket
ern icke
Ġgl argine
ĠHe paran
ĠCl amping
ĠPro gressive
ĠPro gesterone
100 5
ĠPB T
Ġtandem ly
Ġcho lines
eg a
Ġsuff ice
CM MRD
Ġarabin osid
Ġ26 53
Ġ26 40
Ġhydro dynamic
cap ine
44 7439
HL IP
Ġglyc ation
ĠCyt ochemically
ĠER R
pre fibrotic
ER alpha
inf used
Ġpoly rib
Ġpoly pyrimidine
Ġ35 5
Ġcardi ologic
Ġcardi otonic
PB Bs
amin olysis
opy r
Ġsal mon
Ġ48 00
ĠDC leu
Ġmeasure able
Ġven om
ins tig
Ġmegakary ocytosis
ĠMS Ns
ĠPR ND
immun osup
immun oassay
function s
function ality
Ġ34 6
glyc eraldehyde
ml l
Ġtopo II
ian o
IF Ds
ob ile
Ġorgan otypic
ĠInte grin
Ġmacro H
GM ALL
PR ED
GS s
acetyl gluc
Ġregres ses
rog raph
Ġ75 5
ĠHR K
ĠZ IC
glycoprotein s
Ġpreval ently
Ġpreval ences
Ġ44 2
ĠKIT L
66 1
66 68
Ġdiss olution
met astases
Ġvin cristin
ĠImmun ol
Ġpul sing
Ġcluster in
Ġexer tional
68 7
Ġstar ter
Ġstar ved
Ġoxid ases
Ġaden opathy
ĠMR G
97 8
Ġbeh alf
ĠAp plications
87 4
87 114
Ġnan ometric
Ġauto antigen
inte ractive
sign ment
OL FM
Ġmobil ise
ocar zin
ĠCSF IR
FI BA
Ġred iscovered
ĠImport ance
ĠAcc uracy
Ġcis tern
117 3
ĠHealth care
ĠGen asense
Rec urrence
ĠDec iding
Ġexcess es
An tic
Ġpe a
Ġspectrum s
Ġz oled
Ġbus y
mod al
IN D
ĠKIR C
Ġembry ogenic
Ġembry oid
ocomp romised
Ġneg ates
Ġglut aminolysis
angi otensin
bi CEBPA
ĠRe plicate
ĠRe gnase
Ġintr aspinal
Ġfl ap
Ġfl ip
Ġsw ord
Ġhome opathic
Ġhaem ophagocytic
exist ent
eth ionine
Ġdissem inating
Cyt osolic
ĠNA MPT
Ġparticip ant
med ication
ĠAP OC
Ġexc ited
flu orescent
ĠNe onatal
Ġbis phosphonate
OP G
Ġuns ur
Ġuns orted
direct ly
lim it
Ġspecial ization
Ġspecial ties
ĠBi oph
NT ES
inhib itable
Ġleuc aemia
aut y
Ġstart le
ĠAR I
ĠMV E
ĠSp p
ĠSp erm
Ġstimul ant
ĠTF O
Ġbenz imidazole
Ex cessive
ĠDA RA
Ġextra dural
Leuk apheresis
ĠMo ab
ĠPKC zeta
Ġdisapp earing
Ġtub erin
oxid ized
Ġdetermin istic
ĠDL CN
Ġstabil ising
char ged
kel ey
au er
HT dR
Ġoccup ying
Ġnit rated
ĠLA MR
St able
ĠTr unc
ĠMicro biological
Immun oprecipitation
Ġcircum stantial
Ig E
Ġrecur sively
Ġbios imilar
Ġval vular
Ġmultip olar
Ġcys methynil
Ġtrac heal
Ġtom otherapy
Ġpal mar
mo CEBPA
ensiti zes
ĠPl ant
ĠPharmac ol
Ġsem aphorin
ĠMA RT
pa II
sh i
Ġbrom oc
ĠJanus kinase
ĠPL S
Ġphot othermal
Ġphot opheresis
ĠMi STIC
ĠTL X
GL S
CTL P
PBSC H
ĠBe auty
random ization
LM s
Ġenl ight
hyp ereosinophilic
Ġdip lotypes
Ġpseud ogenes
Ġtrich rome
Ġmono valent
ĠLD ara
ĠTA Z
ĠTG CA
Ġcolla genous
Ġgal van
CCR s
Ġtrim etrexate
ĠKnock out
ĠPediatric s
ophosph orylated
Human ized
ĠPF WT
ĠLeukaemia Net
BT Z
Ġplasm as
RE V
RE LA
Ġcav itation
Ġquin oline
Ġquin olones
Ġadip okine
De azaneplanocin
ophyl l
ĠSL CC
Ġnas ogastric
ĠEC LAP
UL K
ĠUV C
Ġfluor imetric
Ġalloc ate
Ġalloc ating
DT X
ĠGP IIb
Mon ocytic
ĠAllo BMT
ĠAllo immunization
prote ase
ĠEl k
fib ro
Ġneon ate
ĠNucle oside
ĠNucle oporin
Ġtax otere
quin avir
ĠBL NK
Del tapsim
Ġcontra ceptive
ĠMet ron
Ġdisp ute
Ġstrict ure
Ġpeg IFNa
Ġdiges ting
Ġopp ose
Ġpericardi ocentesis
LD LT
ĠDU B
TF Os
Ġneurop eptide
che lated
Ġconsolid atory
ohyd ride
Ġ(- ),
Ġfore arms
EBP epsilon
Ġdrop ping
Ġfo rensic
Ġimmunob lots
Ġmatur ated
heum atoid
ĠPAR ylation
ĠAnd rogen
Ġjud ge
Ġgang rene
Ġproc asepase
Ġmultim arker
ycho lic
fe ature
Anti thymocyte
ipodophyllot oxin
ĠRa ised
Ġphenyl but
035 9
Ġdetrim ent
ĠIF Ps
Ġenorm ously
vis ible
ĠMEF s
Ġdoubling s
Ġnorm okaryotype
SK OV
Bi KE
sulf ate
sulf onyl
OV eRY
ĠNE AT
Gal ectin
ĠHem orrhagic
Ġconduct ance
Ġce iling
ĠPhen otype
ester ase
Ġclinico hematologic
Ġphyt o
Ġtubercul ostatic
Ġenlarg ements
ĠClass ically
ĠBFU e
Ġport ending
Ġamen orrhea
Ġsimpl ification
ĠBas ing
Ġont ogenic
ĠReview ing
ĠCHR C
erex pression
ĠGR beta
ĠMAT R
ĠHaemat ol
ĠHaemat ologic
Ġimped iments
Ġannot ations
Ġreapp ear
ĠRef lecting
ĠPatho logists
LN GFR
Ġancest or
ĠSte el
ĠPseud ogene
SO ME
Ġmum ps
ĠLim iting
agglut inins
Ġlic ense
ĠErythro poietic
Ġintermedi ated
ĠDX A
ĠMIC B
DF O
sm oking
Ġtit re
ĠTE AD
ĠFK BP
Ġimmo bil
ĠMH z
Ġket o
hyper cellular
hyper leukocytic
Ġcorrespond ent
BK M
Mal ign
opolym ers
ĠEV l
ĠFU O
Ġquad ratic
Ġextr ude
ĠRE LA
Ġextrap olate
cyclo propyl
Ġanthrac enediones
Ġcustom ize
Down stream
ĠBuCy VP
Ġoct amer
FGFR s
ĠIb a
Ġsubstanti ating
Ġsubstanti ates
ki lodalton
ĠBreak points
ĠGL IPR
Ġradios ensitization
icate chin
Ġchondro cyte
Ġpolys orbate
Ġintric acies
lact ate
Ġta urocholate
ycarb amide
Inte stinal
ĠCar lo
ĠLE ukemia
Ġphleb otomies
Ġblind ness
ĠRelev ance
ĠAV NFH
ĠFusion Map
ĠFusion Finder
Ġapproxim ation
squ ares
ĠTarget Scan
ĠTechn ological
Evalu ate
ĠAim ing
Ġang les
gf p
Ġalign ed
Ġelectr ically
Ġprioriti ze
Comp elling
ĠBer keley
ĠHDA ra
ĠDE AE
leg mon
Ġeg gs
ĠRetin oid
ĠDMP C
Ġrelax ed
Ġtha w
Ġprecon dition
bre eding
Ġ00 37
ĠMethyl stat
ker at
rHu EPO
Ġbreath ing
Ġti ents
Ġhemangi oblast
GEP s
Ġla evis
ĠPort land
Ġcrypt ococcosis
ĠHG SC
Ġdiversi fies
ĠPrac ownia
Ġmetam yelocyte
Ġmetam orphosis
emerg ed
Ġpix antrone
ĠPle k
Ass ociations
osom ally
ĠTRF s
ĠAden ovirus
ĠBo olean
Ġophthalm ologic
hetero zygous
ataly tic
Ġphotos ensitivity
ĠExpl orative
ĠDen osumab
Ġcotrans plantation
ĠDu essel
Qu iescent
piper idin
Ġcytofluor ometric
Ġsuccin yl
oreg ulation
Ġconstell ations
Ġredund antly
ĠSa os
437 70
ĠUni versi
obi opsy
ĠTrk C
Ġfronti ers
Oste opontin
Ġnonp eptidomimetic
Rapid ly
Ġtherm ally
327 65
Ġchin ensis
Ġmultin omial
Tax otere
spon ges
Ġmatric ellular
bed side
Ġunle ashing
Ġubiquity lated
cost ing
Ġwil derness
Ġauthentic ity
Ġcrystall izable
Ġbioen ergetic
Ġpyrid o
ranucle otides
Ġclast ogens
ĠFAN CD
HAT s
HSA NPs
ĠFib roblast
suscepti bility
Ġfabric ate
osystem s
ĠTAN s
ĠLymph omas
Ġpunct ures
zo ites
Ġson ication
Ġenthal pies
Ġvigil ance
ĠFrag ment
Ġparalog ue
Ġsolubil ized
potenti ating
CSP G
Ġleiomy osarcoma
ĠZf rp
ĠSIR s
ĠAdap tive
Ġautoradi ographic
Ġculpr its
rus side
Ġoverestim ate
Pc S
ĠTm em
ĠDQ A
tha wed
ĠExc isional
Ġneurotoxic ities
Ġpuber tal
imp act
Ġcapital izes
Pa ediatric
Pa Ca
differen t
ĠBS BMT
ĠFer tility
akin ra
SER CA
Ġgenu inely
Ġdrr B
Ġsynthes ised
Phen otypic
Ġtib ial
TTF x
youn g
ĠTTF x
Ġcrystallog raphic
Ġpapul o
Ġhygi enic
Ġnif edipine
ĠAntim etabolites
APR IL
Ġeuch romatic
Ġjejun al
Ġphthal ate
Ġunderc ondensed
Ġmetalloprote ase
Ġfaecal is
ĠTrypan osoma
Ġmenstr ual
ĠBikD DA
Ġquadrup le
Morpholog ic
inoc ulated
Ġdyst rophy
Ġterr itory
Ġterr itories
ĠTe h
Ġvent ure
Ġpyrophosph ate
FH IT
0065 55
Ġupt akes
Ġspring board
Ġethn ically
Ġpri ors
Contro versy
ZR SR
LON G
Ġpoli tical
Ġfen retinide
Ġcytogen tic
Ġdisco vers
ĠJud ging
Ġazac itine
Ġhaematopo etic
Ġmisdiagnos ing
Ġtetrach loride
SIA DH
tec avir
Ġsore ly
Ġdisag reement
ĠVi enna
Ġencephal omyelitis
Ġraz oxane
ĠContro versy
Ġindi um
Ġglutathion ylation
shif ted
ĠDISC OVeRY
few er
Ġbund le
Ġtranspl acental
ĠSubstit uting
Ġimmunocomprom ized
Multic olor
760 30
SNA Q
Ġling ering
ĠHun an
ĠPros urvival
ĠIndepend ently
dihydrodaunomycin one
Den osumab
ĠCeb pe
ucc i
ĠGCL m
benzoxad iazol
LIL RB
ĠCCB s
Ġunanim ously
ipar atide
0238 09
Ġmathematic ally
Det ailed
gam mac
ĠCef epime
crystall ine
Ġdoll ars
ĠAET FC
ĠCamb ridge
ĠDav ids
Ġpharmaceu tically
ĠAdmin istering
Ġsubstruct ure
Ġlysophospho lipid
Ġecz ema
Ġcasual ty
Ġmyofibr ils
VRC Z
Ġinequ alities
Ġdith iol
Ġaston ishing
ĠFbx w
Ġmicell ized
ogranul in
ĠMist akes
Ġunsub stantiated
Ġantihypert ensive
67437 265
ĠCrystal lographic
Ġserendip itous
kot ou
ĠFIA U
ĠWisc onsin
ĠRen illa
Ġtriphosph osphate
Americ ans
Ġnitrop russide
ĠManufact uring
Ġperoxyn itri
000027 98
Ġsluggish ly
4694 362
Soci oeconomic
Vigi Base
Ġtant al
Ġanym ore
Ġbambo o
Ġeug lobulin
Ġtoco feril
ĠAdef ovir
Ġprocoagul ants
utaster ide
ifep ristone
Ġlifer ation
Ġdepri ve
Ġvangu ard
ousai kotou
Ġmoxif loxacin
ĠNago ya
Ġlymoho cyte
Ġlymphobal stic
0145 2646
Ġscedospor iosis
Ġcartr id
ĠVITR O
3359 79
26121 00
ĠUnsur prisingly
ocarzin ostatin
Ġzoled ronate
Ġgalvan ized
ĠDuessel dorf
% =
' ;
) %.
* )/
- )-
5 013
6 34
6 37
7 25
7 577
8 53
8 93
9 12
9 217
9 652
A LA
A PM
A po
A round
A PMF
A IDA
A neuploidy
B ar
B PA
B CC
C uring
C FSE
C rick
C ephe
D MD
D AL
D IL
D MSA
D evelop
D PMN
D istinguishing
E O
E MP
E stim
E co
E US
E uros
F il
F MC
F CE
G all
G IS
G CN
G CV
H AS
H NE
H BE
H ercept
H paII
I OP
J AB
K k
K yn
K AT
L ess
L yn
L MS
L UC
L iquid
M il
M ission
M UN
M arch
M CM
M KII
N IP
N ITR
N ORs
N IPAM
P an
P AB
P ten
P IC
P BC
P SS
P neum
P HOX
P roper
P oliovirus
R EM
R ESULTS
S f
S BA
S mo
S NE
S unitinib
S ah
T ag
T EP
T roxacitabine
V a
Z O
a gnostic
a escin
b ig
b actin
b TCE
c ir
c omet
c ould
c CAR
c MPO
c ott
d ac
d isposition
e A
f ear
f ever
f arm
f alls
g M
g c
h or
h PD
i KIRs
l ater
l atin
m c
m ith
m ts
m ally
m og
m otic
m organ
m aturing
m ths
n T
n p
n um
o enzyme
p n
p ure
p CR
p ins
p yro
p Ser
q ing
s f
s FLT
s DMR
s plenectomy
s urvivors
t end
t ling
t ropic
v aptan
w ho
y ch
Ġ erg
Ġ zygosity
Ġa plidin
in oid
in oids
in formation
in organic
in opyr
Ġt ear
Ġt akotsubo
Ġt dLN
re ous
re versible
ti ered
on able
on isin
he avy
en ucleotides
Ġc ep
Ġp S
Ġp ME
Ġp EGFP
Ġin here
Ġin born
Ġin effect
Ġin efficiency
Ġs itus
Ġs FLC
Ġs criptaid
Ġm PB
Ġm oney
Ġm THPC
Ġm ircorarrays
Ġw in
Ġw on
Ġw ings
al mit
is op
or ov
ati al
an amide
ro id
el ix
el ii
as ms
it ines
it amin
Ġd raft
Ġd arinaparsin
er dlow
ent ri
Ġre occurrence
Ġre localized
Ġf es
Ġf ly
Ġf riend
Ġf mk
Ġf athered
Ġf issure
Ġf olylpolyglutamate
at yl
at trib
at oxin
Ġb os
Ġe ating
Ġto ugh
Ġto tipotent
os seous
os ulfate
ith ic
om yelo
om nia
ly cin
ul one
ul line
Ġh d
Ġh on
Ġh MT
Ġh PMS
em entioned
em pty
Ġth iazol
Ġth rive
ra ceu
Ġn orthe
ĠA J
ĠA viv
ĠA ction
ĠA ME
ĠA HI
ĠT os
ĠT OR
ĠT IR
ĠT HL
ĠT MN
ĠT YK
ĠT SSC
ĠT BG
ĠT MPP
ĠT HOC
ur ons
ur istics
ur arinone
Ġcell ulose
ML s
lo France
gen y
si tis
ot ric
un responsive
un methylated
ĠC ode
ĠC MPNs
ĠC RAF
ĠC assette
ĠC arnosic
Ġac anth
Ġac ylc
ter us
Ġfor tu
ce RNAs
Ġex ocrine
Ġleukem agenesis
Ġis odicentric
Ġres in
Ġres et
Ġres ten
Ġres ynthesized
Ġst ab
Ġst ood
op ati
op rophylaxis
Ġcon nex
ĠI ER
ĠI AG
ĠI BMTR
ĠI ADL
ĠI mages
ĠI shi
il iitis
ĠM ult
ĠM CH
ĠM organ
ĠM antle
ĠM igration
ĠM lf
Ġcom ments
Ġcom mission
ol mog
iv atives
Ġim idazo
rom eres
Ġch arco
Ġal arming
Ġmyeloid leukemia
ud il
Ġg ly
Ġg ata
ab i
ab ad
up ogen
Ġdis integration
od act
hem ie
ug l
Ġby passes
Ġv iti
Ġv orex
ĠH amm
ĠH SS
ĠH ugl
ĠP v
ĠP GF
ĠP PD
ĠP ED
ĠP ituitary
ĠP rolong
ĠP roper
ĠP enn
ĠP JP
ir idine
ir AEs
Ġtrans peptidase
Ġtrans cribe
Ġcl av
st om
st abilized
ĠB RP
ĠB sp
Ġr ival
Ġr GH
Ġr uling
Ġinc ited
Ġinc urring
qu it
qu es
ap ical
ri z
ĠD J
ĠD ab
ĠD PC
ĠD EN
ĠD ps
ĠD ES
ĠD kk
ĠD HRS
ĠD DAH
ĠD utasteride
Ġne ucle
Ġun ity
Ġun primed
Ġun stained
pec imens
ĠIn appropriate
ĠIn fluence
ĠIn genuity
ĠF E
ĠF CA
ĠF lor
ĠF ND
ĠF ocused
ĠF EPS
ĠF CGR
ĠS ac
ĠS pro
ĠS ever
ĠS av
ĠS AP
ĠS ulf
ĠS ymptomatic
ĠS ZU
Ġcyt opa
Ġcyt oxan
ĠW B
ĠW WP
ph ycoerythrin
th ro
th ral
Ġrel ay
Ġat ria
Ġk J
Ġk id
pro of
Ġap e
Ġap rt
NA m
NA NOG
00 56
00 50
00 32
00 008
Ġinhib tors
vel bine
Ġmar inopyr
Ġco lo
Ġanti fibrotic
eren t
ĠR TKIs
ĠR SA
ĠR DT
iz as
Ġev ading
oci tic
ĠN DS
ĠN ex
ĠN PD
ĠN ef
ĠN EK
ĠN GAL
ĠN LRP
ĠN asal
ĠN ocardia
Ġnot withstanding
Ġ5 27
Ġ5 67
Ġab ov
ost azol
tem ustine
Ġreg ress
Ġgen otoxins
SC Es
Ġper tuzumab
Ġper ceptive
Ġhigh risk
Ġmon oun
Ġmet allic
ĠO MF
ĠO Bs
ĠO CSC
ĠO glycosylation
ĠO OGS
Ġinv isible
ĠWe aver
Ġint akes
Ġimmun oliposome
ĠG yn
ĠG SD
ĠG DF
ĠG INS
all ergic
Ġpre term
Ġpre blastic
Ġpre exposed
Ġpre eclampsia
Ġno tions
oun ted
Ġrec tus
ĠE O
ĠE AT
ĠE met
ĠE bp
ĠE SCCs
ĠE rdheim
ĠE DAG
Ġ4 14
Ġ4 37
ox idase
ox ime
CR R
Ġout lier
Ġ0 106
Ġinf irmed
ĠL HN
ĠL osses
ĠL HNs
hen olide
hen odeox
Ġover ly
Ġover arching
cy anine
yn ess
Ġph iladelphia
Ġhe ating
ad o
Ġcons ens
Ġcons onant
Ġro under
Ġunder recognized
Ġunder dosing
ers mith
LL A
form ulated
form ans
Ġexp editing
Ġsup plies
Ġsup rathe
Ġmalign omas
LT CIC
Ġ7 71
Ġ7 72
Ġ7 91
Ġdec o
Ġdec arbox
Ġmore cules
Ġdem anded
ifer in
Ġnon identical
Ġnon lineage
Ġnon transplantation
Ġnon selected
Ġnon transplanted
Ġnon self
Ġnon specifically
Ġnon diagnostic
Ġnon mutagenic
34 99
34 65
Ġfol ded
Ġpl ur
%) ].
Ġpred ec
est ral
est rogenic
est amib
Ġ9 17
ag ang
Ġ8 38
Ġ8 27
Ġ8 907
Ġ8 602
Ġ8 558
Ġobser ver
Ġinter quartile
Ġel apses
Ġallo antibodies
Ġallo tetrap
ĠK Is
ĠK onan
ĠK olmog
ch itosan
ch rot
ch allenged
ĠU H
ĠU ACC
omes oder
Ġimport ing
ric itabine
yc le
Ġfe et
11 00
Ġra rest
Ġsec olignan
01 99
01 315
01 3499
ive k
Ġdrugs ensitive
Ġhyp od
Ġhyp orespon
Ġhyp ochromic
Ġprov oc
ucle ar
ile uton
lu tide
av ol
Ġtrial ists
min ing
min us
Ġsecond s
Ġimp arted
21 23
ĠCR ES
Ġqu and
ym ic
Ġmicro con
Ġmicro fluor
Ġmicro gravity
Ġtime frame
Ġcar vedilol
Ġam p
Ġam egakary
LA LA
LA ME
Ġmajor ities
ĠJ CI
ĠJ Ts
ĠJ ilin
ne eded
trans form
trans ducing
omet hoxy
ĠV DC
ĠV illin
ĠV iet
ĠV accine
Ġ12 04
Ġsh unting
Ġdi athe
Ġdi phospho
12 95
ĠMD L
Ġref raining
CL B
CL P
CL EC
Ġcytotox in
az o
Ġ19 00
crib able
HD ara
Ġnumber ing
ene baum
Ġhist ochemically
Ġhist omorphology
ex portin
Ġprof use
ram ater
22 79
Ġhetero typic
Ġpost ure
erg lycin
ĠPh ycoerythrin
19 14
19 73
GF r
56 4
oph ora
oph arynx
ĠAT LL
14 69
Ġer astin
Ġ20 29
Ġ20 64
60 693
Ġcri tic
Ġend o
ep eromin
Ġdown trend
Ġmy ogenin
vir idae
DH S
DH BA
ger ia
Ġonc osup
Ġonc omiRs
rop sin
tr as
Ġes cor
roph ular
20 210
ace pt
Ġcolon oscopy
over load
Ġ14 44
In ositol
Ġx x
Ġmorpholog ists
Ġloc o
Ġevent free
val ently
ĠAB A
MD AS
MD PMN
ST A
ST SS
AL G
Ġflow cytometer
25 93
23 65
Ġ50 25
Ġthromb olytic
Ġthromb ogenicity
Ġpredict ably
Ġrap alogs
cr ude
ophen e
Ġphosph on
lot tis
Ġ16 96
Ġradi ochemical
ind ices
Ġcr uz
Ġcr assa
AP s
AP HSCT
Ġmonitor ization
ev asive
Ġcontin ously
ĠCh art
ĠCh loro
Ġoptim a
Ġlead ed
Ġprote ostasis
CI CC
Ġmethyl prednisone
50 2
50 74
rest rial
mut ants
iod odoxorubicin
Ġ60 9
37 9
37 64
ĠSt ron
ĠSt ably
Ġpharmac ologists
BM EC
BM MNCs
ĠLeuk aem
Ġshort term
Ġnec ros
Ġtri o
Ġtri phosphorylated
ĠNo vi
ĠAm pl
IL D
Ġ25 18
Ġter restrial
CN OP
ĠUn ra
ĠUn differentiated
Ġmed ica
MR CC
Ġins omnia
ĠST IR
35 435
gi os
con trast
MA E
MA LAT
aren ce
Ch ordoma
DA R
SP s
ĠX SCID
ĠX RS
ĠX enografts
Ġlip ofectamine
ĠRes onance
Ġsil icon
PD Z
ĠCom bs
ĠOver production
Ġsp ayed
CP x
plan tion
98 2
98 03
IP C
NP S
NP Cs
ĠEx portin
Ġhyper kal
Ġhyper thyroidism
Ġcandid al
ĠOf atumumab
Ġhere to
orpor ated
cyt ostatic
bil ty
Ġpan myelo
Ġhybrid izations
lympho poiesis
osp asm
Ġtool kit
Ġdu ramater
Ġbiop or
Ġgl ivek
ĠHe ights
ĠHe parin
ĠPro be
ĠPB DCs
Ġadd ictions
Ġintra operative
CM ap
ĠIM MUN
Al dehyde
Al kyl
Ġj ournals
03 21
per haps
Ġhydro lys
cap rol
CB BN
Ġglyc aemia
Ġsummar izas
ĠER s
inf ections
Ġpoly nucleotides
Ġpoly ether
Ġpoly styrene
Ġpoly ethylenimine
AR Bs
PB EF
other mic
ole ana
Ġven ules
ĠAS L
ins en
99 2
Ġmegakary ocytoid
DNA M
TP T
TP s
ĠCP x
ĠCP Ps
ĠMul tifocal
Ġangi oregulation
immun ological
Ġderiv atized
Ġtoler ization
Ġrever ts
ĠMT CP
Ġsuscepti bilty
osin arabinoside
Ġtra il
ob tained
ob atoclax
ĠGM ALL
Ġorgan o
GM s
PR alpha
rog erman
SS B
Ġneuro genic
Ġneuro graphy
Ġneuro beh
Ġatt aching
ĠHR QL
ĠZ p
ĠZ HX
Ġquanti tively
ĠPre therapy
HP CA
inc orporated
CH AF
gal ectin
Ġdr yness
EL R
met hion
AG O
isp henol
96 2
ĠY osh
Ġhaplo deficiency
NPM I
Im paired
68 5
Ġhaematological ly
ĠMy loFrance
ĠRAS GRF
ĠPA MR
ĠAp r
ĠAp plicable
Ġinst able
me R
Ġmeth ide
ps ala
aph n
aph ases
urin ic
Ġsubc ulture
ĠHOX D
co PLA
co valently
Ġred esigned
Ġ67 6
ĠSc Fv
ĠSc rophular
ĠHealth star
Rec ogn
ĠOr tho
Ġmaxim ization
ĠBC VAC
An t
49 35
mark ing
view ed
Ġz al
Ġ57 6
ĠANLL s
Ġamin os
Ġaspir ations
athe rogenic
ocomp atibility
Ġneg lecting
HA US
Ġlys ability
Ġglut am
sc anning
ĠRe ferral
pos ia
pos aconazole
ĠCH AF
Ġfl are
dim ercapt
lic ted
cle rotic
DNR ol
ĠSub dural
col umn
thal ass
oles cent
ĠCo ated
ĠCox sackie
Cyt osinarabinoside
Ġmis regulated
ĠEn t
ĠNA B
ĠNA FLD
82 002
ĠRel iable
Ġparallel ing
month ly
EP P
ĠCol lection
Ġarray CGH
Ġ78 12
ĠOnc oproteins
Ġrib oflavin
EC S
Ġamino terminal
arn itines
ĠDe pression
ĠTdT pos
Ġchlor oplast
Ġrh iz
Ġrh ino
flu enza
ĠEv aG
Ġbis phosphonates
Is odicentric
aden ylate
aden ovirus
ĠMMP I
ĠTR X
ĠTR s
micro bial
Ġmagn ifies
Ġsusp ending
artic le
ĠMK K
ĠSer ving
occ upational
ĠAnti genic
ĠAnti leukemia
Ġuniform ed
non mutated
ĠAR Bs
ĠAR LTS
ĠCCR L
Ġenrich ing
ĠCa MKII
off s
Ġdim ercapt
erc ise
ĠTCR s
ĠMMR N
ĠAz ad
Ġlact ogen
Ġlact ones
Ġbasophil es
polym orphism
ĠMon t
bal ances
ang li
ang led
ang itis
Ġhomo zygote
Ġobtain ment
TL Z
MG CT
ĠCG R
Ġnanop ore
arabinofuranosyl adenine
oxid ans
My oD
Ġent angled
inter vention
ĠEP P
ĠMG CD
Ġdig itonin
SM Cs
glut amic
ĠSD B
TNF AIP
ĠCALR m
Pro k
Ġreprogram ing
ĠPTP RE
Con jug
ĠEle ment
Ġves narinone
ĠAF LP
Ġnit rous
ĠLA SP
St ress
St opping
ĠTr ilineage
ĠTr astuzumab
ĠAut ocrine
Ġcircum ference
ĠInter patient
Ġderm oepid
Ps oral
Ġtryp tases
Ġsurv ial
thi osemicarb
Ġbios pecimens
uly sin
ĠFA SP
MMR N
Clinical trial
ĠBR MS
Ġimmuno escape
ĠRR V
201 8
Ġcomb ats
Ġcomb retastatin
amino ethyl
Pre emptive
ĠPharmac hemie
ĠDn mts
ĠCO UP
Ep igallocatechin
ĠMA O
Ac quisition
Ac etyl
ĠPost chemotherapy
Ġca ecal
ĠEr b
tumour al
ĠLy BC
Ġphot oc
Ġthor ax
Ġneo Treg
Ġneo formans
ĠAss istance
Ġwt p
Ġfer red
Cancer s
but oxycarbonyl
des methyl
ĠBe henoyl
ĠSN X
rox atyl
Ġtren ding
ĠMO s
Ġflav anols
UR E
Ġenl isted
ĠBE Z
Ġagre ements
ĠLAK s
PP LLSG
tub es
Ġtrich loro
ĠTA I
ĠTG CT
Ġcollabor ators
Ġsial idase
ĠHN SCCs
ĠPF T
ĠSyn cytin
opl antar
Bs Abs
ĠPar is
okines is
Ġmill iliter
ĠAMP H
ĠCCL G
ĠCL O
ĠTim ing
Ġ110 7
ĠDr f
Ap optotic
dem onstr
ĠDM s
ĠDM RT
ĠDM APE
ĠDM APT
Ġpenet rated
HU MARA
Ġribonucle otides
BE CN
Ag s
py ruvate
ĠAu BMT
local izing
ori atic
HE A
014 60693
ĠDifferent ly
ĠTM U
Ġobstruc ted
ĠFlu o
ĠFlu vastatin
PE Cs
Ġepigen omics
echan ical
ĠNT S
Ġtax onomic
Ġtax onomy
ĠEnd oscopic
Gen eration
ĠMDA H
Ġalcohol s
TM s
ĠBL V
ĠBL yS
ĠClin Gen
Un regulated
look ing
ĠMet allo
Ġstrict ures
ĠPN L
prim er
Ġdeoxy ribose
Ġamb itious
ĠOb vious
Ġana esthe
Ġalle ged
Int ensified
Ne ither
cardi ogenic
Inc ubation
Hu G
gent amicin
Ġdeterior ate
ĠKore ans
Ġfore arm
ĠRh D
ĠCV RF
Ġpp p
ĠRep etitive
dam aged
Ġmicrotub ular
At axia
ĠLip osome
ĠLip ocalin
benz amide
ĠPred esigned
ĠSet ting
fluor odeoxyuridine
acc ines
Ġchel ates
ĠIN H
Ġbad ly
Ġspe eding
Ġspe aking
Ġmultim erin
ĠFe ijo
Ġchol angitis
MAC IF
ĠHaplo SCT
Ġgreen ish
poly cytidylic
Ġduc k
Ġhypo acetylated
Ġhypo lobulated
ĠBl adder
PO U
pair ment
Ġblue print
NB S
NB MPR
Ġair flow
ĠUT I
prop ane
Ġentero bactin
ĠACM G
ĠConc ordantly
Ġpermeabil izes
Ġnorm ochromic
Ġgingival is
Bi ological
ĠHem orrhage
Ġrepeti tion
036 4
Ġhyal ohyp
El iminating
ĠSal v
Ġsimpl est
Ġroot lets
Ġmonol ithic
PKC alpha
Ġradiolab elled
dis charge
myel osuppressive
abs ent
ĠSB OT
ĠAbs orption
ĠEG b
Ġimped ance
Ġflan ks
SN U
Re ported
Ġbre fel
ĠValid ated
0007 0499
ĠProgram med
LN s
anes ulph
complex es
Ġtetra arsenic
Ġ134 4
Ġmorph ometry
Ġortho don
Ġglob o
Ġmonos accharides
ĠLN s
rospor a
acryl onitrile
Ġtit res
ĠQu i
ĠQu in
Ġsemiqu antitatively
Ġunco ated
Ġhaemoglobin uria
Here in
Ġmoun ted
ĠPDX s
Ġded ifferentiated
ĠRIT A
dihydro carminomycin
ĠGal e
Ġcounsel ed
ĠMic roscopy
ĠMic roglobulin
omethyl ated
UPD s
ĠHV G
Ġfum onisin
ĠTCF EC
exp anding
nitros urea
ĠRE V
ĠPa ul
Ġoct apeptide
Ġlac tis
ĠDP EP
ĠRC UD
Ġcorrobor ating
Ġwarning s
Ġproxim ally
Ġki renol
Ġpay ing
Ġintric ately
184 352
Inte rest
Inte gr
Ġhyperther mic
Ġmicrod oses
Di SC
Ġfoot prints
Ġil ludin
Em b
Em base
Ġblind ly
Ġapproxim ating
Ġconceptual ize
BS BMT
dia meter
do ifosphamide
ĠTarget s
ĠMeas ures
Ġagglut inated
Ġleuko erythroblast
ĠDNase I
Mit ochondrial
Sub type
ĠDnr O
ĠAdj ust
ĠCur iously
Up regulation
Ġpathogn omic
VC EP
Comp eting
Ġunw arranted
Tet ra
fo o
ĠPRT FDC
Ġdiac yl
ĠOA W
Ġ00 858
elec tivity
Ġcyan om
Ġcyan obacteria
rHu GM
Ġpod ocytes
Ġdysmegakary opoesis
Ġcoordin ating
Ġimmunobi ologic
Ġgangren ous
Dis ordered
Ġaer ial
Ġglomerul opathy
Ġ227 2
Ġoligod enucleotides
ĠPrac tical
ĠNITR C
dig ested
ADA Rs
Ġtach y
ĠBar tholomew
eryth rom
Ġchor ionic
ĠPep eromin
Ġortholog s
TRA DD
Ġophthalm ology
hetero geneity
Ġchemoattract ants
bet ad
adenosyl homocysteine
INT ERIM
ochalas ins
Ġelectric ians
Ġsept um
Ġsept ins
Ġafflic ts
smok er
omed icines
Ġtrab ecul
Germ any
ĠRub idazone
ĠHepat otoxicity
Ġcatalys ed
ĠIso b
Ġinterrel ation
ĠApo E
Ġaddi tives
Ġnanos ystem
Ġillum ination
Ġole anolic
Ġclean sing
Ġmist letoe
DAS ISION
ĠImmunocyt ochemistry
Ġopac ity
Ġjeopard ize
Ġretroper itoneum
Ġtonsil s
WE HI
mat ological
Ġfur the
Exper ience
ĠANGPT L
Ġincorrect ly
Ġchemil uminescent
ĠIVI G
ĠBB z
ĠProf essor
otax ime
ĠIk zf
Ġfibr illary
Ġexpendit ure
flav opiridol
ĠReas oning
cre ened
ĠRX RA
Ġnonin vasively
Ġscr atch
Ġradiograph ically
Ġvisc um
Ġss DNA
pp p
ĠBac teroides
ĠPCI Lp
Ġparest hesias
potenti ated
potenti ates
Rib onucleotide
elev ated
Ġmicrocirc ulation
Ġradioiod inated
Ġhindlim bs
Ġreimburs ability
ĠPc dh
methylene tetrahydrofolate
ĠActiv ators
ĠPlas modium
statis tical
Ġdissoci ate
901 228
Si O
Ġbs Abs
Ġeup loid
ĠCEB PB
TIG AR
ĠGre enebaum
Ġrecording s
Ġuncontrol lably
ĠCp NpG
olys osomes
Ġintral ineage
Ġrif ampicin
ĠFOL FOX
Ġwavelength s
Ġneuros urgical
ĠTunis ia
Ġfr ustr
ĠBLA CAT
Ġdrr A
Ġdendrim er
CU EDC
Medi an
Medi astinal
Ġsatur ate
Ġoncof usion
Ġhyperammon emia
Mol t
Sw erdlow
Ġrecon firmed
Ġoligodendrog lial
Pres ent
Ġmt RUNX
Ġbarc odes
Ġarson olipid
PROT ACs
ĠTransduc ers
Thym ic
Ġneutropa enic
Ġocul omotor
Ġgonadotrop ins
Ġaur istatin
Ġars ine
Ġars entri
ĠMultid isciplinary
ĠSplice osomal
Ġmiscarria ges
Prim ing
unting tin
ĠBex arotene
ĠDos ages
Ġobste trical
Ġunderc ondensation
Ġcoryl ifolia
spe ed
Ġreass uring
Ġleukocyt apheresis
ĠSOC E
ĠKC NA
Lac Z
Ġrejec tions
ĠSial ic
dioxo oleana
avoid ed
ĠCollab oration
ĠFluor izoline
Trx R
pseud o
Ġanted ate
Ġdauno blastin
Ġantag omiR
Ġpyrophosph orylase
carbam oyl
Ġgem fibro
0065 1261
Ġmultiv alent
Ġtetram ers
dinitrop henol
Ġhemo lymphopoietic
Eryt hema
Establ ishing
lun isal
Ġquenc hed
Ġnanostruct ures
Ġextramed ulary
Ġdiastere omeric
Sim ultaneous
Ġmotiv ate
Ġcytogen tically
Ġendom it
Ġmisdiagnos es
Ġganglione uroblastoma
Rad otinib
Ġdif lunisal
Ġbinucle ate
omuc or
ĠTrac king
Ġlev amisole
Ġrin se
ĠGran ule
ĠGUS B
ĠLat ent
Ġmorpholin o
verteb ral
ĠNag asaki
ANK RD
ĠDerm atologic
ĠSAL SA
ĠCRBP IV
Meas urement
Ti O
zol izumab
Ġmos quit
ĠTro ponin
utyl tin
umar ins
Ġgibb on
ĠVIV O
ĠAnc estral
metach ronous
hydroxyc arminomycin
Ġredef ine
Ġcomfort able
Ġgarg le
ĠBCA A
ĠWolf son
epithe lioma
Ġmicrospect rofluor
Ġreticulo endothelial
Ġisoschiz omeric
ĠBenef icial
Ġultraf iltration
ĠInterfer ons
senical s
Ġhosp ice
Ġunquestion able
ĠGap meR
Ġpanor ama
Ġsun light
ĠVite k
ĠAnalys ing
ĠAnecd otal
Ġpharmacoec onomy
Ġsout hw
arag ua
Ġach ondro
ĠWi Dr
00000 4935
ĠMah ak
Ġconvul sive
nour ished
sTNF Rs
Ġchir ality
ĠPreex isting
Ġinco herent
Ġhydrochlor ic
Ġgroo ves
ĠCroati an
Ġindiscrim inate
Pel ger
ĠTag raxofusp
ĠCum ulated
dihydrop eperomin
Ġdemarc ation
reconstit uted
ĠMRCK gamma
Ġhamart oma
Ġgermin ation
ĠRefin ements
Pep E
Ġate zolizumab
elem ene
Ġprokary otic
ifen acin
ĠViro therapy
Ġpracti sed
Ġmesench yme
PRK CH
Ġpykn otic
ĠMonitor TM
ĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠĠ ĠĠĠ
ĠSlovak ia
Ke ap
lup oside
isox azol
Ġbib li
lyx o
Ġacous tic
Ġbeig elii
Ġdepolymer ization
Ġincrim inated
Ġmyelosu pression
Ġconcan avalin
electropor ated
NHW s
ĠAntico agulation
Ġphilos ophy
Ġkallikre in
Sec TRAP
Tor rent
bism us
Ġpear ls
orient ated
ĠCant onal
ĠFow ler
Ġ0037 2593
ĠTeh ran
Cephe id
Hercept in
NITR Cs
Sah aran
cir rhotic
fear ful
Ġineffect ual
raceu tical
Ġnorthe astern
Ġacylc arnitines
Ġresten osis
ĠIshi kawa
ĠMorgan a
Ġcharco al
Ġviti lig
Ġvorex olin
ĠHamm ersmith
Ġneucle ophosmin
ĠSpro uty
Ġcytopa enias
Ġabov ementioned
ĠEmet ine
Ġ0106 1177
Ġsuprathe rapeutic
estamib i
Ġallotetrap loids
ĠKolmog orov
chrot ron
omesoder min
01315 925
013499 72
Ġamegakary ocytosis
ĠViet nam
Ġdiathe ses
2279 115
Ġoncosup pressor
Ġescor ting
Ġflowcytometer y
Ġcruz i
rogerman ium
Ġneurobeh avioral
methion yl
Recogn ition
ĠEvaG reen
Ġdermoepid ermal
Psoral ea
ĠFeijo a
Ġbrefel din
Ġorthodon tic
Ġleukoerythroblast osis
Ġ00858 806
Ġarsentri oxid
Ġgemfibro zil
' /(
, .
0 90
0 73
3 12
4 04
4 39
4 62
5 29
6 99
7 46
8 80
8 99
8 79
9 26
9 283
> "
A NA
A fs
A stragalus
A gios
B ac
B ER
B US
B urk
B ryostatin
C adherin
C UL
C kine
D u
D OL
D ye
D arby
D MDAPatA
E IA
F OS
F ocal
F ailure
F FP
F dU
F resenius
F undus
G TKI
G iant
G reen
G AMs
G WH
H er
H yd
H SS
H FD
I clus
K SP
K PT
K CNQ
L ink
L NK
L iver
M g
M os
M CT
M egakary
M aspin
M abs
N Q
N DS
N Cs
O ld
P Y
P HD
P GM
P GA
P atA
P entixafor
Q TL
R op
R ED
S J
S te
S um
S HR
S BC
S MG
S elf
S BU
S plenic
T rin
T ES
T reatments
T poR
T oxicity
U l
U rsolic
V MP
V Es
W RT
W ork
] )-
a ug
a rous
a IPI
b alloon
c lear
c PARP
c lassifiable
c ostimulatory
c amera
d d
d ithiocarb
e in
e ase
e Ag
e gradable
f re
f ig
f ish
f ang
f ollicular
f arnes
g ary
g ently
g lobal
g imer
h id
h ared
i ors
i hood
i EMR
j p
k ling
k inetics
l ateral
m x
m atch
m oidal
m enogaril
m itigation
n ier
n asal
o vo
o encephalopathy
p rem
p ire
p nea
p eptidomimetic
q H
r atase
s em
s ted
s till
s ps
s ynucle
s ICAM
s ocial
t ract
u ance
u vastatin
v WF
v aI
v accines
w ers
w est
y plastic
z d
z inc
z osuquidar
Ġ ?
Ġa le
Ġa ero
Ġa equ
in ent
in th
in ative
in osinic
re r
re press
re test
re generative
re vealed
ti fy
ti body
on istic
on ically
on ances
en anti
Ġc el
Ġc ALLA
Ġc br
Ġc amera
Ġc adherins
te ur
te pe
Ġp up
Ġp ups
Ġp embrolizumab
Ġin verteb
Ġin spection
Ġs old
Ġs ocket
Ġm s
Ġm ater
Ġm oles
Ġm eloid
Ġan abol
Ġthe ra
Ġthe apoptotic
Ġw arm
al con
is and
is olation
or ib
or gin
an ax
ro fen
it ination
it rem
Ġd G
Ġd BET
es ir
er gency
ent ine
ic os
ic illin
Ġre pon
Ġre xin
Ġre approved
Ġre parative
Ġre aff
Ġre organized
Ġre inst
Ġb rc
Ġb irds
Ġb itter
ation wide
id ends
Ġto rem
os ystemic
ith iasis
om orph
om eningitis
Ġwith hol
ul able
Ġh olid
ra vir
Ġn pm
ĠA AT
ĠA OD
tic ut
ĠT rim
ĠT rough
ĠT MTX
ĠT XR
ĠT anz
us ate
im mediate
ia ct
res cine
Ġle up
Ġle pro
Ġpro phase
Ġpro chlor
gen der
un cture
un avir
un detectable
ĠC it
ĠC op
ĠC LT
ĠC MPN
ĠC uring
ĠC ob
ĠC amptothecin
ig s
ig osertib
ut her
et abine
Ġfor min
if unctional
ac ut
ac ific
Ġex its
Ġis ocyan
Ġis atuximab
ant o
ant inine
Ġres onances
Ġst ag
Ġst aving
Ġst yle
Ġst eno
sion al
op tion
Ġcon formed
ĠI p
ĠI BM
ĠI PMN
ĠI kB
il uted
il worth
um ably
ĠM es
ĠM ade
ĠM BCL
ĠM mp
ĠM df
ĠM omelotinib
oc onstr
oc amptothecin
oc erebellar
Ġcom ed
Ġcom pressing
Ġbe ats
ol a
ol enic
ol ian
ol vation
iv oxil
Ġim itated
rom asia
Ġch itinase
ud ding
Ġg ums
her pes
her itance
Ġdis ast
od uoden
ys tyryl
hem e
hem ias
hem olytic
Ġor t
Ġv FLIP
ĠH acet
ĠH NC
ĠP eptides
ĠP iper
ĠP ateamine
Ġtrans posed
anc ou
Ġcl umps
ff imycin
ĠB ST
ĠB CC
ĠB AF
ĠB ob
ĠB uff
ĠB UC
ĠB MDC
ĠB onferroni
ĠB locks
Ġ2 351
Ġcomp utations
ap ine
ist le
ist anol
ist oylated
ĠD c
ĠD s
ĠD ev
ĠD ock
ĠD IP
ĠD Em
ĠD ADI
Ġun phosphorylated
Ġun intended
ub ular
ub ating
ub rod
ĠIn st
ĠIn ters
ĠIn stability
ĠIn ositol
ĠIn surance
ĠIn asmuch
ĠF en
ĠF es
ĠF ap
ĠF ore
ĠF inal
ĠF ractionated
ĠF ormalin
ĠS AC
ĠS EL
ĠS MPD
ĠS MRs
ĠS quamous
ĠS ufficient
por ation
por ous
ĠW H
ĠW ernicke
th reshold
ow sky
der abad
Ġrel igation
Ġat rophic
pro drug
pro lymphocytic
00 471
Ġ3 194
Ġco var
ĠR ising
Ġrem embered
ĠN ull
ĠN TBI
Ġ5 16
Ġ5 652
di tis
tem plated
ure thane
Ġper ish
Ġmon osi
Ġmon opoiesis
Ġmon omers
de aza
ĠO g
ĠO ri
ĠO PM
ĠO TO
ion s
cl oning
cl ipped
Ġhem opathy
Ġhem opoietin
Ġint ras
Ġimmun ospot
Ġcont end
ĠG Q
ĠG ilteritinib
Ġinhibit on
Ġpre g
Ġpre lude
iti ation
Ġag itation
Ġrec A
rac orporeal
rac entrifug
Ġsub version
ĠE SS
ĠE ps
ĠE lig
ĠE NPP
ĠE SI
Ġ4 13
Ġ4 31
Ġ4 97
ox ine
pho xim
Ġhemat opietic
Ġdrug like
Ġout bred
Ġdev iant
rel ix
Ġ0 105
Ġ0 136
Ġ0 702
ĠTh omas
ĠL um
ĠL ov
ĠL VP
ĠL amb
ĠL ACE
ĠL amivudine
ĠL iquid
ore ceptors
Ġover lying
Ġover activation
ros ide
ros ophila
ros etting
ad or
Ġcons erve
so ura
Ġind ivid
Ġ6 11
Ġ6 38
Ġ6 44
eu rop
Ġro x
Ġro ll
Ġunder ly
Ġsyn opsis
own ed
ocy clo
Ġ7 11
Ġ7 47
Ġdec ent
Ġdec etabine
Ġspec k
Ġnon hemat
Ġnon target
Ġnon mutant
Ġnon apeptide
Ġnon genotoxic
Ġnon aggressive
Ġnon pharmacologic
ple ted
34 3329
Ġpl um
Ġstr iving
aus cher
tim ore
pend ed
rim ination
rim idin
est osome
Ġ9 56
Ġ8 17
Ġ8 30
Ġ8 62
Ġ8 73
Ġ8 69
AB S
cri p
Ġinter ferences
Ġinter vaI
ĠK y
ue k
tain ers
ch ae
Ġdes olvation
ĠU k
ĠU ro
ĠU ridine
Ġ10 11
Ġ10 65
ric in
ric an
RA N
reg ardless
Ġsec tioned
MT N
MT s
01 09
Ġvari ances
Ġhyp oderm
ak ayas
Ġmulti ethnic
Ġdisc ounted
Ġup set
ĠAl f
ĠAl ready
ĠAl cohol
KI AA
plic ative
Ġme ro
Ġmicro cytosis
Ġmicro assay
Ġmicro injection
Ġsel iciclib
Ġam egakaryocytic
Ġdef ault
ten e
ten ess
ten iposide
sup eroxide
Ġep im
+) )
Ġanaly te
ne ural
Ġconf using
ĠV IC
ĠV SIG
Ġreac etylation
(+) ]
Ġdi alys
Ġdi versely
Ġdi alog
13 00
12 25
12 41
12 759
16 40
PM C
po ol
qui re
Ġsequ encers
Ġcoun ters
Ġy ew
Ġy oga
HD CA
HD MTX
ex cess
hes on
ram ide
22 28
22 797
Ġop ted
Ġpost mitotic
Ġpost autograft
ĠPh agocytosis
oph ile
oph armac
oph armaceuticals
ĠAT I
14 39
14 93
Ġless ened
ism atch
Ġdaun orb
Ġlim pet
Ġend otox
Ġend omy
Ġend ophy
Ġend oglin
ep ing
ep igen
ĠAs an
Ġprop ri
Ġprop af
Ġprop itiation
rop ol
omic roscopy
lyc osylated
Ġes ophag
38 41
38 974
Ġ14 45
Ġ14 03
In organic
In vol
In terstitial
95 80
ĠAn xA
Ġ13 10
Ġ13 95
ĠOS R
Ġmyel osis
Ġ17 54
Ġloc king
Ġpattern ed
val yl
com elia
ST AR
ST ING
ST EMI
Ġflow ers
ĠRA NTES
Ġset tling
23 777
Ġrearrang ing
Ġ50 7
Ġthromb oprophylaxis
Ġradi ogenic
ind igo
Ġcr ust
Ġcr usting
)( -)
emat ous
euk emia
Ġoptim ised
ethyl maleimide
Ġcare t
Ġcycl ical
ĠRec onstruction
Ġ60 4
rem ely
ĠSt omat
Ġpharmac ogenes
IS EL
orph onuclear
Ġdesign ates
CA CL
CA DM
CA ND
Ġtri hydro
ĠAm putation
HR MA
IL K
ĠAll ele
Ġdetect ability
ĠCN OT
27 12
phosph otyrosine
ĠUn less
ĠUn stimulated
ĠUn adjusted
Ġaz adeoxycytidine
itu it
Ġins till
Ġins ect
Ġins tilled
ĠST UD
ĠST EAP
Ġsynerg isms
Ġalpha fetoprotein
tis h
45 7
Ġtoxic itis
Ġphosphor ic
Ġtumour icidal
Ġimm u
con omic
con trib
con verted
Ġmicroen viro
Ch r
ĠX in
ĠX BP
app ears
Ġsil encer
PD MP
ĠCom b
ĠCom mun
ĠCom ponent
ĠCom plementary
hydro ly
Ġsp asm
Ġretin yl
Ġdys regulates
Ġdys uria
IP P
04 65
imin odaunomycin
point ments
ĠEx osomal
ĠRUNX l
Ġhyper immune
Ġhyper reactive
Ġhyper ploidy
Ġcandid acy
Ġreal ised
Ġhom ed
29 41
29 12759
MRD s
bil ineal
Ġbas elines
Ġbas iliximab
36 67
Ġver ifying
ern ard
acet oxy
acet ophenone
Ġdu ocar
ĠPB RM
Ġly ses
ĠCEBPA mut
As ide
sub hazard
Ġ27 952
Ġintra dural
eg ylated
Ġstrom as
Ġarabin ocytosine
CG D
CG G
FU J
FU T
Ġlen tive
Ġ29 050
per ature
per azine
Ġhydro cephalus
VI STA
Ġglyc ometabolic
Ġsummar ization
Ġchemo immunotherapeutic
ĠER MP
ĠER MAP
ĠCM I
ĠCM ap
Ġpoly oma
Ġpoly ubiquitination
Ġpoly vinyl
Ġpoly urethane
Ġfac ultative
28 5
amin omethyl
Ġmeg abase
Ġequ ated
75 19
Ġ80 8
Ġste el
Ġste ato
AD Es
erox ides
99 1
lor atadine
88 1
rup tions
Ph os
Ph ase
67 38
ysi ologic
ĠMul tivariant
ĠPR OM
ĠPR ISMA
ĠCancer s
uro yl
65 9
rec overy
SA H
glyc an
Ġdepend ences
Ġconte sted
86 2
GM I
ĠQ AO
acetyl galact
Ġcheck s
ĠAN OVA
Ġ55 2
Ġcalc ulators
ĠTrans pos
HP P
inc idental
ĠKIT LG
ĠGO T
39 1
Ġdegra der
Ġ65 2
met HuG
ĠY q
ĠMM SC
ĠIg D
Ġdiv idends
Ġcluster ization
Ġrecombin ational
Ġrecombin ogenic
Ġrecombin antly
Im mature
ĠAL B
ĠAL G
ĠAL S
ĠPT BP
Ġoxid ants
Ġve to
Ġve terin
ĠMR L
ĠMR s
Ġdehydro x
85 5
85 709
Ġmeth icillin
Ġnan obins
LR s
Ġcross roads
uan ido
Ġpharmacok inetically
Ġdeacetyl ated
Ġsubc ohort
48 3
co efficient
Ġnor adrenergic
Ġoste omyelo
ĠPI N
64 67
ĠBC l
RAR G
Ġiso hem
ĠmicroRNA S
Ġmim ick
AN G
mod eled
ras omy
Ġneg ated
ĠNF kB
69 2
ĠPV OD
ES Y
Ġshe pherd
Ġput rescine
ĠMRP m
sc aff
virus es
ĠRe plication
TK is
pos able
ĠCH IC
Ġfl ies
Ġund ec
Ġund iluted
Ġhaem opathies
Ġhaem ograms
Ġconver ged
ĠSub populations
ĠSub stitution
eth anol
004 217
ĠReg istered
Ġrib osyl
Ġweak ens
ĠAP E
DP Cs
Ġserious ness
IFN gamma
ĠPK R
CTP ss
ĠAr ticles
Me C
Ġelectro des
Ġrh omboid
Ġbis antrene
ĠRAR gamma
Ġuns hared
ĠSystem s
ochrom ocytoma
Ġrevolution ed
ĠTR H
ĠTR KA
ĠBi osystems
ĠMed ication
Ġleuc aemic
Ġcoag ulative
Ġradio actively
non informative
ĠAR Q
ĠAc tivities
ĠLT Rs
ĠSp itz
Ad hesive
Ġstimul ants
ĠTF T
Ġbenz odiazepine
ĠPo lycythaemia
NHL s
Ġpancyt openias
be ads
ĠEp idoxoform
Ġmate rially
Ġtop ologies
Ġtop ographic
ĠMo bilized
Ġeth ics
recip itates
Ġgran ulysin
SM ZL
enes cent
ĠHyp odip
Ġconj oint
kel ihood
Ġunit ary
ĠNR XN
Ġobst inate
Ġpaediatric s
Ġult racentrifug
ĠLA Q
ĠLA LA
Ġdist ressing
Ġimmunos c
tet rachlorodibenzo
Ġcommun ications
rosp ray
Ġinteract omes
Ġsuper antigens
Ġsuper coil
ĠSh ah
Ġintrac aver
Ġval acyclovir
Ġmultip otency
Clinical Trial
Ġtrac tion
Ġtrac ks
Ġtrac tional
PK D
Ġimmuno alkaline
Ġimmuno electrophoresis
ometric s
Ġtriple ts
anth us
mo Abs
mo esin
ensiti sing
amino actinomycin
MO F
ĠPharmac ology
Ġnull ified
ĠHu G
ĠMA As
Ac SG
pa ign
NE H
TR MN
Ġbiosyn the
Ġglobulin s
Ġidi otype
Ġmicrom olecular
ĠEr yt
Ġfer rous
ACS L
CS I
LF LC
cons idering
tol i
ote racil
hyd raz
ĠDOX O
ĠConsid ered
hyp erg
hyp oxia
IDA ol
Ġexperiment ing
Ġdil uent
Ġdip ivoxil
carb oplatin
Chrom othripsis
ĠImmunohist ological
Ġvascul itic
ars on
ars onous
ĠCCN H
chem okines
ĠSyn ergism
Ġplasm atic
hom ycosis
Ġcav al
Trans plant
Trans ferrin
ĠIs otope
De pletion
ĠGl anz
Ġfibrin ous
ĠArsenic um
ĠCy TBI
ĠMan soura
Ġsphing anine
tetra hydropyranyl
induc ibility
ĠMin er
Ġneph rosis
Ġfluor odeoxyuridine
Ġfluor ochromes
Ġ105 9734
Ġhypers plenism
nit rop
ĠGP ER
Ġiod omycin
ĠAllo reactivity
With out
Ġobstruc ting
ĠFB XO
ĠEl f
Ġepigen omes
syn ergistic
ligand ed
ĠNT D
ĠNucle i
Gen eric
sho re
oprote renol
quin olone
quin imod
Ġantiviral s
standard ised
Un iparental
Ġ) =
ĠMal es
ĠMal di
ĠDH M
pur posing
pur istanol
Fas R
Ġforward s
Ġintrap leural
ert k
ĠAltern atives
ĠOb served
Ġdetox ication
ĠLM s
che l
Ġsegreg ates
Flu idigm
Ly tic
Ġreser ving
ĠCV T
ĠCV Ds
021 968
FT s
ĠCr ude
ĠCr isp
ĠMyc ophen
ĠLip itor
ession al
benz imidazole
Ġdimethyl amino
Ġ111 9
igor ous
Ġnanom aterials
Ġproc aine
Ġproc urement
RN R
RN ase
Acc elerated
istin ction
NL Cs
meth anone
meth anones
LV SD
Jun e
elect ronic
ĠPolym eric
Ġphenyl arsine
MI CL
Ġuro logic
prec ip
ĠVit rectomy
ĠVit reous
Ġ000 23777
Ġ000 85709
SV C
Ġpermeabil ised
Ġspot lights
ĠTS AP
sulf ation
Ġpi oglitazone
ĠPE PCK
Ġrepeti tively
Ġge otric
Ġbronch oscopic
ĠAct in
Ġsym b
ĠLys ozyme
Ġpas te
Ġport osystemic
Ġ121 3
ĠPAP D
ĠBio availability
answ er
Ġchond rogenic
ĠTranscript omics
ĠCHR F
ĠIndi ans
ĠSil ver
Ġsee ing
ĠGG H
Ġperi osteal
Ġharm less
Ġhered ity
034 9
uma rol
pass enger
Ġchima eras
ĠPatho logist
Ġunequ al
arin ess
Ġathe rogenic
GP IIb
Ġtetra valent
ĠSUMO ylated
ĠCAs E
Ġgall ic
ĠNY H
ĠCal gary
ĠCAF dA
ĠDX M
ĠDX S
Ġisot retinoin
Ġimmo bility
ĠLog rank
TI MPs
ĠHB eAg
oflu orescein
Ġcentros omal
Ġstand alone
Ġautotrans planted
ĠDelta Np
Ġpseudo is
ĠIntegr ating
Ġfuc osyltransferase
rophyl actic
Ġvas ostatin
Ġvas oconstr
Le ptomeningeal
ĠPCA F
Ġbr uce
cyclo pent
Ġdeoxyribonucle otides
Ġanthrac is
Ġster ility
Ġtot ality
ĠFcgamma RIII
Ġoct anol
ĠCluster ONE
ĠDP PC
ĠNeuro toxicity
ĠCF AP
Ġadvoc acy
hal ving
Ġmetach romasia
ĠAv ailability
030 3
FOX M
FLA NG
ĠRad ical
Ġros uvastatin
ĠVin orelbine
Ġconsult ants
Ġarbitr ariness
Ġoverlook ing
Ġculmin ate
ĠTer at
Ġphoto active
ĠProlifer ative
Au BMT
Ġfed eral
Ġfa ulty
Ġethyl ene
Ġendow s
prob es
Ġcir cles
ĠMX N
Ġdisper sibility
Mac ro
Mac rophage
SU A
Mi HA
156 31
Mit ox
Sp anish
Ġped iact
Ġnos capine
ĠMax im
Ġepi physeal
Allo reactive
ĠSem en
Impro vement
ĠDnr N
Ġaver t
ĠDF F
ĠGW HAS
Ġinternucle ar
Ġ238 5
mas ter
Ġferro portin
MIT F
Ang pt
ĠAnaly zer
ĠMel atonin
ĠPEL O
ĠAlong side
Ġdrain s
methoxy estradiol
ĠDrr AB
mer capto
Ġcircuit ries
Ġdestabil izes
COL s
Ġ298 3
324 62
Ġemo tion
Ġ00 1439
Ġ00 004217
ĠSSC P
DD IT
Py ruvate
fac ial
ĠGEP s
Ġviro logical
ĠNET osis
Ġspectrophot ometrically
900 776
PcG s
osom iasis
ĠTri ptolide
Ġophthalm ologist
osamin oglycan
ĠAsc ites
ĠExp edited
Ġveter ans
ĠInternal ization
Ġpin pointed
ĠMor ris
Ġhum eral
Ġbiotechn ical
ĠECG s
Ġdebul k
otub e
ĠHepat omegaly
Ġker atitis
Ġker ato
ĠEntero bacteria
ĠDar unavir
Ġsuccin ic
Ġsuccin ct
Ġanthracyclin ones
ĠAcad emic
Ġole yl
AO Es
ĠTryp tase
palmitoyl amino
terpen oids
Ġswe ating
Ġpione ers
Ġphagocyt osing
ĠOs aka
aberr ations
ĠOlig omer
ĠOlig onucleotide
LPD s
Ġpt osis
ĠCer amide
ĠPanc reas
ĠRNF L
Ġenfor cing
Dec reased
Ġsurge ons
ĠConnec ticut
perme ant
DU B
ĠHydro carbon
Ġ013 38974
Ġhous ed
Ġsurm ise
Ġosteo arthropathy
Af rican
ĠOste oclasts
Ġdmin s
icul i
icul ata
sig lec
ĠPir h
(-/- );
Ġimpression s
ĠWal es
Ġoutweigh s
cyano acrylate
Pt d
ĠBro viac
ĠLm r
Ġaqu aglyceroporin
pyrid azine
Syn ergistic
ĠThom sen
Ġspectrat ypes
ĠmiRN omes
meloxif ene
ĠEco RI
ĠAdap ted
frag ments
ĠPTCL s
Ġinacc uracy
Ġintox icated
Ġreferen ts
interfer ons
Prolifer ating
ocho lesterolemia
Ġamid ox
Phosph orylation
Ġquer ies
olys ine
Ġpetech ial
hept yl
Ġexpedi te
ĠEURO CARE
ĠCent res
ĠCCC P
opiper azine
ĠFer ro
methox yb
ĠHy derabad
ĠDaun oxome
ophy lotoxins
Ġneutron s
Ġsalic ylate
Ġperpetu ate
ĠFung us
Haemat opoietic
ĠRoman owsky
Ġmonomethyl arsonic
Ġimag inative
Ġmastoid itis
ĠPRKAC G
Ġoligodendrog liomas
Pres ented
SUMO ylation
Nur r
bas eline
ĠLac Z
Ġpuzz le
dynamic s
ĠAHNMD s
adec ane
Ġ00899 171
Ġ00899 743
Prim itive
Ġplug s
709 0018
carboxy fluorescein
Ġhydrop eroxide
Ġgeranylger anyl
Ġstock ed
0047 8
0047 1497
Ġinsid iously
replic ative
imidaz olyl
ĠBos entan
Ġ326 8
neuro blastoma
Ġsesqui terpenes
Cho lesterol
Ġdispos able
Ġimmunot argeting
Ġpreadip ocyte
ĠTermin ator
Ġrhe ological
Ġcytosp in
ĠChlor ambucil
Ġethn ical
Ġsta gnant
ĠPot entiation
ript ine
Ġdipeptidyl peptidase
Establ ished
Ġcholecys titis
ben zyloxycarbonyl
gamm adelta
ĠMir na
ĠFO LR
Ġmicrov asculature
epit ope
ĠProt otypes
Ġsheath s
Ġnong lycosylated
Ġmotiv ator
Ġimproper ly
Immunohist ochemical
Ġganglione u
Carcin oembryonic
Daun oxome
ĠSqu ibb
Ġ014 3329
Ġ014 343329
homogene ous
pyridin ium
Ġmem orable
Ġdent ate
Ġcongru ence
ĠEti ologic
Ġnanob odies
ĠScot tish
Ġtex tile
Ġlumin ometric
ĠMong olian
ĠNip pon
ĠPIAS y
ĠNanop ore
Ġpaus ed
ĠTER F
Ġadmix tures
ĠLink ing
sour cing
priv ate
ĠHNRNP H
Ġtouc hed
aprox en
ĠAtten uated
daun orubicine
differenti ate
Ġvial s
Ġrecre ate
Ġmaneu ver
Ġhypermet aphase
tetram ethyl
Ġbaical ensis
Ġepipod ophylotoxins
Fo am
Ġtank yrase
Ġpho comelia
Ġsoc ieties
Ġalumin um
Ġgame tes
ĠComm ens
Ġdistor tion
investig ated
ĠIntrat umoral
Ġpetro chemical
Ġdescend ants
bus ulphan
Ġcrow ding
occlusion s
ĠFul ly
ĠJer antinine
Ġswallow ing
Ġarachnoid itis
scaven ging
John son
Ġcil ostazol
atetra hydro
impro vement
strept avidin
Ġarte fact
Ġdiscoura ge
ĠJian gsu
ĠAspir in
Ġmegac olon
Phospho inositide
Rhabdomy olysis
GWAS s
paren ts
onig rin
undrug able
competi tively
Struct ural
Pat tern
ĠMur phy
ĠPrin cess
ĠRFL P
Ġamygd ala
Ġrefract orines
Ġusefull ness
Ġcyclopent enyl
OBJECT IVE
Ġthioapt amer
Ġcaroten oids
Ġhyg romycin
ĠHmg a
Ġinvent ory
clam ped
ĠKen ilworth
Ġdesquam ation
Ġaceto hexamide
equil ibrative
Ġchemorespon siveness
ĠCatal ase
Ġlucid um
Ġmicrobic idal
1088 3841
Ġhaematoc rit
Ġcholines terase
Ġbromoc riptine
Malign ancies
kerat otic
Fil grastim
big uanido
tend entially
attrib utable
Ġacanth osis
ĠFlor ida
Ġquand ary
ĠChloro quine
Ġmedica ment
ĠYosh ida
Ġhyalohyp homycosis
Ġtrabecul ae
GWH AS
Iclus ig
Rop eg
Sum mary
gimer acil
synucle in
alcon es
itrem orgin
esir itide
Ġtorem ifene
Ġwithhol ding
ĠTanz ania
Ġlepro sy
Ġprochlor perazine
Ġdisast rous
oduoden ectomy
ĠHacet tepe
ancou ver
ĠDEm RNAs
Ġcovar iables
ĠOTO A
ĠElig ibility
phoxim ine
Ġ0105 9734
Ġ0136 0125
ĠLov astatin
ĠLamb a
chae te
akayas u
22797 44
Ġdaunorb icin
Ġendomy ocardial
Invol vement
ĠStomat ococcus
Ġtrihydro chloride
ĠSTUD Y
contrib utory
Ġduocar mycin
Ġsteato hepatitis
Ġveterin arians
Ġleucaemic us
ĠGlanz mann
021968 57
Ġgeotric osis
Ġpediact ric
Ġ001439 75
* '.
, '
. *
0 95
3 14
4 11
4 56
4 147
4 673
5 47
6 97
7 84
8 04
9 70
9 41
; -
A x
A IM
A GM
A GS
A vascular
A HF
B in
B NP
B ORIS
C e
C t
C MD
C ES
C ysteine
C arminomycin
D o
D ip
D ok
D BM
D ynamic
D KK
D ido
D acogen
E RA
E ach
E PR
E me
E bp
E YA
E QA
E rdheim
F i
F atal
F ED
F atigue
F rameshift
G b
G DF
G ATE
G ugliel
H o
H es
H IN
H dA
H ETE
I Y
I AG
I ARC
J PF
K BP
L ig
L ife
L SA
L SS
L ower
L andmark
L EDGF
M W
M po
M HR
M ice
M ID
M ats
M egakaryocytic
N DP
N IH
O v
O verex
O MA
O BF
O Me
O PTN
P ap
P ast
P rem
P eric
P LAP
P ui
Q N
R educ
R OM
R alphabeta
S an
S ST
S MF
S plenomegaly
S MDs
T an
T ech
T RD
T LI
T SH
T TC
T oxic
U PC
U RF
U rd
U nit
U rinary
V y
V cr
V oD
V eliparib
V CMs
W ide
W CC
W IL
W CP
W GA
X q
X PD
Y in
Z r
a SCT
a HCT
b ard
b HLH
b ivudine
c ry
c Abl
c ian
c CCyR
c igarette
c itic
c ulturing
c ithin
d ise
d ental
d eregulated
d odec
d istributed
e rol
e omycin
f amilies
g rafts
g anciclovir
g arian
h at
h yt
h ERG
h MYADM
h yaluron
i oses
i olytic
i otomy
j ise
k A
k off
l id
l inical
l antic
l omustine
m others
n ever
n ormally
n ausea
n early
o ul
p I
p ath
p tid
p DFS
p CCR
p otency
p HLIP
q i
r udes
s j
s yl
s emi
s anctu
s ufficient
t MNs
t rad
t win
u iting
v N
v orum
w id
w omen
w elling
x CD
x enografts
y xin
y rophilin
y cetes
z ar
} -
Ġ \
Ġ ura
Ġa CD
Ġa pha
in j
in vasively
Ġt ic
Ġt ens
Ġt APL
Ġt DRs
re ation
re ce
re com
re anine
re plating
on ally
on ial
he art
en ior
en ium
en asidenib
en olide
Ġc and
Ġc age
Ġc opro
Ġc asp
Ġc MPO
Ġc Met
Ġc ecal
Ġc PLA
Ġc KS
Ġc imetidine
Ġo re
Ġo ros
Ġo xime
te fosine
te aroyl
Ġp c
Ġp end
Ġp ad
Ġp ET
Ġp Akt
Ġp RCC
Ġp ayer
Ġp DLT
Ġp TLOL
Ġp VAX
Ġp kat
Ġin k
Ġin ward
Ġs ay
Ġs ild
Ġs yros
Ġs RNAs
Ġs HGF
Ġs udan
Ġs TLS
Ġs EVs
Ġs ncRNAs
Ġm ission
Ġm po
Ġm BM
Ġm MRD
Ġm ES
Ġan tero
Ġan gin
Ġw edge
al most
is q
is ian
is land
is omiRs
or tem
or ally
ati f
ati gable
ro bacter
ro fulven
as ynchronous
it ain
it otri
Ġd ide
Ġd ating
Ġd UCBT
Ġd cm
Ġd uty
ed ec
ed ged
er ator
Ġre iter
Ġre interpre
Ġre analy
Ġre defining
Ġre silencing
Ġre tested
Ġre analyzed
Ġre rio
Ġf MDSCs
Ġf adraciclib
at ally
at rin
at ologia
Ġb inase
Ġb risk
ing ent
ing opine
Ġto wn
os ulf
os opathy
os clerotic
os oxidans
om imetic
ul ent
ul se
ul ites
Ġh us
Ġh Hb
Ġh Zip
ra b
Ġn Eryt
Ġn edd
ĠA ph
ĠA CP
ĠA DNR
ĠA SCC
ĠA OM
ĠA EBP
ĠA monafide
ĠA RRY
ĠT u
ĠT ay
ĠT ric
ĠT IT
ĠT CI
ĠT XL
ĠT GS
ĠT OI
ĠT iazofurin
ĠT ERS
ĠT akotsubo
ĠT HTR
us sed
us ination
us pid
im planted
im mobilized
res hw
res olving
ur b
ur ified
Ġpati et
Ġle ts
Ġle cithin
Ġpro thym
Ġpro apoptosis
lo p
ot ension
ot axine
un ch
un ique
un Ch
ĠC b
ĠC cl
ĠC yn
ĠC ry
ĠC ause
ĠC Cs
ĠC UT
ĠC nt
ĠC ancerous
ĠC VA
ĠC MPS
ĠC esarean
ĠC ortex
ĠC LFLC
ig ma
ut z
ut reanine
et ts
et ogenic
Ġac yltransferase
ter dam
ere rs
Ġfor got
if lavine
ac ements
ac aa
Ġex iting
Ġas cribable
Ġis avuconazole
ant oin
Ġmyelo genesis
Ġmyelo proliferations
Ġl am
Ġl and
Ġl amellar
Ġwas hes
uc ellosis
op ted
op ened
ib er
ib ric
ĠI Q
ĠI i
ĠI SC
ĠI SS
ĠI OP
ĠI ARC
ĠI vermectin
ĠI RDs
ĠI ressa
ĠI GROV
um ox
Ġ1 110
ĠM and
ĠM HR
ĠM tase
ĠM emory
ĠM XR
ĠM NKL
ĠM ODY
oc ell
oc iaz
oc idin
Ġbe at
ol ing
ol ates
ol oration
Ġde pressing
Ġde generated
iv il
Ġim ide
Ġim ip
Ġim atn
ity dine
pl aced
pl anchnic
rom o
rom urin
Ġg ates
Ġg alan
ab ep
up rofen
Ġdis able
Ġdis inf
Ġtre p
od ynamically
Ġv CD
Ġv Ph
Ġv icinal
Ġv ailable
Ġv Wf
ĠH ome
ĠH GC
ĠH CFC
ĠH nr
yt rans
gn o
ĠP b
ĠP s
ĠP ron
ĠP aus
ĠP li
ĠP rem
ĠP NT
ĠP SCC
ĠP HG
ĠP AGE
ĠP loidy
ĠP XR
ĠP ericardial
ĠP WS
ĠP EMMT
ĠP indel
ĠP azopanib
red ited
Ġtrans hepatic
Ġtrans activates
Ġcl amp
st hol
st arting
st ressed
ĠB an
ĠB ap
ĠB ox
ĠB ench
ĠB enzyl
ĠB rentuximab
ĠB afA
Ġr G
Ġr id
Ġr RQ
Ġr GBM
Ġr Gel
Ġr pL
Ġ2 119
am d
ge ometric
ap k
ap yrase
ri olar
ist ochemical
ĠD MT
ĠD ck
ĠD DCs
ĠD IPSS
ĠD GC
ĠD CIS
ĠD ZR
ĠD ilution
ĠD inaciclib
ĠD ako
Ġun reas
Ġun transfected
Ġun formulated
ĠIn strum
ĠIn termittent
Ġstud ents
ĠF o
ĠF ors
ĠF DR
ĠF IV
ĠF CE
ĠF rail
ĠF orest
ĠF rat
ĠF ALS
ĠF emales
ĠS in
ĠS ine
ĠS oc
ĠS NF
ĠS pir
ĠS LR
ĠS SD
ĠS NAs
ĠS udden
ĠS afe
ĠS ickle
ĠS ketch
ĠS enior
Ġcyt omic
Ġcyt ophagocytosis
Ġcyt opathological
ĠW I
ĠW BM
ĠW RO
ph ine
th ly
der ia
enti eth
Ġk bp
Ġk hat
pro tin
Ġmo esin
Ġap ocrine
AML patients
Ġmut ating
Ġmut ans
NA DCs
Ġwe e
Ġwe bin
othe ranos
00 24
00 40
00 0005
vel ing
Ġ3 33
Ġ3 999
Ġco infection
Ġco amplification
ther mia
Ġanti d
Ġanti acute
Ġanti tub
Ġanti moesin
eren tial
ĠR m
ĠR ate
ĠR ome
ĠR oss
ĠR etic
ĠR MI
ĠR FP
ĠR YR
ĠR auscher
act yl
ĠN Q
ĠN GFR
ĠN ij
ĠN itrogen
ĠN CNC
ĠN ationwide
Ġ5 38
Ġ5 98
Ġ5 48
Ġab ate
Ġab ated
Ġab elson
ost atis
di rection
tem ortem
Ġchem otypes
ren yl
SC NT
ĠO ra
ĠO CN
ĠO sthol
Ġinv ites
Ġhem ophil
Ġimmun es
Ġimmun isation
Ġimmun olabeling
ĠG d
ĠG i
ĠG HI
ĠG RN
ĠG NG
ĠG arcin
ĠG KAP
Ġpre empt
Ġactiv atory
Ġrec irc
Ġrec onc
rac tility
Ġsub compartment
Ġsub proteome
ĠE PA
ĠE DR
ĠE bers
ĠE AR
ĠE CH
ĠE MF
ĠE ya
ĠE asy
ĠE DNRB
CR E
Ġout grow
bin obin
bin omial
Ġ0 45
Ġinf ra
Ġinf ormal
Ġinduc tively
ĠTh orac
ĠL X
ĠL CR
ĠL ive
ĠL ET
ĠL CC
ĠL MSCs
ĠL GG
ĠL SI
ĠL ARG
DS RT
ip ine
Ġover used
ros so
ros atellites
yn yl
Ġph legmon
end oplasmic
ype ptid
ad ded
ad ders
Ġtumor genesis
term ind
opo enia
Ġ6 13
Ġ6 12
Ġ6 90
Ġ6 98
Ġ6 91
Ġcyto kinin
ast y
ast ain
Ġresist ing
form ulations
Ġexp els
oth yroidism
Ġsup pres
Ġpar anuclear
Ġcombin ator
Ġ7 01
Ġ7 18
Ġ7 36
Ġ7 64
Ġdec entral
Ġbi opro
Ġnon standard
Ġnon metastatic
Ġnon anthracycline
Ġnon intercalating
Ġnon sialylated
ple ment
%) (
tim ulating
ail l
Ġ9 01
Ġ9 10
Ġ9 04
Ġ9 72
ag l
ag r
ag omycin
Ġ8 56
ite can
irst en
cri tical
Ġleukemic s
Ġel bow
ased ependent
ĠK N
ĠK eratin
ĠU R
ĠU HPLC
mon otonic
ric ans
yc el
yc ur
yc ytosine
Ġfe e
11 59
our ces
Ġra mp
Ġfactor ies
ens ory
MT F
MT mx
01 53
01 015
01 3821
Ġhyp other
og rafts
av id
Ġtrial ed
Ġmulti factor
Ġdisc oloration
Ġup modulated
ĠAl beit
ĠAl kb
ber ing
ass emble
plic ating
Ġnum atrin
fer tility
Ġimp utation
Ġimp inge
21 21
Ġqu a
LA N
LA MPs
cess ing
ath ymic
ten bach
IT RA
IT MO
tho od
Ġantib i
ĠJ oint
Ġstrateg ically
15 50
ne onatal
10 25
10 46
veal ing
Ġpop ulated
ĠV as
ĠV ivo
ĠV LI
ĠV ersican
ĠV ancouver
(+) )-
Ġ12 69
Ġsh CRIP
13 76
13 010
16 88
ĠMD DC
Ġref rame
Ġref using
AT LL
AT PR
po id
Ġ19 58
Ġ19 59
Ġpos tero
Ġmin erals
Ġphen ol
Ġphen othiaz
Ġhist ogenesis
Ġhist otypes
ex posing
Ġ+ +
Ġ+ /+
AC LA
AC NU
Ġkary orr
olid in
Ġperipheral ization
Ġprof it
22 56
22 41
Ġem itting
Ġpost marketing
ĠTo bacco
int uitive
Ġimpact ful
19 20
19 36
19 57
GF MS
oph ot
Ġtes ticles
Ġsingle ton
sequ enced
PL WH
Ġ20 56
ax in
Ġend ued
Ġend odon
Ġ15 50
yd ig
prolifer ate
Ġpolym icrobial
ep icatechin
OS TIM
ET D
Ġdown regulator
Ġprop elled
Ġprop ionyl
ger in
Ġonc ogen
Ġonc arb
Ġonc ostatic
Ġonc ostatin
Ġonc opterin
Ġonc omiR
af ix
establ ishes
ĠDN F
20 78
ace us
38 96
Ġ14 85
Ġtotal is
EB M
EB RT
ĠAn aemia
Ġ13 66
Ġ17 00
atin ous
Ġregion ally
val es
val proic
ĠAB P
MD L
Ġ30 82
enia ble
AL B
AL CAM
AL WP
Ġtr ifluor
Ġ50 6
Ġ18 97
Ġ18 83
Ġ18 59
ĠBM ME
cr kl
Ġso bering
Ġfam ous
ophen ol
Ġ16 20
Ġradi um
05 07
Ġvia bly
ĠCh ile
ĠCh loride
ĠCh Ip
ĠWT p
Ġbiom olecules
arc illin
ĠAd s
Ġsaf est
iod on
iod ine
iod ide
ĠHL E
ĠHL DA
ĠHL PDs
Ġfocus sed
CC GG
ĠRec over
Ġcytok inetics
18 31
18 46
18 008
rem itting
osup pressed
ĠSt om
ust at
Ġpharmac otherapeutic
BM AL
IS D
RT VP
Ġrepresent ational
ĠAm lodipine
asc iminib
IL M
the ophylline
Ġ25 83
ĠCN KI
ink inase
gra vir
rid one
rid ging
cal cein
27 50
27 138
Ġweek ends
Ġeng ages
mic romolar
ĠUn ilateral
Ġu VIN
Ġaz iridine
Ġins ure
ĠFor um
ĠST BC
Ġcur tail
Ġcur cum
Ġalpha GC
45 47
Ġtoxic s
con ceptions
NK RLs
ĠCT O
ĠCT PS
Ġarsenic s
SP F
ect ants
ĠX vivo
ĠX imel
Ġlip opoly
Ġlip osomally
02 952
ulin a
